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RESUMEN 
En la actualidad, la industria alimentaria está apostando por la incorporación de sustancias 
naturales a envases alimentarios con el fin de incrementar la perdurabilidad del alimento en el 
mercado. Debido al empleo de estas sustancias en esta nueva aplicación, la seguridad de los 
consumidores y del medio ambiente puede verse comprometida debido a una mayor 
exposición, desconociéndose en gran medida, hasta el momento, las posibles consecuencias. 
De entre las sustancias naturales seleccionadas por la industria alimentaria para este fin, 
destacan las arcillas y minerales de arcillas, y los aceites esenciales y sus respectivos 
componentes mayoritarios, constituyendo las primeras (arcillas) el principal objeto de estudio 
de la presente Tesis Doctoral. Por todo ello, decidimos realizar una evaluación toxicológica 
mediante una batería de ensayos tanto in vitro como in vivo, para investigar los posibles 
efectos tóxicos que pueden desencadenarse tras la exposición a estas sustancias, tanto puras 
como ya incorporadas en el envase. La relevancia de la información toxicológica de estas 
sustancias es tal que constituye un requisito reglamentario por parte de las autoridades 
competentes antes de su comercialización.  
En el caso de las arcillas y minerales de arcilla, se ha demostrado una mejora de las 
propiedades mecánicas, térmicas y barrera de las matrices poliméricas debido a su 
incorporación, lo que está, íntimamente relacionado con el incremento de la vida útil de los 
alimentos. Con el fin de contextualizar la situación ante la que se encontraban las arcillas y 
sus derivados en el área del envasado de la industria alimentaria y así abordar posteriores 
estudios, nos pareció importante realizar una exhaustiva revisión bibliográfica sobre los datos 
de toxicidad publicados en la literatura científica hasta la actualidad. La disparidad de los 
resultados disponibles hasta el momento hace necesaria una evaluación toxicológica caso por 
caso. Diferentes parámetros pueden estar involucrados en la respuesta obtenida, incluyendo: 
(i) condiciones de exposición tales como concentraciones seleccionadas o tiempos ensayados; 
(ii) modelos experimentales elegidos; (iii) modificadores o surfactantes incorporados a la 
estructura de la arcilla, (iv) sensibilidad de los ensayos llevados a cabo, etc. Dicha revisión 
bibliográfica ha dado lugar a la siguiente publicación:  
 TOXICOLOGICAL EVALUATION OF CLAY MINERALS AND DERIVED 
NANOCOMPOSITES: A REVIEW. (Maisanaba y col., 2015; Environmental 
Research 138, 233-254). 
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La vía de exposición más importante en el contexto que nos engloba es la vía oral, dado 
que las arcillas van a ser incorporadas a un envase que posteriormente se va a poner en 
contacto con un alimento, y éste último será ingerido por los consumidores. En este caso los 
órganos que principalmente se podrían ver afectados serán los que componen el sistema 
digestivo, destacando entre ellos el intestino, encargado de la absorción de nutrientes, y el 
hígado, crucial en la biotransformación de xenobióticos. Se llevó a cabo una batería de 
ensayos de los materiales objeto de estudio con el fin de esclarecer sus principales efectos 
tóxicos, teniendo en cuenta la escasez y disparidad de los datos disponibles. Las líneas 
celulares seleccionadas fueron una línea celular de hepatoma humano (HepG2) y una línea 
celular de adenocarcinoma de colon (Caco-2). Éstas fueron expuestas a diversas arcillas no 
modificadas y modificadas con sales de amonio cuaternario, tanto comercializadas 
(Cloisite®Na
+
 (CNa
+
), Cloisite®20A (C20A) y Cloisite®30B (C30B)) o desarrolladas por el 
Instituto Tecnológico de Embalaje, Transporte, y Logística (ITENE) de Valencia (Clay1 y 
Clay2). Los experimentos llevados a cabo incluyeron la evaluación de: citotoxicidad basal, 
análisis de la morfología celular, genotoxicidad (ensayo cometa y ensayo de micronúcleos 
(MN)) y estrés oxidativo (producción de especies reactivas de oxígeno (ERO) y contenido de 
glutatión (GSH)). De forma general se obtuvo ausencia de toxicidad en el caso de las arcillas 
CNa
+
, C20A y Clay1, y sólo en el caso de la primera arcilla mencionada se obtuvo una 
inducción de MN significativa y alguna alteración de la morfología celular. Sin embargo, 
pudimos observar daño en ambas líneas celulares tras la exposición a C30B y Clay2 en la 
mayoría de los parámetros evaluados. Además, se ha llevado a cabo por primera vez en la 
línea celular HepG2 el estudio de la influencia de las arcillas en la modulación de la expresión 
génica de un extenso grupo de genes involucrados en activación/destoxicación y otros 
mecanismos de acción tóxica. CNa
+
 y Clay2 sí demostraron alterar la regulación de distintos 
genes, no así C30B y Clay1. Los resultados de estos experimentos han dado lugar a las 
siguientes publicaciones: 
 IN VITRO TOXICOLOGICAL ASSESSMENT OF CLAYS FOR THEIR USE IN 
FOOD PACKAGING APPLICATIONS. (Maisanaba y col., 2013, Food and 
Chemical Toxicology 37, 266-275). 
 GENETIC POTENTIAL OF MONTMORILLONITE CLAY MINERAL AND 
ALTERATION IN THE EXPRESSION OF GENES INVOLVED IN TOXICITY 
MECHANISMS IN THE HUMAN HEPATOMA CELL LINE HEPG2. (Maisanaba 
y col., 2015; Journal of Hazardous Materials (en revision/ under revision)). 
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 INDUCTION OF MICRONUCLEI AND ALTERATION OF GENE EXPRESSION 
BY AN ORGANOMODIFIED CLAY IN HEPG2 CELLS. (Maisanaba y col., 2015; 
Archives of Toxicology (en revisión/ under revision)). 
 EFFECTS OF TWO ORGANOMODIFIED CLAYS INTENDED TO FOOD 
CONTACT MATERIALS ON THE GENOMIC INSTABILITY AND GENE 
EXPRESSION OF HEPATOMA CELLS. (Maisanaba y col., 2015); Toxicology 
Letters (en revision/ under revision). 
 TOXIC EFFECTS OF A MODIFIED MONTMORILLONITE CLAY ON THE 
HUMAN INTESTINAL CELL LINE CACO-2. (Maisanaba y col., 2014; Journal of 
Applied Toxicology 34, 714-725). 
 TOXICITY ASSESSMENT OF ORGANOMODIFIED CLAYS USED IN FOOD 
CONTACT MATERIALS ON HUMAN TARGET CELL LINES. (Houtman y col., 
2014; Applied Clay Science 90, 150-158). 
 
Aunque los órganos y tejidos del sistema digestivo serían probablemente los más 
afectados por exposición a las arcillas, hay otras dianas que también podrían verse dañadas, 
destacando el tejido endotelial vascular, involucrado en la distribución y absorción. Hasta el 
momento los datos disponibles acerca de los efectos de este modelo experimental expuesto a 
arcillas son limitados. Por ello, se ha llevado a cabo la evaluación de la viabilidad de la línea 
celular endotelial de vena umbilical humana (HUVEC) expuestas a CNa
+
, C30B, Clay1 y 
Clay2. Los resultados obtenidos indicaron que las células HUVEC seguían un patrón de 
respuesta muy similar al de HepG2 y Caco-2 ante la exposición a las arcillas, presentando una 
sensibilidad parecida a la línea celular hepática. Además, el estudio del potencial mutagénico 
mediante el Test de Ames es una prueba exigida antes de la comercialización de cualquier 
producto que vaya a entrar en contacto con alimentos (EFSA 2011b, 2015), siendo en este 
caso necesaria la evaluación de las arcillas que estén destinadas a ser incorporadas al 
envasado alimentario. El modelo experimental seleccionado fue Salmonella typhimurium (5 
cepas), el cual se expuso a las cuatro arcillas mencionadas, en ausencia y presencia de 
fracción metabólica externa. Únicamente pudimos observar una respuesta mutagénica positiva 
en el caso de C30B y Clay1. Los resultados obtenidos se reflejan en la siguiente publicación: 
 CYTOTOXICITY AND MUTAGENICITY ASSESSMENT OF 
ORGANOMODIFIED CLAYS POTENTIALLY USED IN FOOD PACKAGING. 
(Maisanaba y col., 2015; Toxicology In Vitro 29, 1222-1230). 
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La Autoridad Europea de Seguridad Alimentaria (EFSA) no sólo propone la evaluación de 
los materiales que se incorporan a las matrices poliméricas de envasado, sino también, siendo 
incluso de mayor importancia, la evaluación de los envases resultantes (EFSA, 2011a,b). En 
este sentido, ITENE desarrolló dos materiales nanocompuestos basados en ácido poli(láctico) 
(PLA) y Clay1/Clay2, ambas arcillas diseñadas por ellos. Con estos materiales se llevaron a 
cabo ensayos de migración, utilizando como simulante alimentario agua destilada, aceptado 
por el Reglamento UE Nº 10/2011 dado el tipo de alimentos hacia los que van dirigidos los 
mismos (hidrófilos). 
Una vez obtenidos los extractos de migración de PLA-Clay1 y PLA-Clay2, se evaluaron 
distintos parámetros con el fin de determinar los posibles efectos tóxicos debido a la 
migración de las arcillas tras la exposición a los mismos. En este sentido, se evaluó la 
viabilidad celular de HepG2 y Caco-2 expuestas a ambos extractos, así como el potencial 
mutagénico de los mismos mediante el Test de Ames. En los ensayos llevados a cabo se 
observó la ausencia de citotoxicidad y mutagenicidad en las condiciones ensayadas. Por otro 
lado, teniendo en cuenta que la presencia de los metales mayoritarios de la estructura de las 
arcillas son Al, Ca, Fe, Mg y Si, se evaluó el contenido de los mismos en los extractos de 
migración mediante Espectrometría de Masas con Plasma Acoplado Inductivamente (ICP-
MS) y Espectroscopía de Plasma Inductivo acoplado a Espectroscopía de Emisión Óptica 
(ICP-OES), no obteniéndose diferencias significativas con respecto al grupo control. Estos 
resultados se recogen en la siguiente publicación: 
 
 CYTOTOXICITY AND MUTAGENICITY STUDIES ON MIGRATION 
EXTRACTS FROM NANOCOMPOSITES WITH POTENTIAL USE IN FOOD 
PACKAGING. (Maisanaba y col., 2014 Food and Chemical Toxicology 66, 366-372). 
 
Una vez realizado el estudio toxicológico in vitro de las arcillas y considerando las 
mejoras tecnológicas presentadas por los polímeros nanocompuestos resultantes, se 
seleccionó la arcilla de mejor perfil toxicológico y tecnológico, siendo en este caso Clay1 la 
seleccionada para continuar la investigación. Con el fin de completar los resultados obtenidos 
in vitro y dada la escasez de información in vivo, se realizó un ensayo de toxicidad subcrónica 
durante 90 días en ratas Wistar expuestas a Clay1 (40 mg/kg/día) en la dieta y su extracto de 
migración (PLA-Clay1) como agua de bebida (ad libitum). En este sentido, transcurrido el 
periodo de exposición, los animales fueron sacrificados y se extrajeron sus órganos (hígado, 
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riñón, intestino, cerebro, corazón, testículos, pulmones y bazo) y sangre mediante punción 
cardiaca. Se evaluaron una serie de parámetros, incluyendo: análisis histopatológico de todos 
los tejidos, bioquímica clínica del suero sanguíneo, liberación de interleucina 6 (IL-6), 
biomarcadores involucrados en la respuesta del posible estrés oxidativo generado en hígado y 
riñón, tales como la ratio glutatión reducido/glutatión oxidado (GSH/GSSG), peroxidación 
lipídica (LPO), y actividades de enzimas  antioxidantes (superóxido dismutasa (SOD), 
catalasa (CAT), glutatión peroxidasa (GPx) y glutatión–S-transferasa (GST). Además, la 
expresión génica y abundancia proteica de SOD y CAT en hígado y riñón también fueron 
evaluadas. Podemos destacar un aumento de la actividad de CAT en riñón, así como de 
expresión génica y abundancia proteica, observado tras la exposición a Clay1. El resto de los 
marcadores evaluados tras la exposición a la arcilla o al extracto no se vieron afectados.  
Por otro lado, nos pareció interesante evaluar el contenido de los metales característicos 
de la composición de la arcilla en bazo de ratas expuestas a la arcilla y el extracto, no hallando 
diferencias notables con respecto a las ratas controles.  
Los resultados obtenidos en estos experimentos han dado lugar a las siguientes 
publicaciones: 
 EFFECTS OF THE SUBCHRONIC EXPOSURE TO AN ORGANOMODIFIED 
CLAY MINERAL FOR FOOD PACKAGING APPLICATIONS ON WISTAR 
RATS. (Maisanaba y col., 2014; Applied Clay Science 95, 37-40). 
 IN VIVO EVALUATION OF ACTIVITIES AND EXPRESSION OF 
ANTIOXIDANT ENZYMES IN WISTAR RATS EXPOSED FOR 90 DAYS TO A 
MODIFIED CLAY. (Maisanaba y col., 2014; Journal of Toxicology and 
Environmental Health, Part A: Current Issues 77,456-466). 
 IN VIVO TOXICITY EVALUATION OF THE MIGRATION EXTRACT OF AN 
ORGANOMODIFIED CLAY-POLY(LACTIC) ACID NANOCOMPOSITE. 
(Maisanaba y col., 2014; Journal of Toxicology and Environmental Health, Part A: 
Current Issues 77,731-446). 
 EVALUACIÓN DE LA SEGURIDAD DE UNA ARCILLA MODIFICADA Y SU 
EXTRACTO DE MIGRACIÓN EN BAZO DE RATAS WISTAR EXPUESTAS DE 
FORMA SUBCRÓNICA. (Maisanaba y col., 2013 Revista de Toxicología 30, 125-
130). 
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Para la realización de esta Tesis Doctoral, la doctoranda realizó una estancia de 
investigación en ITENE, bajo la dirección de las Dras. Susana Aucejo y María Jordá, en la 
que se abordaron varios objetivos. 
Durante la estancia, se llevó a cabo el desarrollo de nuevas arcillas basadas en CNa
+
 
modificadas con silanos, Clay3, Clay4A y Clay4B, destinadas al envasado. La caracterización 
de las mismas se realizó por espectroscopía de infrarrojos (FTIR), difracción de rayos X y 
termogravimetría (TGA). Los resultados preliminares mostraron una buena incorporación de 
los modificadores y mejoraron el perfil tecnológico de la arcilla original no modificada.  
Posteriormente, se evaluó la toxicidad de las tres arcillas sintetizadas. Los biomarcadores 
estudiados incluyeron citotoxidad basal, genotoxicidad (mediante el ensayo cometa) y estrés 
oxidativo (producción de ERO y contenido de GSH) en las líneas HepG2 y Caco-2. Por otro 
lado, también se determinó mediante citometría de flujo el posible mecanismo de muerte 
celular de células Caco-2 expuestas a Clay4A y Clay4B. Además, se evaluó el potencial 
mutagénico de las arcillas mediante el Test de Ames. De forma general, los resultados 
preliminares dieron lugar a una ausencia de efectos tóxicos por parte de Clay3, sin embargo, 
tanto Clay4A y Clay4B mostraron toxicidad en la mayoría de los parámetros ensayados. Dado 
que Clay3 fue la arcilla con mejor perfil tecnológico y toxicológico ésta fue seleccionada para 
realizar ensayos de vida útil, observándose un incremento de aproximadamente 24h en 
comparación con el control. 
Por otro lado, se valoró la migración de metales (Al, Ca, Fe, Mg y Fe) en dos simulantes 
diferentes, etanol al 10% e isooctano, procedentes de materiales nanocompuestos de 
polipropileno (PP) más Clay3 o PP-Clay4A. En todos los casos se obtuvieron diferencias con 
el control en alguno de los metales determinados. 
Los resultados obtenidos en estos experimentos darán lugar a diferentes publicaciones, 
aún pendientes de envío: 
 DEVELOPMENT, CHARACTERIZATION AND CYTOTOXICITY OF NOVEL 
SILANES MODIFIED CLAYS INTENDED TO PACKAGING (Título provisional). 
 TOXICITY EVALUATION OF A NEW SILANE-MODIFIED CLAY AND ITS 
MIGRATION EXTRACT FROM A NANOCOMPOSITE INTENDED TO FOOD 
PACKAGING (Título provisional). 
Resumen / Summary 
7 
 
 TOXICOLOGICAL ASSESSMENT OF TWO SILANE-MODIFIED CLAYS IN 
HUMAN HEPATOMA CELLS AND SALMONELLA TYPHIMURIUM STRAINS 
(Título provisional). 
 CYTOTOXICITY, OXIDATIVE STRESS AND GENOTOXICITY ASSAYS OF 
SILANES-MODIFIED CLAYS IN THE HUMAN INTESTINAL CELL LINE 
CACO-2 (Título provisional). 
 
En relación a los aceites esenciales y sus componentes mayoritarios, también éstos están 
teniendo un gran auge en la industria alimentaria, empleándose en un nuevo tipo de envasado 
conocido como envasado activo. En este sentido, en vez de dar lugar a mejoras tecnológicas 
en sí como en el caso de las arcillas, lo que se aprovecha de estos aceites y sus componentes 
es su potencial antioxidante y antimicrobiano natural. Sin embargo, debe ser establecido un 
rango de concentraciones seguro para evitar los posibles efectos contraproducentes que 
puedan desencadenarse por un abuso de los mismos. En primer lugar, vimos necesario 
realizar una contextualización del uso actual de este tipo de envasado y las propiedades 
antimicrobianas y antioxidantes que presentan, así como una revisión de los principales 
efectos citotóxicos en diferentes líneas celulares de origen humano. Dicha revisión ha dado 
lugar a la presente publicación: 
 NEW ADVANCES IN ACTIVE PACKAGING INCORPORATED WITH 
ESSENTIAL OILS OR THEIR MAIN COMPONENTS FOR FOOD 
PRESERVATION. (Maisanaba y col., 2015. Food Reviews International (en revisión, 
under revision). 
 
Por último, la evaluación de los componentes mayoritarios de los aceites esenciales antes 
de ser incorporados a los envases es también obligatoria, tal y como establece la EFSA 
(EFSA, 2011b). En este sentido, el aceite esencial de orégano es uno de los más utilizados por 
sus destacadas propiedades antimicrobianas, siendo timol y carvacrol sus dos componentes 
mayoritarios. Existen en la bibliografía resultados sobre sus perfiles genotóxicos obtenidos 
por otros autores (Azizan y Blevins, 1995; Stammati y col., 1999; Ipek y col., 2005; 
Buyukleyla y Recuzogullari, 2009; Llana-Ruíz-Cabello y col., 2014). Estos resultados son 
dispares en algunos aspectos, siendo necesaria una evaluación de su toxicidad más amplia con 
el fin de esclarecer el perfil genotóxico de estos dos compuestos mayoritarios. Por 
consiguiente nos pareció interesante llevar a cabo el ensayo de MN, y, por primera vez, el 
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ensayo de Linfoma de Ratón. Los resultados obtenidos no mostraron una relevancia biológica 
notable para ninguno de los compuestos bajo las condiciones ensayadas. Dichos resultados se 
reflejan en la siguiente publicación: 
 
 IN VITRO GENOTOXICITY TESTING OF CARVACROL AND THYMOL USING 
THE MICRONUCLEUS AND MOUSE LYMPHOMA ASSAYS. (Maisanaba y col., 
2015; Mutation Research 784-785, 37-44). 
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SUMMARY 
 
Currently, the food industry is betting on the incorporation of natural substances to 
food packaging in order to increase the perdurability of food products in the market. Due to 
the use of these substances in this new application, the safety of consumers and the 
environment may be compromised due to an increased exposure, with unknown 
consequences. Among the natural substances selected by the food industry for this aim, clays 
and clay minerals are included, as well as essential oils and their major components, being the 
first ones (clays) the main topic of study of this Doctoral Thesis. Therefore, we decided to 
carry out a toxicological assessment, both in vitro and in vivo, using a battery of toxicological 
tests, in order to investigate the possible toxic effects that can arise after the exposure to these 
substances, either pure or already incorporated into the package. The toxicological 
information of these substances constitutes a regulatory requirement of the competent 
authorities before their commercialization. 
 
In the case of clays and clay minerals, their incorporation have been shown to improve 
the mechanical, thermal and barrier properties of the polymer matrix, which are intimately 
related to the increase of the shelf-life of food. In order to contextualize the state of the art of 
the clays and their derivatives in the food packaging industry, as start-point to address further 
studies, it is important to carry out a comprehensive review of the toxicity data published in 
the scientific literature up to now. Taking into account the disparity of available results, a case 
by case toxicological evaluation is required. Different parameters may be involved in the 
response observed, including: (i) exposure conditions such as selected concentrations and 
times of exposure tested; (ii) selected experimental models; (iii) modifiers or surfactants 
incorporated into the clay structure, (iv) sensitivity of the assays performed, etc. This review 
has led to the following publication: 
 
 TOXICOLOGICAL EVALUATION OF CLAY MINERALS AND DERIVED 
NANOCOMPOSITES: A REVIEW. (Maisanaba y col., 2015; Environmental 
Research 138, 233-254). 
 
The most important route of exposure in the context of the present work is the oral route, 
since clays will be incorporated into a package which is going to be in contact with food, that 
will be further ingested by consumers. In this case, the most affected organs could be those of 
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the digestive system, such as the intestine, responsible for nutrients absorption, and liver, 
crucial in the xenobiotics biotransformation. A set of tests with the materials under study was 
performed in order to clarify their major toxic effects, as the available data are scarce and 
contradictory. The selected cell lines were a human hepatoma cell line (HepG2) and a colon 
adenocarcinoma cell line (Caco-2). They were exposed to several unmodified and quaternary 
ammonium salts-modified clays, both commercialized (Cloisite®Na
+
 (CNa
+
), Cloisite®20A 
(C20A) and Cloisite®30B (C30B)) or to clays developed by the Technological Institute of 
Packaging, Transport and Logistics (ITENE) Valencia (Clay1 and Clay2). The experiments 
performed were: basal cytotoxicity, cell morphology analysis, genotoxicity assays (comet 
assay and micronuclei (MN)) and oxidative stress (production of reactive oxygen species 
(ROS) and glutathione content (GSH)). In general, no toxicity was obtained in the case of 
CNa
+
, C20A and Clay1, and only in the case of the first one, a significant induction of MN 
and some alteration of cell morphology were obtained. However, important toxic effects were 
observed in both cell lines after exposure to C30B and Clay2 in most of the parameters 
evaluated. Furthermore, it has been carried out by the first time in the HepG2 cell line the 
study of the influence of clays in the modulation of the gene expression of a large group of 
genes involved in activation/detoxification and other toxicity mechanisms. CNa
+
 and Clay2 
showed deregulation in different genes, but C30B and Clay1 did not. The results of these 
experiments have led to the following publications: 
 
 IN VITRO TOXICOLOGICAL ASSESSMENT OF CLAYS FOR THEIR USE IN 
FOOD PACKAGING APPLICATIONS. (Maisanaba y col., 2013, Food and 
Chemical Toxicology 37, 266-275). 
 GENETIC POTENTIAL OF MONTMORILLONITE CLAY MINERAL AND 
ALTERATION IN THE EXPRESSION OF GENES INVOLVED IN TOXICITY 
MECHANISMS IN THE HUMAN HEPATOMA CELL LINE HEPG2. (Maisanaba 
y col., 2015; Journal of Hazardous Materials (en revision/ under revision)). 
 INDUCTION OF MICRONUCLEI AND ALTERATION OF GENE EXPRESSION 
BY AN ORGANOMODIFIED CLAY IN HEPG2 CELLS. (Maisanaba y col., 2015; 
Archives of Toxicology (en revisión/ under revision)). 
 EFFECTS OF TWO ORGANOMODIFIED CLAYS INTENDED TO FOOD 
CONTACT MATERIALS ON THE GENOMIC INSTABILITY AND GENE 
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EXPRESSION OF HEPATOMA CELLS. (Maisanaba y col., 2015); Toxicology 
Letters (en revision/ under revision). 
 TOXIC EFFECTS OF A MODIFIED MONTMORILLONITE CLAY ON THE 
HUMAN INTESTINAL CELL LINE CACO-2. (Maisanaba y col., 2014; Journal of 
Applied Toxicology 34, 714-725). 
 TOXICITY ASSESSMENT OF ORGANOMODIFIED CLAYS USED IN FOOD 
CONTACT MATERIALS ON HUMAN TARGET CELL LINES. (Houtman y col., 
2014; Applied Clay Science 90, 150-158). 
 
Furthermore, although the organs and tissues of the digestive system would probably be 
the most affected by the exposure to clays, other targets could also be damaged, highlighting 
the vascular endothelial tissue, involved in distribution and absorption. In this concern, data 
on the effects of this experimental model after exposure to clays are limited so far. Therefore, 
cell viability evaluation of human umbilical vein endothelial cells (HUVEC) exposed to 
CNa
+
, C30B, Clay1 and Clay2 was carried out. The results showed that HUVEC response 
followed a similar pattern than HepG2 and Caco-2 upon exposure to clays, with a sensitivity 
close to the hepatic cell line. In addition, the study of the mutagenic potential using the Ames 
test is required before marketing any product that come into contact with food (EFSA 2011b, 
2015), such as clays, which are intended to be used in food packaging. The experimental 
model selected was Salmonella typhimurium (5 strains), which were exposed to the four 
mentioned clays, in the absence and presence of external metabolic activation. We only 
observed a positive mutagenic response in the case of C30B and Clay1. The results obtained 
are compiled in the following publication: 
 
 CYTOTOXICITY AND MUTAGENICITY ASSESSMENT OF 
ORGANOMODIFIED CLAYS POTENTIALLY USED IN FOOD PACKAGING. 
(Maisanaba y col., 2015; Toxicology In Vitro 29, 1222-1230). 
 
The European Food Safety Authority (EFSA) proposes, not only the evaluation of 
materials that are incorporated into packaging polymer matrices, but also the evaluation of the 
resulting packages (EFSA, 2011a, b). Thus, ITENE developed two nanocomposites based on 
poly (lactic acid) (PLA) and Clay1, and PLA-Clay2, both modified clays designed by them. 
With these materials migration tests were carried out. The food stimulant used was distilled 
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water, accepted by the EU Regulation No. 10/2011, due to the type of food products these 
nanocomposites will be used for (hydrophilic food). 
Once the migration extracts of PLA-Clay1 and PLA-Clay2 were obtained, several 
parameters were evaluated in order to determine the potential toxic effects induced after their 
exposure. Cell viability of HepG2 and Caco-2 exposed to both extracts and the mutagenic 
potential by the Ames test were evaluated. The results shown an absence of cytotoxicity and 
mutagenicity under the conditions tested. Moreover, considering that the main metals present 
in clays structure are Al, Ca, Fe, Mg and Si, their contents in the migration extracts were 
analyzed by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and Inductively 
Coupled Plasma Optical Emission Spectroscopy (ICP-OES). No significant differences with 
respect to the control group were found. These results are summarized in the following 
publication: 
 
 CYTOTOXICITY AND MUTAGENICITY STUDIES ON MIGRATION 
EXTRACTS FROM NANOCOMPOSITES WITH POTENTIAL USE IN FOOD 
PACKAGING. (Maisanaba y col., 2014 Food and Chemical Toxicology 66, 366-372). 
 
Once the in vitro toxicology studies were conducted, the clay with the best technological 
properties and toxicological profile was selected for further experiments, Clay1. In order to 
complete the in vitro results and taking into account that in vivo data are scarce, a repeated 
dose 90-day oral toxicity study in Wistar rats exposed to Clay1 (40 mg/kg/day) with the diet 
and its migration extract (PLA-Clay1) as drinking water (ad libitum) was performed. In this 
sense, after the exposure period, the animals were sacrificed and their organs (liver, kidney, 
intestine, brain, heart, testicles, lungs and spleen) and blood by cardiac puncture were 
removed. Several parameters were evaluated, including: histopathological analysis, clinical 
biochemistry of blood serum, interleukin 6 (IL-6) leackage, biomarkers involved in oxidative 
stress response in liver and kidney, such as reduced/oxidized glutathione ratio (GSH/GSSG), 
lipid peroxidation (LPO), and activities of antioxidant enzymes (superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx) and glutathione S-Transferase (GST). 
Moreover, gene expression and protein abundance of SOD and CAT in liver and kidney were 
also evaluated. We can highlight an increase of CAT activity in kidney, as well as an 
alteration in gene expression and protein abundance after exposure to Clay1. All these 
biomarkers remained unaltered after the exposure to PLA-Clay1 migration extract. 
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In addition, it was interesting to evaluate the content of the typical metals presented in 
clays composition in the spleen of exposed rats. Significant differences were not observed 
compared to control rats. 
The results obtained in these experiments have led to the following publications: 
 
 EFFECTS OF THE SUBCHRONIC EXPOSURE TO AN ORGANOMODIFIED 
CLAY MINERAL FOR FOOD PACKAGING APPLICATIONS ON WISTAR 
RATS. (Maisanaba y col., 2014; Applied Clay Science 95, 37-40). 
 IN VIVO EVALUATION OF ACTIVITIES AND EXPRESSION OF 
ANTIOXIDANT ENZYMES IN WISTAR RATS EXPOSED FOR 90 DAYS TO A 
MODIFIED CLAY. (Maisanaba y col., 2014; Journal of Toxicology and 
Environmental Health, Part A: Current Issues 77,456-466). 
 IN VIVO TOXICITY EVALUATION OF THE MIGRATION EXTRACT OF AN 
ORGANOMODIFIED CLAY-POLY(LACTIC) ACID NANOCOMPOSITE. 
(Maisanaba y col., 2014; Journal of Toxicology and Environmental Health, Part A: 
Current Issues 77,731-446). 
 EVALUACIÓN DE LA SEGURIDAD DE UNA ARCILLA MODIFICADA Y SU 
EXTRACTO DE MIGRACIÓN EN BAZO DE RATAS WISTAR EXPUESTAS DE 
FORMA SUBCRÓNICA. (Maisanaba y col., 2013 Revista de Toxicología 30, 125-
130). 
 
For the fulfillment of this thesis, the PhD student performed an internship in ITENE, 
under the direction of Drs. Susana Aucejo and Maria Jordá, where different objectives were 
addressed. 
During the internship, new silanes-modified clays based in CNa
+
, Clay3, Clay4A and 
Clay4B, were developed intended to food packaging. The characterization of these clays was 
performed by infrared spectroscopy (FTIR), X-ray diffraction and thermogravimetric analysis 
(TGA). Preliminary results showed good incorporation of modifiers and improved 
technological profile in comparison to the raw clay. 
 
Subsequently, a toxicological evaluation of the three synthesized clays was performed. 
Biomarkers studied included basal cytotoxicity, genotoxicity (by the comet assay) and 
oxidative stress induction (production of ROS and GSH content) in HepG2 and Caco-2 cell 
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lines. Furthermore, the possible mechanism of cell death of Caco-2 cells exposed to Clay4A 
and Clay4B was studied by flow cytometry. In addition, the mutagenic potential of clays was 
evaluated by the Ames test. In general, the preliminary results led to an absence of toxic 
effects by Clay3; however, both Clay4A and Clay4B showed toxicity in almost all parameters 
tested. In this sense, Clay3 showed the best technological and toxicological profile. Therefore, 
it was selected for food shelf- life testing, giving an increase of approximately 24 hours 
compared with the control. 
Moreover, the migration of metals (Al, Ca, Fe, Mg and Fe) from nanocomposites of 
polypropylene (PP)-Clay3 or PP-Clay4A was evaluated. In all cases differences from controls 
in some of the specific metals studied were obtained. 
The results of these experiments will be included in different publications, pending to be 
send: 
 
 DEVELOPMENT, CHARACTERIZATION AND CYTOTOXICITY OF NOVEL 
SILANES MODIFIED CLAYS INTENDED TO PACKAGING (provisional title). 
 TOXICITY EVALUATION OF A NEW SILANE-MODIFIED CLAY AND ITS 
MIGRATION EXTRACT FROM A NANOCOMPOSITE INTENDED TO FOOD 
PACKAGING (provisional title). 
 TOXICOLOGICAL ASSESSMENT OF TWO SILANE-MODIFIED CLAYS IN 
HUMAN HEPATOMA CELLS AND SALMONELLA TYPHIMURIUM STRAINS 
(provisional title). 
 CYTOTOXICITY, OXIDATIVE STRESS AND GENOTOXICITY ASSAYS OF 
SILANES-MODIFIED CLAYS IN THE HUMAN INTESTINAL CELL LINE 
CACO-2 (provisional title). 
 
Regarding to the essential oils and their main components, they are also having a boom in 
the food industry, being used in a new type of packaging known as active packaging. In this 
case, the technological improvements are due to the antioxidant and antimicrobial natural 
properties presented by this kind of substances. However, it should be established a safe range 
of use to avoid the possible adverse effects due to their abuse. First, we carried out a 
contextualization of the current use of this type of packaging and the antimicrobial/ 
antioxidant properties they showed, and also, a review of their main cytotoxic effects in 
different cell lines of human origin. That review has resulted in this publication: 
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 NEW ADVANCES IN ACTIVE PACKAGING INCORPORATED WITH 
ESSENTIAL OILS OR THEIR MAIN COMPONENTS FOR FOOD 
PRESERVATION. (Maisanaba y col., 2015. Food Reviews International (en revisión, 
under revision). 
 
Finally, the evaluation of the major components of the essential oils before their 
incorporation to the packaging is also mandatory, as established by the EFSA (EFSA, 2011b). 
In this regard, oregano essential oil is one of the most used for its outstanding antimicrobial 
properties, being thymol and carvacrol their two main components. In the literature, there are 
several data about their genotoxic profiles (Azizan and Blevins, 1995; Stammati et al., 1999; 
Ipek et al., 2005; Buyukleyla and Recuzogullari, 2009; Llana-Ruiz-Cabello et al, 2014). 
These results are inconclusive in some aspects, so a comprehensive assessment of thymol and 
carvacrol, focussed in their genotoxic profile, is necessary. Therefore, it was interesting to 
conduct the MN test and, for the first time, the mouse lymphoma assay. The results showed 
no significant biological relevance for any of the compounds under the conditions tested. 
These results are described in the following publication: 
 
 IN VITRO GENOTOXICITY TESTING OF CARVACROL AND THYMOL USING 
THE MICRONUCLEUS AND MOUSE LYMPHOMA ASSAYS. (Maisanaba y col., 
2015; Mutation Research 784-785, 37-44). 
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1. ORIGEN DE LAS ARCILLAS Y MINERALES DE ARCILLA 
 
Las arcillas y minerales de arcilla (también conocidos como láminas de silicatos)  
pertenecen al grupo de filosilicatos (del griego “phyllon”: hoja, y del latín “silic”: 
piedra) (Meunier, 2005). Estos materiales se caracterizan por ser muy pequeños (un 
tamaño máximo de micrómetros), pudiéndolos encontrar de forma de forma natural, 
provenientes de rocas o cenizas volcánicas, bajo superficie (suelos y sedimentos), como 
es el caso de las arcillas, o bien, como resultado de la meteorización química (diagénesis 
y alteraciones hidrotermales) de otros minerales de silicato, en el caso de los minerales 
de arcilla (Meunier, 2005; Bergaya y Lagaly, 2006; Choy y col, 2007; Floody y col, 
2009). A pesar de presentar características muy similares, existen varios aspectos que 
diferencian a las arcillas y minerales de arcilla que se exponen en la Tabla 1. 
 
Arcilla Minerales de Arcilla 
Natural Natural o sintética 
Grano fino (<2-4 µm) No hay criterio establecido para el tamaño 
Filosilicatos como principales 
constituyentes 
Pueden no incluirse filosilicatos en su 
estructura 
Plásticas (con excepción de arcillas con 
origen pedroso) 
Plásticas 
Se endurece con el secado o cocción Se endurece con el secado o cocción 
Tabla 1. Diferencias entre arcillas y minerales de arcillas (tomada de Bergaya y Lagaly, 2006). 
 
 
2. CLASIFICACIÓN Y PRINCIPALES CARACTERÍSTICAS DE 
ARCILLAS Y MINERALES DE ARCILLA 
 
Las propiedades físicas y químicas de las arcillas y minerales de arcillas 
dependen de su estructura y composición, pudiendo clasificar de tal forma un amplio 
grupo según las características presentadas (Fig. 1). 
Las arcillas son materiales conformados en láminas de tetraedros de silicato 
(SiO4) y octaedros (conteniendo Al, Mg y Fe). Estos minerales arcillosos naturales se 
construyen basados en unidades estructurales laminadas con un espesor individual de 
cada lámina de aproximadamente uno a unos pocos nanómetros y dimensiones laterales 
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que van desde 30 nm a varios micrómetros, obteniendo una relación de longitud - 
espesor superior a 1000 nm (Zhu y Njuguna, 2014).  
De acuerdo con su composición química, características de la estructura y la 
carga neta, podemos clasificar siete grupos: (1) caolinita-serpentina, (2) talco- pirofilita, 
(3) esmectita, (4) vermiculita, (5) mica, (6) clorita, y (7) arcillas interestratificadas 
(Martin y col., 1991). 
El grupo más simple presenta una estructura con una relación 1:1, en el que una 
capa tetraédrica de sílice se fusiona por compartición de átomos de oxígeno a un 
octaedro de aluminio (por ejemplo, caolinita). El siguiente grupo presenta una estructura 
con relación 2:1, conocido generalmente como el grupo de los filosilicatos, el cual 
consta de una lámina octaédrica central de aluminio ubicada entre dos láminas 
tetraédricas de sílice. Las unidades laminadas del silicato, a menudo conocidas como 
estructura interlaminar o galería laminar, se encuentran posicionadas en paralelo y están 
unidas por fuerzas de Van der Waals y electrostáticas. La sustitución isomórfica dentro 
de las láminas genera cargas negativas que normalmente se ven contrarrestadas por 
sodio o calcio presentes en el espacio interlaminar. Estos cationes intercambiables 
pueden ser reemplazados por cationes orgánicos e inorgánicos a través de reacciones de 
intercambio iónico. Dentro de la familia de los filosilicatos 2:1 se encuentran los 
silicatos más ampliamente conocidos en el mundo científico y usados por la industria, 
las esmectitas (Bignon, 1990; Gilman, 1999; Williams y col., 2004; Goettler y col., 
2007; Leszczynska y col., 2007a, 2007b; Drummy y col. ,2010; Garrido-Ramírez y col., 
2010; Gatica y Vidal, 2010; Kiliaris y Papaspyrides, 2010; Yamada y col., 2011). 
 
Figura 1. Clasificación de silicatos y principales subgrupos de arcillas (tomada de OMS, 2005). 
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En el grupo de las esmectitas, una de las más relevantes es la Montorillonita 
(Mt). Las esmectitas están compuestas por una capa octaédrica custodiada por dos 
láminas opuestas tetraédricas, siendo la estructura general de este tipo de filosilicatos 
(Leszczynska y col, 2007a, 2007b; Theng, 2012) (Fig. 2). La molécula de Si
4+
 del 
tetraedro de SiO4 está dispuesta entre cuatro O
2-
 para conformar una red con estructura 
hexagonal, compartiendo tres esquinas con tetraedros adyacentes. Cada octaedro que 
forma la arcilla (p.ej. AlO6 o MgO6) en la capa octaédrica está conectado a octaedros 
vecinos mediante los bordes de los mismos, en los cuales están presentes grupos 
hidroxilos, formando una estructura hexagonal o pseudohexagonal simétrica. La carga 
neta de la esmectita es negativa debido a la sustitución isomorfa de iones de silicio y 
otros metales de baja carga (p.ej. Al
3+
 sustituido por Mg
2+
 y Fe
2+
, o Mg
2+
 sustituido por 
Li
1+
). Las cargas negativas son contrarrestadas por cationes alcalinos y alcalinotérreos 
presentes entre las dos láminas tetraédricas dispuestas una frente a otra. Los cationes 
intercambiables son hidratados, entrando el agua o solvente en la capa intermedia de la 
estructura y ampliando el armazón de la arcilla, pudiendo acomodar compuestos 
adicionales, incluyendo especies con carga neutra y/o negativas. Debido a la capacidad 
única de la esmectita para incorporar diversos iones, la superficie de la misma puede ser 
hidrófila o hidrófoba dependiendo de la carga y solutos disponibles.  
 
 
Figura 2. Representación esquemática de la estructura de la Mt. a) tetraedro de sílice 
coordinado por cuatro O
2-
; b) octaedro en el cual el ión central está coordinado por seis 
hidroxilos; c) estructura de la Mt, indicando los componentes de la unidad interlaminar y el 
espacio interlaminar (tomada de Zhu y Njuguna, 2014). 
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Debido a la relativa alta capacidad de intercambio catiónico, alto ratio 
dimensional que presentan, y a la facilidad de expansión del espacio de capa 
interlaminar, las esmectitas pueden interactuar con una amplia gama de especies 
orgánicas, siendo una propiedad crítica requerida para muchas aplicaciones llevadas a 
cabo en varios sectores de la industria (Zhu y Njuguna, 2014). 
 
3. USOS GENERALES DE LAS ARCILLAS Y MINERALES DE ARCILLA 
Como materiales naturales, ecológicos, abundantes, de bajo costo y altamente 
reactivos, las arcillas se han utilizado desde hace muchos años para una amplia variedad 
de propósitos en nuestra sociedad, y actualmente se les conoce como los uno de los 
materiales en la industria de minerales de los cuales se pueden sacar mayor provecho, 
conociéndose como los materiales del siglo XXI (Bergaya y Lagaly, 2013; Zhu y 
Njuguna, 2014). A día de hoy, podemos encontrar en bibliografía más de 100 
aplicaciones industriales de materiales de arcilla. Cabe destacar su uso en el sector de 
las industrias de procesado, en industrias agrícolas para el uso en la nutrición de 
animales de granja como agentes y aditivos de unión para piensos, con el fin de 
promover el crecimiento y la salud de los animales, además de como suplemento para el 
tratamiento de trastornos gastrointestinales, en la industria de la ingeniería y 
construcción, para remedios ecológicos y geología, en medicina como transportadores 
de fármacos, y otras tantas aplicaciones industriales (Murray y col., 2007; Baek et al., 
2012). Es también muy importante mencionar que en la última década, motivado 
también por el auge de la nanotecnología, el interés por los materiales que nos competen 
ha aumentado considerablemente. Como curiosidad, comentar que se han publicado más 
de 10000 artículos científicos considerando todas las áreas de aplicación mencionadas 
anteriormente, principalmente en los años 2008-2009 (Zhu y Njuguna, 2014).  
Actualmente, como veremos a lo largo de esta tesis doctoral, la apuesta por el 
uso de arcillas, sobre todo las ya mencionadas Mt y caolinita, en la industria 
alimentaria, y más específicamente en el área de envasado de alimentos, es una realidad, 
dando lugar a una mejora del envasado tradicional frente al envasado modificado. 
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4. ENVASADO ALIMENTARIO Y ARCILLAS: MATERIALES 
NANOCOMPUESTOS 
Como se ha comentado anteriormente, la industria alimentaria y más 
concretamente el área de envasado de alimentos, está apostando a día de hoy por el uso 
de un nuevo tipo de envasado, el cual va íntimamente ligado al uso de arcillas, 
destacando entre ellas la Mt y la caolinita, gracias a las propiedades y características que 
ellas presentan, y a la ciencia que a día de hoy está en auge, la nanotecnología. En el 
contexto de envases de alimentos y bebidas, el uso de la nanotecnología para introducir 
mejoras a la propiedad de materiales se refiere en gran parte a la introducción de 
nanorellenos en polímeros tradicionales para generar nuevos compuestos poliméricos 
(Plackett y Siró, 2012). Entre estos posibles nanorellenos se encuentran las arcillas y 
minerales de arcillas, generalmente considerados como nanomateriales, ya que poseen, 
como hemos descrito previamente, láminas con un grosor nanométrico, pudiéndose de 
tal forma nombrarlas indistintamente como arcillas o nanoarcillas (Zhu y Njuguna, 
2014). Por esta característica y por todas las ventajas comentadas en los apartados 
anteriores es por lo que se destacan sus usos en éste área, dando lugar a materiales 
novedosos con características mejoradas.  
 
4.1. POLÍMEROS NANOCOMPUESTOS: QUÉ SON Y QUÉ VENTAJAS 
PRESENTAN  
Los polímeros nanocompuestos se pueden definir como materiales poliméricos 
que contienen nanorellenos bien dispersados en forma de partículas, fibras, láminas u 
otros elementos, que exhiben una mejora notable en una serie de características 
comparado con el polímero tradicional, incluyendo las propiedades mecánicas, 
propiedades de barrera, estabilidad térmica, y retardo en la ignición, entre otras 
(Plackett y Siró, 2012).  En el caso de los polímeros nanocompuestos obtenidos por la 
incorporación de arcillas, sobre todo Mt, surgen por la adición de pequeñas cantidades 
de arcillas o minerales de arcillas a la matriz de un polímero tradicional, obteniéndose 
un material final mejorado destinado a enriquecer el fin último del polímero 
convencional, incrementar la vida útil en el mercado de los alimentos perecederos 
(Annabi-Bergaya, 2008). 
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Como hemos descrito anteriormente, la Mt cuenta con una estructura 
multilaminar. Cada una de las láminas que componen ese conjunto presenta dos capas 
tetraédricas que acogen a una capa central octaédrica, siendo la suma de las tres de 
tamaño nanométrico con una alta relación dimensional (Uyama y col., 2003), frente al 
tamaño micrométrico que presentaría la partícula completa. Cuando las arcillas son 
dispersadas en la matriz polimérica, experimentan una hinchazón haciendo que todas las 
láminas que forman la partícula se separen, dividiéndose individualmente en unidades 
con grosor nanométrico, obteniéndose a partir de este momento el ya nombrado 
polímero nanocompuesto.  
La separación de las plaquetas de arcilla obligan a los gases a seguir un camino 
tortuoso a través del material que reduce en gran medida su transmisión y llegada al 
alimento (Fig. 3). Como resultado podríamos decir que se obtiene una estructura de 
arcilla dispuesta en nanocapas aumentándose el camino de difusión de las moléculas 
externas y el tiempo de penetración de gases y otras sustancias, proporcionando 
productos sustancialmente mejorados (Abacha y col.,2009; Choudalakis y Gotsis, 2009; 
Herrera- Alonso y col., 2010).  
 
Figura 3. Representación esquemática que explica cómo las nanoarcillas pueden dar lugar a un 
camino tortuoso hasta llegar al alimento que influye en la capacidad de permeabilidad de los 
gases a través de la matriz polimérica (d: espesor de la membrana polimérica; d´: 
trayectoria/longitud de la difusión del gas en presencia de las nanoláminas de arcillas; L: espesor 
de las nanoláminas de arcilla; W: grosor de las nanoláminas de arcilla). 
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El efecto de las nanoarcillas en las propiedades de la matriz polimérica se centra 
fundamentalmente en la alta relación superficie-volumen, ya que las interacciones 
polímero-relleno están principalmente gobernadas por las fuerzas presentes en la 
estructura interlaminar (Arora y Padua, 2010), descritas anteriormente en el apartado 2. 
 
4.2. ELABORACIÓN DE UN MATERIAL NANOCOMPUESTO 
POLIMÉRICO DE ARCILLA 
Existen diferentes métodos para la preparación de una material nanocompuesto 
polimérico de arcilla: a) Intercalación por fusión/fundición, b) polimerización in situ y 
c) dispersión por solución. El método de intercalación por fusión es el seleccionado en 
mayor medida por la industria debido a la naturaleza continua del proceso, por tener 
consecuencias poco severas para el medio ambiente, y, por los factores económicos 
(Zhu y Njuguna, 2014). Esta técnica consiste en mezclar el silicato estratificado con la 
matriz polimérica en estado fundido. Si se cuenta con una alta compatibilidad entre las 
láminas de las arcillas y el polímero, las primeras pueden quedar perfectamente 
imbuidas en la matriz, penetrando el polímero en el espacio interlaminar (Pavlidou y 
Papaspyrides, 2008). 
Sin embargo, la formación exitosa de un material nanocompuesto polimérico de 
arcilla, además de en la buena elección del método de preparación, se basa en dos 
características clave del componente de refuerzo, la arcilla. La primera característica, 
presente en el grupo de las esmectitas como ya se ha comentado, es la habilidad de  
poder modificar la superficie química de los silicatos mediante reacciones de 
intercambio iónico con cationes orgánicos e inorgánicos con el fin de producir un 
“nanocomponente” compatible con el polímero. La segunda característica es la 
capacidad de dispersión de las partículas de silicato en la matriz polimérica, dando lugar 
a un material nanocompuesto exfoliado. En este sentido, podemos encontrar tres 
disposiciones diferentes de arcilla tras su incorporación: 1) disposición en bloque, 
dándose cuando el espacio interlaminar de la estructura o galería laminar no se expande, 
debido, por lo general, a la pobre afinidad con el polímero. No se conocen por el 
momento polímeros nanocompuestos con esta disposición (Alexandre y Dubois, 2000). 
2) disposición intercalada de las láminas de la arcilla, obteniéndose una moderada 
expansión de la capa intermedia de arcilla. En este caso, los espacios entre capas se 
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expanden ligeramente a medida que las cadenas de polímero penetran el espaciamiento 
basal de la arcilla, pero la forma de bloque  en capas permanece.  Este es el resultado de 
una afinidad moderada entre el polímero y la arcilla. Y por último, 3) disposición 
dilatada de las estructuras laminares, las partículas de arcilla pierden su identidad en 
capas y están bien separados en láminas sueltas dentro de la matriz. Esto se debe a una 
gran afinidad entre el polímero y arcilla (Arora y Padua, 2010) (Fig. 4). Estas dos 
características se encuentran, por supuesto, conectadas entre sí debido a que el grado de 
dispersión de las láminas de un silicato matriz polimérica depende de la modificación de 
cationes capa intermedia (Ray y Okamoto y col., 2003).  
Sin embargo, una dispersión simple de arcillas, dígase Mt, en una matriz 
polimérica, no va a producir un material nanocompuesto con destacadas mejoras, 
debido a las pobres  interacciones interfaciales entre los sitios de reacción hidrófilos de 
la arcilla y la alta hidrofobicidad con la que cuentan las cadenas del polímero (Pisticelli 
y col. , 2010). En este sentido, la solución para esta notable desventaja se puede 
solventar mediante la introducción de grupos orgánicos para mejorar la interacción entre 
las arcillas y polímeros (Silva y col., 2011). 
 
Figura 4. Representación esquemática de la posible disposición de la arcilla para conformar el 
polímero nanocompuesto (tomada de Arora y Padua, 2010, con modificaciones). 
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4.3. ARCILLAS Y MODIFICADORES ORGÁNICOS 
Como se ha expuesto en el apartado anterior, debido al bajo grado de exfoliación 
que presentan las arcillas en la matriz polimérica por la naturaleza hidrofílica con la que 
cuentan y el carácter hidrófobico presentado por las cadenas del polímero, el sector 
industrial lleva a cabo una serie de modificaciones en la estructura de las mismas con el 
fin de mejorar este aspecto.  
Los métodos llevados a cabo para conseguir una arcilla más organofílica son 
varios, destacando principalmente a) la reacción de intercambio iónico (ion exchange 
reaction) y b) la reacción de injerto (grafting reaction). 
a. Reacción de intercambio iónico 
La reacción de intercambio iónico, un proceso de modificación química 
ampliamente utilizado para dar lugar a arcillas más organofílicas,  se define como una 
reacción reversible en la que los cationes se intercambian estequiométricamente entre 
una solución electrolítica y la fase superficial del material intercambiador (Bladel y 
Laudelout, 1996; Pisticelli y col., 2010), en nuestro caso, la arcilla.  
Cabe considerar a las arcillas como polielectrolitos multivalentes ideales para 
este tipo de reacciones. El exceso de carga negativa de las capas de silicatos y su 
capacidad de intercambio de iones se puede cuantificar mediante una específica 
propiedad conocida como la capacidad de intercambio catiónico (CIC), expresada en 
mequiv./g (Alexandre y Dubois, 2000; Manias y col., 2001). En el caso de las 
esmectitas, grupo de filosilicatos con mayor CEC (0.7-1.2 moles/kg) (Sherman, 2011),  
cuentan con una capa de intermedia de cationes hidratados, pudiendo ser desplazados 
por otros grupos orgánicos mediante una solución acuosa dando lugar a la modificación 
en su composición y por tanto obteniendo una arcilla modificada con características 
mejoradas de compatibilidad (Sherman, 2011). Más específicamente, la Mt sódica (CIC 
110 mequiv./100g (Ray y Okamoto, 2003)), formadapor dos capas tetraédricas 
constituidas por átomos de Si
4+
 y O
2-
, y, fusionadas con una capa octaédrica con átomos 
Al
3+
 y Mg
2+
 unidos a grupos oxígeno e hidroxilo, es ampliamente utilizada en este tipo 
de modificaciones. Debido a una sustitución isomórfica, el Al
3+
 puede ser sustituido por 
el Mg
2+
, creando un exceso de carga negativa, que se equilibra por cationes (p. ej. Na
+
, 
Ca
2+
) colocado en el espacio entre la capa intermedia plaquetas (Jordá-Beneyto y col., 
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2014). Para la mejora de la miscibilidad e interacción de las láminas de silicato entre 
esta arcilla y el polímero, uno debe convertir la superficie hidrófila del silicato a una 
organófila. Generalmente, esto se lleva a cabo gracias a la reacción de intercambio 
iónico mediante la incorporación de tensioactivos catiónicos como modificadores. Entre 
los modificadores más utilizados para obtener estas organoarcillas encontramos los 
cationes cuaternarios de alquilamonio, comúnmente conocidos como sales de amonio 
cuaternario, siendo los más destacados en la industria del envasado alimentario (Fig. 5), 
junto con los cationes alquilofosfonio. Estos cationes modificadores, una vez que son 
incorporados, reducen la energía superficial de las láminas de arcilla y mejoran las 
características de humectación de la matriz polimérica, dando como resultado un mayor 
espaciamiento de las mismas. Además, estos modificadores pueden proporcionar grupos 
funcionales que pueden reaccionar con la matriz polimérica, o, en algunos casos, inician 
la polimerización de monómeros para mejorar la resistencia entre la interfase inorgánica 
y la matriz polimérica orgánica (Blumstein, 1965; Krishnamoorti y col., 1996). 
 
 
Figura 5. Modificadores comerciales de sales de amonio cuaternario más usados en arcillas 
modificadas. 
Introducción/Introduction 
 
29 
 
La mejora por la incorporación de arcillas modificadas con sales de amonio 
cuaternarias a polímeros bien conocidos está más que corroborada. Por ejemplo, 
Fukushima y col. (2012) describieron como dos tipos de nanocompuestos de ácido 
poliláctico (PLA), polímero orgánico y biodegradable (Jamshidian y col., 2010), uno 
con un 5% de una Mt modificada orgánicamente, Cloisite®20A (C20A), y otro con 
sepiolita no modificada, presentaron una mejora tras la incorporación de las arcillas, 
siendo más destacadas en aquel basado en la Mt modificada. Ambos tipos de 
nanocompuestos dieron lugar a propiedades térmicas y de viscosidad mejoradas 
Además, no se afectó la transparencia del polímero tras la incorporación de las 
partículas. Sin embargo, la permeabilidad del plástico únicamente tuvo una variación 
significativa en el caso del nanocompuesto de PLA-C20A. 
b. Reacción de inserción 
Debido a la degradación de las sales de amonio cuaternario a altas temperaturas a 
través de la reacción de Hoffman, la inestabilidad térmica de la arcilla orgánica se 
convierte en una notable limitación en el procesamiento de nanocompuestos poliméricos 
de arcilla modificadas con estos tensioactivos (Xie y col, 2001, 2002; Wang y col, 
2012). 
Por esta razón, la reacción de injerto de grupos hidrófobos en las superficies de la 
capa ha supuesto una alternativa alcanzable. Esta reacción de injerto, se lleva a cabo 
generalmente entre los agentes de acoplamiento de silanos y los grupos silanoles 
reactivos que se encuentran en los bordes de las plaquetas de arcilla y en los defectos 
estructurales situados en la superficie de la capa intermedia y externa (Di Gianni y col., 
2008; Herrera y col., 2010; Pisticelli y col., 2010). En resumen, la reacción de injerto es 
una solución irreversible para obtener arcilla modificadas químicamente en las que las 
moléculas del modificador silano (Fig. 6) están unidas a las capas de la arcilla 
seleccionada mayoritariamente, en este caso Mt (Wypych, 2004). Varios autores han 
investigado la modificación de arcillas con silanos incorporados a diferentes polímeros 
teniendo en cuenta los diferentes métodos de modificación y la obtención de varios 
resultados, la mejora o la disminución de las propiedades en comparación con la arcilla 
sin modificar y los polímeros a granel (Di Gianni y otros, 2008; Shen y col., 2007; 
Pisticelli y col., 2010; Silva y col., 2011). 
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Figura 6. Silanos utilizados como modificadores de arcillas. 
 
En la actualidad, en la industria alimentaria podemos encontrar arcillas 
organomodificadas con estos tipos de modificadores ya patentados y comercializados, y 
otras tantas, bajo desarrollo y evaluación. El fin último es dar lugar a una arcilla con el 
mejor perfil tecnológico y toxicológico, con el objetivo de obtener el nanocompuesto 
polimérico de arcilla con las mejores propiedades para incrementar la vida útil del 
alimento y que sea seguro para el consumidor. Las principales arcillas comercializadas 
y en desarrollo se muestran en la Tabla 2.  
 
Nombre 
Composición química 
Modificador orgánico 
Concentración del 
modificador 
Cloisite®Na
+ 
(CNa
+
, 
comercial) 
No modificada (Mt natural) No presenta 
Cloisite®30B(C30B, 
comercial) 
Mt modificada con sal de amonio 
cuaternario (MT2EtOH) 
90meq/100g clay 
Cloisite®20A(C20A, 
comercial) 
Mt modificada con sal de amonio 
cuaternario (2M2HT) 
95meq/100g clay 
Cloisite®93A(C93A, 
comercial) 
Mt modificada con sal de amonio 
terciario (M2HT) 
90meq/100g clay 
Cloisite®15A(C15A, 
comercial) 
Mt modificada con sal de amonio 
cuaternario (2M2HT) 
125meq/100g clay 
Cloisite®10A(C10A, 
comercial) 
Mt modificada con sal de amonio 
cuaternario (2MBHT) 
125meq/100g clay 
Clay1(en desarrollo) 
Mt modificada con sal de amonio 
cuaternario (HDTA) 
6 veces del CEC de la 
Mt, CEC de Mt= 92.6 
meq/100g 
Clay2(en desarrollo) 
Mt modificada con sal de amonio 
cuaternario (HDTA+ACO) 
HDTA en 5.75 y ACO 
en 0.25 veces del CEC 
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de Mt , CEC de Mt = 
92.6meq/100g 
Clay3(en desarrollo) 
Mt modificada con silano  
(3-Aminopropiltrietoxisilano) 
4 veces del CEC de la 
Mt 
Clay4A(en desarrollo) 
Mt modificada con silano 
(Viniltrimetoxisilano) 
4 veces del CEC de la 
Mt 
Clay4B(en desarrollo) 
Mt modificada con silano 
(Viniltrimetoxisilano) 
8 veces del CEC de la 
Mt 
Tabla 2. Principales arcillas comerciales y en desarrollo destinadas a la industria alimentaria. 
 
5. EVALUACIÓN TOXICOLÓGICA DE ARCILLAS NO MODIFICADAS, 
ORGANOARCILLAS Y MATERIALES NANOCOMPUESTOS. 
 
Teniendo en cuenta que los materiales nanocompuestos poliméricos de arcilla están 
teniendo una gran potencialidad de aplicaciones en el sector del envasado de alimentos 
como un innovador material de embalaje con propiedades funcionales nuevas que dan 
lugar a la protección y mejor calidad de los alimentos.  Se hace necesario evaluar la 
seguridad hacia los consumidores, ya que estamos ante materiales en contacto con 
alimentos que posteriormente serán ingeridos (Rhim y col., 2013).  
Aunque los efectos tecnológicos son conocidos y están generalmente bien descritos 
desde hace años, los potenciales efectos toxicológicos y el impacto de las arcillas sin 
modificar o modificados y de los nanocompuestos poliméricos derivados sobre la salud 
humana y el medio ambiente, están actualmente siendo investigados exhaustivamente 
con mayor interés. Hay que tener en cuenta que la exposición de la población en general 
a bajas concentraciones de Mt, caolinita y otros minerales de arcilla en su forma natural 
es ubicua (OMS, 2005).  
Respecto a la incorporación de las arcillas a los polímeros empleados en la industria 
alimentaria puede resultar como una exposición no intencionada a ellas para el 
consumidor, por lo que es necesario no sólo evaluar la arcilla microestructurada 
modificada o no, sino también el nanocompuesto resultante una vez imbuida ésta, 
debido a la posible migración al producto alimenticio (EFSA, 2011a; Guillard y col, 
2010; Song y col., 2011; EFSA, 2015).  
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Es razonable asumir que esta migración se produce a causa de las pequeñas 
dimensiones que presentan estos nanocomponentes. También, hay indicios de que la 
migración podría estar relacionada con el desgaste en el tiempo del film/plástico 
(Rejinders, 2006). En consecuencia, la principal preocupación sobre la aplicación de 
nanocompuestos poliméricos usados en envasado en contacto con alimentos está 
relacionada con la exposición indirecta debido a la potencial migración del envase al 
alimento. Por ello, para los consumidores, la primera preocupación es verificar la 
medida de la migración de las nanoarcillas del film al alimento, y, posteriormente, si 
esto ocurre, a qué efectos pueden dar lugar desde que las ingieren hasta el final del 
tracto gastrointestinal. 
Actualmente, en relación a las arcillas, modificadas o no, podemos encontrar varios 
trabajos sobre la evaluación toxicológica de arcillas ya comerciales utilizadas en 
envasado y los ensayos toxicológicos que se han llevado a cabo con las mismas. Los 
resultados publicados por diversos autores presentan resultados contradictorios en 
muchos casos (Sharma y col., 2010; Baek y col., 2012), haciendo necesaria una 
evaluación toxicológica exhaustiva y consideración individualizada de cada una. En el 
caso de extractos de migración obtenidos a partir de materiales nanocompuestos, los 
estudios son mucho más escasos (Avella y col., 2005; Simon y col., 2008).  
Debido al auge que está presentando el uso de arcillas y nanocompuestos 
poliméricos de arcilla, sería necesaria hacer una revisión bibliográfica, caso por caso, 
con el fin de ir recopilando la mayor información posible y poder determinar el estado 
del arte de cada material con el fin de encaminar y completar una adecuada evaluación 
toxicológica y ser conscientes de la información sobre seguridad que hay hasta el 
momento. 
La Autoridad Europea de Seguridad Alimentaria (EFSA) es la piedra angular de la 
Unión Europea (UE) centrada en la evaluación de riesgos en relación con la 
alimentación y la seguridad de los piensos. En estrecha colaboración con las autoridades 
nacionales y en consulta abierta con grupos de interés, la EFSA proporciona 
asesoramiento científico independiente y comunicación clara sobre los riesgos 
existentes y emergentes. La EFSA ha desarrollado un enfoque práctico para evaluar los 
riesgos potenciales derivados desde las aplicaciones de la nanociencia y la 
nanotecnología en la cadena alimentaria humana y animal (EFSA, 2011). En este 
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aspecto, para llevar a cabo una rigurosa evaluación de las arcillas, como nanoarcillas, se 
tienen en cuenta los pasos propuestos por esta autoridad, con el fin de ser 
comercializadas en un futuro cercano en Europa. 
 En su informe, la EFSA proporciona orientación sobre: (I) los requisitos de 
caracterización físico-química de nanomateriales artificiales utilizados por ejemplo 
como aditivos alimentarios, enzimas, aromatizantes, materiales en contacto con 
alimentos, alimentos nuevos, aditivos para piensos y plaguicidas y; (II) las pruebas para 
identificar y caracterizar los peligros derivados de las propiedades de los materiales en 
evaluación que, en general, incluye, información sobe genotoxicidad in vitro, absorción, 
distribución, metabolismo y excreción, además de ensayos de toxicidad oral de dosis 
repetida durante 90 días en roedores. Esta guía indica todas las incertidumbres que 
deben ser consideradas para llevar a cabo una correcta y completa evaluación de riesgo 
(EFSA, 2011a). 
Además, la EFSA ha publicado recientemente, “Acontecimientos recientes en la 
evaluación del riesgo de sustancias químicas en  alimentos y su potencial impacto en la 
evaluación de la seguridad de sustancias utilizadas en los materiales en contacto con 
alimentos”, un boceto-guía con estructura similar a la anteriormente mencionada, 
destacando que una evaluación genotóxica es requerida en cualquier caso (EFSA, 
2015). Éste último documento completaría en parte a la información proporcionada por 
el primero. 
Muchos de estos aspectos toxicológicos de las nanoarcillas han sido abordado por 
numerosos autores. A continuación se expondrán los mecanismos de toxicidad que 
hasta el momento se han descrito sobre los materiales que nos competen, esbozando 
resultados disponibles más relevantes. 
5.1. ENSAYOS TOXICOLÓGICOS IN VITRO Y MECANISMOS DE 
TOXICIDAD 
Los métodos in vitro proporcionan un medio efectivo y rápido para la selección 
(screening) y clasificación de compuestos, además de ser ética y moralmente más 
correctos que los ensayos in vivo. Entre otras ventajas destacan que el uso de animales 
es considerablemente menor, e incluso nulo en muchas ocasiones, se utiliza material 
muy homogéneo obtenido con técnicas estandarizadas, posibilitan el uso de material de 
Introducción/Introduction 
 
34 
 
origen humano, lo que se puede simplificar por extrapolación, son más fácilmente 
objetivables y cuantificables que los ensayos in vivo y los resultados presentan mayor 
reproducibilidad. A todo ello se le une un menor coste, mayor rapidez e instalaciones 
menos complejas (Eisenbrand y col., 2002). 
Las evaluaciones toxicológicas in vitro evaluaciones toxicológicas son útiles para la 
obtención de información acerca del mecanismo de toxicidad de los materiales de 
estudio. Las células responden rápidamente al estrés que genera el tóxico mediante la 
alteración, por ejemplo, de diferentes biomarcadores basales, tales como la generación 
de especies reactivas de oxígeno (ERO) y contenido de glutatión (GSH), o alteraciones 
en varios orgánulos, como las mitocondrias y lisosomas. Teniendo esto en cuenta, una 
cuestión importante de resolver es cómo los materiales estudiados, en este caso, 
organoarcillas y  nanocompuestos que las contengan, son capaces de alterar estos 
parámetros y cómo estas alteraciones pueden afectar a la tasas metabólicas, crecimiento 
celular y la transcripción génica (Eisenbrand et al., 2002). 
La interacción, influencia y potencial de toxicidad de los materiales con las 
proteínas y las células son un enfoque esencial para evaluar y entender la 
compatibilidad de los materiales frente a la toxicidad (Jones y Grainger, 2009). Las 
reacciones de células de interés como material de absorción celular, las perturbaciones 
integridad de la membrana, o la alteración en la viabilidad de orgánulos vitales. Por lo 
tanto, los puntos finales tales como la generación de ERO y otros parámetros 
relacionados con la respuesta al estrés celular (GSH, la actividad de la superóxido 
dismutasa (SOD), la peroxidación lipídica (LPO), etc.), daño en el ADN, la respuesta de 
la inflamación y la necrosis y apoptosis proporcionan una valiosa información para la 
comprensión de la respuesta tóxica. 
Entre los indicadores de toxicidad que se pueden determinar con los métodos in 
vitro, destacan que a continuación se exponen. 
 
a) Citotoxicidad basal 
Los cultivos de células juegan un papel esencial en la evaluación toxicológica de los 
minerales de arcilla, ya que proporcionan los sistemas de alto rendimiento para la 
detección rápida y rentable de los peligros. Seleccionadas las líneas celulares de trabajo, 
teniendo un gran interés las líneas de órganos diana del aparato digestivo, los ensayos 
de citotoxicidad son los llevados a cabo en primera instancia para valorar los efectos 
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adversos o interferencias con estructuras y/o propiedades esenciales para la 
supervivencia, proliferación y/o función celular una vez que se les ha expuesto el 
compuesto objeto de estudio. 
Diversos grupos han evaluado mediante diferentes biomarcadores de citotoxicidad 
la alteración funcional producida por exposición de diferentes líneas celulares a dichas 
arcillas organomodificadas. 
Son diferentes los métodos que podemos encontrar para evaluar el descenso de 
viabilidad tras exposición de las arcillas, así como extractos de migración de materiales 
nanocompuestos. Entre ellos destacan, la reducción de Bromuro de 3-(4,5-dimetiltiazol-
2-ilo)-2,5-difeniltetrazol (MTT) y sal de tetrazolio MTS (MTS) (Baltrop y col., 1991), 
comprobando la funcionalidad mitocondrial tras la exposición al compuesto; liberación 
de la enzima Lactato Deshidrogenasa (LDH) para evaluar el daño en la membrana 
celular; el ensayo Azul Trypan (Binderup y col., 2002) para evaluar la proliferación 
celular; el ensayo de Rojo Neutro (RN) (Borenfreud y Puerner., 1984) que constata el 
daño lisosomal y la valoración del contenido de proteinas (Bradford, 1976), con el fin 
de evaluar la proliferación celular.  
La Organización Mundial de la Salud (OMS) revisó los efectos en sistemas in vitro 
de bentonita, caolín y otros minerales de arcilla (OMS, 2005). Sin embargo, las obras 
mencionadas fechan del período 1969-1996, no resultando ser una información actual y 
extrapolable a la realidad, haciéndose de tal forma necesaria una profunda revisión de 
los datos disponibles hasta día de hoy. 
Estudios más actuales han demostrado diferentes comportamientos de líneas 
celulares tras la exposición de la Mt o Cloisite®Na
+ 
(CNa
+
). Por ejemplo, Sharma y 
col., (2010) observaron un efecto no citotóxico en la línea de adenocarcinoma de colon 
Caco-2 expuesta a la arcilla en las condiciones ensayadas, sin embargo, Li y col. (2010) 
y Baek y col., (2012), obtuvieron un descenso de viabilidad tras la exposición de la 
misma en la línea celular de ovario de hámster chino (CHO) y en células intestinales 
humanas, respectivamente.  
Respecto a otras arcillas modificadas disponibles comercialmente, los resultados 
obtenidos también fueron muy diversos, presentándose de forma general efectos tóxicos 
tras la exposición a las arcillas. En el caso de Cloisite®30B (C30B) y Cloisite®93A 
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(C93A)) se observaron efectos citotóxicos tras su exposición en Caco-2 y la línea de 
hepatoma humano HepG2 (Sharma y col., 2010; Lordan y col., 2011). Por otro lado, 
Liu y col. (2011) también observaron un descenso de la viabilidad celular y un aumento 
en la liberación de lactato deshidrogenasa (LDH) en fibroblastos embrionarios de ratón 
(NIH 3T3) y células de riñón embrionario 293 (293 HEK) tras la exposición a una Mt 
modificada con oligo (estireno-co-acrilonitrilo). 
En definitiva, cada arcilla, puede presentar un perfil toxicológico diferente teniendo 
en cuenta las líneas celulares expuestas, tiempos ensayados y concentraciones de 
exposición, obteniendo de tal forma una amplia diversidad en los resultados, haciéndose 
necesaria una evaluación caso por caso. 
Respecto los ensayos de citotocidad llevados a cabo con extractos de migración de 
materiales nanocompuestos poliméricos de arcilla son muy escasos hasta el momento, 
siendo necesaria una exhaustiva investigación de los mismos antes de la 
comercialización del envase. Zia y col. (2011), obtuvieron una mejor adhesión de 
células en envases con arcillas sin modificar que con arcillas modificadas, viendo 
efectos adversos ante la presencia de modificadores. 
 
b) Estrés oxidativo 
La expresión / generación de respuestas de estrés y las alteraciones bioquímicas 
posteriores puede ser potenciales marcadores para la toxicidad inducida por el 
compuesto (Eisenbrand et al., 2002). Existe una considerable evidencia que indica que 
muchas de las respuestas de estrés se producen antes de que cualquier citotoxicidad 
medible; por lo tanto, también se recomienda la vigilancia de las vías de estrés a nivel 
subtóxicas. La producción de formas reactivas de oxígeno es tóxica para los organismos 
y un exceso de las mismas da lugar a lo que se conoce como estrés oxidativo (Fig. 7).  
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Figura 7. Principales especies reactivas de oxígeno (tomada de Guzmán-Guillén, 2015). 
La estructura electrónica del oxígeno hace que sea susceptible de reducciones 
parciales, dando lugar a especies reactivas de oxígeno (ERO). Las ERO se producen 
normalmente en las células como producto del metabolismo celular. Si un agente 
estresante induce un aumento en la producción de ERO, este equilibrio puede romperse 
causándose daños en las estructuras celulares, tales como disfunción de la membrana, 
peroxidación lipídica (LPO), lo que significa un mayor nivel de malondialdehído 
(MDA) en la membrana celular, daño de ADN y una inactivación drástica de las 
proteínas. La concentración de ERO está controlada por acción de la barrera de defensa 
antioxidante enzimática. Ejemplos de estas enzimas son la superóxido dismutasa 
(SOD), catalasa (CAT), glutatión peroxidasa (GPx) y glutatión reductasa (GR) (Puerto 
et al., 2009, 2010) (Fig. 8).  
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Figura 8. Principal barrera antioxidante enzimática del organismo (Tomada de Guzmán-
Guillén, 2015). 
Las mediciones de actividad de este grupo de enzimas antioxidantes pueden 
proporcionar un marcador de estrés oxidativo, lo que se puede completar con el estudio 
de otros parámetros, tales como el GSH, MDA y los niveles de carbonilo (Puerto y col., 
2014). Si no se recupera el equilibrio se producirán disfunciones que pueden 
desembocar en la muerte celular.  
Del mismo modo que para los ensayos de citotoxicidad basal, los resultados que 
encontramos en bibliografía acerca de generación de ERO e inhibición de la síntesis de 
GSH suelen ser contradictorios y no concluyentes. Sharma y col. (2010) no encontraron 
una respuesta en la que se generara ERO tras la exposición de CNa+ y C30B a Caco-2, 
sin embargo, otros autores confirmaron la producción de estrés oxidativo con CNa
+
 
expuesta a HepG2 y células intestinales humanas (Lordan y col., 2011; Baek y col., 
2012). Además, tras la exposición de diferentes líneas celulares a otras arcillas 
comerciales, como C93A en HepG2, también se observó un incremento en la 
generación de ERO (Lordan y col., 2011). 
Poco se sabe acerca de la producción de estrés oxidativo por extractos de migración 
de materiales nanocompuestos derivados de arcilla destinados al envasado al alimento, 
siendo necesaria dicha información previa comercialización de estos productos. 
Podemos encontrar estudios acerca de otros materiales nanocompuestos poliméricos de 
arcilla destinados a otros usos médicos, observándose una ausencia de estrés según los 
biomarcadores evaluados (MDA, SOD, GSH, etc) (Kevadiya y col., 2013,2014). 
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c) Genotoxicidad/Mutagenicidad 
Entre los efectos que podemos encontrar por exposición de concentraciones 
subcitotóxicas de productos químicos se encuentra la interacción directa con el ADN, 
traduciéndose dicha interacción en diversos tipos de daño, incluyendo lesiones 
promutagénicas, que provocan la activación de protooncogenes y la inactivación de 
genes supresores de tumores (Kensler y col., 2003). Las lesiones genéticas no sólo son 
un reflejo de acontecimientos inducidos por el compuesto, sino también indicadores de 
inestabilidades genéticas causadas por deficiencias de la reparación del ADN 
(Eisenbrand y col., 2002). 
Debido a la variedad de mecanismos que conducen al daño del ADN inducido por 
xenobióticos y el abanico de acontecimientos mutágenos que pueden ocurrir como 
resultado, se requiere una batería de ensayos para el establecimiento del potencial 
genotóxico de una sustancia que se encuentre bajo investigación (Doak y col., 2012). En 
la actualidad, los ensayos de mutagenicidad/genotoxicidad in vitro se incluyen entre el 
conjunto básico de pruebas de toxicidad para la evaluación de la seguridad requerida 
por la legislación europea para autorizar diferentes sustancias que se pretendan emplear 
en la industria alimentaria (EFSA, 2011b). Los ensayos de genotoxicidad de uso más 
frecuente son el el ensayo de micronúcleos (MN), el Test de Ames y el ensayo cometa, 
(Fig.9). 
De acuerdo con la directriz de la OCDE 487 (OCDE, 2014), el ensayo in vitro de 
MN es una prueba que determina rápidamente la frecuencia de daño cromosómico bruto 
inducida por un agente de estudio. Esta técnica, ha ganado popularidad frente al ensayo 
de aberraciones cromosómicas, ya que es sustancialmente es más rápida de realizar, más 
fácil de analizar y detecta fácilmente compuestos aneugénicos y clastogénicos (que el 
ensayo de aberración cromosómica no puede hacerlo a menos que se modifique 
específicamente). Por lo tanto, la MN actualmente se recomienda y exige como uno de 
los sistemas de ensayo in vitro para caracterizar la genotoxicidad de nuevas sustancias 
(EFSA, 2011b; Kirkland y col., 2011; EFSA, 2015). 
Otro ensayo realizado para evaluar diferentes alteraciones que podrían ocurrir en el 
material genético es el Test de Ames. Dicha prueba, de acuerdo con la directriz de la 
OCDE para los ensayos de productos químicos 471 (OCDE, 1997), es el ensayo de 
mutación inversa bacteriana utilizado para determinar la mutagenicidad de sustancias 
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exógenas. El ensayo identifica la capacidad de compuestos de revertir mutaciones 
puntuales los genes de la biosíntesis de histidina o triptófano, en Salmonella 
typhimurium o Escherichia coli, respectivamente,  restaurándose la capacidad de las 
bacterias para generar estos aminoácidos esenciales. Por lo general, una combinación de 
5 cepas de S. typhimurium o 4 cepas de S. typhimurium, además de 1 o 2 cepas de E. 
coli se exigen para detectar mutaciones por sustitución de bases o desplazamiento en el 
marco de lectura. La facilidad y la rentabilidad de este ensayo hacen que sea 
ampliamente utilizado en el análisis de seguridad de xenobióticos. Es una prueba 
esencial dentro de la batería actual de ensayos requeridos para la evaluación de la 
genotoxicidad (EFSA, 2011b; Doak y col., 2012; EFSA, 2015). 
El ensayo cometa (electroforesis en gel de una sola célula) es un método simple para 
medir roturas de la cadena de ADN en células eucariotas (Collins, 2004). Este ensayo 
presenta una serie de ventajas en comparación con otras pruebas de genotoxicidad. 
Además de la capacidad de este ensayo para identificar el daño del ADN a nivel de una 
sola célula, entre otras de las ventajas significativas se incluyen: su sensibilidad para la 
detección de bajos niveles de daño en el ADN, requerimiento de un pequeño número de 
células por muestra, su fácil de aplicación, y, bajo costo y tiempo necesario para la 
realización del ensayo. Además, este ensayo es flexible porque puede ser usadao para 
evaluar diversos tipos de daño del ADN, como el oxidativo, y es fácilmente modificable 
para la adaptación a una variedad de requerimientos experimentales (Tice y col., 2000). 
Por lo tanto, no es de extrañar que el ensayo cometa haya y esté siendo utilizado en 
muchos estudios para investigar el daño y reparación del ADN en una amplia gama de 
células tumorales con una extensa variedad de agentes que dañan el ADN (Liao ey col., 
2009). 
 
Figura 9. Visualización del resultado del Ensayo Cometa (a), Test de Ames (b) y Micronúcleos 
(c).  
 
a b c 
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En este sentido, la evaluación genotoxicidad de las arcillas y nanocompuestos 
derivados utilizados o destinados para la industria alimentaria es de gran interés y está 
exigida en cualquier caso, tal y como ha publicado la EFSA recientemente (EFSA, 
2015). 
Respecto a los ensayos de genotoxicidad llevados a cabo con arcillas, destacar que 
siguen presentándose datos no concluyentes. Li y col. (2010) observaron la ausencia de 
genotoxicidad mediante los tres ensayos descritos de láminas de silicatos, mientras que 
Sharma y col. (2010) obtuvieron una respuesta genotóxica y mutagénica positiva para 
C30B. Por otro lado, hasta el momento, bajo nuestro conocimiento, los estudios de 
genotoxicidad realizados sobre materiales nanocompuestos son inexistentes.  
d) Marcadores inflamatorios 
La inflamación es un intento de protección por el organismo para eliminar los 
estímulos nocivos y para iniciar el proceso de curación. Durante este proceso, algunos 
biomarcadores pueden ser liberados, determinándose si la exposición a una sustancia en 
particular puede conducir a una respuesta del sistema inmune. Entre los biomarcadores 
que se analizan con mayor frecuencia en relación con el proceso de inflamación están la 
liberación de citoquinas, principalmente la interleucina-6-factor α (IL-6) y la necrosis 
tumoral (TNF-α) (Lopresti y col., 2014). 
Actualmente, podemos mencionar por ejemplo la evaluación realizada por Elmore 
(2003), que publicó que diferentes arcillas, incluída la Mt, inducían citotoxicidad en 
diferentes líneas celulares de macrófagos y que se presenciaba una respuesta hemolítica 
en líneas celulares sanguíneas de diferentes especies. 
e) Muerte celular 
Diferentes marcadores pueden ser utilizados para determinar el mecanismo de la 
muerte celular después de la exposición a una sustancia tóxica. La citometría de flujo y 
anexina V se utilizan para determinar cuantitativamente el porcentaje de células dentro 
de una población que están experimentando apoptosis de forma activa, ya que se unen 
los fosfolípidos de membrana externalizados (Napierska y col., 2009). Por otra parte, 
otro biomarcador importante es la actividad de caspasas, principalmente la actividad de 
la caspasa 3, que es considerada la más importante de las caspasas efectoras y su 
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activación se utiliza a menudo como un indicador de un evento apoptótico (Lordan y 
col., 2011). 
Lordan y col. (2011) observó una ausencia en el incremento de actividad capasas 
tras exposición de CNa
+
 en una línea celular hepática diana; sin embargo, Janer y col. 
(2014) sí obtuvieron un incremento en diferentes cultivos celulares tras la exposición de 
Mt, a tiempos tanto cortos como más amplios de exposición. Por otro lado, Geh y col. 
(2006), también observaron como respuesta de muerte celular necrosis y apoptosis tras 
exposición de bentonita. 
5.2.  ENSAYOS TOXICOLÓGICOS IN VIVO  
Estos ensayos incluyen la experimentación hecha dentro o en el tejido vivo de un 
organismo vivo. Los ensayos in vivo  enriquecen la información preliminar obtenida de 
los ensayos in vitro. Éstos dan una información más completa de lo que ocurre en el 
organismo cuando se encuentra expuesto a cualquier xenobiótico objeto de estudio, 
proporcionando datos extrapolables al ser humano y pudiendo detectar efectos 
secundarios. Son métodos validados formalmente y son los que comúnmente se llevan a 
cabo para los ensayos clínicos y registro de nuevos fármacos, además de otras nuevas 
sustancias. 
Los ensayos in vivo llevados a cabo con arcillas y materiales nanocompuestos son 
más escasos que los publicados  in vitro, y la mayoría se centran en cortos periodos de 
exposición. Varios autoreshan llevado a cabo estudios de toxicidad oral evaluando 
diferentes parámetros tras  exponer a roedores a concentraciones mucho más elevadas 
que las usadas  in vitro. En el caso de Li y col. (2010) y Baek y col. (2012) no 
observaron ninguna anomalía ni pérdida de peso en los animales durante el periodo de 
tratamiento con láminas de nanosilicato. Sin embargo, otros autores han mostrado como 
nontronitas y hectoritas, otro tipo de arcillas, han dado lugar a la generación de LPO en 
el cerebro de roedores expuestos a altas concentraciones (Kibanova y col., 2009).  
Por otro lado, la EFSA llevó a cabo la evaluación de la bentonita como aditivo de 
alimentación, no encontrando resultados de genotoxicidad mediante el ensayo de 
aberraciones cromosómicas in vivo (EFSA, 2013). Además, la Agencia Internacional de 
Investigación sobre el Cáncer (IARC) no obtuvo ningún dato sobre la carcinogenicidad 
de la Mt o caolinita (IARC, 1997). 
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Respecto a la absorción y acumulación en el organismo de este tipo de compuestos 
poco se sabe, siendo muy limitados los estudios encontrados en bibliografía, 
requiriéndose una profunda revisión debido a la antigüedad de muchos de los artículos 
disponibles. Destacar algunos resultados publicados que constatan la acumulación 
progresiva en orina y en determinados órganos (riñón>hígado>corazón>cerebro) de 
restos de arcillas destinadas a diferentes usos en el ámbito de la medicina (Mascolo y 
col., 1999; 2004). Sin embargo, en el informe mencionado de la EFSA, ni bentonita ni 
sepiolita, comparadas con otras arcillas, presentan un grado de absorción medible 
(EFSA, 2013). 
En cuanto a la evaluación toxicológica in vivo de materiales nanocompuestos de 
arcillas sólo hemos encontrado en bibliografía un único trabajo, donde se ve una mayor 
compatibilidad in vivo de un polímero reforzado con Mt comparado con el polímero 
puro (Hsu y col., 2012). 
5.3.ENSAYOS TOXICOLÓGICOS A NIVEL MOLECULAR 
La evaluación de efectos a nivel molecular nos da una información a nivel 
génico y proteico de los efectos desencadenados tras la exposición a un xenobiótico. En 
este sentido los datos obtenidos completarían el perfil toxicológico de una sustancia, ya 
que los ensayos llevados a cabo para determinar estos parámetros pueden realizarse 
tanto in vitro como in vivo. Los ensayos más destacados a nivel molecular son la 
Reacción en Cadena Polimerasa Cuantitativa a Tiempo Real (qPCR), que evalúa la 
expresión génica, y, el Western Blot, destinado a la evaluación de la abundancia 
proteica. 
La invención de la reacción en cadena de la polimerasa (PCR) por K. Mullis y 
sus colaboradores en 1985 ha revolucionado la biología y la medicina molecular (Saiki 
y col., 1985). La reacción en cadena de la polimerasa es una técnica in vitro utilizada 
para amplificar enzimáticamente una región determinada de ADN situada entre dos 
regiones de ADN cuya secuencia se conoce. Mientras que antes solo podían obtenerse 
cantidades mínimas de un gen específico, ahora incluso un único ejemplar de un gen 
puede amplificarse con la PCR hasta un millón de ejemplares en poco tiempo. Las 
técnicas de PCR se han hecho indispensables para muchos procedimientos comunes, 
como la clonación de fragmentos específicos de ADN, la detección e identificación de 
genes para diagnóstico y medicina legal, y en la investigación de modelos de expresión 
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de los genes, siendo este último el aspecto que más nos interesa. Más recientemente, la 
PCR ha permitido la investigación de nuevos campos, como el control de la 
autenticidad de los alimentos, la presencia de ADN modificado genéticamente y la 
contaminación microbiológica (Somma y Querci, 2007). 
En el caso de la qPCR, se mide la cantidad de ADN después de cada ciclo por el uso 
de marcadores fluorescentes que se incorporan en la reacción final o bien en la mezcla 
del gen seleccionado (sonda+gen). El aumento de la señal fluorescente es directamente 
proporcional al número de moléculas del gen (amplicones) generados en la fase 
exponencial de la de reacción. Se usan indicadores fluorescentes que se incluyen en el 
ADN de doble cadena a colorantes de unión, moléculas de colorante unidas a los 
cebadores de PCR o sondas que son incorporadas en el producto durante la 
amplificación. Se mide el cambio en la fluorescencia durante el transcurso de la 
reacción por un instrumento que combina el ciclo térmico con capacidad de escaneado. 
El instrumento de qPCR genera una trama de amplificación que representa la 
acumulación de producto durante la duración de toda la reacción de PCR, finalmente se 
compara con la expresión de un estándar conocido normalizándose de tal forma la 
cantidad expresada del gen seleccionado. Los datos obtenidos mostrarán una baja o 
sobreexpresión con respecto al grupo control, determinando el tipo de afectación 
producido por la sustancia objeto de estudio (Invitrogen, Life Technologies). 
Por otro lado, el Western blot se utiliza a menudo en la investigación para separar e 
identificar las proteínas. Esta técnica se centra en la separación de proteínas en base al 
peso molecular de cada una a través de electroforesis en gel. Estos resultados son 
transferidos a una membrana donde aparece una banda para cada proteína. La 
membrana se incuba a continuación con anticuerpos específicos para la proteína de 
interés, uniéndose a ella y dando lugar a la banda de señal. El espesor de la banda 
corresponde a la cantidad de proteína presente; por lo tanto, haciendo un estándar puede 
indicar la cantidad de proteína presente (Mahmood y Yang, 2012). 
En literatura no existen hasta el momento estudios que evalúen la influencia de las 
arcillas destinadas a la industria alimentaria en la modulación de la expresión génica y 
abundancia proteica tras su exposición. 
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6. COMERCIALIZACIÓN Y ASPECTOS REGULATORIOS 
Como hemos estado viendo a lo largo de esta introducción, no sólo es importante la 
optimización de procesos y la creación de productos nanocompuestos poliméricos de 
arcilla destinados al mercado, sino que también hay otras dos cuestiones que hasta el 
momento han recibido poca atención: la migración y la toxicidad de estos nuevos 
materiales. De esta forma, la evaluación de organoarcillas debe centrarse no solo en la 
arcilla modificada incorporada ya al polímero, sino también, en la propia arcilla antes y 
después de la modificación e incorporación.  
Hasta la fecha, no existe una evidencia científica rotunda que sugiera motivo de 
preocupación por el uso de arcillas modificadas; sin embargo, es lógico que los nuevos 
alimentos y materiales de envasado deben ser minuciosamente evaluados con el fin de 
cumplir con los requisitos de la EFSA y otros organismos reguladores, siendo probable 
que la investigación sobre propiedades de migración y la toxicidad de polímeros 
nanocompuestos usados en la industria alimentaria como materiales en contacto con 
alimentos se amplíe en un futuro muy cercano (Plackett y Siró, 2012). 
Si bien es cierto, que hasta el momento no se han comercializado en Europa, 
productos nanocompuestos de arcilla destinados al envasado de alimentos, la EFSA, si 
propone diferentes guías, ya mencionadas en el apartado 5, para la evaluación de nuevos 
materiales destinados al contacto de alimentos (EFSA, 2011a, 2011b, 2015).Para ello, 
sería necesaria realizar una exhaustiva evaluación en la actualidad, con el fin de que en 
un futuro temprano se puedan comercializar estos envases mejorados, y sobre todo, 
seguros.  
Además, es muy importante destacar el Reglamento UE Nº 10/2011 de la Comisión 
de 14 de enero de 2011 sobre materiales y objetos plásticos destinados a entrar en 
contacto con alimentos y la Directiva del Consejo del 18 de octubre de 1982, por la que 
se establecen las normas básicas necesarias para evaluar la migración de los 
constituyentes de materiales y objetos plásticos destinados a entrar en contacto con 
productos alimenticios. En ambos se recogen los aspectos relacionados con los 
materiales plásticos y objetos destinados a entrar en contacto con los alimentos (en 
nuestro caso, materiales nanocompuestos poliméricos de arcilla) y los productos 
alimenticios, así como los simuladores utilizados en los ensayos de migración, 
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estableciendo que la evaluación del riesgo debe cubrir la migración potencial en las 
peores condiciones previsibles de uso y toxicidad. 
Por otra parte, el Reglamento UE Nº 10/2011 de la Comisión también establece un 
límite de migración global de 10 mg / dm
2
, basándose en que los materiales plásticos y 
artículos derivados no deberán ceder sus componentes a los alimentos simuladores en 
cantidades superiores a 10 mg de los componentes totales liberados por dm
2
 de 
superficie en contacto con el alimento. 
Como curiosidad, comentar que en otros países ajenos a la UE, como es el caso de 
EE.UU., podemos encontrar materiales ya comercializados y aprobados por la 
Admistración de Drogas y Alimentos (U.S. Food and Drug Administration, FDA), 
Autoridad Americana de Alimentación, homóloga a la EFSA en Europa. Por ejemplo, 
Bayer Polymers (Pittsburgh, PA, EE.UU) ha introducido Durethan®, una poliamida que 
contiene silicato en capas como nanorrelleno para proveer mejores propiedades contra 
el gas y la humedad al polímero, y así proporcionar una mayor vida útil a los productos 
alimenticios (Anon, 2009). Nanocor (Arlington Heights, IL, EE.UU.) anuncia la oferta 
de nanocristales que pueden ser usados para mejorar las propiedades de barrera de 
plásticos de botellas de cerveza y mejorar así la vida útil de la bebida. Además, el 
ejército de EE.UU. ha llevado a cabo una investigación acerca de la  producción de 
bolsas de comidas preparadas listas para consumir a base de polietileno de baja 
densidad con un refuerzo de un 7,5% de lámina de silicatos, más específicamente Mt, 
como nanorelleno. Por la incorporación de estás láminas de silicato se han conseguido 
mejoras térmicas, mecánicas y de barrera muy significativas comparadas con el material 
de partida (National Nanotechnology Initiative, 2009). Por otro lado, Honeywell ofrece 
seis resinas con diferentes grados de rellenos basados en nanoarcillas-nylon, bajo el 
nombre comercial Aegis®. Estos productos han sido utilizados por Anchor Brewing 
Company (San Francisco) para botellas de cervezas y films especiales. Un ejemplo de 
estos materiales es Nanocor Nano-PA-6,conocido por ser el primer plástico comercial 
nanocompuesto usado como empaquetado flexible, así como revestimiento para cartón 
con fin de aumentar la barrera contra la humedad y el oxígeno, por ejemplo para 
tetrabricks de leche y zumos. Además se ha visto que proporciona una mejor rigidez y 
resistencia al calor. Por otro lado, otros nanocompuestos de resinas de Nanocor se han 
utilizado para botellas multilaminadas de polietileno (PET) y en botellas que alberguen 
alimentos sensibles al dióxido de carbono y al oxígeno. En diciembre de 2009, la FDA 
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aprobó la comercialización de el producto Nanocor-Mt, tratado con sales de amonio 
cuaternario, destinado a incrementar las propiedades barrera de botellas de PET 
(Plackett y Siró, 2012). 
Siempre que sea posible, teniendo en cuenta como fin último la seguridad de los 
consumidores, la producción de polímeros nanocompuestos en áreas especializadas 
podría tener ventajas significativas en términos de manejo y seguridad, especialmente 
teniendo en cuenta los materiales para envases de alimentos y bebidas. 
 
7. OTROS USOS Y VÍAS DE EXPOSICIÓN 
A lo largo de la historia las arcillas han sido utilizadas por el ser humano con fines 
terapéuticos. Los minerales de arcilla pueden ser beneficiosos para la salud humana, 
sirviendo como principios activos o excipientes en forma de preparados farmacéuticos, 
en los balnearios y en la medicina terapéutica de belleza (Carretero y col., 2006). 
El uso de minerales de arcilla en las formulaciones farmacéuticas ha sido descrito 
por muchos autores, destacando el uso de caolinita, talco, paligorskita, y esmectitas, 
como principios activos o excipientes de las mismas (Viseras y López-Galindo, 1999; 
López-Galindo y Viseras, 2000; Carretero, 2002). Las propiedades fundamentales por 
las que los minerales de arcilla se utilizan en la industria farmacéutica son las 
comentadas a lo largo de secciones anteriores: el alta área específica y capacidad de 
absorción, contar con características reológicas favorables, la inercia química, baja o 
nula toxicidad para el paciente (aspecto que habría que corroborar), y bajo precio 
(Carretero y col., 2006). 
Las arcillas pueden ser administradas a los pacientes como protectores  
gastrointestinales, antiácidos y/o antidiarreicos, bien por vía oral en forma de píldoras, 
polvos, suspensiones, y emulsiones, o bien, por vía tópica usándose como protectores 
dermatológicos o por razones de estéticas. 
Además, la caolinita, el talco, la paligorskita, y las esmectitas también se utilizan 
como excipientes en cosmética y preparaciones farmacéuticas, funcionando como: 
lubricantes para facilitar la fabricación de pastillas; agentes para ayudar a la 
desintegración a través de su capacidad de hincharse en presencia de agua o por medio 
Introducción/Introduction 
 
48 
 
de la dispersión de fibras, promoviendo la liberación de la droga cuando llega al 
estómago; y, como emulsionantes, geles polares y agentes espesantes por sus 
características coloidales, evitando la segregación de los componentes de la formulación 
farmacéutica y la formación de un sedimento que precipite y no se distribuya (Carretero 
y col., 2006). 
Por otro lado, Carretero y col. (2006) también describieron que las arcillas pueden 
utilizarse también en spas y tratamientos de belleza, como es el caso de las caolinitas y 
esmectitas. 
Las principales propiedades de los minerales de arcilla que determinan su utilidad 
en el spa y medicina estética, son: a) la suavidad y el pequeño tamaño de la partícula, 
ideal para la aplicación del lodo o la mascarilla facial o corporal; b) las propiedades 
reológicas adecuadas para la formación de una viscosa y consistente pasta, y buenas 
propiedades plásticas para una fácil aplicación y adhesión a la piel durante el 
tratamiento; c) la similitud en el pH al de la piel con el fin de evitar la irritación u otra 
alteración dermatológica; d) gran capacidad de absorción(las arcillas pueden eliminar el 
exceso de grasa y las sustancias tóxicas de la piel, siendo muy eficaces contra las 
enfermedades dermatológicas tales como forúnculos, acné, úlceras, abscesos y 
seborrea); e) alta capacidad de intercambio iónico, permitiendo un intercambio de 
nutrientes (Ca
+
 ó Na
+
) mientras la arcilla está en contacto con la piel; f) alta capacidad 
de retención de calor. Como el calor es también un agente terapéutico, las arcillas se 
aplican en caliente para tratar inflamaciones reumáticas, traumatismos deportivos 
crónicos, y problemas dermatológicos. 
A parte de las dos vías de exposición ya nombradas, la oral y la dérmica, la vía de 
entrada de minerales de arcillas al organismo más común es la vía inhalatoria (Zhao y 
Castranova, 2011; Silvestre y col., 2011). No obstante, en la actualidad existe escasa 
información sobre la exposición ocupacional a los minerales de arcilla en las minas, 
plantas de procesamiento, y las industrias. Sin embargo, se saben que el altos niveles de 
minerales de arcilla o la exposición inadecuada a estos en el medio ambiente y los seres 
humanos pueden dar lugar a efectos indeseables (Zhu y Njuguna, 2014). 
Los polvos minerales causan daños por inhalación, y rara vez por ingestión o 
penetración en la piel. En los pulmones, los minerales pueden producir diversas 
patologías como cáncer de pulmón o mesotelial y neumoconiosis. Las patologías 
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provocadas por minerales puede ser determinada mediante estudios epidemiológicos, 
basados en la evaluación de la relación que hay entre la exposición humana a una 
sustancia peligrosa y los efectos potenciales para la salud que se pueden dar tras esa 
exposición; además puede evaluarse mediante estudios in vivo  e in vitro, estudiando los 
efectos de la exposición a polvos minerales en modelos animales o bien determinando la 
actividad biológica de un mineral en líneas celulares específicas, respectivamente 
(Guthrie, 1992). 
Aunque los datos son antiguos, hasta el momento, el efecto nocivo causado por 
inhalación de la caolinita, está principalmente relacionado con la presencia de diversos 
minerales en las rocas, entre los que se encuentra el cuarzo. Trabajadores expuestos al 
polvo de la caolinita han desarrollado en muchos casos neumoconiosis; sin embargo no 
hay un gran número de datos relacionados con el cáncer de pulmón (Ross y col., 1993). 
Los estudios epidemiológicos llevados a cabo con trabajadores expuestos a sepiolita 
no mostraron datos que supusiesen riesgo de padecer enfermedad pulmonar, pudiendo 
concluir que la exposición a este tipo de minerales no supone ningún riesgo (Mc 
Connochie y col., 1993; Ross y col., 1993; Santaren y Alvarez, 1994). 
Respecto al grupo de las esmectitas, en bibliografía científica hay pocos estudios 
epidemiológicos disponibles de enfermedades respiratorias causadas por la exposición a 
ellas. Algunos estudios sugieren que determinadas muestras pueden provocar una 
respuesta fibrogénica dependiente de la dosis ante altos niveles de exposición. 
Generalmente, sin embargo, hay una exposición concomitante a otros minerales (por 
ejemplo, sílice y anfíboles), complicándose la interpretación de los datos obtenidos. Así, 
los depósitos de bentonita generalmente contienen otros minerales, incluyendo cuarzo 
de grano muy fino y sílice. En el caso de Wyoming (EE.UU.) el contenido de bentonitas 
en sílice y cuarzo oscila entre un 0 a 24% (Ross y col., 1993). 
En conclusión, para todo tipo de aplicaciones sería necesaria una evaluación caso 
por caso, teniendo en cuenta tipo de arcilla, tiempo y vía de exposición, y dosis 
empleadas como factores más importantes para una correcta evaluación de riesgo. 
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8. ACEITES ESENCIALES, OTRA ALTERNATIVA PARA EL 
ENVASADO ALIMENTARIO 
La industria alimentaria, como hemos visto en el caso de materiales 
nanocompuestos, con idea de suplir carencias presentes en la conservación de 
alimentos, han hecho necesaria la aparición de un nuevos tipos de envases que permitan 
cubrir tanto las necesidades de los consumidores, enfocadas a alimentos más sanos y 
naturales, como las derivadas de la globalización de la alimentación, que necesita 
alimentos que permanezcan con sus cualidades inalteradas durante períodos de tiempo 
más prolongados.  
Los materiales nanocompuestos poliméricos de arcilla son una alternativa real en 
diversas zonas del mundo, que persigue el aumento de la vida útil del alimento 
centrándose en las propiedades tecnológicas del envasado en sí, dando lugar a las 
mejoras descritas, pero no ejerce ningún efecto directo sobre el propio alimento.  
Sin embargo, no es la única opción que se baraja dentro del área del envasado, 
valorándose y desarrollándose una perspectiva ecológica y sostenible, compartida por 
las empresas de la industria alimentaria, el envasado activo (Tharanathan, 2003). 
Además, la presión ejercida por parte de los consumidores, siendo cada vez más 
conscientes de los problemas derivados del uso de aditivos sintéticos en los alimentos, 
unida a la necesidad de gestionar los subproductos de las industrias y buscar fuentes 
renovables para la creación de polímeros, hace que empiecen a desarrollarse envases 
con compuestos naturales (Llana-Ruíz Cabello, 2014). 
El envasado activo permite que los alimentos puedan estar en una atmósfera natural, 
donde constituyentes del envase, generalmente  aceites esenciales, interaccionan durante 
el tiempo que el alimento está envasado, aprovechando estas propiedades 
antibacterianas y antioxidantes que presentan estos extractos naturales y aumentando así 
la durabilidad de los alimentos. Este nuevo concepto de envase en el que se fuerza la 
interacción del mismo con el alimento plantea una serie de retos, en relación a la 
evaluación de la seguridad, en comparación con el envasado tradicional que buscaba 
materiales inertes que actuasen como mera barrera frente al ambiente externo (Danielli 
y col., 2008). 
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En la actualidad, este tipo de envasado está siendo utilizado en determinados países 
como Japón y EE.UU.; sin embargo, la legislación europea, más restrictiva, ha retrasado 
su incorporación al mercado comunitario por demandar estudios que aseguren la 
utilidad e inocuidad de estos nuevos materiales. La nueva normativa comunitaria 
(EFSA, 2009b, 2011b; Reglamento UE 119/2011) intenta agilizar y sistematizar los 
procedimientos de presentación de solicitudes de autorización de sustancias activas, la 
evaluación de los riesgos inherentes a estos materiales y las normas relativas al 
etiquetado. Sin embargo, estos nuevos materiales son mínimamente utilizados por la 
industria alimentaria, pudiendo ser debido a factores socio‐económicos, inquietudes y 
elecciones de los consumidores y, cuestiones no resueltas e inseguridades sobre la 
implementación (Chaves Sánchez, 2011). 
Entre los constituyentes principales de estos nuevos envasados se encuentran los ya 
mencionados aceites esenciales, cuyo uso, con el fin de beneficiarse de sus propiedades 
antibacterianas, antioxidantes y/o aromáticas una vez que se ponen en contacto con los 
alimentos, se ha demostrado a lo largo de los años en muchas partes del mundo 
(Dainielli y col., 2008). Estos conocimientos previos sobre los aceites esenciales han 
hecho posible que aumente el interés del uso de los mismos, respondiendo a las 
demandas de la población y aumentando la vida útil de los alimentos, cubriendo 
debilidades presentes en la industria alimentaria. Los aceites esenciales y extractos de 
diferentes géneros de especies vegetales se han convertido, así, en un recurso a estudiar 
en el desarrollo de envases activos. 
Muchos de estos aceites y sus componentes principales están recogidos en la 
Decisión de la Comisión 2002/113/EC como aromatizantes permitidos en la UE, por 
ejemplo el timol, linalol, carvacrol, limoneno o eugenol, para los que no se considera 
que exista riesgo para la salud del consumidor (Hyldgaard y col., 2012). En EE.UU., 
existen aceites esenciales (orégano, timo, mostaza o albahaca) que ya están clasificados 
como Generally Recognized as Safe (GRAS) por la FDA (Zhou y col., 2006; López y 
col., 2007). A parte de sus aplicaciones conocidas como aromatizantes se han 
desarrollado aplicaciones como conservantes en alimentación por las propiedades 
antioxidantes y antibacterianas que presentan (Dusan y col., 2006). Existen algunos 
trabajos en bibliografía que combinan la presencia de arcillas y aceites esenciales en 
matrices poliméricas, destacando la mejora de las propiedades barrera (causado por las 
arcillas) y el aumento de las propiedades antimicrobianas (debido a los aceites 
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esenciales de mejorana o clavo), dando lugar a un producto final con un perfil muy 
mejorado (Alboofetileh y col., 2014). 
Teniendo en cuenta que la seguridad alimentaria y la calidad son las dos principales 
preocupaciones para la industria alimentaria, si el uso de estos aceites conduce a una 
mejora por su potencial antimicrobiano en el deterioro producido por microorganismos 
de los productos alimenticios y, consecuentemente, una disminución de diversas 
enfermedades en los seres humanos, estamos ante una opción muy atractiva. Además, la 
oxidación como proceso de degradación también juega un papel en numerosos 
productos alimenticios, siendo el potencial antioxidante de estas sustancias bien 
reconocido, presentándose así un papel crucial en este aspecto. Ortega-Ramírez y col. 
(2014) declararon que las propiedades antimicrobianas y antioxidantes de los 
compuestos bioactivos se deben principalmente a sus propiedades redox, su capacidad 
quelante de metales, y la capacidad de extinguir a especies reactivas de oxígeno 
singlete. Por esta razón, los aceites esenciales o sus componentes individuales son una 
buena opción para ser utilizados en la industria alimentaria para la mejora de la vida útil 
de los productos alimenticios. Sin embargo, hay algunas limitaciones para la aplicación 
de estas sustancias, ya que la variabilidad química en su composición  podría 
desempeñar un papel importante en su actividad (Prakash y col., 2015). 
Solórzano-Santos y Miranda-Novales (2012) publicaron que los efectos deseables 
(antimicrobiano/antioxidante) de los aceites esenciales o sus componentes añadidos 
directamente a los alimentos, se observaban a determinadas concentraciones, ya que a 
concentraciones superiores se producían cambios indeseables en el sabor, el olor, etc. 
Alcanzar concentraciones efectivas sin añadir grandes cantidades de estas sustancias ha 
llevado a la industria alimentaria a desarrollar diversos métodos de envasado activo en 
los que el aceite no es añadido como un ingrediente directo del alimento, sino como un 
componente del envase, produciéndose una liberación controlada de los mismos y 
ejerciéndose los efectos beneficiosos de manera gradual. 
Con esta nueva propuesta de envasado alimentario, en los que se produce migración 
de las sustancias al espacio de cabeza y se genera inevitablemente contacto con el 
alimento, es necesario realizar una evaluación del riego exhaustiva para salvaguardar la 
salud del consumidor y cumplir así con el requisito de evaluación de la seguridad 
exigido por el Reglamento 1935/2004 y EFSA (2011b, 2015) sobre los materiales y 
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objetos destinados a entrar en contacto con alimentos. De tal forma, sería necesaria una 
evaluación caso por caso y una exhaustiva revisión bibliográfica de los estudios 
disponibles en bibliografía acerca del estado del arte de estos nuevos e interesantes 
sistemas de envasado activos, así como el riesgo asociado a la posible comercialización 
de estos envases.  
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Teniendo en cuenta lo descrito previamente, se deduce que aunque la aplicación 
de diferentes sustancias de origen natural incorporadas al envasado alimentario, tales 
como arcillas o aceites esenciales, es de interés con el fin de aumentar la vida útil del 
alimento, también supone un riesgo potencial para el hombre y el medio ambiente. Este 
riesgo está íntimamente ligado a la posible migración de dichos materiales incorporados 
a los polímeros de envase, que serían ingeridos junto con el alimento por el consumidor. 
De tal forma, una correcta evaluación de los riesgos derivados de la exposición humana 
a estas sustancias, arcillas o aceites esenciales, así como a los nuevos materiales de 
envasado que surgen tras su incorporación, se hace obligatoria. Esta evaluación requiere 
de una detallada caracterización del peligro, conociendo los efectos tóxicos que se 
producen tras la exposición de líneas celulares de órganos diana a los mismos, así como 
el resultado de la exposición de modelos experimentales in vivo, con el objetivo de 
poder extrapolar los datos de forma más certera al escenario de exposición humana real. 
En este sentido, tras una exhaustiva revisión bibliográfica en la que se verificó la 
disparidad de los resultados disponibles, se planteó el estudio de los efectos tóxicos de 
distintas organoarcillas modificadas con sales de amonio cuaternario y silanos, tanto in 
vitro como in vivo. De algunas de estas arcillas además, no existían datos en la literatura 
científica al ser de reciente desarrollo, por lo que su evaluación toxicológica se hacía 
más necesaria si cabe. Por otro lado, se evaluó in vitro el potencial genotóxico de 
compuestos mayoritarios del aceite esencial de orégano, una de las opciones más 
utilizadas en el área del envasado activo alimentario. 
Teniendo en cuenta que la vía de exposición humana más probable es la oral, 
resulta de gran interés evaluar la respuesta de líneas celulares de órganos involucrados 
en el proceso digestivo, destacando el órgano primordial implicado en la absorción, el 
intestino, y el principal órgano implicado en la biotransformación de xenobióticos, el 
hígado. Por otro lado, sería interesante comprobar también el efecto tóxico tras la 
posible distribución a través de la circulación sanguínea de los materiales de estudio. Es 
por ello que se decidió investigar in vitro, en las células humanas Caco-2 (intestinales), 
HepG2 (hepáticas), y HUVEC (endoteliales), el potencial citotóxico y mecanismos de 
acción tóxica, a diferentes tiempos de exposición, de arcillas destinadas a ser 
incorporadas al envasado alimentario, así como el efecto a nivel molecular evaluando su 
expresión génica tras la exposición a concentraciones subcitotóxicas. Además, la 
evaluación toxicológica de extractos de migración obtenidos a partir del contacto de 
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simulantes alimentarios con los materiales nanocompuestos con arcillas incorporadas 
era necesaria, siendo evaluados éstos en diferentes modelos experimentales in vitro. 
Una vez comprobado el potencial tóxico in vitro y seleccionada la arcilla de 
mejor perfil tecnológico y toxicológico, se consideró interesante llevar a cabo un 
estudio in vivo de toxicidad subcrónica a dosis respetidas (90 días) en roedores, 
basándonos en el peor escenario posible de migración al cual podría estar expuesto el 
consumidor. Se realizaron estudios histopatológicos en una amplia diversidad de 
órganos que podrían verse afectados y se evaluaron mediante diferentes ensayos 
marcadores de estrés oxidativo, de inflamación, expresión génica y abundancia proteica. 
Igualmente, se investigó la presencia de metales característicos de la estructura de las 
arcillas, ahondando más en la investigación para identificar posibles alteraciones.  
En cuanto a los aceites esenciales y sus componentes mayoritarios los datos 
disponibles hasta el momento sobre su uso en el envasado de alimentos son 
contradictorios , , siendo necesaria también una amplia revisión de los principales 
efectos antimicrobianos/antioxidantes sobre el alimento proporcionados tras su 
incorporación al envase, y los principales efectos citotóxicos en líneas celulares 
humanas. Además, dentro de las apuestas de la industria alimentaria, destaca el aceite de 
orégano y sus componentes más importantes, el carvacrol y el timol. El uso de estos 
compuestos ha sido descrito por diversos autores pero los resultados publicados por el 
momento no indican un comportamiento similar de los mismos. Por ello, nos resultó 
interesante evaluar la genotoxicidad del carvacrol y timol mediante dos ensayos 
exigidos por la EFSA, el ensayo de micronúcleos y el ensayo de linfoma de ratón, el 
segundo de ellos no llevado a cabo hasta el momento, completando así la información 
toxicológica disponible de estas sustancias. 
Para la realización de esta Tesis Doctoral, la doctoranda llevó a cabo dos 
estancias nacionales y una estancia internacional de investigación, en la que se 
abordaron tres objetivos fundamentales: a) Desarrollo y diseño de nuevas arcillas 
modificadas con silanos destinadas al envasado alimentario, así como un acercamiento a 
las técnicas de evaluación de propiedades tecnológicas: mecánicas, térmicas y de 
barrera; b) aprendizaje de nuevos ensayos de genotoxicidad de acuerdo con la normativa 
de la Organización para la Cooperación y Desarrollo Económico (OCDE), tales como el 
ensayo de micronúcleos y el ensayo de linfoma de ratón, exigidos por las autoridades 
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competentes para la comercialización de nuevos productos que van a estar en contacto 
con alimentos; c) aprendizaje de técnicas de biología molecular como aislamiento de 
ARN y PCR cuantitativa a tiempo real (q-PCR), investigando la influencia que tienen 
las arcillas destinadas al envasado de alimentos en la modulación de la expresión génica 
a nivel de ARNm. 
Por todo ello, los objetivos específicos establecidos en la presente Tesis Doctoral 
han sido: 
1. Realizar una exhaustiva valoración y revisión bibliográfica del estado del arte 
actual y los datos de toxicidad disponibles de arcillas no modificadas y 
modificadas destinadas a la industria alimentaria, así como de los materiales 
poliméricos resultantes que las contienen. 
2. Evaluar el potencial tóxico in vitro de la arcilla no modificada, la montmorillonita 
(Cloisite®Na
+
 (CNa
+
)), y de arcillas modificadas con sales de amonio cuaternario 
(Cloisite®30B (C30B), Cloisite20A (C20A), Clay1 y Clay2) en líneas celulares 
de órganos diana (HepG2, Caco-2 y HUVEC), determinando los mecanismos de 
acción tóxica mediante la realización de ensayos de genotoxicidad/mutagenicidad, 
estrés oxidativo, inflamación, etc., y definiendo el perfil toxicológico de cada una, 
además de una evaluación mediante microscopía de posibles alteraciones celulares 
ultraestructurales. 
3. Poner a punto e investigar por primera vez, la influencia que tienen las arcillas 
(CNa
+
, C30B, Clay1 y Clay2) en la modulación de la expresión génica a nivel de 
ARNm de células HepG2 mediante la técnica q-PCR. 
4. Estudiar el potencial citotóxico y mutagénico de los extractos de migración 
obtenidos a partir de polímeros (ácido poliláctico) con organoarcillas incorporadas 
(Clay1 y Clay2), además del contenido de metales (Al, Ca, Fe, Mg, Si) que hayan 
migrado del envase al simulante alimentario. 
5. Evaluar el potencial tóxico in vivo, mediante un ensayo de toxicidad oral 
subcrónica de 90 días en roedores (rata Wistar), de una arcilla modificada (Clay1) 
y su extracto de migración, investigando la inducción de estrés oxidativo como 
mecanismo de acción tóxica, los cambios y alteraciones histopatológicas de 
distintos órganos tras la exposición, marcadores de inflamación y análisis de la 
bioquímica clínica. 
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6. Explorar las alteraciones a nivel de expresión génica mediante qPCR y Western 
Blot de enzimas involucradas en la defensa antioxidante (CAT y SOD) en órganos 
diana (hígado y riñón) tras la exposición subcrónica de roedores a la arcilla 
modificada Clay1 y su extracto de migración. 
7. Analizar la presencia de metales comunes de la estructura de las arcillas en el 
bazo de roedores, tras la exposición durante 90 días a la arcilla modificada Clay1 
y su extracto de migración. 
8. Desarrollo y caracterización de tres nuevas arcillas modificadas con silanos 
(Clay3, Clay4A y Clay4B) destinadas a ser incorporadas a polipropileno con el fin 
de mejorar sus propiedades para su aplicación en envasado alimentario y 
evaluación del incremento de la vida útil de alimentos. 
9. Investigar el potencial tóxico in vitro de las nuevas arcillas modificadas con 
silanos y sus extractos de migración en dos líneas celulares de órganos diana 
(HepG2 y Caco-2) mediante ensayos de citotoxicidad, 
genotoxicidad/mutagenicidad, estrés oxidativo y citometría de flujo.  
10. Evaluar la migración de metales propios de la estructura de las arcillas en 
simulantes alimentarios que han estado en contacto con materiales 
nanocompuestos poliméricos conteniendo Clay3 y Clay4B. 
11. Revisar la bibliografía disponible sobre los efectos antioxidantes y 
antimicrobianos de los aceites esenciales y sus componentes mayoritarios 
incorporados a envases y las propiedades de los envases resultantes, así como 
llevar a cabo un estudio de sus principales efectos citotóxicos. 
12. Estudiar la genotoxicidad de los compuestos mayoritarios del aceite esencial de 
orégano, timol y carvacrol, mediante el ensayo de micronúcleos y, por primera 
vez, el ensayo de linfoma de ratón. 
 
El trabajo experimental se ha realizado en el Área de Toxicología de la Facultad 
de Farmacia de la Universidad de Sevilla, haciendo uso, así mismo, del Servicio de 
Biología y de Microscopía del Centro de Investigación, Tecnología e Innovación de la 
Universidad de Sevilla (CITIUS). El desarrollo de las arcillas se ha llevado a cabo en 
colaboración con el Área de Materiales del Instituto Tecnológico del Embalaje, 
Transporte y Logística (ITENE) de Valencia, gracias a las Dras. Susana Aucejo y María 
Jordá. Parte de la investigación llevada a cabo a nivel molecular, así como el ensayo de 
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genotoxicidad de micronúcleos en células HepG2, fueron llevados a cabo en el 
Departamento de Toxicología Genética y Biología del Cáncer, del Instituto Nacional de 
Biología (NIB) de Ljubljana (Eslovenia), bajo la dirección y supervisión de la Dras. 
Metka Filipic y Bojana Zegura. El análisis morfológico a nivel celular ha sido realizado 
en colaboración con el Dr. Javier Moreno Onorato del grupo de Citoquímica 
Ultraestructural del Departamento de Biología Celular de la Facultad de Biología de la 
Universidad de Sevilla. Así mismo, los estudios histopatológicos se han realizado en 
colaboración con el Área de Toxicología y el Departamento de Anatomía y Anatomía 
Patológica Comparadas, ambos de la Universidad de Córdoba, gracias a la colaboración 
de la Dra. Rosario Moyano y el Dr. Alfonso Blanco. La evaluación de la bioquímica 
clínica del suero sanguíneo se ha llevado a cabo en la Unidad de Bioquímica Clínica del 
Hospital Universitario Virgen Macarena de Sevilla. Para el aprendizaje de los ensayos 
de MN y linfoma de ratón se contó con la colaboración del Grupo de Mutagénesis del 
Departamento de Genética y Microbiología de la Universidad Autónoma de Barcelona 
bajo la dirección del Dr. Ricard Marcos. 
Siguiendo la normativa de la Universidad de Sevilla, el resumen, la justificación 
y objetivos, y las conclusiones se redactan tanto en español como en inglés para optar a 
la “Mención Internacional en el Título de Doctor”. 
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Taking into account the state of the art previously described, it is important to 
note that although the new incorporation of natural substances, such as clays or essential 
oils, into food packaging has a great interest in order increase the shelf life of food, they 
also poses a potential risk for humans and the environment. This risk is closely linked to 
the possible migration of the materials incorporated into packaging polymers, which 
would be ingested with food by the consumer. Therefore, a comprehensive assessment 
of human exposure risks to these substances, clays or essential oils, together with the 
new packaging materials created with them, is mandatory. This assessment requires a 
detailed characterization of the  hazard, exploring the toxic effects that occur after 
exposure of several cell lines from target organs, as well as, the result of the exposure 
with in vivo experimental models, in order to extrapolate the data obtained to real 
human exposure scenario. In this sense, after a thorough literature review in which the 
disparity of the available results has been verified, the study of the toxic effects of 
different organomodified clays with quaternary ammonium salts and silanes, both in 
vitro and in vivo, has been performed. In addition, some of these clays have been 
recently developed, therefore no available data in the literature have been found, being 
the toxicological evaluation even more necessary. On the other hand, in vitro genotoxic 
potential of major compounds of the oregano essential oil was evaluated, being one of 
the most used essential oils in active food packaging. 
In this sense, considering that the oral route is the most important to human 
exposure in this kind of substances, it is of great interest to evaluate the response of 
target cell lines from organs involved in the digestive process, emphasizing the first 
organ involved in the absorption, intestine, and the main organ involved in xenobiotics 
biotransformation, liver. On the other hand, it would be also interesting to check the 
toxic effect after a possible distribution through the bloodstream of the materials under 
study. We decided to investigate in vitro, in human cell lines such as Caco-2 (intestinal), 
HepG2 (liver), and HUVEC (endothelial), the cytotoxic potential and the main 
mechanisms of toxicity at different exposure times of several clays intended to be 
incorporated into food packaging. Moreover, the effects produced at the molecular level 
were also evaluated through the gene expression analysis at subcytotoxic 
concentrations. In addition, the toxicological evaluation of migration extracts obtained 
from polymer-clay nanocomposites was necessary, being evaluated in different in vitro 
experimental models. 
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After the in vitro toxicity approach, the clay with the best technological and 
toxicological profile was selected to perform a repeated dose 90-day oral toxicity study 
in Wistar rats, based on the worst scenario of migration which could be exposed the 
consumer. Histopathological studies were performed in a wide variety of organs that 
could be affected and different markers of oxidative stress, inflammation, gene 
expression and protein abundance were evaluated. Similarly, the presence of the major 
metal present in clays structure was determined in order to identify other possible 
alterations. 
Regarding to the essential oils and their main components the available data on 
their use in food packaging, are contradictory so far, being necessary an exhaustive 
review of the main antimicrobial/antioxidant effects of the resultant active packaging on 
the food, and the main cytotoxic effects on human cell lines. Moreover, oregano 
essential oil and its major components, carvacrol and thymol, are one of the options 
most used in the food industry. The use of these compounds has been described by 
several authors but the results published do not indicate a similar behavior of them so 
far. Therefore, we found it interesting to evaluate the genotoxicity of carvacrol and 
thymol by two tests required by EFSA, the micronucleus test and mouse lymphoma 
assay, the second one has not been carried out until now, being completed the available 
toxicological information of these substances. 
For the fulfillment of this thesis, the PhD student performed internships, two 
nationals and one international, in which several objectives were addressed: a) 
development and design of new silane-modified clays intended to be used in food 
packaging as well as an approach to techniques to evaluation their technological 
properties: mechanical, thermal and barrier; b) learn new genotoxicity tests according to 
the rules of the Organization for Economic Cooperation and Development (OECD), 
such as the micronucleus test and mouse lymphoma assay, required by the competent 
authorities to commercialize new products that will be in contact with food; c) learn 
molecular biology techniques as RNA isolation and real-time quantitative PCR (q-
PCR), to investigate the influence of clays in the modulation of gene expression at the 
mRNA level. 
Therefore, the specific objectives in this PhD thesis were: 
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1. To perform a comprehensive assessment and literature review of the current 
state of art and toxicity data of unmodified and modified clays intended to be 
used in the food industry, as well as, the resulting polymeric materials that 
contain them. 
2. To evaluate the in vitro toxicity potential of the unmodified clay, 
montmorillonite (Cloisite®Na
+
(CNa
+
)) and quaternary ammonium salts-
modified clays (Cloisite®30B (C30B), Cloisite20A (C20A) and Clay2 clay1 ) in 
target cell lines (HepG2, Caco-2 and HUVEC), determining the action 
mechanisms by testing genotoxicity/mutagenicity, oxidative stress, 
inflammation, etc., defining each toxicological profile, and possible 
ultrastructural cellular alterations by microscopy. 
3.  To develop and investigate the influence of clays (CNa+, C30B, Clay1 and 
Clay2) in the modulation of gene expression at the mRNA level of HepG2 cells 
by q-PCR. 
4. To study the cytotoxic and mutagenic potential of migration extracts obtained 
from polymers (polylactic acid) with organomodified clays (Clay1 and Clay2) 
and the migration of metals content (Al, Ca, Fe, Mg, Si) presented in the food 
simulants. 
5. To analyze the in vivo toxicity potential, by performing a repeated dose 90-day 
oral toxicity study in Wistar rats exposed to a modified clay (Clay1) and its 
migration extract, researching the induction of oxidative stress as a toxicity 
mechanism, histopathological alterations of different organs, inflammation 
responses and analysis of clinical biochemistry. 
6. To explore the alterations in gene expression by qPCR and Western blotting of 
enzymes involved in antioxidant defense (SOD and CAT) from target organs 
(liver and kidney) of rats exposed subchronically to modified clay, Clay1, and 
its migration extract. 
7. To determine the presence of major metals of clays structure in the spleen of 
rodents after exposure during 90 days to a modified clay, Clay1, and its 
migration extract. 
8. To develop and characterize three new silane-modified clays (Clay3, Clay4A 
and Clay4B) intended to be incorporated to polypropylene (PP) in order to 
improve their properties for application in food packaging and evaluation of the 
increase of food shelf life. 
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9. To investigate the in vitro toxicity potential of new silane-modified clays and 
their migration extracts in two target cell lines (HepG2 and Caco-2) by testing 
cytotoxicity, genotoxicity / mutagenicity, oxidative stress and flow cytometry. 
10.  To evaluate the metals migration presented in clays structure in food simulants 
which have been in contact with Clay3 and Clay4A polymer nanocomposites. 
11. To review the available literature on antioxidants and antimicrobial effects of 
essential oils and their major components incorporated into packaging and 
properties of the resulting packages, as well as, conducting a study of their main 
cytotoxic effects. 
12. To study the genotoxicity of the main compounds of oregano essential oil, 
thymol and carvacrol, using the micronucleus test and, for the first time, the 
mouse lymphoma assay. 
The experimental work has been performed in the Area of Toxicology, Faculty of 
Pharmacy, University of Sevilla, using also the Biology Services from Centro de 
Investigación, Tecnología e Innovación from the University of Sevilla (CITIUS). The 
development of the clays was carried out in collaboration with the Department of 
Materials from the Technological Institute of Packaging, Transport and Logistics 
(ITENE) from Valencia, thanks to Drs. Susana Aucejo and Maria Jorda. Part of the 
research conducted at the molecular level, as well as, genotoxicity testing of 
micronuclei in HepG2 cells were carried out in the Department of Genetic Toxicology 
and Cancer Biology, National Institute of Biology (NIB) to Ljubljana (Slovenia), under 
the direction and supervision of Drs. Metka Filipic and Bojana Zegura. Cellular 
morphological analysis has been conducted in collaboration with Dr. Javier Moreno 
Onorato, belonging to Ultrastructural Cytochemistry group from the Department of Cell 
Biology, Faculty of Biology, University of Sevilla. Histopathological studies have been 
performed in the Area of Toxicology and in the Department of Anatomy and 
Comparative Pathology and Anatomy, both from the University of Córdoba, thanks to 
the collaboration of Dr. Rosario Moyano and Dr. Alfonso Blanco, respectively. The 
clinical biochemistry evaluation of blood serum has been carried out in the Clinical 
Biochemistry Unit of the University Hospital Virgen Macarena in Seville. MN and 
mouse lymphoma assays were learned thanks to the collaboration with the Group of 
Mutagenesis of the Department of Genetics and Microbiology at the University 
Autónoma of Barcelona under the direction of Dr. Ricard Marcos. 
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Following the regulations from the University of Sevilla, the summary, 
significance and purposes, and conclusions have been written both in Spanish and 
English to aim for a PhD with International Mention. 
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Clays and clay minerals are widely used in many facets of our society. This review addresses the main
clays of each phyllosilicate groups, namely, kaolinite, montmorillonite (Mt) and sepiolite, placing special
emphasis on Mt and kaolinite, which are the clays that are more frequently used in food packaging, one
of the applications that are currently exhibiting higher development. The improvements in the com-
posite materials obtained from clays and polymeric matrices are remarkable and well known, but the
potential toxicological effects of unmodiﬁed or modiﬁed clay minerals and derived nanocomposites are
currently being investigated with increased interest. In this sense, this work focused on a review of the
published reports related to the analysis of the toxicological proﬁle of commercial and novel modiﬁed
clays and derived nanocomposites. An exhaustive review of the main in vitro and in vivo toxicological
studies, antimicrobial activity assessments, and the human and environmental impacts of clays and
derived nanocomposites was performed. From the analysis of the scientiﬁc literature different conclu-
sions can be derived. Thus, in vitro studies suggest that clays in general induce cytotoxicity (with de-
pendence on the clay, concentration, experimental system, etc.) with different underlying mechanisms
such as necrosis/apoptosis, oxidative stress or genotoxicity. However, most of in vivo experiments per-
formed in rodents showed no clear evidences of systemic toxicity even at doses of 5000 mg/kg. Re-
garding to humans, pulmonary exposure is the most frequent, and although clays are usually mixed with
other minerals, they have been reported to induce pneumoconiosis per se. Oral exposure is also common
both intentionally and unintentionally. Although they do not show a high toxicity through this pathway,
toxic effects could be induced due to the increased or reduced exposure to mineral elements. Finally,
there are few studies about the effects of clay minerals on wildlife, with laboratory trials showing
contradictory outcomes. Clay minerals have different applications in the environment, thus with a strict
control of the concentrations used, they can provide beneﬁcial uses.
Despite the extensive number of reports available, there is also a need of systematic in vitro–in vivo
extrapolation studies, with still scarce information on toxicity biomarkers such as inmunomodulatory
effects or alteration of the genetic expression. In conclusion, a case by case toxicological evaluation is
required taking into account that different clays have their own toxicological proﬁles, their modiﬁcation
can change this proﬁle, and the potential increase of the human/environmental exposure to clay minerals
due to their novel applications.
& 2014 Elsevier Inc. All rights reserved.1. Introduction
Clays and clay minerals (Table 1) belong to the phyllosilicate
group (from the Greek “phyllon”: leaf, and from the Latin “silic”:
ﬂint) (Fig. 1). As a distinctive feature, these materials are very small
(a few micrometres maximum), and their preferred formation
occurs under the surface (alterites, soils, and sediments) oral., Toxicological evaluation
vres.2014.12.024isubsurface (diagenesis and hydrothermal alterations) conditions
(Meunier, 2005). The physical and chemical properties of a parti-
cular clay mineral are dependent on its structure and composition.
The structure and composition of the main industrial clays, i.e.,
kaolins (1:1 phyllosilicates), smectites (2:1 phyllosilicates) and
sepiolite (2:1 inverted ribbons), are very different (Table 2), even
though each is composed of octahedral and tetrahedral sheets as
their basic building blocks. However, the arrangement and com-
position of the octahedral and tetrahedral sheets account for most
of the differences in their physical and chemical properties
(Murray, 2007a).of clay minerals and derived nanocomposites: A review. Environ.
Table 1
Diferences between clay and clay mineral (Bergaya and Lagaly,
2013).
Clay Clay mineral
Natural Natural and synthetic
Fine-grained (o2 or o4 mm) No size criterion
Phyllosilicates as principal constituents May include non-phyllosilicates
Plastic (with some exceptions like ﬂint clays) Plastic
Hardens on drying or ﬁring Hardens on drying or ﬁring
S. Maisanaba et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎2Clays and clay minerals, either as such or after modiﬁcation, are
recognized as the materials of the 21st century because they are
abundant, inexpensive and environmentally friendly. Further in-
troductory aspects of clays have been described by Bergaya and
Lagaly (2013). Phyllosilicates are very important industrial mi-
nerals. There are well over 100 documented industrial applications
of clay materials. Clays are utilized in the process industries, in
agricultural applications, in engineering and construction appli-
cations, in environmental remediation, in geology, and in many
other miscellaneous applications (Murray, 2007b). Currently, the
use of several clays in the food industry is a reality for improving
food packaging. This review focused on the main clays of each
phyllosilicate group, namely kaolinite, montmorillonite (Mt) and
sepiolite, and placed special emphasis on Mt and kaolinite, which
are the clays that are more frequently used in food packaging.
These two clay minerals are among the most frequently used
solid ﬁllers for obtaining novel polymer composites, named na-
nocomposites, due to the small quantity of clay minerals that is
added to the polymer matrix to control the ﬁnal properties of the
nanocomposite and to yield better workability (Annabi-Bergaya
2008; Arora and Padua, 2010). The octahedral and tetrahedral
sheets of their structure, which are known as platelets, are ap-
proximately 1 nm thick and 100 to 500 nm in diameter, resulting
in platelets with a high aspect ratio (Uyama et al., 2003), but clays
are formed by numerous platelets, yielding submicrometer parti-
cles. When clays are dispersed into a polymer matrix, they ex-
perience swelling, dividing all of the platelets into independent
units at the nanometre scale, hence the name “nanocomposite
materials”. These platelets force gases to follow a tortuous path
through the material which greatly slows their transmission. As a
result, a nanolayer clay structure is obtained, and the path of dif-
fusion of the penetrating molecules of gases and other substances
increases, providing substantially improved products (Abacha
et al., 2009; Choudalakis and Gotsis, 2009; Herrera-Alonso et al.,
2010). The effect of nanoclays on the polymer properties lies
mainly on their high surface-to-volume ratio because polymer–
ﬁller interactions are governed by interfacial forces (Arora andFig. 1. Classiﬁcation of silicates with the m
Please cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024iPadua, 2010). The successful formation of a polymer–clay nano-
composite relies on two key characteristics of the component used
for reinforcement. The ﬁrst characteristic is the ability to modify
the chemical surface of the silicates through ion-exchange reac-
tions with organic and inorganic cations in order to produce a
polymer-compatible nanocomponent. The second characteristic is
the ability of the silicate particles to disperse into the polymer,
yielding an exfoliated nanocomposite. In this regard, three differ-
ent clay dispositions can be obtained: (1) Tactoid structures re-
main in a polymer when the interlayer space of the clay gallery
does not expand, usually due to its poor afﬁnity with the polymer.
No true nanocomposites are formed this way (Alexandre and
Dubois, 2000). (2) Intercalated structures are obtained at moderate
expansion of the clay interlayer. In this case, interlayer spaces
expand slightly as polymer chains penetrate the basal spacing of
clay, but the shape of the layered stack remains. This is the result
of moderate afﬁnity between polymer and clay. (3) Exfoliated
structures, clay clusters lose their layered identity and are well
separated into single sheets within the continuous polymer phase.
This is due to a high afﬁnity between polymer and clay (Arora and
Padua, 2010) (Fig. 2). These two characteristics are, of course,
connected to each other because the degree of dispersion of a
layered silicate in a particular polymer matrix depends on the
interlayer cation modiﬁcation (Ray and Okamoto, 2003). However,
a simple dispersion of clays in a polymer matrix will not produce a
nanocomposite with better properties compared with those of the
bulk material due to the poor interfacial interactions between the
hydrophilic reaction sites of clays and the highly hydrophobic
polymer chains (Pisticelli et al., 2010). The solution for the afore-
mentioned disadvantages can be achieved by introducing organic
groups to enhance the interaction between the clays and polymers
(Silva et al., 2011). In this sense, cation exchange is one of the most
useful chemical modiﬁcation procedures used to prepare more
organophilic clays (Pavlidou and Papaspyrides, 2008; Paul and
Robenson, 2008; Ray and Okamoto, 2003), and one of the modi-
ﬁers that is most frequently used is quaternary ammonium salts
(Fig. 3). This produces modiﬁed clays with a hydrophobic character
and a greater interlayer space (Betega de Paiva et al., 2008; Jordá-
Beneyto et al., 2014). Several quaternary ammonium salt-modiﬁed
clays are available in the market, and other clays are under de-
velopment; thus, all of these result in recognized improvements to
the polymers (Bin-Haron, 2010; Carreu, 2011; Jordá-Beneyto et al.,
2014; Lai and Kim, 2005; Pal et al., 2014).
Although the beneﬁcial technical effects of the nanocomposites
obtained from clay minerals have been known for years and are
generally well described, the potential toxicological effects and
impacts of unmodiﬁed or modiﬁed clay minerals and derived
nanocomposites on human and environmental health areain subgroups of clays (WHO, 2005).
of clay minerals and derived nanocomposites: A review. Environ.
Table 2
Chemical composition of the main clays cited.
Name Chemical composition
Basic chemical formula Modiﬁer and modiﬁer concentration
CloisitesNaþ Montmorillonite(Mt) Na0.2Ca0.1Al2Si4O10(OH)2(H2O)10 None
Cloisites30B Modiﬁed Mt Quaternary ammonium salt (MT2EtOH) 90 meq/100 g clay
Cloisites20A Modiﬁed Mt Quaternary ammonium salt (2M2HT) 95 meq/100 g clay
Cloisites93A Modiﬁed Mt Ternary ammonium salt (M2HT) 90 meq/100 g clay
Cloisites15A Modiﬁed Mt Quaternary ammonium salt (2M2HT) 125 meq/100 g clay
Cloisites10A Modiﬁed Mt Quaternary ammonium salt (2MBHT) 125 meq/100 g clay
Clay1 Modiﬁed Mt Quaternary ammonium salt (HDTA) 6-fold the CEC of raw clay (raw clay with
a cation exchange capacity (CEC)¼92.6 meq/100 g clay)
Clay2 Modiﬁed Mt Quaternary ammonium salt (HDTAþACO) HDTA in 5.75-fold and ACO in
0.25-fold of the CEC of raw clay (92.6 meq/100 g clay)
Oligo(styrene-co-acrylonitrile)
Mt
Modiﬁed Mt Quaternary ammonium salt of poly(styrene-co-acrylonitrile) (CEC¼0.9meg/g
clay)
Bentonite Non-modiﬁed Al2O34SiO2H2O None
Active bentonite Modiﬁed bentonite H2SO4 10–15%
Kaolinite Al2Si2O5(OH)4 None
Sepiolite Mg4Si6O15(OH)2 6H2O None
Erionite (Na2,K2,Ca)2Al4Si14O36 15H2O None
Halloysite Al2Si2O5(OH)4 None
Hectorite Na0.3(Mg,Li)3Si4O10(OH)2 None
Illite (K,H3O)(Al,Mg,Fe)2(Si,Al)4O10[(OH)2,(H2O)] None
1 nm 
 remyloP yalC
Tactoid Intercalated Exfoliated 
Melt Blending 
Fig. 2. Schematic representation of intercalated and exfoliated nanocomposites from layered silicate clay ﬁller and polymer (based on Arora and Padua, 2010).
S. Maisanaba et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎ 3currently being investigated with increased interest. The general
population exposure to low concentrations of Mt, kaolinite, and
other clay minerals in their natural form is ubiquitous (WHO,
2005). The incorporation of the clay minerals into polymers can
result in non-intentional exposure to the consumer, and it is thus
necessary to evaluate not only the microstructured clay but also
the imbued nanomaterial in the polymer due to the possible mi-
gration to the food product (EFSA, 2011a; Guillard et al., 2010;
Song et al., 2011). Moreover, humans can absorb clays through
occupational and environmental exposures and also due to their
presence in consumer products (pharmaceutical formulations,
spas, and beauty therapy) (Carretero et al., 2006). In contrast, the
presence of clays in the environment and their effects on wildlife
can also be derived from intentional and non-intentional sources.
The toxicological evaluation of these products can be assessed
using both in vitro and in vivo methods. Several researchers have
already evaluated the in vitro toxicological proﬁles of differentPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024iclays and derived nanocomposites, concluding that the toxicity
shown depends on various parameters, the most important of
which were the modiﬁers used, the experimental model selected,
the concentration range and the exposure times (Section 2). Re-
garding the in vivo assessments, although it has been recognized
that the interaction of clays with organs may provoke health-de-
leterious consequences, to date, there is little mechanistic under-
standing of the physiological effects due to exposure to clays (Ki-
banova et al., 2009). Some studies performed in vivo can be found
in the literature, and different results have been published (Section
3). Additionally, an evaluation of the impact of these materials on
human and environmental health is also necessary, and different
studies are available on this topic (Section 4).
Thus, this work focused on the review of the published reports
related to the analysis of the toxicological proﬁles of commercial
and novel modiﬁed clays and derived nanocomposites. A review of
the main in vitro and in vivo toxicological studies, antimicrobialof clay minerals and derived nanocomposites: A review. Environ.
Fig. 3. Commercial quaternary ammonium salts modiﬁers used in modiﬁed clays.
S. Maisanaba et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎4activity assessments, and the human and environmental impacts
of clays and derived nanocomposites was performed. The in-
formation used in the review was gathered through an extensive
search of different sources in the public domain (scientiﬁc litera-
ture from PubMed and Sciencedirect, reports from EU/interna-
tional authorities and various other sources). Priority was given to
information from peer-reviewed sources; however, other sources
of available data were also taken also into consideration when
relevant. The main objectives were therefore to identify the state-
of-the-art information on the toxicological proﬁle of clays and
derived composites and to identify possible data gaps and research
needs in this ﬁeld.2. In vitro toxicological assays
In vitro systems are mainly used for screening purposes and for
generating more comprehensive toxicological proﬁles (Eisenbrand
et al., 2002).
Several toxicity endpoints can be determined through in vitro
methods, providing evidence of the basal damage or the me-
chanism of action responsible of the toxic insult. The in vitro
toxicity of clay minerals has been widely studied in the scientiﬁc
literature, and the main ﬁndings are described below.
2.1. Basal cytotoxicity assays and morphological studies
Many cell lines have been used to study the toxicity induced by
clays and clay-containing nanocomposites. A previous study per-
formed by the World Health Organization (WHO) reviewed the
effects on an in vitro system of bentonite, kaolin and other clay
minerals (WHO, 2005). However, the works referred are dated to
the period 1969–1996. In the last four years, studies in this ﬁeldPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024ihave substantially increased; in this respect, the most recent stu-
dies are summarized in Table 3. A wide variety of clay minerals
have been studied, from platelet nanoclays, such as Mt, bentonite,
kaolinite and erionite, to clay nanotubes, such as halloysite, both in
pure form and included in polymeric matrices. Human cell lines
are the most frequently used experimental model, although some
from rodents have also been employed. In regard to the cell type,
intestine and liver cells have been widely used, followed by lung
and skin cell lines, evidencing the interest for the use of these
compounds in the food industry as well as the relevance of their
environmental impact.
Unmodiﬁed Mt, including bentonite, has been reported to
cause cytotoxicity in many cell lines. In this sense, Murphy et al.
(1993a) evidenced a decrease in cell viability in HUVECs exposed
for 24 h to 0.1 mg/mL bentonites, although limited results were
obtained in the neuronal cell lines N1E-115 and ROC-1. Similarly,
CHO cells exposed to 1 mg/mL Mt for up to 24 h underwent a
reduction in cell viability (Li et al., 2010). Baek et al. (2012) re-
ported similar results in intestinal cells (INT-407) exposed to the
same concentration of Mt, showing a concentration- and time-
dependent inhibition of cell proliferation after 24–72 h of ex-
posure, as well as cytotoxicity after long-term exposure to Mt. It
has been suggested that the organo-modiﬁer included in the Mt
modulates the toxicity of the resulting clay (Sharma et al., 2010). In
this sense, CloisitesNaþ (CNaþ) did not show signs of cytotoxicity
in Caco-2 cells, although Cloisites30B (C30B) induced approxi-
mately 40% cytotoxicity at the highest concentration tested
(226 mg/mL) after 24 h of exposure (Sharma et al., 2010). In addi-
tion, the cytotoxicity induced by CNaþ on HepG2 cells was lower
than that obtained after exposure to Cloisites93A (C93A) for 24 h
(Lordan et al., 2011). In addition, active bentonite, which is ben-
tonite that is industrially treated with H2SO4, produced greater
damage in human B lymphoblast cells than the native bentoniteof clay minerals and derived nanocomposites: A review. Environ.
Table 3
Cytotoxic effects of unmodiﬁed/modiﬁed clays and derived nanocomposites.
Material tested Modiﬁer Experimental
model
Assays performed Concentration range Exposure
time
Main results Reference
- Sepiolite Unmodiﬁed Primary rat
hepatocytes
Lactate dehydrogenase (LDH) re-
lease assay
1-10 mg/mL 20 h No signiﬁcant differences
were observed in compar-
ison with the controls.
Denizeau
et al. (1985)
- Mt, bentonite, kaolinite
and erionite
Unmodiﬁed HUVE, N1E-115
and ROC-1 cell
lines
LDH release assay, Trypan Blue ex-
clusion test
0.1 mg/mL 24 h Only HUVE cells experienced
signiﬁcant LDH release after
exposure to bentonite, kaoli-
nite and Mt. Similarly, all
clays changed signiﬁcantly
cell viability in HUVE cells,
but only Mt and erionite did
in N1E-115. No effect was
reported in ROC-1 cells
Murphy et al.
(1993a)
- Quartz
– Kaolin (Both untreated and
treated)
Dipalmitoyl phosphatidylcoline (DPPC) Rat pulmonary al-
veolar macro-
phages cells
Live-Dead assay 0-80 mg/cm2 0-40 mg/cm2 1, 3, 5 days Concentration and time cy-
totoxicity was observed in
cells exposed for 1, 3 and
5 days to untreated quartz
and kaolin. DPPC-surfactant
pretreatment delayed the
toxic effects
Gao et al.
(2000)
-Native Bentonite
- Modiﬁed Bentonites
Unmodiﬁed
α-quartzþchemical modiﬁcations (alkalin,
acid and organic)
IMR90 cell line Alarm Blue assay 1-50 mg/cm2 24 h All bentonite samples in-
duced cytotoxic effects, being
more evident in bentonites
with higher quartz contents
than in untreated bentonites
or those with lower quartz
content
Geh et al.
(2006)
- Native Bentonite (BPN)
- Active Bentonite (BPA)
Unmodiﬁed
H2SO4
HMy2.CIR cell line Cell Counting, neutral red uptake,
LDH release assay
0-1000 mg/mL 4 and 24 h Cell viability decrease with
the exposure concentrations
and time. BPA being more
cytotoxic than BPN
Meibian et al.
(2010)
- Mt Unmodiﬁed CHO cell line 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide
(MTT) assay, LDH release
0-1000 mg/mL 3, 12, 24 h Reduction of 40% cell viabili-
ty and increase in 40% in LDH
levels after 24 h of exposure
to 1000 mg/mL Mt
Li et al.
(2010)
- CNaþ
- C30B (Unﬁltered and
ﬁltered)
Unmodiﬁed
Quaternary ammonium salt (MT2EtOH)
Caco-2 cell line Alarmar Blue assay 0-226 mg/mL 24 h Only the highest concentra-
tion used (226 mg/mL) of the
unﬁltered exposure under-
went signiﬁcant reduction in
cell viability (40%)
Sharma et al.
(2010)
- Halloysite Clay Nanotubes
(HNT) unmodiﬁed and
functionalized
Unmodiﬁed
Aminopropyltriethoxysilane
HeLa and MCF-7
cell line
MTT assay, Trypan Blue assay 1-1000 mg/mL 24, 48, 72 h Both HNTs exhibit growth
inhibition in a concentration
and time dependent manner
at both cell lines and assays.
The cell viability was pre-
served up to 75 mg/mL. No
effect of functionalization
was recorded
Vergaro et al.
(2010)
- Mt (Na-MMT)
- Oligo(styreme-co-acrylo-
nitrile)-modiﬁed Mt
(PSAN-MMT)
Unmodiﬁed
Oligo(styrene-co-acrylonitrile)
HEK 293 and NIH
3T3 cell lines
MTT assay, LDH release 0.1–2 g/L 24 h Signiﬁcant cell viability de-
crease was observed in both
cell lines exposed to both Mt
in the LDH release assay and
MTT assay. PSAN-MMT was
less toxic than MMT
Liu et al.
(2011)
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Table 3 (continued )
Material tested Modiﬁer Experimental
model
Assays performed Concentration range Exposure
time
Main results Reference
- CNaþ
- C93A
Unmodiﬁed
Ternary ammonium salt (M2HT)
HepG2 cell line MTT assay, LDH release 0–1000 mg/mL 24 h Concentration-dependent ef-
fect was observed in cells
treated with both clays,
being signiﬁcant from
1 mg/mL in the MTT assay and
from 50 mg/mL in the LDH
release assay
Lordan et al.
(2011)
- Aminopropyl magnesium
phyllosilicate (AMP)
- Aminopropyl calcium
phyllosilicate (ACP)
Aminopropyl CCD-986sk, A549,
MRC-5, HT-29 cell
lines
MTT assay, LDH release 1–1000 mg/mL 24, 48, 72 h Decrease in cell viability and
membrane damage appeared
at the highest concentrations
of both organoclays assayed
Han et al.
(2011)
- Nanocomposite of halloy-
site clay nanotubes (HNT)
incorporated into chitosan
Unmodiﬁed NIH3T3 cell line MTT assay 2, 5, 7.5 and 10% 1, 3 and
7 days
Both chitosan and chitosan/
HNTs nanocomposites ﬁlms
are biocompatible since no
visible reduction in viability
was found
Liu et al.
(2012)
- Mt Unmodiﬁed INT-407 cell line 2-(4-Iodophenyl)-3-(4-ni-
trophenyl)-5-(2,4-disulfophenyl)-
2 H-tetrazolium (WST-1) assay,
MTT assay, LDH release assay
0-1000 mg/mL 24, 48, 72 h
and 10 days
Cell proliferation was in-
hibited in a concentration
and time dependent in the
short-term WST-1 assay. Si-
milarly, after 10 days of ex-
posure, all concentrations
tested signiﬁcantly reduced
cell viability. Only
1000 mg/mL induced a sig-
niﬁcant release of LDH
Baek et al.
(2012)
- Platelet nanoclays (Ben-
tone MA, ME-100, Cloisite
Naþ , Nanomer PGV, De-
lite LVF) Tubular nano-
clays (Halloysite and Hal-
loysite MP1)
Not speciﬁed A549 cell line High content screening and real-
time impedance sensing
1–250 mg/mL 24 h No toxic effect was recorded
for nanoclays up to 10 mg/mL,
except for Delite LVF. At
higher concentration, cells
grow decreased in a con-
centration dependent man-
ner. Tubular nanoclays
showed lower cytotoxicity
compared to platelet type,
with Bentone MA and ME-
100 showing the better re-
sults in this group
Verma et al.
(2012)
- Nanocomposites of an un-
modiﬁed sepiolite, un-
modiﬁed and modiﬁed Mt
and ﬂuorohectorites
Poly(butylene adipate-co-terephthalate)
and its nanocomposites based on 10 wt.%
clay minerals. Modiﬁed Mt contained a
quaternary ammonium salt (MT2EtOH),
and modiﬁed ﬂuorohectorite contained a
dihydroxy organic modiﬁer.
L929 cell line MTT assay 10 wt% clay minerals 1, 2 and
5 days
No visible reduction in via-
bility was observed at any
experimental condition.
Fukushima
et al. (2012)
- Nanocomposites of an un-
modiﬁed sepiolite, un-
modiﬁed and modiﬁed Mt
and ﬂuorohectorites
Poly(butylene adipate-co-terephthalate)
and its nanocomposites based on 10 wt.%
clay minerals. Modiﬁed Mt contained a
quaternary ammonium salt (MT2EtOH),
and modiﬁed ﬂuorohectorite contained a
dihydroxy organic modiﬁer.
Fibroblast and os-
teoblast cell lines
MTT assay 10 wt% clay minerals 1, 4 and
7 days
No signiﬁcant reduction in
viability was observed in
both cells in all times of
exposure
Fukushima
et al. (2013)
- Halloysite clay nanotubes
(HNT)
Unmodiﬁed Caco-2/HT29-MTX
cells in co-culture
2,3-bis-(2-methoxy-4-nitro-5-sul-
fophenyl)-2 H-tetrazolium-5-car-
boxanilide (XXT) assay, LDH release
and Lucifer yellow permeability
assay
1, 10 and 100 mg/mL 6 h No cytotoxic effects were
observed in any assay
performed
Lai et al.
(2013)
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- CNaþ
- C30B
Unmodiﬁed
Quaternary ammonium salt (MT2EtOH)
HepG2 cell line Protein content, neutral red uptake,
3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sul-
fophenyl)-2 H-tetrazolium (MTS)
reduction assay
0-62.5 mg/mL 0-500 mg/mL 24, 48 h Only C30B showed cytotoxic
effects (EC50¼88 mg/mL)
Maisanaba
et al. (2013)
- 6-MPþ Mt-PLA
nanocomposite
6-Mercaptopurine (6-MP) encapsulated
with Mt
IMR32 cell line Tryan blue dye exclusion test and
MTT assay
10 ppm/test composite 24 h Cell viability was greater
after exposure to the nano-
composite containing the
drug (6-MP)
Kevadiya
et al. (2013)
-C20A
-Clay1
-Clay2
Quaternary ammonium salt (2M2HT)
Hexadecyltrimethylammonium bromide
(HDTA)
HDTAþAcetylcoline (ACO)
Caco-2 and HepG2
cell lines
Protein content, MTS reduction
assay
0-62.5 mg/mL 0-8 mg/mL
0-125 mg/mL
24, 48 h Only Clay2 induced cyto-
toxicity in both cell lines,
being more sensitive Caco-2
than HepG2 (EC50¼34 mg/mL
and EC50¼88 mg/mL,
respectively)
Houtman
et al. (2014)
- CNaþ
- C30B
Unmodiﬁed
Quaternary ammonium salt (MT2EtOH)
Caco-2 cell line Protein content, neutral red uptake,
MTS reduction assay
0-125 mg/mL 0-250 mg/mL 24, 48 h Only C30B showed cytotoxic
effects (EC50¼40 mg/mL)
Maisanaba
et al. (2014a)
-Clay1
-Clay2
Hexadecyltrimethylammonium bromide
(HDTA)
HDTAþAcetylcoline (ACO)
Caco-2 and HepG2
cell lines
Neutral red uptake 0-8 mg/mL 0-125 mg/mL 24, 48 h No signiﬁcant effects were
observed, except for a de-
crease in NR uptake in
HepG2 cells exposed to
8 mg/mL Clay1
Jorda-Bene-
yto et al.
(2014)
-PLA-Clay1 extract
-PLA-Clay2 extract
HDTAþMtþ PLA
HDTAþACOþMtþPLA
Caco-2 and HepG2
cell lines
Protein content, neutral red uptake,
MTS reduction assay
0-100% of extract 24, 48 h No cytotoxic effects were re-
corded in both cell lines at
any concentration and ex-
posure time
Maisanaba
et al. (2014b)
- CAPþ Mt-PLA
nanocomposite
Capecitabine (CAP) encapsulated with Mt IMR32 cell line Tryan blue dye exclusion test and
MTT assay
10 ppm/test composite 24 h Cell viability was greater
when cells were exposed to
the nanocomposite contain-
ing the drug (CAP) than
when exposing cells only to
CAP
Kevadiya
et al. (2014)
- CNaþ
- C30B
- Clay1
- Clay2
Unmodiﬁed
Quaternary ammonium salt (MT2EtOH)
HDTA
HDTAþACO
HUVEC cell line Protein content, neutral red uptake,
MTS reduction assay
0-125 mg/mL
0-250 mg/mL
0-8 mg/mL
0-125 mg/mL
24, 48 h CNaþ and Clay1 showed in
general no signiﬁcant chan-
ges in any of the endpoints
assayed after 24 and 48 h of
exposure. C30B and Clay2
induced cytotoxic effects
(EC50¼ 21.4711.4 mg/mL
and EC50¼55.476.1 mg/mL,
respectively) both at MTS
after 24 h of exposure
Maisanaba
et al. (2014c)
- Unmodiﬁed MT
(MMTdell and MMTdells)
Dimethyl dihydrogenated tallow
ammonium
Ramos, A-549,
HCT-116, SK MEL
28 and HepG2 cell
lines
Alarm Blue assay Serial dilutions from 102 to
102 mg/mL
72 h The nanoclays modiﬁed with
dimethyl benzyl hydro-
genated tallow ammonium
showed higher toxicity than
those modiﬁed with the di-
methyl dihydrogenated tal-
low ammonium
Janer et al.
(2014)
- Modiﬁed MT (MMTdell
43B, MMTdell 67G,
MMTdell 72T, MMTdell
43Bs, MMTdell 67Gs and
MMTdell 72Ts)
Dimethyl benzyl hydrogenated tallow
ammonium
Cell lines: A-549: human alveolar adenocarcinoma cell line; Caco-2: colorectal adenocarcinoma cell line; CCD-986sk: human skin ﬁbroblast; CHO: Chinese hamster ovary cell line; HCT-116: human colorectal carcinoma cell line;
HEK 293: human embryonic kidney cell line; HeLa: human epithelial adenocarcinoma cell line; HepG2: liver hepatocellular carcinoma cell line; HMy2.CIR: human B lymphoblast cell line; HT-29: human colon epithelial carcinoma
cell line; HT29-MTX: human colon adenocarcinoma cells treated with methotrexate; HUVEC: human endothelial cell line; IMR32: human neuroblastoma cell line; IMR90: human lung ﬁbroblast cell line; INT-407: human embryonic
intestine cell line; L929: murine ﬁbroblast cell line; MRC-5: human lung ﬁbroblast cell line; MCF-7: human breast cancer cell line; NIH3T3: mouse ﬁbroblast cell line; N1E-115: neuroblastoma cell line; SK MEL 28: human melanoma
cell line; Ramos: human Burkitt’s lymphoma cell line; ROC-1: oligodendroglial cell line.
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S. Maisanaba et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎8(Meibian et al., 2010). In fact, it has been reported that different
modiﬁers have different effects; hence, Mt delite modiﬁed with
dimethyl benzyl hydrogenated tallow ammonium showed higher
toxicity than those modiﬁed with dimethyl dihydrogenated tallow
ammonium in ﬁve cell lines (Janer et al., 2014). This ﬁnding was
corroborated by analysing the cytotoxic effects of the modiﬁers in
the same cell lines. Studies evaluating the toxicity of quaternary
ammonium compounds potentially used as clay modiﬁers are
scarce. Thus, Jodynis-Liebert et al. (2010) obtained a mean in-
hibitory concentration for didecyldimethylammonium sacchar-
inate among 1.44 and 5.47 mM for the MTT assay in six human cell
lines. Moreover, native Mt (CNaþ) showed lower toxicity than the
modiﬁed Mt (C30B) in HepG-2 and Caco-2 cells (Maisanaba et al.,
2013, 2014a). Additionally, the same cell lines showed the different
cytotoxic proﬁles of the three organo-modiﬁed clay minerals,
evidencing that the type of clay mineral, the concentration range
and the origin of the cell line play an important role in the ob-
served toxicity (Houtman et al., 2014; Jordá-Beneyto et al., 2014).
However, the modiﬁcation of Mt was also demonstrated to de-
crease the toxicity of clay minerals. For instance, the modiﬁcation
of Mt with oligo (styrene-co-acrylonitrile) resulted in a less toxic
material compared with the unmodiﬁed Mt (Liu et al., 2011). In
addition, the modiﬁcation of the organoclay could result in a non-
toxic material, which is the main objective of the synthesis of
these materials intended for human contact. Han et al. (2011) re-
ported no signiﬁcant membrane damage and change in cell via-
bility in four cell types exposed to magnesium and calcium
organophyllosilicates.
The nature of the clay mineral plays an important role in the
observed toxicity. In this regard, Murphy et al. (1993a) reported
the following toxicity scale in HUVE cells after 24 h of incubation
with 0.1 mg/mL clay minerals: Mt4bentonite¼kaolinite
berionite. In addition to the above-mentioned work, most studies
have evaluated the toxicity of Mt and bentonite. To the best of our
knowledge, the toxicity of kaolinite has only been studied by Gao
et al. (2000), who compared the results with another silicate,
namely quartz. Both compounds induced cytotoxic effects on rat
pulmonary alveolar macrophage cells starting on the ﬁrst day of
exposure, although pretreatment with surfactant delayed the
toxicity.
In addition to the platelet clays, tubular nanoclays, another
physical structure of clay minerals, have been assayed. Verma et al.
(2012) compared the toxicity of both structures in the lung epi-
thelial cells A549 and showed that the platelet-structured nano-
clays were more cytotoxic than the tubular types. It is important to
note that the structure was not the only difference among them
because the nature of the clay mineral also differed. In this sense,
platelet clays were mainly bentonites, whereas tubular nanoclays
were halloysites. In this regard, the toxicity of halloysite nanotubes
(HNT) has also been evaluated in a co-culture of intestinal cells
exposed to 0–100 mg/mL HNT, which resulted in no cytotoxic effect
(Lai et al., 2013). However, unmodiﬁed and functionalized HNTs
showed cytotoxic effects on HeLa and MCF-7 cells at concentra-
tions higher than 75 mg/mL (Vergaro et al., 2010). No inﬂuence on
the functionalization of the HNT was observed. Liu et al. (2012)
assessed the safety of HNT incorporated into chitosan to form
bionanocomposite ﬁlms. The Chitosan/HNTs nanocomposite
showed similar cytocompatibility to the chitosan nanocomposite
without the clay nanotube. Despite the latter work, very few stu-
dies have been conducted to date in composites containing clay
minerals. Only Kevadiya et al. (2013, 2014) have reported the in-
teresting potential of clay-based composites as reservoirs of cy-
totoxic drugs because they have been proven to reduce the toxic
effects of the drugs and to also play an important role in the de-
livery proﬁciency.
Among the most frequently used endpoints in cellular toxicityPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024itesting are those based on changes in cell morphology (Boren-
freund and Borrero, 1984). The most remarkable morphological
features altered by clay minerals are listed in Table 4. The mor-
phological changes induced by different clay minerals have been
studied in HUVE cells, which were markedly changed after 24 h of
exposure to 0.1 mg/mL Mt, bentonite and kaolinite, including cell
lysis (Murphy et al., 1993a). The lysis was greater in the case of Mt
compared with bentonite and kaolinite, with only limited lysis
observed after exposure to erionite. This ﬁnding agreed with the
cytotoxicity assay results. In the same manner, in shorter exposure
times, Mt and bentonite were also able to cause complete cell lysis
in the neuronal cultures within 60 min (Murphy et al., 1993b).
Similarly, HepG2 cells exposed for 24 h to 50 and 1000 mg/mL
CNaþ and C93A exhibited a dose-dependent cell death induction
(Lordan et al., 2011). Moreover, C30B induced morphological
changes in HepG2 and Caco-2 cells after 24 and 48 h of exposure,
undergoing ultrastructural features characteristic of cell impair-
ment, such as damage to the mitochondria, nucleus and en-
domembrane systems (Maisanaba et al., 2013, 2014a). In contrast,
no cell organelles were affected in the lung ﬁbroblast cell line
IMR90 exposed to 10 mg/cm2 Mt for 24 h (Geh et al., 2006).
The degeneration of the mitochondria reported in HepG2 and
Caco-2 cells exposed to C30B is in agreement with the changes
observed in the MTT, MTS, WST-1 and XXT (different tetrazolium
salts) assays in many cell types exposed to unmodiﬁed and func-
tionalized Mt and HNT (Baek et al., 2012; Houtman et al., 2014; Lai
et al., 2013; Li et al., 2010; Liu et al., 2011; Lordan et al., 2011;
Maisanaba et al., 2013, 2014a,b,c; Vergaro et al., 2010). Ad-
ditionally, the presence of fat droplets and nuclear lipid inclusions
in HepG2 and Caco-2 cells exposed to C30B revealed an alteration
in the lipid metabolism, which is consistent with the release of
fatty acids reported by Murphy et al. (1993a).
In addition to the studies on clay minerals, the biocompatibility
of bio-nanocomposites containing these materials has also been
assessed by analysing the attachment and spreading of L-929 cells
(Zia et al., 2011). The cells showed higher attachment and growth
on bio-nanocomposites without Mt than those containing the
nanoclay at a concentration of 1%, 2%, 4% and 8%. The staining
results also showed that an increased in the concentration of Mt
has adverse effects on the biocompatibility of the samples. In
contrast, Liu et al. (2012) examined the cytocompatibility of chit-
osan/HNTs nanocomposites ﬁlms, evidencing a positive response
in NIH3T3 cells even at the highest content of HNTs (10%).
When all data above are considered, it is evidenced that in vitro
toxicological research on clays is of high interest nowadays.
However, reports dealing with nanocomposites containing clays
are scarcer. Different clays have their own cytotoxic proﬁle with
dependence on the experimental conditions (type of clay, modi-
ﬁer, cell line, concentrations used, etc.). But they have been shown
to be able to induce deleterious effects on cells, and this deserves
to be investigated, taking into account their multiple applications.
2.2. Toxicity mechanisms
In vitro toxicological assessments are useful for obtaining me-
chanism-derived information. Cells respond rapidly to toxic stress
by altering, for example, different basal biomarkers, such as the
generation of reactive oxygen species (ROS) and glutathione con-
tent (GSH), and making alterations to several organelles, such as
the mitochondria and lysosomes. Taking this into account, im-
portant questions are how the studied materials, in this case, clay
minerals, and derived nanocomposites are able to alter these
parameters and how these alterations can affect the metabolic
rates, cell growth and gene transcription (Eisenbrand et al., 2002).
The interaction, inﬂuence and potential toxicity of materials
with proteins and cells are an essential focus in assessing andof clay minerals and derived nanocomposites: A review. Environ.
Table 4
Morphological changes evaluation of unmodiﬁed/modiﬁed clays and derived nanocomposites.
Material tested Modiﬁer Experimental model Concentration range Exposure
time
Main results Reference
- Mt and bentonite Unmodiﬁed HUVE cell line 0.1 mg/mL 24 h All clays induced morphological changes, including lysis of
the cells. The toxicity observed was:
Mt4bentoniteEkaolinite»erionite
Murphy et al.
(1993a)
- Mt, bentonite and erionite Unmodiﬁed Culture of primary murine
spinal cord neurons and
differentiated N1E-115 cell
line
0.1 mg/mL 5, 15, 60 min
and 18 h
Mt and bentonite caused complete cell lysis in the neuronal
cultures within 60 min after exposure. None of the clays
appeared to be cytotoxic to the differentiated NlE-115 cells
even at 18 h
Murphy et al.
(1993b)
- Native bentonite Unmodiﬁed IMR90 cell line 10 mg/cm2 24 h No organelles were affected in IMR90 cells exposed to clays;
despite Mt crystal was found intracellularly
Geh et al.
(2006)- Modiﬁed bentonites α-Quartzþchemical mod-
iﬁcations (alkalin, acid and
organic)
- CNaþ Unmodiﬁed HepG2 cell line 50 and 1000 mg/mL 24 h Cell death was observed after exposure to nanoclays Lordan et al.
(2011)- C93A Ternary ammonium salt
(M2HT)
- Polyurethane bio-
nanocomposites
4,4’- diphenylmethane
diisocyanate
L-929 cell line PUBNC1: without nanoclay,
PUBNC2: 1.0%, PUBNC3: 2.0%,
PUBNC4: 4.0% and PUBNC5:
8.0% nanoclay
48 h No cytotoxicy was observed in cells exposed to the nano-
composites without nanoclay and that containing only 1%
nanoclay. However, those with higher contents of bentonite
nanoclay showed some toxic and incompatible behaviour
Zia et al. (2011)
- Nanocomposite of halloysite
clay nanotubes (HNT) in-
corporated into chitosan
Unmodiﬁed NIH3T3 cell line Chitosan/HNTs with 5% and
10% HNTs
1, 3, and
7 days
Both chitosan and chitosan/HNTs nanocomposite ﬁlms are
cytocompatibility even when the loading of HNTs is 10%
Liu et al. (2012)
- C30B Quaternary ammonium salt
(MT2EtOH)
HepG2 cell line 0–88 mg/mL 24 and 48 h Mitochondrial degeneration, dilated endomembrane sys-
tems, heterophagosomes formation, fat droplets appearance
and presence of nuclear lipid inclusions were oberved
Maisanaba
et al. (2013)
- C30B Quaternary ammonium salt
(MT2EtOH)
Caco-2 cell line 0–40 mg/mL 24 and 48 h Dilated cisternae edge in the Golgi apparatus and nucleolar
segregation was observed
Maisanaba
et al. (2014a)
Caco-2: colorectal adenocarcinoma cell line; HepG2: liver hepatocellular carcinoma cell line; HUVE: human umbilical vein endothelial cell line; IMR90: human lung ﬁbroblast cell line; L-929: ﬁbroblast cell line; NIH3T3: mouse
ﬁbroblast cell line; and N1E-115: neuroblastoma cell line.
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and Grainger, 2009). The cell-material reactions of interest include
cellular uptake, membrane integrity perturbations, or alteration in
the viability or vital organelles. Thus, endpoints such as the gen-
eration of ROS and other parameters related with the cellular
stress response (GSH, superoxide dismutase activity (SOD), lipid
peroxidation (LPO), etc.), DNA damage, inﬂammation response and
cell necrosis and apoptosis provide valuable information for un-
derstanding the toxic response.
Below, a description of the main studies that focused on the
toxicity mechanisms in different cell lines exposed to clay minerals
and derived nanocomposites is presented. Moreover, the simila-
rities and differences in the results due to different experimental
models and exposures will hopefully be identiﬁed.
2.2.1. Oxidative stress generation
Increases in the intracellular level of ROS represent a potential
toxic mechanism, which if not counteracted will lead to other
disorders, such as membrane dysfunction, LPO, which means a
higher malondialdehyde level (MDA) in the cell membrane, DNA
damage and a drastic inactivation of proteins. To prevent damage
to cellular components, there are numerous enzymatic antioxidant
defences designed to scavenge ROS in the cell. Examples of these
enzymes are the SOD, catalase (CAT), glutathione peroxidase (GPx)
and glutathione reductase (GR) (Puerto et al., 2009, 2010). Activity
measurements of this group of antioxidant enzymes may provide a
marker of oxidative stress because they are able to be completed
with the study of other parameters, such as the GSH, MDA and
carbonyl levels (Puerto et al., 2014).
Several researchers have studied the effects related with ROS
generation and other disorders in several target cell lines exposed
to different unmodiﬁed and modiﬁed clay minerals and derived
micro/nanocomposites (Baek et al., 2012; Governa et al., 1995;
Hansen and Mossman, 1987; Houtman et al., 2014; Kevadiya et al.,
2013, 2014; Lordan et al., 2011; Maisanaba et al., 2013, 2014a;
Meibian et al., 2010; Sharma et al., 2010) (Table 5).
Contradictory results were observed when various cell lines
from digestive origin, such as HepG2, Caco-2 and INT-407, were
exposed to unmodiﬁed Mt, CNaþ . Baek et al. (2012) showed that
the exposure of the INT-407 cell line for 72 h to the lowest con-
centration of Mt tested resulted in ROS generation. However, sig-
niﬁcant differences with respect to the control were only observed
with the highest concentration assayed, 1000 mg/mL, after 24 h.
Similarly, Lordan et al. (2011) also evidenced ROS generation in
HepG2 cells exposed to CNaþ starting with the lower concentra-
tions (50–1000 mg/mL) and at all times of exposure (4, 16 and
24 h). Nevertheless, other researchers did not observe any effects
in ROS generation in Caco-2 cells exposed to the unmodiﬁed clay
at the concentrations (the highest was 226 mg/mL) and times as-
sayed (Sharma et al., 2010). The stress response generated depends
on the cell lines exposed and the concentration ranges assayed.
Lordan et al. (2011) also evaluated the possible ROS generation
in the HepG2 cell line exposed to C93A, a modiﬁed Mt with a
ternary ammonium salt. The results obtained were similar to those
obtained after exposure to CNaþ , but the effect of C93A on in-
tracellular ROS production was less prominent because the in-
creased levels observed were not as substantial as those obtained
with the unmodiﬁed clay and were not consistent over 24 h of
exposure. Sharma et al. (2010) observed that C30B, a quaternary
ammonium salt-modiﬁed clay, did not induce ROS production at
the conditions assayed in Caco-2 cells. In contrast, our research
group (Maisanaba et al., 2013; 2014a) also evaluated the stress
response by analysing the ROS and GSH content of HepG2 and
Caco-2 cells exposed to C30B. In our case, when HepG2 cells were
exposed to the modiﬁed clay, no signiﬁcant alteration in ROS
production was observed at all concentrations (22, 44 andPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024i88 mg/mL) and times of exposure (24 and 48 h). In contrast, a
concentration-dependent decrease in the GSH content was ob-
tained at the highest concentration tested and at both times of
exposure. According to the results obtained by Maisanaba et al.
(2013), Caco-2 cells exposed to C30B experienced a signiﬁcant
decrease in the GSH content at 40 mg/mL after 48 h. Moreover, an
alteration in ROS generation was also observed at 40 mg/mL and at
both times of exposure (24 and 48 h). The production of ROS may
be related to the cell damage induced by C30B at this concentra-
tion, as was also corroborated by an aforementioned morpholo-
gical study (Maisanaba et al., 2014a).
In contrast, Houtman et al. (2014) also evaluated the stress
response in HepG2 and Caco-2 cell lines exposed to the other
novel modiﬁed clay, Clay2, in the presence of the other quaternary
ammonium salt modiﬁer, HDTAþACO. These researchers only
observed an alteration in the GSH content in HepG2 cells exposed
to the modiﬁed clay, and signiﬁcantly differences were obtained at
all concentrations tested (22, 44 and 88 mg/mL) and both times of
exposure (24 and 48 h).
In addition to Mt, studies with other clay minerals with a si-
milar structure have been published in the scientiﬁc literature. For
example, Meibian et al. (2010) studied the ROS generation, SOD
activity and MDA levels of a lymphoblast cell line exposed to two
bentonites, an unmodiﬁed or native bentonite (BPN) and a mod-
iﬁed or active bentonite (BPA) activated with H2SO4. In this study,
the authors observed that the highest oxidative response was
shown after exposure to BPA at all of the conditions tested.
Little is known about in vitro stress assays of nanocomposites
obtained from clays and polymeric matrices. However, some stu-
dies of microcomposite materials used for different biological ap-
plications have been performed. Kevadiya et al. (2013) evaluated
the stress effects of 6-mercaptopurine (an antineoplastic drug)-
Mt-poly (L-lactide) acid (PLA) microcomposite (6-MPMtPLA) in the
neuroblastoma cell line IMR32. The MDA levels, SOD activity,
protein carbonyl levels and GSH content were evaluated, and the
results showed that all of the endpoints in the assayed cells ex-
posed to the test composite (10 ppm) did not show signiﬁcant
differences with respect to the control group. Speciﬁcally, an in-
crease in the protein carbonyl groups was expressed in pristine
6-MP-treated cells, whereas 6-MP-Mt and microcomposite
spheres (MPs) proved to be somewhat less toxic in this parameter.
Intracellular glutathione estimation also revealed similar results as
6-MPMtPLA and MPs, i.e., it was less damaging than the pristine
antineoplastic drug. Similar results were obtained in another study
in which the IMR32 cell line was exposed to capecitabine (CAP)
(other antineoplastic drug) encapsulated in Naþ-Mt and further
compounded with poly (L-lactide) acid. In all cases, cells treated
with CAP-Mt and MPs exhibited behaviour similar to that of the
control group, showing lower oxidative responses compared with
the pristine CAP cell group (Kevadiya et al., 2014). In this sense, the
encapsulation of the antineoplastic drugs into the clays has ame-
liorated the toxicity.
2.2.2. Genotoxicity assays
Due to the variety of mechanisms leading to xenobiotic-in-
duced DNA damage and the range of mutagenic events that may
occur as a result, a battery of testing systems is required for the
establishment of the genotoxic potential of a substance under in-
vestigation (Doak et al., 2012). At present, in vitro mutagenicity
assays are included among the core set of toxicity tests for the
safety assessment required by European legislation to authorize
different substances. The most frequently used genotoxicity assays
are the Comet assay, Ames test and micronucleus assay (Maisa-
naba et al., 2013, 2014a,b,c).
In this regard, the genotoxicity evaluation of clays and derived
nanocomposites used in or destined for the food industry is ofof clay minerals and derived nanocomposites: A review. Environ.
Table 5
Oxidative stress evaluation of unmodiﬁed/modiﬁed clays and derived micro/nanocomposites.
Material tested Modiﬁer Experimental model Assays performed Concentration range Main results Reference
- Sepiolite Unmodiﬁed Hamster and rat al-
veolar macrophagues
Reduction of cytocrome
C (SOD)
5 mg/cm2 dish and 25 mg/cm2 dish in each
cell line, respectively
The clay mineral caused a sig-
niﬁcant increase in the release of
O2 in both cell lines
Hansen and
Mossman (1987)
- Sepiolite Unmodiﬁed (both of them) PMN cell line ROS generation Not speciﬁed Sepiolite was unreactive in ROS
production while a high ROS gen-
eration was observed after kaolinite
exposure
Governa et al.
(1995)- Kaolinite AM cell line
- Native bentonite (BPN) Unmodiﬁed HMy2.CIR cell line ROS generation, SOD
activity, MDA levels
0–240 mg/mL The highest oxidative response was
presented by BPA exposure
Meibian et al.
(2010)- Active bentonite(BPA) H2SO4
- CNaþ Unmodiﬁed Caco-2 cell line ROS generation 0–226 mg/mL ROS production was not observed Sharma et al.
(2010)- C30B (unﬁltered and
ﬁltered)
Quaternary ammonium salt (MT2EtOH)
- CNaþ Unmodiﬁed HepG2 cell line ROS generation 0–1000 mg/mL ROS production was observed with
both clays
Lordan et al.
(2011)- C93A Ternary ammonium salt (M2HT)
- Mt Unmodiﬁed INT-407 cell line ROS generation 0–1000 mg/mL ROS production was observed Baek et al. (2012)
- 6-MPþMt-PLA
microcomposite
6-Mercaptopurine (6-MP) encapsulated with
Mt
IMR32 cell line MDA levels, SOD activ-
ity, protein carbonyl
levels, GSH content
10 ppm/test composite In all cases cells exposed to test
composites showed lower oxidative
responses than the other groups
assayed
Kevadiya et al.
(2013)
- C30B Quaternary ammonium salt (MT2EtOH) HepG2 cell line ROS generation, GSH
content
0–88 mg/mL No signiﬁcant alteration in ROS
generation was observed but a de-
crease of GSH content was showed
Maisanaba et al.
(2013)
- Clay2 Hexadecyltrimethylammonium bromide
(HDTA)þAcetylcoline (ACO)
Caco-2 and HepG2
cell lines
ROS generation, GSH
content
0–34 mg/mL and 0–88 mg/mL Both cell lines exposed to Clay2 did
not present ROS generation. HepG2
showed a signiﬁcant decreased in
GSH content
Houtman et al.
(2014)
- CAPþ Mt-PLA
microcomposite
Capecitabine (CAP) encapsulated with Mt IMR32 cell line MDA levels, SOD activ-
ity, Protein Carbonyl
levels, GSH content
10 ppm/test composite In all endpoints, cells exposed to
test composites showed lower oxi-
dative responses than the other
groups assayed
Kevadiya et al.
(2014)
- C30B Quaternary ammonium salt (MT2EtOH) Caco-2 cell line ROS generation, GSH
content
0–40 mg/mL Increased ROS and decreased GSH
content at the highest concentration
Maisanaba et al.
(2014a)
Cell lines: PMN: human polymorphonuclear leucocytes; AM: bovine alveolar macrophagues; HMy2.CIR: human B lymphoblast cell line; Caco-2: colorectal adenocarcinoma cell line; HepG2: liver hepatocellular carcinoma cell line;
INT-407: human normal intestinal cell line: and IMR32: human neuroblastoma cell line.
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S. Maisanaba et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎12great interest. In previous opinions (EFSA, 2011b and 2012), the
EFSA Panel on Additives and Products or Substances used in Ani-
mal Feed (FEEDAP) has assessed the safety of bentonite and con-
cluded that “montmorillonites are not genotoxic based on a series
of tests” (EFSA, 2013), but different results have been obtained to
date.
An important number of studies related to the possible carci-
nogenic and mutagenic effects of clay minerals in different cell
lines are available in the scientiﬁc literature (Table 6) (Denizeau
et al., 1985; Gao et al., 2000; Houtman et al., 2014; Li et al., 2010;
Maisanaba et al., 2013; Maisanaba et al., 2014a,b,c; Meibian et al.,
2011; Sharma et al., 2010).
Several research groups have evaluated the DNA damage in-
duced by unmodiﬁed Mt and CNaþ through different methods and
experimental models, and all of them agree that Mt does not ex-
hibit genotoxic or mutagenic potential (Li et al.,2010; Maisanaba
et al., 2014c; Sharma et al., 2010). However, different results were
obtained in the case of modiﬁed clays. Maisanaba et al. (2013)
evaluated the DNA damage using the comet assay in HepG2 cells
exposed to C30B, evidencing DNA strand breaks at the highest
concentration assayed (88 mg/mL) after 48 h of exposure. However,
a similar experiment in another cell line, Caco-2, resulted in no
DNA damage (Maisanaba et al., 2014a). In contrast, Sharma et al.
(2010) also studied the exposure to C30B in Caco-2 cells, and
genotoxic effects in a concentration-related manner were ob-
served. In this case, the differences between the results could be
directly related to the concentration assayed because Sharma et al.
(2010) used higher concentrations in comparison to Maisanaba
et al. (2014a). Moreover, the genotoxic potential of two novel
modiﬁed clays, Clay1 and Clay2, has also been evaluated by the
comet assay and compared with that of another modiﬁed clay,
C20A. In this case, only DNA damage was observed in cells (Caco-2
and HepG2) exposed to Clay2 at the highest concentrations tested
(34 and 44-88 mg/mL, respectively) (Houtman et al., 2014).
Other researchers have studied similar structural clays, such as
bentonite and kaolinite. Gao et al. (2000) evaluated the genotoxic
effects in rat pulmonary alveolar macrophages exposed to un-
modiﬁed quartz and kaolinite and their modiﬁcations with di-
palmitoylphosphatidylcholine (DPPC) by a single-cell gel electro-
phoresis assay to detect the DNA damage induced. The results
show that quartz and kaolin, regardless of whether it is treated,
causes genotoxic effects, but DPPC-treated kaolin showed no sta-
tistically signiﬁcant activity until day 5 at the highest concentra-
tion (40 mg/mL), whereas the other samples induce DNA damage at
lower exposure times.
Apart from the comet assay, other mutagenicity trials are per-
formed to evaluate different alterations that could occur in the
genetic material. The Ames test, according to the OECD (1997)
guideline for the testing of chemicals 471, is the bacterial reverse
mutation test used to determine the mutagenicity of exogenous
substances. The test identiﬁes mutagenic compounds as those
capable of reverting point mutations in histidine or tryptophan
biosynthesis genes in Salmonella typhimurium or Escherichia coli,
respectively, restoring the ability of the bacteria to generate these
essential amino acids. Usually, a combination of 5 S. typhimurium
strains or 4 S. typhimurium strains plus 1 or 2 E. coli strains are
required to detect a range of base substitution or frameshift
events. The ease and cost effectiveness of the test system make it
widely used in the safety analysis of chemical substances. It is an
essential test within the current battery of assays required for
genotoxicity evaluation (Doak et al., 2012).
According to the OECD (2010) guideline 487, the in vitro mi-
cronucleus assay (MNvit) is a test that rapidly determines the
frequency of gross chromosomal damage induced by a test agent.
It has gained popularity as the test of choice over the chromosome
aberration assay because it is substantially quicker to perform andPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024ieasier to analyse and readily detects aneugens and clastogens
(which the chromosome aberration assay cannot do unless it is
speciﬁcally modiﬁed). Thus, the MNvit is now recommended as
one of the in vitro test systems to characterize the genotoxicity of
chemical and pharmaceutical agents (Kirkland et al., 2011).
Sharma et al. (2010) studied the mutagenic potential of CNaþ
and C30B in both ﬁltered and unﬁltered suspensions. In any case,
there were no indications of mutagenic activity in the two strains,
TA98 and TA100, assayed either with or without metabolic acti-
vation up to the highest soluble concentration (141 mg/mL). How-
ever, Maisanaba et al. (2014c) also evaluated the mutagenic po-
tential of CNaþ and C30B by the Ames test, obtaining positive
results only in the case of the modiﬁed clay C30B in the presence
of the S9 fraction at four of the ﬁve concentrations assayed (31.25–
250 mg/mL). In the same work, other quaternary ammonium salt-
modiﬁed clays, Clay1 and Clay2, showed a different mutagenic
proﬁle, and only Clay1 showed positive results at the four highest
concentrations (1–8 mg/mL) with S9. The presence of mutagenicity
may be related to the modiﬁer selected, the range of concentra-
tions assayed or the strains used in the test.
In addition to the mutagenic evaluation of CNaþ , Taylor et al.
(2014) also investigated the mutagenicity potential of halloysite.
The most remarkable results from the Ames mutagenicity test
showed a slight but reproducibly elevated growth at all con-
centrations of CNaþ assayed. The authors associated this ﬁnding to
the presence of a beneﬁcial trace mineral component in CNaþ .
However, in the case of halloysite, a diminished growth in the
bacterial strains suggested toxicity rather than a mutagenic effect.
Meibian et al. (2011) also evaluated the possible genotoxic al-
teration in the MHy2.CIR cell line exposed to BPN and BPA through
the comet and micronucleus assays. These results correlate well
with those from the afore-mentioned oxidative stress studies.
Reports on the mutagenicity of nanocomposite materials are
even scarcer. Maisanaba et al. (2014b) analysed the mutagenic
potential of PLA-Clay1 and PLA-Clay2 extracts by the Ames test.
These were obtained from a nanocomposite formed by Clay1þPLA
and Clay2þPLA, respectively, and did not present mutagenic po-
tential in any case. Also, genotoxicty and mutagenicity studies on
potential modiﬁers are lacking and the results available shown
both positive and negative effects (Dmochowska et al., 2011;
Grabinska-Sota, 2011).
Anew, different results dependent on the clays assayed, the
present modiﬁer (if any) and the concentration range tested are
presented in this section.
2.2.3. Inﬂammation responses
Among the biomarkers that are most frequently assayed in
relation to the inﬂammation process is the cytokine release,
mainly interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α)
(Lopresti et al., 2014).
Inﬂammation studies related with modiﬁed clays used in the
food industry are scarce. The Caco-2 and HepG2 cell lines did not
experiment an increase in IL-6 release after exposure to the
modiﬁed clays, Clay2 and C30B (Houtman et al., 2014; Maisanaba
et al., 2013). However, Elmore (2003) reported that different clays,
including Mt, induced cytotoxicity in several macrophage-type cell
lines and have haemolytic activity toward the red blood cells of
different species. Additionally, it has been reported that Mt clay
may promote infection by a direct cytotoxic effect on neutrophils,
making them unavailable for bacterial phagocytosis (Dougherty
et al., 1985).
2.2.4. Cell death
Different markers are used to determine the cell death me-
chanism after exposure to a toxic substance. Among the most used
are ﬂow cytometry and caspase activities (Napierska et al., 2009;of clay minerals and derived nanocomposites: A review. Environ.
Table 6
Genotoxicity of unmodiﬁed/modiﬁed clays and derived nanocomposites.
Material tested Modiﬁer Experimental model Assays performed Concentration range Main results Reference
- Sepiolite Unmodiﬁed Rat hepatocytes Unscheduled DNA synth-
esis (UDS)
1 and 10 mg/mL Sepiolite did not lead to signiﬁcant
UDS-induction
Denizeau et al.
(1985)
- Quartz Dipalmitoyl phosphatidylcoline (DPPC) Rat pulmonary alveolar mac-
rophagues cell line
Single-cell gel electrophor-
esis assay for DNA damage
0–40 mg/mL Genotoxic effects were observed in all
cases
Gao et al. (2000)
- Kaolin (both un-
treated and
treated)
- NSP Unmodiﬁed Salmonella typhimurium
strains (TA98,TA100, TA1535,
TA1537, TA102)
Ames test 0–1000 mg/plate No signiﬁcant genotoxic effects were
observed in any assay
Li et al. (2010)
Rat peripheral-blood cell line Micronucleus assay 0–500 mg/kg bw
CHO cell line Comet assay 0–1000 mg/mL
- CNaþ Unmodiﬁed Salmonella typhimurium
strains (TA98,TA100)
Ames test 0–14.1 mg/plate Genotoxic effects were observed by
Comet assay in Caco-2 cells exposed to
C30B
Sharma et al.
(2010)
- C30B (unﬁltered and
ﬁltered)
Quaternary ammonium salt (MT2EtOH) Caco-2 cell line Comet assay 0–170 mg/mL (un-
ﬁltered)/0–226 mg/mL
(ﬁltered)
- Native bentonite (BPN) Unmodiﬁed
H2SO4
HMy2.CIR cell line Comet assay 0–240 mg/mL The highest genotoxic effects were ob-
served after BPA exposure
Meibian et al.
(2011)- Active bentonite(BPA) Micronucleus assay
- Bentonite Unmodiﬁed Salmonella typhimurium
strains (TA97, TA102)
Ames test 0–10 mg/plate No mutagenic activity was observed EFSA (2013)
- C30B Quaternary ammonium salt (MT2EtOH) HepG2 cell line Comet assay 0–88 mg/mL DNA damage was observed in HepG2
exposed to C30B
Maisanaba et al.
(2013)
- C20A Quaternary ammonium salt (2M2HT) Caco-2 and HepG2 cell lines Comet assay 0–34 mg/mL and 0–
88 mg/mL
Genotoxic effects were observed only in
cells exposed to Clay2
Houtman et al.
(2014)- Clay1 Hexadecyltrimethylammonium bromide
(HDTA)
- Clay2 HDTAþAcetylcoline (ACO)
- C30B Quaternary ammonium salt (MT2EtOH) Caco-2 cell line Comet assay 0–40 mg/mL No DNA damage was observed Maisanaba et al.
(2014a)
- PLA-Clay1 extract HDTAþMtþ PLA Salmonella typhimurium
strains (TA97, TA98,TA100,
TA102, TA104)
Ames test 0–100% of extract No mutagenic potential was observed Maisanaba et al.
(2014b)- PLA-Clay2 extract HDTAþACOþMtþPLA
- CNaþ Unmodiﬁed Salmonella typhimurium
strains (TA97, TA98,TA100,
TA102, TA104)
Ames test 0–125 mg/mL Mutagenic activity was observed for
C30B and Clay1 exposure
Maisanaba et al.
(2014c)- C30B Quaternary ammonium salt (MT2EtOH) 0–250 mg/mL
- Clay1 HDTA 0–8 mg/mL
- Clay2 HDTAþACO 0–125 mg/mL
- CNaþ Unmodiﬁed Salmonella typhimurium
strains (TA1537, TA1538,
TA102)
Ames test 0–0.01 g A slight elevated growth was observed
in CNaþ exposure while a disminished
growth was detected in Hallosyte
exposure
Taylor et al.
(2014)- Hallosyte Unmodiﬁed
CHO: Chinese hamster ovary cell line; HMy2.CIR: human B lymphoblast cell line; Caco-2: colorectal adenocarcinoma cell line; and HepG2: liver hepatocellular carcinoma cell line.
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Some studies related to the evaluation of cell death produced
by exposure to clays can be found in the scientiﬁc literature (Ta-
ble 7) (Geh et al., 2006; Janer et al., 2014; Lordan et al., 2011; Liu
et al., 2011; Maisanaba et al., 2013; Meibian et al., 2010). Liu et al.
(2011) studied the enzymatic activity of caspase 3 and the per-
centage of apoptotic/necrotic cells by ﬂow cytometry in two dif-
ferent cell lines, NIH3T3 and HEK293, exposed to unmodiﬁed Mt
and oligo(Styrene-Co-Acrylonitrile)-modiﬁed Mt (PSAN-Mt) at 1 g/
L. The results of the two assays provided substantial evidence that
less cell apoptosis was induced by PSA-Mt compared with Mt in
both treated cells, although signiﬁcant differences were observed
with respect to the control in both clay exposures. Similar results
were obtained by Janer et al. (2014), who evaluated the same
parameters in the HepG2 and SKMEL28 cell lines exposed to Mt
and other modiﬁed montmorillonites with quaternary ammonium
modiﬁers. An increase in the caspase 3/7 activities were observed
after 4.5 h only in the HepG2 cell line and in both cell lines at the
highest time of exposure (48 h). Regarding the ﬂow cytometry
results, HepG2 exposed to 100 mg/mL large pristine nanoclays for
48 h showed a sevenfold increase in the percentage of cells stained
with Annexin V. However, these results did not match those ob-
tained by Lordan et al. (2011) because after 24 h, no increase in
caspase 3/7 activity was detected in the cells treated with CNaþ ,
the unmodiﬁed Mt, and C93A. Similarly, Maisanaba et al. (2013)
did not detect any variation in caspase 3/7 activity in the HepG2
cell line exposed to C30B for 24 and 48 h.
Native and modiﬁed bentonites have also been evaluated by
other research groups. Geh et al. (2006) used several techniques to
show that the IMR90 cell line exposed to native or alkali-, acid- or
organo-modiﬁed bentonites at a speciﬁc concentration (20 mg/mL)
suffered necrosis and apoptosis as the cell death response. Meibian
et al. (2010) also detected apoptotic cells after exposure to BPN and
BPA in the HMy2.CIR cell line.
Regarding to the toxicity mechanisms of clays, cell death,
genotoxicity, mutagenicity and oxidative stress have been widely
investigated in the recent years, as it has been described above.
Again, clays show speciﬁc toxicity proﬁles. On the other hand, the
research on inmunomodulatory effects of clays is still scarce and it
should be promoted as allergic disorders have a high prevalence
nowadays.
2.3. Antimicrobial activity
In this era, when many bacteria have developed antibiotic re-
sistance and may produce more harmful toxins as a defence me-
chanism (e.g., Shiga-toxin), the investigation of natural alternative
antibacterials is of paramount importance. Natural clays have been
used for healing singe the earliest recorded history, but their
medicinal properties have largely not been scientiﬁcally re-
cognized (Williams et al., 2011). A variety of physical and/or che-
mical processes can provide antibacterial properties to clays.
Physical bactericide can occur by surface attraction between clay
minerals and bacteria, which can hamper the passive and active
uptake of essential nutrients, disrupt cell envelopes or impair the
efﬂux of metabolites (Ferris et al., 1987). The natural antibacterial
clays studied do not kill by physical associations between the clay
and bacterial cells (Williams and Haydel, 2010). Williams et al.
(2011) described various studies verifying the antimicrobial po-
tential against E. coli using clay minerals and Fe-rich phases.
However, two works related to the Mt antibacterial action by na-
nohybrids or derived nanocomposites with polyurethane are
available in the literature (Su et al., 2009; Wang et al., 2012a). Su
et al. (2009) evaluated the potential against several bacterial
strains (Staphylococcus aureus, Pseudomonas aeruginosa, Strepto-
coccus pyrogens, E. coli and the methicillin- and oxacillin-resistantPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation of clay minerals and derived nanocomposites: A review. Environ.
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024i
S. Maisanaba et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎ 15S. aureus) of nanohybrids synthesized via silver nitrate reduction
in the presence of silicate clay, obtaining a higher potency against
bacterial growth. The researchers proved that the Ag/silicate (7/
93) ratio could inhibit the growth of dermal pathogens. Different
antibacterial activity tests were carried out, and the results con-
cluded that the nanohybrids are effective against a broad spectrum
of bacteria, including the resistant bacterial strains, in both agar
and solution. Furthermore, Wang et al. (2012a) demonstrated the
antimicrobial activity of the exfoliated clay nanosilicate platelets
(NSP), three types of surfactant-modiﬁed NSP (NSQa (cationic),
NSQb (nonionic) and NSQc (anionic)), and the nanocomposites
made from polyurethane (PU) and NSQs. NSQ modiﬁed by a ca-
tionic or anionic surfactant (NSQa or NSQc) displayed excellent
antimicrobial activity against S. aureus and E. coli at a concentra-
tion of 1%. The addition of 1% NSQa in the PU matrix inhibited the
growth of bacteria.3. In vivo toxicological assays
The number of recent in vivo experimental toxicity studies with
clay minerals in the scientiﬁc literature is low in comparison to the
in vitro studies, and the results reported are variable because dif-
ferent clay minerals, exposure routes and concentrations have
been used (Table 8). There are two previous reviews on the toxicity
of clay minerals, and these were performed by Elmore (2003) and
WHO (2005). Most of the studies included in those reviews were
performed a long time ago, and an effort to avoid duplicates was
made in the present work.
The exposure to clay minerals results in both toxic and non-
toxic responses. Most of the previous studies show that clay mi-
nerals do not induce macro-toxic or histopathological effects after
acute (Baek et al., 2012; Lee et al., 2005; Mascolo et al., 2004) or
subchronic/chronic exposures (Afriyie-Gyawu et al., 2005; EFSA,
2013; Maisanaba et al., 2014d,e) in rodents. In fact, Baek et al.
(2012) estimated that the median lethal dose (LD50) of Mt was
41000 mg/kg in mice. The absence of toxicity or very low toxicity
was also reported by Wiles et al. (2004) in Sprague–Dawley rats
exposed to Mt during pregnancy, with no signiﬁcant differences
between the animals and the embryos. However, Patterson and
Staszak (1977) found developmental effects, with maternal anae-
mia and reduction in the birth weight of pups after exposure to
20% kaolin during gestation. However, the consumption of clays by
wild animals in nature is common, and the practise of eating clay
by wild animals is well documented (Slamova et al., 2011). Several
hypotheses have been proposed to explain the geophagic beha-
viour: (1) detoxiﬁcation of noxious or unpalatable compounds
present in the diet, (2) alleviation of gastrointestinal upsets, such
as diarrhoea, (3) supplementation of the body with minerals and
(4) alleviation of hyperacidity in the digestive tract (Wilson, 2003).
In fact, many reports are available on the ability of clay to reduce
mycotoxicosis, metals, etc. in different animal models without in-
ducing inherent toxicity, but this is beyond of the scope of this
review.
To the best of our knowledge, in the last 10 years, the toxicity
mechanisms of clay minerals has been scarcely investigated
through in vivo methods. Regarding oxidative stress biomarkers,
Kibanova et al. (2009) reported that nontronites induced higher
LPO than hectorite in brain supernatant solutions exposed to up to
1000 ppm. Maisanaba et al. (2014e), however, did not ﬁnd any
alteration in the LPO, SOD, GPx and GST activities in the liver and
kidney of rats exposed for 90 days to a 40 mg/kg bw/d Mt-mod-
iﬁed clay (Clay1), although the CAT activity, gene expression and
protein abundance were increased in the kidney. In relation to
genotoxicity, EFSA (2013) referred to a study in which no chro-
mosomal aberrations were detected in rats exposed to bentonitePlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024ithrough diet for 15 days. Sharma et al. (2014) did not observe DNA
strand-breaks in the colon, liver and kidney cells of Wistar rats
exposed by gavage to 250–1000 mg/kg bw Closites30B. These
authors also reported the absence of inﬂammatory responses. This
result agreed with those reported by Hsu et al. (2012), who ex-
posed Sprague–Dawley rats to a subcutaneous injection of dela-
minated Mt particles with no induction of tissue inﬂammation.
The International Agency for Research on Cancer (IARC) evaluated
sepiolite and considered that it cannot be classiﬁed due to its
carcinogenicity to humans (Group 3) based on limited evidence in
experimental animals on the carcinogenicity of long sepiolite ﬁ-
bres (45 mm) and inadequate evidence in experimental animals
of the carcinogenicity of short sepiolite ﬁbres (o5 mm) (IARC
1997). No carcinogenicity data on kaolinite or Mt were provided.
Some researchers have justiﬁed the absence of toxic effects
because a systemic exposure was not demonstrated (Sharma et al.,
2014). However, Baek et al. (2012) observed no toxicity even at
1000 mg/kg bw Mt but reported that the clay mineral could be
absorbed into the body within 2 h without a speciﬁc organ for
accumulation. To investigate the intestinal absorption of clay mi-
nerals, the content of the characteristic structural metals (mainly
Al for kaolinites and smectites) is quantiﬁed. In this regard, con-
tradictory results have been found in the scientiﬁc literature.
Mascolo et al. (1999, 2004) observed a progressive increased ac-
cumulation of metals in the urine and tissues of rats in the fol-
lowing order: kidney4 liver4heart4brain. Additionally, Reich-
ardt et al. (2007) reported that kaolinite is dissociated in the lu-
men and that Al passes directly through the intestinal barrier. In
contrast, Sharma et al. (2014) did not ﬁnd an increase in the Al
content in the liver and kidney of rats exposed by gavage to
1000 mg/kg bw Cloisites30B. EFSA (2013) also considered that
bentonite and sepiolite, similarly to other clays, are not absorbed
to any measurable extent.
Taking into account that clays are modiﬁed to organoclays for
their novel applications, the toxicity of the potential modiﬁers is
also of interest. These investigations are scarce but Melin et al.
(2014) found that quaternary ammonium compounds such as the
mixture of alkyl dimethyl benzyl ammonium chloride and didecyl
dimethyl ammonium chloride signiﬁcantly impaired reproductive
health in mice. On the other hand, a subchronic experiment in rats
exposed by gavage to didecyldimethylammonium saccharinate
revealed no treatment-related microscopic changes whereas the
acute exposure to 2000 mg/kg bw resulted in death of all the
animals (Jodynis-Liebert et al., 2010).
Regarding the toxicological evaluation of nanocomposites
containing clays, only two studies have been identiﬁed. Hsu et al.
(2012) reported that an Mt/chitosan nanocomposite showed
higher in vivo compatibility compared with chitosan. Maisanaba
et al. (2014f) exposed rats to the migration extract obtain from a
PLA-Clay1 nanocomposite as a beverage and reported no toxic
effects in the histopathological study nor in the oxidative stress
biomarkers evaluated.4. Environmental impact
4.1. Animal exposure
As was previously mentioned, clay minerals are currently used
for numerous environmental applications due to their physico-
chemical properties. Some of these applications are the following:
prevention of algal blooms, removal of organic/inorganic pollu-
tants from soils and water, removal of pathogens, animal feeding,
and treatment of feedlot waste (Bowman, 2003; Ferrario et al.,
2000; Gillman, 2011; Lee and Tiwari, 2012). However, the presence
of clay minerals on aquatic and terrestrial ecosystems may alsoof clay minerals and derived nanocomposites: A review. Environ.
Table 8
Toxicity assays with rodents exposed to unmodiﬁed/modiﬁed clay minerals and derived nanocomposites.
Material tested Modiﬁer Experimental
Model
Exposure Concentration range Main results Reference
- Kaolin Unmodiﬁed Sprague-Dawley
female rats
In the feed d37-68/69-95/
96-117 prior fertilization
and during gestation
0, 20% kaolin; iron-sup-
plemented 20% kaolin
Rats fed kaolin diet exhibited maternal anaemia
and reduction in the birth weight of the pups.
These effects were not observed with the iron
supplemented diet
Patterson &
Staszak,
(1977)
- Pharmaceutical clay (smectite) -
Commercial herbalist clay (calcite,
illite-mica, kaolinite, smectitic
phases, quartz, feldspars, gypsum)
- Natural clay (quartz, kaolinite,
smectitic phases, sulphides and
accessories)
Unmodiﬁed Rats Acute oral administration 0, 150, 350,450 mg/kg bw The ingestion of clays causes a progressive in-
crease of metals in the urine and presumably in
the blood.
Mascolo et al.
(1999)
- Pharmaceutical clay (Diosmectal©)
- Commercial herbalist clay - natural
clay
Unmodiﬁed Male wistar rats Intragastrically adminis-
tered for 3 days using an
orogastric tube. Trial of
6 days
450 mg/kg bw No macrotoxic effects were detected. The trace
element content in the organs is strictly related
to the clay trace element content. The trace
elemental distribution followed the order:
kidney4 liver4heart4brain
Mascolo et al.
(2004)
- Calcium Mt clay (Novasil Plus) -
Sodium Mt clay
Unmodiﬁed Sprague-Dawley
rats during
pregnancy
In the feed and by gavage
Until d16 of gestation
2% w/w No signiﬁcant differences for total implantations,
resorptions or embryos. No signiﬁcant differ-
ences in tissue weights, maternal body weight
gain or feed intake. Only Rb levels were lowered
signiﬁcantly in treated animals but other ten-
dencies were apparent
Wiles et al.
(2004)
- Naturally occurring calcium Mt clay
(NovaSil)
Unmodiﬁed Sprague-Dawley
rats
In the feed 28 weeks 0, 0.25, 0.5, 1.0, 2.0% w/w No effects in either sex at the doses tested (total
feed consumption, body weight, organ weight,
histopathological changes, etc.) No dose-depen-
dent and isolated differences in hematological
parameters and clinical chemistry
Afriyie–Gya-
wu et al.
(2005)
- Mt (particle size 92.2%48 mm) Unmodiﬁed Wistar rats Oral and intravenous injec-
tion 72 h
A single dose 142.9 mg /kg
bw oral exposure
14.29 mg/kg bw in-
travenous injection
Oral: increase in hemoglobin concentration,
haematocrit and RBC count. Reduction in Naþ ,
Cl- and Caþ2 Injection: no change in the hae-
matological analysis. Increase in ALT, decrease in
Kþ No pathological alterations in any case
Lee et al.
(2005)
- Kaolinite Non-especiﬁed Rats Oral 28 days Non-especiﬁed Signiﬁcant increase in the thickness of the villi,
lengthening of the apical microvilli and in-
creased mitochondrial replication. Stimulation of
the absorption of long chain fatty acids. Kaolinite
is dissociated in the lumen and Al passes directly
through the intestinal barrier
Reichardt et al.
(2007)
- Hectorite (SHCa-1)
- Nontronites (NAu-1 & NAu-2)
Unmodiﬁed Male wistar rats Brain supernatant solutions
were exposed to the clays
0-1000 ppm Nontronites induced higher lipid peroxidation
(LP) than hectorite. LP is clay-surface-controlled
and dependent on clay structural composition
Kibanova et al.
(2009)
- Uncoated and coated sepiolite na-
noclay particulates - Quarz (SiO2) -
Ultraﬁne Titanium dioxide
particles
Unmodiﬁed Male Crl:CD(SD)
Rats
Intratracheal instillation
Analysis at 24 h, 1week,
5weeks, 3 moths
postexposure
A single dose 1 mg/kg bw,
5 mg/kg bw
Sepiolite resulted in multinucleated giant cells at
1, 5 weeks and 3 months Increased BAL ﬂuid
lactate dehydrogenase values at 24 h Transient
increases in cell labeling indices in the high dose
group Lung inﬂammation. With increased time
post installation, pulmonary changes became
less severe
Warheit et al.
(2010)
- Mt Unmodiﬁed Mice Oral gavage Single dose 5, 50, 300 and
1000 mg/kg bw
After 14 days post-administration no remarkable
abnormalities were observed. LD5041000 mg/
kg bw
Baek et al.
(2012)
- Delaminated Mt particles (DMtP)
- Mt/chitosan (CS) nanocomposite
Unmodiﬁed Sprague-Dawley
rats
- Single subcutaneous in-
jection.Sacriﬁce after 21
days
- 1 ml of 10, 102, 103, 104, 3
 104 ppm DMtP solution
- Film 10 mm x 10 mm,
- DMtP at low concentrations (r 100 ppm) did
not provoke tissue reactions - Superior compat-
ibility of DMtP/CS 103 ppm relative to CS. It was
Hsu et al.
(2012)
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manufacturing process, polymer degradation, or landﬁlls (Taylor
et al., 2014).
There are different scientiﬁc reports evaluating the toxic effects
of clay minerals on different animal species, most of which were
performed under laboratory conditions. These studies, although
still scarce, show contradictory results, with some of them in-
dicating the absence of damage, whereas other investigations re-
port positive effects or the absence of toxicity.
Thus, for example, different bentonite clays have been assayed
to establish a toxicological proﬁle. Sodium bentonite was de-
monstrated to be harmless after 24 h when added at a con-
centration of 7.5 g/L in 23 ﬁsh species (Daugherty, 1951). In con-
trast, Wyoming bentonite presented a LC50 of 19 g/L after 96 h of
exposure in rainbow trout (Sprague and Logan, 1979). Sigler et al.
(1984) found, in laboratory studies, that turbidity caused by ben-
tonite clays reduced the growing rate of two different salmon
species. In addition, bentonite has demonstrated its effectiveness
against the parasitic trematode Schistosoma mansoni through ad-
hesion to its surface, reducing its mobility (Olsen, 1987). Moreover,
the modiﬁed clay Phoslocks, which is bentonite clay in which the
sodium and/or calcium ions are exchanged for lanthanum (95%
bentonite and 5% lanthanum), was evaluated by Stauber (2000),
who reported that leachates of the modiﬁed clay did not present
toxicity in Melanotaenia duboulayi juvenile ﬁsh after 96 h of ex-
posure. These clay leachates did not affect the growth of the
freshwater alga Selenastrum capricornutum after 72 h of exposure.
On the contrary, this researcher also described that Phoslocks
presented a low toxicity on the cladoceran Ceriodaphnia dubia
after 48 h but a reduced number of young individuals after seven
days with a NOAEL of o3.1 g clay/L. Two different studies per-
formed on Oncorhynchus mykiss conducted for 48 and 96 h es-
tablished that minimal risk is derived from the application of
Phoslocks at a standard dose (Martin and Hickey, 2004; Watson-
Leung, 2009). Similarly, other studies have demonstrated that even
long exposure times or high concentrations of Phoslocks did not
produce a signiﬁcant impact on different benthic invertebrates,
such as Chironomus zealandicus, Chironomus dilutes, Polypedilum
parvidum, Hyalella azteca, Hexagenia sp., and Daphnia magna
(Clearwater, 2004; Clearwater and Hickey, 2004; Lürling and Tol-
man, 2010; Watson-Leung, 2009). In another study performed by
Oosterhout and Lürling (2011), Phoslocks induced toxic effects on
a Daphnia galeata population, although these researchers stated
that these toxic effects could be due to several factors acting in
synergy. Other researchers studied the species sensitivity dis-
tribution of 12 species and four taxonomic groups exposed to
bentonite, concluding that the organisms living in sediments are
accommodated to address these clays at high density (Smit et al.,
2008). Strachan and Kingston (2012) observed that different spe-
cies of bivalves (Modiolus modiolus, Venerupis senegalensis, Dosinia
exoleta, and Chlamys varia) increased their normal ﬁltration rate
when bentonite was added to the aqueous media. Moreover, the
survival of D. exoleta and V. senegalensis resulted to be compro-
mised during the exposure time (28 days). Robinson et al. (2010)
showed that Mt was more toxic than kaolinite by exposing D.
magna to different doses of the clay, demonstrating a dose-de-
pendent survival. Concerning plants, Asli and Neumann (2009)
demonstrated that the presence of bentonite in water supplies
could lead to an accumulation of this clay on the cell wall surfaces
of the primary root of Zea mays seedlings and consequently in-
duced an inhibition of the cell wall pore size, water transport ca-
pacity, leaf growth and transpiration. Recently, EFSA (2013) con-
sidered a 0.5% bentonite concentration in animal feeding to be safe
for all animal species considered, i.e., chickens, ruminants and
trout.
The environmental impact of kaolinite has also been assayed toof clay minerals and derived nanocomposites: A review. Environ.
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Lee (1976) found that the 24- and 48-h LC50 values for kaolinite to
D. pulex were 41.1 g/L. In addition, different concentrations of
kaolinite caused o10% mortality in some different marine species
within 5–12 days (McFarland and Peddicord, 1980). Isono et al.
(1998) demonstrated that the hatching success and developmental
rates of eggs of four marine ﬁsh species (Pagrus major, Acantho-
pagrus schlegelii, Oplegnathus fasciatus, and Parapristipoma trili-
neatum) was not signiﬁcantly affected after 24 h of exposure to
10 g/L kaolinite. On the contrary, the latter authors also described
larvae mortality in all of the ﬁsh species exposed to different
concentrations of the kaolinite suspension (0.032–10 g/L) for up to
12 h. Similarly, Robinson et al. (2010) described a decrease in
survival after 24 h of exposure of D. magna to a double pulse of
734 mg/L kaolinite.
Another clay mineral, sepiolite, has also been evaluated con-
sidering its beneﬁts in the animal feeding industry. Thus, it has
been evaluated in chickens for fattening, laying hens, pigs and
rabbits, highlighting the absence of adverse effects. EFSA con-
cludes that sepiolite, used individually at concentrations of up to
2% complete feed, is safe for all animal species (EFSA, 2013).
Clay minerals have also demonstrated their utility against
bacteria, mycotoxins and metal absorption in livestock, such as
chickens and piglets (Cabañero et al., 2005; Trckova et al., 2014;
Wang et al., 2012b).
Taking these data into account, it is also important to remark
that many clay minerals are usually combined with surfactants/
modiﬁers to improve their properties. These compounds can also
exhibit toxic effects in animal and plants, as has been stated by
some researchers (Garcia et al., 2001; Nalecz-Jawecki et al., 2003;
Sarkar et al., 2013; Mori et al., 2015). For this reason, it is important
to evaluate the toxicity of clay minerals, the modiﬁers and their
combination.
4.2. Human exposure
The exposure of the general population to low clay con-
centrations is frequent (López-Galindo et al., 2007); however, it
has markedly increased over the last century due to anthropogenic
sources (Oberdörster et al., 2005). Clay minerals occur everywhere,
including in rocks of all types (Moll, 2000; Pédro, 1994), dispersed
in atmospheric aerosols (Sanfeliu et al., 2002), and in water from
oceans, seas, lakes, lagoons, and rivers (Gomes, 1987). Several
diseases have been attributed to the human intake of polluted air
and water (Gomes and Silva, 2007). Inhalation is the most com-
mon route of entrance of clay minerals into the organism, but its
ingestion and absorption by the intestinal tract and dermal pe-
netration also have to be highlighted (Zhao and Castranova, 2011;
Silvestre et al., 2011). Nonetheless, there is currently limited in-
formation on occupational exposure to clay minerals in mines,
processing plants, and industries. However, it is known that high
levels of or inappropriate exposure to clay minerals in the en-
vironment and humans may lead to undesirable effects (Zhu and
Njuguna, 2014).
Regarding to oral exposure, low doses of clay minerals are used
in food preparation (Murray, 2000), in pharmaceuticals for oral
administration (Carretero, 2002; Droy-Lefaix and Tateo, 2006), and
as herbalist remedies (Mascolo et al., 1999; Tateo et al., 2001). They
are used as gastrointestinal protectors (kaolinite and palygorskite),
antacids (smectites and palygorskite), and antidiarrhoeaics (kao-
linite, smectites and palygorskite). The fundamental properties for
which clay minerals are used in pharmaceutical formulations are
high speciﬁc area and sorptive capacity, favourable rheological
characteristics, chemical inertness, low or null toxicity for the
patient, and low price (Carretero et al., 2006). Moreover, due to
their adsorptive properties, clays such as Novasil have beenPlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024iincluded in the diet to protect humans against aﬂatoxins in po-
pulations at high risk of aﬂatoxicosis (Afriyie-Gyawu et al., 2008;
Phillips et al., 2008). But, in some cases, clay minerals could be
dangerous when ingested (Mascolo et al., 1999; Tateo et al., 2001;
Tateo and Summa, 2007; Willhite, et al., 2012). The practice of
drinking clay suspensions can be considered a sort of geophagia
(soil ingestion), which is a very ancestral and debated human
behaviour (Reilly and Henry, 2000; Woywodt and Kiss, 2002;
Wilson, 2003; Ziegler, 1997). Geophagia is not only a voluntary
ingestion of clay or soil but has a more general meaning because it
also includes inadvertent ingestion with possible hazardous im-
plications (Sheppard, 1998; Simon, 1998). Whilst geophagia is re-
cognized as a multi-causal behaviour, a prevalent explanation is
the ‘nutritional hypothesis’ where the deliberate consumption of
soil is attributed to an attempt to regulate a mineral nutrient im-
balance such as sodium deﬁciency. Thus, the habit of eating soil
can lead to increased exposure and metal toxicity (Mwalongo and
Mohammed, 2013). However, paradoxically, some ingested soils
can also result in mineral nutrient deﬁciency problems attribu-
table, for example, to the adsorptive properties of earth materials
that can effectively bind chemical elements (Abrahams 2012).
Ingested soils can have a signiﬁcant impact on the mineral
nutrition of humans being potentially a source and/or sink of es-
sential elements and potentially harmful elements (Hooda et al.,
2004; Abrahams 2012).
The pathogenicity of clay minerals is mainly caused by in-
halation (Carretero et al., 2006). Inside the lung, clay minerals can
cause diverse pathologies, such as cancer, mesothelioma, and
pneumoconiosis, but the toxicity of these minerals is generally
related to both the presence of quartz or asbestos from mining
works and with the geological conditions of formation (Carretero
et al., 2013). However, calcium Mt in the absence of quartz has
been reported to induce pneumoconiosis, characterised micro-
scopically by grey black stellate nodules and microscopically by
centrilobular intersticial collections of brown dust laden macro-
phages associated with slight ﬁbrosis (Gibbs and Pooley, 1994).
Bentonite is a widely distributed material that occurs abun-
dantly as dust and near surface deposits of bentonite and is widely
dispersed by air and moving water (Parker, 1988). The expected
acute oral toxicity of bentonite in humans is very low
(LD50415 g/kg) (HSDB, 2014). However, long-term occupational
exposures to bentonite can cause pneumoconiosis, which is a
chronic inﬂammatory and ﬁbrotic lung disease, in workers in-
volved in mining and processing (Cui and Zhang, 2001; Gibbs and
Pooley, 1994; Phibbs et al., 1971). Kondej and Sosnowski (2013)
reported that aluminosilicate nanoparticles (bentonite, halloysite,
and Mt) in the pulmonary liquid above 0.1 mg/cm3 were capable of
promoting alterations of the original dynamic biophysical activity
of a model pulmonary surfactant and that this effect was indicated
by deviation of the minimum surface tension, stability index and
the size of surface tension hysteresis.
In general, however, there is a concomitant exposure to other
minerals (e.g., silica and amphiboles), and the response to these
minerals complicates the interpretation of the data. For example,
bentonite deposits generally contain other minerals, including
very ﬁne-grained quartz and amorphous silica. In the case of
Wyoming bentonites, the silica content (which includes both
quartz and cristobalite) ranges from 0% to 24% (Ross et al., 1993).
Sampatakakis et al. (2013) performed the ﬁrst epidemiological
study in which a speciﬁc methodology is used to indicate the dust
role of bentonite and perlite in the mortality and morbidity rates
of permanent residents (Milos Island). In these residents, an in-
creased risk of developing diseases of the respiratory system, such
as pneumonia, chronic obstructive pulmonary disease and allergic
rhinitis, has been observed. The morbidity of these diseases was
signiﬁcantly elevated. Moreover, Yuwen et al. (2013) investigatedof clay minerals and derived nanocomposites: A review. Environ.
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inhalation. The results showed that excessive occupational ex-
posure to this clay mineral can lead to detectable genetic damage
and LPO, which may be inﬂuenced by the air exposure con-
centrations of organic bentonite particles. However, bentonite is
not considered toxic to humans; thus, this clay mineral has been
approved as a food additive in different countries, such as Australia
(NICNAS, 2001) and Europe (EFSA, 2013). In this sense, Afsar and
Groves (2009) observed that Phoslocks application to a water
body to remove phosphorus and eliminate the presence of blue-
green algal blooms did not cause damage to human health.
Kaolin and the clay mineral kaolinite are natural components of
soil and occur widely in ambient air as ﬂoating dust. Accordingly,
the exposure of the general population to these materials must be
universal, albeit at low concentrations. In the vicinity of mines and
industrial projects, kaolinite is likely to be present at high con-
centrations in air. The composition of the clay, i.e., the quantity and
quality of minerals other than kaolinite, is an important determi-
nant of the effects (Adamis et al., 2005). The clay mineral kaolinite
has been detected in the lung tissue of bronchoalveolar lavage
ﬂuid of various worker groups (Churg, 1983; Churg and Wiggs
1985; Dumortier et al., 1989; Johnson et al., 1986). Mastin et al.
(1986) also evidenced the presence of inorganic particles in the
lungs of non-occupationally exposed population. Quartz, talc, and
kaolinite could be detected in the lungs of practically all subjects.
Paoletti et al. (1987) identiﬁed 17 different mineral types in the
lung parenchyma of 10 deceased subjects living in an urban area
with no occupational dust exposure. Approximately 70% of the
minerals consisted of phyllosilicates, particularly micas, clays
(kaolin and pyrophyllite) and chlorites. In addition, several dif-
ferent mineral types have been detected in the lungs of 11 un-
selected autopsy cases, including quartz, feldspar, kaolinite, and
mica (Kalliomäki et al., 1989). Kaolinite particles constituted
1075% of the mineral particles in the lungs. More mineral parti-
cles were also found in the lungs of non-smokers, but the differ-
ences were not statistically signiﬁcant. Similarly, Yamada et al.
(1997) also detected (ﬁbrous) talc, mica, silica, chlorite, and kao-
linite particles in the lungs of female lung cancer patients and
residents from urban and rural areas in Japan.
Epidemiological studies, as reviewed by Guthrie (1992), suggest
that kaolinite-bearing dust is ﬁbrogenic only under extraordinary
conditions, notably high concentrations of dust or exposure com-
bined with another respiratory disease, such as tuberculosis. Other
researchers have indicated that excessive exposure to kaolinite
dust may lead to the development of pneumoconiosis (Davis and
Cotton, 1983; Kennedy et al., 1983; Levin et al., 1996; Ross et al.,
1993; Sepulveda et al., 1983; Wagner et al., 1986). However, pul-
monary ﬁbrosis has been found in kaolinite workers in America,
where the mica content is negligible (Lapenas and Gale, 1983; 1984).
Another clay is illite, which is widely distributed in nature,
abundant, and often the dominant mineral clay in soil, terrestrial
deposits, sedimentary rocks, freshwater sediments, and most
deep-sea clays (Grim, 1968). Only a few epidemiological studies of
respiratory disease resulting from exposure to dusts containing
illite and smectites have been published to date. Some researchers
have suggested that inhaled smectite is likely to be less dangerous
to humans than kaolin (López-Galindo et al., 2007).
In contrast, chronic exposures to high concentrations of talc
were associated with the development of talcosis, a type of
pneumoconiosis (Carretero et al., 2006). Although it occurs com-
monly as an occupational hazard, pulmonary disease due to talc is
more often encountered after the intravenous administration of
talc during drug abuse (Neuman et al., 2011). Gibbs et al. (1992)
observed cases of “talc pneumoconiosis”. Mixed dust ﬁbrotic le-
sions were found in two cases in which there were substantial
quantities of quartz present. Great variations in the minerals werePlease cite this article as: Maisanaba, S., et al., Toxicological evaluation
Res. (2015), http://dx.doi.org/10.1016/j.envres.2014.12.024ifound within the lung tissues. This study showed that “talcosis”
frequently represents a disease associated with a variety of mi-
nerals and that talc is a common denominator. Neuman et al.
(2011) presented a case report of a worker who was exposed to
talcum during his work in tire manufacturing. During his lifetime,
an occupational disease was not recognised. The autopsy revealed
lung ﬁbrosis. Based on the pathological and mineralogical ﬁndings,
the conﬁrmed occupational exposure toward talc and the exclu-
sion of other possible causes (asbestos and quartz), the diagnosis
of a talc-induced interstitial lung ﬁbrosis, namely talcosis, was
established. Nath et al. (2014) presented a case of talcosis in a
worker who had considerable exposure to talc during the initial
preparation of “samosa,” a triangular fried Indian savoury. Typical
pulmonary histological ﬁndings of talcosis with extensive de-
position of birefringent crystals in histiocytes were observed.
Talcosis in the course of food adulteration is seldom or hardly
reported.5. Conclusions
The improvements that clay minerals used in technical areas
provide are well known, but their toxicity proﬁle currently has
many gaps. In this sense, the variety of the toxicity results de-
scribed in the scientiﬁc literature is huge, as was shown
throughout the review. Thus, most of in vitro toxicity reports
showed cell death and different toxic mechanisms involved
(genotoxicity, oxidative stress, etc.) whereas human and animal
data showed a lower toxicity. Therefore, it is difﬁcult to reach a
deﬁnitive conclusion regarding the toxicity or security of clays and
their uses. Additionally, few exhaustive comparative studies have
been performed. It is important to note that the toxicity proﬁles of
clay minerals and derived nanocomposites are deﬁned according
to different parameters, including (i) the exposure conditions, such
as the concentrations or exposure times assayed, (ii) the experi-
mental models selected, (iii) the modiﬁers or surfactants in-
corporated in their structures and their concentrations and (iv) the
sensitivity of the assays performed.
In conclusion, many beneﬁts could be derived from clay mi-
nerals and their products, but a case by case toxicological eva-
luation is always required to avoid potential human and environ-
mental risks.Acknowledgements
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1. Introduction 
Clays have an array of commercial applications in differen
ﬁelds: the manufactur e of inks, paints, greases and cosmetics, wate
treatment processes, the controlled release of therapeutic agent
food packaging, etc. (Lordan et al., 2011 ). In regard to food packag
ing applications, clays are used to improve the barrier properties o
food contact materials. This results in a length of the storage tim
while keeping the product fresh. Polymers incorporating clay nano
particles are among the ﬁrst polymer nanocompo sites to emerge o
the market as improved materials for food packaging. This is due t
the easy availabili ty of the raw clay materials and because the
cation exchange chemistry has been intensive ly studied. In add
tion, these clay nanoparticl es have unique properties such as larg
surface areas, large aspect ratios and improved mechanical , therma
and optical properties (Utracki and Kamal, 2002; Pavlidou an
Papaspyrides , 2008 ). The most frequently used clay in the prepara
tion of polymer nanocompo sites is montmorill onite, which is th
major constituent of bentonite . Montmorillonite is a natural cla
which occurs as plate-like particles called platelets. These platelet
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s/n, 41012 Seville, Spains have a wide range of applications that are going to contribute to increas
aterials. One of the most promising uses of clays is the development of rein
ls that results in nanocomposites with improved barrier properties. Differen
loped introducing modiﬁers in the natural clay which is commercially avai
gical aspects of these materials have been scarcely studied so far. In the pre
ects of a non-modiﬁed clay (Cloisite Na+) and an organoclay (Cloisite 30Bere assayed. Moreover, a morphology study with light and electron micro
lts showed genotoxic effe cts and glutathione decrease. The most relevan
observed were mitochondrial degeneration, dilated endomembrane system
n, fat droplets appearance and presence of nuclear lipid inclusions. Cloisite
ic effects in HepG2 cells. Further research is needed to assess the risk of th
 2013 Published by Elsevier Ltlength and width can be measured up to 1 mm (Lordan et a
2011). One limitation of clays is the incompa tibility between th
hydrophi lic clay and a hydrophobi c polymer, which could caus
agglomer ation of clay in polymeric matrices (Elmore and Andersenminerals is an important step to achieve polymer nanocom posite
By cation exchange with organic cations, clays become hydrophob
and thereby compatible with polymers. Such modiﬁed clays ar
referred to as organoclay s (Sharma et al., 2010 ). The most widel
known theories to explain the improved barrier properties o
polymer–clay nanocom posites are based on a theory develope
by Nielsen (1967), which focuses on a tortuous path around the cla
plates, forcing the gas permeant to travel a longer path to diffus
through the ﬁlm.
Successful technical developmen t of nanocom posites for foo
packagin g has to overcome barriers in safety, technology, regula
tion, standardizati on, etc. (Silvestre et al., 2011 ). Regarding t
safety, since the use of clays and organoclays is increasing, it 
important to take into account their toxicity. Clays are natura
materials but they are not free of possible side-effects. In th
sense, toxicity studies of clays have been scarcely performed . Th
toxicolog ical evaluation of these products can be faced using botassessmen t of clays for their use in food packagin g applica tions. Food Chem. 
87 in 
88 to
89 an
90 od
91
92 aft
93 als
94 th
95 in
96 th
97 in
98 M
99 cle
100 ve
101 so
102
103 stu
104 Na
105 ha
106 bio
107 in
108 a h
109 2.
110 2.1
111 
112 (Cl
113 tal
114 cla
115 fra
116 
117 the
118 up
119 7 m
120 an
121 po
122 fac
123 pa
124 dis
125 Ins
126 the
127 me
128 2.2
129 
130 ou
131 sys
132 Na
133 me
134 for
135 con
136 2.3
137 
138 tai
139 we
140 me
141 an
142 5%
143 2.4
144 
145 0.4
146 7.8
147 of 
148 
149 for
150 an
151 blu
152 wa
153 
154 cau
155 to 
156 tra
157 NR
158 for
159 
160 bas
161 ox
162 cel
163 inc
164 49
165 
166 mi
167 cyt
168 gat
1692.5
170 
2 S. Maisanaba et al. / Food and Chemical Toxicology xxx (2013) xxx–xxx
FCT 7238 No. of Pages 11, Model 5G 
13 April 2013 
Pl
Tovivo and in vitro methods. The primary aim of in vitro testing is 
xicity screening and the understand ing of biological responses 
d underlying mechanisms (EFSA, 2011 ). Moreover, in vitro meth-
s are encouraged in toxicologica l research for ethical reasons. 
Toxic effects of clay minerals have been shown to occur mainly 
er inhalation (Carretero et al., 2006; Sharma et al., 2010 ). But 
o, one of the most likely routes of exposure to these clays for 
e general population is the oral pathway, since they are present 
 food contact materials. Tateo and Summa (2007) reported that 
e ingestion of clays is common at low doses in food preparations ,
 pharmac euticals for oral administ ration, and as herbal remedies. 
oreover, distribution studies performed with different nanoparti- 
s showed that they can translocate to several organs such as li- 
r, kidney, lungs. (Kim et al., 2008; Kwon et al., 2008; EFSA, 2009)
 for clays this possibility cannot be discarded. 
In view of the limited toxicolog ical information of clays, in this 
dy we aim to evaluate the toxicity of an unmodiﬁed (Cloisite
+) and an organomodiﬁed clay (Cloisite 30B) in the human 
patocellul ar cell line HepG2. For this purpose, basal cytotoxicity 
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191 markers and mechanistic biomarkers of oxidative stress, 
ﬂammation and genotoxicity have been investigated . Moreover, 
istopatholo gical study has been also performed. 
Materials and methods 
. Clay materials and characterization 
Unmodiﬁed montmorillonite (Cloisite Na+) and the organically modiﬁed one 
oisite 30B) were obtained from Southern Clay Products, INC. (modiﬁer: methyl, 
low, bis-2-hydroxyethyl, quaternary ammonium, concentration: 90 meq/100 g
y). Both clays were characterized by thermogravimetric analysis (TGA), X-ray dif- 
ction (XRD) and particle size distribution (PSD).
TGA analysis of Cloisite Na+ and Cloisite 30B were performed on a Q5000IR 
rmobalance (TA Instruments) by heating the samples from room temperature 
 to 900 C with heating rate of 10 C/min, in nitrogen atmosphere. Approximately 
g of each ﬁnely ground sample was heated in a platinum crucible. Powder XRD 
alyses were performed using a D8ADVANCE A25 Bruker diffractometer. The clay 
wders were mounted on a sample holder with a large cavity and a smooth sur- 
e was obtained by pressing the powders with a glass plate. The X-ray diffraction 
tterns were measured from 1.5 to 25 (2h) at a scan rate of 0.02 s. Particle size 
tributions of the samples were estimated with a Mastersizer 3000 (Malvern
truments Ltd., UK). Dispersion in dry basis was the selected method to perform 
 different assays, with controllable airﬂow and feed rate. This method allows 
asuring particle sizes between the range 0.1–3500 lm.
. Clays test solutions The test concentrations for both clays were selected taking into account previ- 
s dispersion experiments in order to avoid interferences with the measurement 
tem. The highest concentrations tested were 62.5 and 500 lg/mL for Cloisite 
+ and Cloisite  30B, respectively. Test solutions were prepared in serum-free 
dium. Three sonication steps of 10 s each one at an amplitude of 40% were per- 
med using an ultrasonic tip (Dr. Hielscher, Germany) to disperse the test 
centrations.
. Cell culture 
HepG2 (human hepatocellular carcinoma epithelial cell line) (HB-8065) was ob- 
ned from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells 
re cultured in monolayer in Eagle’s Minimum Essential Medium (ATCC) supple- 
nted with 10% of fetal calf serum (FCS, Gibco, New Zealand), 100 U/mL penicillin 
d 100 lg/mL streptomycin (Gibco, New Zealand). Cells were grown at 37 C and
 CO 2 in a humidiﬁed atmosphere. 
. Cytotoxicity assays 
For cytotoxicity assays, exposure concentrations for Cloisite  Na+ were set at 0, 
9, 0.98, 1.95, 3.91, 7.81, 15.63, 31.25, 62.5 lg/mL and for Cloisite  30B at 0, 3.91, 
1, 15.63, 31.25, 62.5, 125, 250, 500 lg/mL. HepG2 cells were seeded at a density 
7.5  105 cell/mL in 96 wells plates and exposed to the clays for 24 and 48 h. 
Total cellular protein content (PC) was quantiﬁed following the method of Brad-
d (1976). After exposure, cells were washed with phosphate buffer saline (PBS)
d incubated with 0.1 N NaOH for 2 h at 37 C. Later, a 22% Coomassie brilliant 
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xicol. (2013), http ://dx.doi. org/10.1016/ j.fct.20 13.03.043 e solution (Biorad, Spain) was added to the wells and within 30 min absorbance 
s read at 595 nm on a microplate reader (Biotek, USA).
Neutral Red (NR) uptake is a suitable endpoint to determine viable cells, be- 
se this dye is taken up by viable lysosomes. This assay was performed according 
Borenfreund and Puerner (1984). Brieﬂy, NR in medium is absorbed and concen- 
ted in lysosomes of cells. NR uptake is proportional to the concentration of the 
 solution and the numbers of viable cells. NR can be extracted from lysosomes 
 quantitative measurement at 540 nm. 
The MTS tetrazolium reduction assay was performed according to a procedure 
ed on Baltrop et al. (1991), being MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carb-
ymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt bioreduced by 
ls into a colored formazan product soluble in culture medium. Cells were directly 
ubated with MTS tetrazolium salt for 2 h at 37 C and absorbance was read at 
2 nm. 
Only when cytotoxicity was observed, mechanistic biomarkers were deter- 
ned. In this case, the mean effective concentration (EC50) of the most sensitive 
otoxicity endpoint was chosen as the higher exposure concentration to investi- 
e mechanistic biomarkers along with the fractions EC 50/2 and EC 50/4.
. Caspase-3/7 activity
Caspase-3 and -7 activities were used as apoptosis biomarkers in cells exposed 
 24 and 48 h to the clays. Manufacturer instructions from the kit (Caspase-Glo
 Assay, Promega, USA) were followed. 
. ROS generation 
The production of ROS was assessed in 96 wells microplates using the dichloro- 
orescein (DCF) assay. Cells were incubated with 200 lL, 40 lM 20 ,70-dichloroﬂu-
scein diacetate (DCFH-DA) in culture medium at 37 C for 30 min, and then 
shed with PBS and resuspended in 200 lL of PBS. The formation of the ﬂuores-
ce oxidized derivative of DCF-DA was monitored at emission wavelength of 
5 nm and excitation wavelength of 485 nm. ROS production was expressed as 
orescence arbitrary units (Puerto et al., 2010).
. GSH content 
Cellular glutathione (GSH) content was evaluated by reaction with the 
orescent probe monochlorobimane (mBCl) (Jos et al., 2009 ). This molecule forms 
hioether adduct with GSH in a reaction catalyzed by the enzyme glutathione- 
ransferase (GST). After the cell exposure the medium was discarded and cells 
re incubated at 37 C for 20 min in the presence of 40 lM mBCl. Later on cells 
re washed with PBS and the ﬂuorescence was recorded in a spectroﬂuorometer
otek, USA) at the following excitation/emission wavelengths: 355/460. Results 
re expressed as ﬂuorescence arbitrary units. 
. Interleukin-6 leakage 
For this assay the culture medium of the cells after 24 and 48 h exposure to the 
192 ys was used. Manufacturer instructions from the kit (EH2IL6, Thermo Scientiﬁc,
193 A) were followed. 
194. Comet assay 
195 The comet assay was performed to detect DNA strand breaks. HepG2 cells were 
196 ded into 12-well tissue culture treated plates (Corning Costar Corporation, New 
197 rk, USA) and left overnight at 37 C in 5% CO 2 to attach to the plates. Approxi- 
198 tely 3.5  105 cells in each well were exposed with different concentrations of 
199 isite  30B (0, 22, 44 or 88 mg/mL) after 24 and 48 h to exposure. 
200 In order to monitor the ongoing process of the assay, a negative control (cells
201 ated with medium without fetal calf serum) and a positive control (cells treated 
202 th a solution of 100 lM H2O2) were included. After treatments cells were washed 
203 d detached in PBS. The comet assay was applied as previously described by 
204llins et al. (1997) with modiﬁcations (Corcuera et al., 2011 ). Brieﬂy, cells were 
205 uspended in PBS at a concentration of 2.5  106 cells/mL. This suspension 
206 re mixed with 1% low melting point agarose and placed on a microscope slide. 
207 ce the gels had become solid, the slides were dipped into lysis solution at 4 C.
208  nucleotides were denatured in a high-pH buffer. Electrophoresis was carried 
209 t approximately at 25 V (300 mA) and the DNA was gently reneutralized in PBS 
210 d washed in H2O. After neutralization, microscope slides are ﬁxed in 96% ethanol 
211 d absolute ethanol. Finally, DNA was stained with SYBR Gold nuclei acid gel stain 
212 d was visualized with an Olympus BX61 ﬂuorescence microscope (20 objective)
213 pled via a CCD camera to an image-analysis system (DP controller-DP manager).
214 ages of randomly selected nuclei (P100) per experimental point were analyzed 
215 th the image analysis software (Comet Assay IV, Perceptive Instruments, UK).
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216 2.10. Morphology 
217 Cells were exposed to different concentrations of Cloisite 30B (0, 22, 44 or 
218 88 mg/mL) during 24 and 48 h of exposure. Afterwards, cultured cells were ﬁxed di- 
219 rectly in the cell culture dish in 1.6% glutaraldehyde in 0.1 M cacodylate buffer, pH 
220 7.2, for 60 min at 4 C. They were all postﬁxed in 1% osmium tetroxide for 60 min at 
221 4 C. Samples were dehydrated in ethanol at progressively higher concentrations 
222 and embedded in Epon (epoxy embedding medium). Toluidine blue-stained semi- 
223 thin sections (0.5 lm thick) used as controls were viewed in a Leitz (Aristoplan)
224 light microscope. Thin sections (60–80 nm thick) were cut on a Reichert-Jung Ultra- 
225 cut E ultramicrotome, stained with uranyl acetate and lead citrate, and examined in 
226 a Philips CM-10 transmission electron microscope. 
227 2.11. Calculations and statistical analysis 
228 All experiments were performed at least three times and at least in duplicate 
229 per concentration. Statistical analysis was carried out using analysis of variance 
230 (ANOVA), followed by Dunnett’s multiple comparison tests. Differences were con- 
231 sidered signiﬁcant from p < 0.05. EC 50 values, mean effective concentration, concen- 
232 tration of test chemical that modiﬁed each biomarker by 50% (positive or negative)
233 in comparison with appropriate untreated controls, were determined by linear 
234 interpolation. 
235 3. Results 
236 3.1. Characterizati on of Cloisite  Na+ and Cloisite  30B
237 TGA results of both clays are presented in Fig. 1. Loss weight 
238 percent (%), and derivative weight (%/C) are presented versus tem- 
239 perature. It can be observed that only the sample Cloisite  30B has 
240 big loss step in the range between 200 and 500 C, indicating that 
241 an organic compound is being released in this step. The percentage 
242 of organic modiﬁer in Cloisite  C30B is 35.98%, as calculated in the 
243 TGA curves. Cloisite  Na+ hardly presents any weight change in 
244 this range of temperature. 
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25730B is lower for all the values (Dv10, Dv50, and DV90) than those 
258of Cloisite  Na+.
2593.2. Cytotoxici ty assays 
260Cloisite Na+ did not induce cytotoxic ity after the exposure of 
261the cells for 24 and 48 h at the concentratio ns assayed (Fig. 3). Only 
262the PC assay showed a small signiﬁcant reduction at the higher 
263concentr ation (62.5 lg/mL). The EC 50 could not be calculated in 
264any of the biomarkers. 
265Protein content was the less sensitive endpoint of Cloisite  30B
266cytoxicity . After 24 h exposure to Cloisite  30B, this endpoint de- 
267creased from 250 lg/mL, with a calculated EC 50 of 285 ± 9 lg/mL.
268Similar reductions of protein content were remarkable after 48 h, 
269although after 2 days of exposure, the decrease could be apprecia- 
270ble already from 125 lg/mL in comparison to 24 h (Fig. 4a).
271Regarding to NR uptake, no signiﬁcant changes were observed in 
272the four lower concentratio ns used, although a concentratio n- 
273depende nt decrease was observed from 62.5 lg/mL with EC 50 val-
274ues of 88 ± 4 and 55 ± 3 lg/mL at 24 and 48 h, respectively
275(Fig. 4b). MTS metabolizati on decreased substantially , with a
276reduction of around 90% at the higher concentration tested com- 
277pared to the control. After 48 h, MTS metaboli zation was signiﬁ-
278cantly reduced between 62.5 and 500 lg/mL. EC 50 values for this 
279endpoint varied between 158 ± 7 and 79 ± 5 lg/mL after 24 h and
28048 h respectively (Fig. 4c).
281The most sensitive endpoint for Cloisite  30B was the neutral 
282red uptake, therefore the EC 50 value of this biomarker (88 lg/mL)
283was chosen as the higher exposure concentratio n for the mecha- 
284nistic studies in the human hepatocellular cell line along with 
285the fractions EC 50/2 and EC 50/4, being the concentr ations used 
28688, 44 and 22 lg/mL.
2873.3. Caspase-3/7 activity
288The caspase activity assay did not show any signiﬁcant varia- 
289tion with any of the concentrations of Cloisite 30B and at any time 
290of exposure (Fig. 5).
2913.4. ROS and GSH content 
292When HepG2 cells were exposed to Cloisite  30B during 24 and 
29348 h, no signiﬁcant alteration on ROS was observed at any of the 
Na
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13 April 2013 XRD results of both clays are presente d in Fig. 2. The signa
intensity is plotted versus de 2h. Results show the typical pattern
associated with a montmorilloni te material. The main differenc
corresponds to the signal associate d to the interlayer space in th
clays (corresponding to the d(001) diffraction peak); in the cas
of Cloisite Na+ is 8.8 (2h), and in the case of Cloisite 30B is 4.
(2h). The distances of silicate layers can be calculated by Bragg
Law (nk = 2dsinh, d = layer distance). The measured d001-spacin
of Cloisite  Na+ is 10.0 Å (2h = 8.8), but after cation exchange wit
the modiﬁer (Cloisite 30B) d001-spacing became 18.7 Å (2h = 4.7
PSD of the samples has been calculated and results are pre
sented in Table 1. It can be observed that particle size of Cloisite
Fig. 1. TGA results for Cloisite Please cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical 
Toxi col. (2013), htt p://dx.doi.org /10.1016/ j.fct.20 13.03.043 + (square) and Cloisite  30B (round).assessmen t of clays for their use in food packagin g applica tions. Food Chem. 
294 exposure concentratio ns in comparison to the control group 
295 (Fig. 6a). In contrast, a concentratio n-dependent decrease of GSH 
296 was observed being the GSH content 10-fold lower at the higher 
297 concentratio n assayed. Moreove r, there were not statistical differ- 
298 ences with respect to the control in any concentration tested and 
299 times of exposure (Fig. 6b).
300 3.5. IL-6 leakage 
301 The IL-6 assay showed no increase in the IL-6 content in the cell 
302 culture medium of the cytotoxicity assays in any of the treatments 
303 performed (data not shown).
304 3.6. Genotoxicity : comet assay
305 Cloisite 30B induced time-dependent increases of DNA strand 
306 breaks in HepG2 cells (Fig. 7). After 24 h of exposure no changes 
307 were observed after exposure to the clay; in contrast a signiﬁcant
308 increase of DNA damage was observed after 48 h incubation with 
309 the highest concentratio n (88 lg/mL). The mean value of the% tail 
310 DNA was 23.4, while in the control group was only 2.9%. The per- 
311 centage of DNA in the tail for 88 lg/mL is not signiﬁcantly different 
312 from the percentage of DNA found for the positive control. 
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Fig. 2. DRX results for Cloisite  Na+ (rhombus) and Cloisite  30B (square).
Table 1
PSD results for Cloisite  Na+ and Cloisite  30B.
Sample Dv 10 (lm) Dv 50 (lm) Dv 90 (lm)
Cloisite  Na+ 5.33 15.71 33.23 
Cloisite  30B 2.63 9.20 24.58 
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To. Morphologic study 
.1. Light microscope observatio ns 
Control HepG2 cells observed under light microscope are shown 
Fig. 8a. After 24 h of exposure to 22 lg/mL Cloisite  30B, they 
e still growing with similar morphological characteri stics to the 
ntrol group. However, after 48 h of exposure to 88 lg/mL Cloi- 
e 30B, a decrease in the growing rate is observed, which could 
 due to a cellular cycle stop and cell death (Fig. 8b). Moreover, ease cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical assess
xicol. (2013), http ://dx.doi. org/10.1016/ j.fct.20 13.03.043 lls show severe morphological changes such as intense 
cuolizati on. 
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. 3. Protein content, PC (a); neutral red uptake, NR (b); and reduction of 
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Fig. 4. Protein content, PC (a); neutral red uptake, NR (b); and reduction of 
tetrazolium salt, MTS (c) of HepG2 cells after 24 h and 48 h of exposure to 0–
500 lg/mL Cloisite  30B. All values are expressed as mean ± SD. Signiﬁcantly
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Fig. 5. Caspase-3/7 activity of HepG2 cells after 24 h and 48 h of exposure to 0–
500 lg/mL Cloisite  30B. All values are expressed as mean ± SD. 
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13 April 2013 3.7.2. Electron microscope observations 
The most remarkable ultrastructu ral features of unexpose
HepG2 cells, observed by electron microscopy , are big irregular nu
clei with numerous heterochromat ic accumulations dispersed i
the nucleopl asm and prominent nucleoli. Moreover, cytoplasm 
rich in mitochond ria with light matrix, endoplasmic reticulum cis
ternae and lipid drops (Fig. 9a). In the culture, undifferentiate
cells coexist with cells under certain degree of differentiation
which exhibit membrane junction complex characterist ic oPlease cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical 
Toxi col. (2013), htt p://dx.doi.org /10.1016/ j.fct.20 13.03.043 epithelial cells such as tight junction, adherent junction and des
mosome s (Fig 9b). All these junctions allow the development o
intracellul ar spaces which are bounded by cytoplasm projection
similar to microvilli, which could resemble the hepatic bile canalic
0
20
Control 22 44 88
%
 
* * *  *  *
      Cloisite® 30B (µg/mL)
Fig. 6. ROS content (a), and GSH content (b) in HepG2 cells after 24 and 48 h
exposure to 22, 44, or 88 lg/mL Cloisite  30B. All values are expressed 
mean ± SD. Signiﬁcantly different from control (p 6 0.05).sayed, 22 lg/mL Cloisite 30B, cells show heterophago somes in th
cytoplasm and accumulati on of secretory material, such as lipi
drops, in certain regions of the cytoplasm , displaying cellula
polarizati on (Fig. 9c). Euchromatic nuclei with visible nucleoli ar
observed , which indicates that cells still maintain their transcrip
tional activity (Fig. 9c). When cells were exposed to 44 lg/mL Clo
site 30B for 24 h, nuclei exhibited a higher content o
heteroch romatin (Fig. 9d). Cells show lipid drops with tendenc
to conﬂuence, heterophago somes and mitochondria with dens
matrix and visible crest. The most remarkabl e changes were ob
served when cells were exposed to the highest concentr ation
88 lg/mL Cloisite  30B (Fig. 9e–g). Cells show dilated endomem
brane systems (endoplasmic reticulum cisternae and dictyosom e
saccules) (Fig. 9e). Moreove r, dense mitochondria underwent mor
phologic al changes resulting in dumbbell ﬁgures, which are fre
quently rounded by rough endoplasmi c reticulum cisterna
(Fig. 9e). In the cytoplasm, conﬂuent lipid drops are abundant a
well as heterophagoso mes with membranous debris, probabl
due to autophagic processes. Trans saccules from dictyosomes pro
duce covered vesicles containing hydrolytic enzymes which fus
with the endosomes to form phagosomes (Ph) (Fig. 9e–g).
When HepG2 cells were exposed to 22 lg/mL Cloisite  30B dur
ing 48 h, a greater injure was observed in comparison to the expo
sure to 24 h (Fig. 10 ). Most of the cells showed nuclei with irregula
borders, heterochromat in accumulations linked to the inner nucle
ar membrane and nucleoli well develope d (Fig. 10 a). Rough endo
plasmic reticulum cisternae, frequently associated wit
mitochondr ia, and dilated dictyosomes are observed in the cyto
plasm (Fig. 10 a). Mitochondria show a higher size compared t
those observed in the control cells, indicating mitochond rial hyper
trophy with disorganized crests (Fig. 10 a). After 48 h of exposure t
44 lg/mL Cloisite  30B, cells exhibit a higher chromati n condensa
tion in the nucleus (Fig. 10 b). Moreover, cytoplasm is intensivelassessmen t of clays for their use in food packagin g applica tions. Food Chem. 
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379could probably correspond to vesicles covered by clatrine with 
380high content in hydrolytic enzymes (Fig. 10 d). After 48 h of expo- 
381sure to 88 lg/mL Cloisite  30B, decrease in the growing rate is ob- 
382served, which was previously described in the light microscope 
383observati on. The surviving cells show highly vacuolated cytoplasm, 
384being these vacuoles big heterophago somes containing membra- 
385nous debris, dense bodies and lipid material (Fig. 10 e). All these 
386ﬁndings are characterist ic of autophagic processes and cell death. 
387Moreove r, dilated endoplasmi c reticulum with big spaces between 
388inner and outer nuclear membrane, mitochondr ial degradat ion, 
389chromati n condensation, and presence of nuclear inclusions, fre- 
390quently of lipid nature, are observed, which are representat ive of 
391cell death (Fig. 10 f).
3924. Discussion 
393Although the use of clays for developing improved polymer 
394nanocom posites is increasing, there is still very few information 
395in relation to the toxicity these materials can induce. Lordan
396et al. (2011) also investigated the cytotoxicity of Cloisite  Na+ in 
397HepG2 cells and found a reduction of viability from 1 lg/mL with 
398the MTT assay, a similar endpoint to the MTS assay used in this 
399study. Our results, however , did not show any signiﬁcant reduction 
400up to 31.25 lg/mL and the highest concentr ation used was 
40162.5 lg/mL, because higher ones were observed to interfere with 
402the measureme nt system. These differences could be derived from 
403different reasons such as the cell density employed for the assays, 
404the origin of the cell culture, etc. Sharma et al., 2010 and Gutiérrez-
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Fig. 7. Comet assay results of HepG2 cells after 24 and 48 h of exposure to 22, 44, or 88 lg/mL Cloisite  30B. All values are expressed as mean ± SD. Signiﬁcantly different 
from control (p 6 0.05).
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Tocuolated with membranous debris inside vacuoles (Fig. 10 b). Di- 
ed rough endoplasmi c reticulum cisternae associated with 
pertrophi c mitochondr ia are still visible (Fig. 10 b and c). How- 
er, mitochondria morphology changes within time, turning into 
 elongated and semicircular appearance (Fig. 10 c). Phagosomes 
th membran ose debris are also found (Fig. 10 c). Near phago- 
mes, Golgi apparatus with dilated dictyosomes are observed 
g. 10 d). In the trans regions of dictyosomes, vesicles rounded 
 swollen electrodens e membrane can be distinguished, which 
. 8. Morphology of HepG2 cells observed by optical microscopy. Bars = 100 lm. 
exposed control culture (a), and exposed to 88 lg/mL Cloisite  30B for 48 h (b).ease cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical assess
xicol. (2013), http ://dx.doi. org/10.1016/ j.fct.20 13.03.043 aena et al. (2011a), Gutiérrez-Praena et al. (2013), studied the 
totoxic ity of the same clay in Caco-2 cells (a human colon-cancer 
ll line) and no cytotoxic effects were observed by both authors. 
oreove r, Lordan and Higginbotham (2012) also investigated the 
totoxic effects of Cloisite  Na+ in U937 monocityc cells and the 
sults showed no signiﬁcant differences with respect to the con- 
l. In the case of Cloisite  30B, a concentration of 500 lg/mL
uld be assayed and resulted in a total reduction of the viability 
 any of the biomarkers employed. However , at the concentratio ns 
sted this clay did not cause an increase in caspase-3/7 activation. 
rdan et al. (2011) obtained similar effects with Cloisite Na+ and
oisite 93A and suggested that necrosis was the toxic mechanis m
volved in the cell death observed. In this case further studies are 
cessar y to elucidate the mechanism of cell death. Cloisite 30B
s been assayed by Gutiérrez-Praena (2011b; 2013) in Caco-2 
lls obtaining also cytotoxic responses. Similarly, Sharma et al. 
010) observed signiﬁcant differences respect to control at the 
ghest concentrations tested (170 and 226 lg/mL) in this cell line. 
Q2men t of clays fo r their use in food packagin g applica tions. Food Chem. 
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Fig. 9. Ultrastructural changes of HepG2 cells after 24 h of exposure to Cloisite  30B observed by electron microscopy. Unexposed control cultures (a and b) and HepG2 cells 
exposed to 22 lg/mL Cloisite  30B (c), 44 lg/mL Cloisite  30B (d), and 88 lg/mL Cloisite  30B (e–g). (a) Unexposed cells with big irregular heterochromatic nuclei (N),
prominent nucleoli (n), mitochondria with light matrix (white arrow head) and lipid drops (white arrow). Bar = 5 lm. (b) Differentiated cells exhibiting tight junction (black
arrow), adherent junction (white arrow) and desmosomes (black arrow head), showing intracellular spaces (asterix). Bar = 2 lm. (c) Presence of heterophagosomes (black
arrow), lipid drops (L) and euchromatic nuclei (N) with visible nucleoli (n). Bar = 1 lm. (d) Cells show heterochromatic nuclei (N), conﬂuent lipid drops (L), heterophagosomes 
(arrow head) and mitochondria with dense matrix and visible crest (white arrow). Bar = 2 lm. (e) Dilated endomembrane systems (black arrow), mitochondria with 
dumbbell-shape (white arrow), conﬂuent lipid drops (L), heterophagosomes with membranous debris (black arrow head), euchromatic nuclei (N) and visible nucleoli (n) are 
observed in the cell. Bar = 2 lm. (f). Dictyosomes (G) producing covered vesicles (black arrow) Bar = 0.5 lm. (g). Endosomes (white arrow) forming phagosomes (Ph).
Bar = 0.5 lm.
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13 April 2013 A lower sensitivity of the hepatic cell line in comparison to th
intestinal cell line has been detected. Thus, the EC 50 (24 h) for th
NR assay was 88 lg/mL for HepG2 cells and 50 lg/mL for Caco-
cells (Gutiérrez-Praena et al., 2011b; Gutiérrez-Praena et al., 2013
When the same concentratio n of both clays are compared, fo
example at 62.5 lg/mL, Cloisite  30B seems to be slightly mor
toxic as the percentage of reduced viability found was higher. Thu
the inclusion of modiﬁers has a role in the toxicity of clays. Othe
organo-mod iﬁed clays, such as Cloisite 93A, have also demon
strated to be cytotoxic in HepG2 cells (Lordan et al., 2011 ). Als
Li et al. (2010) observed a slight decrease in CHO cells viability ex
posed to 62.5–1000 lg/mL nanosilicate platelets as measure d wit
the MTT and LDH assays. 
Considering that Cloisite 30B showed a high cytotoxicity at th
concentratio ns assayed in comparis on to Cloisite Na+, we focuse
on that clay to investigate the mechanisms involved in thos
effects. In the scientiﬁc literature different toxic mechanism s sucPlease cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical 
Toxi col. (2013), htt p://dx.doi.org /10.1016/ j.fct.20 13.03.043 as oxidative stress, inﬂammation responses , genotoxicity , hav
been reported to be related to nanoparticl es exposure (Bouwmees
er et al., 2009 ). Our results showed a deep decrease of the GSH con
tent in all the concentr ations assayed. GSH is the main endogenou
antioxidant and is responsible for the maintenanc e of the intrace
lular redox balance, detoxiﬁcation of xenobioti cs, and reactive oxy
gen species (Schafer and Buettner, 2001 ). GSH depletion could b
related with ROS scavenging resulting in the absence of change
in this biomarker. On the other hand, it might be that Cloisite
30B produces no ROS. In fact, Sharma et al. (2010) also found tha
Cloisite Na+ and 30B did not induce ROS production. Othe
authors, however, observed an increase of intracellul ar ROS produc
tion in HepG2 cells exposed at concentr ations of 50 lg/mL Clo
siteNa+ and higher. Conversel y, the effect of Cloisite 93A in th
same experimental model was less prominent (Lordan et al., 2011
The results obtained indicate that both clays do not induc
inﬂammatory responses in HepG2 cells. However , Elmore anassessmen t of clays for their use in food packagin g applica tions. Food Chem. 
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Pl
Todersen (2003) reported that different clays, including montmo- 
lonite, induced cytotoxicity to several macrophage type cell lines 
d have hemolytic activity towards several species’ red blood 
lls. Also, it has been reported that montmorilloni te clay may pro- 
ote infection by a direct cytotoxic effect on neutrophils, making 
em unavailable for bacterial phagocytos is (Dougherty et al., 
85). In relation to genotoxicity, the DNA strand-break s induced 
 Cloisite  Na+ were not investigated since no cytotoxic effects 
re observed in the range of concentratio ns employed . Li et al. 
010) obtained negative results in the comet assay with CHO cells 
posed up to 1000 lg/mL nanosilicate platelets derived from nat- 
al montmor illonite. Similarly , Sharma et al. (2010) observed no 
notoxic effects induced by unﬁltered and ﬁltered Cloisite  Na+
mples. Apart from montmorilloni te, other clays such as benton- 
 and kaolinite have been reported to be not genotoxic or to have 
light effect in vitro (Sharma et al., 2000). Cloisite 30B, however ,
. 10. Ultrastructural changes of HepG2 cells after 48 h of exposure to Cloisite  30B o
 lg/mL Cloisite  30B (b–d), and 88 lg/mL Cloisite  30B (e and f). (a) Cells showed n
clear membrane (N), nucleoli well developed (n), rough endoplasmic reticulum c
tochondria with disorganized crests (black arrow). Bar = 0.5 lm. (b) Cells exhibit c
hite arrow), dilated rough endoplasmic reticulum cisternae associated with hype
iculum cisternae (white arrow) associated with elongated and semicircular mitocho
ad). Bar = 0.2 lm. (d) Phagosomes (Ph), Golgi apparatus with dilated dictyosomes
r = 0.25 lm. (e) Cells show heterophagosomes (Ph) containing membranous debris (bl
doplasmic reticulum with big spaces in the nuclear membrane (black arrow), mitoc
r = 0.5 lm.ease cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical assess
xicol. (2013), http ://dx.doi. org/10.1016/ j.fct.20 13.03.043 duced a signiﬁcant increase in DNA damage after 48 h exposure
 88 lg/mL in our work. This ﬁnding agree with Sharma et al. 
010), who found positive results in Caco-2 cells exposed to ﬁl-
red and unﬁltered samples of the organomodi ﬁed clay from 
3 lg/mL. They reported no genotoxicity after 24 h exposure at 
lg/mL, a concentratio n similar to the one used in the present 
dy. However , in our case the effect was only observed after a
gher exposure time, 48 h. These authors indicated that the qua- 
rnary ammonium compound used to modify the clay, was con- 
buting to the genotoxic effects and also that genotoxic effects 
re not due to oxidative damage. The absence of ROS increase 
 this study agrees with this hypothesis. 
Morphol ogical studies on cell lines exposed to clays are very 
arce. In this sense, the present study describes for the ﬁrst time 
e ultraestruct ural changes induced by Cloisite 30B on hepatic 
lls. The ultrastructural study constitutes an important key in 
ved by electron microscopy. HepG2 cells exposed to 22 lg/mL Cloisite  30B (a),
i with irregular border and heterochromatin accumulations linked to the inner 
nae (white arrow), dilated dictyosomes (white arrow head) and hypertrophic 
atin condensation (N), vacuolated cytoplasm with membranous debris inside 
hic mitochondria (black arrow). Bar = 0.5 lm. (c) Dilated rough endoplasmic 
ia (black arrow), as well as phagosomes with membranose debris (white arrow 
ck arrow) and vesicles covered by clatrine (white arrow head) are observed. 
rrow), dense bodies (white arrow) and lipid material (L). Bar = 0.5 lm. (f) Dilated 
drial degradation (m) and presence of nuclear lipid inclusions (L) are observed. men t of clays fo r their use in food packagin g applica tions. Food Chem. 
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exploring the intracellul ar targets of the clay. The most relevan
alterations observed in this study were mitochondr ial degenera
tion, dilated endomembr ane systems, heterophago somes forma
tion, fat droplets appearance and presence of nuclear lipi
inclusions. The extent and severity of the cell damage becam
more widespre ad as concentr ation and time after exposure in
creased. In the present study, cells observed under light micros
copy after 48 h of exposure to 88 lg/mL Cloisite  30B showed 
decrease in the growing rate, which indicates cell death. Simila
ﬁndings were observed by Zia et al. (2011), reporting a concentra
tion-dependen t cell rounding and detachment on ﬁbroblast cel
exposed to chitin-be ntonite clay. Also, bentonite and montmori
lonite induced cell lysis on primary neuronal cells after 1 h of incu
bation; however, no effect was observed on differentiate d N1E-11
neuroblastom a cells (Murphy et al., 1993a ). Similarly, Murph
et al. (1993b) reported lysis of human umbilical vein endothelia
(HUVE) cells exposed to aluminum silicate clays, although undi
ferentiated N1E-115 neuroblas toma cells and ROC-1 oligodendrog
lial cells were not lysed by the clays. In addition, in the presen
study alteration in the lipid metabolism was observed with fa
droplets appearan ce and presence of nuclear lipid inclusions. I
this regard, Murphy et al. (1993b) also indicated that all the cel
incubated during 6 h with the clays released fatty acids, althoug
it was only signiﬁcant in the case of HUVE cells, being montmori
lonite the clay exerting the highest effects. Moreover, the presenc
of intranuclear lipid inclusions observed in the present work ha
been also reported in mouse and rat hepatocytes exposed to othe
toxicants (Karasaki, 1973; Martino et al., 1981 ). In our researc
group, we have previously found the presence of lipid drops i
the cytoplasm (Gutiérrez-Praena et al., 2013). However, as far a
we know, this is the ﬁrst work reporting the presence of nuclear l
pid inclusions induced by a clay. The intranucl ear inclusions ap
pear to be related to abnormal ities of membranes of th
endoplasmi c reticulum and nuclear envelope (Karasaki, 1973 ). Re
cently, nuclear lipid droplets have been considered as a domai
within the nucleus where nuclear neutral-lipid are stored and or- 
ganized, which may be involved in nuclear lipid homeostasis (Lay-
erenza et al., 2013 ). In the present study, the accumulation of lipid 
drops is related to autophag ic processes , since they are frequent ly 
found in the heterophago somes together with membranous debris, 
and dense bodies. This ﬁnding has been also reported in HepG2 
cells treated with culture medium without amino acids (Martinet
et al., 2006 ). They state that initiation of autophagy is associated 
with accumulation of lipid in the cytoplasm. In addition, also the 
mitochondr ial degradation observed in the present work has been 
related with this cell survival pathway. Hence, regulated changes 
in mitochondr ia morphology determine the fate of the cell during 
autophagy (Gomes et al., 2011 ). Moreove r, the relationship be- 
tween autophagy and apoptosis is still unclear. Many substances 
can induces both autophagy and apoptosis in HepG2 cells (Yan
et al., 2007; Mei et al., 2011; Xie et al., 2011; Wen et al., 2012 ).
Therefore, autophagy can either cause apoptosis or may be a con- 
sequence of apoptosis (Wang et al., 2010 ).
Studies have been published that used very high doses of micro 
and nanoparticl es for the testing. Unrealistic high dosing can lead 
to outcomes that may not be related to the inherent toxicity of 
the material but to the high amount of the material administered 
(EFSA, 2011 ). The concentratio ns used in this study are below the 
quantity of clay used for nanocompo sites in food packaging appli- 
cations. Making an approximation of what can happen in a real 
exposure scenario, it is important to know that polymer nanocom- 
posites used as food contact materials contain 4% of clay. Thus, a
rigid packagin g of 20 g (a small bottle) would contain 0.8 g of clay. 
The results have shown that 500 lg/mL in a well of a cell culture 
plate, this is 50 lg Cloisite  30B, induce a high cytotoxic ity. 
581
Please cite this article in press as: Maisan aba , S. , et al. In vitro toxicolog ical 
Toxi col. (2013), htt p://dx.doi.org /10.1016/ j.fct.20 13.03.043 Therefore, if the clay containe d in the polymer reaches the con
sumer, the potential of toxic effects is not negligible. EFSA (2011
considers that in the absence of exposure data, and where it 
not possible to determine the nanoform in the food matrix, 
should be assumed that all added nanomat erial is present, ingeste
and absorbed in the nanoform. 
5. Conclusion s
Our results suggest that caution is necessar y as different clay
differ in toxicity. The concentrations of Cloisite  Na+ assayed di
not show toxicity whereas Cloisite  30B induced cytotoxicit
GSH decrease, genotoxici ty and morphological alteration s i
HepG2 cells. Further research is needed to determine the potentia
migration of the clays, to assess the real exposure and to evaluat
toxicity with in vivo experime ntal models. Thus, a clearer idea o
the food safety of these materials could be derived. 
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Abstract 
Montmorillonite, also known as Cloisite®Na+ (CNa+), is a natural clay with a wide range 
of well-documented and novel applications, such as pharmaceutical products or food 
packaging. Although considered a low toxic product, the expected increased exposure to 
CNa+arises concern on the potential consequences on human and environmental health 
especially as its genotoxicity has scarcely been investigated so far. Thus, we investigated, for 
the first time, the influence of non-cytotoxic concentrations of CNa+ (15.65, 31.25 and 62.5 
µg/mL) on genomic instability of human hepatoma cell line (HepG2) by determining the 
formation of micronuclei (MNi), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) with 
the Cytokinesis block micronucleus cytome assay. Further on we studied the influence of CNa+ 
on the expression of several genes involved in toxicity mechanisms using the real-time 
quantitative PCR. The results showed that CNa+ increased the number of MNi, while the 
numbers of NBUDs and NPBs were not affected. In addition it deregulated genes in all the 
groups studied, mainly after longer time of exposure. These findings provide the evidence that 
CNa+ is potentially genotoxic. Therefore further studies that will elucidate the molecular 
mechanisms involved in toxic activity of CNa+ are needed for hazard identification and human 
safety assessment.  
 
Keywords: Cloisite®Na+; toxicity; micronucleus; gene expression; qPCR. 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
1. Introduction 
 
Clays and clay minerals are recognized as the materials of the 21st century because 
they are abundant, inexpensive and environmentally friendly [1].There are well over 100 
documented industrial applications of clay materials. Clays are utilized in the process 
industries, in agricultural applications, in engineering and construction applications, in 
environmental remediation, in geology [2], as pharmaceutical and cosmetic products [3], and 
in many other miscellaneous applications. They belong to the phyllosilicate group that 
comprises different structurally related compounds [4]. Among them, montmorillonite (Mt) is 
a smectite, 2:1 phyllosilicate, meaning that it has two tetrahedral sheets sandwiching a central 
octahedral sheet, and the particles are plate-shaped [5]. It has the following molecular 
formula: (Na, Ca)0.33(Al, Mg)2 (Si4O10) (OH)2∙nH2O [6].  
 
Mt, also commercially known as Cloisite®Na+ (CNa+), has some of the potential 
applications mentioned above. For example, it is used as drug delivery system [7] because it is 
generally considered as a low toxic material compared to other inorganic delivery carriers [8]. 
Also, in the food industry, it is chemically modified to be incorporated in the food packaging in 
order to give new materials known as nanocomposites, which represent a new alternative to 
conventional technologies for improving polymer properties [9]. 
 
Taking into account all these well-known and new applications that clay minerals have, 
the human and environmental exposure to these compounds will probably increase in the near 
future. Therefore, the potential consequences on human and environmental health are of 
concern and a safety evaluation of clays is required. Recently the toxic effects and the 
underlying mechanisms of different clays, including CNa+, have been reviewed by Maisanaba et 
al. [10]. Toxic effects of clay minerals in general have been shown to occur mainly after 
inhalation [5,11], but one of the most likely routes of exposure to these clay minerals for the 
general population is by oral ingestion, since they are potentially present in food and 
pharmaceutical products, etc.  
 
Due to the commercial availability of CNa+ reports on its toxicity are more abundant in the 
scientific literature compared to others clay minerals. Moreover, due to its wide application 
and increasing use the interest in toxicological aspects of CNa+ and its derivatives has increased 
in the recent years [10]. CNa+ has been reported to be not toxic in animals [12], however, in 
vitro, CNa+ has been shown to reduce the proliferation of human normal intestinal cells (INT-
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407) and has been cytotoxic at high concentrations [6]. Similarly, Lordan et al., [13] reported 
cytotoxic activity of CNa+ in human hepatoma cell line (HepG2), while Maisanaba et al. [14] at 
lower tested concentrations did not detect cytotoxic activity of CNa+ in the same cell line as 
well as in a human colon cell line (Caco-2) [15].  
 
Genotoxicity studies showed that CNa+ is not mutagenic in Salmonella typhimurium [5, 
16] and does not induce DNA strand breaks in Caco-2 cells [5]. In vitro data on the induction of 
reactive oxygen species (ROS) by CNa+ are contradictory. Some literature data report that CNa+ 
induces ROS formation [13], while at lower concentrations no oxidative stress has been 
detected [5]. Although these scarce data point out that CNa+ is not genotoxic there is a need 
for further research on its genotoxic potential to obtain information that will enable the 
elucidation of the underlying mechanisms of its action at the molecular level. Therefore, the 
aim of our study was to evaluate whether CNa+ had influence on genomic instability by 
analyzing the formation of micronuclei (MNi), nuclear buds (NBUD), and nucleoplasmic bridges 
(NPB) in the human hepatoma cell line (HepG2 cells) by the Cytokinesis block micronucleus 
cytome assay (CBMN). Moreover, the CNa+ induced modulation of the expression of selected 
genes involved in the metabolism, immediate-early response/signaling, DNA damage 
response, oxidative stress and programmed cell death was investigated by real-time 
quantitative PCR (qRT-PCR). 
 
 
2. Materials and Methods 
2.1. Chemicals  
Minimum essential medium (MEM), TRIzol® reagent and B27 supplement were from 
Gibco BRL (Paisley, Scotland); foetal bovine serum (FBS), non-essential aminoacids (NEAA), 
penicillin/streptomycin, L-glutamine and phosphate buffered saline (PBS) from PAA (Pasching, 
Austria). Cytochalasin B (Cyt-B), acridine orange (AO), dimethyl sulfoxide (DMSO [CAS 67-68-
5]), trypsin, etoposide (ET) [CAS 33419-42-0] and benzo(a)pyrene (B(a)P) [CAS 50-32-8], were 
obtained from Sigma–Aldrich (St. Louis, USA). High Capacity cDNA Archive Kit and Taqman 
Gene Expression Assays were from Applied Biosystems (Forest City, CA, USA), TaqMan 
Universal PCR Master Mix from Applied Biosystems, (Branchburg, NJ, USA) and Human GAPDH 
from Applied Biosystems (Warrington, UK).  
Cloisite® Na+ was obtained from Southern Clay Products, INC (Austin, Texas, USA). The clay was 
characterized by thermogravimetric analysis (TGA), X-ray dif- 115 fraction (XRD) and particle 
size distribution (PSD) as described in Maisanaba et al. [14]. 
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2.2. Clay test solutions 
 
The test concentrations for the clay were selected according to previous dispersion 
experiments in order to avoid interferences with the measurement system [14]. The highest 
concentration tested was 62.5 µg/mL. Test solutions were prepared in serum-free medium 
supplemented with B27. Three sonication steps of 10 s each one at an amplitude of 40% were 
performed using an ultrasonic tip (Dr. Hielscher, Germany) to disperse the test concentrations. 
 
2.3. Cell culture and treatment 
 
HepG2 (human hepatocellular carcinoma epithelial cell line) was obtained from the 
American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in a 
monolayer in Eagle’s Minimum Essential Medium (ATCC) supplemented with 2% B27 (Gibco, 
New Zealand), 2 mM L-glutamine, 1% NEAA, 100 U/mL penicillin/ streptomycin (Gibco, New 
Zealand). Cells were grown at 37°C and 5% CO2 in humidified atmosphere. Cells were used at 
passages between 12 and 18. 
 
  Prior to the treatment, the cells were seeded onto 96-well plates (4000 cells/well) to 
evaluate the cytotoxicity with the MTS assay, 6-well tissue culture treated plates (400 000 
cells/ well) for the CBMN assay and 25 cm2 culture ﬂask (800 000 cells/ plate) (all Corning 
Costar Corporation, New York, USA) for qRT-PCR gene expression analysis, and incubated for 
24h to attach. The medium was then replaced with fresh medium containing graded 
concentrations of CNa+ and incubated for 4 and 24h for the MTS assay and qRT-PCR gene 
expression analysis and 24h for the CBMN test. The cytotoxicity of the clay was determined at 
6.25, and 62.5 µg/mL. For the CBMN test and gene expression analyses the cells were exposed 
to non-cytotoxic concentrations, 15.65, 31.25, 62.5 µg/mL and 6.25, 62.5 µg/mL, respectively. 
B(a)P (2.5 µM in CBMN and 30 µM in q-PCR), a well established pro-carcinogen that needs 
metabolic activation was used as the positive control. In the CBMN assay an additional positive 
control, etoposide (ET; 1µg/mL), was used. 
 
 
2.4. Cytotoxicity assay 
 
Cytotoxicity of CNa+ was determined with the MTS assay (CellTiter96 AQueous Non 
Radioactive Cell Proliferation Assay; Promega, Madison, USA) according to the manufacturer’s 
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instructions. Cell viability was determined by comparing the optical density of the wells 
containing the cells treated with the clay with those of the control group. Two independent 
experiments were performed, each in ﬁve replicates per treatment point. Student’s t test was 
used in order to evaluate significant differences.  
 
2.5. Cytokinesis block micronucleus assay (CBMN) 
 
After the 24-h treatment, the cells were washed twice with 1x PBS buffer, the medium 
containing Cyt-B (2 µg/ml) was added and the cells were incubated for additional 26 h at 37°C 
and 5% CO2 in humidified atmosphere. At the end of the exposure floating and adherent cells 
were collected by trypsinization. Subsequently the cells were incubated in a cold hypotonic 
solution (75 mM KCl) for 5 min and fixed with a mix of methanol/acetic (3:1; v/v) and 
formaldehyde. The fixation was repeated three times and the fixed cells were put on 
microscope slides and air dried. The slides were stained with acridine orange (10 µg/ml) and 
examined under the ﬂuorescence microscope (Olympus BX61, Japan). Micronuclei (MNi), 
nucleoplasmic bridges (NPBs) and nuclear buds (NBs) were counted in 1000 binucleated cells 
(BNC) per experimental point at 400x magniﬁcation according to the criteria published by 
Fenech [17,18]. The nuclear division index (NDI) was estimated by scoring 500 cells with one to 
four nuclei. The NDI was calculated using the formula [M1+ 2M2 + 3(M3 +M4)]/500, where 
M1, M2, M3 and M4 represent the number of cells with one to four nuclei, respectively. The 
experiments were repeated three times independently. Chi-square test was used to compare 
the number of MNi, NBUDs, or NPBs between the control group and CNa+ exposed cells; P < 
0.05 (*) and P < 0.01 (**) was considered as statistically significant. 
 
2.6. Real-time quantitative PCR (QRT-PCR) analysis 
 
After the incubation, cells were washed twice with 1x PBS and total RNA was isolated 
using TRIzol reagent according to the manufacturer’s protocol with minor modifications 
described in Štraser et al. [19]. Briefly, glycogen (20 µg/mL) was added to the cell lysate. The 
RNA was incubated with isopropyl alcohol overnight at -20°C to precipitate. All solutions 
needed for RNA isolation were prepared in RNase-free water. Three independent experiments 
were performed. The RNA was transcribed to cDNA using 1 μg of total RNA and cDNA High 
Capacity Archive Kit, according to the manufacturer’s protocol. Gene expression was 
quantified by RT-qPCR using TaqMan Universal PCR Master Mix and the following Taqman 
Gene Expression Assays: CYP1A1 (cytochrome P450, family 1, subfamily A, polypeptide 1), 
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Hs01054797_g1; CYP1A2 (cytochrome P450, family 1, subfamily A, polypeptide 2), 
Hs00167927_m1; CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) 
Hs00604506_m1; GSTA1 (glutathione S-transferase alpha 1), Hs00275575_m1; UGT1A1 (UDP 
glucuronosyltransferase 1 family, polypeptide A1), Hs02511055_s1; FOS (FBJ murine 
osteosarcoma viral oncogene homolog), Hs04194186_s1; JUNB (jun B proto-oncogene) 
Hs00357891_s1; MYC (v-myc avian myelocytomatosis viral oncogene homolog) 
Hs00153408_m1; TGFB2 (transforming growth factor, beta 2) Hs00234244_m1; CDKN1A 
(cyclin-dependent kinase inhibitor 1A’) Hs00355782_m1; CHEK1 (checkpoint kinase 1) 
Hs00967506_m1; ERCC4 (excision repair cross-complementing rodent repair deficiency, 
complementation group 4) Hs00193342_m1;  GADD45A (‘growth arrest and DNA damage-
inducible gene, alpha’), Hs00169255_m1; MDM2 (Mdm2, ‘MDM2 oncogene, E3 ubiquitin 
protein ligase), Hs01066930_m1; TP53 (tumor protein P53), Hs01034249_m1; BAX (BCL2-
associated X protein), Hs00180269_m1; BCL2 (B-cell CLL/lymphoma 2), Hs00608023_m1; 
CASP3 (caspase 3, apoptosis-related cysteine peptidase), Hs00234387_m1; CASP8 (caspase 8, 
apoptosis-related cysteine peptidase), Hs01018151_m1; CASP9 (caspase 9, apoptosis-related 
cysteine peptidase), Hs00609647_m1; FAS (Fas cell surface death receptor), Hs00236330_m1; 
CAT (catalase), Hs00156308_m1; GCLC (glutamate-cysteine ligase, catalytic subunit), 
Hs00155249_m1; GPX1 (glutathione peroxidase 1), Hs00829989_gH; GSR (glutathione 
reductase), Hs00167317_m1; SOD1A (superoxide dismutase 1), Hs00533490_m1. 
Ampliﬁcation of GAPDH probe (Human Endogenous Controls, Cat. No.: 4310884E, Applied 
Biosystems, USA) was performed as an internal control. The conditions for the PCR were 50°C 
for 2 min, 95°C for 10 min and 40 cycles of 95°C for 15 s and 60°C for 1 min. The data obtained 
from Taqman Gene Expression Assays were analyzed using an accurate quantification taking 
into account a control pattern (10x, 100x, 1000x, 10000x) and a normalization with the control 
group. The expression levels of target mRNAs were normalized to the GAPDH mRNA level. Two 
independent experiments were performed each time in triplicates. Statistical significance 
between treated groups and controls was determined by two tailed Student’s t test, and P < 
0.05 (*), P < 0.01 (**) and P < 0.001 (***) was considered significant with respect the control 
group. An up-regulation and down-regulation of ≥ 1.5-fold change and ≤ 0.7, respectively, 
compared to control was considered a positive response. 
3. Results 
3.1. Viability of HepG2 exposed to CNa+ 
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No significant decrease of cell viability was observed after CNa+ (6.25 and 62.5 µg/mL) 
treatment for 4 and 24h (data not shown); therefore, these concentrations were used for 
further experiments.  
3.2. Genotoxicity of CNa+ in HepG2: Induction of micronuclei, nucleoplasmic bridges and 
nuclear buds  
The genotoxic activity of CNa+ in HepG2 cells was evaluated using the CBMN assay (Fig. 
1). Following 24h exposure, CNa+ induced a statistically significant increase only in the 
frequency of MNi (2.8-fold more) in BNCs at the highest concentration tested (62.5 µg/mL) 
(P<0.0001), as well as, significant differences in MNed cells (P<0.001), being about 2.6-fold 
higher than in the control group, while no induction of NPBs and NBUDs was observed. At 
lower concentrations used (15.65 and 31.25 µg/mL) no changes in the frequency of MNi, NPBs 
or NBUDs compared to non-treated control were determined. The positive controls B(a)P (2.5 
µM) and ET (1 µg/mL) induced statistically significant 2.5-fold and 3.7-fold increases in the 
frequency of MNed cells and 2.6-fold and 4.2-fold increases in the frequency of MNi, 
respectively (Fig.2). CNa+ did not affect division of cells, while positive controls decreased NDI 
in a statistically significant way (Fig.3).  
 
3.3. Effect of CNa+ on mRNA expression 
 
The mRNa expression of a wide range of selected genes was analyzed after 4 and 24h 
of exposure to 6.25 and 62.5 µg/mL of CNa+ by quantitative real-time PCR (Table 1). The values 
presented in the Table 1 represent relative increase of gene expression of the selected genes 
compared to control group (untreated cells). 
 
3.3.1. Effect of CNa+ on mRNA expression of genes involved in metabolism 
 
In HepG2 cells exposed to CNa+ for 4h, the mRNA levels of the genes assayed did not 
show any change compared to the control group. However, after 24h of exposure, four out of 
five genes tested (CYP1A1, CYP1A2, CYP3A4 and GST1A) were more than 1.7-fold up-regulated 
at applied concentrations. On the other hand, UGT1A1 presented a significant (P<0.01) down-
regulation (0.69±0.04) at 62.5 µg/mL CNa+. 
3.3.2. Effect of CNa+ on mRNA expression of immediate –early response/signaling genes 
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After the exposure of HepG2 cells to CNa+ for 4h, the mRNA expressions of FOS, MYC 
and TGFB2 were not affected, while after 24h the expression of these genes was up-regulated 
(≥ 1.5 fold). FOS and TGFB2 at both concentrations tested, while for MYC only at the highest. 
The expression of JUNB was significantly down-regulated at 62.5 µg/mL CNa+ after 4h 
exposure, while after 24h CNa+ treatment JUNB mRNA level increased dose dependently. 
 
3.3.3. Effect of CNa+ on mRNA expression of DNA damage responsive genes 
 
After 4h exposure to CNa+ no changes in the expression of TP53 and its downstream-
regulated genes MDM2, CDKN1A, GADD45A, CHEK1 and ERCC4 were determined. Following 
24h exposure DNA damage responsive genes CDKN1A (approximately 1.5-fold increase at both 
concentrations) and GADD45A (2-fold and 4-fold at 6.25 and 62.5 µg/mL, respectively) were 
significantly up-regulated, while other DNA damage responsive genes studied were not 
affected by CNa+.  
 
3.3.4. Effect of CNa+ on mRNA expression of oxidative stress responsive genes 
 
In cells exposed to CNa+ for 4h, the mRNA levels of the genes selected did not show 
significant changes. After 24h, only CAT presented an important down-regulation at both 
concentrations used (0.67 and 0.52-fold, respectively), and GCLC showed a significant 1.92-fold 
up-regulation at 62.5 µg/mL. Other oxidative stress induced genes (GPX1, GSR and SOD1A) 
included were not affected under the conditions applied in the study.  
 
3.3.5. Effect of CNa+ on mRNA expression of apoptosis responsive genes 
 
No changes in the expressions of selected apoptosis/survival responsive genes were 
observed in HepG2 cells exposed to CNa+ for 4h. After 24h exposure only the expression of 
anti-apoptotic gene BCL2 (approximately 2-fold increase) at both concentrations assayed, and 
CASP3 (1.5-fold increase) at the highest concentration used, displayed significant up-regulation 
compared to the control group. The expression of pro-apoptotic genes BAX, CASP8 and CASP9 
were not altered by CNa+ after 24h exposure. 
 
 
4. Discussion 
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In spite of the wide number of applications that clay minerals have, their toxic 
potential has scarcely been investigated so far. Previous reports have indicated that CNa+ is not 
genotoxic in different systems like Salmonella typhimurium in the Ames test [5, 16] and the 
Comet Assay in Caco-2 cells [5]. To our knowledge this is the first study to show that CNa+ can 
affect the genomic instability of HepG2 cells determined with CBMN assay. This method 
enables simultaneous detection of multiple parameters associated with chromosomal 
instability: micronuclei (MNi) induction that reflect structural and numerical chromosomal 
aberration, nucleoplasmic bridges (NPB) formation that are an indicator of chromosomal 
rearrangements, DNA miss-repair, or telomere end-fusions, and nuclear buds (NPBs) that are a 
marker of gene amplification [17]. CNa+ increased the frequency of micronuclei but there was 
no influence of the formation of NPBs and NBUDs in HepG2 cells.  
 
Till now the genotoxicity of CNa+was studied only with the comet assay in human colon 
(Caco-2) and hepatic (HepG2) cancer cell lines. The results showed that CNa+ (up to the 
concentration 170 µg/mL) did not induce DNA strand breaks after 24 h of exposure in Caco-2 
cells. Similarly, CNa+ was not genotoxic in HepG2 [20]. However, genotoxicity data of 
quaternary ammonium salt modified clays based on CNa+ showed a different profile. Thus, 
Cloisite®20A and Clay1 did not induce changes in both cell lines [21], whereas Cloisite®30B and 
Clay2, induced DNA damage under the same conditions of the exposure [5, 21]. 
 
Toxicogenomic analyses are becoming widely used as a tool for hazard identification 
and risk assessment of genotoxic properties of different substances; therefore, we further 
elucidated the mechanisms of CNa+ toxic activity by measuring the changes in the expression 
of the genes involved in different key pathways. To the best of our knowledge this is the first 
study where the influence of CNa+ on the mRNA level was researched. Until now there are no 
literature data on the biotransformation and detoxification of CNa+. In the present study CNa+ 
increased the mRNA level of studied CYP450 isoforms (CYP1A1, CYP1A2, CYP3A4) that are 
highly inducible phase I enzymes and are activators of numerous xenobiotic compounds. For 
the first time the involvement of CYPs as a response to toxicity of CNa+ was shown. Moreover, 
the level of mRNA of glutathione S-transferase (GST1A1) was increased. Glutatione-S-
transferases (GSTs) are principal phase II enzymes in metabolic detoxification process and play 
a significant role in the detoxification of electrophiles by glutation conjugation [22]. Another 
very important family of phase II enzymes is UDP-glucuronosyltransferases (UGTs) that 
catalyze the glucuronidation of endogenous and exogenous compounds (reviewed in Oda et al. 
[23]). CNa+ significantly down-regulated the expression of UGT1A1 in HepG2 cells. In general, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11 
 
conjugation with phase II enzymes is considered the detoxification phase of xenobiotic 
metabolism, although in certain situations, it could result in activated metabolites and increase 
in toxicity [24]. 
 
Some of the immediate early response genes exhibit a very rapid and significant 
enhancement of their mRNA levels when liver cells are induced to proliferate. These genes 
include many proto-oncogenes, such as c-MYC, c-FOS, c-JUN, JUNB, JUND [25] and their 
deregulation contributes to the genesis of most human tumours [26]. In HepG2 cells all studied 
genes involved in signaling and immediate-early response (FOS, JUNB, MYC, TGFB2) have 
shown strong up-regulation after 24 hours of exposure to CNa+. The induction of FOS is known 
to be indicative for DNA-damage and is increased by a wide variety of DNA-damaging agents 
[27], while MYC proto-oncogene regulates many biological functions, including cell growth, 
proliferation, apoptosis, differentiation, and transformation [28]. JUNB is a key cell cycle 
regulator able to arrest the G1/S phase transition through transcriptional inhibition of Cyclin 
D1 [29]. TGFB2, a potent anti-inflamatory cytokine, belongs to the transforming growth factor 
Bs (TGF-Bs) that regulate a wide variety of cellular processes, and were shown to inhibit 
epithelial cell proliferation by delaying or arresting progression through the late portion of G1 
[30]. The results of the present study show that CNa+ influences cell signaling processes that 
determine the faith of the cell that can be either cell-cycle arrest, proliferation, apoptosis, or 
DNA damage repair. 
 
 The tumor-suppressor gene, TP53, plays the central role in the cellular response to 
agents or conditions that damage DNA by activating the transcription of several essential 
genes controlling cell cycle arrest/DNA repair, senescence, differentiation and apoptosis [31]. 
In the present study we did not detect any changes in the expression of TP53. This is not 
unusual, as it is known that DNA damage activates the p53 protein predominantly through its 
phosphorylation by DNA damage- responsive kinases and, to lesser extent, through up-
regulation of gene expression [32]. After 24 h exposure TP53 downstream regulated genes, 
CDKN1A and GADD45A, were up-regulated, which can be associated with the cell cycle arrest 
due to DNA damage. Cyclin-dependent kinase inhibitor 1A (CDKN1A), is an important CDKI that 
induces cell cycle arrest, inhibits cell proliferation and is directly involved in DNA repair, 
including nucleotide excision repair (NER) [33]. The role of GADD45A is to control the cell cycle 
G2-M checkpoint, the DNA repair process and apoptosis [34]. On the contrary, the gene 
expression of checkpoint kinase 1 (CHEK1), a Ser/Thr kinase that is involved in mediating the 
cellular response to DNA-damage (reviewed in Oza et al. [35]), and ERCC4 that is involved in 
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NER, as well as MDM2 that enhances the tumorigenic potential of the cells and promotes cell 
survival and cell cycle progression [36], were not affected by CNa+.  
 
To date, there are no published reports concerning possible changes in the expression 
of genes involved in oxidative stress in cells exposed to CNa+. Therefore in the present study 
we measured the expression of the most important antioxidant enzymes at the mRNA level. As 
already mentioned above CNa+ increased the mRNA level of GST1A1, a member of glutathione 
S-transferase (GST) family, which participate in a detoxification pathway that acts via the 
conjugation of the substance with glutathione (GSH). GSH plays a central role in intracellular 
antioxidant defense. It can exist in either a reduced (GSH) or oxidized (GSSG) form. Under 
steady state conditions, cells maintain a resting level of GSH/GSSG know as the redox state 
[37]. Two enzymes are involved in maintaining cellular redox, namely GPX that catalysis the 
reduction of peroxides and the formation of GSSG and GSR that reduces the GSSG back to GSH 
[38]. As a response to oxidative stress GSH can be depleted in cells and is then consequently 
synthesized de novo in a so called -glutamyl cycle that requires two ATP dependent enzymes, 
glutamate-cysteine ligase (GCLC) and glutathione synthase (GS) [39]. The up-regulation of the 
gene coding for GCLC in HepG2 cells exposed to CNa+, indicated possible response of cells to a 
depletion of GSH and its biosynthesis due to the toxic effects of CNa+. The enzymes involved in 
maintaining cellular redox, GPX1 and GSR, were not affected at the transcriptional level by 
CNa+ at none of the exposed times and concentrations. Furthermore, we explored the gene 
expression of the primary antioxidant enzymes in cells, superoxide dismutase (SOD) and 
catalase (CAT) that are more important in the protection of cells than the glutathione redox 
cycle when severe oxidative stress occurs [40]. The mRNA level of SOD1A was not changed, 
while CAT was significantly dose dependently down-regulated after 24h exposure of HepG2 
cell to CNa+. 
 
There is only limited data describing the induction of oxidative stress by CNa+. In 
HepG2 cells CNa+ at relatively high concentrations ranging from 50-1000 µg/ml increased the 
formation of reactive oxygen species (ROS), which coincided with increased cell membrane 
damage [13]. On the contrary Sharma et al. [5] did not detect induction of ROS in Caco-2 cells 
at concentrations up to 170 µg/ml. A subchronic in vivo study on rats that were orally exposed 
to Clay1 (40 mg/kg/day in the diet), a Mt modified with a quaternary ammonium salt for 90 
days, showed in the liver no induction of oxidative stress markers such as GSH/GSSG levels and 
their ratio [41], lipid peroxidation, and the activities and protein content of antioxidative 
enzymes such as SOD, CAT, GPX and GST. In addition no changes in expression of SOD and CAT 
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at the gene and protein level determined with the qRT-PCR and Western blot, respectively, 
were confirmed [41]. 
 
The most common form of cell death that plays a pivotal role in the maintenance of 
tissue homeostasis is apoptosis, programmed cell death. The major apoptotic pathways 
include the extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway 
[42]. In this respect we measured the expression of several genes involved in the apoptotic 
processes. In the present study we showed that exposure of HepG2 cells to CNa+ induced 
significant transcriptional changes of anti-apoptoptic gene BCL2, while the expression of pro-
apoptotic gene BAX was not affected. From all caspase genes included in our study only CASP3 
was up-regulated by CNa+, while the mRNA levels of CASP9 and CASP8 were not changed. 
Caspases are proteases that act as essential initiators and executioners of the apoptotic 
process. Classically, the caspase cascade is initiated via cleavage of the so-called initiator 
caspases (-2, -8, -9, and -10), most likely by autoproteolysis. Initiator caspases, in turn, cleave 
and activate the executioner caspases (-3, -6, and -7) [43]. This results in mediation and 
amplification of the death signal and eventually cell death. The results of gene deregulations of 
pro- and anti-apoptotic genes do not allow for clear interpretation whether CNa+ induced 
apoptosis or not. The up-regulation of BCL2 suggests that apoptosis is suppressed; while on 
the other hand the up-regulation of CASP3 indicates potential involvement of intrinsic pathway 
of apoptosis in CNa+ toxicity. As the obtained results are contradictory the mechanisms 
involved in cell death induced by CNa+ need to be further elucidated. 
 
Regarding to programmed cell death, other authors such as Lordan et al. [13] reported 
that after 24 h, no increase in caspase-3/7 activity was detected in HepG2 cells treated with 
CNa+ and Cloisite 93A, an organically modified Mt. Similarly also Maisanaba et al. [14] reported 
no induction of apoptosis with the commercial CNa+-based clay Cloisite®30B in the same cell 
type. In another study on HepG2 cells, CNa+ statistically significantly increased the activity of 
caspase 3/7 after 4.5h (at 500 µg/mL) and 48h (33-500 µg/mL) of exposure [44]. On the 
contrary, it induced apoptosis in SK-MEL 28 human melanoma cells only after 48 hours of 
exposure at 33 µg/mL and higher [44]. Moreover, Liu et al. [12] observed an increase in the 
caspase 3 activity in human embryonic kidney (HEK) 293 cells treated with 1 g/L CNa+, whereas 
with the modified oligo(styrene-co-acrylonitrile)-montmorillonite (PSAN-MMT) the increase 
was lower compared to CNa+. In addition PSAN-MMT and CNa+ influence on p53 mRNA and 
protein level showed higher effect of CNa+ clay in HEK 293 cells.  
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5. Conclusions 
Based on the results of the present study we can conclude that CNa+ is potentially 
genotoxic as it induced the formation of micronuclei at non-cytotoxic concentrations and can 
therefore represent a risk for human health especially when considering long term exposure. 
The changes of the expression of several studied genes provide new insights into the 
mechanisms of CNa+ potential toxicity. Nevertheless, there is still a need to further confirm 
these results on the protein level, which will help to clarify the mechanisms involved in CNa+ 
genotoxic activity. 
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Figure captions 
Figure 1. Flourescent micrographs of HepG2 cells exposed to CNa+ (62.5 µg/ml for 24 h) a) 
binucleated cell, b) binucleated cell with MN, c) binucleated cell with two MNi, d) binucleated 
cells with NBUD, e) binucleated cells with NBUD and MN and f) binucleated cell with NBP. 
Figure 2. Number of binucleated cells with a) micronucleated cells (MNed cells), b) micronuclei 
(MNi), c) nuclear bridges (NPBs) and d) cells with nuclear buds (NBUDs) per 1000 binucleated 
HepG2 cells after the exposure to CNa+ (0, 15.65, 31.25 and 62.5 µg/mL) for 24 h. The number 
of MN cells shows how many cells contained MN, while MNi shows the overall number of MN 
as some cells can possess more than one MN. Significant differences between CNa+ treated 
cells and the control group (0) is indicated by *P < 0.05, ** P < 0.01, *** P < 0.001, and 
****P<0.0001. Benzo(a)pyrene (2.5 µM) and Etoposide (1 µg/mL) were used as the positive 
controls. 
 
Figure 3. The influence of CNa+ (0, 15.65, 31.25 and 62.5 µg/mL) on the nuclear division index 
(NDI) after 24h exposure. Significant differences between CNa+-treated cells and the control 
group (0) is indicated by *P < 0.05 and **P < 0.01. Benzo(a)pyrene (2.5 µM) and Etoposide (1 
µg/mL) were used as the positive controls.  
 
Table caption 
Table 1. Effect of CNa+ on expression of mRNAs of selected genes involved in metabolism, 
inmediate-early response/signaling, DNA damage, apoptosis/survival and oxidative stress 
responses in HepG2 cells. 
Mechanisms involved Gene symbol CNa
+
 (µg/mL) 4h 24h Entrez gene name 
   Mean±SD Mean±SD  
Metabolism 
(activation/detoxification) 
CYP1A1 
6.25 0.95±0.07 1.70±0.13* 
Cytochrome P450 family 1. Subfamily A. polypeptide 1 62.5 0.95±0.05 1.72±0.3 
B(a)P 30µM 1.91±0.43 130.32±9.22** 
     
CYP1A2 
6.25 0.80±0.15 2.60±2.45 
Cytochrome P450 family 1. Subfamily A. polypeptide 2 62.5 1.19±0.18 1.82±0.78 
B(a)P 30µM 1.76±0.73 79.78±15.01* 
     
CYP3A4 
6.25 0.91±0.24 2.90±1.16 
Cytochrome P450 family 3. Subfamily A. polypeptide 4 
 
62.5 0.80±0.33 4.06±1.84 
B(a)P 30µM 1.11±0.17 2.66±0.18** 
     
GST1A1 
6.25 0.80±0.15 1.88±0.34 
Glutathione S-transferase alpha 1 62.5 0.85±0.07 1.90±0.48 
B(a)P 30µM 0.75±0.01*** 0.60±0.25 
     
UGT1A1 
6.25 0.92±0.13 0.84±0.26 
UDP glucuronosyltransferase 1 family. polypeptide A1 62.5 0.85±0.23 0.69±0.04** 
B(a)P 30µM 0.97±0.02 5.57±0.96* 
Immediate-early 
response/signaling 
 
     
FOS 
6.25 1.05±0.12 10.35±2.32* 
FBJ murine osteosarcoma via oncogene homolog B 62.5 0.94±0.68 20.38±6.74 
B(a)P 30µM 1.23±0.73 12.49±5.54 
     
JUNB 
6.25 0.94±0.01** 1.77±0.35 
Jun B proto-oncogen 62.5 0.63±0.09* 2.76±0.02*** 
B(a)P 30µM 1.13±0.36 2.41±0.46* 
     
MYC 
6.25 1.06±0.08 1.29±0.14 
V-Myc avian myelocytomatosis viral oncogene homolog 62.5 1.00±0.06 1.66±0.32 
B(a)P 30µM 1.07±0.07 0.78±0.06* 
     
TGFB2 6.25 1.26±0.34 4.04±1.05 
Transforming growth factor. beta 2   62.5 1.07±0.7 2.94±0.62* 
B(a)P 30µM 0.10±0.77 0.36±0.09* 
Table
DNA damage responsive  
TP53 
   
Tumor protein p53 
6.25 1.01±0.1 1.12±0.08 
62.5 1.04±0.01* 0.92±0.04 
B(a)P 30µM 0.10±0.03 1.23±0.16 
MDM2 
   
Oncogene, E3 Ubiquitin Protein Ligase  
6.25 1.08±0.01** 1.15±0.07 
62.5 1.05±0.02 1.15±0.01** 
B(a)P 30µM 0.10±0.03 1.13±0.21 
CDKN1A 
   
Cyclin-dependent kinase inhibitor 1A (p21.Cip 1) 
6.25 1.04±0.02 1.49±0.002 
62.5 1.00±0.02 1.48±0.07** 
B(a)P 30µM 1.11±0.08 7.33±2.02* 
GADD45A 
   
Growth arrest and DNA-damage-inducible. alpha  
6.25 1.08±0.11 1.92±0.59 
62.5 1.08±0.05 3.91±0.77* 
B(a)P 30µM 1.05±0.24 2.81±0.31* 
CHEK1 
   
Checkpoint kinase 1 
6.25 0.99±0.06 1.03±0.28 
62.5 0.94±0.06 0.99±0.24 
B(a)P 30µM 1.06±0.02 0.7±0.01*** 
ERCC4 
   
Excision repair cross-complementing rodent repair 
deficiency. complementation group 4 
6.25 1.00±0.02 1.09±0.05 
62.5 1.01±0.13 1.04±0.05 
B(a)P 30µM 1.06±0.04 1.68±0.31 
Oxidative stress 
GCLC 
    
6.25 0.91±0.2 1.38±0.12*  
62.5 0.88±0.18 1.92±0.23* Glutamate-cysteine ligase. catalytic subunit 
B(a)P 30µM 0.96±0.16 2.14±0.21*  
GPX1 
    
6.25 0.81±0.12 1.03±0.29  
62.5 0.75±0.04 1.04±0.2 Glutathione peroxidase 1 
B(a)P 30µM 0.73±0.01 1.67±0.19  
GSR 
    
6.25 0.83±0.16 1.10±0.13  
62.5 0.86±0.07 1.11±0.07 Glutathione reductase 
B(a)P 30µM 0.82±0.15 1.43±0.24  
     
 SOD1A 
6.25 
62.5 
B(a)P 30µM 
0.81±0.16 1.14±0.35  
0.77±0.03** 1.02±0.21 Superoxide dismutase 1 
0.77±0.001*** 1.15±0.21  
CAT 
    
6.25 1.00±0.07 0.67±0.29  
62.5 0.94±0.11 0.52±0.26 Catalase 
B(a)P 30µM 0.88±0.07 0.43±0.02***  
Apoptosis/survival 
BAX 
    
6.25 0.97±0.04 1.17±0.24  
62.5 0.97±0.11 0.81±0.02 Apoptosis regulator BAX. BCL2 associated X protein 
B(a)P 30µM 0.97±0.16 1.35±0.05  
BCL2 
    
6.25 0.9±0.08 1.90±0.24 B-cell CLL/lymphoma 2 
62.5 0.95±0.06 1.88±0.02***  
B(a)P 30µM 1.05±0.11 0.10±0.05*  
CASP3 
    
6.25 1.00±0.09 1.12±0.06 Caspase 3 apoptosis-related cysteine peptidase 
62.5 0.92±0.08 1.55±0.03**  
B(a)P 30µM 1.13±0.1 1.03±0.17  
CASP8 
    
6.25 1.05±0.09 1.26±0.14  
62.5 0.99±0.11 1.32±0.1* Caspase 8 apoptosis-related cysteine peptidase 
B(a)P 30µM 1.05±0.11 2.11±0.14**  
 
CASP9 
    
6.25 1.06±0.09 1.07±0.07  
62.5 1.03±0.06 0.93±0.02 Caspase 9 apoptosis-related cysteine peptidase 
B(a)P 30µM 1.03±0.08 0.9±0.06  
FAS 
    
6.25 0.97±0.04 1.20±0.2  
62.5 0.99±0.12 1.30±0.09* Fas (TNF receptor superfamily. member 6).  
B(a)P 30µM 1.15±0.07 4.86±0.3**  
 
Table 1. The results are expressed as relative mRNA expression normalized to the control group. Data are means ± SD of three independent experiments. 
Significant differences between CNa+ treated cells and the control group is indicated by *P < 0.05, ** P < 0.01, *** P < 0.001 (One way ANOVA with 
Dunnett´s test post test). Bold values indicate up or down-regulation of genes. 
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Abstract 
Clay2 is an organomodified montmorillonite developed by the Technological Institute of 
Packaging, Transport and Logistic (ITENE) in order to improve polymeric materials used in food 
packaging. There is not much known on Clay2 toxic potential, particularly at DNA level, therefore it is 
mandatory to assess its toxicity prior to its commercialization. In the present study the human hepatoma 
cell line (HepG2) was exposed to non-cytotoxic concentrations of Clay2 and the genomic instability was 
studied with the Cytokinesis block micronucleus cytome assay, by determining the formation of 
micronuclei (MN), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs). Moreover, the expression 
of various genes involved in the mechanisms of its action using the real-time quantitative PCR was 
studied. The results obtained provide the evidence that Clay2 is potentially genotoxic as it increased the 
frequency of micronuclei. In addition it deregulated genes involved in the metabolism, immediate-early 
response/signaling, DNA damage and oxidative stress showing new valuable information on the cellular 
response to Clay2. Nonetheless, further studies are highly needed to elucidate the molecular mechanisms 
of clays toxicity. 
 
 
 
Keywords: modified clay; cytokinesis block micronucleus assay; real-time quantitative PCR; HepG2 
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Introduction 
 Nearly all of the food and drink that we buy and consume is packed in some way. The main 
function of food packaging is to protect and preserve the food, to maintain its quality and safety, and to 
reduce food waste (Bradley et al. 2011). Currently, in order to create new food packaging materials to 
enhance the perdurability of the food, the incorporation of natural materials into the polymeric matrix, as 
clays, is presented as a great alternative. The final result is a new product known as nanocomposite, 
which comes from the disposition of the clay platelets in the polymer (Arora and Padua 2010).  
Montmorillonite (Mt) is a layered mineral clay widely used in various science fields due to its 
good swelling capacity, high specific surface area, good cation-exchange capacity, high platelet aspect 
ratio, strong adsorptive power, high structural stability, chemical inertia, strong capacity to form stable 
suspensions and ease with which its surface can be modified ( Baek et al. 2012; Mallakpour and Dinari 
2012). For these reasons, it is one of the most promising options used in food packaging to obtain 
improved materials. 
However, a simple dispersion of pure Mt, commercially known as Cloisite ®Na+ (CNa+), in a 
polymer matrix will not produce a nanocomposite with better properties compared to those of the bulk 
material due to the poor interfacial interactions between the hydrophilic reaction sites of clays and the 
highly hydrophobic polymer chains (Pisticelli et al. 2010), being necessary a chemical change in the clay 
structure, yielding to organo-modified clays. Cation exchange is one of the most useful chemical 
modification procedures used to prepare more organophilic clays (Pavlidou and Papaspyrides 2008), and 
quaternary ammonium salts are one of the most used options. Several quaternary ammonium salt-
organomodified clays are available on the market, and many more are under development, such as Clay2, 
a modified Mt with acetylcholine (ACO) chloride and hexadecyltrimethyl-ammonium bromide (HDTA) 
(Jordá-Beneyto et al. 2014) that was developed by the Technological Institute of Packaging, Transport 
and Logistic (ITENE). 
Due to the potential presence of organomodified clays such as Clay2 in food packaging materials 
their thorough toxicological assessment is required in order to determine the absence of toxicity for the 
consumers. In the scientific literature there is scarce information on the in vitro toxic profile of Clay2 
tested in different cell lines, and no in vivo data. Cytotoxic effects were determined by different endpoints 
like neutral red uptake, MTS reduction assay and protein content in human cell lines such as HepG2 
(hepatic), Caco-2 (intestinal) and HUVEC (endothelial), demonstrating a decrease in the cellular viability 
after 24 and 48h of exposure in a concentration range 0-125 µg/mL (Houtman et al. 2014; Jordá-Beneyto 
et al. 2014; Maisanaba et al. 2015a). Moreover, Clay2 induced DNA damage in HepG2 and Caco-2 cells 
determined by the Comet assay; however, no mutagenic response was obtained with the Ames assay 
(Houtman et al. 2014; Maisanaba et al. 2015a). Clay2 did not generate reactive oxygen species in HepG2 
and Caco-2 cells, however a decrease in GSH content was determined in HepG2 cells exposed to Clay2 
(Houtman et al. 2014). 
The cytotoxic effects of other organomodified clays, commercially available or under development 
and the underlying mechanisms of their toxicity have recently been reviewed by Maisanaba et al (2015b). 
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Several modified clays such as Cloisite®20A and Clay1 showed almost complete absence of toxicity in 
HepG2 or Caco-2 cells (Houtman et al. 2014, Jordá-Beneyto et al. 2014), while on the contrary a 
commercially available organomodified clay Cloisite®30B induced cytotoxic, genotoxic and mutagenic 
effects as well as oxidative stress in vitro (Sharma et al, 2010; Maisanaba el al. 2013, 2014, 2015a). These 
different responses support the idea that a case by case toxicological evaluation is needed. Currently, a 
genotoxicity evaluation is required by some regulatory and advisory bodies for authorization purposes 
(EFSA 2011; Kirkland et al. 2014) by means of a core set of tests. Among these assays, the micronucleus 
test is one of the main genotoxicity tests proposed, but for modified clay minerals, in general, the 
information about it remains very limited. 
Due to the scarce information on genotoxic potential of modified clays, the aim of our study was to 
elucidate whether Clay2 can influence genomic instability of human hepatoma (HepG2) cells by 
determining the formation of micronuclei and/or other nuclear anomalies, such as buds or bridges with 
the cytokinesis block micronucleus assay (CBMN). Moreover, the alterations in the expression patterns of 
a wide range of selected genes involved in the main activation/detoxification pathways and mechanisms 
of toxicity by Clay2 were investigated by real-time quantitative PCR (qRT-PCR). 
 
Materials and Methods 
Supplies and chemicals 
Minimum essential medium (MEM), TRIzol® reagent, B27 supplement were from Gibco BRL 
(Paisley, Scotland); fetal bovine serum (FBS), non-essential amino acids (NEAA), 
penicillin/streptomycin, L-glutamine, phosphate buffered saline (PBS) from PAA (Pasching, Austria). 
Cytochalasin B (Cyt-B), acridine orange (AO), dimethyl sulfoxide (DMSO [CAS 67-68-5]), trypsin, 
etoposide (ET) [CAS 33419-42-0] and benzo(a)pyrene (B(a)P) [CAS 50-32-8], were obtained from 
Sigma–Aldrich (St. Louis, USA). High Capacity cDNA Archive Kit and Taqman Gene Expression 
Assays were from Applied Biosystems (Forest City, CA, USA), TaqMan Universal PCR Master Mix 
from Applied Biosystems (Branchburg, NJ, USA), and Human GAPDH from Applied Biosystems 
(Warrington, UK).  
 
Modified clay and characterization 
Quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) (C19H42BrN, 
364.46 g/mol, 98%) was supplied from Cymit Quimica S.L. (Spain), acetylcholine chloride (ACO) 
(C7H16ClNO2, 181.66 g/mol, P99%) was provided by Sigma- Aldrich (Spain). 
The non commercial organomodified clay, Clay2 (Fig.1), has been developed and characterized 
by ITENE as described previously (Jordá-Beneyto et al. 2014). Briefly, the organomodified clay was 
prepared by a cation-exchange method, which consists on a displacement of the sodium cations of CNa+ 
with the ammonium cations of the above mentioned salts, obtaining Clay2. 
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The organomodified clay was characterized by thermogravimetric analysis (TGA), Fourier 
Transform InfraRed (FTIR) and X-ray diffraction (XRD) as described in Jordá-Beneyto et al (2014). 
 
Clay test solutions 
 
The test concentrations for the clay were selected according to previous dispersion  
experiments in order to avoid interferences with the measurement system as described Maisanaba et al. 
(2013). Test solutions were prepared in serum-free medium supplemented with B27. Three sonication 
steps of 10 s each one at an amplitude of 40% were performed using an ultrasonic tip (Dr. Hielscher, 
Germany) to disperse the test concentrations. 
 
 Cell culture 
HepG2 (human hepatocellular carcinoma epithelial cell line) was obtained from the American 
Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in monolayer in Eagle’s 
Minimum Essential Medium (ATCC) supplemented with 10% of FBS (Gibco, New Zealand), 2 mM L-
glutamine, 1% NEAA, 100 U/mL penicillin/ streptomycin (Gibco, New Zealand). Cells were grown at 
37°C and 5% CO2 in humidified atmosphere. Cells were used at passages between 12 and 18.  
 
Cytotoxicity assay 
HepG2 cells were seeded onto 96-well tissue-culture plates at a density of 4000 cells/well, and 
incubated at 37°C for 24h prior to exposure. From the initial stock solutions, serial dilutions of Clay2 in 
the medium without FBS supplemented with 2% B27 were prepared. Culture medium without clay was 
used as control group. Before testing genotoxic potential of Clay2 the viability of HepG2 cells was 
determined to avoid false positive results due to cytotoxicity and not genotoxicity. Growth medium was 
replaced with freshly prepared medium containing serial dilutions of Clay2 (1.56, 15.6 and 31.25 µg/mL) 
and incubated at 37 °C for 4 and 24h. Cytotoxicity of Clay2 was determined with the tetrazolium salt 
reduction (MTS) (CellTiter96 AQueous Non Radioactive Cell Proliferation Assay; Promega, Madison, 
USA) according to the manufacturer’s instructions. The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium inner salt) tetrazolium compound added to the 
medium is reduced by cells into a colored formazan product soluble in culture medium, which is directly 
measured with the spectrophotometer at 490 nm after 3h of incubation in the dark. Cell viability was 
determined by comparing the optical density of the wells containing the cells treated with the Clay2 with 
those of the control group. Two independent experiments were performed, each in five replicates per 
treatment point. 
 
 Cytokinesis block micronucleus assay (CBMN) 
Prior to the treatment, the cells were seeded onto 6-well tissue culture treated plates (400 000 
cells/ well) and incubated for 24h to attach. The medium was then replaced with fresh complete medium 
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containing non-cytotoxic concentrations of Clay2 (3.9, 7.8 and 15.6 µg/mL) and incubated for 24h. B(a)P 
(30 µM) and ET (1 µg/mL) were used as positive controls.  
The CBMN assay was performed following the steps described in Straser et al. (2011). Briefly, 
after the treatment, the cells were washed twice with 1x PBS and fresh medium with Cyt-B (3 µg/ml) was 
added for 26h at 37°C. Subsequently, the cells were washed, trypsinized, incubated in a cold hypotonic 
solution (75 mM KCl) for 5 min and fixed with a mix of methanol/acetic (3:1; v/v) and formaldehyde 
37%. The fixed cells were put on microscope slides and air dried, stained with AO (10 µg/ml) and 
examined under the ﬂuorescence microscope (Olympus BX61, Japan). Micronuclei (MN), nucleoplasmic 
bridges (NPBs) and cells with nuclear buds (NBUDs) were counted in 1000 binucleated cells (BNC) per 
experiment and were scored according to the criteria published by Fenech et al. (2000), in two 
independent experiments. In addition, the frequency of the binucleated cells with MN (MNed cells), was 
counted. The nuclear division index (NDI) was determined by scoring 1000 cells with one to four nuclei 
and was calculated using the formula [M1+ 2M2+3 (M3 + M4)]/500, where M1–M4 represent the 
number of cells with one to four nuclei, respectively, and M3 and M4 are equally considered to be in their 
third cycle (Fenech 2000). 
Real-time quantitative PCR (qRT-PCR) analysis 
After the incubation, the cells were washed with 1x PBS and total RNA was isolated using 
TRIzol® reagent, according to the manufacturer’s protocol with minor modifications described in 
Maisanaba et al (2015c). Briefly, glycogen (2 mg/ml) was added to the cell lysate. The RNA was 
incubated with isopropyl alcohol overnight at -20°C to precipitate. All solutions needed for RNA 
isolation were prepared in RNase-free water. The RNA was transcribed to cDNA using 1 µg of total RNA 
and cDNA High Capacity Kit, according to the manufacturer’s protocol. Gene expression was quantified 
with real-time quantitative PCR (ABI 7900 HT Sequence Detection System, Applied Biosystems, USA) 
using TaqMan Universal PCR Master Mix and the Taqman Gene Expression Assays (all from Applied 
Biosystems). The following Taqman Gene Expression Assays were used: CYP1A1 (cytochrome P450, 
family 1, subfamily A, polypeptide 1), Hs01054797_g1; CYP1A2 (cytochrome P450, family 1, subfamily 
A, polypeptide 2), Hs00167927_m1; CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) 
Hs00604506_m1; GSTA1 (glutathione S-transferase alpha 1), Hs00275575_m1; UGT1A1 (UDP 
glucuronosyltransferase 1 family, polypeptide A1), Hs02511055_s1; FOS (FBJ murine osteosarcoma 
viral oncogene homolog), Hs04194186_s1; JUNB (jun B proto-oncogene) Hs00357891_s1; MYC (v-myc 
avian myelocytomatosis viral oncogene homolog) Hs00153408_m1; TGFB2 (transforming growth factor, 
beta 2) Hs00234244_m1; CDKN1A (cyclin-dependent kinase inhibitor 1A’) Hs00355782_m1; CHEK1 
(checkpoint kinase 1) Hs00967506_m1; ERCC4 (excision repair cross-complementing rodent repair 
deficiency, complementation group 4) Hs00193342_m1;  GADD45A (‘growth arrest and DNA damage-
inducible gene, alpha’), Hs00169255_m1; MDM2 (Mdm2, ‘MDM2 oncogene, E3 ubiquitin protein 
ligase), Hs01066930_m1; TP53 (tumor protein P53), Hs01034249_m1; BAX (BCL2-associated X 
protein), Hs00180269_m1; BCL2 (B-cell CLL/lymphoma 2), Hs00608023_m1; CASP3 (caspase 3, 
apoptosis-related cysteine peptidase), Hs00234387_m1; CASP8 (caspase 8, apoptosis-related cysteine 
peptidase), Hs01018151_m1; CASP9 (caspase 9, apoptosis-related cysteine peptidase), Hs00609647_m1; 
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FAS (Fas cell surface death receptor), Hs00236330_m1; CAT (catalase), Hs00156308_m1; GCLC 
(glutamate-cysteine ligase, catalytic subunit), Hs00155249_m1; GPX1 (glutathione peroxidase 1), 
Hs00829989_gH; GSR (glutathione reductase), Hs00167317_m1; SOD1A (superoxide dismutase 1), 
Hs00533490_m1. Ampliﬁcation of GAPDH probe (Human Endogenous Controls, Cat. No.: 4310884E, 
Applied Biosystems, USA) was performed as an internal control. The conditions for the PCR were 50°C 
for 2 min, 95°C for 10 min and 40 cycles of 95°C for 15 s and 60°C for 1 min. The data obtained from 
Taqman Gene Expression Assays were analyzed using an accurate quantification taking into account a 
control pattern (10x, 100x, 1000x, 10000x) and a normalization with the control group. The expression 
levels of target mRNAs were normalized to the GAPDH mRNA level. Two independent experiments 
were performed each time in three parallels. An up-regulation and down-regulation of ≥ 1.5 and ≤ 0.7-
fold change, respectively, compared to control was considered a positive response. 
Statistical analysis 
The statistical analyses were performed with GraphPad Prism 5 software. Dunnett’s test was 
used for multiple comparisons versus the control in the MTS assay. In the CBMN assay Chi-square test 
was used to compare the number of MNs, NBUDs, and NPBs between the control group and Clay2 
exposed cells. When calculating differences between samples for the gene expression profiles, statistical 
significance between treated group and control was determined by Two-tailed Student’s t-test 
comparison. P < 0.05 (*), P < 0.01 (**) and P < 0.001 (***) were considered as statistically significant. 
 
Results 
Viability of HepG2 exposed to Clay2 
After 4h exposure of HepG2 cells to Clay2 no influence on cell viability was observed, while 
after 24h statistically significant decrease of cell viability was determined at 31.25 µg/mL (Fig. 2); 
therefore, the non-cytotoxic concentrations up to 15.6 µg/mL were used in further experiments. 
Genotoxicity of Clay2 in HepG2: Induction of micronuclei, nucleoplasmic bridges and nuclear buds  
The genotoxic activity of Clay2 in HepG2 cells was further evaluated using the CBMN assay 
(Fig. 3). Following 24 h exposure, Clay 2 induced statistically significant increase in the frequency of MN 
(2.7-fold increase) in BNCs, as well as in MNed cells (approximately 2.5-fold higher compared to control 
group) at the highest concentration assayed (15.6 µg/mL). Moreover, slight though statistically significant 
changes were obtained for BUDs (1.7-fold increase) at 15.6 µg/mL, while no changes in the frequency of 
NPBs compared to non-treated control were determined. 
A positive control B(a)P (2.5 µM) induced statistically significant increase in frequencies of MNed cells 
(2.5-fold), MN (2.6-fold), NBUDs (1.3-fold), but not NPBs, while a positive control  ET (1µg/mL)  
statistically significantly induced the number of MNed cells (3.7-fold) and MN (4.2-fold) (Fig.4). NDI 
was slightly decreased in cells exposed to Clay2 and was statistically significant at 7.8 µg/mL. Both 
positive controls, B(a)P and ET, decreased NDI (Fig.5). 
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Effect of Clay2 on mRNA expression 
 
The mRNa expression of a wide range of selected genes was analyzed after 4 and 24h of 
exposure to 1.56 and 15.6 µg/mL of Clay2 by quantitative real-time PCR (Table 1). The values presented 
in the Table 1 represent relative change in the gene expression of the selected genes compared to control 
group (untreated cells). 
 
Effect of Clay2 on mRNA expression of genes involved in metabolism 
 
In HepG2 cells exposed to Clay2 for 4h, the mRNA levels of the genes studied did not show any 
change compared to the control group. However, after 24h of exposure all studied genes from the 
CYP450 family, CYP1A1 (5.28±0.68), CYP1A2 (6.41±0.16) and CYP3A4 (4.33±3.07) were significantly 
up-regulated at 15.6 µg/mL of Clay2, CYP1A2 was more than 1.7-fold up-regulated even at 1.56 µg/mL. 
The expression of gene GST1A from the detoxification pathway was 1.5-fold increased at 15.6 µg/mL of 
Clay2 compared to control, while the expression of UGT1A1 was not statistically significantly changed at 
applied concentrations. 
 
Effect of Clay2 on mRNA expression of immediate –early response/signaling genes 
 
After the exposure of cells to Clay2 for 4h, only the expressions of FOS and JUNB were 
significantly down-regulation at both concentrations tested. On the contrary these two genes, FOS 
(5.08±0.57) and JUNB (1.74±0.34) were statistically up-regulated after 24h at the higher tested 
concentration. Also the expressions of MYC and TGFB2 were increased (approximately 2-fold) compared 
to control at 15.6 and 1.56 µg/mL, respectively. 
 
Effect of Clay2 on mRNA expression of DNA damage responsive genes 
 
Clay2 did not deregulate the mRNA levels of the genes involved in the response to DNA damage 
(TP53, MDM2, CDKN1A, GADD45A, CHEK1 and ERCC4) after 4h of exposure, while after 24h it up-
regulated (≥ 1.5-fold) the expression of TP53 and its downstream regulated genes MDM2, CDKN1A, 
GADD45A at 15.6 µg/mL. The mRNA level of CHECK1 was decreased compare to control (0.68±0.26). 
Clay2 did not affect the expression of ERCC4 at applied tested conditions.  
 
Effect of Clay2 on mRNA expression of oxidative stress responsive genes 
 
In hepatoma cells exposed to Clay2 for 4h, the mRNA levels of the oxidative stress responsive 
genes studied were not changed compared to control group. After 24h, only CAT presented an important 
down-regulation at both concentrations used, and GCLC showed a significant up-regulation (2.14-fold 
change) at the highest one. Clay2 did not affect the expression of other studied genes at applied 
conditions. 
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Effect of Clay2 on mRNA expression of apoptosis responsive genes 
 
No changes in the expressions of selected apoptosis/survival responsive genes (BAX, BCL2, 
CASP3, CASP8, CASP9 and FAS) were observed in HepG2 cells exposed to Clay2 for 4 and 24h under 
the conditions tested.  
 
Discussion 
Clay2 is a novel organoclay developed by ITENE to improve polymer properties used in food 
packaging. The toxicological data available on this clay are scarce but are required in order to comply 
with authorization processes. Previous experiments have shown inconclusive, contradictory and equivocal 
results on Clay2 genotoxic activity in vitro. Clay2 was not mutagenic in Salmonella typhimurium TA97, 
TA98, TA100, TA102 and TA104 (Maisanaba et al. 2015a); however, it induced DNA strand breaks in 
Caco-2 and HepG2 cell lines (Houtman et al. 2014). In such cases, the European Food Safety Authority 
states that it is appropriate to conduct further testing in vitro (EFSA 2011). The CBMN assay provides an 
additional strategy with a different genetic endpoint. Its purpose is to identify substances that cause 
structural and numerical chromosomal damage in cells that have undergone cell division during or after 
the exposure to the test substance (EFSA 2011). In the present study we have shown that Clay2 has 
altered the frequency of MNed cells and MN. Taken together all these data suggest that Clay2 could be 
considered genotoxic in vitro. However, based on these results it is not possible to conclude whether the 
modifiers introduced to the molecular formula of the raw clay are responsible for the genotoxicity 
observed especially as the raw clay, CNa+, has also increased the frequency of MN in the same 
experimental model but at higher concentrations (Maisanaba et al. 2015c).  
 
In addition to the classical toxicology assays we used transcriptomic analyses to identify 
molecular pathways potentially involved in Clay2 toxicity. To our knowledge no similar studies were 
conducted so far on modified clays; therefore we determined the influence of Clay2 on the expression of a 
wide range of selected genes after short (4h) and long (24h) exposure.    
Cytochrome P450 enzymes are responsible for the metabolism of a wide range of endogenous 
compounds, as well as xenobiotics including drugs, environmental pollutants, and dietary products 
(Nebert and Russell 2002). CYP1A1 and CYP1A2 enzymes are not only involved in drug metabolism but 
are also associated with bioactivation of many pro-carcinogens (Ma and Lu 2007). CYP3A4 is the most 
abundantly expressed P450 enzyme in the human liver and is involved in the metabolism of 
approximately half of all currently used prescription drugs (Thummel and Wilkinson 1998; Hao et al. 
2011). Therefore, it is important to know the alterations in the expression of CYP enzymes at the gene 
level. Clay2 induced dose and time dependent up-regulation of all three studied CYP genes. Similar 
expression pattern has already been observed with the raw clay, CNa+ (Maisanaba et al. 2015c). Clay2 
deregulated also the expression of GST1A1, which belongs to the phase II enzymes (mainly related to the 
metabolic detoxification processes), while the expression of UGT1A1 was slightly down-regulated but 
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was not significant. Previously, Maisanaba et al. (2015c) reported that also CNa+ enhanced GST1A1 
expression and significantly decreased UGT1A1 level. Altogether these results clearly show that clays can 
deregulate the expression of genes involved in the metabolism, which is especially important if we 
consider the fact that in real exposure interactions with other xenobiotics can occur. Consequently the 
activation/detoxification of xenobiotics can be changed.  
 
Clay2 deregulated the expression of FOS, JUNB and MYC, immediate-early response/signaling 
genes by down-regulating FOS and JUNB after short time exposure and by up-regulating all three studied 
genes after longer exposure. FOS and JUNB are components of the activator protein 1 (AP-1), which 
consists of Fos (c-Fos, FosB, Fra-1, Fra-2), Jun (JunB, c-Jun, and JunD), and activating transcription 
factor (ATF) families (Yang et al. 2003). The induction of FOS is known to be indicative for DNA-
damage and is increased by a wide variety of DNA-damaging agents (Hollander and Fornace 1989). 
JUNB gene is an immediate-early or primary response gene that is induced by polypeptide growth factors, 
cytokines, and chemical agents in various cell types, including liver (Hsu et al. 1992). MYC genes are also 
key regulators of cell proliferation, and their deregulation contributes to the genesis of most human 
tumors (Adhikary and Eilers 2005). The results obtained in the present study are consistent with those 
obtained with CNa+ (Maisanaba et al. 2015c). TGFB2, a potent anti-inflammatory cytokine, belongs to 
the transforming growth factor Bs (TGF-Bs) that regulate a wide variety of cellular processes, and were 
shown to inhibit epithelial cell proliferation by delaying or arresting progression through the late portion 
of G1 (Roberts and Sporn 1993). Clay2 up-regulated the expression of TGFB2 after 24h, similarly as 
CNa+ (Maisanaba et al. 2015c). Thus, as many other xenobiotics, clays can also affect cell signaling 
pathways with consequences on the cell faith.  
Most of the DNA damage responsive genes studied (TP53, CDKN1A, GADD45A and MDM2) 
were up-regulated at the highest concentration of Clay2, while CNa+ deregulated only CDKN1A and 
GADD45A (Maisanaba et al. 2015c). The tumor-suppressor gene, TP53, has several important functions 
such as activation of DNA repair proteins, cell cycle arrest, differentiation and initiation of apoptosis, 
depending on the level of DNA damage (Vogelstein et al. 2000). The up-regulated expression of TP53 
and its downstream regulated genes, CDKN1A and GADD45A, can be associated with the cell cycle arrest 
due to DNA damage induced by Clay2. MDM2 that enhances the tumorigenic potential of the cells and 
promotes cell survival and cell cycle progression was also up-regulated at mRNA level by Clay2. On the 
other hand, ERCC4 and a Ser/Thr kinase CHEK1, that are involved in nucleotide excision repair and 
mediation of the cellular response to DNA-damage, respectively, did not show any change upon Clay2 
exposure. 
Oxidative stress is defined as a disturbance in the balance between the production of reactive 
oxygen species and antioxidant defenses (Betteridge 2000) and can be induced by a wide range of 
xenobiotics. Among the cellular antioxidant defenses, SOD, CAT and the glutathione (GSH) enzymatic 
system have a main role. The alterations observed in genes involved in the response to oxidative stress  
induced by Clay2 followed the same pattern than those induced by CNa+, namely down-regulation of 
CAT, up-regulation of GCLC and no changes in other genes studied (Maisanaba et al. 2015c). CAT 
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enzyme dismutates hydrogen peroxide into water and molecular oxygen. Low levels of CAT together with 
no effects on GPX could correlate with enhanced H2O2 levels leading to oxidative stress and therefore 
potential serious tissue damage through oxidative damage and excessive cell death. Previously, Houtman 
et al. (2014) reported that Clay2 did not increase the level of ROS in exposed HepG2 cells but it 
decreased the GSH content. In the present study we observed the up-regulation of GCLC, the first rate 
limiting enzyme of glutathione synthesis, which could be explained as a response to the decreased GSH 
levels observed in HepG2 after Clay2 exposure (Houtman et al. 2014). 
Apoptosis, a programmed cell death, is critically important for the survival of multicellular 
organisms by getting rid of damaged or infected cells that may interfere with normal function (Vicencio 
et al. 2008). Two major pathways initiate apoptosis: the intrinsic (or mitochondrial) and the extrinsic 
pathways. In the present study we measured the expression of several genes involved in the 
intrinsic/extrinsic apoptotic processes as it is not know whether Clay2 can induce apoptosis. Although the 
results showed that none of the genes from the apoptotic pathways were deregulated by Clay2, the 
induction of apoptotic processes cannot be excluded as these data shown only that at exposure conditions 
Clay2 did not interfere with studied genes from apoptotic pathways at the transcriptional level.  
Previously, it has been described that Clay2 decreased cell viability of intestinal Caco-2 cells, 
hepatic HepG2 cells and endothelial HUVEC cells with EC50 values of 55, 88 and 42 µg/mL, 
respectively, measured with the MTS assay (Houtman et al. 2014; Maisanaba et al. 2015a), but the 
decrease was not associated to apoptosis. CNa+ however, induced an up-regulation of BCL2 suggesting 
the suppression of apoptosis, while on the other hand it up-regulated CASP3 indicating potential 
involvement of intrinsic pathway of apoptosis in CNa+ toxicity (Maisanaba et al. 2015c). The profile of 
the effects induced by the different modified clays can vary, thus a case by case toxicological evaluation 
is required. For example no increases of caspase-3/7 activity in HepG2 cells treated with CNa+, Cloisite 
®93A (Lordan et al. 2010), and Cloisite 30®B (Maisanaba et al. 2013), the raw Mt and two Mt-
organomodified clays, respectively, were detected. Janer et al. (2014), however, observed that CNa+ 
induced statistically significant increase of caspase-3/7 activity as well as translocation of membrane 
phospholipid phosphatidyleserine to the plasma membrane indicating the induction of apoptotic processes 
in HepG2 cells. 
Overall, when comparing the effects induced by raw (CNa+) (Maisanaba et al. 2015c) and 
modified (Clay2) clay it can be seen that Clay2 was more cytotoxic and had stronger genotoxic potential 
than CNa+ as it at lower concentrations induced the formation of micronuclei and alteration of different 
genes in HepG2 cells. Further research is needed to clarify the molecular mechanism involved in 
genotoxicity of clays and to identify the risk for humans in potential continuous exposure to low doses of 
the clays. 
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Conclusions 
The in vitro results obtained in the present study indicate that Clay2 is a potential genotoxic 
compound by the CBMN assay and also induce alterations of a wide range of genes involved in the 
metabolism, immediate-early response/signaling, DNA damage response and oxidative stress in human 
hepatoma cells mainly after 24h of exposure. Moreover, at concentrations that induced DNA damage 
Clay2 did not deregulate genes involved in apoptotic processes, which may result in an additional hazard 
of Clay2 as cells with damaged DNA are not removed from the population, potentially enhancing the risk 
of mutations and consequently carcinogenesis. Therefore Clay2 requires a thorough toxicological 
assessment before its intended used in food packaging.  
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Figure captions 
Figure 1. Clay2 composition: a) Raw clay structure (Mt) and its modifiers, b) hexadecyltrimethyl 
ammonium bromide (HDTA) and c) acethylcholine (ACO). 
Figure 2. The effect of Clay2 on the viability of HepG2 cells. Viability was determined with the MTS 
assay after the exposure to different concentrations Clay2 (write here the concentrations) for 4 and 24 h. 
Significant differences between Clay2 treated cells and the control group is indicated by *P < 0.05, ** P < 
0.01(One way ANOVA; Dunnett’s test).  
Figure 3. Fluorescent micrographs of HepG2 cells exposed to Clay2 (15.6 μg/ml for 24 h) a) binucleated 
cell, b) binucleated cell with MN, c) binucleated cell with two MNi, d) binucleated cells with NBUD, e) 
binucleated cells with NBUD and MN and f) binucleated cell with NBP. 
Figure 4. Number of binucleated cells with a) micronucleated cells (MNed cells), b) micronuclei (MNi), 
c) nuclear bridges (NPBs) and d) cells with nuclear buds (NBUDs) per 1000 binucleated HepG2 cells 
after the exposure to Clay2 (0, 3.9, 7.8 and 15.6 μg/mL) for 24 h. The number of MNed cells shows the 
number of cells containing MN, while MNi shows the overall number of MN as some cells may contain 
more than one MN. Significant differences between Clay2 treated cells and the control group (0) is 
indicated by *P < 0.05, ** P < 0.01, *** P < 0.001, and ****P<0.0001. Benzo(a)pyrene (B(a)P; 2.5 μM) 
and Etoposide (ET; 1 μg/mL) were used as positive controls. 
Figure 5. The influence of Clay2 (0, 3.9, 7.8 and 15.6 μg/mL) on the nuclear division index (NDI) of 
HepG2 cells after 24h exposure. Significant differences between Clay2-treated cells and the control group 
(0) is indicated by *P < 0.05. Benzo(a)pyrene (B(a)P; 2.5 μM) and Etoposide (ET; 1 μg/mL) were used as 
positive controls. 
 
Table caption 
Table 1. Effect of Clay2 on the expression of mRNAs of selected genes involved in the 
metabolism, immediate-early response/signaling, DNA damage, oxidative stress response and 
apoptosis/survival in HepG2 cells. The cells were exposed to Clay 2 (Concentrations!) for 4 and 24h. 
Statistical significance between treated group and control was determined by Two-tailed Student’s t-test 
comparison. P < 0.05 (*), P < 0.01 (**) and P < 0.001 (***) were considered as statistically significant; 
an up-regulation and down-regulation of ≥ 1.5 and ≤ 0.7-fold change, respectively, compared to control 
was considered a positive response (marked in bold). 
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Table 1. Effect of Clay2 on the expression of mRNAs of selected genes involved in the metabolism, immediate-early response/signaling, DNA damage, oxidative stress 
response and apoptosis/survival in HepG2 cells. 
Mechanisms involved Gene symbol Clay2 (µg/mL) 4h 24h Entrez gene name 
   Mean±SD Mean±SD  
Metabolism 
CYP1A1 
1.5 0.89±0.05 1.16±0.22 
Cytochrome P450 family 1. Subfamily A. polypeptide 1 15.6 0.87±0.06 5.28±0.68** 
B(a)P 30µM 1.91±0.43 130.32±9.22** 
     
CYP1A2 
1.5 1.56±0.65 1.71±0.56 
Cytochrome P450 family 1. Subfamily A. polypeptide 2 15.6 0.97±0.08 6.41±0.16*** 
B(a)P 30µM 1.76±0.73 79.78±15.01** 
     
CYP3A4 
1.5 1.84±0.04 1.19±0.56 
Cytochrome P450 family 3. Subfamily A. polypeptide 4 
 
15.6 1.13±0.22 4.33±3.07 
B(a)P 30µM 1.11±0.17 2.66±0.18** 
     
GST1A1 
1.5 0.76±0.20 1.33±0.32 
Glutathione S-transferase alpha 1 15.6 0.81±0.13 1.53±0.13* 
B(a)P 30µM 0.75±0.01*** 0.60±0.25 
     
UGT1A1 
1.5 0.58±0.13 0.82±0.27 
UDP glucuronosyltransferase 1 family. polypeptide A1 15.6 0.72±0.13 0.81±0.21 
B(a)P 30µM 0.97±0.02 5.57±0.96* 
Inmediate-early 
response/signaling 
     
FOS 
1.5 0.53±0.15* 0.99±0.08 
FBJ murine osteosarcoma via oncogene homolog B 15.6 0.48±0.12* 5.08±0.57** 
B(a)P 30µM 1.23±0.73 12.49±5.54** 
     
JUNB 
1.5 0.64±0.04** 0.93±0.17 
Jun B proto-oncogen 15.6 0.47±0.09** 1.74±0.34* 
B(a)P 30µM 1.13±0.36 2.41±0.46* 
     
Table
MYC 
1.5 0.98±0.04 0.96±0.16 
V-Myc avian myelocytomatosis viral oncogene homolog 15.6 0.92±0.03 2.04±0.03*** 
B(a)P 30µM 1.07±0.07 0.78±0.06* 
     
TGFB2 
1.5 1.13±0.19 1.87±1.25 
Transforming growth factor. beta 2 15.6 1.33±1.06 0.86±0.49 
B(a)P 30µM 0.10±0.77 0.36±0.09** 
DNA damage responsive  
TP53 
   
Tumor protein p53 
1.5 0.97±0.03 1.06±0.12 
15.6 1.09±0.15 1.50±0.22 
B(a)P 30µM 0.10±0.03 1.23±0.16 
MDM2 
   
Oncogene, E3 Ubiquitin Protein Ligase 
1.5 1.00±0.001 1.1±0.20 
15.6 1.11±0.04 1.86±0.48 
B(a)P 30µM 0.10±0.03 1.13±0.21 
CDKN1A 
   
Cyclin-dependent kinase inhibitor 1A (p21.Cip 1) 
1.5 0.85±0.09 1.11±0.31 
15.6 0.96±0.00* 2.17±0.48* 
B(a)P 30µM 1.11±0.08 7.33±2.02* 
GADD45A 
   
Growth arrest and DNA-damage-inducible. alpha 
1.5 0.87±0.11 0.99±0.18 
15.6 0.98±0.09 1.52±0.27 
B(a)P 30µM 1.05±0.24 2.81±0.31* 
CHEK1 
   
Checkpoint kinase 1 
1.5 0.99±0.10 1.13±0.18 
15.6 1.01±0.10 0.68±0.26 
B(a)P 30µM 1.06±0.02 0.7±0.01*** 
ERCC4 
   
Excision repair cross-complementing rodent repair 
deficiency. complementation group 4 
1.5 1.09±0.04 1.07±0.12 
15.6 1.03±0.04 1.25±0.08* 
B(a)P 30µM 1.06±0.04 1.68±0.31 
Oxidative stress GCLC 
   
Glutamate-cysteine ligase. catalytic subunit 1.5 0.84±0.24 1.11±0.21 
15.6 0.85±0.24 2.14±0.20* 
B(a)P 30µM 0.96±0.16 2.14±0.21* 
GPX1 
   Glutathione peroxidase 1 
1.5 0.72±0.16 1.05±0.08 
15.6 0.77±0.12 1.01±0.22 
B(a)P 30µM 0.73±0.01 1.67±0.19 
GSR 
   
Glutathione reductase 
1.5 0.77±0.20 1.09±0.21 
15.6 0.84±0.22 1.37±0.28 
B(a)P 30µM 0.82±0.15 1.43±0.24 
SOD1A 
   
Superoxide dismutase 1 
1.5 0.75±0.29 1.03±0.01* 
15.6 0.88±0.17 0.80±0.27 
B(a)P 30µM 0.77±0.001*** 1.15±0.21 
CAT 
   
Catalase 
1.5 0.74±0.22 0.73±0.28 
15.6 1.10±0.00 0.67±0.01*** 
B(a)P 30µM 0.88±0.07 0.43±0.02*** 
Apoptosis/ survival 
BAX 
    
1.5 0.94±0.01** 1.07±0.46  
15.6 1.03±0.03 1.12±0.05 Apoptosis regulator BAX. BCL2 associated X protein 
B(a)P 30µM 0.97±0.16 1.35±0.05  
BCL2 
    
1.5 0.92±0.13 1.23±0.46 B-cell CLL/lymphoma 2 
15.6 1.03±0.11 1.16±0.05*  
B(a)P 30µM 1.05±0.11 0.10±0.05*  
CASP3 
    
1.5 0.93±0.09 0.97±0.02 Caspase 3. apoptosis-related cysteine peptidase 
15.6 0.89±0.07 1.05±0.05  
B(a)P 30µM 1.13±0.1 1.03±0.17  
CASP8 
    
1.5 1.04±0.10 1.05±0.13  
15.6 1.02±0.05 1.17±0.06 Caspase 8. apoptosis-related cysteine peptidase 
B(a)P 30µM 1.05±0.11 2.11±0.14**  
CASP9 
    
1.5 1.05±0.02 1.01±0.16  
15.6 1.01±0.03 1.23±0.04* Caspase 9. apoptosis-related cysteine peptidase 
B(a)P 30µM 1.03±0.08 0.90±0.06  
FAS 
    
Fas (TNF receptor superfamily. member 6) 
 
1.5 1.04±0.04 1.02±0.16 
15.6 0.95±0.02 1.08±0.20 
B(a)P 30µM 1.15±0.07 4.86±0.3** 
 
The results are expressed as relative mRNA expression normalized to the control group. Data are means ± SD of two independent experiments. Significant differences 
between Clay2 treated cells and the control group is indicated by *P < 0.05, ** P < 0.01, *** P < 0.001 (Two-tailed Student’s t-test comparison). Bold values indicate up or 
down-regulation of genes. 
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Abstract 
Globally, food industries have made significant progress in order to increase the shelf-life 
of food products and have fewer economic losses. In this sense, the use of organomodified 
clays destined to be incorporated in polymer matrices play a novel role, leading to improved 
materials named nanocomposites with enhanced technological profiles. Due to the presence 
of these clays into the package, the safety of the consumers is a main concern. Cloisite®30B 
and Clay1 are two organomodified clays containing quaternary ammonium salts as modifiers, 
that can be potentially used to reinforce packaging polymers. Available toxicity data about 
these clays, specifically genotoxicity, is still limited and inconclusive in some aspects. Thus, the 
purpose of this work was to evaluate both clays ability to induce genomic instability through 
the cytokinesis block micronucleus cytome assay (CBMN) and for the first time, to the extent 
our knowledge, their influence in the modulation of several genes involved in genotoxicity and 
cell death mechanisms. Overall, no genotoxicity response was obtained in any case at the 
conditions tested. Similarly, significant gene deregulations were not observed on the genes 
selected. Nevertheless, further studies are highly needed to elucidate and increase the 
knowledge about the molecular mechanisms of clays toxicity. 
Keywords: food contact material; organomodified clays; cytokinesis block micronucleus 
cytome assay; gene expression; qPCR. 
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1. Introduction 
 
Food and beverage packaging is a large-scale business and, in recent years, a significant 
number of achievements have been made in order to increase the shelf-life of food products 
and have fewer economic losses. The use of natural substances to improve the packaging 
material properties largely refers to the introduction of fillers to generate a new kind of 
polymer. Clay minerals are within those new substances which have been used in the 
development of environmentally and ecologically friendly materials as sustainable solutions 
(Bordes et al., 2009; Hsu et al., 2012). Actually, clays are considered as the materials of the 
21st century due to, among other reasons, their wide range of applications (Bergaya and 
Lagaly, 2013). 
 
Clay minerals are layered substances consisting of sheets of silicate tetrahedra (SiO4) and 
octahedra (containing Al, Mg, and Fe) (Zhu and Njuguna, 2014). Among the most common 
clays stand out the montmorillonite (Mt), an abundant clay in nature, derived from volcanic 
ash and rocks, that belongs to the smectite group, which consists of an octahedral sheet 
sandwiched by two opposing tetrahedral sheets (Leszczynska et al., 2007; Hatzigrigoriou and 
Papaspyrides, 2011; Theng, 2012). Mt is constituted of nanometer scale platelets of 
magnesium aluminumsilicate, which present 1nm thick and 100 to 500 nm in diameter, 
resulting in platelets of high aspect ratio (Uyama et al., 2003). This kind of clay presents the 
unique ability to incorporate various ions, so the surface can be either hydrophilic or 
hydrophobic depending on the charge and available solutes. Due to the relatively high cationic 
exchange capacity, high aspect ratio, and ease of expansion of the interlayer space, Mt can 
interact with a wide range of organic species, which is a critical property required for many 
applications, such as in the food packaging area (Zhu and Njuguna, 2014).  
 
In this manner, the incorporation of Mt into the polymers as nanofillers (due to their 
layers thickness) generates polymer nanocomposites, defined as polymeric materials 
containing well-dispersed nanofillers which exhibit dramatic improvement in a range of 
characteristics, including mechanical properties, barrier properties, thermal stability, and 
flame retardancy, among others (Zhu and Njuguna, 2014). But it is important to highlight that 
clay aggregates must be exfoliated into single platelets and distributed homogeneously 
throughout the polymer phase to take full advantage of nanoclays high surface area (Sinha Ray 
and Okamoto, 2003; Sinha Ray and Bousima, 2005). Dispersion of clay layers into the polymer 
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is affected by mismatches between the hydrophobic/hydrophilic character of polymers and 
clays. Polymers are typically hydrophobic while clays are hydrophilic. In this sense, clays are 
often chemically modified with organic modifiers to render their surface more hydrophobic 
and improve their compatibility with polymers (Arora and Padua, 2010). For example, 
formation of nanocomposites with organoclays have shown pronounced improvements in the 
mechanical properties of various bio-polymers, even with a low level of filler loading (<5 wt%) 
and also excellent barrier properties against gases (e.g., O2 and CO2) and water vapor 
(Choudalakis and Gotsis, 2009; Rhim et al., 2013).  
 
Quaternary ammonium salts are among the most used modifiers, giving improved 
compatible clays. Some of these organomodified clays are commercially available, such as 
Cloisite®30B (C30B) that contains  methyl, tallow, bis-2-hydroxyethyl as modifier, and others 
are under development, such as Clay1, a modified clay with hexadecyltrimethyl-ammonium 
bromide, designed by the Technological Institute of Packaging, Transport and Logistic (ITENE, 
Valencia). Some technological advances are described by Lee et al. (2002) about a 
biodegradable polymer/Mt, where polybutylene succinate (PBST) and C30B were used as 
biodegradable polymer matrix and organomodified clay, respectively. The tensile properties of 
PBST/C30B nanocomposites with various contents of the nanoclays demonstrated a notable 
improvement compared to the raw polymer. 
 
Although the technological profile of nanocomposites are well known, safety issues are 
also of importance, as modified novel clays can reach both humans and the environment. 
Available data on clays toxicity is still limited, but different authors have already described 
toxic effects induced by different organomodified clays, including C30B and Clay1. Cytotoxic 
effects were evaluated by different endpoints like neutral red uptake, MTS reduction assay and 
protein content in several model systems such as HepG2 (human hepatoma cell line), Caco-2 
(human adenocarcinoma cell line) and HUVE cells (human vascular endothelium cell line). It 
was demonstrated a decrease in the cellular viability after C30B exposure in all of the 
biomarkers tested and almost absence of cytotoxic effects after Clay1 exposure for 24 and 
48h, in a concentration range of 0-500 and 0-8 µg/mL of each clay, respectively (Maisanaba et 
al., 2013; Maisanaba et al., 2014; Houtman et al. 2014; Jordá-Beneyto et al. 2014; Maisanaba 
et al. 2015a). Moreover, C30B also induced genotoxic and mutagenic effects, determined by 
the Comet Assay and the Ames test, as well as, oxidative stress alterations in vitro (Maisanaba 
et al., 2013, 2015a). However, Clay1 only showed a mutagenic response in the bacterial assay, 
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in presence of external metabolic activation, but not DNA strand breaks or oxidative effects 
(Sharma et al., 2010; Maisanaba et al., 2013; Houtman et al., 2014; Maisanaba et al., 2015a). 
Maisanaba et al. (2015b) have recently reviewed the scientific literature on the toxicological 
evaluation of clay minerals. Although the data available are scarce in comparison to other 
compounds, cytotoxicity assays are the most abundant while mechanistic studies, such as 
genotoxicity, oxidative stress induction, inflammation, etc., are more limited.  
 
Nowadays, a specific genotoxicity evaluation is required for new substances intended to be 
used as food contact materials by some regulatory and advisory bodies for authorization 
purposes (EFSA 2011, 2015) by means of a core set of tests. In this sense, the micronucleus 
test is one of the main genotoxicity tests proposed, but for modified clay minerals, in general, 
to the extend our knowledge, the information remains very scarce.  
Therefore, due to the limited data about toxicity mechanisms of modified clays, the aim of 
our study was to analyze whether C30B and Clay1 had influence on genomic instability by 
evaluation of the formation of micronucleus (MNs), nuclear buds (NBUD), and nucleoplasmic 
bridges (NPB) in the human hepatoma cell line HepG2 by the Cytokinesis block micronucleus 
cytome assay (CBMN). Moreover, the alterations in the expression patterns of a several genes 
involved in genotoxicity mechanisms as well as cell death pathways by both clays were 
investigated by real-time quantitative PCR (qRT-PCR). Thus, the information obtained would 
allow to complete their toxicological assessment required to ensure their safety as  food 
packaging materials. 
2. Materials and Methods 
 
2.1. Supplies and Chemicals 
Minimum essential medium (MEM), TRIzol® reagent, foetal bovine serum (FBS), non-
essential aminoacids (NEAA), penicillin/streptomycin, L-glutamine and trypsin were from Gibco 
(Biomol, Spain); phosphate buffered saline (PBS), cytochalasin B (Cyt-B), acridine orange (AO), 
dimethyl sulfoxide (DMSO [CAS 67-68-5]), etoposide (ET) [CAS 33419-42-0] and 
benzo(a)pyrene (B(a)P) [CAS 50-32-8], were obtained from Sigma–Aldrich (St. Louis, USA). High 
Capacity cDNA Archive Kit was from Applied Biosystems (Forest City, CA, USA Premix Ex Taq 
(Probe qPCR) (Takara-Clontech, France) and PrimeTime®Std qPCR assays (Integrated DNA 
Technologies (IDT), Madrid, Spain). 
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2.2. Modified clay and characterization 
Cloisite®30B, were obtained from Southern Clay Products, INC. (modifier: methyl, 
tallow, bis-2-hydroxyethyl, quaternary ammonium, concentration: 90 meq/100 g clay). 
Quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) (C19H42BrN, 
364.46 g/mol, 98%) was used for the development of Clay1 by cation exchange and was 
supplied by CymitQuimica S.L. (Spain). Both clays were characterized by thermogravimetric 
analysis (TGA), Fourier Transform InfraRed (FTIR) and X-ray diffraction (XRD) as described in 
previous works (Maisanaba et al., 2013; Jordá-Beneyto et al., 2014). 
2.3. Clay test solutions 
Test concentrations of clays were determined individually in previous experiments in 
order to avoid interferences with the method of measurement according to Maisanaba et al. 
(2013). The concentrations selected for the genotoxicity and gene expression assays were the 
highest ones that did not show cytotoxic effects and statistical differences versus the control. 
Thus, the maximum concentrations were 31.25 µg/mL for C30B and 8 μg/mL for Clay1, 
according to Maisanaba et al. (2013) and Houtman et al. (2014), respectively. 
2.4. Cell culture 
HepG2 cells (human hepatocellular carcinoma epithelial cell line) were obtained from 
the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in 
monolayer in Eagle’s Minimum Essential Medium (ATCC) supplemented with 10% of FBS 
(Gibco, New Zealand), 2 mM L-glutamine, 1% NEAA, 100 U/mL penicillin/ streptomycin (Gibco, 
New Zealand). Cells were grown at 37°C and 5% CO2 in humidified atmosphere. Cells were 
used at passages between 5 and 12. 
2.5. Cytokinesis block micronucleus assay (CBMN) 
Prior to the treatment, the cells were seeded onto 25 cm2 culture flask (1 000 000 cells/ 
plate) (all Corning Costar Corporation, New York, USA) and incubated for 24h to attach. Then, 
medium was replaced with fresh medium containing non-toxic concentrations of C30B (7.8, 
15.65, 31.25 µg/mL) and Clay1 (2, 4, 8 µg/mL ) during 24h, selected by previous cytotoxicity 
assays (Maisanaba et al., 2013; Houtman et al., 2014). B(a)P (30 µM) and ET (1 µg/mL) were 
used as positive controls. 
The CBMN assay was performed according to Straser et al. (2011). After the 24h 
treatment, the cells were washed twice with 1x PBS buffer, the medium containing Cyt-B (3 
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μg/ml) was added and the cells were incubated for additional 26 h at 37°C and 5% CO2 in 
humidified atmosphere. Below, the cells were washed, trypsinized, incubated in a cold 
hypotonic solution (75 mM KCl) for 5 min and fixed with a mix of methanol/acetic (3:1; v/v) 
and formaldehyde 37%. The fixed cells were put on microscope slides and air dried, stained 
with AO (10 µg/ml) and examined under the ﬂuorescence microscope (Olympus BX61, Japan). 
Micronucleus (MNs), nucleoplasmic bridges (NPBs) and nuclear buds (NBs) were counted in 
1000 binucleated cells (BNC) per experimental point at 400x magnification according to the 
criteria published by Fenech (2000) and the OCDE 487 guideline (1997). The NDI was calculated 
using the formula [M1+ 2M2 + 3(M3 +M4)]/500, where M1, M2, M3 and M4 represent the 
number of cells with one to four nuclei, respectively (Fenech, 2000). The experiments were 
repeated three times independently. 
 
2.6. mRNA expression analysis- Real-time quantitative PCR (QRT-PCR) 
After the incubation, the cells were washed with 1x PBS and total RNA was isolated using 
TRIzol® reagent, according to the manufacturer’s protocol with minor modifications described 
in Maisanaba et al (2015c). Briefly, glycogen (2 mg/ml) was added to the cell lysate. The RNA 
was incubated with isopropyl alcohol overnight at -20°C to precipitate. The RNA was 
transcribed to cDNA using 1 µg of total RNA and cDNA High Capacity Kit, according to the 
manufacturer’s protocol (Applied Biosystem, USA). Gene expression was quantified with real-
time quantitative PCR (LightCycler® 480 System, Roche Diagnostic, Spain) using Premix Ex Taq 
(Probe qPCR) (Takara-Clontech, France )and PrimeTime®Std qPCR assays (Integrated DNA 
Technologies (IDT), Madrid, Spain). The following PrimeTime®Std qPCR assays were used: TP53 
(tumor protein P53), NM_001276699; MDM2 (Mdm2, ‘MDM2 oncogene, E3 ubiquitin protein 
ligase), NM_002392; CDKN1A (cyclin-dependent kinase inhibitor 1A’) NM_001220778; 
GADD45A (‘growth arrest and DNA damage-inducible gene, alpha’), NM_001199741; BAX 
(BCL2-associated X protein), NM_004324; BCL2 (B-cell CLL/lymphoma 2), NM_000633. These 
genes were selected based on previous studies that showed their deregulation by other clays 
(Maisanaba et al., 2015c, d). Ampliﬁcation of GAPDH probe (Human Endogenous Controls, 
NM_002046) was performed as an internal control. The conditions for the PCR were 50°C for 2 
min, 95°C for 10 min and 40 cycles of 95°C for 15 s and 60°C for 1 min. The data obtained from 
PrimeTime®Std qPCR assays were analyzed using an accurate quantification taking into 
account a control pattern (10x, 100x, 1000x, 10000x) and a normalization with the control 
group. The expression levels of target mRNAs were normalized to the GAPDH mRNA level. Two 
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independent experiments were performed each time in three parallels. An up-regulation and 
down-regulation of ≥ 1.5 and ≤ 0.7-fold change, respectively, compared to control was 
considered a positive response. 
2.7. Statistical analysis 
The statistical analyses were performed with GraphPad Instat software. In the CBMN 
assay Chi-square test was used to compare the number of MNs, NBUDs, and NPBs between 
the control group and Clay1 or C30B exposed cells. When calculating differences between 
samples for the gene expression profiles, statistical significance between treated group and 
control was determined by Two-tailed Student’s t-test comparison. P < 0.05 (*), P < 0.01 (**) 
and P< 0.001 (***) were considered as statistically significant. 
 
3. Results 
 
3.1. Genotoxicity of C30B and Clay1 in HepG2: Induction of micronuclei, nucleoplasmic 
bridges and nuclear buds by the CBMN 
 
The genotoxic activity of C30B and Clay1 in HepG2 cells has been evaluated using the 
CBMN assay. Regarding to C30B, similar incidences compared to control group were observed 
for all the parameters and significant differences were not obtained in any case (Fig. 1). 
On the other hand, after 24 h exposure, Clay1 induced only a statistically significant 
increase in the frequency of Buds (1.8-fold increase compared to control group) in BNCs at the 
highest concentration assayed (8 µg/mL); however, no changes in the frequency of the other 
parameters studied (MNed cells, MNs and NPBs) were observed (Fig. 2). 
The positive control B(a)P (2.5 µM) induced statistically significant increases in frequencies 
of MNed cells (3.0 (C30B) and 2.7 (Clay1) -fold), MN (3.0 (C30B)and 2.6 (Clay1) -fold) and 
NBUDs (5.3 (C30B)and 4.9 (Clay1) -fold), but not NPBs. The another positive control, ET 
(1µg/mL), also induced statistical differences in the number of MNed cells (4.1 (C30B) and 3.8 
(Clay1) -fold), MN (4.5 (C30B) and 4.0 (Clay1) -fold) and Buds (3.9 (C30B) and 3.3 (Clay1) - fold) 
(Fig.1 and 2). NDI was not affected in cells exposed to C30B or Clay1. Both positive controls, 
B(a)P and ET, decreased NDI (Fig.3a, b). 
 
3.2. Effects of C30B and Clay1 on mRNA expression 
 
9 
 
The mRNa expression of a wide range of selected genes was analyzed after 4 and 24h of 
exposure to 3.125 and 31.25 C30B and, 0.8 and 8 µg/mL of Clay1 by quantitative real-time PCR 
(Table 1). The values presented in the Table 1 represent relative change in the gene expression 
of the selected genes compared to control group (untreated cells). 
 
 
In HepG2 cells exposed to C30B and Clay1 for 4 and 24h, the mRNA levels of the genes 
involved in DNA damage response (TP53, MDM2, CDKN1A, GADD45A) did not show any ≥ 1.5 
or ≤ 0.7-fold change compared to the control group. Therefore, genes are not considered to be 
deregulated although significant differences have been observed in the relative expression of 
all of them. 
 
Moreover, no changes in the expression of selected apoptosis/survival responsive genes (BAX 
and BCL2) were observed in HepG2 cells exposed to C30B and Clay1 for 4 and 24h at the 
conditions tested, in spite of the significant results obtained.  
 
4. Discussion 
 
Toxic effects of clay minerals are of interest as it has been recently reviewed by 
Maisanaba et al. (2015b). This may be due to their increasing number of applications that can 
potentially increase human and environmental exposure. Moreover, the inclusion of modifiers 
in their structure leads to new compounds that can show a different toxicological profile in 
comparison to the raw material. Thus, a case by case toxicological evaluation is necessary. 
 
In this study, C30B and Clay1 showed a similar pattern in the CBMN assay, and they did 
not altered the frequency of micronucleus at the conditions tested. However, both of them 
have shown genotoxic effects when other genotoxicity assays have been used (Sharma et al., 
2010; Maisanaba et al., 2013; Houtman et al., 2014; Maisanaba et al., 2015a). Actually, 
genotoxicity testing requires the use of various assays that covers different genetic endpoints. 
Thus, EFSA (2011) recommends the use of the following two in vitro tests as the first step in 
testing: a bacterial reverse mutation test and an in vitro mammalian cell micronucleus test. 
The first one covers gene mutations and the second one covers both structural and numerical 
chromosome aberrations. Taking into account that both C30B and Clay1 induced mutagenic 
effects by the Ames test (Maisanaba et al., 2015a) they can be considered genotoxic in vitro. 
Other clays, however, show a different profile. The raw clay (Mt, Cloisite®Na+ or CNa+), did not 
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show any effect on the bacterial assay (Maisanaba et al., 2015a) but it induced micronucleus 
(MNs) and important changes at the molecular level in HepG2 cells (Maisanaba et al., 2015c). 
The same authors also investigated the genotoxicity of Clay2, other organomodified clay 
similar to Clay1 but including also acetylcholine chloride as modifier. This one was not 
mutagenic by the Ames test (Maisanaba et al., 2015a), but on the contrary it induced 
important increases in the frequencies of MNs and other nuclear anomalies such as buds 
(Buds) and bridges (NPBs) (Maisanaba et al., 2015d). 
 
Regarding to the effects of both clays on the RNAm levels of selected genes, in any case 
the change was large enough to consider their expression deregulated. However, the pattern 
was mainly a significant reduction in the values, and only 3.125 µg/L C30B after 24h induced 
BAX expression values >1. Nevertheless, the response of the positive control (B(a)P) was 
similar to previous studies performed with CNa+ ( Maisanaba et al., 2015c) and Clay2 
(Maisanaba et al., 2015d). Therefore, all these findings suggested that neither C30B nor Clay1 
induced changes in the expression of the genes studied. Other clays, however, showed 
upregulations of TP53, MDM2 (Clay2), CDKN1A, GADD45A (Clay2 and CNa+) and BCL2 (CNa+) 
(Maisanaba et al., 2015c, d). 
 
Among the damage responsive genes, the tumor suppressor gen P53 is one of the most 
important and studied genes. It activates several genes, which results in the arrest of the 
cellular cycle and cellular repair or apoptosis. Many are the signals that activate P53 function 
including: DNA damage by gamma or ultraviolet radiation and chemical agents and hypoxia, 
among others. The final outcome of the different mechanisms of action of P53 is to maintain 
the genomic stability of the cell (Mendoza-Rodríguez and Cerbón, 2001). MDM2 is an 
important negative regulator of the P53 tumor suppressor gene. Thus, increased levels of 
MDM2 would inactivate the apoptotic and cell cycle arrest functions of P53, as do deletion or 
mutation of P53 (Iwakuma and Lozano, 2003). CDKN1A and GADD45A are TP53 downstream 
regulated genes. CDKN1A encodes a potent cyclin-dependent kinase inhibitor (p21) and 
functions as a regulator of cell cycle progression at G1 (Cazzalini et al., 2010). The role of 
GADD45A is to control the cell cycle G2-M checkpoint, the DNA repair process and apoptosis 
(Wang et al., 1999). Regarding to apoptosis responsive genes, BCL2 is an anti-apoptoptic gene 
that confers negative control in the pathway of cellular suicide machinery. BAX, on the other 
hand, is a pro-apoptotic gene that promotes cell death (Basu and Haldar, 1998). None of them 
showed an altered expression in this case.  
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Taking into account the results presented in this study, it is observed that different clays 
showed different effects, maybe due to the modifiers they contain, or to the concentrations 
used. It is therefore justified the need for a comprehensive and detailed assessment of each 
clay, case by case. 
 
5. Conclusion 
 
The organomodied clays C30B and Clay1 did not show notable genotoxic effects by 
means of the CBMN assay under the conditions tested. Moreover, they did not deregulate the 
RNAm expression of the DNA damage response genes (TP53, MDM2, CDKN1A and GADD45A) 
nor apoptosis/survival genes (BAX and BCL2) genes. Further studies would be required to 
elucidate the mechanisms involved in their reported toxic effects previously to their use as 
polymer fillers. 
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Figure captions 
Figure 1. Number of binucleated cells with a) micronucleated cells (MNed cells), b) micronuclei 
(MN), c) nuclear bridges (NPBs) and d) cells with nuclear buds (NBUDs) per 1000 binucleated 
HepG2 cells after the exposure to C30B (0, 7.8, 15.6 and 31.25 μg/mL) for 24 h. The number of 
MNed cells shows the number of cells containing MN, while MN shows the overall number of 
MN as some cells may contain more than one MN. Benzo(a)pyrene (B(a)P; 2.5 μM) and 
Etoposide (ET; 1 μg/mL) were used as positive controls. Significant differences between 
treated cells and the control group is indicated by *P < 0.05, **P < 0.01.  
Figure 2. Number of binucleated cells with a) micronucleated cells (MNed cells), b) micronuclei 
(MN), c) nuclear bridges (NPBs) and d) cells with nuclear buds (NBUDs) per 1000 binucleated 
HepG2 cells after the exposure to Clay1 (0, 2, 4 and 8 μg/mL) for 24 h. The number of MNed 
cells shows the number of cells containing MN, while MN shows the overall number of MN as 
some cells may contain more than one MN. Benzo(a)pyrene (B(a)P; 2.5 μM) and Etoposide (ET; 
1 μg/mL) were used as positive controls. Significant differences between treated cells and the 
control group is indicated by *P < 0.05, **P < 0.01, 
Figure 3. The influence of a) C30B (0, 7.8, 15.6 and 31.25 μg/mL) and b) Clay1 (0, 2, 4 and 8 
μg/mL) on the nuclear division index (NDI) of HepG2 cells after 24h exposure. Benzo(a)pyrene 
(B(a)P; 2.5 μM) and Etoposide (ET; 1 μg/mL) were used as positive controls. Significant 
differences between treated cells and the control group is indicated by *P < 0.05, **P<0.01. 
Table caption 
Table 1. Effect of C30B and Clay1 on the expression of mRNAs of selected genes involved in 
DNA damage response and apoptosis/survival in HepG2 cells. The cells were exposed to C30B 
(0, 3.125 and 31.25 µg/mL) or Clay1 (0, 0.8 and 8 µg/mL) for 4 and 24h. Benzo(a)pyrene (B(a)P; 
30μM) was used as positive control. Statistical significance between treated and control group 
was determined by Two-tailed Student’s t-test comparison. P < 0.05 (*), P < 0.01 (**) and P < 
0.001 (***) were considered as statistically significant; an up-regulation and down-regulation 
of ≥ 1.5 and ≤ 0.7-fold change, respectively, compared to control was considered a positive 
response (marked in bold). 
 
 
 Clay1 Cloisite®30B Benzo(a)pyrene (30µM) 
 4h 24h 4h 24h 
4h 24h 
 0.8µg/µL 8µg/µL 0.8µg/µL 8µg/µL 3.125µg/µL 31.25µg/µL 3.125µg/µL 31.25µg/µL 
TP53 0.83±0.04** 0.79±0.04** 0.86±0.02*** 1.02±0.21 0.78±0.06 0.78±0.03 0.89±0.11 1.03±0.21 0.87±0.10 1.30±0.33 
MDM2 0.81±0.01*** 0.80±0.07** 0.93±0.00*** 0.84±0.18 0.78±0.05** 0.77±0.05** 0.91±0.01*** 0.83±0.21 0.95±0.05 1.00±0.08 
CDKN1A 0.78±0.03*** 0.83±0.11 0.73±0.05* 0.74±0.05 0.84±0.07*** 0.87±0.12*** 0.80±0.06** 0.81±0.28 1.07±0.05 4.61±1.33** 
GADD45A 0.76±0.04*** 0.83±0.10 0.74±0.03 0.76±0.10 0.90±0.08*** 0.99±0.43** 0.86±0.02*** 0.94±0.33 0.97±0.04 2.74±0.42** 
BAX 1.06±0.08 1.02±0.06 1.02±0.14 0.98±0.02 1.10±0.09 0.95±0.09 1.14±0.07* 0.90±0.13 0.85±0.06** 0.90±0.15 
BCL2 0.78±0.13* 0.76±0.15* 0.64±0.12 1.12±0.15 0.98±0.26 0.92±0.19** 0.64±0.14 1.26±0.23 1.29±0.33 0.30±0.17** 
The results are expressed as relative mRNA expression normalized to the control group. Data are means ± SD of three independent experiments. Significant 
differences between Clay1 and Cloisite®30B treated cells and the control group is indicated by *P < 0.05, ** P < 0.01, *** P < 0.001 (Two-tailed Student’s t-
test comparison). Bold values indicate up or down-regulation of genes. 
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Toxic effects of a modiﬁed montmorillonite
clay on the human intestinal cell line Caco-2
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F. Javier Morenob, María Jordác, Ana M. Cameána, Susana Aucejoc
and Ángeles Josa
ABSTRACT:Q1 The incorporation of the natural mineral clay montmorillonite into polymeric systems enhances their barrier
properties as well as their thermal and mechanical resistance, making them suitable for a wide range of industrial applica-
tions, e.g., in the food industry. Considering humans could easily be exposed to these clays due to migration into food,
toxicological and health effects of clay exposure should be studied. In the present work, the cytotoxic effects induced by
two different clays (the unmodiﬁed clay Cloisite® Na+, and the organically modiﬁed Cloisite® 30B) on Caco-2 cells were
studied after 24 and 48 h of exposure. The basal cytotoxicity endpoints assessed were total protein content, neutral red up-
take and a tetrazolium salt reduction. Our results showed that only Cloisite® 30B induced toxic effects. Therefore, the effects
of subcytotoxic concentrations of this clay on the generation of intracellular reactive oxygen species, glutathione content and
DNA damage (comet assay) were investigated. Results indicate that oxidative stress may be implicated in the toxicity induced
by Closite® 30B, in regards of the increases in intracellular reactive oxygen species production and glutathione content at the
highest concentration assayed, while no damage was observed in DNA. The most remarkable morphological alterations ob-
served were dilated cisternae edge in the Golgi apparatus and nucleolar segregation, suggesting impairment in the secretory
functions, which could be related to inhibition in the synthesis of proteins. Copyright © 2013 John Wiley & Sons, Ltd.
Keywords: clays; Cloisite®; cytotoxicity; oxidative stress; morphology; cell culture
Introduction
Q2 Modern food packaging has made great advances as result of
global trends and consumer preferences, which are oriented to
obtain improved food quality and safety. Technological innova-
tion in this ﬁeld comprises the addition of different compounds
to the polymeric matrix to obtain improved packaging materials
(Silvestre et al., 2011). One of the preferred compounds used for
these applications are clays, such as montmorillonite, which
acquire nanoscale dimensions when incorporated to polymers,
resulting in nanocomposites (Rhim and Ng, 2007). These
nanocomposites are among the ﬁrst polymer nanomaterials to
emerge on the market as improved materials for food packaging
(Silvestre et al., 2011). Montmorillonite is a hydrated alumina-
silicate layered clay consisting of an edge-shared octahedral
sheet of aluminum hydroxide between two silica tetrahedral
layers, which is a relatively cheap and widely available natural
clay derived from volcanic ash/rocks (Paiva et al., 2008).
Layered clays have been widely studied and are of particular
interest due to successful incorporation into composite mate-
rials and the advantageous properties that reinforced materials
exhibit, which are attributed to their high aspect ratio (Rhim
and Ng, 2007). This is particularly important when high barrier
properties are needed. Several methods have been used to
obtain a homogeneous distribution of clay in the matrix and
exfoliation of the clay, which led to a nanoclay structure of
the montmorillonite into the polymer (Silvestre et al., 2011).
Although beneﬁcial effects of nanotechnologies are generally
well described, the possible toxicological effects and impacts of
nanocomposites on human health have received little attention
so far. There are still many important knowledge gaps in human
risk assessment concerning nanofood-related products, that if
resolved will bring the risk assessment of nanocomposites,
following oral exposure, a step forward (Bouwmeester et al.,
2009). In this sense, indirect contamination of food can be
expected when nanoparticles or nanotechnological devices are
incorporated in to packaging materials or storage containers to
lengthen the storage time while keeping the products fresh.
Considering that migration of these kinds of materials from the
packaging to food could occur, their safety in the food industry
should be studied (EFSA, 2011). In this sense, despite great
research into using montmorillonite in food packaging and
other applications, the toxic effects on humans remains limited;
therefore the need to generate better understanding about its
potential negative impacts on biological systems urges
(Bouwmeester et al., 2009). However, different experiments have
assessed the toxicity of montmorillonite for other applications in
the food industry. In this concern, Wang et al. (2005) have
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reported the relative safety of calcium montmorillonite in human
subjects when added to the diet to diminish exposure and health
risk from aﬂatoxin-contaminated food. Moreover, the safety of
calcium montmorillonite used for this purpose have been also
conﬁrmed in multiple animal species as well as in humans, and
even in long-term animal studies (Afriyie-Gyawu et al., 2005;
Phillips et al., 2008; Robinson et al., 2012). Additionally, calcium
and sodium montmorillonite showed no toxicity in pregnant rats
at levels in the diet up to 2% w/w (Wiles et al., 2004).
It is clear that cell culture-based toxicity tests are of interest,
having the potential to screen samples for a biochemical
response, while retaining the ability to detect more general cyto-
toxicity endpoints (Puerto et al., 2009). Hence, the Caco-2 cell
line is a commonly used enterocytic model, established from
human colon carcinoma, which in culture undergoes a process
of spontaneous differentiation that leads to the formation of a
monolayer of cells, expressing morphological and functional
characteristics of the mature enterocyte (Sambuy et al., 2005).
Plenty of experiments have been already conducted in this cell
line evidencing its accuracy as an experimental model to assess
toxic effects of substances that could target the gastrointestinal
system (Da Violante et al., 2002; Jos et al., 2009a, 2009bQ7 ; Gutiérrez-
Praena et al., 2012; Loh et al., 2012; Pichardo et al., 2012).
Taking into account all this background information, the pres-
ent work aims to assess the biochemical andmorphological alter-
ation caused by two clays (the unmodiﬁed clay Cloisite® Na+, and
the organically modiﬁed Cloisite® 30B) on the human colon cell
line Caco-2 after 24 and 48 h of exposure. First, the cytotoxic
response of exposure to clays was studied by three different
endpoints: total protein content (PC), neutral red uptake (NR)
and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium salt (MTS) reduction. Moreover,
the alteration in the oxidative status, DNA damage as well as
the implication of glutathione (GSH) in the toxic mechanism of
clays has been assessed. Finally, morphological alterations were
observed by light and electron microscopy to explore the intra-
cellular targets of these clays.
Materials and Methods
Supplies and Chemicals
Culture medium, fetal bovine serum and cell culture reagents
were obtained from BioWhittaker (Spain). Chemicals for the
different assays were provided by Sigma-Aldrich (Spain) and
VWR International Eurolab (Spain). The protein reagent assay
was obtained from BioRad (Spain)Q8 .
Clay Materials and Characterization
Unmodiﬁed montmorillonite (Cloisite® Na+) and the organically
modiﬁed one (Cloisite® 30B) were obtained from Southern Clay
Products, INC.Q9 (modiﬁer: methyl, tallow, bis-2-hydroxyethyl, qua-
ternary ammonium, concentration: 90 meq 100 g–1 clay). Both
clays were characterized by termogravimetric analysis, X-ray dif-
fraction and particle size distribution as described in Maisanaba
et al. (2013). Termogravimetric analysis showed a large loss of
mass for the Cloisite® 30BQ10 in the range 200–500 °C whereas
Cloisite® Na+ did not present any change in the same range of
temperature. The X-ray diffraction analysis for both materials
showed the typical pattern associated with a montmorillonite
material. Finally, the particle size distribution analysis showed
that the particle size of Cloisite® 30B is lower than those of
Cloisite® Na+ with both of them at the microscale (Maisanaba
et al., 2013).
Model System
The Caco-2 cell line derived from a human colon carcinoma
(ATCC® HTB-37, passages 29–48) was maintained at 37 °C in an
atmosphere containing 5% CO2 at 95% relative humidity (CO2
incubator, NuAire®, Spain Q11), in a medium consisting of Eagle’s
medium supplemented with 10% fetal bovine serum, 1% non-
essential amino acids, 50 μg ml–1 gentamicin, 1.25 μg ml–1
fungizone, 2 mM L-glutamine and 1 mM pyruvate. Cells were
grown near conﬂuence in 75 cm2 plastic ﬂasks and harvested
weekly with 0.25% trypsin. They were counted in an improved
Neubauer hemocytometer and viability was determined by ex-
clusion of Trypan Blue. The Caco-2 cells were plated at a density
of 7.5 × 105 cells ml–1 and incubated at 37 °C for 24 h until con-
ﬂuence was achieved to perform the experiments.
Cytotoxicity Assays
The test concentrations of both clays were determined individu-
ally in previous experiments to avoid interferences with the
method of measurement. For this reason the absorbance of clay
solutions (1000 μg ml–1 and serial half dilutions) were measured
at 0, 24 and 48 h. Q12The highest concentrations selected were the
ones that did not show statistical differences versus the control.
Stock solutions were 1000 μg ml–1 for both clays. Three sonica-
tion steps of 10 s each one at an amplitude of 40% were
performed used an ultrasonic tip (Dr. Hielscher, Germany Q13) to
disperse the test concentration. From the initial solution, serial
dilutions in medium were prepared (0.98, 1.95, 3.91, 7.81,
15.63, 31.25, 62.5 and 125 μg ml–1 for Cloisite® Na+; 3.91, 7.81,
15.63, 31.25, 62.5, 125 and 250 μg ml–1 for Cloisite® 30B). The
culture medium without clay was used as the control group.
After replacing the previous medium, the exposure solutions
were added to the systems, and incubated at 37 °C for 24 and
48 h. The basal cytotoxicity endpoints were PC, supravital dye
NR cellular uptake, and MTS.
PC is a very useful endpoint to assess cytotoxicity, as it gives
data about cell damage independence of the toxic mechanism
involved (Pichardo et al., 2007). PC was quantiﬁed in situ,
according to the procedure given by Bradford (1976), using
Coomassie Brilliant Blue G-250 in the same 96-well tissue culture
plates in which exposure originally took place, to determine the
total cell number present in the culture. The culture medium was
replaced by 200 μl NaOH 0.1 M and after 2 h incubation at 37 °C,
180 μl was replaced by the same volume of a 22% Coomassie
Brilliant Blue G-250 solution. After 30 min incubation at room
temperature, absorbance was read at 595 nm (Inﬁnite M200;
Tecan, Austria Q14).
NR uptake is a suitable endpoint to determine viable cells, be-
cause this dye is taken up by viable lysosomes. This assay was
performed according to Borenfreund and Puerner (1984). Brieﬂy,
NR in medium is absorbed and concentrated in lysosomes of
cells. NR uptake is proportional to the concentration of the NR
solution and the numbers of viable cells. The NR can be
extracted from lysosomes for quantitative measurement of cells
viability and cytotoxicity of xenobiotics. Culture medium was re-
placed by 100 μl medium without serum containing 10 mg ml–1
NR. The 96-well plate with the NR-containing medium was
S. Maisanaba et al.
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returned to the incubator for another 3 h to allow the uptake of NR
into the lysosomes of viable, intact cells. Thereafter, the medium
was removed and cells were ﬁxed for 1 min with a formaldehyde–
CaCl2 solution. By adding 0.2 ml of acetic acid–ethanol solution to
the wells, the NR absorbed by the cells was extracted, brought into
solution and quantiﬁed at 540 nm (Inﬁnite M200; Tecan).
MTS reduction is carried out by dehydrogenase enzymes pres-
ent in mitochondria, being this endpoint a good marker of the
damage induced in this organelle.Q15 MTS reduction was measured
according to the procedure of Baltrop et al. (1991). The MTS
tetrazolium compound added to the medium is bioreduced by
cells seeded in the 96-well plate into a colored formazan product
soluble in culture medium and is directly measured spectropho-
tometrically at 490 nm (Inﬁnite M200; Tecan) after 2 h of incuba-
tion in the dark.
Oxidative Stress Assays
Considering that only Cloisite® 30B showed remarkable cytotoxic
effects, it was chosen to perform further studies. The concentra-
tions used in these assays were calculated based on the cytotox-
icity study previously performed. The most sensitive endpoint
was PC; therefore, the mean effective concentration (EC50) value
obtained for this endpoint at 24 h, 40 ± 3.4 μg ml–1, was chosen
as the higher exposure concentration for the oxidative stress
studies in the Caco-2 cell line, along with fractions EC50/2 and
EC50/4, and the concentrations used here for Cloisite® 30B were
0, 10, 20 and 40 μg ml–1.Q16
After replacing the previous medium, the exposure solutions
were added to the cells, and incubated at 37 °C for 24 h. Culture
medium without clay was used as a control group. The oxidative
stress endpoints measured were reactive oxygen species (ROS)
content and GSH levels.
The production of ROS was assessed in 96-well plates using
the dichloroﬂuorescein (DCF) assay. The probe 2′,7′-
dichloroﬂuorescein diacetate (DCFH-DA) (Molecular Probes,
InvitrogenQ17 ) readily diffuses through the cell membrane and is
hydrolyzed by intracellular esterases to the non-ﬂuorescent
compound (DCFH), which is rapidly oxidized in the presence of
ROS to the highly ﬂuorescent DCF. Speciﬁcally, cells were incu-
bated with 200 μl 20 μM DCFH-DA in culture medium at 37 °C
for 30 min, and then washed with phosphate-buffered saline
(PBS) and resuspended in 200 μl of PBS. The formation of the
ﬂuorescence-oxidized derivative of DCF-DA was monitored at
an emission wavelength of 535 nm and excitation wavelength
of 485 nm (Inﬁnite M200; Tecan). ROS production was expressed
as ﬂuorescence arbitrary units (Pichardo et al., 2012).
GSH content in cells was evaluated in 96-well plates by reac-
tion with the ﬂuorescent probe monochlorobimane (Molecular
Probes, Invitrogen) (Jos et al., 2009a, 2009b). This molecule forms
a thioether adduct with GSH in a reaction catalyzed by the en-
zyme GST. After cell exposure to the clay, medium was discarded
and cells were incubated at 37 °C for 20 min in the presence of
40 μM monochlorobimane. Later on, cells were washed with PBS
and the ﬂuorescence was recorded in a spectroﬂuorometer (Inﬁ-
nite M200; Tecan) at excitation/emission wavelengths 380/460.
Results were expressed as arbitrary units.
Comet Assay
The comet assay was performed to detect DNA strand breaks.
Caco-2 cells were seeded on to 12-well tissue culture-treated
plates (Corning Costar Corporation, New York, USA). Approxi-
mately 3.5 × 105 cells in each well were exposed with a different
concentrations of Cloisite® 30B (0, 10, 20 or 40 μg ml–1) for 24
and 48 h.
To monitor the ongoing process of the assay, a negative
control (cells treated with medium without fetal calf serum)
and a positive control (cells treated with a solution of 100 μM
H2O2) were included. After treatments, cells were washed and
detached in PBS. The comet assay was applied as previously
described by Collins et al. (1997) with modiﬁcations (Corcuera
et al., 2011). Brieﬂy, cells were resuspended in PBS at a concen-
tration of 2.5 × 106 cells ml–1. This suspension were mixed with
1% low melting point agarose and placed on a microscope slide.
Once the gels had become solid, the slides were dipped into
lysis solution at 4 °C. All nucleotides were denatured in a high
pH buffer (0.3 M NaOH, 1 mM EDTA, pH 13). Electrophoresis was
carried out at approximately at 25 V (300 mA) and the DNA
was gently reneutralized in PBS and washed in H2O. After
neutralization, microscope slides are ﬁxed in 96% ethanol and
absolute ethanol. Finally, DNA was stained with SYBR Gold nuclei
acid gel stain and was visualized with an Olympus BX61 ﬂuores-
cence microscope (20 × objective) coupled via a CCD camera to
an image analysis system (DP controller–DP manager). Images
of randomly selected nuclei (≥ 100) per experimental point were
analyzed with the image analysis software (Comet Assay IV;
Perceptive Instruments, UK Q18). The results from four independent
experiments are expressed as percentage of tail DNA and are
shown as box plots.
Morphology
Cells were exposed to two different concentrations of Cloisite®
30B, 10, 20 and 40 μg ml–1, during 24 and 48 h of exposure.
Afterwards, cultured cells were ﬁxed directly in the cell culture
dish in 1.6% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2,
for 60 min at 4 °C. They were all postﬁxed in 1% osmium tetrox-
ide for 60 min at 4 °C. Subsequently, cells were scraped and
pelleted by centrifugation. Samples were washed in 0.1 M
cacodylate buffer, pH 7.3. Samples were dehydrated in ethanol
at progressively higher concentrations and embedded in Epon
(epoxy embedding medium). Toluidine blue-stained semithin
sections (0.5 μm thick) used as controls were viewed in a Leitz
(Aristoplan) light microscope Q19. The presence of lipids was con-
ﬁrmed by Sudan III cytochemical technique.
Thin sections (60–80 nm thick) were cut on a Reichert-Jung
Ultracut E ultramicrotome, stained with uranyl acetate and lead
citrate, and examined in a Philips CM-10 transmission electron
microscope. The cell growth and development of morphology
damage was checked using a Leica DMIL inverted microscope by
phase contrast and photographed using a Leica DC 100 camera. Q20
Calculations and Statistical Analysis
All experiments were performed at least three times and in du-
plicate per concentration. Data for the concentration-dependent
cytotoxicity relationships of all experiments were presented as
the arithmetic mean percentage ± standard deviation (SD) in
relation to control. Statistical analysis was carried out using
analysis of variance (ANOVA), followed by Dunnett’s multiple
comparison tests. Differences were considered signiﬁcant from
P< 0.05.
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EC50 values (mean effective concentration, concentration that
modiﬁed each biomarker by 50%, positive or negative, in com-
parison with appropriate untreated controls) were determined
by probit analysis.
Results
Results of the Cytotoxicity Assays
Caco-2 cells exposed to Cloisite® Na+ showed no signiﬁcant
changes in PC after both exposure times at any concentration
assayed (Fig.F1 1a). Similarly, NR uptake assay also indicated no
signiﬁcant alterations at 24 and 48 h (Fig. 1b). MTS reduction
performed by cells exposed to Cloisite® Na+ also remained
unaltered with respect to the control cells after 24 h, whereas
after 48 h signiﬁcant reductions were observed from the concen-
tration of 31.25 μg ml–1 Cloisite® Na+ (Fig. 1c).
On the other hand, Caco-2 cells exposed to Cloisite® 30B
underwent a concentration and time-dependent decrease in
PC. Signiﬁcant reductions in cell viability were shown from the
concentrations of 31.25 μg ml–1 Cloisite® 30B in cells exposed
for 24 h and from the concentration of 15.63 μg ml–1 Cloisite®
30B after 48 h of exposure (Fig. F22a). In addition, considering
the EC50 values obtained, toxic effects were higher in the longest
exposure, being 40± 3 μg ml–1 for 24 h and 34± 6 μg ml–1 for 48
h. However, this increase was not statistically different. The
remaining cell viability of 5% was recorded after 24 h and 48 h
of exposure to the highest concentration tested (250 μg ml–1).
NR uptake assay also indicated a reduction in cell viability. These
decreases were signiﬁcantly different from the control group at
the concentration 62.50 μg ml–1 at 24 h, and from 31.25 μg
ml–1 in cells exposed for 48 h (Fig. 2b). Moreover, signiﬁcant
differences were observed for the EC50 values in the NR uptake
assay, being lower in the longest exposure time (50 ± 2 μg ml–1
Figure 1. Protein content (a); neutral red uptake (b); and reduction of tetrazolium salt (c) of Caco-2 cells after 24 h and 48 h of exposure to 0–125 μg
ml–1 Cloisite® Na+. All values are expressed as mean ± SD. *Signiﬁcantly different from control (P ≤ 0.05).
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for 24 h and 40± 1 μg ml–1 for 48 h). Similarly, MTS reduction
performed by cells exposed to Cloisite® 30B also decreased in
a concentration- and time-dependent way, showing signiﬁcant
changes with respect to the control group from 62.50 μg ml–1
at 24 h of exposure, and from 3.91 μg ml–1 at 48 h (Fig. 2c).
The EC50 values for the MTS assay also evidenced a greater effect
in cells after a longer exposure time (79 ± 4 μg ml–1 for 24 h in
comparison to 12 ± 1 μg ml–1 for 48 h); this difference was statis-
tically signiﬁcant.
Results of the Oxidative Stress Assays and Comet Assay
When Caco-2 cells were exposed to 10 and 20 μg ml–1 Cloisite®
30B, the ROS content was not altered; whereas at exposure to 40
μg ml–1 Cloisite® 30B it enhanced signiﬁcantly with respect to
the control group at both exposure times (Fig.F3 3a). Similarly,
GSH content only suffered a signiﬁcant decrease at 40 μg ml–1
Cloisite® 30B after 48 h (Fig. 3b). However, Caco-2 exposed to
Cloisite® 30B did not induce any DNA damage at the concentra-
tions assayed (Fig. F44).
Results of the Morphology Study
Light microscope observation. Caco-2 cultured cells exhibit
morphological features characteristic of differentiated cells, with
a tendency to form aggregates, making it difﬁcult to obtain a
homogeneous culture. A decrease in cell growing is observed
when cells are treated with 20 μg ml–1 Cloisite® 30B. Meanwhile,
after exposure to the highest concentration assayed, 40 μg ml–1
Cloisite® 30B, cell death is induced. When cells are observed
under phase contrast microscopy, morphological changes are
more evident from the concentration of 20 μg ml–1 Cloisite®
30B. Intense vacuolization in the cytoplasm is observed in cells
exposed to 20 and 40 μg ml–1 Cloisite® 30B (Fig. F55b,e,f). Most of
Figure 2. Protein content (a); neutral red uptake (b); and reduction of tetrazolium salt (c) of Caco-2 cells after 24 h and 48 h of exposure to 0–250 μg
ml–1 Cloisite® 30B. All values are expressed as mean ± SD. *Signiﬁcantly different from control (P ≤ 0.05).
C
ol
ou
r
on
lin
e,
B
&
W
in
pr
in
t
Montmorillonite-based clays induce toxic effects on Caco-2 cells
J. Appl. Toxicol. 2013 Copyright © 2013 John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jat
5
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
the vacuoles correspond to lipid drops. Large euchromatic irreg-
ular nuclei are also observed (Fig. 5b,c). Moreover, as it has been
already mentioned, cell death is induced and apoptotic cells are
shown in the exposure to 40 μg ml–1 Cloisite® 30B (Fig. 5c).
Electron microscope observation. When unexposed Caco-2 cells
after 24 h of culture are observed by electron microscopy, they
show euchromatic nuclei (Fig.F6 6a) with regular surface and
prominent nucleoli. Numerous ribosomes are observed free in
the cytoplasm (Fig. 6b). Mitochondria with light matrix and visi-
ble crest (Fig. 6b), intermediate ﬁlaments (Fig. 6a) and lipid drops
(Fig. 6a) are also shown in the cytoplasm. The endomembrane
system, especially in the Golgi apparatus, is very well developed
(Fig. 6b). When unexposed Caco-2 cells are observed after 48 h
of culture, slight changes are observed in the nucleus, with a
more irregular nuclear surface (Fig. 6c). In the cytoplasm, an
increase in the lipid drop content is visible (Fig. 6c) as well as
tonoﬁlaments. Mitochondria show light matrix and scarce thin
crest (Fig. 6d). The most remarkable ultrastructural feature after
24 and 48 h of exposure to the lowest concentration assayed,
10 μg ml–1 Cloisite® 30B, is nucleolar segregation (Fig. 6e), show-
ing the ﬁbrillar component completely separated from the gran-
ular one (Fig. 6e). In the cytoplasm, the increase in the number of
lipid drops (Fig. 6f) and degradation in the mitochondrial crest
are observed. The endomembrane systems, especially the
dictyosomes (Fig. 6g) show dilated cisternae edges (Fig. 6g).
All the morphological alterations previously observed were
more severe when Caco-2 cells were exposed to 20 μg ml–1
Cloisite® 30B during 24 and 48 h, with mitochondria exhibiting
matrix and inner membrane degradation, and dilated dictyo-
somes (Fig. F77a). Moreover, morphological signs of cellular differ-
entiation are observed, such as membrane specializations
formingmicrovilli, development of endocytic vesicles and dilated
cisternae from the rough endoplasmic reticulum (Fig. 7b). How-
ever, the most remarkable changes were observed when cells
were exposed to the highest concentration, 40 μg ml–1 Cloisite®
30B (Fig. 7c–f). Heterophagosomes with laminar content and
Figure 3. Reactive oxygen species content (a), and glutathione content (c) in Caco-2 cells after 24 and 48 h of exposure to 10, 20 or 40 μg ml–1
Cloisite® 30B. All values are expressed as mean ± SD. *Signiﬁcantly different from control (P ≤ 0.05).
Figure 4. Comet assay results of Caco-2 cells after 24 and 48 h of exposure to 10, 20 or 40 μg ml–1 Cloisite® 30B. All values are expressed as mean ± SD.
*Signiﬁcantly different from control (P ≤ 0.05).
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small vesicles with endocytic origin are visible in the cytoplasm.
The laminar structure observed in the heterophagosome could
correspond to agglomerated clay. Moreover, intense dilatation
in the trans face of Golgi apparatus, autophagosome with mito-
chondrial origin, lobed nucleus sections and lipid drops are also
observed (Fig. 7c). Scarce viable cells are distinguished in the
culture showing nucleus with irregular surface (Fig. 7d), cyto-
plasm intensely vacuolated (Fig. 7d) as a result of mitochondrial
degradation (Fig. 7e), and presence of lipid drops (Fig. 7e),
secondary lysosomes (Fig. 7e), segregated nucleoli (Fig. 7e) and
dilated cisternae in the Golgi apparatus and rough endoplasmic
reticulum (Fig. 87).
Figure 5. Morphology of Caco-2 cells observed by bright-ﬁeld microscopy (a–c) and phase contrast microscopy (d–f). Unexposed control culture (a,d).
Cells exposed for 48 h to 20 μg ml–1 (e) or 40 μg ml–1 Cloisite® 30B (b.c.f). (a) Bar = 200 μm. (b–f) Bars = 100 μm. (b) Intense vacuolization in the
cytoplasm (black arrow) and large euchromatic irregular nuclei (black arrowhead). (c) Apoptotic cells (black arrow). (e,f) Vacuolization in the cytoplasm
(white arrow).
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Discussion
Because of the growing use of clays, human exposure is inevita-
ble and so an evaluation of their potential toxicity is necessary
(Lordan et al., 2011). In the present study, biochemical and
morphological alterations of two different clays, the natural
mineral sodium montmorillonite Cloisite® Na+ and the same clay
modiﬁed with a quaternary ammonium compound (Cloisite®
30B) were studied in the human cell line Caco-2. Results
obtained showed no signiﬁcant cytotoxic effects in Caco-2 cells
exposed to the selected concentrations of Cloisite® Na+ for 24
and 48 h; however, all the endpoints assayed for Cloisite® 30B
appeared altered. In this sense, other authors have also studied
the cytotoxic effects of different clays in permanent cell lines
Figure 6. Ultrastructural features of unexposed Caco-2 cells and after exposure to Cloisite® 30B observed by electron microscopy. Unexposed control
cells after 24 h of culture (a,b) and after 48 h (c,d), and Caco-2 cells exposed to 10 μg ml–1 Cloisite® 30B (e–g). (a) Unexposed cells showing euchromatic
nuclei with regular surface (N), mitochondria (white arrow), intermediate ﬁlaments (black arrow) and lipid drops (black arrowhead). Bar = 2 μm. (b)
Numerous polyribosomes in the cytoplasm (black arrowhead), mitochondria with light matrix and visible crest (black arrow), well developed Golgi
apparatus (white arrow). Bar = 2 μm. (c) Unexposed Caco-2 cells after 48 h of culture show nuclei (N) with irregular surface, nucleolus (n) and lipid drops
in the cytoplasm (L). Bar = 2 μm. (d) Mitochondria with light matrix and scarce thin crest (black arrow). Bar = 2 μm. (e) Exposed Caco-2 cells show
nucleolar segregation (n), showing the ﬁbrillar component (f) completely separated from the granular one (g). Bar = 1 μm. (f) Increase in the number
of lipid drops (L) and degradation in the mitochondrial crest (black arrow) are observed in the cytoplasm. Bar = 1 μm. (g) Dictyosomes (G) show dilated
cisternae edges (black arrow) and dilated cisternae from the rough endoplasmic reticulum (black arrowhead). Bar = 0.5 μm.
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(Gao et al., 2000; Geh et al., 2006a; Li et al., 2010). Murphy et al.
(1993a) highlighted the importance of studying the effects of
montmorillonite as this clay exhibited the most toxic effects in dif-
ferent cell lines, being the order of tested particles: montmorillonite
bentonite=kaolin >> erionite.
Surface modiﬁcation of clays has been commonly used to
achieve a greater compatibility of the clay with polymer, and
therefore reach higher exfoliation degrees, and in consequence
better properties (Hetzer and De Kee, 2008). However, it has
been suggested that the modiﬁcation introduced in the
Figure 7. Ultrastructural changes of Caco-2 cells after exposure to Cloisite® 30B observed by electron microscopy. Caco-2 cells exposed to 20 μg ml–1
Cloisite® 30B (a,b) or 40 μg ml–1 Cloisite® 30B (c–f). (a) Cells with mitochondria exhibiting matrix and inner membrane degradation (black arrow), and
dilated Golgi apparatus (G). Bar = 1 μm. (b) Differentiated cells show membrane specializations forming microvilli (black arrow), development of
endocytic vesicles (black arrowhead) and dilated cisternae from the rough endoplasmic reticulum (white arrow). Bar = 2 μm. (c) Heterophagosome
(Hph) with laminar content (arrow) and small vesicles with endocytic origin (arrowhead) are visible in the cytoplasm. Intense dilatation in the trans face
of Golgi apparatus (asterisc), autophagosomes with mitochondrial origin (Ph), lobed nucleus sections (N) and lipid drops (L) are also observed. Bar = 2
μm. (d) Scarce viable cells are distinguished in Caco-2 culture exposed to 40 μg ml–1 Cloisite® 30B, showing nucleus with irregular surface (N), segre-
gated nucleoli (n) and cytoplasm intensely vacuolated (black arrow). Bar = 1 μm. (e) Mitochondrial degradation (black arrow), and presence of lipid
drops (L), secondary lysosomes (black arrowhead) and segregated nucleoli (n). Bar = 1 μm. (f) Dilated cisternae (black arrow) in the Golgi apparatus
(G). Bar = 1 μm.
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montmorillonite substantially changes its behavior in the exper-
imental model. Actually, it changes the hydrophilic characteris-
tics of the clays, and therefore their toxicity can be affected. In
this sense, the oligo (styrene-co-acrylonitrile)-modiﬁed montmo-
rillonite showed little cytotoxicity in mouse embryonic ﬁbroblast
(NIH 3T3) cells and human embryonic kidney 293 cells, and
lower level of apoptosis was induced when cells were incubated
with a high montmorillonite content (1 g l–1) (Liu et al., 2011).
However, a concentration-dependent response in HepG2 cells
exposed to Cloisite® Na+ and Cloisite® 93A was evident following
24 h of treatment with each of the clays, with a signiﬁcant
decrease in viable cells observed from 1 μg ml–1 (Lordan et al.,
2011). In our study, the modiﬁcation of the montmorillonite
Cloisite® Na+, to turn into Cloisite® 30B, produced an increase
in the toxic effects observed in Caco-2 cells. Thus, for example
after 48 h of exposure 62.5 μg ml–1 the percentage of viable cells
measured with the MTS assay was 72% with Cloisite® Na+ and
only 21% with Cloisite® 30B.
In addition, the mechanism of montmorillonite to produce
toxic effects is still unknown. The implication of oxidative stress
in the toxic effects induced by Cloisite® 30B has been assayed
in the present work, showing increases in the ROS content only
when cells were exposed to the highest concentration tested
(40 μg ml–1) at both exposure times (24 and 48 h). The produc-
tion of ROS could be related to the cell damage induced by
Cloisite® 30B at this concentration that was also corroborated
with the morphological study. Similarly, Lordan et al. (2011)
reported that Cloisite® Na+ induced intracellular ROS formation,
which coincided with increased cell membrane damage, while
ROS generation did not play a role in Cloisite 93A-induced cell
death in human hepatoma cells (HepG2). By contrast, Sharma
et al. (2010) found that Cloisite® Na+ and Cloisite® 30B did not
produce ROS in a cell-free test system at the concentrations
assayed (0–226 μg ml–1).
Furthermore, no genotoxicity was found in the present work
for Cloisite® 30B in the comet assay on Caco-2 cells exposed to
10, 20 and 40 μg ml–1 for 24 and 48 h. However, higher concen-
trations of unﬁltered and ﬁltered Cloisite® 30B samples (113 and
170 μg ml–1) were found to be genotoxic in a concentration-
related manner in the same cell line (Sharma et al., 2010).
Moreover, genotoxic effects of different clays (bentonite
kaolinite, quartz and exfoliated silicate nanoclay) on several ex-
perimental models have been previously reported (Gao et al.,
2000; Geh et al., 2006b; Li et al., 2010; Meibian et al., 2011).
Despite several morphological studies have been conducted
on animals and cell lines exposed to montmorillonite, to our
knowledge, this is the ﬁrst work reporting ultrastructural
changes in the intestinal cell line Caco-2 exposed to two differ-
ent types of clays. The most remarkable morphological changes
observed in the present work were degraded mitochondria,
increase in the presence of lipid drops, dilated cisternae edge
in the Golgi apparatus and nucleolar segregation. The nucleolar
segregation found in the present study was previously described
in HeLa cells treated with 2 μg ml–1 actinomycin D for 5 h, in
which a segregated nucleolus with the ﬁbrillar component
forming a cap-like structure in the nucleolar periphery, sepa-
rated from the granular component was observed (Rendón
et al., 1992). Actinomycin D is known to inhibit the synthesis of
proteins by inhibiting the rRNA synthesis (Rendón et al., 1992);
therefore, considering the similarities in ultrastructural ﬁndings
observed in our work, they could be due to inhibition in the
synthesis of protein caused by montmorillonite; although it has
not been conﬁrmed. Consequently, to this inhibition, impair-
ment in the secretory functions has been observed in the dilata-
tion of the Golgi apparatus, probably due to the accumulation of
glycoprotein. Ratcliffe et al. (1985) reported accumulation of
glycoprotein in the Golgi apparatus in chondrocytes treated
with monensin, as it interferes with intracellular translocation
of secretory proteins in many different cell types inhibiting trans-
port within the Golgi complex.
Moreover, in vivo morphological studies have reported that a
non-modiﬁed montmorillonite used to pharmaceutical purposes
was non-toxic to Wistar rats (Lee et al., 2005). Additionally,
copper bearing montmorillonite dietary exposed to pigs and
broilers Q21may improve small intestinal mucosal morphology (Xu
et al., 2003; Xia et al., 2005). However, in vitro studies have
evidenced cell damage induced by clays. In this sense, Murphy
et al. (1993a) performed a similar assay on HUVEC, N1E-115
and ROC1 cells exposed to 100 μg ml–1 of aluminum silicate-
containing montmorillonites showed morphological alterations
with cell death, as well as an increase in the release of fatty acids
and decrease of cell viability measured by Trypan Blue exclusion
after 24 h of exposure. This research Q22group also reported cell
lyses in neuronal cultures within 60 min following exposure to
aluminum silicate-containing bentonite and montmorillonite
(Murphy et al., 1993b). Moreover, Banin and Meiri (1990)
reported clear morphological signs of cell deterioration in
murine neuroblastoma cells exposed to montmorillonite. In ad-
dition, bentonite samples induced necrotic as well as apoptotic
cell death in human lung ﬁbroblasts, although in the morpho-
logical study, no cell organelles were affected (nucleus, mito-
chondria or endoplasmic reticulum) after 24 h of exposure to
10 μg cm–2 of bentonite (Geh et al., 2006a). In the present work,
the laminar structure observed in the heterophagosome could
correspond to agglomerated clay. In this sense, Woodworth
et al. (1982) also observed by scanning electron microscope
and phase contrast microscopy that tracheal epithelial cells
exposed to montmorillonite phagocytized the particle. More-
over, they reported that cells containing intracellular particles
demonstrated retraction of lamellopoidal extensions, surface
blebbing and a changed morphology from ﬂattened to round
(Woodworth et al., 1982). In addition, Geh et al. (2006a) reported
that activated bentonite particles are better taken up by human
lung cells than untreated (native) bentonite particles. Concerning
intestinal cells, the uptake of compounds in the gastrointestinal
tract depends on diffusion and accessibility through mucus, ini-
tial contact with the gut epithelium and various uptake and
translocation processes (Bouwmeester et al., 2009). Once they
pass the gastrointestinal epithelium and end up in the blood
circulation, they are distributed around the body (Nemmar
et al., 2002). In the present study, the concentrations assayed
are lower than those used in the manufacture of food contact
materials and consequently human contact with toxic concentra-
tions is feasible considering the worst case scenario of exposure.
Considering that polymer nanocomposites used as food contact
materials contain 4% of clay, a rigid packaging of 20 g (a small
bottle) would contain 0.8 g of clay. Our results have shown that
250 μg ml–1 in the well of a cell culture plate, which is 50 μg
Cloisite 30B, induce a high cytotoxicity. In addition, EFSA (2011)
considers that in the absence of exposure data (as in our case),
and where it is not possible to determine the nanoform in the
food matrix, it should be assumed that all added nanomaterial
is present, ingested and absorbed in the nanoform. Therefore, if
the clay contained in the polymer reaches the consumer, the
S. Maisanaba et al.
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potential of toxic effects is not negligible. Our results indicate that
a case by case toxicological evaluation of clays is needed as
modiﬁers change their toxicity proﬁle. Moreover, further research
is required to clarify the uptake of the clay into the cell as well as
its kinetics for a better understanding of its toxic mechanism.
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Abstract 25 
Nowadays, the incorporation of organomodified clays based on montmorillonite into polymers 26 
intended for packaging industry is a reality. The final result is a polymer nanocomposite with 27 
enhanced barrier properties. Different organomodified clays are already commercially available 28 
and others new ones are being developed, however little is known about their safety. 29 
In the present work, the cytotoxic effects (a tetrazolium salt reduction and protein content) of 30 
three organomodified clays, Cloisite®20A, a commercial clay, and Clay 1 and Clay 2, two novel 31 
modified clays developed by the Packaging, Transport, & Logistics Research Institute, were 32 
evaluated in Caco-2 and HepG2 cells after 24 and 48h of exposure. Our results showed that only 33 
Clay 2 induced toxic effects in both cell lines. The mean effective concentration was calculated for 34 
each case, showing Caco-2 to be more sensitive than HepG2. Moreover, in order to elucidate the 35 
toxicity mechanisms of Clay 2, different mechanistic biomarkers were investigated. Interleukin 36 
leakage and generation of intracellular reactive oxygen species was not observed, whereas 37 
glutathione content decreased in HepG2. DNA damage (comet assay) was induced in both cell 38 
lines at the highest concentration tested. Overall, results show that the type of clay, the 39 
concentrations range and the type of cell line play an important role in the toxicity observed. 40 
 41 
Keywords: clay, montmorillonite, cytotoxicity, cell lines, DNA damage 42 
 43 
44 
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1. Introduction 45 
 46 
Over the last decades, the use of polymers as food packaging materials has increased 47 
enormously due to their advantages over other traditional materials (Jordan et al., 2005; Silvestre 48 
et al., 2011). Latest innovations include the use of “improved” food contact materials, this is the 49 
addition of different reinforcements, for example nanoparticles, to the polymeric matrix in order to 50 
enhance the functional properties of packaging materials, and thus improve the shelf life of food 51 
and beverage products. The resulting nanocomposites are a multi-phase material in which the 52 
majority of the dispersed phase components have one or more dimensions of the order of 100 nm 53 
or less (SCENIHR, 2007). 54 
 55 
Smectite clays, such as montmorillonite (MMT), belong to the structural family called 2:1 56 
phyllosilicates, which present a structure composed by two tetrahedral layers formed by Si and O 57 
atoms, fused with an octahedral layer with aluminum and magnesium atoms bonded to oxygen 58 
and hydroxyl groups (Jordá-Beneyto et al., 2008). They are one of the main choices for designing 59 
polymer nanocomposites due to their low cost and rich intercalation chemistry allowing them to 60 
be chemically modified (organoclays) and to improve the compatibility with the polymer matrix 61 
(Bitinis et al., 2011). Once the final clay nanocomposites are ready, the resulting material 62 
presents a specific disposition of the clays, such as platelets, giving a tortuous path to the gas 63 
permeant, forcing it to travel a longer path to diffuse through the film (Nielsen, 1967). Several 64 
authors reviewed the advantages, and in few cases the limitations, of the layered 65 
nanocomposites. Great improvements in thermal, mechanical and barrier (permeability) 66 
properties are presented, as well as strength, stiffness, dimensional stability, and heat resistance 67 
(De Azeredo, 2009; Duncan et al., 2011; Hatzigrigoriou et al., 2011; Hetzer et al., 2008). 68 
Moreover, they also offer good barrier properties under different packing, handling, shipping, and 69 
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storage conditions (Avella et al., 2005; Brody, 2006; Ray et  al., 2006; Timoty and Duncan 2011; 70 
Volpe, 2005), therefore they could improve the quality and safety of packaged food 71 
(Lagaron,2006). 72 
 73 
Although there is a lot of evidence for the good technological performance of nanocomposites, 74 
safety issues are also of importance. Available data on clay’s toxicity is still scarce, but different 75 
authors have already described toxic effects induced by montmorillonite and organoclays 76 
(Gutiérrez-Praena et al., 2013; Lordan et al., 2011; Maisanaba et al., 2013a,c; Sharma et al., 77 
2010). Moreover, the modifier used to synthesize the organoclay has a role in the toxicity 78 
observed (Maisanaba et al., 2013a). 79 
 80 
In the case of organoclays, Tthe oral pathway is the most important entrance route for the 81 
consumers, as they are exposed to the possible migrants from packaging nanocomposites to the 82 
food products, and they should know the possible effects of the ingestion of these 83 
nanosubstances to the gastrointestinal tract (Silvestre et al., 2011). When the nanoparticles reach 84 
the blood circulation, the liver is among the main organs for distribution (SCENIHR, 2009), so for 85 
clays imbued in the nanocomposite material this possibility cannot be discarded. 86 
 87 
Taking into account that the production of nanocomposites is going to increase in the near future, 88 
the human exposure will also increase. Therefore, potential toxic effects should be investigated in 89 
order to guarantee the safety of the food products. 90 
 91 
The aim of this study is to evaluate the toxicity of three modified montmorillonite clays used in the 92 
production of nanocomposites with applications as food contact materials in two target human cell 93 
lines of the digestive system, Caco-2 and HepG2 from intestinal and hepatocellular origin, 94 
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respectively. For this issue, basal cytotoxicity biomarkers and mechanistic biomarkers of 95 
inflammation, oxidative stress and genotoxicity have been investigated with Cloisite®20A, a 96 
commercial clay, and Clay 1 and Clay 2, two novel modified organoclays developed by the 97 
Technological Institute of Packaging, Transport and Logistics (ITENE). 98 
 99 
2. Materials and Methods 100 
 101 
2.1. Supplies and Chemicals 102 
Culture medium, fetal bovine serum and cell culture reagents were obtained from BioWhittaker 103 
(Spain). Chemicals for the different assays were provided by Sigma-Aldrich (Spain) and VWR 104 
International Eurolab (Spain). Protein reagent assay was obtained from BioRad (Spain). 105 
 106 
2.2. Clays 107 
Clay1 and Clay2 are two novel microsized clays that have been developed and characterized by 108 
Thermogravimetric Analysis (TGA) and Fourier Transform InfraRed (FTIR), as described in 109 
Maisanaba et al, (2013b) and Jordá-Beneyto et al., (2008, 2013).Clay 1 contains as modifier 110 
quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) and Clay 2 contains 111 
HDTA and acetylcholine chloride (ACO). Both clays are obtained by cation exchange reaction 112 
from Cloisite®Na+ (Southern Clay Products, INC.). This raw clay has a typical dry particle size 113 
less than 25μm (d50). Cloisite®20A was also obtained from Southern Clay Products, INC. 114 
(modifier: dimethyl, dehydrogenated tallow, quaternary ammonium, concentration: 95 meq/100g 115 
clay). This modified clay has a typical dry particle size less than 10μm (d50) and has been 116 
characterized by Thermogravimetric Analysis (TGA) and Fourier Transform InfraRed (FTIR).  117 
TGA analysis of Cloisite®20A and Cloisite®Na+ (the original non-modified clay included as 118 
control) were performed on a Q5000IR thermobalance (TA Instruments) by heating the samples 119 
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from room temperature up to 900 °C with heating rate of 10 °C/min, in nitrogen atmosphere. 120 
Approximately 7 mg of each finely ground sample was heated in a platinum crucible. 121 
 122 
FTIR Spectra were obtained on an Equinox 55 spectrometer (Bruker), coupled to a microscope 123 
modulus with ATR objetive (Hiperion, Bruker). This technique was used to characterize both clays 124 
Cloisite®Na+ and Cloisite®20A. For each sample 128 scans were recorded with a resolution of 4 125 
cm-1. 126 
 127 
2.3. Model systems 128 
Caco-2 cell line derives from a human colon carcinoma (ATCC® HTB-37) and HepG2 is a human 129 
hepatocellular carcinoma epithelial cell line (ATCC® HB-8065). Both of them were obtained from 130 
the American Type Culture Collection. Caco-2 cell line was maintained in   Eagle’s medium 131 
(EMEM) supplemented with 10% fetal bovine serum (FBS), 1% non-essential amino acids, 50 132 
μg/mL gentamicine, 2 mM L-glutamine, and 1 mM pyruvate. HepG2 cell line was maintained in 133 
EMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells 134 
were grown near confluence in 75-cm2 plastic flasks at 37ºC in an atmosphere containing 5% 135 
CO2 at 95% relative humidity (CO2 incubator, NuAire®, Spain) and harvested weekly with 0.25% 136 
trypsin. They were counted in an improved Neubauer haemocytometer and viability was 137 
determined by the Trypan Blue exclusion test. The cells were used at passages between 10 and 138 
21. Both cell lines were plated at a density of 7.5 x 105 cells/mL to perform all experiments. 139 
 140 
2.4. Clays test solutions 141 
Test concentrations of clays were determined individually in previous experiments in order to 142 
avoid interference with the method of measurement. With this purpose the absorbance of clay 143 
solutions (1000 µg/mL and serial ½ dilutions) were measured at 0, 24 and 48h. The 144 
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concentrations selected were the highest ones that did not show statistical differences versus the 145 
control. Thus, the maximum concentrations were 8 μg/mL for Clay 1, 125 μg/mL for Clay 2, and 146 
62.5 μg/mL for Cloisite®20A. Test solutions were prepared in serum-free medium. An ultrasonic 147 
tip (Dr. Hielscher, Germany) at an amplitude of 40% for a total time of 30 s was employed to 148 
disperse the test concentrations. 149 
 150 
2.5. Cytotoxicity assays 151 
From the initial solutions, serial dilutions in medium without serum were prepared. Culture 152 
medium without clay was used as control group. After replacing the previous medium, the 153 
exposure solutions were added to the systems, and incubated at 37ºC for 24 and 48 hours. The 154 
basal cytotoxicity endpoints assayed were tetrazolium salt reduction (MTS) and protein content 155 
(PC).  156 
 157 
MTS reduction is carried out by dehydrogenases, enzymes present in mitochondria, making this 158 
endpoint a good marker for the damage induced in this organelle. MTS reduction was measured 159 
according to the procedure of Baltrop et al. (1991). The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-160 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium salt) added to the medium is reduced 161 
by the enzymes to a colored formazan product soluble in culture medium and is measured by a 162 
spectrophotometer at 490 nm after 2 hours of incubation in the dark. 163 
 164 
Protein content (PC) is a very useful endpoint to assess cytotoxicity, since it gives data about cell 165 
damage with independence of the toxic mechanism involved (Pichardo et al. 2007). PC was 166 
quantified in situ, according to the procedure given by Bradford (1976), using Coomassie Brilliant 167 
Blue G-250 in the same 96-well tissue culture plates in which exposure originally took place, in 168 
order to determine the total cell number present in the wells. The culture medium was replaced by 169 
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200 μL NaOH and after 2 h of incubation at 37ºC, 180 μL were replaced by the same volume of a 170 
22% Coomassie Brilliant Blue G-250 solution. After 30 min incubation at room temperature, 171 
absorbance was read at 595 nm in a microplate spectrophotometer (Tecan Infinite M200, 172 
Austria). 173 
 174 
2.6. Oxidative stress assays  175 
Considering that only Clay 2 showed remarkable cytotoxic effects, this clay was chosen to 176 
perform mechanistic studies. For this purpose low cytotoxic concentrations were selected: 0, 8.5, 177 
17 and 34 μg/mL for Caco-2 cells and 22, 44 and 88 µg/mL for HepG2 cultures. These 178 
concentrations correspond to the mean effective concentration (EC50) value obtained for the most 179 
sensitive cytotoxicity endpoint at 24h along with the fractions EC50/2 and EC50/4. After replacing 180 
the previous medium, the exposure solutions were added to the cells, and incubated at 37ºC for 181 
24 and 48 hours. Culture medium without clay was used as control group. The oxidative stress 182 
endpoints measured were reactive oxygen species (ROS) content and glutathione (GSH) levels. 183 
 184 
The production of ROS was assessed in 96 well microplates using the dichlorofluorescein (DCF) 185 
assay. The probe 2’,7’-dichlorofluorescein diacetate (DCFH-DA) (Molecular probes, Invitrogen) 186 
readily diffuses through the cell membrane and is hydrolyzed by intracellular esterases to non-187 
fluorescent compound (DCFH), which is rapidly oxidized in the presence of ROS to the highly 188 
fluorescent DCF. Specifically, cells were incubated with 200 µl 20 µM DCFH-DA in culture 189 
medium at 37ºC for 30 min, and then washed with phosphate buffered saline (PBS) and 190 
resuspended in 200 µl of PBS. The formation of the fluorescence oxidized derivative of DCF-DA 191 
was monitored at emission wavelength of 535 nm and excitation wavelength of 485 nm. ROS 192 
production was expressed as fluorescence arbitrary units (Puerto et al. 2010). 193 
 194 
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GSH content in cells was evaluated by reaction with the fluorescent probe monochlorobimane 195 
(mBCl, Molecular probes, Invitrogen) (Jos et al. 2009). This molecule forms a thioether adduct 196 
with GSH in a reaction catalyzed by the enzyme GST. After the cell exposure to the clay, medium 197 
was discarded and cells were incubated at 37°C for 20 min in the presence of 40 μM mBCl. Later 198 
on, cells were washed with PBS and the fluorescence was recorded in a spectrofluorometer 199 
(Biotek, USA) at the excitation/emission wavelengths of 380/460 nm. Results were expressed as 200 
arbitrary units. 201 
 202 
2.7. Interleukin-6 leakage 203 
For this assay, the culture medium of the cells after 24 and 48h exposure to Clay 2 was used. 204 
Manufacturer instructions from the kit (EH2IL6, Thermo Scientific, USA) were followed.   205 
 206 
2.8. Comet assay 207 
The comet assay was performed to detect DNA strand breaks. The cells lines were seeded into 208 
12-well tissue culture treated plates (Corning Costar Corporation, New York, USA) and left 209 
overnight at 37ºC in 5% CO2 to attach to the plates. Approximately 3.5×105 Caco-2 or HepG2 210 
cells were exposed to different concentrations of Clay 2: 0, 8.5, 17, 34 µg/ml and 0, 22, 44 an 88 211 
µg/ml, respectively, for  24 and 48 h. 212 
 213 
In order to monitor the ongoing process of the assay, a negative control (cells treated with culture 214 
medium) and a positive control (cells treated with a solution of 100 µM H2O2) were included. After 215 
treatments cells were washed and detached in PBS. The comet assay was applied as previously 216 
described by Collins et al. (1997) with modifications (Corcuera et al., 2011). Briefly, cells were 217 
resuspended in PBS at a concentration of 2.5x106 cells/mL. This suspension was mixed with 1% 218 
low melting point agarose and placed on a microscope slide (12 gels per slide). Once the gels 219 
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became solid, the slides were dipped into lysis solution at 4ºC. All nucleotides were denatured in 220 
a high-pH buffer. Electrophoresis was carried out at approximately  25 V (300 mA, ~ 1V/cm),and 221 
the DNA was gently reneutralized in PBS and washed in H2O. After neutralization, microscope 222 
slides are fixed in 96% ethanol and absolute ethanol. Finally, DNA was stained with SYBR Gold 223 
nucleic acid gel stain and was visualized with an Olympus BX61 fluorescence microscope (20× 224 
objective) coupled via a CCD camera to an image-analysis system (DP controller-DP manager). 225 
Images of randomly selected nuclei (≥100) per experimental point were analyzed with the image 226 
analysis software (Comet Assay IV, Perceptive Instruments, UK). The results from four 227 
independent experiments are expressed as % of tail DNA. 228 
 229 
2.9. Calculations and statistical analysis 230 
All experiments were performed at least three times and at least in duplicate per concentration 231 
(n=3). Data for the concentration-dependent cytotoxicity relationships of all experiments were 232 
presented as the arithmetic mean percentage ± standard deviation (SD) in relation to control. 233 
Statistical analysis was carried out with GraphPad InStat3 software (La Jolla, CA, USA) using 234 
analysis of variance (ANOVA), followed by Dunnett’s multiple comparison tests. This test 235 
compares the response of the different exposure concentrations versus the controls. Previous to 236 
ANOVA, normality was checked with Kolmogorov–Smirnov test (p>0.05) and variance 237 
homogeneity among groups assessed with Bartlett's homocedasticity test (p>0.05). Differences 238 
among groups were considered significant atfrom Pp<0.05.  239 
 240 
EC50 values (mean effective concentration, concentration that modified each biomarker by 50%, 241 
positive or negative, in comparison with appropriate untreated controls) were derived by linear 242 
regression in the concentration-response curves. 243 
 244 
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3. Results 245 
3.1. Characterization of Cloisite®20A 246 
TGA results of both clays (Cloisite®Na+ as control and Cloisite®20A) are presented in Figure 1. 247 
Loss weight percent (%), and derivative weight (%/°C) are presented versus temperature. It can 248 
be observed that only the sample Cloisite®20A has a big loss step in the range between 200 and 249 
500 ºC, indicating that an organic compound is being released in this stepdescomposed. The 250 
percentage of organic modifier in Cloisite®20A is 24.87 % w/w, as calculated in the TGA curves. 251 
Cloisite®Na+ hardly presents any weight change in this range of temperature.  252 
The presence of modifiers in the clays was determined by FTIR. The ATR spectra are shown in 253 
Figure 2. Characteristic Si-O stretching vibration band of the unmodified montmorillonite (cloisite 254 
Na+) occurs at  1030 cm-1, whereas in the spectra of the corresponding organoclay (cloisite20A) 255 
the band appears slightly shifted (1000 cm-1)(Madejova, 2003) It can be observed the presence of 256 
a peak under 1200 cm-1 which corresponds to Si-O absorptions and OH bands that are typical of 257 
clay minerals. Inner hydroxyl groups, lying between the tetrahedral and octahedral sheets, gives 258 
the absorption near 3620 cm-1, as it can be seen in both spectra in Figure 2. The C-H stretching 259 
bands of alkylammnium cations occur in the range of 3020-2800 cm-1. The C-H stretching Two 260 
strong bands atnear 2930 cm-1 and at 2850 cm-1 are present in spectra of Cloisite®20A, which is 261 
a organo-modified clay. A characteristic C-H bending vibration of the (CH3)4N+ cation at 1487 262 
cm-1 is seen in the spectrum of the modified clay, which corresponds with the alkylammonium 263 
modifier in this clay. The spectrum of Cloisite®Na+ does not present these peaks, showing that in 264 
this clay there is no presence of any organic modifier. 265 
 266 
3.2. Cytotoxicity assays 267 
MTS reduction performed by Caco-2 and HepG2 cells exposed to Clay 1 remained unaltered with 268 
respect to the control cells after 24 and 48 h (Fig. 3a & 3b). In respect to PC, Caco-2 cell line 269 
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showed no alterations at 24 h, whereas at 48 h only experienced a significant ( p<0.05)  decrease 270 
respect to the control at 8 µg/mL (Fig. 3c). In the case of HepG2 cells, PC did not show 271 
significant changes with respect to the control after both exposure times, except at the highest 272 
concentration assayed in both cases (Fig. 3d). * p<0.05 significantly different from control. 273 
 274 
On the other hand, the MTS assay with Clay 2 presented a significant ( p<0.05)  decrease from 275 
30 µg/mL at both exposure times in Caco-2 cell line (Fig. 4a). Similarly, MTS reduction in HepG2 276 
cells presented a decrease from the concentration of 62.5 µg/mL after both exposure times, with 277 
significant differences at 48h (Fig. 4b). Moreover, Caco-2 cells showed a concentration and time-278 
dependent decrease in PC, with significant (p<0.05)  reductions in cell viability from10 µg/mL 279 
onwards in cells exposed for 24 h and from 5µg/mL onwards after 48 h of exposure (Fig. 4c). 280 
Concerning to HepG2 cells, significant (p<0.05) changes appeared at the highest concentration 281 
assayed after 24 h, and from 62.5 µg/mL after 48 h (Fig. 4d). * p<0.05 significantly different from 282 
control. 283 
 284 
 285 
Regarding to Cloisite®20A, both cytotoxicity biomarkers assayed in Caco-2 and HepG2 cell lines, 286 
MTS (Fig. 5a & 5b) and PC (Fig. 5c & 5d), remained unaltered at any concentration assayed in 287 
respect to control cells after 24 and 48 h. 288 
 289 
EC50 values could be obtained for Clay 2 only, showing a higher toxicity at the longest exposures 290 
(Table 1). Moreover, these data indicate that, in relation to cytotoxicity, Caco-2 cells have a 291 
higher sensitivity than HepG2 cells, as EC50 values are lower. 292 
 293 
3.2. Oxidative stress assays 294 
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When Caco-2 or HepG2 cells were exposed to Clay 2 during 24 and 48 h, no significant alteration 295 
on ROS was observed at any of the exposure concentrations in comparison to the control group 296 
(Fig. 6a & 6b). Similarly, GSH content was not affected when Caco-2 was exposed to Clay 2 (Fig. 297 
7a) In contrast, GSH content significantly (p<0.01) depleted in HepG2 cells, especially from 44 298 
µg/mL onwards. The percentage of GSH for 44 µg/ml was 8 fold lower in comparison to the 299 
control group (Fig. 7b). ** p<0.01 significantly different from control. 300 
3.3. IL-6 leakage 301 
The IL-6 assay showed no increase in the IL-6 content in the cell culture medium of the 302 
cytotoxicity assays in any of the treatments performed (data not shown). 303 
 304 
3.4. Comet assay 305 
Cloisite®20A and Clay 1 did not induce DNA strand-breaks in Caco-2 and Hep-G2 cells at the 306 
concentrations tested after 24 and 48h of exposure (Fig. 8 and 9). In regard to Caco-2 cells 307 
exposed to 8.5 and 17 µg/mL of Clay 2, no significant variations of the DNA strand breaks were 308 
detected after 24 h and 48 h of exposure. However, the highest exposure concentration (34 309 
µg/mL) led to a significant (p<0.05) increase of DNA in the tails, compared to the control (Fig. 310 
10a). The percentage of DNA in the tail with this concentration was not significantly different from 311 
the results obtained for the positive control H2O2( * p<0.05 significantly different from control). In 312 
treated HepG2 cells a significant (p<0.01)  increase of DNA damage was observed after 24h 313 
exposure at the highest concentration only (88 µg/mL). In contrast, after 48h, a significant 314 
increase of DNA strand breaks was detected in cells exposed to 44 (p<0.05) and 88 (p<0.01) 315 
µg/mL (Fig. 10b). The percentage of DNA in the tail for 44 and 88 µg/mL was 3.5 and 13 fold 316 
higher respectively, in comparison to the control group. * p<0.05 **p<0.01 significantly different 317 
from control. 318 
 319 
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4. Discussion 320 
The use of modified clays is a great option to obtain nanocomposites with improved properties 321 
that have been shown to be very useful in food packaging applications. Massive quantities of 322 
nanomaterials would need to be produced, thereby increasing the potential risk of human 323 
exposure and raising additional concern about their short and long term toxicological effects 324 
(Hussain et al., 2009). Due to this lack of information, a specific toxicity assessment of these 325 
materials and their precursors (non modified and chemically organomodified clays) is necessary. 326 
Therefore, in the present study, biochemical alterations with three different montmorillonite-based 327 
clays, all of them chemically modified with quaternary ammonium salts; a commercial one, 328 
Cloisite®20A, and two developed by ITENE, Clay 1 and Clay 2, were studied in the human cell 329 
lines Caco-2 and HepG2. The results obtained showed that, at the concentrations assayed, the 330 
main cytotoxic effects are induced by Clay 2 with a time-dependent pattern. Nevertheless, the 331 
toxicity assessment of Cloisite®20A and Clay 1 showed no toxic (cytotoxic and genotoxic) effects 332 
at the concentrations assayed, although they were lower than those used for Clay2.In this sense, 333 
the importance of the modifiers that are used to improve the compatibility with the polymer matrix 334 
must be highlighted. The incorporation of ACO in Clay 2 structure could be related with the 335 
different toxicity profile of Clay 1 and Clay 2 observed in both cell lines. ACO provides a lower 336 
hydrophobicity to the clay that allows testing higher concentrations in the aqueous culture 337 
medium. When the same test concentration (8 µg/mL) of both clays is compared in Caco-2 cells, 338 
results are quite similar with a low decrease of viability. In HepG2 on the other hand, 8 µg/mL 339 
Clay 1 induced a significant decrease of protein content, but 8 µg/mL Clay 2 did not induce any 340 
effect. Unfortunately, higher concentrations of Clay 1 could be not assayed due to the presence 341 
of interferences with the measurement system. A similar comparison performed with the same 342 
concentration (62.5 µg/ml) of Clay 2 and Cloisite®20A shows the higher toxicity of Clay 2.  343 
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Others authors have evaluated the toxicity of the commercial non modified montmorillonite in the 344 
same cell lines (Gutierrez- Praena et al., 2011; Lordan et al., 2011; Maisanaba et al., 2013a,c; 345 
Sharma et al., 2010). The toxicity assays carried out by Lordan et al. (2011) with the commercial 346 
unmodified clay, designated as Cloisite®Na+ showed a significant cell viability decrease in all the 347 
concentrations assayed, from 1 to 1000 µg/mL, in the HepG2 cell line. These results do not 348 
agree with Maisanaba et al. (2013a,c), who observed that HepG2 and Caco-2 exposed to 349 
Cloisite®Na+ did not present higher significant reductions of viability with respect to the controls in 350 
the range of concentrations assayed, from 0-62.5 and 0-125 µg/mL, after 24 and 48h of 351 
exposure, respectively. Moreover, Sharma et al. (2010), did not obtain any cytotoxic effects in 352 
Caco-2 exposed to Cloisite®Na+, in agreement with our results. In this case, the concentration 353 
range used of the modified clays Cloisite®20A and Clay 1 showed the same behaviour compared 354 
to the starting material, unmodified montmorillonite, indicating that the modifiers employed could 355 
not involve changes in the safety profile of the modified clays. 356 
There are a limited number of toxicological studies in the literature about commercial modified 357 
clays in Caco-2 and HepG2. Lordan et al. (2011) also evaluated a commercial modified clay, 358 
Cloisite®93A, in the hepatic cell line, obtaining cytotoxic effects at all concentrations tested (1-359 
1000µg/mL). Other commercial modified montmorillonite, Cloisite®30B, has been evaluated in 360 
Caco-2 cells by Sharma et al. (2010). The research group evaluated filtered and unfiltered 361 
suspensions of Cloisite®30B. The results showed a notably cytotoxic effect at the highest 362 
concentrations assayed in both cases, reporting a 40% cell viability reduction at 226 µg/mL. The 363 
cytotoxic effects of this modified clay in Caco-2 and HepG2 have been also studied by our 364 
research group, obtaining cytotoxicity for all the biomarkers assayed, being the highest 365 
concentration assayed 250 and 500 µg/mL, respectively (Maisanaba et al., 2013a,c).  366 
 367 
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The results obtained showed that the intestinal cell line, Caco-2 was more sensitive in cytotoxicity 368 
parameters to the modified clays exposure. Thus, in the present study the EC50 (24h) for the PC 369 
assay calculated after Clay 2 exposure was 93 µg/mL for HepG2 and 34 µg/mL for Caco-2. 370 
These results agree with those obtained by the other authors, that also observed a higher 371 
sensitivity after exposure to Cloisite®30B in Caco-2, with an EC50 = 40µg/mL (Maisanaba et al., 372 
2013c) versus an EC50 = 88 µg/mL for HepG2 (Maisanaba et al., 2013a). However, biomarkers 373 
showed a different sensitivity in both cell lines, the PC was the most sensitive in Caco-2 whereas 374 
MTS was the most sensitive in HepG2. This could be related with their different origin and 375 
therefore to their different capacity to face toxic insults. 376 
 377 
Others authors have studied the cytotoxic effects of commercial clays in other target cell lines. 378 
Baek et al. (2012) evaluated the toxicity effects in human normal intestinal cells (INT-407) in a 379 
short and long term exposure, 24, 48, 72h, and, 10 days, to MMT. Thereby, a decrease in cell 380 
proliferation showed at all times assayed. On the one hand, significant differences in the short 381 
term assays were found above 100 µg/mL concentration levels, on the other hand, a significant 382 
inhibition of normal colony formation in the long term was observed at all concentrations tested. 383 
Even though, alterations in LDH release were only observed at the highest concentrations at 48 384 
and 72h. Li et al. (2010) also studied CHO cell viability, when exposed to 62.5 – 1000 µg/mL 385 
nanosilicate platelets, obtaining a slight decrease in MTT and LDH assays. Also, the oligo 386 
(styrene- co- acrylonitrile)- modified clay montmorillonite showed an increased LDH release 387 
activity and cell viability reduction at a concentration of 1g/L in mouse embryonic fibroblast (NIH 388 
3T3) cells and human embryonic kidney 293 (HEK 293) cells (Liu et al., 2011). 389 
 390 
Taking into account that Clay 2 showed a clear cytotoxic profile at the concentration range tested 391 
in comparison to Closite®20A and Clay 1, the toxic mechanisms of this organoclay were 392 
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considered to require further study. The implication of oxidative stress, inflammation or DNA 393 
damage, among others, could be related to micro and nanoparticles exposure (Bouwmeester et 394 
al., 2009). For this reason, levels of ROS and GSH were assayed in this study, obtaining only 395 
significant differences with respect to the control group on the GSH levels of HepG2. The results 396 
showed therefore a higher sensitivity of the HepG2 cell line to oxidative stress biomarkers in 397 
contrast to the results obtained in the cytotoxicity study. Other authors have previously reported 398 
that HepG2 cells are generally more susceptible to oxidant-induced stress than Caco-2 cells 399 
(Martin et al., 1997). Our research group has also observed a deep decrease in GSH content in 400 
HepG2 exposed to Cloisite®30B at all timepoints assayed, however no changes were observed 401 
in ROS levels (Maisanaba et al., 2013a). This might be due because GSH have many biological 402 
functions apart from ROS scavenging such as signal transduction, gene expression and 403 
apoptosis, etc. (Sies 1999). Moreover, Sharma et al. (2010) also reported that Closite®Na+ and 404 
Closite®30B did not induce ROS production in Caco-2, in agreement with our results for those 405 
clays (Maisanaba et al., 2013a) and although there was no change in ROS levels they observed 406 
genotoxic effects. By contrast, Lordan et al. (2011) reported that Cloisite®Na+ induced 407 
intracellular ROS formation, whereas, the effect of Cloisite®93A in the generation of ROS was 408 
less prominent. Furthermore, Baek et al. (2012) evaluated the ROS production in INT-407 cells 409 
exposed to MMT, obtaining significant levels of ROS at the highest concentration (1000 µg/ mL) 410 
at all three timepoints assayed (24, 48 and 72h).  411 
 412 
Clay 2 did not induce leakage of IL-6, biomarker of an inflammatory response, in any of the cell 413 
lines. MMT, on the other hand, has been reported to rapidly lyses neutrophils and erythrocytes in 414 
vitro. Furthermore, it can stimulate chemiluminescence, the neutrophil oxidative metabolic burst 415 
(Dougherty et al., 1985). 416 
 417 
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In relation to genotoxicity, Clay 2 induced DNA strand breaks in both cell lines Moreover, Clay 2 418 
induced time-dependent increases of DNA strand breaks in HepG2 cells. Similar results were 419 
also found by Maisanaba et al., (2013a) for Cloisite30®B in HepG2 cells. Other authors evaluated 420 
the genotoxicity of other commercial clays in similar cell lines. Sharma et al. (2010), showed no 421 
DNA damage in Caco-2 exposed to unfiltered and filtered Cloisite®Na+ samples. Nevertheless, 422 
DNA damage was observed in the intestinal cell line Caco-2 exposed to Cloisite®30B from 113 423 
µg/mL after 24h. By contrast, the results obtained by Maisanaba et al., (2013c) with the intestinal 424 
cell line exposed to Cloisite®30B, did not coincide with the aforementioned research group, and 425 
this can be related with the lower concentrations tested in this case (10, 20 and 40 µg/mL). 426 
Maisanaba et al. (2013a), however, showed differences with respect to the control at the highest 427 
concentration assayed (88 µg/mL) in HepG2 after 48 h. In this case, it is difficult to compare 428 
because Sharma et al. (2010) only presented results after 24h, and at this concentration DNA 429 
damage in the intestinal cell line was not observed.  430 
Sharma et al. (2010), also indicated that the modifiers used to modify the clay contributed to the 431 
genotoxic effects, and these effects were not due to oxidative damage. In this sense, the absence 432 
of ROS obtained in this work after exposure to Clay 2 coincides with the Sharma´s hypothesis. 433 
On the other hand, Li et al. (2010) observed no genotoxic results in the comet assay with CHO 434 
cells exposed up to 1000µg/mL nanosilicate platelets derived from MMT.  435 
Regarding to in vivo toxicity data, there is no information about the three organoclays selected in 436 
the present study, but Li et al. (2010) did not reported acute oral toxicity of MMT in rats exposed 437 
to a single dose of 5700 mg/kg. Also Baek et al. (2012) did not find any remarkable toxicity in 438 
mice orally exposed to a single dose of 1000 mg/kg MTT. 439 
 440 
In summary, our results showed that at the concentrations assayed Cloisite®20A and Clay 1 did 441 
not induce cytotoxicity. Clay 2, however, showed cytotoxic and genotoxic effects, as well as an 442 
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alteration in GSH content. Therefore, a case by case toxicological assessment is required, as the 443 
modifier has a role in the toxicity observed. Moreover, a different sensitivity was observed 444 
depending on the cell line employed.  445 
More studies are required to elucidate the risks of these clays for human health as their use is 446 
going to increase widely in the near future.  447 
 448 
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Table captions 577 
Table 1. EC50 values (µg/mL) obtained after 24 and 48h exposure to Clay 2 in both cell lines. 578 
 579 
Figure captions 580 
Figure 1. TGA results for Cloisite®Na+ (round) and Cloisite®20A (square). 581 
 582 
Figure 2. FTIR results for Cloisite®Na+ (up) and Cloisite®20A (down). 583 
 584 
Figure 3. MTS tetrazolium salt reduction (a,b) and total protein content (c,d) of Caco-2 (a,c) and 585 
HepG2 (b,d) cells after 24h and 48h of exposure to 0-8 μg/mL Clay 1. Results from 3 independent 586 
experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. Differences 587 
were considered significant from p<0.05 (*).  588 
 589 
Figure 4. MTS tetrazolium salt reduction (a,b) and total protein content (c,d) of Caco-2 (a,c) and 590 
HepG2 (b,d) cells after 24h and 48h of exposure to 0-125 μg/mL Clay 2. Results from 3 591 
independent experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. 592 
Differences were considered significant from p<0.05 (*). 593 
 594 
Figure 5. MTS tetrazolium salt reduction (a,b) and total protein content (c,d) of Caco-2 (a,c) and 595 
HepG2 (b,d) cells after 24h and 48h of exposure to 0-62.5 μg/mL Cloisite®20A. Results from 3 596 
independent experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. 597 
Differences were considered significant from p<0.05 (*). 598 
 599 
Figure 6. ROS content (a) in Caco-2 cells after 24 and 48h of exposure to 8.5, 17, or 34 µg/mL 600 
Clay 2. ROS content (b) in HepG2 cells after 24 and 48h of exposure to 22, 44, or 88 µg/mL Clay 601 
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2. Results from 3 independent experiments with 3 replicates/experiment. All values are expressed 602 
as mean ± s.d.  603 
 604 
Figure 7. GSH content (a) in Caco-2 cells after 24 and 48h of exposure to 8.5, 17, or 34 µg/mL 605 
Clay 2. GSH content (b) in HepG2 cells after 24 and 48h of exposure to 22, 44, or 88 µg/mL Clay 606 
2. Results from 3 independent experiments with 3 replicates/experiment. All values are expressed 607 
as mean ± s.d. ** significantly different from control (p < 0.01). 608 
 609 
Figure 8. Comet assay results (a) of Caco-2  and (b) HepG2 cells after 24 and 48h of exposure to 610 
15.65, 31.25, or 62.5 µg/mL Cloisite®20A. Results from 3 independent experiments with 2 611 
replicates/experiment. All values are expressed as mean ± s.d. * significantly different from 612 
control (p < 0.05).  613 
 614 
Figure 9. Comet assay results (a) of Caco-2 and (b) HepG2 cells after 24 and 48h of exposure to 615 
2, 4 or 8 µg/mL Clay 1. Results from 3 independent experiments with 2 replicates/experiment. All 616 
values are expressed as mean ± s.d. * significantly different from control (p < 0.05).  617 
 618 
Figure 10. Comet assay results (a) of Caco-2 cells after 24 and 48h of exposure to 8.5, 17 , or 34 619 
µg/mL Clay 2. Comet assay results (b) of HepG2 cells after 24 and 48h of exposure to 22, 44 and 620 
88µg/mL. Results from 3 independent experiments with 2 replicates/experiment. All values are 621 
expressed as mean ± s.d. * significantly different from control (p < 0.05). ** significantly different 622 
from control (p ≤ 0.01). 623 
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Abstract 25 
Nowadays, the incorporation of organomodified clays based on montmorillonite into polymers 26 
intended for packaging industry is a reality. The final result is a polymer nanocomposite with 27 
enhanced barrier properties. Different organomodified clays are already commercially available 28 
and others new ones are being developed, however little is known about their safety. 29 
In the present work, the cytotoxic effects (a tetrazolium salt reduction and protein content) of 30 
three organomodified clays, Cloisite®20A, a commercial clay, and Clay 1 and Clay 2, two novel 31 
modified clays developed by the Packaging, Transport, & Logistics Research Institute, were 32 
evaluated in Caco-2 and HepG2 cells after 24 and 48h of exposure. Our results showed that only 33 
Clay 2 induced toxic effects in both cell lines. The mean effective concentration was calculated for 34 
each case, showing Caco-2 to be more sensitive than HepG2. Moreover, in order to elucidate the 35 
toxicity mechanisms of Clay 2, different mechanistic biomarkers were investigated. Interleukin 36 
leakage and generation of intracellular reactive oxygen species was not observed, whereas 37 
glutathione content decreased in HepG2. DNA damage (comet assay) was induced in both cell 38 
lines at the highest concentration tested. Overall, results show that the type of clay, the 39 
concentrations range and the type of cell line play an important role in the toxicity observed. 40 
 41 
Keywords: clay, montmorillonite, cytotoxicity, cell lines, DNA damage 42 
 43 
44 
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1. Introduction 45 
 46 
Over the last decades, the use of polymers as food packaging materials has increased 47 
enormously due to their advantages over other traditional materials (Jordan et al., 2005; Silvestre 48 
et al., 2011). Latest innovations include the use of “improved” food contact materials, this is the 49 
addition of different reinforcements, for example nanoparticles, to the polymeric matrix in order to 50 
enhance the functional properties of packaging materials, and thus improve the shelf life of food 51 
and beverage products. The resulting nanocomposites are a multi-phase material in which the 52 
majority of the dispersed phase components have one or more dimensions of the order of 100 nm 53 
or less (SCENIHR, 2007). 54 
 55 
Smectite clays, such as montmorillonite (MMT), belong to the structural family called 2:1 56 
phyllosilicates, which present a structure composed by two tetrahedral layers formed by Si and O 57 
atoms, fused with an octahedral layer with aluminum and magnesium atoms bonded to oxygen 58 
and hydroxyl groups (Jordá-Beneyto et al., 2008). They are one of the main choices for designing 59 
polymer nanocomposites due to their low cost and rich intercalation chemistry allowing them to 60 
be chemically modified (organoclays) and to improve the compatibility with the polymer matrix 61 
(Bitinis et al., 2011). Once the final clay nanocomposites are ready, the resulting material 62 
presents a specific disposition of the clays, such as platelets, giving a tortuous path to the gas 63 
permeant, forcing it to travel a longer path to diffuse through the film (Nielsen, 1967). Several 64 
authors reviewed the advantages, and in few cases the limitations, of the layered 65 
nanocomposites. Great improvements in thermal, mechanical and barrier (permeability) 66 
properties are presented, as well as strength, stiffness, dimensional stability, and heat resistance 67 
(De Azeredo, 2009; Duncan et al., 2011; Hatzigrigoriou et al., 2011; Hetzer et al., 2008). 68 
Moreover, they also offer good barrier properties under different packing, handling, shipping, and 69 
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storage conditions (Avella et al., 2005; Brody, 2006; Ray et  al., 2006; Timoty and Duncan 2011; 70 
Volpe, 2005), therefore they could improve the quality and safety of packaged food 71 
(Lagaron,2006). 72 
 73 
Although there is a lot of evidence for the good technological performance of nanocomposites, 74 
safety issues are also of importance. Available data on clay’s toxicity is still scarce, but different 75 
authors have already described toxic effects induced by montmorillonite and organoclays (Lordan 76 
et al., 2011; Maisanaba et al., 2013a,c; Sharma et al., 2010). Moreover, the modifier used to 77 
synthesize the organoclay has a role in the toxicity observed (Maisanaba et al., 2013a). 78 
 79 
In the case of organoclays, the oral pathway is the most important entrance route for the 80 
consumers, as they are exposed to the possible migrants from packaging nanocomposites to the 81 
food products, and they should know the possible effects of the ingestion of these 82 
nanosubstances to the gastrointestinal tract (Silvestre et al., 2011). When the nanoparticles reach 83 
the blood circulation, the liver is among the main organs for distribution (SCENIHR, 2009), so for 84 
clays imbued in the nanocomposite material this possibility cannot be discarded. 85 
 86 
Taking into account that the production of nanocomposites is going to increase in the near future, 87 
the human exposure will also increase. Therefore, potential toxic effects should be investigated in 88 
order to guarantee the safety of the food products. 89 
 90 
The aim of this study is to evaluate the toxicity of three modified montmorillonite clays used in the 91 
production of nanocomposites with applications as food contact materials in two target human cell 92 
lines of the digestive system, Caco-2 and HepG2 from intestinal and hepatocellular origin, 93 
respectively. For this issue, basal cytotoxicity biomarkers and mechanistic biomarkers of 94 
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inflammation, oxidative stress and genotoxicity have been investigated with Cloisite®20A, a 95 
commercial clay, and Clay 1 and Clay 2, two novel modified organoclays developed by the 96 
Technological Institute of Packaging, Transport and Logistics (ITENE). 97 
 98 
2. Materials and Methods 99 
 100 
2.1. Supplies and Chemicals 101 
Culture medium, fetal bovine serum and cell culture reagents were obtained from BioWhittaker 102 
(Spain). Chemicals for the different assays were provided by Sigma-Aldrich (Spain) and VWR 103 
International Eurolab (Spain). Protein reagent assay was obtained from BioRad (Spain). 104 
 105 
2.2. Clays 106 
Clay1 and Clay2 are two novel microsized clays that have been developed and characterized by 107 
Thermogravimetric Analysis (TGA) and Fourier Transform InfraRed (FTIR), as described in 108 
Maisanaba et al, (2013b) and Jordá-Beneyto et al., (2008, 2013).Clay 1 contains as modifier 109 
quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) and Clay 2 contains 110 
HDTA and acetylcholine chloride (ACO). Both clays are obtained by cation exchange reaction 111 
from Cloisite®Na+ (Southern Clay Products, INC.). This raw clay has a typical dry particle size 112 
less than 25μm (d50). Cloisite®20A was also obtained from Southern Clay Products, INC. 113 
(modifier: dimethyl, dehydrogenated tallow, quaternary ammonium, concentration: 95 meq/100g 114 
clay). This modified clay has a typical dry particle size less than 10μm (d50) and has been 115 
characterized by Thermogravimetric Analysis (TGA) and Fourier Transform InfraRed (FTIR).  116 
TGA analysis of Cloisite®20A and Cloisite®Na+ (the original non-modified clay included as 117 
control) were performed on a Q5000IR thermobalance (TA Instruments) by heating the samples 118 
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from room temperature up to 900 °C with heating rate of 10 °C/min, in nitrogen atmosphere. 119 
Approximately 7 mg of each finely ground sample was heated in a platinum crucible. 120 
 121 
FTIR Spectra were obtained on an Equinox 55 spectrometer (Bruker), coupled to a microscope 122 
modulus with ATR objetive (Hiperion, Bruker). This technique was used to characterize both clays 123 
Cloisite®Na+ and Cloisite®20A. For each sample 128 scans were recorded with a resolution of 4 124 
cm-1. 125 
 126 
2.3. Model systems 127 
Caco-2 cell line derives from a human colon carcinoma (ATCC® HTB-37) and HepG2 is a human 128 
hepatocellular carcinoma epithelial cell line (ATCC® HB-8065). Both of them were obtained from 129 
the American Type Culture Collection. Caco-2 cell line was maintained in   Eagle’s medium 130 
(EMEM) supplemented with 10% fetal bovine serum (FBS), 1% non-essential amino acids, 50 131 
μg/mL gentamicine, 2 mM L-glutamine, and 1 mM pyruvate. HepG2 cell line was maintained in 132 
EMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells 133 
were grown near confluence in 75-cm2 plastic flasks at 37ºC in an atmosphere containing 5% 134 
CO2 at 95% relative humidity (CO2 incubator, NuAire®, Spain) and harvested weekly with 0.25% 135 
trypsin. They were counted in an improved Neubauer haemocytometer and viability was 136 
determined by the Trypan Blue exclusion test. The cells were used at passages between 10 and 137 
21. Both cell lines were plated at a density of 7.5 x 105 cells/mL to perform all experiments. 138 
 139 
2.4. Clays test solutions 140 
Test concentrations of clays were determined individually in previous experiments in order to 141 
avoid interference with the method of measurement. With this purpose the absorbance of clay 142 
solutions (1000 µg/mL and serial ½ dilutions) were measured at 0, 24 and 48h. The 143 
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concentrations selected were the highest ones that did not show statistical differences versus the 144 
control. Thus, the maximum concentrations were 8 μg/mL for Clay 1, 125 μg/mL for Clay 2, and 145 
62.5 μg/mL for Cloisite®20A. Test solutions were prepared in serum-free medium. An ultrasonic 146 
tip (Dr. Hielscher, Germany) at an amplitude of 40% for a total time of 30 s was employed to 147 
disperse the test concentrations. 148 
 149 
2.5. Cytotoxicity assays 150 
From the initial solutions, serial dilutions in medium without serum were prepared. Culture 151 
medium without clay was used as control group. After replacing the previous medium, the 152 
exposure solutions were added to the systems, and incubated at 37ºC for 24 and 48 hours. The 153 
basal cytotoxicity endpoints assayed were tetrazolium salt reduction (MTS) and protein content 154 
(PC).  155 
 156 
MTS reduction is carried out by dehydrogenases, enzymes present in mitochondria, making this 157 
endpoint a good marker for the damage induced in this organelle. MTS reduction was measured 158 
according to the procedure of Baltrop et al. (1991). The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-159 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium salt) added to the medium is reduced 160 
by the enzymes to a colored formazan product soluble in culture medium and is measured by a 161 
spectrophotometer at 490 nm after 2 hours of incubation in the dark. 162 
 163 
Protein content (PC) is a very useful endpoint to assess cytotoxicity, since it gives data about cell 164 
damage with independence of the toxic mechanism involved (Pichardo et al. 2007). PC was 165 
quantified in situ, according to the procedure given by Bradford (1976), using Coomassie Brilliant 166 
Blue G-250 in the same 96-well tissue culture plates in which exposure originally took place, in 167 
order to determine the total cell number present in the wells. The culture medium was replaced by 168 
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200 μL NaOH and after 2 h of incubation at 37ºC, 180 μL were replaced by the same volume of a 169 
22% Coomassie Brilliant Blue G-250 solution. After 30 min incubation at room temperature, 170 
absorbance was read at 595 nm in a microplate spectrophotometer (Tecan Infinite M200, 171 
Austria). 172 
 173 
2.6. Oxidative stress assays  174 
Considering that only Clay 2 showed remarkable cytotoxic effects, this clay was chosen to 175 
perform mechanistic studies. For this purpose low cytotoxic concentrations were selected: 0, 8.5, 176 
17 and 34 μg/mL for Caco-2 cells and 22, 44 and 88 µg/mL for HepG2 cultures. These 177 
concentrations correspond to the mean effective concentration (EC50) value obtained for the most 178 
sensitive cytotoxicity endpoint at 24h along with the fractions EC50/2 and EC50/4. After replacing 179 
the previous medium, the exposure solutions were added to the cells, and incubated at 37ºC for 180 
24 and 48 hours. Culture medium without clay was used as control group. The oxidative stress 181 
endpoints measured were reactive oxygen species (ROS) content and glutathione (GSH) levels. 182 
 183 
The production of ROS was assessed in 96 well microplates using the dichlorofluorescein (DCF) 184 
assay. The probe 2’,7’-dichlorofluorescein diacetate (DCFH-DA) (Molecular probes, Invitrogen) 185 
readily diffuses through the cell membrane and is hydrolyzed by intracellular esterases to non-186 
fluorescent compound (DCFH), which is rapidly oxidized in the presence of ROS to the highly 187 
fluorescent DCF. Specifically, cells were incubated with 200 µl 20 µM DCFH-DA in culture 188 
medium at 37ºC for 30 min, and then washed with phosphate buffered saline (PBS) and 189 
resuspended in 200 µl of PBS. The formation of the fluorescence oxidized derivative of DCF-DA 190 
was monitored at emission wavelength of 535 nm and excitation wavelength of 485 nm. ROS 191 
production was expressed as fluorescence arbitrary units (Puerto et al. 2010). 192 
 193 
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GSH content in cells was evaluated by reaction with the fluorescent probe monochlorobimane 194 
(mBCl, Molecular probes, Invitrogen) (Jos et al. 2009). This molecule forms a thioether adduct 195 
with GSH in a reaction catalyzed by the enzyme GST. After the cell exposure to the clay, medium 196 
was discarded and cells were incubated at 37°C for 20 min in the presence of 40 μM mBCl. Later 197 
on, cells were washed with PBS and the fluorescence was recorded in a spectrofluorometer 198 
(Biotek, USA) at the excitation/emission wavelengths of 380/460 nm. Results were expressed as 199 
arbitrary units. 200 
 201 
2.7. Interleukin-6 leakage 202 
For this assay, the culture medium of the cells after 24 and 48h exposure to Clay 2 was used. 203 
Manufacturer instructions from the kit (EH2IL6, Thermo Scientific, USA) were followed.   204 
 205 
2.8. Comet assay 206 
The comet assay was performed to detect DNA strand breaks. The cells lines were seeded into 207 
12-well tissue culture treated plates (Corning Costar Corporation, New York, USA) and left 208 
overnight at 37ºC in 5% CO2 to attach to the plates. Approximately 3.5×105 Caco-2 or HepG2 209 
cells were exposed to different concentrations of Clay 2: 0, 8.5, 17, 34 µg/ml and 0, 22, 44 an 88 210 
µg/ml, respectively, for  24 and 48 h. 211 
 212 
In order to monitor the ongoing process of the assay, a negative control (cells treated with culture 213 
medium) and a positive control (cells treated with a solution of 100 µM H2O2) were included. After 214 
treatments cells were washed and detached in PBS. The comet assay was applied as previously 215 
described by Collins et al. (1997) with modifications (Corcuera et al., 2011). Briefly, cells were 216 
resuspended in PBS at a concentration of 2.5x106 cells/mL. This suspension was mixed with 1% 217 
low melting point agarose and placed on a microscope slide (12 gels per slide). Once the gels 218 
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became solid, the slides were dipped into lysis solution at 4ºC. All nucleotides were denatured in 219 
a high-pH buffer. Electrophoresis was carried out at approximately  25 V (300 mA, ~ 1V/cm),and 220 
the DNA was gently reneutralized in PBS and washed in H2O. After neutralization, microscope 221 
slides are fixed in 96% ethanol and absolute ethanol. Finally, DNA was stained with SYBR Gold 222 
nucleic acid gel stain and was visualized with an Olympus BX61 fluorescence microscope (20× 223 
objective) coupled via a CCD camera to an image-analysis system (DP controller-DP manager). 224 
Images of randomly selected nuclei (≥100) per experimental point were analyzed with the image 225 
analysis software (Comet Assay IV, Perceptive Instruments, UK). The results from four 226 
independent experiments are expressed as % of tail DNA. 227 
 228 
2.9. Calculations and statistical analysis 229 
All experiments were performed at least three times and at least in duplicate per concentration 230 
(n=3). Data for the concentration-dependent cytotoxicity relationships of all experiments were 231 
presented as the arithmetic mean percentage ± standard deviation (SD) in relation to control. 232 
Statistical analysis was carried out with GraphPad InStat3 software (La Jolla, CA, USA) using 233 
analysis of variance (ANOVA), followed by Dunnett’s multiple comparison tests. This test 234 
compares the response of the different exposure concentrations versus the controls. Previous to 235 
ANOVA, normality was checked with Kolmogorov–Smirnov test (p>0.05) and variance 236 
homogeneity among groups assessed with Bartlett's homocedasticity test (p>0.05). Differences 237 
among groups were considered significant at p<0.05.  238 
EC50 values (mean effective concentration, concentration that modified each biomarker by 50%, 239 
positive or negative, in comparison with appropriate untreated controls) were derived by linear 240 
regression in the concentration-response curves. 241 
 242 
3. Results 243 
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3.1. Characterization of Cloisite®20A 244 
TGA results of both clays (Cloisite®Na+ as control and Cloisite®20A) are presented in Figure 1. 245 
Loss weight percent (%), and derivative weight (%/°C) are presented versus temperature. It can 246 
be observed that only the sample Cloisite®20A has a big loss step in the range between 200 and 247 
500 ºC, indicating that an organic compound is decomposed. The percentage of organic modifier 248 
in Cloisite®20A is 24.87 % w/w, as calculated in the TGA curves. Cloisite®Na+ hardly presents 249 
any weight change in this range of temperature.  250 
The presence of modifiers in the clays was determined by FTIR. The ATR spectra are shown in 251 
Figure 2. Characteristic Si-O stretching vibration band of the unmodified montmorillonite (cloisite Na+) 252 
occurs at 1030 cm-1, whereas in the spectra of the corresponding organoclay (cloisite20A) the band 253 
appears slightly shifted (1000 cm-1)(Madejova, 2003). Inner hydroxyl groups, lying between the 254 
tetrahedral and octahedral sheets, gives the absorption near 3620 cm-1, as it can be seen in both 255 
spectra in Figure 2. The C-H stretching bands of alkylammnium cations occur in the range of 256 
3020-2800 cm-1. The C-H stretching bands at 2930 cm-1 and at 2850 cm-1 are present in spectra 257 
of Cloisite®20A, which is a organo-modified clay. A characteristic C-H bending vibration of the 258 
(CH3)4N+ cation at 1487 cm-1 is seen in the spectrum of the modified clay, which corresponds 259 
with the alkylammonium modifier in this clay. The spectrum of Cloisite®Na+ does not present 260 
these peaks, showing that in this clay there is no presence of any organic modifier. 261 
 262 
3.2. Cytotoxicity assays 263 
MTS reduction performed by Caco-2 and HepG2 cells exposed to Clay 1 remained unaltered with 264 
respect to the control cells after 24 and 48 h (Fig. 3a & 3b). In respect to PC, Caco-2 cell line 265 
showed no alterations at 24 h, whereas at 48 h only experienced a significant (p<0.05) decrease 266 
respect to the control at 8 µg/mL (Fig. 3c). In the case of HepG2 cells, PC did not show 267 
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significant changes with respect to the control after both exposure times, except at the highest 268 
concentration assayed in both cases (Fig. 3d).  269 
 270 
On the other hand, the MTS assay with Clay 2 presented a significant (p<0.05) decrease from 30 271 
µg/mL at both exposure times in Caco-2 cell line (Fig. 4a). Similarly, MTS reduction in HepG2 272 
cells presented a decrease from the concentration of 62.5 µg/mL after both exposure times, with 273 
significant differences at 48h (Fig. 4b). Moreover, Caco-2 cells showed a concentration and time-274 
dependent decrease in PC, with significant (p<0.05) reductions in cell viability from10 µg/mL 275 
onwards in cells exposed for 24 h and from 5µg/mL onwards after 48 h of exposure (Fig. 4c). 276 
Concerning to HepG2 cells, significant (p<0.05) changes appeared at the highest concentration 277 
assayed after 24 h, and from 62.5 µg/mL after 48 h (Fig. 4d).  278 
 279 
 280 
Regarding to Cloisite®20A, both cytotoxicity biomarkers assayed in Caco-2 and HepG2 cell lines, 281 
MTS (Fig. 5a & 5b) and PC (Fig. 5c & 5d), remained unaltered at any concentration assayed in 282 
respect to control cells after 24 and 48 h. 283 
 284 
EC50 values could be obtained for Clay 2 only, showing a higher toxicity at the longest exposures 285 
(Table 1). Moreover, these data indicate that, in relation to cytotoxicity, Caco-2 cells have a 286 
higher sensitivity than HepG2 cells, as EC50 values are lower. 287 
 288 
3.2. Oxidative stress assays 289 
When Caco-2 or HepG2 cells were exposed to Clay 2 during 24 and 48 h, no significant alteration 290 
on ROS was observed at any of the exposure concentrations in comparison to the control group 291 
(Fig. 6a & 6b). Similarly, GSH content was not affected when Caco-2 was exposed to Clay 2 (Fig. 292 
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7a) In contrast, GSH content significantly (p<0.01) depleted in HepG2 cells, especially from 44 293 
µg/mL onwards. The percentage of GSH for 44 µg/ml was 8 fold lower in comparison to the 294 
control group (Fig. 7b).  295 
3.3. IL-6 leakage 296 
The IL-6 assay showed no increase in the IL-6 content in the cell culture medium of the 297 
cytotoxicity assays in any of the treatments performed (data not shown). 298 
 299 
3.4. Comet assay 300 
Cloisite®20A and Clay 1 did not induce DNA strand-breaks in Caco-2 and Hep-G2 cells at the 301 
concentrations tested after 24 and 48h of exposure (Fig. 8 and 9). In regard to Caco-2 cells 302 
exposed to 8.5 and 17 µg/mL of Clay 2, no significant variations of the DNA strand breaks were 303 
detected after 24 h and 48 h of exposure. However, the highest exposure concentration (34 304 
µg/mL) led to a significant (p<0.05) increase of DNA in the tails, compared to the control (Fig. 305 
10a). The percentage of DNA in the tail with this concentration was not significantly different from 306 
the results obtained for the positive control H2O2. In treated HepG2 cells a significant (p<0.01)  307 
increase of DNA damage was observed after 24h exposure at the highest concentration only (88 308 
µg/mL). In contrast, after 48h, a significant  increase of DNA strand breaks was detected in cells 309 
exposed to 44 (p<0.05) and 88 (p<0.01) µg/mL (Fig. 10b). The percentage of DNA in the tail for 310 
44 and 88 µg/mL was 3.5 and 13 fold higher respectively, in comparison to the control group.  311 
4. Discussion 312 
The use of modified clays is a great option to obtain nanocomposites with improved properties 313 
that have been shown to be very useful in food packaging applications. Massive quantities of 314 
nanomaterials would need to be produced, thereby increasing the potential risk of human 315 
exposure and raising additional concern about their short and long term toxicological effects 316 
(Hussain et al., 2009). Due to this lack of information, a specific toxicity assessment of these 317 
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materials and their precursors (non modified and chemically organomodified clays) is necessary. 318 
Therefore, in the present study, biochemical alterations with three different montmorillonite-based 319 
clays, all of them chemically modified with quaternary ammonium salts; a commercial one, 320 
Cloisite®20A, and two developed by ITENE, Clay 1 and Clay 2, were studied in the human cell 321 
lines Caco-2 and HepG2. The results obtained showed that, at the concentrations assayed, the 322 
main cytotoxic effects are induced by Clay 2 with a time-dependent pattern. Nevertheless, the 323 
toxicity assessment of Cloisite®20A and Clay 1 showed no toxic (cytotoxic and genotoxic) effects 324 
at the concentrations assayed, although they were lower than those used for Clay2.In this sense, 325 
the importance of the modifiers that are used to improve the compatibility with the polymer matrix 326 
must be highlighted. The incorporation of ACO in Clay 2 structure could be related with the 327 
different toxicity profile of Clay 1 and Clay 2 observed in both cell lines. ACO provides a lower 328 
hydrophobicity to the clay that allows testing higher concentrations in the aqueous culture 329 
medium. When the same test concentration (8 µg/mL) of both clays is compared in Caco-2 cells, 330 
results are quite similar with a low decrease of viability. In HepG2 on the other hand, 8 µg/mL 331 
Clay 1 induced a significant decrease of protein content, but 8 µg/mL Clay 2 did not induce any 332 
effect. Unfortunately, higher concentrations of Clay 1 could be not assayed due to the presence 333 
of interferences with the measurement system. A similar comparison performed with the same 334 
concentration (62.5 µg/ml) of Clay 2 and Cloisite®20A shows the higher toxicity of Clay 2.  335 
Others authors have evaluated the toxicity of the commercial non modified montmorillonite in the 336 
same cell lines (Gutierrez- Praena et al., 2011; Lordan et al., 2011; Maisanaba et al., 2013a,c; 337 
Sharma et al., 2010). The toxicity assays carried out by Lordan et al. (2011) with the commercial 338 
unmodified clay, designated as Cloisite®Na+ showed a significant cell viability decrease in all the 339 
concentrations assayed, from 1 to 1000 µg/mL, in the HepG2 cell line. These results do not 340 
agree with Maisanaba et al. (2013a,c), who observed that HepG2 and Caco-2 exposed to 341 
Cloisite®Na+ did not present higher significant reductions of viability with respect to the controls in 342 
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the range of concentrations assayed, from 0-62.5 and 0-125 µg/mL, after 24 and 48h of 343 
exposure, respectively. Moreover, Sharma et al. (2010), did not obtain any cytotoxic effects in 344 
Caco-2 exposed to Cloisite®Na+, in agreement with our results. In this case, the concentration 345 
range used of the modified clays Cloisite®20A and Clay 1 showed the same behaviour compared 346 
to the starting material, unmodified montmorillonite, indicating that the modifiers employed could 347 
not involve changes in the safety profile of the modified clays. 348 
There are a limited number of toxicological studies in the literature about commercial modified 349 
clays in Caco-2 and HepG2. Lordan et al. (2011) also evaluated a commercial modified clay, 350 
Cloisite®93A, in the hepatic cell line, obtaining cytotoxic effects at all concentrations tested (1-351 
1000µg/mL). Other commercial modified montmorillonite, Cloisite®30B, has been evaluated in 352 
Caco-2 cells by Sharma et al. (2010). The research group evaluated filtered and unfiltered 353 
suspensions of Cloisite®30B. The results showed a notably cytotoxic effect at the highest 354 
concentrations assayed in both cases, reporting a 40% cell viability reduction at 226 µg/mL. The 355 
cytotoxic effects of this modified clay in Caco-2 and HepG2 have been also studied by our 356 
research group, obtaining cytotoxicity for all the biomarkers assayed, being the highest 357 
concentration assayed 250 and 500 µg/mL, respectively (Maisanaba et al., 2013a,c).  358 
 359 
The results obtained showed that the intestinal cell line, Caco-2 was more sensitive in cytotoxicity 360 
parameters to the modified clays exposure. Thus, in the present study the EC50 (24h) for the PC 361 
assay calculated after Clay 2 exposure was 93 µg/mL for HepG2 and 34 µg/mL for Caco-2. 362 
These results agree with those obtained by the other authors, that also observed a higher 363 
sensitivity after exposure to Cloisite®30B in Caco-2, with an EC50 = 40µg/mL (Maisanaba et al., 364 
2013c) versus an EC50 = 88 µg/mL for HepG2 (Maisanaba et al., 2013a). However, biomarkers 365 
showed a different sensitivity in both cell lines, the PC was the most sensitive in Caco-2 whereas 366 
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MTS was the most sensitive in HepG2. This could be related with their different origin and 367 
therefore to their different capacity to face toxic insults. 368 
 369 
Others authors have studied the cytotoxic effects of commercial clays in other target cell lines. 370 
Baek et al. (2012) evaluated the toxicity effects in human normal intestinal cells (INT-407) in a 371 
short and long term exposure, 24, 48, 72h, and, 10 days, to MMT. Thereby, a decrease in cell 372 
proliferation showed at all times assayed. On the one hand, significant differences in the short 373 
term assays were found above 100 µg/mL concentration levels, on the other hand, a significant 374 
inhibition of normal colony formation in the long term was observed at all concentrations tested. 375 
Even though, alterations in LDH release were only observed at the highest concentrations at 48 376 
and 72h. Li et al. (2010) also studied CHO cell viability, when exposed to 62.5 – 1000 µg/mL 377 
nanosilicate platelets, obtaining a slight decrease in MTT and LDH assays. Also, the oligo 378 
(styrene- co- acrylonitrile)- modified clay montmorillonite showed an increased LDH release 379 
activity and cell viability reduction at a concentration of 1g/L in mouse embryonic fibroblast (NIH 380 
3T3) cells and human embryonic kidney 293 (HEK 293) cells (Liu et al., 2011). 381 
 382 
Taking into account that Clay 2 showed a clear cytotoxic profile at the concentration range tested 383 
in comparison to Closite®20A and Clay 1, the toxic mechanisms of this organoclay were 384 
considered to require further study. The implication of oxidative stress, inflammation or DNA 385 
damage, among others, could be related to micro and nanoparticles exposure (Bouwmeester et 386 
al., 2009). For this reason, levels of ROS and GSH were assayed in this study, obtaining only 387 
significant differences with respect to the control group on the GSH levels of HepG2. The results 388 
showed therefore a higher sensitivity of the HepG2 cell line to oxidative stress biomarkers in 389 
contrast to the results obtained in the cytotoxicity study. Other authors have previously reported 390 
that HepG2 cells are generally more susceptible to oxidant-induced stress than Caco-2 cells 391 
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(Martin et al., 1997). Our research group has also observed a deep decrease in GSH content in 392 
HepG2 exposed to Cloisite®30B at all timepoints assayed, however no changes were observed 393 
in ROS levels (Maisanaba et al., 2013a). This might be due because GSH have many biological 394 
functions apart from ROS scavenging such as signal transduction, gene expression and 395 
apoptosis, etc. (Sies 1999). Moreover, Sharma et al. (2010) also reported that Closite®Na+ and 396 
Closite®30B did not induce ROS production in Caco-2, in agreement with our results for those 397 
clays (Maisanaba et al., 2013a) and although there was no change in ROS levels they observed 398 
genotoxic effects. By contrast, Lordan et al. (2011) reported that Cloisite®Na+ induced 399 
intracellular ROS formation, whereas, the effect of Cloisite®93A in the generation of ROS was 400 
less prominent. Furthermore, Baek et al. (2012) evaluated the ROS production in INT-407 cells 401 
exposed to MMT, obtaining significant levels of ROS at the highest concentration (1000 µg/ mL) 402 
at all three timepoints assayed (24, 48 and 72h).  403 
 404 
Clay 2 did not induce leakage of IL-6, biomarker of an inflammatory response, in any of the cell 405 
lines. MMT, on the other hand, has been reported to rapidly lyses neutrophils and erythrocytes in 406 
vitro. Furthermore, it can stimulate chemiluminescence, the neutrophil oxidative metabolic burst 407 
(Dougherty et al., 1985). 408 
 409 
In relation to genotoxicity, Clay 2 induced DNA strand breaks in both cell lines Moreover, Clay 2 410 
induced time-dependent increases of DNA strand breaks in HepG2 cells. Similar results were 411 
also found by Maisanaba et al., (2013a) for Cloisite30®B in HepG2 cells. Other authors evaluated 412 
the genotoxicity of other commercial clays in similar cell lines. Sharma et al. (2010), showed no 413 
DNA damage in Caco-2 exposed to unfiltered and filtered Cloisite®Na+ samples. Nevertheless, 414 
DNA damage was observed in the intestinal cell line Caco-2 exposed to Cloisite®30B from 113 415 
µg/mL after 24h. By contrast, the results obtained by Maisanaba et al., (2013c) with the intestinal 416 
18 
 
cell line exposed to Cloisite®30B, did not coincide with the aforementioned research group, and 417 
this can be related with the lower concentrations tested in this case (10, 20 and 40 µg/mL). 418 
Maisanaba et al. (2013a), however, showed differences with respect to the control at the highest 419 
concentration assayed (88 µg/mL) in HepG2 after 48 h. In this case, it is difficult to compare 420 
because Sharma et al. (2010) only presented results after 24h, and at this concentration DNA 421 
damage in the intestinal cell line was not observed.  422 
Sharma et al. (2010), also indicated that the modifiers used to modify the clay contributed to the 423 
genotoxic effects, and these effects were not due to oxidative damage. In this sense, the absence 424 
of ROS obtained in this work after exposure to Clay 2 coincides with the Sharma´s hypothesis. 425 
On the other hand, Li et al. (2010) observed no genotoxic results in the comet assay with CHO 426 
cells exposed up to 1000µg/mL nanosilicate platelets derived from MMT.  427 
Regarding to in vivo toxicity data, there is no information about the three organoclays selected in 428 
the present study, but Li et al. (2010) did not reported acute oral toxicity of MMT in rats exposed 429 
to a single dose of 5700 mg/kg. Also Baek et al. (2012) did not find any remarkable toxicity in 430 
mice orally exposed to a single dose of 1000 mg/kg MTT. 431 
 432 
In summary, our results showed that at the concentrations assayed Cloisite®20A and Clay 1 did 433 
not induce cytotoxicity. Clay 2, however, showed cytotoxic and genotoxic effects, as well as an 434 
alteration in GSH content. Therefore, a case by case toxicological assessment is required, as the 435 
modifier has a role in the toxicity observed. Moreover, a different sensitivity was observed 436 
depending on the cell line employed.  437 
More studies are required to elucidate the risks of these clays for human health as their use is 438 
going to increase widely in the near future.  439 
 440 
 441 
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Table captions 569 
Table 1. EC50 values (µg/mL) obtained after 24 and 48h exposure to Clay 2 in both cell lines. 570 
 571 
Figure captions 572 
Figure 1. TGA results for Cloisite®Na+ (round) and Cloisite®20A (square). 573 
 574 
Figure 2. FTIR results for Cloisite®Na+ (up) and Cloisite®20A (down). 575 
 576 
Figure 3. MTS tetrazolium salt reduction (a,b) and total protein content (c,d) of Caco-2 (a,c) and 577 
HepG2 (b,d) cells after 24h and 48h of exposure to 0-8 μg/mL Clay 1. Results from 3 independent 578 
experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. Differences 579 
were considered significant from p<0.05 (*).  580 
 581 
Figure 4. MTS tetrazolium salt reduction (a,b) and total protein content (c,d) of Caco-2 (a,c) and 582 
HepG2 (b,d) cells after 24h and 48h of exposure to 0-125 μg/mL Clay 2. Results from 3 583 
independent experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. 584 
Differences were considered significant from p<0.05 (*). 585 
 586 
Figure 5. MTS tetrazolium salt reduction (a,b) and total protein content (c,d) of Caco-2 (a,c) and 587 
HepG2 (b,d) cells after 24h and 48h of exposure to 0-62.5 μg/mL Cloisite®20A. Results from 3 588 
independent experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. 589 
Differences were considered significant from p<0.05 (*). 590 
 591 
Figure 6. ROS content (a) in Caco-2 cells after 24 and 48h of exposure to 8.5, 17, or 34 µg/mL 592 
Clay 2. ROS content (b) in HepG2 cells after 24 and 48h of exposure to 22, 44, or 88 µg/mL Clay 593 
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2. Results from 3 independent experiments with 3 replicates/experiment. All values are expressed 594 
as mean ± s.d.  595 
 596 
Figure 7. GSH content (a) in Caco-2 cells after 24 and 48h of exposure to 8.5, 17, or 34 µg/mL 597 
Clay 2. GSH content (b) in HepG2 cells after 24 and 48h of exposure to 22, 44, or 88 µg/mL Clay 598 
2. Results from 3 independent experiments with 3 replicates/experiment. All values are expressed 599 
as mean ± s.d. ** significantly different from control (p < 0.01). 600 
 601 
Figure 8. Comet assay results (a) of Caco-2 and (b) HepG2 cells after 24 and 48h of exposure to 602 
15.65, 31.25, or 62.5 µg/mL Cloisite®20A. Results from 3 independent experiments with 2 603 
replicates/experiment. All values are expressed as mean ± s.d. * significantly different from 604 
control (p < 0.05).  605 
 606 
Figure 9. Comet assay results (a) of Caco-2 and (b) HepG2 cells after 24 and 48h of exposure to 607 
2, 4 or 8 µg/mL Clay 1. Results from 3 independent experiments with 2 replicates/experiment. All 608 
values are expressed as mean ± s.d. * significantly different from control (p < 0.05).  609 
 610 
Figure 10. Comet assay results (a) of Caco-2 cells after 24 and 48h of exposure to 8.5, 17, or 34 611 
µg/mL Clay 2. Comet assay results (b) of HepG2 cells after 24 and 48h of exposure to 22, 44 and 612 
88µg/mL. Results from 3 independent experiments with 2 replicates/experiment. All values are 613 
expressed as mean ± s.d. * significantly different from control (p < 0.05). ** significantly different 614 
from control (p ≤ 0.01). 615 
Table 1 
 
 
  EC50 (µg/mL) 
Cell line Exposure time MTS PC 
Caco-2 
24h 55±6 34±3 
48h 26±3 18±2 
HepG2 
24h 88±4 93±5 
48h 51±3 74±3   
Table 1
Click here to download Table: Table 1.docx
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Abstract 
Modern food packaging has made great advances as result of global trends and 
consumer preferences, which are oriented to obtain improved food quality and safety. 
In this regard, clay minerals, and mainly Montmorillonite (Mt)  are attracting 
considerable interest in food packaging because of the improvements developed in 
mechanical and barrier properties. Hence, the present work aim to assess the toxicity 
of four Montmorillonite-based clay minerals, an unmodified clay, Cloisite®Na+ (CNa+), 
and three modified Mt clays: Cloisite®30B (C30B), a commercial clay, and Clay1 and 
Clay2, two novel modified organoclays developed by the Packaging, Transport, & 
Logistics Research Institute (ITENE). First, the cytotoxic effects were studied in the 
human endothelial cell line (HUVEC). In addition, the potential mutagenicity of the 
clays was evaluated by the Ames test. Clay1 did not induce any cytotoxic effects in 
HUVE cells, although it exhibited potential mutagenicity in TA98 S. thyphimurium 
strain. In contrast, Clay2 produced cytotoxicity in endothelial cells but no mutagenicity 
was recorded. However, CNa+ was not cytotoxic neither mutagenic. And finally, C30B 
showed positive results in both assays. Therefore, results showed that clay minerals 
have a different toxicity profile and a case by case toxicity evaluation is required.  
 
 
Keywords: clay minerals, cytotoxicity; mutagenicity; Ames test; HUVEC. 
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3 
Introduction 
Clay minerals have many potential applications due to their specific properties 
(Sharma et al., 2010). Montmorillonite (Mt) is a bio-inspired layered clay mineral 
widely used in various science fields due to their good swelling capacity, high specific 
surface area, good cation-exchange capacity, high platelet aspect ratio, strong 
adsorptive power, high structural stability, chemical inertia, strong capacity to form 
stable suspensions and ease with which their surface can be modified (Hu et al., 2007; 
Mallakpour and Dinari, 2011; Baek et al., 2012). Layered clays are of particular interest 
due to the successful incorporation into composite materials and the advantageous 
properties that reinforced materials exhibit, which is essential when high barrier 
properties are needed, for example, in food packaging (Rhim and Ng, 2007). But for 
the successful incorporation of the clays to the polymer matrix their compatibility 
should be improved by means of surface modification (Bitinis et al., 2011). This is 
accomplished, among others methods, by cation exchange with organic cations leading 
to organoclays (Maisanaba et al., 2014a). Once the clays have been incorporated into 
the polymer they become into nanoclays. These are defined as natural layered 
structures, where the layers or platelets have sub-micrometer dimensions, except for 
their thickness, which is only about 1 nm (Hatzigrigoriou et al., 2011). These platelets 
force gases and other external agents to follow a tortuous path through the material, 
decreasing and slowing the contact with the product obtaining more resistant plastics 
(Pereira de Abreu et al., 2007). In this regard, the Technological Institute of Packaging, 
Transport and Logistic (ITENE) is developing modified clays based in Mt to be 
incorporated in food packaging. Clay1 was prepared with Mt modified with 
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4 
hexadecyltrimethyl-ammonium bromide (HDTA) and Clay2 contained HDTA and 
acetylcholine chloride as modifiers (Jordá-Beneyto et al., 2014).   
 
New approaches and standardized test procedures to study the impact of organoclays 
on living cells are urgently needed for the evaluation of potential hazards relating to 
human exposure to these substances (Sekhon, 2010). In this sense, in vitro assays 
could be useful as screening method to detect toxicity. Several authors have evaluated 
the potential toxicity of modified clay minerals destined to food packaging in target cell 
lines from intestinal  (Houtman et al., 2014; Maisanaba et al., 2014; Sharma et al., 
2010) or hepatic origin (Lordan et al., 2011; Maisanaba et al., 2013). However there 
are other potential targets for clay minerals, such as the vascular endothelial tissue, 
with no information of their effects on HUVEC permanent cell line.  
Additionally, cytotoxic effects are frequently induced by high doses at acute exposure. 
Therefore, subtle cellular alterations that may arise at lower concentrations are 
overlooked (Singh et al., 2009). In this regards, genotoxicity studies should be included 
in the toxicity assessment of new substances that human could be routinely exposed 
to, such as clay minerals used in food packaging. Actually, European legislation in 
relation to the authorization of food contact materials includes genotoxicity tests 
among the toxicological assays required (European Commission, 2011) Therefore, the 
first step in the toxicological assessment of clay minerals intended to be used in food 
packaging should be the cytotoxic and genotoxic evaluation of the material as 
manufactured, this is, before being incorporated in the package.  
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5 
Taking into account all this background, the present work aims to assess the toxicity of 
four Mt-based clays, an unmodified clay, Cloisite®Na+ (CNa+), and three modified Mt 
clays: Cloisite®30B (C30B), a commercial clay, and Clay1 and Clay2, two novel modified 
organoclays developed by ITENE. The toxicological assessment included the 
cytotoxicity in a human endothelial cell line (HUVEC) and the genotoxicity by the Ames 
test after 24 and 48 hours of exposure to the selected clay minerals.  
 
Materials and Methods 
Supplies and Chemicals 
Culture medium, fetal bovine serum and cell culture reagents were obtained from 
BioWhittaker (Spain). Chemicals for the different assays were provided by Sigma-
Aldrich (Spain) and VWR International Eurolab (Spain). Protein reagent assay was 
obtained from BioRad (Spain).  
 
Clay minerals characterization 
Purified sodium montmorillonite (Mt) (CNa+), with cationic exchange capacity (CEC) of 
116 meq/100 g as well as the organically modified one (C30B) (modifier: methyl, 
tallow, bis-2-hydroxyethyl, quaternary ammonium, concentration: 90 meq/100g clay) 
were purchased from Southern Clay Products (COMITEX, S.A. Spain).  
Quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) 
(C19H42BrN, 364.46 g/mol, 98%) was supplied from CymitQuimica S.L. (Spain), 
acetylcholine chloride (ACO) (C7H16ClNO2, 181.66 g/mol, P99%) was provided by 
Sigma-Aldrich (Spain). 
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6 
The non commercial organo-modified clays, Clay1 and Clay2, have been developed and 
characterized by ITENE based on a previous work (Jordá-Beneyto et al., 2014). Briefly, 
two different organo-modified clays were prepared by a cation-exchange method, 
which consists on a displacement of the sodium cations of CNa+ with the ammonium 
cations of the above mentioned salts, obtaining Clay1 and Clay2.  
Clay minerals were characterized by termogravimetric analysis (TGA), Fourier 
Transform InfraRed (FTIR), X-ray diffraction (XRD) and Particle size Distribution (PSD) as 
described in Jordá-Beneyto et al. (2014). 
 
Cell culture 
HUVEC permanent cell line derived from a human vascular endothelium (ATCC No. 
CRL-1730) were maintained at 37º C in an atmosphere containing 5% CO2 at 95% 
relative humidity (CO2 incubator, NuAire®, Spain), in a medium consisting in F-12K 
(LGC Standards, Spain) supplemented with fetal bovine serum, heparin and endothelial 
cell growth supplement. Cells were grown near confluence in 75-cm2 plastic flasks and 
harvested weekly with 0.25% trypsin. They were counted in an improved Neubauer 
haemocytometer and viability was determined by exclusion of Trypan Blue. HUVECs 
were plated at density of 5 x 104 cells/ml to perform the experiments. 
 
Cytotoxicity assays 
The test concentrations of the clay minerals were determined individually in previous 
experiments in order to avoid interferences with the method of measurement. For this 
reason the absorbance of clay solutions (1000 μg/mL and serial half dilutions) were 
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7 
measured at 0, 24 and 48 h. The highest concentrations selected were the ones that 
did not show statistical differences versus the control. Stock solutions were 1000 
µg/mL for each clay. From the initial solution, serial dilutions in medium were prepared 
(0-125 µg/mL for CNa+; 0-250 µg/mL for C30B; 0-8 µg/mL for Clay1 and 0-125 µg/mL 
for Clay2). Culture medium without clay was used as control group. After replacing the 
previous medium, the exposure solutions were added to the systems, and incubated at 
37ºC for 24 and 48 hours. The basal cytotoxicity endpoints were protein content (PC), 
supravital dye neutral red cellular uptake (NR), and tetrazolium salt reduction (MTS).  
 
Protein content (PC) is a very useful endpoint to assess cytotoxicity, since it gives data 
about cell damage with independence of the toxic mechanism involved (Pichardo et 
al., 2007). PC was quantified in situ, according to the procedure given by Bradford 
(1976), using Coomassie Brilliant Blue G-250 in the same 96-well tissue culture plates 
in which exposure originally took place, in order to determine the total cell number 
present in the culture. The culture medium was replaced by 200 μL NaOH 0.1N and 
after 2h incubation at 37ºC, 180 μL was replaced by the same volume of a 22% 
Coomassie Brilliant Blue G-250 solution. After 30 min incubation at room temperature, 
absorbance was read at 595 nm (Infinite M200, Tecan, Austria).  
 
NR uptake is a suitable endpoint to determine viable cells, because this dye is taken up 
by viable lysosomes. This assay was performed according to Borenfreund and Puerner 
(1984). Briefly, NR in medium is absorbed and concentrated in lysosomes of cells. NR 
uptake is proportional to the concentration of the NR solution and the numbers of 
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8 
viable cells. The NR can be extracted from lysosomes for quantitative measurement of 
cell viability and cytotoxicity of xenobiotics. Culture medium was replaced by 100 μL 
medium without serum containing 10 mg/mL NR. The 96-well plate with the NR-
containing medium was returned to the incubator for another 3 h to allow the uptake 
of NR into the lysosomes of viable, intact cells. Thereafter, the medium was removed 
and cells were fixed for 1 min with a formaldehyde-CaCl2 solution. By adding 0.2 mL of 
acetic acid-ethanol solution to the wells, the NR absorbed by the cells was extracted, 
brought into solution and quantified at 540 nm (Infinite M200, Tecan, Austria). 
 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium salt) reduction is carried out by dehydrogenases enzymes present in 
mitochondria, being this endpoint a good marker of the damage induced in this 
organelle. MTS reduction was measured according to the procedure of Baltrop et al. 
(1991). The MTS tetrazolium compound added to the medium is bioreduced by cells 
seeded in the 96-well plate into a colored formazan product soluble in culture medium 
and is directly measured spectrophotometrically at 490 nm (Infinite M200, Tecan, 
Austria) after 2 hours of incubation in the dark.  
 
Ames Test 
The incorporation version of the Ames test was performed according to the 
recommendations of Maron & Ames (1983) and following the principles of OCDE 
guideline 471 (1997). Five Salmonella typhimurium histidine-auxotrophic strains 
TA97A, TA98, TA100, TA102 and TA104 were used for the assay. Cultures of each 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
9 
tester strain were prepared from their main strain plates, and used in late exponential 
growth phase. Each test substance was assessed in three independent experiments, 
each conducted in absence and presence of S9 metabolic activation system from rat 
liver (Aroclor 1254, Sigma, Spain), using triplicate plates for each test substance 
concentration. Five different concentrations of the clay minerals were tested. Briefly, 
0.1 mL of test substance, 0.1mL of bacterial culture and 0.5mL of S9 mix, were added 
to 2 mL molten agar at 42° and poured onto Vogel Bonner-E minimal glucose agar 
plates. Plates were inverted and incubated 65-70 h at 37°C in the dark. Revertant 
colonies were counted and background lawn was inspected for signs of toxicity or 
compound precipitation. 2-Nitrofluorene (2-NF) (0.1 µg/plate) and sodium azide 
(NaN3) (1 µg/plate) were selected as positive controls for assays performed without 
metabolic activation system. 2-Aminofluorene (2-AF) (20 µg/plate) was the positive 
control used in plates with S9 mix. MilliQ water (100µl/plate) and DMSO (10µl /plate) 
were selected as negative controls for this assay, being the solvents of clays solution 
and positive controls, respectively. 
 
Calculations and statistical analysis 
All experiments were performed at least three times and in duplicate per 
concentration. Data for the concentration-dependent cytotoxicity relationships of all 
experiments were presented as the arithmetic mean percentage ± standard deviation 
(SD) in relation to control. Statistical analysis was carried out using analysis of variance 
(ANOVA), followed by Dunnett’s multiple comparison tests. Differences were 
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10 
considered significant from P<0.05. All values passed the normality tests (Kolmogorov 
& Smirnov’s test, and Bartlett´s test). 
 
EC50 values (mean effective concentration, concentration that modified each 
biomarker by 50%, positive or negative, in comparison with appropriate untreated 
controls) were derived by linear regression in the concentration-response curves. 
 
Results 
Results of the cytotoxicity assays 
HUVE cells exposed to CNa+ showed no significant changes in any of the endpoints 
assayed after 24 and 48 h of exposure (Figure 1). 
 
On the other hand, when HUVE cells were exposed to C30B a concentration and time-
dependent decrease was recorded in all endpoints. PC content was significantly 
reduced from the concentrations of 31.25 µg/mL C30B in cells exposed for 24 h and 
from the concentration of 15.63 µg/mL C30B after 48 h of exposure (Figure 2a). 
Moreover, significant differences were observed for the EC50 values in the PC content 
assay, being lower in the longest exposure time (64.3±9.7 µg/mL for 24 h and 
28.3±11.2 µg/mL for 48 h). Similarly, NR uptake assay and MTS reduction indicated 
significant decreases in cell viability at the concentration 31.25 µg/mL at 24 h, and 
from 15.63 µg/mL in cells exposed for 48h (Figure 2b,c); although the level of statistical 
significance was higher in comparison to those obtained in PC content assay. The EC50 
values for the NR uptake assay and MTS assay also evidenced a greater effect in cells 
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11 
after a longer exposure time, being 49.7±10.0 and 42.3±9.5 µg/mL for 24h, 
respectively, and 21.4±11.4 and 24.4±10.4 µg/mL for 48h, respectively). 
 
Clay1 did not induce any significant alterations in PC content and NR uptake assays in 
HUVE cells at any exposure and concentration used (Figure 3a,c). However, MTS 
reduction assay showed a significant decrease at the highest concentration assayed (8 
µg/mL) after 48 h of exposure (Figure 3b).  
 
HUVE cells exposed to Clay2 underwent a concentration and time-dependent decrease 
in all the endpoints assays. Significant reductions in cell viability measured by PC 
content were shown from the concentration of 15.63 µg/mL Clay2 in cells exposed for 
24 and 48 h of exposure (Figure 4a). In addition, considering the EC50 values obtained, 
toxic effects were higher in the longest exposure, being 61.8±6.1 µg/mL for 24 h and 
47.6±6.1 µg/mL for 48 h. NR uptake assay also indicated a reduction in cell viability. 
These decreases were significantly different from the control group at the 
concentration 15.63 µg/mL at 24 h, and from 7.8 µg/mL in cells exposed for 48h 
(Figure 4b). Moreover, marked differences were observed for the EC50 values in the NR 
uptake assay, being significantly lower after 24 h in comparison to 48 h (123.9±2.2 
µg/mL for 24h and 23.1±9.1 µg/mL for 48h). Similarly, MTS reduction performed by 
cells exposed to Clay2 also decreased from 31.25 µg/mL at both exposure times (Figure 
2c). However, the EC50 values for the MTS assay at both exposure times were very 
similar (55.4±6.1 µg/mL for 24h and 54.4±7.0 µg/mL for 48h). In addition, a remaining 
cell viability of approximately 20% was recorded after 24h and 48h of exposure to the 
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highest concentration tested (250 µg/mL) in PC content and MTS assays; however, RN 
uptake assayed showed higher cell viabilities (around 50% after 24h and 35% at 48h). 
 
Results of the mutagenicity study 
After exposure to CNa+, no significant changes were detected in any of the strains 
exposed to the clay mineral (Table I). 
C30B showed significant increases in the revertant colonies compared to the negative 
control in TA98 with S9 at all concentrations assayed, while no change was recorded in 
the exposure without metabolic activation. However, no change was recorded in the 
other strains (Table I). 
Similarly, Clay1 induced statistically significant enhancements in the number of 
revertant colonies in TA98 with S9 at all concentrations assayed. However, no change 
was observed for the same strain without S9 fraction or in the rest of the strains for 
this clay mineral (Table II).   
In the exposure to Clay2, there was no change in the number of revertants and no 
indication of mutagenic activity in any of the treated strains up to the highest 
concentration (125 µg/mL), either in the presence or absence of S9 (Table II). The 
results showed that this clay was not potentially mutagenic in this bacterial assay. 
 
In all exposures, positive controls produced statistically significant increases (P<0.01) in 
the number of revertant colonies, confirming the sensitivity of the test system and the 
activity of the S9 mix. Moreover, no toxicity was observed at any concentration tested. 
This was measured as a decrease in background lawn and in revertant frequency. 
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Discussion 
Clay minerals are naturally occurring inexpensive and eco-friendly materials and have 
found multifarious applications (Majeed et al., 2013). Despite the growing use of clays, 
very little research has been performed regarding their potential toxicity (Lordan et al., 
2011). Mt, a widely used clay mineral, has been traditionally considered as safe to 
human (Liu et al., 2011); however, several authors have already pointed out toxic 
effects in different experimental models (Lordan et al., 2011; Sharma et al., 2010; Baek 
et al., 2012; Maisanaba et al., 2013,2014a,b; Houtman et al., 2014). Considering the 
large use of Mt in food packaging, due to the improvements developed in mechanical 
and barrier properties (Majeed et al., 2013), one of the most expected ways of 
exposure is the oral route. Once Mt passes the gastrointestinal epithelium and ends up 
in the blood circulation, particles are distributed around the body (Nemmar et al., 
2002). Baek et al. (2012) demonstrated that Mt could be absorbed into the body 
within 2 h, but it did not significantly accumulate in any specific organ. Therefore, it 
can be easily found in blood vessels. Considering that endothelial cells could be the 
target of clay minerals, the present work studied for the first time the cytotoxic effects 
of different clay minerals in the human cell line HUVEC and their mutagenicity. 
 
As far as we know, only Murphy et al. (1993) have studied the toxicity of clay minerals 
in HUVEC. They evidenced that aluminum silicate clay minerals (Mt, kaolinite and 
bentonite) are able to cause a dose-dependent release of fatty acids in human 
umbilical vein endothelial, neuroblastoma and oligodendroglial cells, being Mt the clay 
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14 
mineral inducing the highest effect and HUVEC the cells exhibiting the highest release. 
In addition, only HUVE cells were susceptible to cell lysis, indicating a higher sensibility 
in comparison to the other cell lines (Murphy et al., 1993). Moreover, several authors 
have used other cell lines to study the toxic effects of CNa+ and C30B. In this sense, the 
absence of cytotoxic effects of CNa+ shown in the present work has been previously 
observed in U937 monocityc cells (Lordan and Higginbotham, 2012). Similarly, no 
cytotoxic effect was recorded in Caco-2 cells exposed up to 31.25 µg/mL of CNa+; 
however, significant decreases were observed when cells were exposed to the highest 
concentrations of this clay mineral (31.25-125 µg/mL) (Maisanaba et al., 2013,2014a). 
In addition, a concentration-dependent response in HepG2 cells exposed to CNa+, as 
well as with the modified clay Cloisite® 93A, was evident following 24 h of treatment 
with each of the clay minerals (Lordan et al., 2011). Also, Li et al. (2010) observed a 
slight decrease in CHO cells viability exposed to 62.5-1000 µg/mL nanosilicate platelets 
as measured with the MTT and lactate dehidrogenase (LDH) assays. In the case of 
C30B, Sharma et al. (2010) reported that this clay mineral induced about 40% 
cytotoxicity in Caco-2 cells at the highest concentration tested (226 µg/mL).  
 
Considering that Clay1 and Clay2 are not commercially available, the results obtained 
can only be compared with previous studies performed in our laboratory. In the 
present work, no significant cytotoxic effects in HUVE cells exposed to Clay1 for 24 and 
48 h was observed; however, all the endpoints assayed were significantly changed in 
exposure to Clay2. Caco-2 and HepG2 cells treated with Clay1 underwent significant 
reductions in the cytotoxicity assays only at 8 µg/mL (Houtman et al., 2014), likewise to 
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the results obtained in the present study for HUVEC in the MTS assay. In addition, the 
concentration and time-dependent reduction in the viability of HUVEC exposed to 
Clay2, was similar to those observed in Caco-2 and HepG2 cells (Maisanaba et al., 
2013, 2014a). When EC50 values are compared, HUVEC showed a similar sensitivity to 
Caco-2 cells to the toxic effects of the studied clay minerals, and higher than HepG2 
cells.  
 
The present study demonstrates for the first time that cytotoxity and genotoxicity 
induced by exposure to clay minerals may not be always related.  Clay1 did not induce 
any cytotoxic effects in HUVE cells, although it exhibited potential mutagenicity in 
TA98 S. thyphimurium strain. In contrast, Clay2 produced cytotoxicity in endothelial 
cells but no mutagenicity was recorded. However, CNa+ was not cytotoxic neither 
mutagenic. And finally, C30B showed positive results in both assays. Similarly, Sharma 
et al. (2010) observed no mutagenic activity in TA98 and TA100 exposed to sodium Mt 
(CNa+) and C30B in concentrations up to 141 µg/mL; CNa+ showed no cytotoxic effect 
but C30B did. Similarly, Li et al. (2010) reported no mutagenic potential in TA98, 
TA100, TA1535, TA1537 and TA102 exposed to exfoliate silicate nanoclay, although 
this material showed low cytotoxicity on CHO cells below 1000 μg/mL after 12 and 24 
h of exposure. 
 
However, our results correlate well with previous genotoxic studies performed in our 
laboratory with these clay minerals. No genotoxicity measured by the Comet assay was 
observed in Caco-2 cells exposed to C30B (Maisanaba et al., 2014a). However, this clay 
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induced DNA damage in the hepatic cell line HepG2 (Maisanaba et al., 2013). In 
addition, Clay2 showed DNA damage, measure by comet assay in Caco-2 and HepG-2 
cells, although no genotoxicity was observed for Clay1 (Houtman et al., 2014). 
Moreover, genotoxic effects of different clays (bentonite kaolinite, quartz and 
exfoliated silicate nanoclay) on several experimental models have been previously 
reported (Gao et al., 2000; Geh et al., 2006; Li et al., 2010; Meibian et al., 2011).  
 
In the present study, CNa+ was the only clay not showing any toxic effect. This finding 
suggests that the toxicity of organo-modified Mt was caused by the organo-modifier. 
In this sense, surface modification of clays has been commonly used to achieve a 
greater compatibility of the clay mineral with the polymer, and therefore reach higher 
exfoliation degrees, and in consequence better properties (Hetzer and De Kee, 2008). 
However, it has been suggested that the modification introduced in the Mt changes 
substantially its behavior in the experimental model (Maisanaba et al., 2014a). Baker 
et al. (2007) reported that the changes in clay structure and surface property may alter 
their response to blood-clotting. Therefore, it seems that the organo-modifiers used 
are the responsible for the higher toxic effects observed in the endothelial cells. 
However, other modifiers, such as amine or carboxyl groups, have shown to be useful 
for the development of safer nanosilica particles, exhibiting lower cytotoxicity and DNA 
damage than the unmodified ones (Yoshida et al., 2012). In this regard, amorphous 
silica nanoparticles have been shown to induce multinuclei and cell dysfunction in the 
human hepatic cell line L-02 (Wang et al., 2013). 
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In conclusion, the present work evidenced cytotoxicity in HUVE cells and genototoxic 
damage induced by organo-modified Mt-based clay minerals, whereas the unmodified 
clay mineral resulted to be safer at the concentrations tested. These results will 
contribute to the development of safer organoclays intended to be used in the food 
packaging industry. However, further studies are needed to assure the safety of these 
clays on human health. 
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Legends to figures 
 
Figure 1. Protein content, PC (a); Neutral red uptake, NR (b); and reduction of 
tetrazolium salt, MTS (c) of HUVECs after 24h and 48h of exposure to 0-62.5 µg/mL 
Cloisite ® Na+. All values are expressed as mean ± SD.  
 
Figure 2. Protein content, PC (a); Neutral red uptake, NR (b); and reduction of 
tetrazolium salt, MTS (c) of HUVECs after 24h and 48h of exposure to 0-250 µg/mL 
Cloisite ® 30B. All values are expressed as mean ± SD. * significantly different from 
control (P<0.05) and ** very significantly different from control (P<0.01). 
 
Figure 3. Protein content, PC (a); Neutral red uptake, NR (b); and reduction of 
tetrazolium salt, MTS (c) of HUVECs after 24h and 48h of exposure to 0-8 µg/mL Clay1. 
All values are expressed as mean ± SD. * significantly different from control (P<0.05).  
 
Figure 4. Protein content, PC (a); Neutral red uptake, NR (b); and reduction of 
tetrazolium salt, MTS (c) of HUVECs after 24h and 48h of exposure to 0-125 µg/mL 
Clay2. All values are expressed as mean ± SD. * significantly different from control 
(P<0.05) and ** very significantly different from control (P<0.01).  
 
 
 
  Concentration 
(µg/mL) 
TA97A TA98 TA100 TA102 TA104 
 
 
 
 
 
C®Na+ 
 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 
Negative controls 283±52 321±84 25±9 31±14 112±26 124±22 325±84 387±81 359±52 454±34 
7.8 177±63 177±63 27±8 45±18 121±27 105±27 349±81 390±73 214±52 350±43 
15.63 319±40 278±91 28±8 46±15 147±43 129±7 322±49 316±41 255±60 378±62 
31.25 278±63 207±44 24±17 30±8 91±6 158±16 297±63 320±71 248±24 266±35 
62.5 334±87 209±43 20±7 38±20 143±10 161±14 351±91 432±25 290±62 284±45 
125 244±55 255±30 19±3 23±3 149±40 149±33 282±90 305±35 314±75 314±75 
Positive controls 676±78** 676±10** >1000** >1000** 458±37** 395±4** 741±24** 774±11** 734±29** 741±46** 
 DMSO 297±37 320±34 27±7 39±2 119±16 115±3 267±13 381±32 373±25 360±13 
 
 
 
C®30B 
Negative controls 224±48 267±20 35±10 37±11 77±5 75±10 253±44 257±34 295±74 388±74 
15.63 258±59 323±49 35±19 872±56** 115±38 104±26 292±71 269±63 309±21 451±56 
31.25 118±20 225±34 36±17 930±99** 124±6 104±31 279±59 298±78 380±38 473±49 
62.5 303±68 229±62 20±4 930±99** 108±12 107±9 160±8 353±78 461±76 535±65 
125 245±48 275±55 26±6 >1000** 101±8 98±3 332±95 347±18 328±55 252±36 
250 289±33 279±47 36±22 766±48** 116±36 98±9 317±36 291±45 355±52 350±25 
Positive controls 649±14** 668±15** >1000** >1000** 372±7** 560±39** 486±58** 520±30** 594±49** 710±25** 
 DMSO 236±8 239±33 29±8 39±2 96±5 101±13 248±4 249±19 265±35 352±10 
 
Table I. Results of Ames test conducted with Cloisite® Na+ and Cloisite® 30B for three independent experiments. MilliQ water was used as negative control 
and DMSO as solvent for positive controls. Data are given as mean±SD revertants/plate for three replicates for each concentration in each experiment. 
Positive controls: TA97A/ TA98/ TA102/ TA104 without S9 mix: 2-NF (0.1 μg/plate) and TA100 without S9 mix: NaN3 (1μg/plate). Positive controls for all 
strains with S9: 2-AF (20µg/ plate). ** very significantly different from control (P<0.01).  
Table 1
 Concentration 
(µg/mL) 
TA97A TA98 TA100 TA102 TA104 
 
 
 
 
 
Clay1  
 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 
Negative controls 216±28 206±12 21±3 38±14 85±16 80±18 183±25 216±45 252±45 285±45 
0.5 241±75 213±30 25±7 68±12* 91±26 87±17 142±45 166±12 221±51 228±54 
1 236±69 254±55 29±10 144±22** 79±15 79±24 180±25 230±43 252±69 236±54 
2 211±54 254±51 35±10 303±100** 70±11 88±18 189±48 173±66 270±73 367±69 
4 262±70 260±87 28±8 521±26** 89±21 85±18 281±72 242±67 309±51 341±86 
8 211±26 260±51 34±20 150±61** 80±15 89±32 218±84 202±41 295±47 323±83 
Positive controls 387±60** 485±86** >1000** >1000** 347±50** 411±120** 483±51** 541±29** 749±120** >1000** 
 DMSO 230±21 270±27 33±2 32±6 97±5 102±11 253±20 252±13 331±29 356±40 
 
 
 
Clay2 
Negative controls 241±15 255±30 33±12 29±10 73±8 79±11 252±28 217±30 292±68 252±47 
7.8 234±28 206±9 21±5 34±17 74±4 68±6 236±42 262±34 269±75 306±50 
15.65 255±56 278±50 34±7 35±1 78±9 67±12 247±81 236±73 306±95 282±94 
31.25 289±47 307±83 23±8 40±14 74±17 95±8 233±24 192±12 259±32 152±8 
62.5 278±63 228±28 24±4 35±18 59±4 67±1 207±36 181±23 265±55 228±76 
125 231±27 248±17 37±7 41±20 70±5 69±1 243±33 203±13 250±50 232±20 
Positive controls 642±14** 665±9** >1000** >1000** 549±86** 550±46** 494±67** 506±34** 615±18** 671±71** 
 DMSO 223±55 287±28 35±3 36±4 98±2 104±14 238±10 259±19 333±11 349±10 
 
Table II. Results of Ames test conducted with Clay 1 and Clay 2 for three independent experiments. MilliQ water was used as negative control and DMSO as 
solvent for positive controls. Data are given as mean±SD revertants/plate for three replicates for each concentration in each experiment. Positive controls: 
TA97A/ TA98/ TA102/ TA104 without S9 mix: 2-NF (0.1 μg/plate) and TA100 without S9 mix: NaN3 (1μg/plate). Positive controls for all strains with S9: 2-AF 
(20µg/ plate). * significantly different from control (P<0.05) and ** very significantly different from control (P<0.01). 
Table 2
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Clay1 was not cytotoxic to HUVEC, although potential mutagenicity was found 
 
Clay2 produced cytotoxicity in endothelial cells but no mutagenicity was recorded 
 
CNa+ was not cytotoxic neither mutagenic 
 
C30B showed positive results in cytotoxic and mutagenic studies 
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1. Introduction 
Nanotechnology is a science that involves research and technology development at the 
atomic, molecular and macromolecular levels, aimed at creating and using structures, 
devices, and systems with novel properties and functions based on their small size (Farhang, 
2009). Nanotechnology has opened up new avenues of research and development in 
numerous fields, including medicine, cosmetic and agro-food area (Chaundry et al., 2008). 
The application of this technology in food and agriculture plays an important role in 
improving production, processing, storage, transportation, traceability, safety and security of 
food (Chaundry et al., 2008). Among the wide range of applications of nanomaterials in the 
food industry, the one with the main development in the near future is their employ as food 
contact materials (AESAN, 2010). Nanomaterials have demonstrated to possess novel 
characteristics that can be applied in developing new packaging with better properties than 
packaging produced with micromaterials (Pereira de Abreu et al., 2007). The resulting 
materials, which are frequently polymers with nanoparticles incorporated in their structure, 
present improvements of barrier properties, such as thermal, mechanical or permeability 
characteristics, providing innovative solutions to increase the performance of the polymers 
(Silvestre et al., 2011). Therefore, nanotechnology plays an important role in the 
preservation of perishable food.  
 
Among the most commonly used materials in food packaging are nanocomposites based on 
organic polymers and inorganic clay minerals (Pereira de Abreu et al., 2007). These clays 
consist of silicate nanoplates whose structure presents platelet morphology. Once the clays 
have been incorporated into the polymer, the resulting platelets force gases and other 
*Manuscript showing all track changes
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external agents to follow a tortuous path through the material, decreasing and slowing the 
contact with the product obtaining more resistant plastics (Pereira de Abreu et al., 2007; 
AESAN, 2010). 
The Technological Institute of Packaging, Transport and Logistic (ITENE) is developing 
modified clays based in montmorillonite (natural phyllosilicate), one of the main mineral 
clays used to be incorporated in food packaging. The use of functionalized clays, immersed 
and dispersed in the polymers for packaging results in nanocomposite materials, conformed 
by platelets with submicrometer dimensions, except for their thickness, which present 
nanometric dimensions (Hatzigrigoriou et al., 2011). These dispositions allow preventing the 
exchange of oxygen, carbon dioxide and humidity with the food, maintaining its organoleptic 
and nutritional characteristics for a longest period of time (Farhang, 2009). 
 
The nanoscale formulation of materials change physicochemical properties compared with 
the bulk or microstructurated material. Smaller size, higher surface to volume ratio and 
greater reactivity are properties that confer advantages to the use of nanomaterials. 
Moreover, the toxicity and toxic kinetic profile also change, since it cannot be inferred from 
data of their non-nanostructured homologous. Therefore, the potential risk for the health 
and the environment could be modified (EFSA, 2009), making necessary to investigate the 
toxicity profile of these modified clays, even more, taking into account the scarce 
toxicological information available so far. 
 
Considering that the consumer exposure to these nanoclays is likely since they are present in 
the food packaging, it is interesting to evaluate not only the microstructured clay, but also 
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the imbued nanomaterial in the polymer, due to the possible migration to the food product 
(Guillard et al., 2010; EFSA, 2011; Song et al., 2011).  
The EU Commission Regulation N° 10/2011 and the Council Directive 82/711/EEC collect the 
aspects related to plastic materials and articles intended to come in contact with food and 
foodstuffs, as well as the simulants used in the migration assays, and it states that the risk 
assessment should cover the potential migration under worst foreseeable conditions of use 
and the toxicity. Moreover, the Commission Regulation EU nº 10/2011 also establish an 
overall migration limit of 10 mg/dm2, this is plastic materials and articles shall not transfer 
their constituents to food simulants in quantities exceeding 10 milligrams of total 
constituents released per dm2 of food contact surface. 
 
As nanoclays are substances that could be potentially present in food, the oral pathway 
would be the most commonly entry for these substances in the organism. Thus, it would be 
interesting to establish the toxicological profile of the migration extracts with in vitro assays, 
and thereby contribute to the risk assessment of nanomaterials used in food industry, 
claimed by the European Food Safety Authority (EFSA, 2011). In this sense, the present study 
provides a toxicological evaluation of two migration extracts obtained from nanocomposite 
materials with PLA and two modified clays developed by ITENE, Clay1 and Clay2, through 
several cytotoxicity assays on two specific and target cell lines (Caco-2 and HepG2 cells, from 
intestinal and liver origin, respectively) and a mutagenicity assay, the Ames test. 
Moreover, the presence of characteristic metallic elements of the clays structure (Al, Ca, Fe, 
Mg, Si) was also determined in the migration extracts.  
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2. Materials and Methods 
2.1. Supplies and Chemicals 
Minimal Essential Medium (MEM) powder (1x) with Earle´s Salts was obtained from PPA 
laboratories GmbH (Austria) and other cell culture reagents were supplied from Gibco (New 
Zealand). Chemicals for the different assays were provided by Sigma-Aldrich (Spain) and 
VWR International Eurolab (Spain). Protein reagent assay was obtained from BioRad (Spain). 
 
2.2. Cell Culture 
Caco-2 cell line derived from human colon carcinoma (ATCC Nº HTB-37) was maintained at 
37ºC in an atmosphere containing 5% CO2 at 95% relative humidity (CO2 incubator, NuAire, 
Spain), in a medium consisting of Minimum Essential Eagle’s medium (EMEM) supplemented 
with 10% fetal bovine serum (FBS), 1% non-essential amino acids, 50 mg/mL gentamicin, 
1.25 mg/ml fungizone, 2 mM L-glutamine and 1 mM pyruvate. The cells were used at 
passages between 12-21. HepG2 derived from a liver hepatocellular carcinoma (ATCC Nº HB-
8065) was maintained at similar conditions in EMEM supplemented with 10% FBS, 100 U/mL 
penicillin and 100µg/mL streptomycin. Cells were grown near confluence in 75-cm2 plastic 
flasks and harvested each two-three days with 0.25% trypsin. The cells passes used were 16-
32. 
 
2.3. Clays and polymer 
Purified sodium montmorillonite (MMT) (Cloisite® Na+), with cationic exchange capacity (CEC) 
of 116meq/100g was purchased in Southern Clay Products (COMITEX, S.A. Spain). 
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Quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) (C19H42BrN, 
364.46 g/mol, 98%) was supplied from CymitQuímica S.L. (Spain), acetylcholine chloride 
(ACO) (C7H16ClNO2, 181.66 g/mol, ≥99%) was provided by Sigma-Aldrich (Spain). Polylactide 
(PLA) pellets were purchased from Cargill Dow (NatureWorks ® PLA 7032 polymer) for the 
preparation of filled biopolymers (Fig.1). 
 
2.4. Organo-modified nanoclays  
Organo- modified clays have been developed and characterized by ITENE based on previous 
works (Jordá Beneyto et al., 2008; Jordá et al., 2009). Briefly, two different organo-modified 
clays were prepared by a cation-exchange method, which consists on a displacement of the 
sodium cations of Cloisite® Na+ with the ammonium cations of the above mentioned salts, 
obtaining Clay1 and Clay2. Both clays were characterized by Fourier Transform InfraRed 
(FTIR), Wide-angle X-ray Diffraction and Termogravimetric Analysis (TG) following the 
methods described in Jordá- Beneyto et al. (2013). 
 
2.5. Nanocomposites preparation 
Different PLA nanocomposites samples have been obtained with the prepared modified 
clays, Clay1 (MMT + HDTA) and Clay 2 (MMT + HDTA + ACO) with 4 % clay content. For this 
purpose a twin screw extruder DSE 20/40 (COPERION) was used. The twin screw extruder 
was used to prepare the samples through melt- direct intercalation. PLA pellets (dried 
overnight at 90ºC and vacuum for 2 hours (MANN HUMMEL PicolinoDehumidifier)) were 
blended with 4% in weight of Clay1 and Clay2, respectively. Bottles were obtained by 
injection stretch blow moulding (ISBM). An important part of the process is the mechanical 
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stretching of the preform during the moulding process, which helps to increase the impact 
resistance of the container and also helps to produce a very thin walled container, affecting 
final mechanical, thermal and chemical properties of the nanocomposite material.  The 
thermal, mechanical and barrier properties of the materials obtained were analyzed 
following the techniques described in Jordá-Beneyto et al. (2013). 
 
2.6. Migration Extracts   
Migrations extracts of both nanocomposites were provided by ITENE. Migration tests were 
carried out according to UNE-EN 1186-9:2002 (AENOR, 2002). The samples, bottles of 150 
mL of nanocomposite materials PLA+ Clay 1 and PLA+ Clay 2, (123,655 dm2 and 590-598 µm 
thick) were filled with the simulant chosen according to the law (EU Commission Regulation 
N° 10/2011 and Council Directive 82/711/EEC), distilled water, at the specific conditions 
established by the regulations (Temperature(C°): 40; Time (days): 10). Then, all volume of 
simulants were poured into cell glasses and exposed to heat in order to the simulants were 
evaporated. Afterwards, the residues were weighed and compared with control cells glasses 
(without simulants) and the presented difference is the global migration from the simulants. 
Moreover, nanocomposites of PLA -Clay1, and, PLA -Clay2, were also filled with the specific 
culture medium of each cell line used as simulant. Each sample was evaluated by triplicate.  
 
2.7. Analysis of Metal Content in the Migration Extracts 
The presence of characteristic metals of the clays structure in PLA-Clay1, PLA-Clay 2 and only 
PLA (as control) unfiltered extracts was analyzed. Al, Fe and Mg were quantified by (ICP-MS) 
(Agilent 7500C, Agilent ICP-MS Systems, USA). Also, Si and Ca were studied by (ICP-OES) 
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(Horiba Jobin Yvon 2). These determinations were carried out in the Microanalysis service of 
the Research, Technology and Innovation Center of University of Seville (CITIUS) based on 
standard operating protocols.  
 
2.8. Cytotoxicity assays 
Caco-2 and HepG2 cells were seeded in a 96-well tissue-culture plates at 7·x 105 cells/mL, 
and incubated at 37°C for 24 h prior to exposure. Cells were exposed for 24 and 48h to the 
following concentrations: 2.5, 5, 10, 20, 40, 60, 80 and 100% of the migration extracts of 
PLA-Clay1 and PLA-Clay2 reconstituted with powder culture medium. Exposures were also 
performed with culture medium used as simulant in the migration tests. The basal 
cytotoxicity biomarkers assayed were: tetrazolium salt reduction (MTS), neutral red cellular 
uptake (NR) and protein content (PC). 
MTS reduction is carried out by dehydrogenases enzymes present in mitochondria. MTS 
reduction was measured in intact cells according to the procedure of Baltrop et al. (1991). 
The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H 
tetrazolium inner salt) tetrazolium compound added to the medium is bioreduced by cells 
into a colored formazan product soluble in culture medium which is directly measured with 
the spectrophotometer at 490 nm after 3 h of incubation in the dark. The lysosomal uptake 
neutral red (NR) was performed according to Borenfreund and Puerner (1984). The 
absorbance of the extracted NR from the viable cells was measured in a spectrophotometer 
at 540 nm. Protein content (PC) was quantified in situ, according to the procedure given by 
Bradford (1976). The culture medium was replaced by 200 mL NaOH and after 2 h incubation 
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at 37 ºC, 180 µL was replaced by the same volume of a 22% Coomassie Brilliant Blue G-250 
solution. After 30 min incubation at room temperature absorbance was read at 620 nm. 
 
2.9. Ames test 
The incorporation version of the Ames test was performed according to the 
recommendations of Maron and Ames (1983) and following the principles of OCDE guideline 
471 (1997). Five Salmonella typhimurium histidine-auxotrophic strains TA97A, TA98, TA100, 
TA102 and TA104 were used for the assay. Cultures of each tester strain were prepared from 
their main strain plates, and use in late exponential growth phase. Each test substance was 
assessed in three independent experiments, each conducted in absence and presence of S9 
metabolic activation system from rats livers (Aroclor 1254, Sigma, Spain), using triplicate 
plates for each test substance concentration. Both extracts were tested in five different 
concentrations (20%, 40%, 60%, 80%, 100%).  Briefly, 0.1mL of test substance, 0.1mL of 
bacterial culture and 0.5mL of S9 mix, were added to 2mL molten agar at 42° and poured 
onto Vogel Bonner-E minimal glucose agar plates. Plates were inverted and incubated 65-70 
h at 37°C in the dark. Revertant colonies were counted and background lawn was inspected 
for signs of toxicity or compound precipitation. 2-Nitrofluorene (2-NF) (0.1 µg/plate) and 
sodium azide (NaN3) (1 µg/plate) were selected as positive controls. 
 
2.10. Calculations and statistical analysis 
All experiments were performed three times and at least in triplicate per concentration. 
Data of all experiments were presented as the arithmetic mean percentage ± standard 
deviation (SD) in relation to control group, being unexposed cells. Statistical analysis was 
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carried out using analysis of variance (ANOVA), followed by Dunnett’s multiple comparison 
tests using GraphPadInStat software (GraphPadSoftware Inc., La Jolla, USA). The normality of 
the distribution and the homogeneity of variances were confirmed using Kolmogorov and 
Smirnov’s test, and Bartlett´s test, respectively. Differences were considered significant from 
p< 0.05. 
 
3. Results 
3.1. Migration Extracts of PLA-Clay1 and PLA-Clay2. 
Overall migration tests were carried out in 150 mL bottles of nanocomposite materials 
(123.655104 cm2 total area) according to UNE-EN 1186-9 standard (2002). The results 
showed values of 0.1 ± 0.2 mg/dm2 for each sample.  
 
3.2. Metal Content on the Migration Extracts 
Aluminum contents of the control and PLA-Clay2 extract were lower than the limit of 
detection (LOD) and quantitation (LOQ) of the technique, respectively (Table 1). However 
PLA-Clay1 extract showed 0.7± 0.2 µg/L Al. Ca contents could not be quantified in any 
sample. Similarly, Fe contents were ≤ LOD in all the samples. Mg contents in PLA-Clay1 
showed the highest value in comparison to PLA and PLA-Clay2 extracts. Finally, Si was the 
most abundant element, showing similar contents in PLA and PLA-Clay1, but lower content 
was presented in PLA-Clay2. Overall, the metal levels found were very low and always under 
the currently values permitted by the European Union (Commission Regulation EU nº 
10/2011). 
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3.3. Basal Cytotoxicity assays  
3.3.1. Migration Extract of PLA-Clay1 in Caco-2 and HepG2 cell lines. 
The migration extract of PLA-Clay1 showed no cytotoxic effects on Caco-2 cells in the three 
biomarkers assayed. In the MTS assay, no significant differences with respect the control 
were observed in any concentration assayed after 24 and 48 h exposure (Fig. 2A). Similar 
results were obtained with neutral red uptake (Fig. 2B); no significant differences were 
observed from 0% to 100% after 24 and 48 h of exposure. Regarding protein content, the 
same pattern was followed in this endpoint; however, lower results were observed after 48h 
of exposure respect to 24h (Fig.2C).  
The results obtained in the MTS, NR and PC assays for the HepG2 cell line exposed to the 
migration extract of PLA-Clay1 did not show significant differences with respect to control 
group in any of the concentrations assayed after 24 and 48 h of exposure (data not 
shownFig. 3).  
 
3.3.2. Migration extract of PLA-Clay2 in Caco-2 and HepG2 cell lines. 
When Caco-2 cells were exposed to the migration extract of PLA-Clay 2 similar results were 
observed to those obtained with the migration extract of PLA-Clay1 in the same cell line. No 
evidence of cytotoxicity was observed in any of the biomarkers assayed (Fig. 34). 
The results observed when HepG2 cells were exposed to the migration extracts of PLA-Clay 2 
did not show significant differences at the range of concentrations assayed after 24 and 48 h 
of exposure in the MTS metabolization, NR uptake and PC assay (data not shown) (Fig. 5).  
However, in the three biomarkers, a higher effect was observed at 48h of exposure, 
although it was not significantly different from the control group. 
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The absence of cytotoxic effects was also observed when cells were exposed to the cell 
culture medium used as simulant. 
 
3.4. Ames test 
After exposure to PLA-Clay1 and PLA-Clay2 there was no increase in the number of 
revertants and no indication of mutagenic activity in any of the treated strains up to the 
highest concentration (100%) of the extracts, either in the presence or absence of S9 ( Table 
2). Toxicity, measured as a decrease in background lawn and in revertant frequency, was not 
observed at any concentration tested. Positive controls produced statistically significant 
increases (p<0.01) in the number of revertant colonies, confirming the sensitivity of the test 
system and the activity of the S9 mix. It was concluded that both extracts were not 
genotoxic in this bacterial assay. 
  
4. Discussion 
There is a major concern about food safety of packaging materials relative to the possible 
migration of packaging constituents, even more when the packaging is produced by a novel 
technology. In the present research work, in order to evaluate novel nanocomposite 
materials intended to be used in food packaging, several in vitro toxicity studies have been 
performed with their migration extracts. 
The results obtained in the migration tests with the two nanocomposite materials employed 
are the first reported for these compounds since they have been developed by our research 
group and they are not yet commercialized. The values obtained are below the migration 
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limits required by the legislation (Commission Regulation (UE) Nº 10/2011), which 
establishes that the plastic materials should not release more than 10 mg of substance per 1 
dm2 of the plastic surface. Other researchers have evaluated several modified polymers with 
other different modified clays, including in some cases MMT. Thus, Schmidt et al. (2012), 
Busolo et al. (2012) or Avella et al. (2005) also found migration levels in accordance with the 
EU legislation. Nevertheless, Commission Regulation (UE) Nº 10/2011 establishes that these 
substances (nanoparticles) should be assessed on a case-by-case basis as regards their risk 
until more information is known about such new technology. 
 
Cytotoxicity assays on Caco-2 and HepG2 cells exposed to migration extracts of the 
nanocomposite materials showed similar results in both cases. No significant differences 
were observed in the range of concentrations assayed, and total cell viability was unaltered 
in all cases. These results confirm that the migration extracts of the nanocomposite 
materials containing Clay1 and Clay2 are not cytotoxic at the conditions assayed. This could 
be considered an important start-point for the potential commercial launch of these 
nanocomposites for food packaging applications considering that consumer’s safety is 
requested. 
Scarce studies have reported so far regarding to cytotoxic effects induced by extracts of 
nanocomposite materials and modified montmorillonite clays. Rodrigues da Silva et al. 
(2010) observed the biocompatibility and cytotoxicity of the biodegradation products of two 
modified polyurethanes (PUD) intended to medical applications; PUD5 that contains poly 
(caprolactone) as soft segment, and PUD6, which has poly (caprolactone) and poly (ethylene 
glycol) as soft segment, with montomorillonite. After 48h, at 3:10 ratio, the cell viability of 
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the human retinal pigment epithelial cell (ARPE-19), measured by mitochondrial conversion 
of the tetrazolium salt, 3-[4,5- dimethylthiazol-2-yl]-2,5-dipheniltetrazolium bromide (MTT), 
decreased in the modified polyurethanes and nanocomposites supplemented mediums (94,2 
± 3,26 %), although the statistical analysis showed no significant differences on the viability 
of ARPE-19 cells cultures in the PUD supplemented and control mediums. Fukushima et al. 
(2012) also studied the cytotoxicity of the degradation products of poly(butylenesadipate-
co-terephthalate)(PBAT) modified with modified and unmodified montmorillonites, and 
other two clays, modified and unmodified fluorohectorites and unmodified sepiolite 
(intended to medical and industrial applications). This research group evaluated the 
biocompatibility of PBTA and nanocomposites with 10% of clay content trough an in vitro 
cytotoxicity and a protein adsorption test, chosen as experiment model fibroblast 929 cells. 
Cell viability and morphology were measured using MTT assay and inverted microscopy, 
respectively, after 0, 24, 72 and 120 h of incubation with a dilution of each extract. MTT 
results revealed no visible reduction in viability between the negative control and 
experimental groups at all times assayed. At the same time, PBAT and nanocomposites 
showed similar increases in the relative cell growth depending on the time of incubation, 
evaluated by direct observation from micrographs, evidencing that the addition of the 
nanoparticles did not induced further cytotoxic effects in L929 cells. In addition, the 
cytotoxicity of degradation products of chitin based polyurethane bio-nanocomposites 
(PUBNC), intended to food packaging, and prepared with bentonite nanoclay enriched in 
montmorillonite (MMT) and other compounds have been investigated by Zia et al. (2011). 
The cytotoxicity was measured by live/dead staining of L-929 fibroblast cells exposed to 
different concentrations of degradation products of the nanocomposite material, 0, 1, 2, 4 
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and 8% clay content showing significant differences in the groups containing  2-8% of 
bentonite nanoclay with respect to control and 1% bentonite content group. 
 
Interestingly, the cytotoxicity results obtained with the migration extracts from 
nanocomposites containing Clay1 and Clay2 differs from the in vitro evaluation of the initial 
microstructured clays. In previous studies carried out in our laboratory, no cytotoxic effects 
were observed in HepG2 cells exposed to Clay1 from 0 to 8 µg/mL (no higher concentrations 
could be tested due to its hydrophobicity) after 24 and 48 h (Houtman et al., 2013). 
However, our research group observed significant cytotoxicity effects on HepG2 exposed to 
Clay 2, in a range of 0 to 125 µg/mL during 24 and 48h, obtaining mean effective 
concentration (EC50) values for the MTS assay of 88 and 51 µg/mL, respectively (Houtman et 
al.,2013, Jordá-Beneyto et al., 2013). Similarly, no effect was recorded in Caco-2 cells 
exposed to Clay1, although in the case of Clay2, EC50 values of 34 and 18.5 µg/mL after 24 
and 48h, respectively were found for the PC. Overall, Clay1 did not show cytotoxic effects in 
any case, whereas Clay2 in its microstructured formulation seems to be toxic on HepG2 and 
Caco-2 cells; but no toxicity was found once the clay was imbued in the polymer. 
 
A test for induction of gene mutations in bacteria is among the core set of toxicological tests 
required in the Guidelines of the Scientific Committee on Food for the presentation of an 
application for safety assessment of a substance to be used in food contact materials prior to 
its authorization (European Commission 2001). In the present study any of the extracts have 
shown mutagenic potential with and without metabolic activation. Sharma et al. (2010) also 
observed no mutagenic activity in TA98 and TA100 exposed to filtered and unfiltered 
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suspensions of purified sodium MMT (Cloisite® Na+) and the commercial organoclay Cloisite® 
30B. Also, Li et al. (2010) evaluated the mutagenic potential of exfoliated silicate nanoclay in 
TA98, TA100, TA1535, TA1537 and TA102. In this case, revertants colonies were not present 
in any strain assayed compared to the negative control plates, in presence or absence of S9. 
The absence of a toxic response in this test is in accordance with the results obtained in the 
cytotoxicity studies.  
 
Regarding the study about the presence of metals in the migration extracts, no significant 
differences were observed in the analysis. However, Avella et al. (2005) studied the metals 
migration from nanocomposites films with potato starch and montmorillonite to lettuce and 
spinach. No differences were observed in Fe and Mg content in the vegetables, while a 
higher Si content was observed. This finding could be easily attributable to the fact that clay 
nanoparticles are mainly composed of this element. On the other hand, Busolo et al. (2012) 
investigated the migration of Al and Fe from polyolefin nanocomposite films containing an 
iron modified kaolinite with two simulants, water and isooctane, and, no differences were 
observed in any samples assayed.  
 
 
5. Conclusion 
The global migration obtained for the nanocomposites assayed was below the legislation 
recommendations, as well as their metallic content. Moreover, no cytotoxic and genotoxic 
effects were observed with the migrations extracts. Thus, the nanocomposites assayed seem 
to be safe for their use in food packaging applications. However, Ffurther toxicological 
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studies are needed to confirm the safety of these nanocomposites for their use in food 
packaging applicationsconfirm this hypothesis.  
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Table captions 
Table 1. Al, Ca, Fe, Mg and Si content in the migration extracts from PLA, PLA-Clay1 and PLA-
Clay2 bottles (all the concentrations are expressed in µg/L).  
 
Table 2. Results of Ames test conducted with PLA-Clay1 and PLA-Clay2 extracts for three 
independent experiments. Water was used as negative control and DMSO as solvent for 
positive controls. Data are given as mean±SD revertants/plate for three replicates for each 
concentration in each experiment. Positive controls: TA97A/ TA98/ TA102/ TA104 with and 
without S9: 2-NF (0.1 µg/plate) and TA100 with and without S9: NaN3 (1µg/plate). **p<0.01 
significantly different from control. 
 
Figure captions 
Figure 1. Structure of the quaternary ammonium salts: Acetylcholine chloride (a) and 
Hexadecyltrimethylammonium bromide (b) used to modify the montmorillonite. 
Figure 2.  Cytotoxicity assays: MTS metabolism (A), neutral red uptake (B) and total protein 
content (C) in Caco-2 cells after 24 and 48 h of exposure to 0 – 100% PLA-Clay1 migration 
extract (n=3). All values are expressed as mean ± SD. *Significantly different from control (p 
≤ 0.05). 
Figure 3. Cytotoxicity assays: MTS metabolism (A), neutral red uptake (B) and total protein 
content (C) in HepG2 cells after 24 and 48 h of exposure to 0 – 100% PLA-Clay1 migration 
extract (n=3). All values are expressed as mean ± SD. *Significantly different from control (p 
≤ 0.05). 
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Figure 34. Cytotoxicity assays: MTS metabolism (A), neutral red uptake (B) and total protein 
content (C) in Caco-2 cells after 24 and 48 h of exposure to 0 – 100% PLA-Clay2 migration 
extract (n=3). All values are expressed as mean ± SD. *Significantly different from control (p 
≤ 0.05). 
Figure 5. Cytotoxicity assays: MTS metabolism (A), neutral red uptake (B) and total protein 
content (C) in HepG2 cells after 24 and 48 h of exposure to 0 – 100% PLA-Clay2 migration 
extract (n=3). All values are expressed as mean ± SD. *Significantly different from control (p 
≤ 0.05). 
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1. Introduction 
Nanotechnology is a science that involves research and technology development at the 
atomic, molecular and macromolecular levels, aimed at creating and using structures, 
devices, and systems with novel properties and functions based on their small size (Farhang, 
2009). Nanotechnology has opened up new avenues of research and development in 
numerous fields, including medicine, cosmetic and agro-food area (Chaundry et al., 2008). 
The application of this technology in food and agriculture plays an important role in 
improving production, processing, storage, transportation, traceability, safety and security of 
food (Chaundry et al., 2008). Among the wide range of applications of nanomaterials in the 
food industry, the one with the main development in the near future is their employ as food 
contact materials (AESAN, 2010). Nanomaterials have demonstrated to possess novel 
characteristics that can be applied in developing new packaging with better properties than 
packaging produced with micromaterials (Pereira de Abreu et al., 2007). The resulting 
materials, which are frequently polymers with nanoparticles incorporated in their structure, 
present improvements of barrier properties, such as thermal, mechanical or permeability 
characteristics, providing innovative solutions to increase the performance of the polymers 
(Silvestre et al., 2011). Therefore, nanotechnology plays an important role in the 
preservation of perishable food.  
 
Among the most commonly used materials in food packaging are nanocomposites based on 
organic polymers and inorganic clay minerals (Pereira de Abreu et al., 2007). These clays 
consist of silicate nanoplates whose structure presents platelet morphology. Once the clays 
have been incorporated into the polymer, the resulting platelets force gases and other 
*Manuscript for revision (track changes hidden)
Click here to view linked References
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external agents to follow a tortuous path through the material, decreasing and slowing the 
contact with the product obtaining more resistant plastics (Pereira de Abreu et al., 2007; 
AESAN, 2010). 
The Technological Institute of Packaging, Transport and Logistic (ITENE) is developing 
modified clays based in montmorillonite (natural phyllosilicate), one of the main mineral 
clays used to be incorporated in food packaging. The use of functionalized clays, immersed 
and dispersed in the polymers for packaging results in nanocomposite materials, conformed 
by platelets with submicrometer dimensions, except for their thickness, which present 
nanometric dimensions (Hatzigrigoriou et al., 2011). These dispositions allow preventing the 
exchange of oxygen, carbon dioxide and humidity with the food, maintaining its organoleptic 
and nutritional characteristics for a longest period of time (Farhang, 2009). 
 
The nanoscale formulation of materials change physicochemical properties compared with 
the bulk or microstructurated material. Smaller size, higher surface to volume ratio and 
greater reactivity are properties that confer advantages to the use of nanomaterials. 
Moreover, the toxicity and toxic kinetic profile also change, since it cannot be inferred from 
data of their non-nanostructured homologous. Therefore, the potential risk for the health 
and the environment could be modified (EFSA, 2009), making necessary to investigate the 
toxicity profile of these modified clays, even more, taking into account the scarce 
toxicological information available so far. 
 
Considering that the consumer exposure to these nanoclays is likely since they are present in 
the food packaging, it is interesting to evaluate not only the microstructured clay, but also 
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the imbued nanomaterial in the polymer, due to the possible migration to the food product 
(Guillard et al., 2010; EFSA, 2011; Song et al., 2011).  
The EU Commission Regulation N° 10/2011 and the Council Directive 82/711/EEC collect the 
aspects related to plastic materials and articles intended to come in contact with food and 
foodstuffs, as well as the simulants used in the migration assays, and it states that the risk 
assessment should cover the potential migration under worst foreseeable conditions of use 
and the toxicity. Moreover, the Commission Regulation EU nº 10/2011 also establish an 
overall migration limit of 10 mg/dm2, this is plastic materials and articles shall not transfer 
their constituents to food simulants in quantities exceeding 10 milligrams of total 
constituents released per dm2 of food contact surface. 
 
As nanoclays are substances that could be potentially present in food, the oral pathway 
would be the most commonly entry for these substances in the organism. Thus, it would be 
interesting to establish the toxicological profile of the migration extracts with in vitro assays, 
and thereby contribute to the risk assessment of nanomaterials used in food industry, 
claimed by the European Food Safety Authority (EFSA, 2011). In this sense, the present study 
provides a toxicological evaluation of two migration extracts obtained from nanocomposite 
materials with PLA and two modified clays developed by ITENE, Clay1 and Clay2, through 
several cytotoxicity assays on two specific and target cell lines (Caco-2 and HepG2 cells, from 
intestinal and liver origin, respectively) and a mutagenicity assay, the Ames test. 
Moreover, the presence of characteristic metallic elements of the clays structure (Al, Ca, Fe, 
Mg, Si) was also determined in the migration extracts.  
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2. Materials and Methods 
2.1. Supplies and Chemicals 
Minimal Essential Medium (MEM) powder (1x) with Earle´s Salts was obtained from PPA 
laboratories GmbH (Austria) and other cell culture reagents were supplied from Gibco (New 
Zealand). Chemicals for the different assays were provided by Sigma-Aldrich (Spain) and 
VWR International Eurolab (Spain). Protein reagent assay was obtained from BioRad (Spain). 
 
2.2. Cell Culture 
Caco-2 cell line derived from human colon carcinoma (ATCC Nº HTB-37) was maintained at 
37ºC in an atmosphere containing 5% CO2 at 95% relative humidity (CO2 incubator, NuAire, 
Spain), in a medium consisting of Minimum Essential Eagle’s medium (EMEM) supplemented 
with 10% fetal bovine serum (FBS), 1% non-essential amino acids, 50 mg/mL gentamicin, 
1.25 mg/ml fungizone, 2 mM L-glutamine and 1 mM pyruvate. The cells were used at 
passages between 12-21. HepG2 derived from a liver hepatocellular carcinoma (ATCC Nº HB-
8065) was maintained at similar conditions in EMEM supplemented with 10% FBS, 100 U/mL 
penicillin and 100µg/mL streptomycin. Cells were grown near confluence in 75-cm2 plastic 
flasks and harvested each two-three days with 0.25% trypsin. The cells passes used were 16-
32. 
 
2.3. Clays and polymer 
Purified sodium montmorillonite (MMT) (Cloisite® Na+), with cationic exchange capacity (CEC) 
of 116meq/100g was purchased in Southern Clay Products (COMITEX, S.A. Spain). 
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Quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) (C19H42BrN, 
364.46 g/mol, 98%) was supplied from CymitQuímica S.L. (Spain), acetylcholine chloride 
(ACO) (C7H16ClNO2, 181.66 g/mol, ≥99%) was provided by Sigma-Aldrich (Spain). Polylactide 
(PLA) pellets were purchased from Cargill Dow (NatureWorks ® PLA 7032 polymer) for the 
preparation of filled biopolymers (Fig.1). 
 
2.4. Organo-modified nanoclays  
Organo- modified clays have been developed and characterized by ITENE based on previous 
works (Jordá Beneyto et al., 2008; Jordá et al., 2009). Briefly, two different organo-modified 
clays were prepared by a cation-exchange method, which consists on a displacement of the 
sodium cations of Cloisite® Na+ with the ammonium cations of the above mentioned salts, 
obtaining Clay1 and Clay2. Both clays were characterized by Fourier Transform InfraRed 
(FTIR), Wide-angle X-ray Diffraction and Termogravimetric Analysis (TG) following the 
methods described in Jordá- Beneyto et al. (2013). 
 
2.5. Nanocomposites preparation 
Different PLA nanocomposites samples have been obtained with the prepared modified 
clays, Clay1 (MMT + HDTA) and Clay 2 (MMT + HDTA + ACO) with 4 % clay content. For this 
purpose a twin screw extruder DSE 20/40 (COPERION) was used. The twin screw extruder 
was used to prepare the samples through melt- direct intercalation. PLA pellets (dried 
overnight at 90ºC and vacuum for 2 hours (MANN HUMMEL PicolinoDehumidifier)) were 
blended with 4% in weight of Clay1 and Clay2, respectively. Bottles were obtained by 
injection stretch blow moulding (ISBM). An important part of the process is the mechanical 
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stretching of the preform during the moulding process, which helps to increase the impact 
resistance of the container and also helps to produce a very thin walled container, affecting 
final mechanical, thermal and chemical properties of the nanocomposite material.  The 
thermal, mechanical and barrier properties of the materials obtained were analyzed 
following the techniques described in Jordá-Beneyto et al. (2013). 
 
2.6. Migration Extracts   
Migrations extracts of both nanocomposites were provided by ITENE. Migration tests were 
carried out according to UNE-EN 1186-9:2002 (AENOR, 2002). The samples, bottles of 150 
mL of nanocomposite materials PLA+ Clay 1 and PLA+ Clay 2, (123,655 dm2 and 590-598 µm 
thick) were filled with the simulant chosen according to the law (EU Commission Regulation 
N° 10/2011 and Council Directive 82/711/EEC), distilled water, at the specific conditions 
established by the regulations (Temperature(C°): 40; Time (days): 10). Then, all volume of 
simulants were poured into cell glasses and exposed to heat in order to the simulants were 
evaporated. Afterwards, the residues were weighed and compared with control cells glasses 
(without simulants) and the presented difference is the global migration from the simulants. 
Moreover, nanocomposites of PLA -Clay1, and, PLA -Clay2, were also filled with the specific 
culture medium of each cell line used as simulant. Each sample was evaluated by triplicate.  
 
2.7. Analysis of Metal Content in the Migration Extracts 
The presence of characteristic metals of the clays structure in PLA-Clay1, PLA-Clay2 and only 
PLA (as control) unfiltered extracts was analyzed. Al, Fe and Mg were quantified by (ICP-MS) 
(Agilent 7500C, Agilent ICP-MS Systems, USA). Also, Si and Ca were studied by (ICP-OES) 
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(Horiba Jobin Yvon 2). These determinations were carried out in the Microanalysis service of 
the Research, Technology and Innovation Center of University of Seville (CITIUS) based on 
standard operating protocols.  
 
2.8. Cytotoxicity assays 
Caco-2 and HepG2 cells were seeded in a 96-well tissue-culture plates at 7·x 105 cells/mL, 
and incubated at 37°C for 24 h prior to exposure. Cells were exposed for 24 and 48h to the 
following concentrations: 2.5, 5, 10, 20, 40, 60, 80 and 100% of the migration extracts of 
PLA-Clay1 and PLA-Clay2 reconstituted with powder culture medium. Exposures were also 
performed with culture medium used as simulant in the migration tests. The basal 
cytotoxicity biomarkers assayed were: tetrazolium salt reduction (MTS), neutral red cellular 
uptake (NR) and protein content (PC). 
MTS reduction is carried out by dehydrogenases enzymes present in mitochondria. MTS 
reduction was measured in intact cells according to the procedure of Baltrop et al. (1991). 
The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H 
tetrazolium inner salt) tetrazolium compound added to the medium is bioreduced by cells 
into a colored formazan product soluble in culture medium which is directly measured with 
the spectrophotometer at 490 nm after 3 h of incubation in the dark. The lysosomal uptake 
neutral red (NR) was performed according to Borenfreund and Puerner (1984). The 
absorbance of the extracted NR from the viable cells was measured in a spectrophotometer 
at 540 nm. Protein content (PC) was quantified in situ, according to the procedure given by 
Bradford (1976). The culture medium was replaced by 200 mL NaOH and after 2 h incubation 
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at 37 ºC, 180 µL was replaced by the same volume of a 22% Coomassie Brilliant Blue G-250 
solution. After 30 min incubation at room temperature absorbance was read at 620 nm. 
 
2.9. Ames test 
The incorporation version of the Ames test was performed according to the 
recommendations of Maron and Ames (1983) and following the principles of OCDE guideline 
471 (1997). Five Salmonella typhimurium histidine-auxotrophic strains TA97A, TA98, TA100, 
TA102 and TA104 were used for the assay. Cultures of each tester strain were prepared from 
their main strain plates, and use in late exponential growth phase. Each test substance was 
assessed in three independent experiments, each conducted in absence and presence of S9 
metabolic activation system from rats livers (Aroclor 1254, Sigma, Spain), using triplicate 
plates for each test substance concentration. Both extracts were tested in five different 
concentrations (20%, 40%, 60%, 80%, 100%).  Briefly, 0.1mL of test substance, 0.1mL of 
bacterial culture and 0.5mL of S9 mix, were added to 2mL molten agar at 42° and poured 
onto Vogel Bonner-E minimal glucose agar plates. Plates were inverted and incubated 65-70 
h at 37°C in the dark. Revertant colonies were counted and background lawn was inspected 
for signs of toxicity or compound precipitation. 2-Nitrofluorene (2-NF) (0.1 µg/plate) and 
sodium azide (NaN3) (1 µg/plate) were selected as positive controls. 
 
2.10. Calculations and statistical analysis 
All experiments were performed three times and at least in triplicate per concentration. 
Data of all experiments were presented as the arithmetic mean percentage ± standard 
deviation (SD) in relation to control group, being unexposed cells. Statistical analysis was 
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carried out using analysis of variance (ANOVA), followed by Dunnett’s multiple comparison 
tests using GraphPadInStat software (GraphPadSoftware Inc., La Jolla, USA). The normality of 
the distribution and the homogeneity of variances were confirmed using Kolmogorov and 
Smirnov’s test, and Bartlett´s test, respectively. Differences were considered significant from 
p< 0.05. 
 
3. Results 
3.1. Migration Extracts of PLA-Clay1 and PLA-Clay2. 
Overall migration tests were carried out in 150 mL bottles of nanocomposite materials 
(123.655104 cm2 total area) according to UNE-EN 1186-9 standard (2002). The results 
showed values of 0.1 ± 0.2 mg/dm2 for each sample.  
 
3.2. Metal Content on the Migration Extracts 
Aluminum contents of the control and PLA-Clay2 extract were lower than the limit of 
detection (LOD) and quantitation (LOQ) of the technique, respectively (Table 1). However 
PLA-Clay1 extract showed 0.7± 0.2 µg/L Al. Ca contents could not be quantified in any 
sample. Similarly, Fe contents were ≤ LOD in all the samples. Mg contents in PLA-Clay1 
showed the highest value in comparison to PLA and PLA-Clay2 extracts. Finally, Si was the 
most abundant element, showing similar contents in PLA and PLA-Clay1, but lower content 
was presented in PLA-Clay2. Overall, the metal levels found were very low and always under 
the currently values permitted by the European Union (Commission Regulation EU nº 
10/2011). 
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3.3. Basal Cytotoxicity assays  
3.3.1. Migration Extract of PLA-Clay1 in Caco-2 and HepG2 cell lines. 
The migration extract of PLA-Clay1 showed no cytotoxic effects on Caco-2 cells in the three 
biomarkers assayed. In the MTS assay, no significant differences with respect the control 
were observed in any concentration assayed after 24 and 48 h exposure (Fig. 2A). Similar 
results were obtained with neutral red uptake (Fig. 2B); no significant differences were 
observed from 0% to 100% after 24 and 48 h of exposure. Regarding protein content, the 
same pattern was followed in this endpoint; however, lower results were observed after 48h 
of exposure respect to 24h (Fig.2C).  
The results obtained in the MTS, NR and PC assays for the HepG2 cell line exposed to the 
migration extract of PLA-Clay1 did not show significant differences with respect to control 
group in any of the concentrations assayed after 24 and 48 h of exposure (data not shown).  
 
3.3.2. Migration extract of PLA-Clay2 in Caco-2 and HepG2 cell lines. 
When Caco-2 cells were exposed to the migration extract of PLA-Clay2 similar results were 
observed to those obtained with the migration extract of PLA-Clay1 in the same cell line. No 
evidence of cytotoxicity was observed in any of the biomarkers assayed (Fig. 3). 
The results observed when HepG2 cells were exposed to the migration extracts of PLA-Clay2 
did not show significant differences at the range of concentrations assayed after 24 and 48 h 
of exposure in the MTS metabolization, NR uptake and PC assay(data not shown).  
The absence of cytotoxic effects was also observed when cells were exposed to the cell 
culture medium used as simulant. 
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3.4. Ames test 
After exposure to PLA-Clay1 and PLA-Clay2 there was no increase in the number of 
revertants and no indication of mutagenic activity in any of the treated strains up to the 
highest concentration (100%) of the extracts, either in the presence or absence of S9 ( Table 
2). Toxicity, measured as a decrease in background lawn and in revertant frequency, was not 
observed at any concentration tested. Positive controls produced statistically significant 
increases (p<0.01) in the number of revertant colonies, confirming the sensitivity of the test 
system and the activity of the S9 mix. It was concluded that both extracts were not 
genotoxic in this bacterial assay. 
  
4. Discussion 
There is a major concern about food safety of packaging materials relative to the possible 
migration of packaging constituents, even more when the packaging is produced by a novel 
technology. In the present research work, in order to evaluate novel nanocomposite 
materials intended to be used in food packaging, several in vitro toxicity studies have been 
performed with their migration extracts. 
The results obtained in the migration tests with the two nanocomposite materials employed 
are the first reported for these compounds since they have been developed by our research 
group and they are not yet commercialized. The values obtained are below the migration 
limits required by the legislation (Commission Regulation (UE) Nº 10/2011), which 
establishes that the plastic materials should not release more than 10 mg of substance per 1 
dm2 of the plastic surface. Other researchers have evaluated several modified polymers with 
other different modified clays, including in some cases MMT. Thus, Schmidt et al. (2012), 
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Busolo et al. (2012) or Avella et al. (2005) also found migration levels in accordance with the 
EU legislation. Nevertheless, Commission Regulation (UE) Nº 10/2011 establishes that these 
substances (nanoparticles) should be assessed on a case-by-case basis as regards their risk 
until more information is known about such new technology. 
 
Cytotoxicity assays on Caco-2 and HepG2 cells exposed to migration extracts of the 
nanocomposite materials showed similar results in both cases. No significant differences 
were observed in the range of concentrations assayed, and total cell viability was unaltered 
in all cases. These results confirm that the migration extracts of the nanocomposite 
materials containing Clay1 and Clay2 are not cytotoxic at the conditions assayed. This could 
be considered an important start-point for the potential commercial launch of these 
nanocomposites for food packaging applications considering that consumer’s safety is 
requested. 
Scarce studies have reported so far regarding to cytotoxic effects induced by extracts of 
nanocomposite materials and modified montmorillonite clays. Rodrigues da Silva et al. 
(2010) observed the biocompatibility and cytotoxicity of the biodegradation products of two 
modified polyurethanes (PUD) intended to medical applications; PUD5 that contains poly 
(caprolactone) as soft segment, and PUD6, which has poly (caprolactone) and poly (ethylene 
glycol) as soft segment, with montomorillonite. After 48h, at 3:10 ratio, the cell viability of 
the human retinal pigment epithelial cell (ARPE-19), measured by mitochondrial conversion 
of the tetrazolium salt, 3-[4,5- dimethylthiazol-2-yl]-2,5-dipheniltetrazolium bromide (MTT), 
decreased in the modified polyurethanes and nanocomposites supplemented mediums (94,2 
± 3,26 %), although the statistical analysis showed no significant differences on the viability 
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of ARPE-19 cells cultures in the PUD supplemented and control mediums. Fukushima et al. 
(2012) also studied the cytotoxicity of the degradation products of poly(butylenesadipate-
co-terephthalate)(PBAT) modified with modified and unmodified montmorillonites, and 
other two clays, modified and unmodified fluorohectorites and unmodified sepiolite 
(intended to medical and industrial applications). This research group evaluated the 
biocompatibility of PBTA and nanocomposites with 10% of clay content trough an in vitro 
cytotoxicity and a protein adsorption test, chosen as experiment model fibroblast 929 cells. 
Cell viability and morphology were measured using MTT assay and inverted microscopy, 
respectively, after 0, 24, 72 and 120 h of incubation with a dilution of each extract. MTT 
results revealed no visible reduction in viability between the negative control and 
experimental groups at all times assayed. At the same time, PBAT and nanocomposites 
showed similar increases in the relative cell growth depending on the time of incubation, 
evaluated by direct observation from micrographs, evidencing that the addition of the 
nanoparticles did not induced further cytotoxic effects in L929 cells. In addition, the 
cytotoxicity of degradation products of chitin based polyurethane bio-nanocomposites 
(PUBNC), intended to food packaging, and prepared with bentonite nanoclay enriched in 
montmorillonite (MMT) and other compounds have been investigated by Zia et al. (2011). 
The cytotoxicity was measured by live/dead staining of L-929 fibroblast cells exposed to 
different concentrations of degradation products of the nanocomposite material, 0, 1, 2, 4 
and 8% clay content showing significant differences in the groups containing  2-8% of 
bentonite nanoclay with respect to control and 1% bentonite content group. 
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Interestingly, the cytotoxicity results obtained with the migration extracts from 
nanocomposites containing Clay1 and Clay2 differs from the in vitro evaluation of the initial 
microstructured clays. In previous studies carried out in our laboratory, no cytotoxic effects 
were observed in HepG2 cells exposed to Clay1 from 0 to 8 µg/mL (no higher concentrations 
could be tested due to its hydrophobicity) after 24 and 48 h (Houtman et al., 2013). 
However, our research group observed significant cytotoxicity effects on HepG2 exposed to 
Clay2, in a range of 0 to 125 µg/mL during 24 and 48h, obtaining mean effective 
concentration (EC50) values for the MTS assay of 88 and 51 µg/mL, respectively (Houtman et 
al.,2013, Jordá-Beneyto et al., 2013). Similarly, no effect was recorded in Caco-2 cells 
exposed to Clay1, although in the case of Clay2, EC50 values of 34 and 18.5 µg/mL after 24 
and 48h, respectively were found for the PC. Overall, Clay1 did not show cytotoxic effects in 
any case, whereas Clay2 in its microstructured formulation seems to be toxic on HepG2 and 
Caco-2 cells; but no toxicity was found once the clay was imbued in the polymer. 
 
A test for induction of gene mutations in bacteria is among the core set of toxicological tests 
required in the Guidelines of the Scientific Committee on Food for the presentation of an 
application for safety assessment of a substance to be used in food contact materials prior to 
its authorization (European Commission 2001). In the present study any of the extracts have 
shown mutagenic potential with and without metabolic activation. Sharma et al. (2010) also 
observed no mutagenic activity in TA98 and TA100 exposed to filtered and unfiltered 
suspensions of purified sodium MMT (Cloisite® Na+) and the commercial organoclay Cloisite® 
30B. Also, Li et al. (2010) evaluated the mutagenic potential of exfoliated silicate nanoclay in 
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TA98, TA100, TA1535, TA1537 and TA102. In this case, revertants colonies were not present 
in any strain assayed compared to the negative control plates, in presence or absence of S9. 
The absence of a toxic response in this test is in accordance with the results obtained in the 
cytotoxicity studies.  
 
Regarding the study about the presence of metals in the migration extracts, no significant 
differences were observed in the analysis. However, Avella et al. (2005) studied the metals 
migration from nanocomposites films with potato starch and montmorillonite to lettuce and 
spinach. No differences were observed in Fe and Mg content in the vegetables, while a 
higher Si content was observed. This finding could be easily attributable to the fact that clay 
nanoparticles are mainly composed of this element. On the other hand, Busolo et al. (2012) 
investigated the migration of Al and Fe from polyolefin nanocomposite films containing an 
iron modified kaolinite with two simulants, water and isooctane, and, no differences were 
observed in any samples assayed.  
 
 
5. Conclusion 
The global migration obtained for the nanocomposites assayed was below the legislation 
recommendations, as well as their metallic content. Moreover, no cytotoxic and genotoxic 
effects were observed with the migrations extracts.Further toxicological studies are needed 
to confirm the safety of these nanocomposites for their use in food packaging applications.  
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Table captions 
Table 1. Al, Ca, Fe, Mg and Si content in the migration extracts from PLA, PLA-Clay1 and PLA-
Clay2 bottles (all the concentrations are expressed in µg/L).  
 
Table 2. Results of Ames test conducted with PLA-Clay1 and PLA-Clay2 extracts for three 
independent experiments. Water was used as negative control and DMSO as solvent for 
positive controls. Data are given as mean±SD revertants/plate for three replicates for each 
concentration in each experiment. Positive controls: TA97A/ TA98/ TA102/ TA104 with and 
without S9: 2-NF (0.1 µg/plate) and TA100 with and without S9: NaN3 (1µg/plate). **p<0.01 
significantly different from control. 
 
Figure captions 
Figure 1. Structure of the quaternary ammonium salts: Acetylcholine chloride (a) and 
Hexadecyltrimethylammonium bromide (b) used to modify the montmorillonite. 
Figure 2. Cytotoxicity assays: MTS metabolism (A), neutral red uptake (B) and total protein 
content (C) in Caco-2 cells after 24 and 48 h of exposure to 0 – 100% PLA-Clay1 migration 
extract (n=3). All values are expressed as mean ± SD. *Significantly different from control (p 
≤ 0.05). 
Figure 3. Cytotoxicity assays: MTS metabolism (A), neutral red uptake (B) and total protein 
content (C) in Caco-2 cells after 24 and 48 h of exposure to 0 – 100% PLA-Clay2 migration 
extract (n=3). All values are expressed as mean ± SD. *Significantly different from control (p 
≤ 0.05). 
 
 LOD for Al, Ca, Fe, Mg and Si were 0.2, 42, 0.3, 0.4, 5 µg/L, respectively. 
LOQ for Al, Ca, Fe, Mg and Si were 0.5, 140, 0.6, 1, 14 µg/L, respectively. 
 
Mean ± SD (µg/L) 
 Al Ca Fe Mg Si 
PLA ≤LOD ≤LOD-≤LOQ ≤LOD ≤LOD-2.1 28.5±1.5 
PLA-Clay1 0.7±0.2 ≤LOD ≤LOD 3.6±0.7 29.1±1.1 
PLA-Clay2 ≤LOQ ≤LOD ≤LOD 1.51±0.1 20.5±3.5 
Table 1
 Concentration 
(%) 
TA97A TA98 TA100 TA102 TA104 
 
 
 
 
 
PLA-Clay 
1 Extract 
 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 
Negative 
controls 
402±18 338±54 20±1 21±4 123±34 115±25 246±65 246±40 326±26 320±59 
20% 286±67 368±2 22±6 23±9 104±35 100±26 236±30 221±92 320±99 349±7 
40% 438±10 409±65 24±5 21±3 101±40 109±19 352±62 324±76 418±40 409±65 
60% 424±11 320±11 32±2 27±4 122±1 124±20 365±57 353±120 284±22 307±16 
80% 357±22 343±42 25±1 18±1 96±36 107±29 297±47 256±9 256±42 295±61 
100% 342±34 271±49 30±5 21±3 143±1 154±8 260±8 272±53 286±40 266±41 
Positive 
controls 
722±28** 751±24** >1000** >1000** >1000** >1000** 853±174** 621±172** >1000** 884±79** 
 
 
 
 
PLA-Clay 
2 Extract 
Negative 
controls 
344±47 398±17 41±5 26±18 125±33 115±19 223±23 244±46 315±41 297±44 
20% 342±5 299±24 47±13 27±7 109±20 106±10 296±9 291±21 317±3 293±46 
40% 396±34 317±47 37±1 19±6 103±8 116±62 265±54 271±35 334±27 272±31 
60% 393±12 323±27 38±8 26±8 134±25 112±25 294±17 277±46 341±33 308±34 
80% 285±49 301±3 26±1 29±11 96±29 96±14 324±178 281±73 297±12 283±14 
100% 331±19 340±37 31±18 24±4 110±40 96±15 279±2 264±33 289±46 248±46 
Positive 
controls 
650±13** 754±6** >1000** >1000** >1000** >1000** 853±175** 722±30** >1000** 917±32** 
 
Table 2
Figure 1
Click here to download high resolution image
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Abstract 27 
Organomodified clay minerals have many present and potential applications in different 28 
fields, including food packaging. For these applications become a reality they need a 29 
successful technological development but also they have to demonstrate their safety. 30 
There are in vitro toxicological studies that have shown a reduction of viability and 31 
oxidative stress induced by organomodified clay minerals in human cell lines. However, 32 
in vivo toxicity reports are scarce, particularly those using the oral pathway. The aim of 33 
this work was to evaluate the toxicity of an organomodified clay mineral, Clay1, 34 
developed from montmorillonite (Mt) and using hexadecyltrimethylammonium bromide 35 
as modifier. A repeated dose 90-day oral toxicity study was performed in Wistar rats 36 
exposed to 40 mg/kg/day Clay1. The morphological study of the main organ tissues by 37 
optic and electronic microscopy did not reveal any adverse effect. Also, blood clinical 38 
biochemistry parameters, the reduced/oxidized glutathione (GSH/GSSG) ratio, and 39 
interleukin-6 leakage in serum did not show any significant alterations. These results 40 
suggest that Clay1 do not cause remarkable toxic effects at the conditions tested. 41 
 42 
Keywords: clay mineral, montmorillonite, sub-chronic toxicity, rat, histopathology 43 
 44 
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1. Introduction 45 
 46 
Natural clay minerals are widely used in catalysis, as adsorbents, in clay 47 
polymer nanocomposites (CPN), as antibacterial materials, nuclear waste storage, 48 
pesticide carriers, etc. (Liu, 2007). Particularly food packaging industry has mainly 49 
focused its attention on layered inorganic solids, such as clay minerals and silicates, due 50 
to their availability, low cost, significant enhancements and relative simple 51 
processability (De Azeredo, 2009; Hatzigrigoriou et al., 2011). As a result, CPN were 52 
the first nanocomposites to be developed and introduced to the market as enhanced 53 
materials for the food- packaging sector (Hatzigrigoriou et al., 2011.). The most widely 54 
studied type of clay mineral as fillers is  montmorillonite (Mt)sheets (Weiss et al., 55 
2006).  56 
 57 
The main advantage of using clay minerals as fillers is a marked increase in the 58 
barrier of the polymer material to gas and water (Silvestre et al., 2011). Other authors 59 
also mention the improvements in mechanical, thermal, optical and rheological 60 
properties of the CPN (De Azeredo, 2009; Haztigrigoriou et al., 2011), thus increasing 61 
the product shelf life.  62 
 63 
One limitation of using clay minerals as nanofillers is the incompatibility 64 
between the hydrophilic clay mineral and a hydrophobic polymer (Elmore and 65 
Andersen, 2003; Zeng et al., 2005). Therefore, chemical modification of clay minerals 66 
is an important step to achieve CPN. In this sense by ion exchange with long-chain 67 
organic cations, clay minerals become hydrophobic and thereby compatible with 68 
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polymers. Such modified clay minerals are referred to as organoclays minerals(OC) 69 
(Sharma et al., 2010). 70 
 71 
Due to the aforementioned wide range of applications organoclay mineralsOC 72 
can have, the human exposure to this kind of compounds is likely going to increase in 73 
the near future. This makes necessary a safety evaluation since potential toxic effects 74 
cannot be discarded. Toxic effects of clay minerals have been shown to occur mainly 75 
after inhalation (Carretero et al., 2006; Sharma et al., 2010), but the oral pathway is one 76 
of the most likely routes of exposure to these clay minerals for the general population, 77 
since they are present in food contact materials.  78 
 79 
Although toxicological information of clay minerals is scarce, different authors 80 
have reported toxic effects on in vitro systems, such as reduced viability or reactive 81 
oxygen species production  (Lordan et al., 2011) Houtman et al. (2014)  and Maisanaba 82 
et al. (2013a,b), have found a different toxic profile of different modified and 83 
unmodified clay minerals in Caco-2 and Hep-G2 cells and have suggested that a case by 84 
case toxicological assessment is required for clay minerals, as the modifiers employed 85 
to improve their technological aspects play an important role in the toxicity observed. 86 
 87 
In vivo toxicity data of clay minerals are even scarcer, and most of the trials 88 
performed are not representative of the likely human exposure to these compounds, 89 
which corresponds to a repeated and low dose exposure for a long time. Taking all this 90 
into account, the aim of this study was to determine the oral subchronic toxicity of an 91 
organoclay mineralOC on Wistar rats. A morphological study of the main organ tissues 92 
by optic and electronic microscopy was performed. Blood clinical biochemistry 93 
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parameters, interleukin leakage in serum and blood glutathione levels were also 94 
determined. 95 
 96 
2. Materials and Methods 97 
 98 
2.1. Supplies and Chemicals 99 
General chemicals were provided by Sigma Aldrich (Madrid, Spain) and VWR 100 
International Eurolab (Spain).  101 
The organomodified clay mineral encoded as Clay1 was obtained by cation exchange 102 
reaction from Cloisite Na
+
® (Southern Clay Products, INC.), adding the quaternary 103 
ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) in 6 fold the cation 104 
exchange capacity (CEC) of pristine clay mineral, following the method described by 105 
Mittal (2007), Jordá- Beneyto et al., (2008) and Jorda et al., (2009). The modified clay 106 
mineral was characterized by Fourier Transform Infrared (FTIR) spectroscopy, 107 
thermogravimetric analysis (TGA) and X-ray diffraction (XRD) as shown in Jordá-108 
Beneyto et al., (2014).  109 
 110 
2.2. Animals and Experimental Design 111 
A repeated dose 90-day oral toxicity study was performed in rats. Briefly, 112 
twenty male Wistar rats provided by Janvier S.A.S (France) with a mean weight of 113 
240.2 ± 2.04 g were used. Rats were fed during the acclimation week with a standard 114 
laboratory diet (Harlan 2014, Harlan Laboratories, Barcelona, Spain), and water, both 115 
ad libitum, in a controlled-temperature room (23 ± 1ºC) with 12 h dark/light cycle, and 116 
free from any source of chemical contamination. After this period, animals were 117 
randomly divided in two groups, a control group (n=10) and an exposed group (n=10). 118 
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The control group was fed with the standard diet, while the exposed group was orally 119 
administered with 40 mg/kg/day of Clay1 in the diet. This dose was selected to 120 
reproduce 2-fold the  dose that a person would received daily from a 1.5L bottle made 121 
of the CPN. This is, assuming that all the clay mineral incorporated into the packaging 122 
polymer is present in the food. During the treatment period clinical signs, body weight, 123 
and food and water consumption were recorded weekly.  124 
All animals received human care in compliance with the guidelines for the protection of 125 
animals used for scientific purposes and all the procedures were previously accepted by 126 
the Ethic Committee of the University of Seville. 127 
 128 
2.3. Organs and blood sampling  129 
At the end of the experimental period, rats were fasted for 18 h before sacrifice. 130 
Liver, kidneys, lungs, spleen, brain, testes, gastrointestinal (g.i.) tract and heart were 131 
excised, rinsed with cold saline solution and weighted. Blood samples were obtained by 132 
cardiac punction and collected in test tubes with/without lithium heparin depending on 133 
the experiment. Serum was separated by low speed centrifugation at 1500 x g at 4ºC for 134 
15 min, and stored at -80ºC until analysis of IL-6 leakage and clinical biochemistry 135 
parameters.  136 
 137 
2.4. Histopathogical analysis 138 
The histopatological examination by optic (Hematoxylin-Eosin HE staining) and 139 
electronic microscopy was performed as described by Maisanaba et al. (2014).  140 
 141 
2.5. GSH/GSSG levels 142 
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The ratio GSH/GSSG was determined in blood samples using a commercial kit 143 
(Bioxytech GSH/GSSG- 412; Oxis Research, Foster City, CA, USA).  144 
 145 
2.6. IL-6 leackage 146 
For this assay the blood serum of experimental animals were used. Manufacturer 147 
instructions from the kit (Thermo Scientific Rat Interleukin-6 (IL-6) ELISA) were 148 
followed.  149 
 150 
2.7. Statistical analysis 151 
Data are expressed as mean ± standard deviation of ten animals per group. 152 
Statistical analysis was performed by analysis of variance (ANOVA) using GraphPad 153 
InStat software (GraphPad Software Inc., La Jolla, USA). 154 
 155 
3. Results 156 
No rats died during the experimental period and there were no remarkable 157 
clinical signs. Body weight, body weight gain , food and water consumption , organs 158 
weight and the somatic index of the different organs (Table 1) did not show statistical 159 
differences between the control and the exposed group.  160 
 161 
3.1. Histopathogical results 162 
Microscopic examination of the HE-stained tissue sections of the exposed 163 
animals did not show remarkable changes in comparison to the control group (Fig. 1). 164 
Moreover, the ultrastructural study did not reveal alterations related with the treatment 165 
(Fig. 2). 166 
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 167 
3.2. Clinic Biochemistry Parameters 168 
Results showed no significant changes in any of them in comparison to the 169 
control group (Table 2). 170 
 171 
3.3. GSH/GSSG levels 172 
Blood GSH/GSSG ratio experienced a non significant alteration in rats exposed 173 
to Clay1 in comparison to the control group (Fig. 3). 174 
 175 
3.4. IL-6 leackage 176 
No IL-6 leakage was observed in the serum of any of the experimental groups 177 
(data not shown). 178 
 179 
4. Discussion 180 
Clay1 has been developed to reinforce food packaging materials, thus being 181 
considered as a food contact material (Jordá-Beneyto et al., 2014). Human exposure to 182 
chemicals from packaging and other materials in contact with food may occur as a result 183 
of migration from the packaging materials into foodstuffs. The extent of this migration 184 
and the specific toxicity of the substance in question are the two main factors which 185 
define the human health risk which a packaging material represents (Pocas and Hogg, 186 
2007). Regarding to its toxicity, Houtman et al., (2014)  evaluated the cytotoxic effects 187 
of Clay1 in the human intestinal cell line Caco-2 and in the hepatocellular cell line 188 
HepG2  and observed a very low toxicity in the range of concentrations assayed (0-8 189 
µg/mL)  190 
 191 
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To the best of our knowledge, there is no other in vivo toxicology report 192 
available of Clay1. In the present study, the results have shown that there are no 193 
remarkable toxic effects in the rats exposed for 90 days to Clay1. Baek et al. (2012) 194 
performed an acute oral toxicity test in mice with Mt and did not found adverse effects. 195 
Similar results were obtained by Li et al. (2010) in rats exposed to exfoliated clay 196 
mineral layersexfoliated silicate plates  prepared from the natural clay mineral. Lee et 197 
al., (2005) on the contrary, observed a significant reduction of Na
+
, Cl
-
 and Ca
2+
 in the 198 
blood-biochemical analysis. In these studies a single oral dose was used. Afriyie-Gyawu 199 
et al., (2005) performed a 28 week feeding study with NovaSil (calcium Mt) and 200 
suggested that levels of 2% w/w did not result in overt toxicity. The absence of 201 
histopathological effects of these studies contrast with the morphological adverse effects 202 
reported for other clay minerals in vitro (Banin and Mairi, 1990; Elmore et al., 2003; 203 
Maisanaba et al., 2013a,b). However, those studies were performed with clay minerals 204 
different to Clay1 and the modifiers contained in the organoclay mineralOC have a role 205 
in their toxicity. 206 
 207 
Mascolo et al. (2004) also performed an in vivo assay with several clay minerals 208 
but they focused on a different aspect of clay mineral ingestion, the distribution of 209 
hazardous chemical elements into organs. Mascolo et al. (1999) documented this fact 210 
analyzing the urine of rats fed with different clay minerals and concluded that the 211 
chemical elements entered in blood dealing with possible hazardous effects on organs 212 
and/or the whole body.  213 
  214 
Powell et al. (2007) reported that the human oral exposure to exogenous 215 
microparticles appeared to be almost exclusively additives to food, pharmaceuticals and 216 
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toothpaste and that they were chiefly aluminosilicates and titanium dioxide. These 217 
particles are very resistant to chemical breakdown so, following ingestion and mucosal 218 
uptake, they survive both gastrointestinal digestion and cellular processing. Authors 219 
hypothesized that exogenous microparticles hijack the putative route for endogenous 220 
microparticle uptake but, due to their chemically-resistant nature, they cannot then 221 
contribute to tolerance induction and may even, in susceptible individuals, establish 222 
abnormal immune responsiveness. In the present study IL-6 in serum has been not 223 
detected but a single parameter is not enough to conclude the absence of effects on the 224 
immune system.  225 
 226 
It has been reported that hemolytic activity of silicate minerals decreases in the 227 
order smectites>silica>palygorskite E ≈sepiolite>chrysotile>kaolinite (Oscarson et al., 228 
1986; Carretero et al., 2006; Oscarson et al., 1986). Clay1 is based on Mt, a clay 229 
mineral of the smectites family, but in this case no hemolytic activity and no changes in 230 
the clinical biochemistry parameters of the animals after the experimental period has 231 
been detected.  232 
 233 
5. Conclusion 234 
The morphologic study performed on the tissues of Wistar rats exposed to 40 235 
mg/kg/day Clay1 for 90 days did not evidence any remarkable effect. Similarly, the 236 
basic clinical biochemistry parameters, the GSH/GSSG ratio and the IL-6 leakage in 237 
serum did not show significant alterations.  238 
 239 
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Figure captions 329 
 330 
 331 
Figure 1. Histopathological changes of Wistar rats exposed to 40 mg/kg/day Clay1 for 332 
90 days. HE-stained sections of liver, kidney, lung, spleen, brain, testes, intestine and 333 
heart.  334 
 335 
Figure 2. Histopathological changes of Wistar rats exposed to 40 mg/kg/day Clay1 for 336 
90 days. Ultrastructural observations of liver, kidney, lung, spleen, brain, testes, 337 
intestine and heart. 338 
 339 
Figure 3. Blood GSH/GSSG ratio in control Wistar rats and rats exposed to 40 340 
mg/kg/day Clay1 for 90 days. Results are expressed as mean ± s.d. 341 
- 40 mg/kg/day Clay 1 did not induce subchronic oral toxicity in Wistar rats 
- the histopathological study did not reveal remarkable effects induced by Clay1 at the 
conditions assayed 
- clinic biochemistry parameters, glutathione content and IL-6 leakage were not altered by the 
exposure to Clay1 
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Abstract 27 
Organomodified clay minerals have many present and potential applications in different 28 
fields, including food packaging. For these applications become a reality they need a 29 
successful technological development but also they have to demonstrate their safety. 30 
There are in vitro toxicological studies that have shown a reduction of viability and 31 
oxidative stress induced by organomodified clay minerals in human cell lines. However, 32 
in vivo toxicity reports are scarce, particularly those using the oral pathway. The aim of 33 
this work was to evaluate the toxicity of an organomodified clay mineral, Clay1, 34 
developed from montmorillonite (Mt) and using hexadecyltrimethylammonium bromide 35 
as modifier. A repeated dose 90-day oral toxicity study was performed in Wistar rats 36 
exposed to 40 mg/kg/day Clay1. The morphological study of the main organ tissues by 37 
optic and electronic microscopy did not reveal any adverse effect. Also, blood clinical 38 
biochemistry parameters, the reduced/oxidized glutathione (GSH/GSSG) ratio, and 39 
interleukin-6 leakage in serum did not show any significant alterations. These results 40 
suggest that Clay1 do not cause remarkable toxic effects at the conditions tested. 41 
 42 
Keywords: clay mineral, montmorillonite, sub-chronic toxicity, rat, histopathology 43 
 44 
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1. Introduction 45 
 46 
Natural clay minerals are widely used in catalysis, as adsorbents, in clay 47 
polymer nanocomposites (CPN), as antibacterial materials, nuclear waste storage, 48 
pesticide carriers, etc. (Liu, 2007). Particularly food packaging industry has mainly 49 
focused its attention on layered inorganic solids, such as clay minerals, due to their 50 
availability, low cost, significant enhancements and relative simple processability (De 51 
Azeredo, 2009; Hatzigrigoriou et al., 2011). As a result, CPN were the first 52 
nanocomposites to be developed and introduced to the market as enhanced materials for 53 
the food- packaging sector (Hatzigrigoriou et al., 2011.). The most widely studied  clay 54 
mineral as fillers is  montmorillonite (Mt) (Weiss et al., 2006).  55 
 56 
The main advantage of using clay minerals as fillers is a marked increase in the 57 
barrier of the polymer material to gas and water (Silvestre et al., 2011). Other authors 58 
also mention the improvements in mechanical, thermal, optical and rheological 59 
properties of the CPN (De Azeredo, 2009; Haztigrigoriou et al., 2011), thus increasing 60 
the product shelf life.  61 
 62 
One limitation of using clay minerals as nanofillers is the incompatibility 63 
between the hydrophilic clay mineral and a hydrophobic polymer (Elmore and 64 
Andersen, 2003; Zeng et al., 2005). Therefore, chemical modification of clay minerals 65 
is an important step to achieve CPN. In this sense by ion exchange with long-chain 66 
organic cations, clay minerals become hydrophobic and thereby compatible with 67 
polymers. Such modified clay minerals are referred to as organoclays (OC) (Sharma et 68 
al., 2010). 69 
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 70 
Due to the aforementioned wide range of applications OC can have, the human 71 
exposure to this kind of compounds is likely going to increase in the near future. This 72 
makes necessary a safety evaluation since potential toxic effects cannot be discarded. 73 
Toxic effects of clay minerals have been shown to occur mainly after inhalation 74 
(Carretero et al., 2006; Sharma et al., 2010), but the oral pathway is one of the most 75 
likely routes of exposure to these clay minerals for the general population, since they 76 
are present in food contact materials.  77 
 78 
Although toxicological information of clay minerals is scarce, different authors 79 
have reported toxic effects on in vitro systems, such as reduced viability or reactive 80 
oxygen species production  (Lordan et al., 2011) Houtman et al. (2014)  and Maisanaba 81 
et al. (2013a,b), have found a different toxic profile of different modified and 82 
unmodified clay minerals in Caco-2 and Hep-G2 cells and have suggested that a case by 83 
case toxicological assessment is required for clay minerals, as the modifiers employed 84 
to improve their technological aspects play an important role in the toxicity observed. 85 
 86 
In vivo toxicity data of clay minerals are even scarcer, and most of the trials 87 
performed are not representative of the likely human exposure to these compounds, 88 
which corresponds to a repeated and low dose exposure for a long time. Taking all this 89 
into account, the aim of this study was to determine the oral subchronic toxicity of an 90 
OC on Wistar rats. A morphological study of the main organ tissues by optic and 91 
electronic microscopy was performed. Blood clinical biochemistry parameters, 92 
interleukin leakage in serum and blood glutathione levels were also determined. 93 
 94 
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2. Materials and Methods 95 
 96 
2.1. Supplies and Chemicals 97 
General chemicals were provided by Sigma Aldrich (Madrid, Spain) and VWR 98 
International Eurolab (Spain).  99 
The organomodified clay mineral encoded as Clay1 was obtained by cation exchange 100 
reaction from Cloisite Na
+
® (Southern Clay Products, INC.), adding the quaternary 101 
ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) in 6 fold the cation 102 
exchange capacity (CEC) of pristine clay mineral, following the method described by 103 
Mittal (2007), Jordá- Beneyto et al., (2008) and Jorda et al., (2009). The modified clay 104 
mineral was characterized by Fourier Transform Infrared (FTIR) spectroscopy, 105 
thermogravimetric analysis (TGA) and X-ray diffraction (XRD) as shown in Jordá-106 
Beneyto et al., (2014).  107 
 108 
2.2. Animals and Experimental Design 109 
A repeated dose 90-day oral toxicity study was performed in rats. Briefly, 110 
twenty male Wistar rats provided by Janvier S.A.S (France) with a mean weight of 111 
240.2 ± 2.04 g were used. Rats were fed during the acclimation week with a standard 112 
laboratory diet (Harlan 2014, Harlan Laboratories, Barcelona, Spain), and water, both 113 
ad libitum, in a controlled-temperature room (23 ± 1ºC) with 12 h dark/light cycle, and 114 
free from any source of chemical contamination. After this period, animals were 115 
randomly divided in two groups, a control group (n=10) and an exposed group (n=10). 116 
The control group was fed with the standard diet, while the exposed group was orally 117 
administered with 40 mg/kg/day of Clay1 in the diet. This dose was selected to 118 
reproduce 2-fold the  dose that a person would received daily from a 1.5L bottle made 119 
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of the CPN. This is, assuming that all the clay mineral incorporated into the packaging 120 
polymer is present in the food. During the treatment period clinical signs, body weight, 121 
and food and water consumption were recorded weekly.  122 
All animals received human care in compliance with the guidelines for the protection of 123 
animals used for scientific purposes and all the procedures were previously accepted by 124 
the Ethic Committee of the University of Seville. 125 
 126 
2.3. Organs and blood sampling  127 
At the end of the experimental period, rats were fasted for 18 h before sacrifice. 128 
Liver, kidneys, lungs, spleen, brain, testes, gastrointestinal (g.i.) tract and heart were 129 
excised, rinsed with cold saline solution and weighted. Blood samples were obtained by 130 
cardiac punction and collected in test tubes with/without lithium heparin depending on 131 
the experiment. Serum was separated by low speed centrifugation at 1500 x g at 4ºC for 132 
15 min, and stored at -80ºC until analysis of IL-6 leakage and clinical biochemistry 133 
parameters.  134 
 135 
2.4. Histopathogical analysis 136 
The histopatological examination by optic (Hematoxylin-Eosin HE staining) and 137 
electronic microscopy was performed as described by Maisanaba et al. (2014).  138 
 139 
2.5. GSH/GSSG levels 140 
The ratio GSH/GSSG was determined in blood samples using a commercial kit 141 
(Bioxytech GSH/GSSG- 412; Oxis Research, Foster City, CA, USA).  142 
 143 
2.6. IL-6 leackage 144 
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For this assay the blood serum of experimental animals were used. Manufacturer 145 
instructions from the kit (Thermo Scientific Rat Interleukin-6 (IL-6) ELISA) were 146 
followed.  147 
 148 
2.7. Statistical analysis 149 
Data are expressed as mean ± standard deviation of ten animals per group. 150 
Statistical analysis was performed by analysis of variance (ANOVA) using GraphPad 151 
InStat software (GraphPad Software Inc., La Jolla, USA). 152 
 153 
3. Results 154 
No rats died during the experimental period and there were no remarkable 155 
clinical signs. Body weight, body weight gain, food and water consumption , organs 156 
weight and the somatic index of the different organs (Table 1) did not show statistical 157 
differences between the control and the exposed group.  158 
 159 
3.1. Histopathogical results 160 
Microscopic examination of the HE-stained tissue sections of the exposed 161 
animals did not show remarkable changes in comparison to the control group (Fig. 1). 162 
Moreover, the ultrastructural study did not reveal alterations related with the treatment 163 
(Fig. 2). 164 
 165 
3.2. Clinic Biochemistry Parameters 166 
Results showed no significant changes in any of them in comparison to the 167 
control group (Table 2). 168 
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 169 
3.3. GSH/GSSG levels 170 
Blood GSH/GSSG ratio experienced a non significant alteration in rats exposed 171 
to Clay1 in comparison to the control group (Fig. 3). 172 
 173 
3.4. IL-6 leackage 174 
No IL-6 leakage was observed in the serum of any of the experimental groups 175 
(data not shown). 176 
 177 
4. Discussion 178 
Clay1 has been developed to reinforce food packaging materials, thus being 179 
considered as a food contact material (Jordá-Beneyto et al., 2014). Human exposure to 180 
chemicals from packaging and other materials in contact with food may occur as a result 181 
of migration from the packaging materials into foodstuffs. The extent of this migration 182 
and the specific toxicity of the substance in question are the two main factors which 183 
define the human health risk which a packaging material represents (Pocas and Hogg, 184 
2007). Regarding to its toxicity, Houtman et al., (2014)  evaluated the cytotoxic effects 185 
of Clay1 in the human intestinal cell line Caco-2 and in the hepatocellular cell line 186 
HepG2  and observed a very low toxicity in the range of concentrations assayed (0-8 187 
µg/mL)  188 
 189 
To the best of our knowledge, there is no other in vivo toxicology report 190 
available of Clay1. In the present study, the results have shown that there are no 191 
remarkable toxic effects in the rats exposed for 90 days to Clay1. Baek et al. (2012) 192 
performed an acute oral toxicity test in mice with Mt and did not found adverse effects. 193 
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Similar results were obtained by Li et al. (2010) in rats exposed to exfoliated clay 194 
mineral layers prepared from the natural clay mineral. Lee et al., (2005) on the contrary, 195 
observed a significant reduction of Na
+
, Cl
-
 and Ca
2+
 in the blood-biochemical analysis. 196 
In these studies a single oral dose was used. Afriyie-Gyawu et al., (2005) performed a 197 
28 week feeding study with NovaSil (calcium Mt) and suggested that levels of 2% w/w 198 
did not result in overt toxicity. The absence of histopathological effects of these studies 199 
contrast with the morphological adverse effects reported for other clay minerals in vitro 200 
(Banin and Mairi, 1990; Elmore et al., 2003; Maisanaba et al., 2013a,b). However, those 201 
studies were performed with clay minerals different to Clay1 and the modifiers 202 
contained in the OC have a role in their toxicity. 203 
 204 
Mascolo et al. (2004) also performed an in vivo assay with several clay minerals 205 
but they focused on a different aspect of clay mineral ingestion, the distribution of 206 
hazardous chemical elements into organs. Mascolo et al. (1999) documented this fact 207 
analyzing the urine of rats fed with different clay minerals and concluded that the 208 
chemical elements entered in blood dealing with possible hazardous effects on organs 209 
and/or the whole body.  210 
  211 
Powell et al. (2007) reported that the human oral exposure to exogenous 212 
microparticles appeared to be almost exclusively additives to food, pharmaceuticals and 213 
toothpaste and that they were chiefly aluminosilicates and titanium dioxide. These 214 
particles are very resistant to chemical breakdown so, following ingestion and mucosal 215 
uptake, they survive both gastrointestinal digestion and cellular processing. Authors 216 
hypothesized that exogenous microparticles hijack the putative route for endogenous 217 
microparticle uptake but, due to their chemically-resistant nature, they cannot then 218 
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contribute to tolerance induction and may even, in susceptible individuals, establish 219 
abnormal immune responsiveness. In the present study IL-6 in serum has been not 220 
detected but a single parameter is not enough to conclude the absence of effects on the 221 
immune system.  222 
 223 
It has been reported that hemolytic activity of silicate minerals decreases in the 224 
order smectites>silica>palygorskite ≈sepiolite>chrysotile>kaolinite (Oscarson et al., 225 
1986; Carretero et al., 2006). Clay1 is based on Mt, a clay mineral of the smectites 226 
family, but in this case no hemolytic activity and no changes in the clinical biochemistry 227 
parameters of the animals after the experimental period has been detected.  228 
 229 
5. Conclusion 230 
The morphologic study performed on the tissues of Wistar rats exposed to 40 231 
mg/kg/day Clay1 for 90 days did not evidence any remarkable effect. Similarly, the 232 
basic clinical biochemistry parameters, the GSH/GSSG ratio and the IL-6 leakage in 233 
serum did not show significant alterations.  234 
 235 
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Figure captions 325 
 326 
 327 
Figure 1. Histopathological changes of Wistar rats exposed to 40 mg/kg/day Clay1 for 328 
90 days. HE-stained sections of liver, kidney, lung, spleen, brain, testes, intestine and 329 
heart.  330 
 331 
Figure 2. Histopathological changes of Wistar rats exposed to 40 mg/kg/day Clay1 for 332 
90 days. Ultrastructural observations of liver, kidney, lung, spleen, brain, testes, 333 
intestine and heart. 334 
 335 
Figure 3. Blood GSH/GSSG ratio in control Wistar rats and rats exposed to 40 336 
mg/kg/day Clay1 for 90 days. Results are expressed as mean ± s.d. 337 
  Control Group 
Mean ± SD 
40 mg/kg/day Clay1 
Mean ± SD 
Liver (g) 13.12 ± 2.44 12.84 ± 1.67 
Liver Somatic Index (%) 2.83 ± 0.40 2.53 ± 0.30 
Kidneys (g) 3.02 ± 0.63 2.89 ± 0.26 
Kidney Somatic Index (%) 0.65 ±0.11 0.60 ± 0.05 
Lungs (g) 2.75 ± 0.78 2.72 ± 0.66 
Lung Somatic Index (%) 0.60 ± 0.09 0.53 ± 0.12 
Spleen (g) 1.02 ± 0.17 1.04 ± 0.13 
Splenic Somatic Index (%) 0.22 ± 0.02 0.20 ± 0.02 
Brain (g) 2.06 ± 0.18 2.14 ± 0.22 
Brain Somatic Index (%) 0.45 ± 0.05 0.42 ± 0.05 
Testes (g) 3.66 ± 0.75 3.77 ± 0.52 
Testicle Somatic Index (%) 0.79 ± 0.11 0.75 ± 0.14 
Intestine (g) 4.99 ± 1.022 5.68 ± 1.86 
Intestine Somatic Index (%) 1.10 ± 0.37 1.00 ± 0.50 
Heart (g) 1.82 ± 0.12 1.75 ± 0.19 
Heart Somatic Index (%) 0.40 ± 0.05 0.34 ± 0.04 
 
 
 
Table 1. Organs weight (g) and somatic index (%) of the different organs of control Wistar rats 
and rats exposed to 40 mg/kg/day Clay1 for 90 days. Results are expressed as mean ± sd. 
Table 1
Click here to download Table: Table 1 Organ Weights Somatic.docx
  
 
Table 2. Clinic biochemistry parameters of control Wistar rats and rats exposed to 40 
mg/kg/day Clay1 for 90 days. Results are expressed as mean ± sd. 
Parameters Control 40 mg/kg/day Clay1 
Mean ± SD Mean ± SD 
Glucose (mg/dL) 141.83 ± 61.95 149.75 ± 20.32 
Urea (mg/dL) 58.00 ± 7.95 60.75 ± 7.50 
Creatinine (mg/dL) 0.78 ± 0.08 0.78 ± 0.03 
Total protein (g/dL) 6.17 ± 0.19 6.13 ± 0.25 
Albumin (g/dL) 4.12 ± 0.22 4.10 ± 0.24 
Cholesterol (mg/dL) 90.00 ± 15.61 83.50 ± 16.62 
Aspartate Aminotransferase (AST) (U/L) 187.83 ± 67.29 189.75 ± 17.97 
Alanine Aminotransferase (ALT) (U/L) 52.67 ± 16.28 49.50 ± 11.21 
Alkaline Fosfatase (ALP) (U/L) 185.67 ± 54.64 193.50 ± 46.22  
Sodium (mEq/L) 152.67 ± 1.21 151.00 ± 1.15 
Potassium (mEq/L) 7.68 ± 1.12 7.40 ± 1.31 
Table 2
Click here to download Table: Table 2.doc
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Abstract 
Clays have uses in a wide range of applications. Despite their increasing use, the 
toxicity assessment of these new materials is still scarce. In the present work, the 
oxidative stress induced by Clay 1, a novel clay, has been evaluated in rats after 90 
days of oral exposure. The activities of the antioxidant enzymes, namely superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione-S-
transferase (GST) were studied. In addition, the genetic expression of SOD and CAT and 
the relative protein abundance of CAT were also evaluated. Our results showed that 
most of the biomarkers assayed stayed unaltered. Only CAT activity, as well as its 
genetic and protein expressions, appeared enhanced in the kidney. Therefore, further 
studies are needed to clarify the consequences of this finding to ensure the safety of 
this clay.  
 
Keywords: clay; food packaging; organomodified clay; oxidative stress; rat 
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Introduction 
Clays and polymer-layered nanocomposites have uses in a wide range of 
applications (Lordan et al. 2010). Organically modified clays, or organoclays are 
currently employed in the manufacture of inks, paints, greases and cosmetics, in water 
treatment applications (Patel et al. 2006), controlled release of therapeutic agents 
(Park et al. 2008), or in food packaging products, among others. Polymer composites 
incorporating clay particles were among the first nanocomposites to emerge on the 
market as improved materials for food packaging (Chaudhry et al. 2008). The surface 
modification of the clay minerals is the key to achieve new applications of these 
materials (Betega de Paiva t al. 2008). The result is the creation of polymer layered 
nanocomposites, one of the most currently developed areas in nanotechnology. 
Smectite clays, and particularly montmorillonite (MMT), are one of the best choices for 
designing new polymer nanocomposites. Some of their advantages include low price 
worldwide spread and easy intercalation chemistry, which allows them to be 
chemically modified in order to improve the compatibility with some different 
polymeric matrices (Bitinis et al. 2011). Moreover, their high surface area (700-800 
m2/g) and large aspect ratio (50-1000) make them effective reinforcement fillers 
(Majeed et al. 2013). 
 
When clays are dispersed into the polymer, they acquire a natural layered 
structure. These layers have sub-micrometer dimensions, except for their thickness, 
which is only about 1 nm (Hatzigrigoriou and Papaspyrides 2011). The presence of 
clays in the polymer matrix generates a material with improved barrier properties due 
to the disposition of the clays, giving a tortuous path around the polymer for gases and 
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water vapor (Nielsen 1967). These properties are partially due to the dispersion level 
(or major exfoliation) of clays into the polymer, which is different for each one and 
depends on the cationic exchange capacity (CEC) of the clay (Dean et al. 2007). In the 
case of MMT, modifications by exchanging inorganic cations with organic ammonium 
ions are justified (Baek et al. 2012). These modifications lead to a more regular 
organization of the layers in the structure, thus enhancing the compatibility of the clay 
with the organic polymers, and decreasing the water uptake by the nanocomposite 
(Osman et al. 2003). As a result, these improvements lead to an increase in the shelf 
life of the products. 
 
Although the presence of organoclays in polymers is growing for various 
applications, little is known about the potential physiological effects these clays can 
induce if they enter in the human organism. That is, despite the large applications of 
organoclays, toxicity studies are still scarce. In this sense, the oral pathway is the most 
likely route of intake for clays incorporated in food packaging. Currently, the European 
Food Security Agency (EFSA) requires a complete study about the toxic effects 
generated by nanostructures formed by clays incorporated in polymers and their 
migration from the packaging to the food and into the organism afterwards (EFSA 
2011), in order to perform their risk assessment. 
 
The toxicological analysis of clays can be performed both by in vitro and in vivo 
methods. In vitro methods are required by the European Authorities for ethical 
reasons, being the aim to perform a toxicity screening, evaluating potential cytotoxic 
effects as well as the identification of toxic mechanisms (EFSA 2011). Limited 
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 5 
information about toxicological effects caused by clays can be found in the literature, 
although some authors have studied their toxic effects in different cell lines. In this 
sense, Sharma et al. (2010) evaluated the cytotoxicity and genotoxicity of non-
modified and modified MMT (Cloisite®Na+ and Cloisite®30B, respectively) in the 
human intestinal Caco-2 cell line, concluding that the modifier of Cloisite®30B was 
responsible of the observed genotoxic effects. Moreover, Baek et al. (2012) also 
evaluated in vitro the toxic effects of MMT in human normal intestinal cells (INT-407), 
which experienced an inhibition of proliferation in a concentration- and time-
dependent manner. Furthermore, Lordan et al. (2011) observed that Cloisite®Na+ and 
Cloisite®93A reduced the viability of human hepatoma HepG2 cells. In addition, our 
research group has obtained different toxic profiles of several modified and 
unmodified clays in Caco-2 and Hep-G2 cells (Houtman et al. 2013; Maisanaba et al. 
2013a, 2013b). This suggests that a specific toxicity evaluation is necessary for each 
clay, and also that modifiers may be involved in the toxicity of polymer clays.  
 
Most of the few assays performed so far in vivo reference to studies with a 
short exposure time and a high dose of clays (Mascolo et al. 2004; Wang et al. 2005), 
which is not representative of the chronic exposure that could occur in a daily 
consumer. Due to the scarce number of studies, the toxic mechanism for these clays is 
still unknown. One of the principal mechanisms that could initiate adverse biological 
responses, leading to toxicological effects of manufactured nanoparticles, is the ability 
to cause oxidative stress (Lordan et al. 2010). Therefore, the purpose of this study was 
to assess a possible implication of the novel organoclay, Clay 1, in the induction of 
oxidative stress in Wistar rats exposed to 40 mg/kg/day of Clay 1 for 90 days. An 
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 6 
evaluation of the activities of the antioxidant enzymes, superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx) and glutathione-S-transferase (GST), was 
performed. In addition, the genetic expression of SOD and CAT, and the relative 
protein abundance of CAT, were also evaluated. 
 
Materials and Methods  
Supplies and Chemicals 
General chemicals were provided by Sigma Aldrich (Madrid, Spain) and VWR 
International Eurolab (Spain). The organomodified clay encoded as Clay 1 was obtained 
by cation exchange reaction from Cloisite ®Na+ (Southern Clay Products, INC.) adding 
the quaternary ammonium salt hexadecyltrimethyl-ammonium bromide (HDTA) in 6 
fold the cation exchange capacity (CEC) of pristine clay, following the method 
described by Jordá-Beneyto et al. (2013). Briefly, the modified clay was characterized 
by Fourier Transform InfraRed (FTIR) spectroscopy, thermogravimetric analysis (TGA) 
and X-ray diffraction (XRD). Regarding FTIR analysis, the presence of typical absorption 
bands attributed to Si-O-Si and Al-O-Si stretching vibrations were observed at 910, 972 
and 1118 cm-1. Furthermore, hydroxyl groups bonded to Al and/or Mg (3620 cm-1), the 
methylene symmetric and antisymmetric stretching bands (3020-2800 cm-1) and the 
characteristic bending vibration of the alkylammonium cation (1487 cm-1) were also 
shown in the FTIR spectrum. The amount of organic cation in the modified Cloisite 
®Na+ was determined by TGA. Thermograms revealed a loss weight (%) of 24% for Clay 
1 in the temperature range of 200-500°C, ascribed to hexadecylammonium thermal 
decomposition. Moreover, XRD patterns of Clay 1 showed an expanded interlayer 
d(001)-spacing of 18.00 Å (peak position at 2θº=4.93 in X-ray diffractogram) compared 
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 7 
to that displayed by the pristine Cloisite ®Na+, d(001)-spacing of 12.1 Å (2θ0=7.31). 
These data and additional characterization data of Clay 1 are available in Jordá-
Beneyto et al. (2013). 
 
Experimental animals and tissue sampling 
A repeated dose 90-day oral toxicity study was performed in rats. Briefly, 
twenty male Wistar rats provided by Janvier S.A.S (France) with a mean weight of 
240.2 ± 2.04 g were used. Rats were fed during the acclimation week with a standard 
laboratory diet (Harlan 2014, Harlan Laboratories, Barcelona, Spain) and water, both 
ad libitum, in a controlled temperature room (23 ± 1ºC) with 12 h dark/light cycle, and 
free from any source of chemical contamination. After this period, animals were 
randomly divided in two groups, a control group (n=10) and an exposed group (n=10). 
The control group was fed with the standard diet, while the exposed group was orally 
administered with 40 mg/kg/day of Clay 1 in the diet. This dose was selected to 
reproduce 2-fold the highest dose of the worst case scenario of human exposure (that 
is, assuming that all the clay incorporated into the packaging polymer was transferred 
into the food). During the treatment period clinical signs, body weight, and food and 
water consumption were recorded weekly. 
 
All animals received human care in compliance with the guidelines for the 
protection of animals used for scientific purposes, and all the procedures were 
previously accepted by the Ethic Committee of the University of Seville.  
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 8 
At the end of the experimental period, rats were fasted for 18 h before 
sacrifice. Liver and kidneys were excised, rinsed with cold saline solution and weighted. 
Briefly, tissues were homogenized using 50mM phosphate monobasic, 1mM 
tetrasodium dihydrate salt and bovine serum albumin (BSA) buffer (pH 7,5) at 0-4 ºC 
with a polytron homogenizer (Heidolph RZR2102 Control, Sigma, Madrid, Spain). The 
homogenates were centrifuged 20 min at 4000 rpm at 4°C. The remaining supernatant, 
defined as the soluble (cytosolic) fraction, was used for enzyme measurements.  
 
Protein estimation 
 Protein contents in the samples were estimated by the method of Bradford 
(1976) using bovine γ-globulin as standard. Briefly, 5 µL of the diluted samples were 
mixed with 245 µL Coomassie brilliant blue dye (Biorad Laboratories, Hercules, USA) 
and the absorbance was read at 595 nm in the microplate reader (Tecan Infinite M200, 
Austria). 
 
Lipid peroxidation 
Lipid peroxidation products were quantified by the thiobarbituric acid (TBA) 
method (Esterbauer and Cheeseman 1990). Malondialdehyde (MDA) was formed as a 
lipid peroxidation end-product that reacts with TBA reagent under acidic conditions to 
generate a pink coloured product. Briefly, 0.5 mL of the homogenized tissue, obtained 
previously, was treated with 25 µl of butylhydroxytoluene 1% (v/v) in acetic acid and 
mixed with 0.2 mL of sodium lauryl sulphate (8%), 1 mL of acetic acid (20% v/v) and 1 
mL of 0.8% thiobarbituric acid. This mixture was then heated at 95°C for 30 min. The 
resulting chromogen was extracted with 3 mL of 2-butanol and, after centrifugation 
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 9 
(1500 x g for 10 min), the absorbance of the organic phase was determined at 532 nm. 
1,1,3,3- Tetraethoxypropan (TEP) was used as a standard. Values were expressed as 
nmol of thiobarbituric acid reactive substances (TBARs)/ g tissue. 
 
Antioxidant enzymes activities 
Catalase (Enzyme Commission [EC] 1.11.1.6) activity was assayed in liver and 
renal homogenates following the method described by Beers and Sizer (1995), 
measuring the initial rate of H2O2 (10 mM) decomposition at 240 nm. Total superoxide 
dismutase (EC 1.15.1.1) activity was determined based on the method described by 
McCord and Fridovich (1969). Glutathione peroxidase (EC 1.11.1.9) activity was 
assayed by following the rate of reduced nicotinamide adenine dinucleotide phosphate 
oxidation at 340 nm by the coupled reaction with glutathione reductase. The specific 
activity was determined using the extinction coefficient of 6.22/mM/cm (Lawrence and 
Burk, 1976). Glutathione S-transferase activity (EC 2.5.1.18) was measured according 
to the method described by Habig et al. (1974), using 1-chloro-2,4- dinitrobenzene as a 
substrate. All enzymatic activities are expressed in nKat/mg protein. 
 
Genetic expression analysis 
RNA preparation and reverse transcription 
Total RNA was extracted and purified using the RNAeasy Mini Kit™ (Qiagen, 
Madrid, Spain) according to the manufacturer’s instructions. The RNA integrity was 
assessed by agarose gel electrophoresis. RNA quality was assessed from the 260/280 
nm absorbance ratio using a NanoDrop 2000 (Thermo Scientific, USA). The RNA was 
then stored at 80ºC. The RNA transcription into cDNA was carried out with a High 
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Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA) following the 
manufacturer’s instructions. The cDNA was stored at -20ºC until further use. 
 
Reverse transcription and real-time polymerase chain reaction (RT-PCR) for CAT and 
SOD 
A semi-quantitative RT-PCR protocol was developed to measure the mRNA 
levels of SOD and CAT in liver and kidney, using GAPDH as protein control. The cDNA 
obtained was diluted in milliQ sterile water and used for amplification by real-time 
PCR. The forward and reverse primers used in this study are shown in Table 1. All 
mRNA sequences for SOD, CAT and GAPDH were obtained from GenBank. PCR primers 
were obtained from Sigma-Aldrich (Madrid, Spain). Each specific gene product was 
amplified by RT-PCR using a LightCycler®480 System (Roche, Germany) according to 
the following parameters: 50ºC for 2 min, 95ºC for 10 min, 95ºC for 15 s , 60ºC for 1 
min (40 cycles) and 72ºC for 10 min (40 cycles), and 4ºC until the pickup of the 
samples. Amplification data were collected and analyzed with the software supplied by 
the manufacturer. The quantitative fold changes in mRNA expression were determined 
relative to the GAPDH mRNA levels in each corresponding group and calculated using 
the 2–ΔΔCTmethod (Gutiérrez-Praena et al. 2013). 
 
Western blot analysis for CAT 
Liver and kidney tissues were prepared for the measurement of CAT abundance by a 
Western blot analysis. Liver and kidney homogenized samples were mixed (1:1) with 
sample buffer containing β-mercaptoethanol (5%). Proteins were electrotransferred 
onto nitrocellulose membranes and inmunoblotted as described by Gutiérrez-Praena 
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et al. (2013) using monoclonal anti-CAT antibodies (Sigma-Aldrich, Madrid, Spain), 
diluted at 1/10000. The anti-CAT was detected by the enhanced chemiluminiscence 
(ECL) method according to the supplier´s protocol (Sigma, Madrid, Spain) and using a 
goat anti-mouse IgG-HRP (Santa Cruz Biotechnology, USA) as secondary antibody 
(1/10000). 
 
Statistics 
Data are expressed as mean ± standard deviation of ten animals per group. 
Statistical analysis was performed by analysis of variance (ANOVA) using GraphPad 
InStat software (GraphPad Software Inc., La Jolla, USA).  
 
Results  
No rat died during the experimental period and no remarkable clinical or 
behavioral signs were observed. Moreover, body weight gain, and food and water 
consumption was unaltered by exposure to Clay 1. 
 
Lipid peroxidation 
MDA levels remained unaltered in rats fed with Clay 1 in comparison to the 
control group in liver and kidney (Fig. 1). 
 
Antioxidant enzymes activities 
No significant changes in CAT activity were recorded in the liver of rats exposed 
to Clay 1 (Fig. 2A). However, in the kidney, CAT activity underwent a significant 
enhancement in comparison to the control group (Fig. 2B). Concerning the activities of 
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the other antioxidant enzymes (SOD, GPx, and GST), no statistical differences were 
observed in any of the studied organs (Figs. 2C, 2D, 3). 
 
RT-PCR for CAT and SOD 
In liver of rats orally exposed to Clay 1, no significant alterations were observed 
in the relative gene expression of CAT (Fig. 4A). Meanwhile, a 4-fold enhancement of 
the transcription of this enzyme was observed in kidney (Fig. 4B). In the case of SOD, 
the relative gene expression was unaltered in the liver (Fig. 4C). However, although the 
gene expression of SOD was increased in kidney, it was not significant in comparison to 
the control group (Fig. 4D).  
 
Western blot analysis for CAT  
Considering that only CAT showed alterations in both, the activity and the 
relative gene expression, the analyses of its protein expression was also performed. 
Similarly, no effect was recorded in the case of liver in the Western blot assay (Fig. 5A); 
on the other hand, there was a significant increase in the protein expression of CAT in 
the kidney of rats fed with Clay 1 (Fig. 5B). 
 
Discussion 
The expanding use of MMT in different applications including food packaging 
makes it unavoidable an evaluation of its potential toxicity. The present work aims to 
assess the safety of an organomodified MMT, namely Clay 1, which has been 
manufactured by the Packaging, Transport, & Logistics Research Institute (ITENE, 
Valencia, Spain). It has been developed to reinforce food packaging materials, thus it is 
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potentially suitable for food contact materials (Jordá-Beneyto et al. 2013). Previous 
studies performed in our laboratory have showed that Clay 1 had low cytotoxic effects 
and no genotoxicity at the concentrations assayed up to 8 µg/mL on the human 
permanent cell lines Caco-2 and HepG2 (Houtman et al. 2013). Higher concentrations 
could not be assessed in vitro, due to its low solubility that interfered with the 
measurement system (i.e., spectrophotometry). In order to assess its safety, and 
considering the lack of information for this clay, an oral sub-chronic toxicity assay has 
now been performed.  
 
In our study, no rat died during the experimental period, nor remarkable clinical 
signs were observed. Moreover, a histopathological study of the main organs of these 
animals did not show toxic injure (Maisanaba et al. 2013c). Similarly, mice orally 
exposed up to a single dose of 1000 mg/kg of MMT did not show any remarkable 
abnormal behavior, symptons or body weight loss during 14 days post-administration 
(Baek et al. 2012). Also, Mascolo et al. (2004) reported no macro-toxic effects during a 
6-day trial on male Wistar rats orally exposed to bentonite and black shale. In fact, the 
safety of different clays has been already stated. Wang et al. (2005) reported that a Ca-
MMT was safe on a group of volunteers during a short term experiment (2 weeks). 
Moreover, clays have been reported to have positive effects in several in vivo 
experiments. Thus, Cu2+-exchanged montmorillonite exhibited antibacterial activity in 
vivo and protected the intestinal mucosa from the invasion of pathogenic bacterium 
and toxins, resulting in a positive effect on the growth performance (Hu et al. 2007). 
Additionally, the external utilization of bentonite for wound healing was found to be 
safe and feasible on rats (Emami-Razavi et al. 2006). However, human intestinal cells 
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exposed to a MMT for 10 days underwent significant damage; while no remarkable 
toxic effects were found in mice receiving up to 1000 mg/kg of this MMT (Baek et al. 
2012). Therefore, in vivo experiments are needed in order to verify the toxic effects 
observed in the in vitro assays. Moreover, considering the differences in the chemical 
structure for each organomodified clay, the toxic profile could also be different, thus 
making necessary a toxic assessment on an individual basis.  
 
Concerning the toxic mechanism of clays, some in vitro experiments have 
already suggested the implication of the oxidative stress in the pathogenicity of MMT, 
since it has been pointed out as one of the principal toxic mechanisms of 
manufactured nanoclays (Lordan et al. 2010). Oxidative stress occurs in a cell or 
organism when there is an imbalance between the generation and removal of reactive 
oxygen species (ROS), resulting in DNA, lipid and protein damage. To keep destructive 
free radical levels low, the cell has enzymatic antioxidant defences (e.g., SOD, CAT, 
GPx, GST) and non-enzymatic defences, such as GSH (Puerto et al. 2010). Lordan et al. 
(2010) reported that Cloisite®Na+ induced intracellular ROS formation, which coincided 
with increased cell membrane damage. However, on the intestinal cell line Caco-2, 
neither Cloisite®Na+ nor the organo-modified MMT Cloisite®30B produced ROS 
(Sharma et al. 2010). Moreover, our research group found no alterations on the ROS 
values in any of the cell lines (HepG-2 and Caco-2) exposed to Clay 2, a similar clay as 
the one used in this study that also contains as modifier an acetylcholine chloride 
group, although a decrease in the GSH levels in HepG2 cells was observed (Houtman et 
al. 2013). Furthermore, Baek et al. (2012) evaluated the ROS production in INT-407 
cells exposed to MMT, obtaining significant levels of ROS at the highest concentration 
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(1000 μg/ mL) at the three timepoints assayed (24, 48 and 72h). Therefore, the 
modifiers used in the organoclays contributed to the toxic effects (Houtman et al. 
2013; Maisanaba et al. 2013a, 2013b). Malondialdehyde (MDA) is often used as a 
marker of the lipid peroxidation (Esterbauer and Cheeseman 1990) and is therefore an 
indicator of oxidative damage in cell membranes. In the present study, no alterations 
in the MDA levels nor in the antioxidant enzymes (SOD, GPx and GST) were recorded. 
Similarly, Shi et al. (2006) reported no changes in the SOD, GPx, and MDA levels in liver 
and serum of broiler chickens orally exposed to a modified MMT nanocomposite. On 
the contrary, the addition of MMT to a diet containing aflatoxin restored the 
antioxidant capacity of the chicks. Likewise, MDA content decreased in carps exposed 
to a Cd-contaminated basal diet supplemented with MMT in comparison with the Cd-
contaminated group (Kim et al. 2011). In the present work, although no significant 
changes in the activities of SOD, GPx, and GST were recorded in liver and kidney, CAT 
activity underwent a significant enhancement in kidney.  
The transcriptional regulation of CAT induced by Clay 1 in kidney agrees with 
the protein abundance observed in this organ. Besides, the quantity of the enzyme 
detected by Western blot analysis coincides with the activity of this enzyme. 
Therefore, our results show an adaptive response of rats exposed to Clay 1, which 
increases antioxidant enzymatic activity of CAT to overwhelm the oxidative insult. This 
finding is in contrast to the lack of histopathological lesions observed in liver and 
kidney, which may indicate the need for a higher change in the biomarkers assayed for 
the onset of histological changes. In fact, rats gavaged with sediment consisting of 15% 
MMT clay and hexachlorbenzene showed normal histochemical examinations while 
biochemical analysis did evidence damage (Lee et al. 2005). 
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Finally, it would be interesting to clarify the organospecificity of clays. In this 
sense, MMT (Cloisite®Na+) has recently been reported to be absorbed into the body 
within 2 h, without significant accumulation in any specific organ (Baek et al. 2012). 
However, Mascolo et al. (2004) showed that the distribution of trace elements from 
clays in male Wistar rats fed with bentonite and black shale was not homogeneous 
throughout the body, finding the highest amounts of them in kidney followed by liver. 
This could explain, in part, the findings observed in our study, where CAT activity was 
altered only in kidney. 
 
Conclusion 
Considering the results obtained, we cannot conclude that Clay 1 induces oxidative 
stress in rats orally exposed to it, since most of the biomarkers assayed stayed 
unaltered. However, taking into account that CAT activity, as well as its genetic and 
protein expression were enhanced, it is undeniable that Clay 1 is able to induce some 
alterations. Therefore, further studies are needed to clarify the consequences of our 
findings in order to ensure the safety of this clay.  
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Table captions 
Table 1. Nucleotides sequences (5’-3’) of PCR primers of GAPDH, SOD, and CAT. 
 
Figure captions 
Figure 1. Effect of Clay 1 on lipid peroxidation on liver (a) and kidney (b) of rat. The 
values are expressed as mean±S.D. (n=10). LPO value is expressed as nmol TBARs/g 
tissue.  
 
Figure 2. Catalase (CAT) and superoxide dismutase (SOD) activities (nkat/mg protein) in 
liver (a,c) and kidney (b,d) of rat exposed to Clay 1. The values are expressed as 
mean±S.D. (n=10). The significance levels observed are **p < 0.01 in comparison to 
control group values. 
 
Figure 3. Glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities 
(nkat/mg protein) in liver (a,c) and kidney (b,d) of rat exposed to Clay 1. The values are 
expressed as mean±S.D. (n=10).  
 
Figure 4. Relative gene expression of catalase (CAT) and superoxide dismutase (SOD) in 
liver (a,c) and kidney (b,d) of rat exposed to Clay 1. The values are expressed as 
mean±S.D. (n=10). The significance levels observed are ***p < 0.001 in comparison to 
control group values. 
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Figure 5. Relative abundance of catalase (CAT) protein in liver (a) and kidney (b) of rat 
exposed to Clay 1. The values are expressed as mean±S.D. (n=10). The significance 
levels observed are *p < 0.05 in comparison to control group values. 
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Table 1.Nucleotides sequences (5’-3’) of PCR primers of GAPDH, SOD, and CAT 
Gene* Forward primer Reverse primer 
GAPDH GCCAAAAGGGTCATCATCTCCGC GGATGACCTTGCCCACAGCCTTG 
SOD CGTCATTCACTTCGAGCAGAAGG GTCTGAGACTCAGACCACATA 
CAT CCTTTATCCATAGCCAGAAG AGCGTGAGTCTGCGCTTCAG 
* GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; SOD: Superoxide dismutase; CAT: Catalase 
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Abstract 
Food packaging industry is in a continuous development in order to obtain more secure 
and stable food and beverages. The incorporation of inorganic and organic materials to 
plastic polymers leads to polymer-composites. Among inorganic compounds, clays such 
as montmorillonite (MTT) and its derivatives are of great interest due to their 
advantageous properties. The Technological Institute of Packaging, Transport and 
Logistic (ITENE) has developed a novel nanocomposite based on a poly (lactic) acid 
(PLA) polymer using a MMT-derivate, named Clay1, as filler, to be used in the 
beverage industry. The improvement of the technological properties of this new material 
has been demonstrated but safety issues are also of concern. In the present work, a 
histopathological study by optical and electron microscopy of organs from Wistar rats 
exposed during 90 days to a migration extract of PLA-Clay 1 nanocomposite, was 
carried out. Moreover, different clinical biochemistry, inflammation and oxidative stress 
biomarkers were evaluated. Results showed no evidence of damage, indicating that this 
nanocomposite has a good profile to be used in the food packaging industry, although 
further research is still needed. 
 
Keywords: clay, nanocomposite, montmorillonite, toxicity, migration extract 
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Introduction 
Food market demands technology advances, which are essential to keep the 
market leadership in the food processing industry, in order to produce fresh, convenient 
and flavourful food products (Alfadul et al., 2010). Nanotechnology can possibly 
improve production processes, providing products with better characteristics and new 
functionalities in food and bio-processing industries (Roco, 2002). One of the potential 
application and possible concern over the use of nanomaterials and nanotechnology in 
food industry is the development of polymer nanocomposites, which are very useful in 
the food packaging industry. Hence, nanomaterials are incorporated in to the packaging 
to improve physical performance, durability, barrier properties, biodegradation, etc. 
(Bradley et al., 2011; Neethirajan et al., 2011). 
 
Among different kinds of materials used in food packaging industry, the use of 
composites must be emphasized. Composites typically consist of a polymer matrix or 
continuous phase and a discontinuous phase or filler (Matthews et al., 1994). In this 
way, nanocomposites are materials in which the filler has at least one dimension smaller 
than 100 nm (Arora et al., 2010). The mixture of polymers with inorganic and organic 
additives results in polymer-composites, which present certain geometries. In order to 
create novel polymer composites, various inorganic nanoparticles have been recognized 
as possible additives to enhance polymers performance (Sorrentino et al., 2007). Among 
these, organoclays are the most dominant commercial materials to prepare this kind of 
nanomaterials (Markarian, 2005). One of the most used clays to form these organoclays 
has been montmorillonite (MMT), a natural phyllosilicate. This compound exhibits 
excellent properties, such as high cation exchange, swelling behaviour, good adsorption 
properties and large surface area (Betega de Paiva et al., 2008). Once the clays have 
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been incorporated into the polymer they become into nanoclays. These are defined as 
natural layered structures, where the layers or platelets have sub-micrometer 
dimensions, except for their thickness, which is only about 1 nm (Hatzigrigoriou et al., 
2011). The main advantages of nanoclays are flame retardant synergy, improved 
balance of stiffness and toughness, and barrier properties (Markarian, 2005). The 
aforementioned properties could be explained through the most widely known theories 
to improved barrier properties of polymer-clay nanocomposites, described by Nielsen 
(1967). This theory focuses on a tortuous path around the clay plates, forcing the 
permeant gases to travel a longer path to diffuse through the film. 
 
The improvements and benefits that polymer-clay nanocomposites could exhibit 
are a reality nowadays. However, the potential toxicological effects and impacts in the 
fields of human health and food safety are still unknown in many ways, being necessary 
to carry out studies in order to clarify these effects (Ellenbecker et al., 2011; 
Bouwmeester et al., 2009). 
 
Engineered nanomaterials, nanoclays in this particular case, present specific 
physicochemical properties, whose should be correlated with a unique and specific 
toxicokinetics profile in each case. Moreover, these physicochemical and toxicological 
properties cannot be inferred from their bulk counterparts. But, on the other hand, these 
nanoclays will only reach the consumers if their migration from the package to the food 
is evidenced. According with the current legislation, all the aspects related to plastic 
materials and articles intended to come in contact with food and foodstuffs, as well as 
the simulants used in the migration assays are embraced in both the EU Commission 
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Regulation N° 10/2011 and the Council Directive 82/711/EEC. The final aim of these 
regulations is to ensure the safety of the final material or article. 
 
The Technological Institute of Packaging, Transport and Logistic (ITENE) is 
developing modified-clays based on MMT to be incorporated into polymers. Thus, a 
novel nanocomposite with .poly(lactic) acid (PLA) and a modified organoclay (Clay1) 
has been created to be used in the beverage industry. The improvement of the 
technological aspects of this new material have been evidenced (Jordá-Beneyto et al., 
2014) but there are no data yet on safety issues. Moreover, few studies are present in the 
literature about migration from nanocomposites used as packaging of food or beverages, 
and the toxicological effects of the migrants.  
 
Taking into account the previous background, this study provides an in vivo 
toxicological evaluation of the migration extract of an organomodified clay 
nanocomposite (PLA-Clay1). For this purpose, a histopathological study was performed 
by optical and electron microscopy in the main organs of Wistar rats after 90 days of 
oral exposure. Moreover, clinical biochemistry, inflammation and oxidative stress 
biomarkers were also investigated.  
 
Materials and Methods 
Supplies and Chemicals 
General chemicals were provided by Sigma Aldrich (Madrid, Spain) and VWR 
International Eurolab (Barcelona, Spain).  
 
Nanocomposite synthesis and migration extract 
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Poly (lactic) acid nanocomposite was obtained by ITENE with the modified 
clay, Clay1. This was prepared by a cation-exchange method, which consists on a 
displacement of the sodium cations of MMT with the ammonium cations of the 
hexadecyltrimethyl-ammonium bromide (HDTA) salt. PLA pellets were blended with 
4% in weight of Clay1 as described by Jordá-Beneyto et al. (2014). 
 
Migration test was carried out according to UNE-EN 1186-9:2002 (AENOR, 
2002) as described by Maisanaba et al. (2014a). Samples, bottles of 150 mL of 
nanocomposite material PLA+ Clay 1 (123,655 dm2 and 590-598 µm thick) were filled 
with the simulant chosen according to the law (EU Commission Regulation N° 10/2011 
and Council Directive 82/711/EEC), distilled water, at the specific conditions 
established by the regulations (Temperature (°C): 40; Time (days): 10).  
 
Animals and Experimental Design 
A repeated dose 90-day oral toxicity study was performed in rats. Briefly, 20 
male Wistar rats provided by Janvier S.A.S (France) with a mean weight of 239±1 g 
were used. Rats were fed during the acclimation week with a standard laboratory diet 
(Harlan 2014, Harlan Laboratories, Barcelona, Spain), and water, both ad libitum, in a 
controlled-temperature room (23 ± 1ºC) with 12 h dark/light cycle, and free from any 
source of chemical contamination. After this period, animals were randomly divided in 
two groups, a control group (n=10) and an exposed group (n=10). Both groups were fed 
with standard diet; the control group received distilled water as beverage while the 
exposed group was administered with PLA-Clay1 extract as beverage. Glass bottles 
were used in both groups along the trial to avoid interferences. During the treatment 
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period clinical signs, body weight, and food and water/extract consumption were 
recorded weekly.  
 
All animals received human care in compliance with the guidelines for the 
protection of animals used for scientific purposes (Directive 2010/63/EU) and all the 
procedures were previously accepted by the Ethic Committee of the University of 
Seville. 
 
Organs and blood sampling  
At the end of the experimental period, rats were fasted for 18 h before sacrifice. 
Liver, kidneys, lungs, spleen, brain, testes, gastrointestinal (g.i.) tract and heart were 
excised, rinsed with cold saline solution and weighted. Blood samples were obtained by 
cardiac punction and collected in test tubes with/without lithium heparin depending on 
the experiment. Serum was separated by low speed centrifugation at 1500 x g at 4ºC for 
15 min, and stored at -80ºC until analysis of IL-6 leakage and clinical biochemistry 
parameters. Liver and kidney sections were homogenized using 50mM phosphate 
monobasic, 1mM tetrasodium dihydrate salt and bovine serum albumin (BSA) buffer 
(pH 7,5) at 0-4 ºC with a polytron homogenizer (Heidolph RZR2102 Control, Sigma, 
Madrid, Spain). The homogenates were centrifuged 20 min at 4000 rpm at 4°C. The 
remaining supernatant, defined as the soluble (cytosolic) fraction, was used for enzyme 
measurements.  
 
Histopathogical analysis 
Tissue samples for histological examination were taken from liver, kidneys, 
lungs, spleen, brain, testes, intestine and heart of control and exposed rats. For light 
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microscopy, samples were first fixed in 10% buffered formalin for 24 h at 4ºC, and then 
immediately dehydrated in a graded series of ethanol, immersed in xylol and embedded 
in paraffin wax using an automatic processor. Sections of 3-5 mm were mounted. After 
they had been deparaffinized, sections were rehydrated, stained with haematoxylin 
adenosin (HE), and mounted with Crystal/Mount (Paraplast, Oxford Labware, St. Louis, 
MO). Liver tissue sections were also stained with periodic acid Schiff (PAS) (Sigma-
Aldrich, Madrid, Spain) for glycogen content assessment. For electron microscopy 
(EM), samples were prefixed in 2% glutaraldehyde fixative (in pH 7.4 phosphate buffer 
for 10 h at 4ºC) and postfixed in 1% osmium tetroxide fixative (in pH 7.4 phosphate 
buffer for 30 min at 4ºC). Subsequently, they were dehydrated in a graded ethanol series 
and embedded in epon. Ultrathin sections, 50–60 nm, were cut with a LKB microtome. 
The sections were mounted on a copper grid and stained with uranylacetate and lead 
citrate. The tissue sections were examined in a Philips CM10 electron microscope (FEI, 
Eindhoven, The Netherlands). 
 
IL-6 leackage 
For this assay the blood serum of experimental animals were used. Manufacturer 
instructions from the kit (Thermo Scientific Rat Interleukin-6 (IL-6) ELISA) were 
followed.  
 
Oxidative stress biomarkers 
GSH/GSSG levels 
The ratio GSH/GSSG was determined in blood samples using a commercial kit 
(Bioxytech GSH/GSSG- 412; Oxis Research, Foster City, CA, USA).  
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Lipid peroxidation 
Lipid peroxidation products were quantified by the thiobarbituric acid (TBA) 
method (Esterbauer and Cheeseman 1990). Malondialdehyde (MDA) was formed as a 
lipid peroxidation end-product that reacts with TBA reagent under acidic conditions to 
generate a pink coloured product. Values were expressed as nmol of thiobarbituric acid 
reactive substances (TBARs)/ g tissue. 
 
Antioxidant enzymes activities 
Catalase (Enzyme Commission [EC] 1.11.1.6) activity was assayed in liver and 
renal homogenates following the method described by Beers and Sizer (1995), 
measuring the initial rate of H2O2 (10 mM) decomposition at 240 nm. Total superoxide 
dismutase (EC 1.15.1.1) activity was determined based on the method described by 
McCord and Fridovich (1969). Glutathione peroxidase (EC 1.11.1.9) activity was 
assayed by following the rate of reduced nicotinamide adenine dinucleotide phosphate 
oxidation at 340 nm by the coupled reaction with glutathione reductase. The specific 
activity was determined using the extinction coefficient of 6.22/mM/cm (Lawrence and 
Burk, 1976). Glutathione S-transferase activity (EC 2.5.1.18) was measured according 
to the method described by Habig et al. (1974), using 1-chloro-2,4-dinitrobenzene as a 
substrate. All enzymatic activities are expressed in nKat/mg protein. Protein content in 
the samples was estimated by the method of Bradford (1976). 
 
Genetic expression analysis 
RNA preparation and reverse transcription 
Total RNA was extracted and purified using the RNAeasy Mini Kit™ (Qiagen, 
Madrid, Spain) according to the manufacturer’s instructions. The RNA integrity was 
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assessed by agarose gel electrophoresis. RNA quality was assessed from the 260/280 
nm absorbance ratio using a NanoDrop 2000 (Thermo Scientific, USA). The RNA was 
then stored at 80ºC. The RNA transcription into cDNA was carried out with a High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA) following the 
manufacturer’s instructions. The cDNA was stored at -20ºC until further use. 
 
Reverse transcription and real-time polymerase chain reaction (RT-PCR) for CAT and 
SOD 
A semi-quantitative RT-PCR protocol was developed to measure the mRNA 
levels of SOD and CAT in liver and kidney, using GAPDH as protein control, as 
described in Maisanaba et al. (2014b). The forward and reverse primers used in this 
study are shown in Table 1. All mRNA sequences for SOD, CAT and GAPDH were 
obtained from GenBank. PCR primers were obtained from Sigma-Aldrich (Madrid, 
Spain). The quantitative fold changes in mRNA expression were determined relative to 
the GAPDH mRNA levels in each corresponding group and calculated using the 2–
∆∆CTmethod (Gutiérrez-Praena et al., 2013). 
 
Western blot analysis for CAT 
Liver and kidney tissues were prepared for the measurement of CAT abundance 
by a Western blot analysis. Liver and kidney homogenized samples were mixed (1:1) 
with sample buffer containing β-mercaptoethanol (5%). Proteins were electrotransferred 
onto nitrocellulose membranes and inmunoblotted as described by Gutiérrez-Praena et 
al. (2013) and Maisanaba et al. (2014b) using monoclonal anti-CAT antibodies (Sigma-
Aldrich, Madrid, Spain), diluted at 1/10000. The anti-CAT was detected by the 
enhanced chemiluminiscence (ECL) method according to the supplier´s protocol 
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(Sigma, Madrid, Spain) and using a goat anti-mouse IgG-HRP (Santa Cruz 
Biotechnology, USA) as secondary antibody (1/10000). 
 
Statistical analysis 
Data are expressed as mean ± standard deviation of ten animals per group. 
Statistical analysis was performed by analysis of variance (ANOVA) using GraphPad 
InStat software (GraphPad Software Inc., La Jolla, USA). 
 
Results  
No rat died during the experimental period and there were no remarkable clinical 
signs. Body weight, body weight gain (Fig. 1), food and water/extract consumption 
(Fig. 2), organs weight and the somatic index of the different organs (Table 2) did not 
show statistical differences between the control and the exposed group. 
 
Histopathogical results 
In general, histopathological results from rats exposed to the extract did not 
show significant variations respect to the control group. More specifically, when the 
microscopic examination of the HE-stained liver section was carried out, no differences 
appeared between the exposed group (Fig. 3C) and the control group (Fig. 3A). Thus, 
hepatocytes from the parenchyma appeared with a normal conformation and normally 
disposed in hepatic cords. Furthermore, nuclei of the hepatocytes are shown well 
centered and the cytoplasm was clear. Ultrastructurally, hepatocytes from both control 
and exposed groups appeared with centered nuclei, numerous organoids, and 
amorphous glycogen (Figs. 3B, 3D). 
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Kidneys presented a normal parenchyma in the control group (Fig. 4A) as well 
as in the exposed group (Fig. 4C). They showed well disposed glomeruli. The 
Bowman’s capsule presented a regular disposition, as well as the distal and the proximal 
convoluted tubules. Under electronic microscopy, fenestrated capillary, podocytes, and 
pedicels from both groups appeared without any sign of damage (Figs. 4B, 4D). 
 
Regarding to the microscopic examination of the HE-stained lung sections of 
both experimental groups, the parenchyma did not show any alteration. Thus, 
bronchioles and alveolar sacculations were easily observable (Figs. 5A, 5C). The 
electron microscopy images showed the presence of pneumocytes type I covering the 
alveolar lumen, as well as intra-alveolar macrophages with abundant lysosomes (Figs. 
5B, 5D). 
 
Spleen also showed a normal structural conformation under light microscopy in 
both groups. The white pulp was perfectly identified, as well as other inside structures 
such as lymphoid follicles, crossed by the central artery (Figs. 6A, 6C). When studying 
the images obtained from electron microscopy, lymphoid follicles showed abundant 
lymphocytes and reticular cells (Figs. 6B, 6D). 
 
Concerning to the brain, no observable damage appeared in the neural tissue in 
any of the groups. In fact, light and the electron microscopy studies showed the same 
cellular structures. That is, normal neuronal bodies with rounded nuclei as well as the 
neuropiles (Fig. 7). 
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Testes did not show remarkable variations in their parenchyma in the control 
group, not even in the exposed group. Under light microscopy, both seminiferous 
tubules and interstitial tissue were well disposed (Figs. 8A, 8C). Ultrastructurally, a type 
B spermatogonium was evidenced in the control group (Fig. 8B), and also a type A 
spermatogonium in the exposed group (Fig. 8D). Both processes correspond to a normal 
status of the testes. 
 
The gastrointestinal tract presented unaltered villi with abundant enterocytes, in 
both experimental groups (Figs. 9A, 9C). At ultrastructural level, enterocytes presented 
well developed microvilli. Unaffected caliciform cells were also observed (Figs. 9B, 
9D). 
 
Finally, heart was apparently normal in the two studied groups. Under light 
microscopy, cardiac fibers presented uniformed size and morphology. Images showed 
the cardiac fibers longitudinally cut (Fig. 10A) or perpendicularly cut (Fig. 10C). The 
electron microscopy study revealed that the cardiac fibers presented well centered 
nuclei, and apparently normal myofibrils and desmosomes union zones were also 
observable (Figs. 10B, 10D).  
 
Clinic Biochemistry Parameters 
Results showed no significant changes in any of them in comparison to the 
control group (Table 3). 
 
 IL-6 leackage 
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No IL-6 leakage was observed in the serum of any of the experimental groups 
(data not shown). 
 
Oxidative stress biomarkers 
GSH/GSSG levels and Lipid peroxidation 
Blood GSH/GSSG ratio did not experience a significant alteration in rats 
exposed to PLA-Clay1 extract in comparison to the control group (Fig. 11). Similarly, 
lipid peroxidation was altered neither in liver nor in kidney (Fig. 12). 
 
Antioxidant enzymes activities 
CAT and SOD activities were not affected by the PLA-Clay1 exposure in any of 
the organs studied (Fig. 13). In a similar way, GPx and GST activity did not show any 
change after 90 days of exposure (Fig. 14). 
 
Genetic expression analysis 
CAT and SOD gene expression showed the same pattern that their activities, 
with no noticeable changes in the exposed group in comparison to the control group 
(Fig. 15). 
 
Western blot analysis for CAT 
The protein abundance of CAT in the liver and the kidney were not altered by 
the treatment (Fig. 16).  
 
Discussion 
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The incorporation of nanoparticles to food products is of concern due to the 
potential exposure of consumers and the scarce toxicological data available about this 
kind of compounds. In the present study, the subchronic oral exposure of rats to the 
migration extract of a PLA-Clay1 nanocomposite did not derive in observable adverse 
effects in any of the biomarkers studied. Clay1 is a no commercially available 
organoclay developed by ITENE. A previous in vitro evaluation showed that Clay1 did 
not produce cytotoxicity on the intestinal human cell line Caco-2 up to 8 µg/mL. 
However, a significant decrease of viability at this concentration in the human 
hepatocellular cell line Hep-G2 measured by the neutral red uptake assay was observed 
(Jordá-Beneyto et al., 2014). Higher Clay1 concentrations could not be assayed in vitro 
due to its hydrophobicity resulting in interferences with the spectrophotometic 
measurements. Similarly, other organoclays have shown to induce toxic effects in vitro 
(Sharma et al., 2010; Lordan et al., 2011; Baek et al., 2012; Maisanaba et al., 2013a, b) 
including genotoxicity and oxidative stress. Others, however, have not shown cytotoxic 
effects (Maisanaba et al., 2013a, b; Houtman et al., 2014) suggesting that a case by case 
evaluation is needed. 
 
Moreover, it is also important to evaluate the toxicity in animal models, since in 
vitro cell culture systems does not fully mimic the complicated in vivo system, being 
devoid of immune systems, diverse protein reactions, and dynamic fluidic environments 
(Baek et al., 2012). In this sense, Wistar rats exposed to 40 mg/kg/day Clay1 in the diet 
for 90 days did not show histophatological damages (Maisanaba et al., 2014c). 
Moreover, they did not find changes in the clinic biochemistry parameters and 
inflammatory biomarkers. Among oxidative stress biomarkers, however, they observed 
a significant increase in the activity, genetic expression and protein abundance of 
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catalase in the kidney, an enzyme involved in the detoxification of reactive oxygen 
species (ROS) (Maisanaba et al., 2014b). Apart from the aforementioned study, 
toxicological oral in vivo experiments with clays are still scarce in the scientific 
literature and most of them are related to acute exposures. Thus, Baek et al., (2012) 
exposed mice to a single dose of up to 1000 mg/kg MMT by gavage, not evidencing any 
mortality or remarkable abnormal behavior or symptom 14 days after exposure. 
Similarly, male Wistar rats exposed to 450 mg/kg of different clays for 3 days did not 
show any macro-toxic effects, although they the ingestion of clays caused an increase of 
metals in the urine and organs (kidney>liver>heart>brain) that could be toxicologically 
relevant (Mascolo et al., 1999, 2004).  
 
In addition, despite little is known about the toxicological profile of bulk clays 
the toxicity of nanoclays is a different concern, since this cannot be inferred from their 
bulk counterparts. In this sense, clays have a size in the micrometer range and when 
they are imbued in the polymeric matrix they split up in platelets with a nanometric 
thick, constituting a nanocomposite. This makes the toxicological evaluation of these 
new products more difficult to perform. Li et al. (2010) evaluated the cytotoxicity and 
genotoxicity of exfoliated silica plates with a thickness of 1 nm obtained from MMT. 
They observed a reduction in cell viability from 62.5 µg/mL in CHO cells, no DNA 
damage by the Comet assay, no chromosomal damages in the micronucleus assay and 
no mutagenicity in five different Salmonella typhimurium strains. Moreover, they did 
not observe any mortality, clinical signs or macroscopic changes in an acute oral 
toxicity in rats. On the contrary, Yoshida et al. (2012) found that amorphous nanosilica 
particles (external diameter, 70 nm) induced cytotoxicity, ROS generation and DNA 
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damage in various mammalian cells and that these toxic effects were reduced by surface 
modification. 
 
In the present work, the toxicological evaluation of the migration extract from a 
PLA-Clay1 nanocomposite has been performed. This represents a more real exposure 
scenario because consumers would be potentially exposed to the migrants. A 
preliminary characterization performed on the PLA-Clay1 extract by Maisanaba et al. 
(2014a), indicated no significant migration of the main metallic elements present in 
Clay1 (Al, Ca, Mg, Fe, Si). However, a fully analytical determination, including the 
study of nanosilica platelets in the extract, has been not performed. Actually, the 
European Food Safety Authority (EFSA) (2011) recognizes that currently it is not 
possible to routinely determine engineered nanomaterials in situ in the food. The 
absence of toxic effects observed is in agreement with the scarce presence of the 
migrants analyzed. Also, the changes observed in the activity, genetic expression and 
protein abundance of CAT enzyme in rats exposed to Clay1 are suppressed with the 
PLA-Clay1 exposure. The PLA-Clay1 extract have also shown that it does not induce 
cytotoxicity in Caco-2 and HepG2 cell lines (Maisanaba et al., 2014a) in comparison to 
Clay1 (Jordá-Beneyto et al., 2014, Houtman et al., 2014). Also, the PLA-Clay1 extract 
has demonstrated to induce no mutagenic effects by the Ames test (Maisanaba et al., 
2014a). 
 
Conclusion 
Results of the present work suggest that, regarding safety issues, PLA-Clay1 
nanocomposite has a good profile to be used in the food packaging industry, however 
further studies are needed to confirm this hypothesis. 
Page 17 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
18 
 
 
Acknowledgments 
The authors wish to thank Ministerio de Ciencia e Innovación (AGL2010-21210) and 
Junta de Andalucía (AGR5969) for the financial support for this study. 
Page 18 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
19 
 
References 
Alfadul, S.M., Elneshwy, A.A. 2010. Use of the nanotechnology in food processing, 
packaging and safety - Review. AJFAND. 10: 2719-2739. 
Arora, A., Padua, G.W. 2010. Review: Nanocomposites in Food Packaging. J. Food Sci. 
75: 43-49. 
Baek, M., Lee,J., Cho, S. 2012. Toxicological effects of a cationic clay, montmorillonite 
in vitro and in vivo. Mol. Cell. Toxicol. 8: 95-101. 
Beers, R.F., Sizer, I.W. 1952. A spectrophotometric method for measuring the 
breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195: 133-140. 
Betega de Paiva, L., Morales, A.R., Valenzuela-Díaz, F.R. 2008. Organoclays: 
properties, preparation and applications. Appl. Clay Sci. 42: 8-24. 
Bouwmeester, H., Dekkers, S., Noordan, M.Y., Hagens, W.I., Bulder, A.S., de Heer, C., 
Ten Voorde, S.C.E.G.,  Wijnhiven, S.W.P., Marvin, H.J.P., Sips, A.J.A.M. 2009. 
Review of health safety aspects of nanotechnologies in food production. Regul. 
Toxicol. Pharmacol. 53, 52-62. 
Bradford, M. 1976. A rapid sensitive method for quantification of microgram quantities 
of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254. 
Bradley, E.L., Castle, L., Chaundry, Q. 2011. Applications of nanomaterials in food 
packaging with a consideration of opportunities for developing countries. Trends 
Food Sci. Technol. 22: 604-610. 
Commission Regulation (EU) No 10/2011 of 14 January 2011 on plastic materials and 
articles intended to come into contact with food. OJEU. 
Council Directive 82/711/EEC. The basic rules necessary for testing migration of the 
constituents of plastic materials and articles to come into contact with foodstuffs. 
OJEU. 
Page 19 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
20 
 
Ellenbecker, M., Tsai, S. 2011. Engineered nanoparticles: safer substitutes for toxic 
materials, or a new hazard? J. Clean. Prod. 19, 483-487. 
Esterbauer, H., Cheeseman, K.H. 1990. Determination of aldehydic lipid peroxidation 
products: malonaldehyde and 4-hydroxynonetal. Method. Enzymol. 186: 407-421. 
European Food Security Authority (EFSA). 2011. Guidance on risk assessment of the 
application of nanoscience and nanotechnologies in the food and feed chain. EFSA 
Journal. 9: 2140.  
Gutiérrez-Praena, D., Jos, A., Pichardo, S., Puerto, M., Cameán, A.M. 2013. Influence 
of the exposure way and the time of sacrifice on the effects induced by a single dose 
of pure Cylindrospermopsin on the activity and transcription of glutathione 
peroxidase and glutathione-S-transferase enzymes in Tilapia (Oreochromis 
niloticus). Chemosphere. 90: 986-992. 
Habig, W.H., Pabst, M.J., Jakoby, W.B. 1974. Glutathione S-transferase. The first 
enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7139. 
Hatzigrigoriou, N.B., Papaspyrides, C.D. 2011. Nanotechnology in Plastic Food- 
Contact Materials. J. Appl. Polymer Sci. 122: 3720-3739. 
Houtman, J., Maisanaba, S., Puerto, M., Gutiérrez-Praena, D., Jordá, M., Aucejo, S., 
Jos, A. Toxicity assessment of organomodified clays used in food contact materials 
on human target cell lines. Appl. Clay Sci. In press. 
Jordá-Beneyto, M., Ortuño, N., Devis, A., Aucejo, S., Puerto, M., Gutiérrez-Praena, D.,  
Houtman, J., Pichardo, S., Maisanaba, S., Jos, A. 2013. Use of nanoclay platelets in 
food packaging materials: technical and cytotoxicity approach. Food Addit. Contam. 
Part A.  In press. DOI: 10.1080/19440049.2013.874045. 
Lawrence, A., Burk, R.F. 1976. Glutathione peroxidase activity in selenium deficient rat 
liver. Biochem. Biophys. Res. Commun. 71: 952-958. 
Page 20 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
21 
 
Li, P. R., Wei, J.C., Chiu, Y.F., Su, H.L., Peng, F.C., Lin, J.J. 2010. Evaluation on 
cytotoxicity and genotoxicity of the exfoliated silicate nanoclay. Appl. Mater. 
Interfaces. 2: 1608-1613. 
Lordan, S., Kennedy, J.E., Higginbothamb, C.L. 2011. Cytotoxic effects induced by 
unmodified and organically modified nanoclays in the human hepatic HepG2 cell 
line. J. Appl. Toxicol. 31: 27-35. 
Maisanaba, S., Puerto, M., Pichardo, S., Jordá, M., Moreno, F.J., Aucejo, S., Jos, A. 
2013a. In vitro toxicological assessment of clays for their use in food packaging 
applications. Food Chem. Toxicol. 57: 266–275. 
Maisanaba, S., Gutiérrez-Praena, D., Pichardo, S., Moreno, F.J., Jordá, M., Cameán, 
A.M., Aucejo, S., Jos, A. 2013b. Toxic effects of a modified montmorillonite clay on 
the human intestinal cell line Caco-2. J. Appl. Toxicol. In press. DOI: 
10.1002/jat.2945. 
Maisanaba, S., Pichardo, S., Jordá- Beneyto, M., Aucejo, S., Cameán, A.M., Jos, A. 
Submitted for Publication. 2014a. Cytotoxicity and mutagenicty studies on Migration 
Extracts from Nanocomposites with potential use in Food Packaging. Food Chem. 
Toxicol. 
Maisanaba, S., Puerto, M., Gutiérrez-Praena, D., Llana-Ruíz-Cabello, M., Pichardo, S.,  
Mate, A., Jordá-Beneyto, M., Cameán, A.M., Aucejo, S., Jos, A. 2014b. In vivo 
evaluation of activities and expression of antioxidant enzymes in Wistar rats exposed 
for 90 days to a modified clay. J. Toxicol. Environ. Health Part A. In press. 
Maisanaba, S., Gutiérrez-Praena, D., Puerto, M., Moyano, R., Blanco, A., Jordá, M., 
Cameán, A.M., Aucejo, S., Jos, A. Submitted for Publication. 2014c. Effects of the 
subchronic exposure to organomodified clay for food packaging applications on 
Wistar rats. Appl. Clay Sci. 
Page 21 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
22 
 
Markarian, J. 2005. Automotive and packaging offer growth opportunities for 
nancomposites. Plastics, Additives & Compounding. 7: 18-21. 
Mascolo, N., Summa, V., Tateo, F. 1999. Characterization of toxic elements in clays for 
human healing use. Appl. Clay Sci. 15: 491-500. 
Mascolo, N., Summa, V., Tateo, F. 2004. In vivo experimental data on the mobility of 
hazardous chemical elements from clays. Appl. Clay Sci. 25: 23-28. 
Matthews, F. L., Rawlings, R.D. 1999. Composite Materials: Engineering and Science. 
Woodhead Publishing, London. 
McCord, J.M., Fridovich, I. 1969. Superoxide dismutase. An enzymic function 
forerythrocuprein (hemocuprein). J. Biol. Chem. 244: 6049-6055. 
Neethirajan, S., Jayas, D.S. 2011. Nanotechnology for the food and bioprocessing 
industries. Food Bioprocess Technol. 4: 39-47. 
Nielsen, L. E. 1967. Models for the permeability of filled polymer systems. J. 
Macromol. Sci. Chem. 1: 929-942. 
Roco, M. C.  2002. Nanoscale science and engineering for agriculture and food systems. 
Washington: National Planning Workshop, USDA/CSREES. 
Sharma, A.K., Schmidt, B., Frandsen, H., Jacobsen, N.R., Larsen, E.H., Binderup, M.L. 
2010. Genotoxicity of unmodified 687 and organo-modified montmorillonite. J.  
Mutat. Res. 700, 18-25. 
Sorrentino, A., Gorrasi, G., Vittoria, V. 2007. Potential perspectives of bio-
nanocomposites for food packaging applications. Trends Food Sci. Technol. 18: 84-
95. 
Yoshida, T., Yoshioka, Y., Matsuyama, K., Nakazato, Y., Tochigi, S., Hirai, T.,  
Kondoh, S., Nagano, K., Abe, Y., Kamada, H., Tsunoda, S., Nabeshi, H., 
Yoshikawa, T., Tsutsumi, Y. 2012. Surface modification of amorphous nanosilica 
Page 22 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
23 
 
particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA 
damage in various mammalian cells. Biochem. Biophys. Res. Commun. 427: 748-
752. 
Page 23 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
24 
 
Figures legends 
 
Figure 1. Body weight (a) and body weight gain (b) of control Wistar rats and rats 
exposed to PLA-Clay 1 extract as beverage for 90 days. Results are expressed as mean 
± sd. 
 
Figure 2. Water/extract (a) and food consumption (b) of control Wistar rats and rats 
exposed to PLA-Clay1 extract as beverage for 90 days. Results are expressed as mean ± 
sd. 
 
Figure 3. Histopathological changes in liver of Wistar rats exposed to a PLA-Clay1 
extract as beverage for 90 days. (A, C): HE-stained liver section. Bars, 100 µm. (B, D): 
Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Liver parenchyma with 
hepatocytes with normal polyedric morphology, central nuclei and light cytoplasm (He), 
organized in hepatic cords (circle). B. Detail of the hepatocyte with its central nuclei 
(N), many organoids (Or) and amorphous glycogen (GI). C, D: Exposed rats. C. Liver 
parenchyma with hepatocytes with normal polyedric morphology, central nuclei and 
light cytoplasm (He), organized in hepatic cords (circle). D. Detail of the hepatocyte 
with its central nuclei (N), many organoids (Or) and amorphous glycogen (GI). 
 
Figure 4. Histopathological changes in kidney of Wistar rats exposed to a PLA-Clay1 
extract as beverage for 90 days. (A, C): HE-stained kidney section. Bars, 100 µm. (B, 
D): Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Normal structure of 
kidney parenchyma with glomerulus (circle), proximal convoluted tubules (Pct) and 
distal convoluted tubules (Dct). B. Detail of the renal glomerulus with fenestrated 
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capillaries, podocytes (PO) and pedicels (Pe). C, D: Exposed rats. C. Normal structure 
of kidney parenchyma with glomerulus (circle), proximal convoluted tubules (Pct) and 
distal convoluted tubules (Dct). D. Detail of the renal glomerulus with fenestrated 
capillaries, podocytes (PO) and pedicels (Pe). 
 
Figure 5. Histopathological changes in lungs of Wistar rats exposed to a PLA-Clay1 
extract as beverage for 90 days. (A, C): HE-stained lung section. Bars, 100 µm. (B, D): 
Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Pulmonary 
parenchyma with normal alveoli (AI). B. Detail of pulmonary alveoli with long 
pneumocytes type I (NI) covering the alveoli (Al). C, D: Exposed rats. C. Pulmonary 
parenchyma with normal alveoli (Al) and bronchi (Br). D. Detail of pulmonary alveoli. 
 
Figure 6. Histopathological changes in spleen of Wistar rats exposed to a PLA-Clay1 
extract as beverage for 90 days. (A, C): HE-stained spleen section. Bars, 100 µm. (B, 
D): Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Detail of normal 
white pulp with the lymph corpuscle (Lc) crossed by the central artery (Ca). B. Detail of 
the lymph corpuscle with plenty of lymphocytes (L) and reticular cells (Rc). C, D: 
Exposed rats. C. Detail of normal white pulp with the lymph corpuscle (Lc) crossed by 
the central artery (Ca). D. Detail of the lymph corpuscle with plenty of lymphocytes (L) 
and reticular cells (Rc). 
 
Figure 7. Histopathological changes in the nervous system of Wistar rats exposed to a 
PLA-Clay1 extract as beverage for 90 days. (A, C): HE-stained brain section. Bars, 100 
µm. (B, D): Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Detail of 
brain, with neurons (N) and the irregular substance or neuropil (Ne). B. Detail of neuron 
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(N) and neuropil (Ne) and presence of some nerve fibers (Nf). C, D: Exposed rats. C. 
Detail of brain, with neurons (N) and neuropil (Ne). D. Detail of neuron (N) and 
neuropil (Ne) and presence of some nerve fibers (Nf). 
 
Figure 8. Histopathological changes in the testes of Wistar rats exposed to a PLA-Clay1 
extract as beverage for 90 days. (A, C): HE-stained testes section. Bars, 100 µm. (B, D): 
Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Detail of testicular 
parenchyma with seminiferous tubules (St) and interstitial tissue (Int). B. Detail of 
seminiferous tubule with spermatogonia (G). C, D: Exposed rats. C. Detail of testicular 
parenchyma with seminiferous tubules (St) and interstitial tissue (Int). D. Detail of 
seminiferous tubule with plenty of spermatids (Sd). 
 
Figure 9. Histopathological changes in the intestine of Wistar rats exposed to a PLA-
Clay1 extract as beverage for 90 days. (A, C): HE-stained intestine section. Bars, 100 
µm. (B, D): Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Normal 
intestinal villi (V) and normal enterocytes (En). B. Enterocytes (En) with highly 
developed microvilli (Mi) with normal appearance. C, D: Exposed rats. C. Normal 
intestinal villi (V) and normal enterocytes (En). D. Enterocytes (En) with highly 
developed microvilli (Mi) with normal appearance. 
 
Figure 10. Histopathological changes in the heart of Wistar rats exposed to a PLA-
Clay1 extract as beverage for 90 days. (A, C): HE-stained heart section. Bars, 100 µm. 
(B, D): Ultrastructural observations. Bars, 10 µm. A, B: Control rats. A. Normal cardiac 
parenchyma with cardiac fibers (Cf) in a longitudinal section. B. Detail of a cardiac 
fiber (Cf), with central nuclei and apparently normal myofibrils (Mi). C, D: Exposed 
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rats. C. Normal cardiac parenchyma with cardiac fibers (Cf) in a transversal section. D. 
Detail of a cardiac fiber (Cf), with central nuclei and apparently normal myofibrils (Mi). 
 
Figure 11. Blood GSH/GSSG ratio in control Wistar rats and rats exposed to PLA-
Clay1 extract for 90 days. Results are expressed as mean ± s.d. 
 
Figure 12. Effect of PLA-Clay1 extract on lipid peroxidation on liver (a) and kidney (b) 
of rat. The values are expressed as mean±S.D. (n=10). LPO value is expressed as nmol 
TBARs/g tissue.  
 
Figure 13. Catalase (CAT) and superoxide dismutase (SOD) activities (nkat/mg protein) 
in liver (a,c) and kidney (b,d) of rat exposed to PLA-Clay1 extract. The values are 
expressed as mean±sd. (n=10).  
 
Figure 14. Glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities 
(nkat/mg protein) in liver (a,c) and kidney (b,d) of rat exposed to PLA-Clay1 extract. 
The values are expressed as mean±sd. (n=10).  
 
Figure 15. Relative gene expression of catalase (CAT) and superoxide dismutase (SOD) 
in liver (a,c) and kidney (b,d) of rat exposed to PLA-Clay1 extract. The values are 
expressed as mean±sd. (n=10).  
 
Figure 16. Relative abundance of catalase (CAT) protein in liver (a) and kidney (b) of 
rat exposed to PLA-Clay1 extract. The values are expressed as mean±sd. (n=10).  
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Figure 1. Body weight (a) and body weight gain (b) of control Wistar rats and rats exposed to PLA-Clay 1 
extract as beverage for 90 days. Results are expressed as mean ± sd.  
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Figure 2. Water/extract (a) and food consumption (b) of control Wistar rats and rats exposed to PLA-Clay1 
extract as beverage for 90 days. Results are expressed as mean ± sd.  
190x186mm (300 x 300 DPI)  
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Figure 3. Histopathological changes in liver of Wistar rats exposed to a PLA-Clay1 extract as beverage for 90 
days. (A, C): HE-stained liver section. Bars, 100 µm. (B, D): Ultrastructural observations. Bars, 10 µm. A, B: 
Control rats. A. Liver parenchyma with hepatocytes with normal polyedric morphology, central nuclei and 
light cytoplasm (He), organized in hepatic cords (circle). B. Detail of the hepatocyte with its central nuclei 
(N), many organoids (Or) and amorphous glycogen (GI). C, D: Exposed rats. C. Liver parenchyma with 
hepatocytes with normal polyedric morphology, central nuclei and light cytoplasm (He), organized in hepatic 
cords (circle). D. Detail of the hepatocyte with its central nuclei (N), many organoids (Or) and amorphous 
glycogen (GI).  
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Figure 4. Histopathological changes in kidney of Wistar rats exposed to a PLA-Clay1 extract as beverage for 
90 days. (A, C): HE-stained kidney section. Bars, 100 µm. (B, D): Ultrastructural observations. Bars, 10 µm. 
A, B: Control rats. A. Normal structure of kidney parenchyma with glomerulus (circle), proximal convoluted 
tubules (Pct) and distal convoluted tubules (Dct). B. Detail of the renal glomerulus with fenestrated 
capillaries, podocytes (PO) and pedicels (Pe). C, D: Exposed rats. C. Normal structure of kidney parenchyma 
with glomerulus (circle), proximal convoluted tubules (Pct) and distal convoluted tubules (Dct). D. Detail of 
the renal glomerulus with fenestrated capillaries, podocytes (PO) and pedicels (Pe).  
61x42mm (300 x 300 DPI)  
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Figure 5. Histopathological changes in lungs of Wistar rats exposed to a PLA-Clay1 extract as beverage for 
90 days. (A, C): HE-stained lung section. Bars, 100 µm. (B, D): Ultrastructural observations. Bars, 10 µm. 
A, B: Control rats. A. Pulmonary parenchyma with normal alveoli (AI). B. Detail of pulmonary alveoli with 
long pneumocytes type I (NI) covering the alveoli (Al). C, D: Exposed rats. C. Pulmonary parenchyma with 
normal alveoli (Al) and bronchi (Br). D. Detail of pulmonary alveoli.  
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Figure 6. Histopathological changes in spleen of Wistar rats exposed to a PLA-Clay1 extract as beverage for 
90 days. (A, C): HE-stained spleen section. Bars, 100 µm. (B, D): Ultrastructural observations. Bars, 10 µm. 
A, B: Control rats. A. Detail of normal white pulp with the lymph corpuscle (Lc) crossed by the central artery 
(Ca). B. Detail of the lymph corpuscle with plenty of lymphocytes (L) and reticular cells (Rc). C, D: Exposed 
rats. C. Detail of normal white pulp with the lymph corpuscle (Lc) crossed by the central artery (Ca). D. 
Detail of the lymph corpuscle with plenty of lymphocytes (L) and reticular cells (Rc).  
61x42mm (300 x 300 DPI)  
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Figure 7. Histopathological changes in the nervous system of Wistar rats exposed to a PLA-Clay1 extract as 
beverage for 90 days. (A, C): HE-stained brain section. Bars, 100 µm. (B, D): Ultrastructural observations. 
Bars, 10 µm. A, B: Control rats. A. Detail of brain, with neurons (N) and the irregular substance or neuropil 
(Ne). B. Detail of neuron (N) and neuropil (Ne) and presence of some nerve fibers (Nf). C, D: Exposed rats. 
C. Detail of brain, with neurons (N) and neuropil (Ne). D. Detail of neuron (N) and neuropil (Ne) and 
presence of some nerve fibers (Nf).  
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Figure 8. Histopathological changes in the testes of Wistar rats exposed to a PLA-Clay1 extract as beverage 
for 90 days. (A, C): HE-stained testes section. Bars, 100 µm. (B, D): Ultrastructural observations. Bars, 10 
µm. A, B: Control rats. A. Detail of testicular parenchyma with seminiferous tubules (St) and interstitial 
tissue (Int). B. Detail of seminiferous tubule with spermatogonia (G). C, D: Exposed rats. C. Detail of 
testicular parenchyma with seminiferous tubules (St) and interstitial tissue (Int). D. Detail of seminiferous 
tubule with plenty of spermatids (Sd).  
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Figure 9. Histopathological changes in the intestine of Wistar rats exposed to a PLA-Clay1 extract as 
beverage for 90 days. (A, C): HE-stained intestine section. Bars, 100 µm. (B, D): Ultrastructural 
observations. Bars, 10 µm. A, B: Control rats. A. Normal intestinal villi (V) and normal enterocytes (En). B. 
Enterocytes (En) with highly developed microvilli (Mi) with normal appearance. C, D: Exposed rats. C. 
Normal intestinal villi (V) and normal enterocytes (En). D. Enterocytes (En) with highly developed microvilli 
(Mi) with normal appearance.  
61x42mm (300 x 300 DPI)  
 
 
Page 36 of 46
URL: http://mc.manuscriptcentral.com/jteha  Email: skacew@uottawa.ca
Journal of Toxicology and Environmental Health, Part A: Current Issues
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
  
 
 
Figure 10. Histopathological changes in the heart of Wistar rats exposed to a PLA-Clay1 extract as beverage 
for 90 days. (A, C): HE-stained heart section. Bars, 100 µm. (B, D): Ultrastructural observations. Bars, 10 
µm. A, B: Control rats. A. Normal cardiac parenchyma with cardiac fibers (Cf) in a longitudinal section. B. 
Detail of a cardiac fiber (Cf), with central nuclei and apparently normal myofibrils (Mi). C, D: Exposed rats. 
C. Normal cardiac parenchyma with cardiac fibers (Cf) in a transversal section. D. Detail of a cardiac fiber 
(Cf), with central nuclei and apparently normal myofibrils (Mi).  
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Figure 11. Blood GSH/GSSG ratio in control Wistar rats and rats exposed to PLA-Clay1 extract for 90 days. 
Results are expressed as mean ± s.d.  
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Figure 12. Effect of PLA-Clay1 extract on lipid peroxidation on liver (a) and kidney (b) of rat. The values are 
expressed as mean±S.D. (n=10). LPO value is expressed as nmol TBARs/g tissue.  
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Figure 13. Catalase (CAT) and superoxide dismutase (SOD) activities (nkat/mg protein) in liver (a,c) and 
kidney (b,d) of rat exposed to PLA-Clay1 extract. The values are expressed as mean±sd. (n=10).  
270x191mm (300 x 300 DPI)  
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Figure 14. Glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities (nkat/mg protein) in 
liver (a,c) and kidney (b,d) of rat exposed to PLA-Clay1 extract. The values are expressed as mean±sd. 
(n=10).  
270x191mm (300 x 300 DPI)  
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Figure 15. Relative gene expression of catalase (CAT) and superoxide dismutase (SOD) in liver (a,c) and 
kidney (b,d) of rat exposed to PLA-Clay1 extract. The values are expressed as mean±sd. (n=10).  
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Figure 16. Relative abundance of catalase (CAT) protein in liver (a) and kidney (b) of rat exposed to PLA-
Clay1 extract. The values are expressed as mean±sd. (n=10).  
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Table 1. Nucleotides sequences (5’-3’) of PCR primers of GAPDH, SOD, and CAT. 
Gene* Forward primer Reverse primer 
GAPDH GCCAAAAGGGTCATCATCTCCGC GGATGACCTTGCCCACAGCCTTG 
SOD CGTCATTCACTTCGAGCAGAAGG GTCTGAGACTCAGACCACATA 
CAT CCTTTATCCATAGCCAGAAG AGCGTGAGTCTGCGCTTCAG 
* GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; SOD: Superoxide dismutase; CAT: Catalase 
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Table 2. Organs weight (g) and somatic index (%) of the different organs of control 
Wistar rats and rats exposed to PLA-Clay1 extract for 90 days. Results are expressed as 
mean ± sd. 
 
 
Control 
Mean ± SD 
PLA-Clay1 Extract 
Mean ± SD 
Liver (g) 13.12 ± 2.44 12.43±0.83 
Somatic Liver Index 2.83 ± 0.40 2.41±0.14 
Kidneys (g) 3.02 ± 0.63 2.91±0.22 
Somatic Kidney Index 0.65 ±0.11 0.57±0.05 
Lungs (g) 2.75 ± 0.78 2.84±0.39 
Somatic Lung Index 0.6 ± 0.09 0.56±0.10 
Spleen (g) 1.02 ± 0.17 1.10±0.14 
Somatic Splenic Index 0.22 ± 0.02 0.21±0.02 
Brain (g) 2.06 ± 0.18 2.25±0.08 
Somatic Brain Index 0.45 ± 0.05 0.44±0.03 
Testes (g) 3.66 ± 0.75 4.22±0.90 
Somatic Testicle Index 0.79 ± 0.11 0.80±0.19 
Intestine (g) 4.99 ± 1.02 5.27±2.77 
Somatic Intestine Index 1.10 ± 0.37 1.00±0.49 
Heart (g) 1.82 ± 0.12 1.78±0.20 
Somatic Heart Index 0.40 ± 0.05 0.34±0.04 
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Table 3. Clinic biochemistry parameters of control Wistar rats and rats exposed to PLA-
Clay1 extract for 90 days. Results are expressed as mean ± sd. 
 
Parameters 
Control PLA-Clay1 EXTRACT 
Mean ± SD Mean ± SD 
Glucose (mg/dL) 141.83 ± 61.95 156.50±64.8 
Urea (mg/dL) 58.00 ± 7.95 54.75±7.93 
Creatinine (mg/dL) 0.78 ± 0.08 0.78±0.06 
Total protein (g/dL) 6.17 ± 0.19 5.97±0.38 
Albumin (g/dL) 4.12 ± 0.22 3.90±0.16 
Cholesterol (mg/dL) 90.00 ± 15.61 78.00±11.69 
Aspartate Aminotransferase (AST) (U/L) 187.83 ± 67.29 136.25±21.61 
Alanine Aminotransferase (ALT) (U/L) 52.67 ± 16.28 48.75±3.09 
Alkaline Fosfatase (ALP) (U/L) 185.67 ± 54.64 162.50±36.15 
Sodium (mEq/L) 152.67 ± 1.21 150.50±1.73 
Potassium (mEq/L) 7.68 ± 1.12 7.40±0.91 
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CAPÍTULO 13/ CHAPTER 13 
 
Maisanaba S, Pichardo S, Jordá M, Aucejo S, Cameán A, Jos A 
 
EVALUACIÓN DE LA SEGURIDAD DE UNA ARCILLA MODIFICADA Y SU 
EXTRACTO DE MIGRACIÓN EN BAZO DE RATAS WISTAR EXPUESTAS DE 
FORMA SUBCRÓNICA 
 
 
Revista de Toxicología 30, 125-130, 2013 
 
Resumen: Las ventajas tecnológicas de la incorporación de arcillas 
modificadas en polímeros para el envasado de alimentos son bien 
conocidas, pero aún quedan muchas incertidumbres sobre la 
seguridad de estos materiales. El Instituto Tecnológico del Embalaje, 
Transporte y Logística ha desarrollado una arcilla, Clay1, 
modificando una montmorillonita con una sal de amonio cuaternario. 
Esta organoarcilla, incorporada al polímero (ácido poliláctico), da 
lugar a un material nanocompuesto, reforzándose así el material de 
partida. El principal objetivo de este estudio es evaluar la actividad de 
biomarcadores de estrés oxidativo en bazo de ratas expuestas durante 
90 días a Clay1 (40 mg/kg/día) y al extracto de migración obtenido a 
partir del material nanocompuesto resultante. Los parámetros 
evaluados fueron la peroxidación lipídica y las actividades 
enzimáticas superóxido dismutasa y catalasa. Además, se realizó un 
análisis del contenido en bazo de los metales más característicos que 
componen la organoarcilla (Al, Ca, Fe, Mg, Si) para comprobar su 
posible acumulación. En dicho estudio se trabajó con tres grupos de 
ratas Wistar (n=10): control (comida estándar + agua como bebida), 
Clay1 (comida estándar mezclada con 40mg/kg/día de arcilla + agua) 
y extracto de Clay1 (comida estándar + extracto como bebida). Tras el 
tiempo de exposición los animales se sacrificaron y se extrajo el bazo. 
De forma general, no se observaron diferencias significativas en 
ninguno de los parámetros evaluados con respecto al grupo control, 
por lo que Clay1 muestra un buen perfil toxicológico respecto a los 
biomarcadores ensayados con vistas a su uso en la industria 
alimentaria.
Palabras clave: arcilla modificada, envasado de alimentos, 
exposición subcrónica, estrés oxidativo
Abstract: Influence of a subchronical exposure to a modified clay 
and its migration extract in the spleen of Wistar rats. The 
technological advantages of the incorporation of modified clays into 
polymers for food packaging are well known. However, there are still 
many uncertainties about the safety of these materials. The 
Technological Institute of Packaging, Transport and Logistic has 
developed Clay1, a modified clay with a quaternary ammonium salt. 
This organoclay is incorporated into the polymer (polylactic acid), 
giving a nanocomposite material and reinforcing the bulk material. 
The aim of this study is to evaluate the activity of several oxidative 
stress biomarkers in the spleen of rats exposed for 90 days to Clay1 
(40 mg/kg/day) and its migration extract obtained from the resultant 
nanocomposite material. The parameters evaluated were lipid 
peroxidation and superoxide dismutase and catalase activities. 
Moreover, the characteristic metallic components of the organoclay 
(Al, Ca, Fe, Mg, Si) were also analyzed to test the possible 
accumulation. In this study, three groups of Wistar rats (n=10) were 
used: control (standard food + water), Clay1 (food with Clay1+water) 
and Clay1 extract (standard food+ Clay1 extract as water). After the 
exposure the spleen was removed. In general, no significant 
differences were observed in any of the parameters evaluated 
compared to the control group, therefore Clay1 showed a good 
toxicologic profile regarding the biomarkers assayed for its use in the 
food industry. 
Keywords: modified clay, food packaging, subchronical exposure, 
oxidative stress
Introducción
El uso de arcillas naturales como la montmorillonita (MMT), 
kaolinita, bentonita, etc., está en auge en diversos campos de trabajo. 
Por ejemplo, podemos encontrarlas actuando como catalizadores, 
adsorbentes, en materiales nanocompuestos, en sensores y 
electrodos, como antibacterianos en determinados materiales, en 
almacenaje de desechos nucleares y transportadores de pesticidas, 
etc. [1]. El papel que juegan dentro de la industria alimentaria, y más 
concretamente en el área de envasado, es cada vez más destacado. El 
uso de plásticos en el envasado de alimentos está ampliamente 
instaurado dentro de la industria de la alimentación, pero se debe 
tener en cuenta que la calidad y seguridad de los alimentos envasados 
puede verse comprometida si existe la posibilidad de intercambio 
gaseoso, acuoso y/o de componentes aromáticos [2]. En este aspecto 
en particular, el uso de las arcillas anteriormente mencionadas cobra 
un papel importante. La modificación de la superficie de las arcillas 
minerales recibe una especial atención ya que da lugar a nuevas 
aplicaciones y a nuevos materiales, siendo destacable el desarrollo de 
nuevos polímeros nanocompuestos [3]. Las organoarcillas son los 
nanomateriales más usados en el comercio para preparar estos 
polímeros nanocompuestos [4]. Así mismo, el aspecto económico es 
también muy beneficioso, logrando con estos materiales una relación 
coste-precio-eficiencia notable [5,6].
Entre las arcillas que más destacan para dar lugar a los materiales 
nanocompuestos se encuentra la MMT sódica, comercialmente 
+ +
conocida como Cloisite®Na  (C®Na ), un hidroxisilicato de 
magnesio y aluminio, con otros posibles elementos presentes. Tiene 
una estructura laminar, compuesta por dos láminas tetraédricas 
formadas por silicio (Si) y oxígeno (O) acoplada a una lámina 
octaédrica formada por átomos de magnesio (Mg) y aluminio (Al) 
unidos a O y grupos hidroxilo (OH) [7].
Una vez que la arcilla se imbuye y dispersa en el polímero 
seleccionado, sus láminas se disponen dando lugar a una estructura 
que obliga a los gases a seguir una trayectoria tortuosa, consiguiendo 
de tal forma que se disminuya la permeabilidad. La principal ventaja 
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del uso de estas arcillas como “relleno” es la mejora que se produce en 
las propiedades barrera del polímero [8]. Además, otros autores 
también destacan las mejoras en las propiedades mecánicas, térmicas, 
reológicas y ópticas de los materiales nanocompuestos [6,9], 
incrementándose así la vida comercial del producto.
Una de las limitaciones del uso de las arcillas como nano-rellenos es 
la incompatibilidad entre la hidrofilia de la arcilla y la hidrofobicidad 
del polímero, lo cual puede dar lugar a la aglomeración de la arcilla en 
la matriz polimérica [10,11]. Una apropiada modificación orgánica 
de la arcilla es la clave para una exitosa exfoliación en la matriz 
polimérica, reduciéndose la hidrofilia de la arcilla y mejorando la 
compatibilidad con la misma [12]. Finalmente, se obtiene un material 
nanocompuesto con una disposición de la arcilla en forma laminar 
con un grosor de las mismas de tamaño nanométrico, de ahí que 
reciban el nombre de nanoarcillas. 
En el caso de la MMT, una de las modificaciones más usuales llevadas 
a cabo y de la cual se ha obtenido un buen resultado, es la 
modificación por intercambio iónico. El cambio de iones inorgánicos 
de la MMT con iones orgánicos de amonio, alcaliamonios, da lugar a 
unos silicatos laminares organomodificados más organizados que 
mejoran la compatibilidad de la MMT con polímeros orgánicos 
[7,13].
Debido al amplio espectro de aplicaciones que tienen estas arcillas 
organomodificadas, el consumidor cada vez va a estar más expuesto a 
ellas. Por ello, se hace necesaria una rigurosa evaluación de estos 
nuevos materiales que se incorporan al mercado, dilucidando qué 
posibles efectos tóxicos podría ocasionar en el ser humano y las 
consecuencias de los mismos. Hasta el momento, la intoxicación por 
arcillas minerales ha ocurrido con más frecuencia por vía inhalatoria 
[10,14]. Sin embargo, al estar presente estas arcillas en materiales de 
envasado, la vía de entrada más común en la actualidad es la oral, 
pudiendo presentarse migración de las mismas desde el material de 
envasado hasta el alimento. Tateo y Summa [15], han descrito que la 
ingestión de arcillas minerales es común a bajas dosis teniendo en 
cuenta la presencia de las mismas en los productos, no sólo 
alimenticios sino también farmacéuticos y hierbas medicinales.
La evaluación toxicológica de estos productos puede llevarse a cabo 
tanto in vitro con in vivo. En la literatura científica podemos encontrar 
diversos estudios realizados in vitro con arcillas modificadas y los 
efectos observados tras la exposición a las mismas. Sharma y col. 
[16], evaluaron el potencial genotóxico de la MMT sin modificar, 
+
C®Na , así como el de la arcilla organomodificada Cloisite®30B 
(C®30B) en la línea celular intestinal humana Caco-2, concluyendo 
que la genotoxicidad observada podía deberse a la sal de amonio 
cuaternario usada como modificador de la arcilla. Por otro lado, 
también se ha evaluado la citotoxidad producida por exposición de las 
+
células hepáticas HepG2 a C®Na  y la arcilla modificada 
Cloisite®93A (C®93A), en las cuales se pudo observar un 
significativo descenso de la viabilidad celular [17]. En nuestro 
laboratorio, también se ha evaluado el potencial tóxico de arcillas 
modificadas en las líneas celulares mencionadas, observándose 
resultados diversos. Se sugiere por tanto que  los modificadores 
empleados  pueden estar involucrados en el perfil de toxicidad 
observado [18-21]. 
Por otro lado, los datos de ensayos in vivo realizados hasta el 
momento con este tipo de materiales aún son escasos, y, la 
información disponible no es representativa para la población 
humana, puesto que suelen ser ensayos a dosis repetidas en un 
periodo corto de tiempo. Por todo ello, el objetivo de este trabajo es 
determinar la toxicidad oral subcrónica de una arcilla modificada 
desarrollada por el Instituto Tecnológico del Embalaje, Transporte y 
Logística (ITENE) destinada a ser incorporada a ácido poliláctico 
para ser utilizada en la industria de envasado, así como del extracto de 
migración derivado del material nanocompuesto resultante, 
empleando como modelo experimental la rata Wistar. Se evaluó, en 
bazo, el contenido proteico, la posible peroxidación lipídica (LPO), la 
actividad de dos enzimas antioxidantes, superóxido dismutasa (SOD) 
y catalasa (CAT), y un análisis de contenido de metales (Al, Fe, Mg, 
Si y Ca) que hayan podido acumularse debido a la ingestión de la 
arcilla.
Materiales y Métodos
Materiales y reactivos
Los reactivos de uso general fueron proporcionados por Sigma 
Aldrich (Madrid, España) y VWR International Eurolab (España).
La arcilla organomodificada designada como Clay1 fue obtenida 
mediante una reacción de intercambio catiónico a partir de C®Na+ 
(Southern Clay Products, INC.), añadiendo una sal de amonio 
cuaternario, bromuro de hexadeciltrimetilamonio (HDTA), en una 
proporción seis veces mayor a la capacidad de intercambio catiónico 
(CEC) de la arcilla madre, de acuerdo con el método descrito por 
Mittal [22], Jordá- Beneyto y col. [23] y Jordá y col. [7]. La arcilla fue 
caracterizada mediante espectroscopía de infrarrojos (FTIR), análisis 
termogravimétrico (TGA) y difracción de rayos X (XRD) por Jordá- 
Beneyto y col. [24].
El extracto de migración se obtuvo de acuerdo a lo descrito en 
Maisanaba y col. [25] siguiendo la norma UNE-EN 1186-9:2002 [26] 
y utilizando como simulante alimentario el agua, ya que es el menos 
tóxico de entre los autorizados por la legislación vigente. 
Posteriormente, este agua fue utilizada como agua de bebida para el 
ensayo in vivo.
Animales y diseño experimental
Se realizó un estudio de toxicidad oral durante 90 días en ratas. Se 
usaron 30 ratas Wistar macho, con un peso medio de 240±2, 
proporcionadas por Janvier S.A.S (Francia). Las ratas fueron tratadas 
durante la semana de aclimatación con una alimentación estándar de 
laboratorio (Harlan 2014, Harlan Laboratories, Barcelona, España) y 
agua, ambos ad libitum, en una habitación con control de temperatura 
(23±1°C), con períodos de 12h de luz y 12h de oscuridad y libres de 
cualquier fuente de contaminación química. Posteriormente, los 
animales se dividieron en tres grupos, el grupo control (n=10), grupo 
expuesto a Clay1 (n=10) y grupo expuesto al extracto de Clay1 
(n=10). El grupo control fue alimentado con dieta estándar y agua, al 
grupo expuesto a Clay1 se le administró una dosis de 40 mg/kg/día de 
la arcilla en la comida y, como bebida agua, y al grupo expuesto al 
extracto de Clay1 se le expuso a la dieta estándar y al extracto de 
migración como bebida. La dosis de arcilla fue seleccionada teniendo 
en cuenta el peor escenario de exposición para el ser humano. El 
consumo de comida y agua fue ad libitum en los tres grupos, 
registrándose éstos semanalmente, así como el incremento de peso de 
los animales.
Los animales fueron manipulados teniendo en cuenta las directrices 
establecidas para la protección de los animales utilizados en 
experimentación y otros fines científicos [27]. Así mismo, todos los 
procedimientos fueron aceptados previamente por el Comité Ético de 
la Universidad de Sevilla.
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Extracción del  bazo y  preparación del  sobrenadante 
postmitocondrial
Transcurridos los 90 días de exposición, las ratas se sometieron a un 
ayuno de 18h antes del sacrificio. El estudio se realizó en bazo por ser 
éste un órgano muy proclive a la acumulación de partículas [28] y por 
tanto podría ser una diana para este tipo de compuestos. Los órganos 
fueron lavados  en frío con solución salina y posteriormente se 
pesaron. Las muestras se mantuvieron congeladas a -80°C hasta el 
análisis de los diferentes parámetros. Para el estudio de los 
biomarcadores de estrés oxidativo, el tejido se homogenizó usando 
un tampón compuesto por KH2PO4 50mM, Na4EDTA2H2O 1mM y 
albúmina de suero bovino (BSA). Realizada la homogenización se 
procedió a la centrifugación de las muestras (2500 x g durante 
20min), eliminación del sobrenadante y recogida del homogenizado 
limpio en alícuotas de 2 mL. 
Contenido proteico y LPO
El contenido proteico de las muestras de bazo fue determinado 
mediante el protocolo descrito por Bradford [29], usando como 
estándar la γ-globulina. Los resultados fueron expresados como mg 
proteína/g de tejido.
La LPO se cuantificó mediante el método del ácido tiobarbitúrico 
(TBA) [30]. Los valores fueron representados como nmoles de 
TBARS/g de tejido.
Enzimas antioxidantes
La actividad total de la SOD (EC 1.15.1.1) se determinó por el 
método de McCord y Fridovich [31]. Este ensayo depende de la 
capacidad de la SOD para inhibir la reducción del citocromo C 
mediada por el O  generado por el sistema de la xantina oxidasa. La 
2
actividad de la enzima fue medida a espectrofotométricamente a 505 
nm. Los valores fueron representados como nkat/mg de proteínas. La 
actividad CAT (EC 1.11.1.6) fue calculada mediante el método de 
Beers y Sizer [32]. La reducción del peróxido de hidrógeno se mide 
espectrofotométricamente a 240 nm, usando cubetas de cuarzo de 1 
mL con paso de luz de 1cm. Los resultados fueron expresados como 
nkat/mg de proteínas.
Análisis de metales
La presencia de Al, Fe y Mg en bazo fue determinada mediante 
espectrometría de masas con plasma de acoplamiento inductivo (ICP-
MS) (Agilent 7500C, Agilent ICP-MS Systems, USA) utilizando los 
siguientes isótopos: Mg-24, Al-27 y Fe-56 (con celda de reacción 
octupolar presurizada con hidrógeno para eliminar la interferencia 
del ArO sobre el Fe-56). En el caso del Si y Ca, ambos fueron 
determinados mediante espectrometría de emisión atómica de plasma 
acoplado inductivamente (ICP-AES, Horiba Jobin Yvon, modelo 
última 2) empleando líneas de emisión 251.611 nm y 317.933 nm 
para Si y Ca, respectivamente. Estas determinaciones se llevaron a 
cabo en el Centro de Investigación, Tecnología e Innovación de la 
Universidad de Sevilla (CITIUS) en base a protocolos normalizados 
de trabajo realizando previamente una digestión del tejido con HNO  
3
al 65%. Los datos se expresan como mg de metal/g de tejido.
Análisis estadístico
Los resultados se muestran como la media± DE de diez animales por 
grupo. El análisis estadístico llevado a cabo fue el análisis de la 
varianza (ANOVA) usando el software GraphPad InStat (GraphPad 
Software Inc., La Jolla, USA).
Resultados
Durante el periodo experimental no se produjo la muerte de ningún 
animal, siendo la evolución de los pesos y consumos normal. De igual 
forma, no se observaron efectos clínicos significativos.
Efectos sobre contenido proteico y LPO
El contenido proteico de los tres grupos experimentales, control, 
Clay1 y extracto de Clay1, fue muy similar (Fig. 1). La concentración 
proteica media resultó ser 32,5±3 mg de proteína/ g de tejido, no 
presentándose diferencias estadísticamente significativas entre los 
grupos.
Los resultados obtenidos en LPO reflejaron que no hubo cambios 
significativos en ninguno de los grupos de exposición, Clay1 y 
extracto de Clay1, con respecto al grupo control (Fig. 2). En el grupo 
control fue obtenido un valor medio de 720±172 nmoles de TBARS/g 
de tejido. En el caso de los grupos tratados Clay1 y extracto de Clay1 
fueron 712±164 y 676±69 nmoles de TBARS/g de tejido, 
respectivamente.
Efectos sobre enzimas antioxidantes
La actividad SOD no se alteró tras la exposición a 40 mg/kg/día de 
Clay1 tras el periodo de exposición, no observándose diferencias 
significativas con respecto el grupo control (Fig. 3a). Del mismo 
modo, los valores obtenidos en el caso del grupo expuesto al extracto 
de Clay1 fueron similares a los obtenidos en el grupo control. Los 
valores medios por grupo fueron: 133±26, 141±35 y 122±15 nkat/mg 
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Figura 1. Contenido proteico (mg proteínas/mg tejido) de bazo de 
ratas control, ratas expuestas a 40 mg Clay1/kg rata/día y ratas 
expuestas a extracto de migración de Clay1 durante 90 días. Los 
valores están representados como la media± DE (n=10).
Figura 2. Valores de LPO en bazo de ratas control, ratas expuestas a 
40 mg Clay1/kg rata/día y ratas expuestas al extracto de migración de 
Clay1 durante 90 días. Los valores están representados como la 
media± DE (n=10).
Maisanaba S, Pichardo S, Jordá M, Aucejo S, Cameán A, Jos A
Rev. Toxicol. (2013) 30: 138-143
de proteínas para el grupo control, Clay1 y extracto de Clay1, 
respectivamente. 
En el caso de CAT, se obtuvieron resultados similares en los tres 
grupos (Fig. 3B), no afectando a la actividad de la enzima la 
exposición a la arcilla modificada o al extracto de migración. Las 
actividades medias de la enzima en los grupos experimentales, 
control, Clay1 y extracto de Clay1, fueron 5±0,8, 5,2±1,2 y 5±0,7 
nkat/mg de proteínas, respectivamente.
Determinación de metales en bazo
En la tabla 1 se recogen los datos obtenidos en el análisis del 
contenido de metales en el bazo. En ningún caso se observaron 
cambios significativos tras 90 días de exposición. 
Discusión
El uso de arcillas minerales en diferentes aplicaciones industriales, y 
más concretamente en la industria alimentaria, está en auge debido a 
los buenos resultados técnicos obtenidos. Por tanto, la exposición a la 
mismas se ve aumentada pudiéndose ver comprometida la seguridad 
del ser humano. La arcilla modificada Clay1 ha sido desarrollada con 
el fin de reforzar envases alimentarios, y es considerada por tanto 
como material de contacto alimentario [24]. La exposición del 
consumidor a compuestos químicos presentes en el material de 
envasado de alimentos podría ocurrir debido a la migración de los 
mismos desde el envase [33]. Tanto la migración como la toxicidad de 
una determinada sustancia se convierten en los dos factores 
principales que podrían definir el riesgo para el consumidor expuesto 
a estos nuevos materiales incorporados a los envases [34]. En relación 
a su toxicidad, se han realizado ensayos in vitro con Clay1 en la línea 
celular intestinal humana Caco-2 y en la línea hepática HepG2 
[18,19]. Los resultados obtenidos mostraron una muy baja toxicidad 
en el rango de concentraciones ensayadas (0-8 µg/mL). Únicamente 
en uno de los biomarcadores (contenido proteico total) y en la línea 
celular Caco-2 tras 48h de exposición a la concentración más alta se 
obtuvieron diferencias significativas. Concentraciones superiores no 
pudieron ensayarse debido a la hidrofobicidad de la arcilla.
Según la Comisión Europea [35], para que una sustancia que va a 
entrar en contacto con alimentos se comercialice, ésta debe pasar 
antes por una serie de evaluaciones, entre la que se encuentra una 
evaluación toxicológica precisa que recoge ensayos de diversa 
índole. Entre estos ensayos debe realizarse un estudio de toxicidad 
oral de 90 días. En el presente estudio, los resultados obtenidos, 
teniendo en cuenta que se ha trabajado con el peor escenario de 
exposición (migración total de la arcilla), no han mostrado efectos 
tóxicos notables en las ratas. Otros autores también han llevado a 
cabo estudios in vivo por vía oral con arcillas, aunque usando 
periodos de exposición más cortos. Li y col. [36] llevaron a cabo un 
ensayo de toxicidad oral en ratas, a las cuales se les expuso por una 
única vez a 4 dosis diferentes de una arcilla proveniente de MMT, sin 
encontrar finalmente efectos adversos tras 14 días desde la 
administración. Por otro lado, resultados similares fueron obtenidos 
por Baek y col. [37] después de realizar un ensayo de toxicidad oral 
aguda en ratones expuestos a MMT. No obstante, considerando la 
aplicación de estas arcillas en el envasado de alimentos el escenario 
de exposición más realista se correspondería con una ingesta de dosis 
bajas y repetidas en el tiempo como el empleado en el presente 
estudio. 
Los resultados observados en el presente estudio, son consecuentes 
con los obtenidos previamente por nuestro equipo de investigación 
tras realizar en los mismos grupos experimentales un análisis de la 
bioquímica clínica del suero, interleukina-6 (IL-6) como marcador 
inflamatorio y contenido en glutatión reducido y oxidado 
(GSH/GSSG). En ningún caso se observaron diferencias 
significativas con respecto al grupo control en las determinaciones 
llevadas a cabo [38]. De forma similar en hígado y riñón tampoco se 
encontraron cambios en los tres biomarcadores considerados [39,40]. 
Esta ausencia de efectos adversos contrasta con los resultados 
obtenidos con ensayos in vitro con la MMT y/o arcillas 
organomodificadas derivadas de ella por otros autores [18-21,25]. En 
los mismos cabe destacar la generación de especies reactivas de 
oxígeno (ERO) y por tanto producción de estrés oxidativo por 
exposición de dichas arcillas a las diferentes líneas celulares. Sin 
embargo, los estudios anteriores fueron llevados a cabo con arcillas 
diferentes a Clay1, pudiendo intervenir en el perfil de toxicidad de la 
arcilla el modificador empleado.
Meibian y col. [41] expusieron la línea celular humana de linfoblastos 
B (HMy2, CIR), a otras arcillas diferentes a la MMT, dos tipos de 
bentonitas (BP), activa y no activa, además de partículas de cuarzo y 
141
Figura 3. Actividad enzimática de SOD (Fig.3A) y CAT (Fig.3B) 
(nkat/mg proteína) en bazo de ratas control, ratas expuestas a 40 mg 
Clay1/kg rata/día y ratas expuestas al extracto de migración de Clay1 
durante 90 días. Los valores están representados como la media± DE 
(n=10).
Tabla 1. Contenido de Al, Ca, Fe, Mg y Si (mg metal/g tejido) en bazo 
de ratas control, ratas expuestas a 40 mg Clay1/kg rata/día y ratas 
expuestas a extracto de migración de Clay1 durante 90 días. Los 
valores están representados como la media± DE (n=10).
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yeso. Estos autores evaluaron in vitro la actividad de SOD y la 
producción de ácido malonildialdehído (MDA) por exposición a 
estos materiales, observando una inhibición de la enzima 
antioxidante tras la exposición de las bentonitas y no tras la 
exposición a las otras partículas, e incluso presentándose una mayor 
inhibición por exposición de la BP activa. En el caso de la producción 
de MDA ocurre algo similar a lo anterior, produciéndose de forma 
muy significativa un aumento de la LPO en la línea celular tras la 
exposición de ambas bentonitas. En este caso, la modificación de la 
bentonita activa no estaría involucrada en el perfil de toxicidad 
presentado.
En cuanto a la presencia de metales en órganos como consecuencia de 
la exposición a arcillas, varios autores han realizado diferentes 
estudios. Mascolo y col. [42] llevaron a cabo un ensayo in vivo de 
toxicidad oral aguda centrado en la ingestión y distribución de 
elementos químicos presentes en distintas arcillas, ya que el 
organismo puede absorber dichos elementos procedentes de las 
mismas. Estos autores expusieron a los animales a una dosis de 450 
mg/kg de arcilla, sacrificándolos a los tres días. No se observaron 
efectos tóxicos notables en las ratas aunque sí un incremento de las 
concentraciones de los elementos traza en determinados órganos. 
Finalmente los autores concluyeron que la exposición a arcillas 
podría derivar en serios problemas de salud por el incremento en el 
contenido metálico observado en los órganos.
Nuestro estudio llevado a cabo en bazo de ratas Wistar expuestas a 40 
mg/kg/día de Clay1 y a su extracto de migración durante 90 días no 
dio lugar a ninguna alteración en los parámetros estudiados, ni a un 
incremento del contenido metálico en los grupos experimentales, 
pudiendo concluir que la arcilla modificada podría no comprometer 
la seguridad del consumidor en un futuro si ésta se comercializara.
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14.1. Development, Characterization and Cytotoxicity of Novel Silanes Modified 
Clays intended to Packaging 
Introduction 
Nanocomposites materials based on modified clays imbued in polymers as 
reinforcements, have been intensively studied in the last years aiming to obtain final 
products with enhanced mechanical, thermal and barriers properties for the food 
industry (Smolander and Chaundry, 2010). Among the layered silicates most used in 
this research area, montmorillonite (Mt), commercially known as Cloisite®Na
+
 (CNa
+
), 
stand out by its high aspect ratio, capacity for swelling and ion exchange, softness, high 
solvent resistance, good mechanical strength, high capacity for delamination and low 
cost (Betega de Paiva et al., 2008). The clay presents a 2:1 structure, composed by two 
tetrahedral layers formed by Si and O atoms, fused with an octahedral layer with 
aluminum and magnesium atoms bonded to oxygen and hydroxyl groups (Jordá-
Beneyto et al., 2014).  
The Mt has 1-nanometer-thick layers when is incorporated to a polymer, stacked 
on each other and loosely bound by Van der Waals forces, which allow the penetration 
of water and/or other polar molecules. To compensate for the negative charges 
generated by the isomorphic substitutions which occur in the tetrahedral and octahedral 
sheets of the Mt, exchangeable cations such as Na
+
, Ca2
+
 and Li
+
 are electrostatically 
fixed in the interlayer space of the clay minerals (Bertuoli et al., 2014; Paul and 
Robenson, 2008). However, a simple dispersion of a Mt in a polymer matrix will not 
produce a nanocomposite with better properties compared to the bulk material. This is 
due to the poor interfacial interactions between Mt hydrophilic reaction sites and the 
highly hydrophobic polymers chains (Pisticelli et al., 2010). The solution for the 
aforementioned disadvantages can be achieved by introducing organic groups; 
providing more supports to the interaction between clays and polymers (Silva et al., 
2011).  
The most useful chemical modifications procedure to prepare a more 
organophilic Mt is a cation exchange (Ray and Okamoto, 2003; Paul and Robenson, 
2008: Pavlidou and Papaspyrides, 2008). One of the most commonly performed 
modifications is by quaternary ammonium salts, producing modified organoclays with 
an hydrophobic character and a greater interlayer space (Betega de Paiva et al., 2008; 
Jordá-Beneyto et al., 2014). However, due to the quaternary ammonium salt degradation 
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at high temperatures through Hoffman-degradation, the thermal instability of the 
organoclay becomes a strong limitation in the processing of clay mineral/ polymer 
nanocomposites (Xie et al., 2001, 2002; Wang et al., 2012). 
For these reasons, the grafting silylation reaction of hydrophobic groups into the 
layer surfaces has attracted great attention. It is usually performed through the reaction 
between silane coupling agents and the reactive silanol groups which are located at the 
broken edges of the clay platelets and at the structural defects located at the interlayer 
and external surface (Herrera et al., 2005; Di Gianni et al., 2008; Pisticelli et al., 2010). 
In summary, the irreversible grafting reaction is the solution to obtain chemically 
modified clay in which the molecule of the silanes modifiers is bonded to the layers of 
the selected clay, in this case Mt (Wypych, 2004). Several authors have investigated the 
modification of clays with silanes incorporated to different polymers, taking in account 
different modification methods and obtaining various results, improving or declining the 
properties compared to the unmodified clay and the bulk polymers (He et al., 2005; 
Shen et al., 2007; Di Gianni et al., 2008; Pisticelli et al., 2010; Silva et al., 2011). 
Respect to the toxicity of silanes modified clays used in packaging the 
information is very limited, even non-existent, being necessary a strict evaluation 
according to the authorities in charge of  the regulation about new materials intended as 
food contact materials (EFSA, 2011, 2015). 
For all this, the present work studies the modification of Mt with different 
silanes. The modifiers used were 3-aminopropyltriethoxysilane (APTES), obtaining 
Clay3, and vinyltrimethoxysilane (VMTS) in two different proportions (4 and 8% w/w), 
giving Clay4A and Clay4B, respectively. The development of the organomodified clays 
was carried out with aqua and N2 atmosphere as dispersion media and functionalization 
conditions. X-ray diffraction (XRD), thermogravimetric analysis (TGA) and Fourier 
transform infrared (FTIR) spectroscopy were employed to characterize the modified 
clay minerals. Moreover, a toxicological study with the modified clays was also 
performed, considering a cytotoxicity biomarker in human cell lines from intestinal and 
hepatic origin. 
  
Materials and Methods 
Supplies and Materials 
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Purified sodium montmorillonite (Mt or CNa
+
) was purchased from Southern Clay 
Products, with moisture content between 4 and 9 %. The cation exchange capacity 
(CEC) of MMT is 92.6 mequiv/100g. Silanes were supplied by Sigma Aldrich (Madrid, 
Spain). APTES and VMTS with ≥98 % of purity were used for the preparation of the 
modified clays, Clay3, Clay4A and Clay4B, respectively.  
Culture medium, fetal bovine serum and cell culture reagents were obtained from 
Gibco (Biomol, Spain). Chemicals for the cytotoxicity assay were provided by Sigma-
Aldrich (Madrid, Spain) and VWR International Eurolab (Spain). Protein reagent assay 
was obtained from BioRad (Spain). 
Organomodified clays preparation 
The silylation of the Mt was performed according to Silva et al. (2011) with 
modifications. Briefly, 10g of dry MMT were dispersed in 500mL of distilled water at 
80°C during at least 2 hours with the help of a UltraTurrax (IKA, Spain) working 
between 9000- 11000 rpm. Then, 5.7 mL of APTES or VMTS for Clay3 and Clay4A, 
and a higher amount, approximately 10 mL, of VTMS for Clay4B were added. The 
resulting dispersion was stirred for 30 min under nitrogen atmosphere. The dispersion 
was left overnight at room temperature and the reaction product was washed with water 
at 60°C and recovered by centrifugation at 3500 rpm. Then, the silane modified clays 
was dried between 60-70°C during 24h. After, the dry clays were crushed and 
maintained other 24h in the oven under vacuum. A grafting reaction between the clay 
and the silanes is carried out in an aqueous solution. 
Materials characterization methods 
Clays were characterized using different techniques. FTIR (Fourier Transform 
InfraRed) Spectra were obtained on a Tensor 27spectrometer (Bruker): For this purpose 
an ATR (Golden Gate Single Reflection Diamond ATR, Specac) objective was used. 
This technique was used to characterize clays. For each sample 64 scans were recorded 
with a resolution of 4 cm-1.WAXD (wide-angle X-ray diffraction) analysis were 
performed on clay powders (clay pellets were obtained by pressing), using a Bruker 
AXS D5005 difractometer equipped with a Cu hollow cathode (l=0.154 nm) and a 
oscillation detector. The X-ray diffraction pattern was measured from 3 to 30 degrees 
(2θ) at a scan rate of 0.02 ºC/min. Thermogravimetric analysis (TGA) was performed on 
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clay powders using a TA Q5000IR thermobalance. 10.0 mg of sample was heated from 
25 to 900 °C at a heating rate of 20 °C/minute in nitrogen atmosphere.  
 
Model systems for the cytotoxicity test 
Caco-2 cell line derives from a human colon carcinoma (ATCC® HTB-37, passages 
10-18) and HepG2 derives from a human hepatocellular carcinoma (ATCC
®
HB-8065, 
passages 5-15) both of them were obtained from the American Type Culture Collection 
(ATCC, Manassas, VA, USA). HepG2 cells were cultured in monolayer in Eagle´s 
medium (EMEM) supplemented with 10% of FBS and 100 U/mL penicillin and 
100Ug/mL streptomycin (Gibco, Biomol, Spain). Caco-2 cell line was maintained in 
Eagle's minimal essential medium (EMEM) supplemented with 10% fetal bovine serum 
(FBS), 1% non-essential amino acids, 50 μg/mL gentamicine, 2 mM L-glutamine, and 1 
mM pyruvate. HepG2 cell line was cultured in monolayer in EMEN supplemented with 
10% of FBS, 2 mM L-glutamine, 1% NEAA, 100 U/mL penicillin/ streptomycin 
(Gibco, Biomol, Spain). Cells were grown near confluence in 75-cm
2
 plastic flasks at 37 
°C in an atmosphere containing 5% CO2 at 95% relative humidity (CO2 incubator, 
NuAire®, Spain) and harvested weekly with 0.25% trypsin. They were counted in an 
improved Neubauer hemocytometer and viability was determined by the Trypan Blue 
exclusion test. Both cell lines were plated at a density of 7 × 10
5
 cells/mL to perform the 
experiments. 
 
Clay test solutions 
The test concentrations of the three clays were determined individually in 
previous experiments to avoid interferences with the method of measurement. For this 
reason the absorbance of clay solutions (1000 μg ml–1 and serial half dilutions) were 
measured at 0, 24 and 48 h. The highest concentrations selected were the ones that did 
not show statistical differences versus the control (culture medium without clays). Stock 
solutions were 1000 μg ml–1 for the three clays. An ultrasonic tip (Dr. Hielscher, 
Germany) at amplitude of 40% for a total time of 30 s carried out in 10 s sequential 
steps was employed to disperse the test concentrations. From the initial solution, serial 
dilutions in free-serum medium were prepared (1.95, 3.91, 7.81, 15.63, 31.25, 62.5, 125 
and 250 µg/ mL of Clay3, Clay4A and Clay4B). After replacing the previous medium, 
the exposure solutions were added to systems, and incubated at 37 °C for 24 and 48h. 
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Cytotoxicity assay 
From the initial solution, serial dilutions in free-serum medium of the three 
modified clays were prepared (0-250 µg/mL). After replacing the previous medium, the 
exposure solutions were added to systems, and incubated at 37 °C for 24 and 48h. After 
that time, the basal cytotoxicity was analyzed by the Protein Content (PC). The use of 
this biomarker has been recognized by the European Union Reference Laboratory for 
alternatives to animal testing for basal cytotoxicity studies. PC is a very useful endpoint 
to assess cytotoxicity, as it gives data about cell damage with independence of the toxic 
mechanism involved (Pichardo et al., 2007). PC was quantified in situ, according to the 
procedure given by Bradford (1976), using Coomassie Brilliant Blue G-250 in the same 
96-well tissue culture plates in which exposure originally took place, to determine the 
total cell number present in the culture. The culture medium was replaced by 200 μl 
NaOH 0.1 M and after 2 h incubation at 37 °C, 180 μl was replaced by the same volume 
of a 22% Coomassie Brilliant Blue G-250 solution. After 30 min incubation at room 
temperature, absorbance was read at 595 nm (Infinite M200, Tecan). 
 
Calculations and Statitical Analysis 
Results are expressed in graphs as mean ± standard deviation (s.d.). Statistical 
analysis was carried out using analysis of variance (ANOVA), followed by a Dunnet´s 
test. Differences were considered significant from p <0.05; p<0.01.  
 
Results 
Organo-modified clays characterization 
Fourier Transform InfraRed (FTIR) 
Three different modified clays were obtained from Mt following the method 
described previously. The presence of modifiers in the clay was determined by FTIR. 
Figs. 1a, 1b and 1c, gave strong evidence that the experimental procedure used in this 
work was successful in altering the chemistry of Mt. The ATR spectra in Figure 1 show 
the presence of a peak under 1200 cm−1, which corresponds to Si-O absorptions and 
OH bands that are typical of clay minerals and also marked the presence of the silanes 
modifiers. Inner hydroxyl groups, lying between the tetrahedral and octahedral sheets, 
give the absorption as being near 3620 cm−1, as can be seen in all the spectra in Fig. 1 
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(Madejova, 2003).Two strong bands near 2930 and 3620 cm−1 are present in spectra of 
the modified clays . 
 
 
 
 
Figure 1. Fourier transform infrared spectrum of a) Clay3, b) Clay4A and c) Clay4B 
 
Wide-angle X-ray diffraction 
X-ray diffraction of the raw clay and modified ones are shown in Fig. 2. Interlayer 
space has been especially enlarged with the silylation in Clay 3. Results of interlayer 
space are shown in ¡Error! No se encuentra el origen de la referencia.. It can be observed 
that the interlayer space in Clay3 is twice of the raw clay (Mt) and higher than in 
Clay4A and B modified clays. The measured d (001) spacing of pristine Mt is 9.99 Å 
(2θ = 8.85). After cation exchange with silanes, the d (001) spacing became 18.80 Å (2θ 
= 4.70) in the case of Clay3, 12.33 Å (2θ = 7.17) in the case of Clay4A and 12.13 Å (2θ 
= 7.29) in the case of Clay4B. These results provide evidence that the modifier 
a) Clay3 
b) Clay4A 
c) Clay4B 
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intercalates inside the Mt galleries. This is an important step to reach a good exfoliation 
in the final nanocomposite. 
 
Figure 2. X-ray spectrum of raw clay N116, and organosilane-modified clays (Clay3, Clay4A and B). 
Samples 2 d001 (Å) 
Mt 8.85 9.99 
Clay3 4.70 18.80 
Clay4A 7.17 12.33 
Clay4B 7.29 12.13 
 
Table 1. Interlayer space results of raw clay Mt, and organosilane-modified clays (Clay3, Clay4A and 
Clay4B). 
Thermogravimetric analysis (TGA) 
The exchange degree of the modifier inside the Mt was determined by TGA. The 
results are shown in Figs 3a, 3b. Xie et al. (2001) determined that the TGA curves of 
organo-modified layer silicates are divided into four parts: (1) the free water region in 
the temperature range below 200°C; (2) the region where organic substances evolve in 
the temperature range 200–500°C; (3) the structural water region in the temperature 
range 500–800°C; and (4) a region between 800 and 1000°C where organic carbon 
reacts in some yet unknown way. The weight losses (%) of organic substances for 
Clay3, Clay4A and Clay4B, between 200°C and 500°C approximately, were: 16.2%, 
14.6% and 11.2%, respectively. A higher loss in the weight of sample Clay3, was 
observed. 
         Mt 
       Clay3 
       Clay4A and B 
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Figure 3. Thermogravimetric analysis (TGA) of the raw and modified clay: a) Clay3 and b) Clay4A and 
Clay4B 
Cytotoxicity tests  
Caco-2 and HepG2 cells exposed to Clay3 remained unaltered with respect to 
the control cells after both times of exposure at all concentrations tested (Fig. 4a, d). 
However, Clay4A and Clay4B produced a decrease in cell viability in both cell lines 
after 24 and 48h of exposure, being stronger with Clay4B (Fig. 4b, c, e, f). 
Mt 
Clay3 
a 
Mt 
Clay4A 
Clay4B 
b 
299°C 
450°C 
68°C 
692°C 
172°C 
192°C 
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Figure 4. Total protein content of Caco-2 (a, b, c) and HepG2 (d, e, f) cells after 24 h and 48 h of 
exposure to 0–250 μg/mL Clay3 (a, d), Clay4A (b, e) and Clay4B (c, f). Results from 3 independent 
experiments with 6 replicates/experiment. All values are expressed as mean ± s.d. Differences were 
considered significant from p ≤0.05 (*) or p ≤ 0.01 (**). 
 
Discussion 
The development and characterization of three silane-modified clays and their 
cytotoxicity effects have been performed in the present work. Others authors have 
described the incorporation and characterization of similar modifiers in other layered 
silicates, obtaining results which agree with exposed results in this study (Mansur et al., 
2002; Ahmed et al., 2009). Regarding cytotoxic effects, to extent out knowledge, no 
toxicity information is available in the bibliography. In chapter 13.2, 13.3 and 13.4 are 
showed the results obtained with other cytotoxicity biomarkers, neutral red uptake (NR) 
and MTS reduction, in the same cell lines selected in this work. Similarly, no cytotoxic 
effects were obtained with Clay3, however, a significant decrease in cell viability with 
Clay4´s modified clays was observed. Moreover, the results of genotoxicity and stress 
oxidative results of the modified clays were also carried out, giving an absence of 
toxicity in Clay3 and positive response with the other ones. 
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Several authors reported the effects of other organomodified clays which have 
quaternary ammonium salts as modifiers (Sharma et al., 2010; Lordan et al., 2011; 
Houtman et al., 2014). Different results were obtained with each modified clay, as well 
as, contradictory or inconclusive data depending on the conditions applied. Taking into 
account the results obtained an individually case by case evaluation of clays under 
different conditions are required in order to reach the most complete toxicity 
information. 
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14.2. TOXICITY EVALUATION OF A NEW SILANE-MODIFIED CLAY AND ITS 
MIGRATION EXTRACT FROM A NANOCOMPOSITE INTENDED TO FOOD 
PACKAGING. 
Introduction 
In order to improve the features of food packaging, the food industry is 
developing new materials based on the incorporation of organomodified clays into 
polymers. Clays or layered silicates typically have a stacked arrangement of silicate 
layers (nanoplatelets) with nanometric thickness, hence they are named as nanoclays. 
The resulting material should present better physical properties than the polymer 
without clay, enhancing therefore the perdurability of packaged food. 
The Technological Institute of Packaging, Transport and Logistic (ITENE, 
Valencia) has developed a novel silane organoclays using aminopropyltriethoxysilane 
(APTES), obtaining Clay3. The complete process is described in the chapter 13.1. 
Considering that the this nanoclay is intended to be used in food packaging and 
consumer could be in contact with them, toxicological assessment is required. In the 
present study the toxicity of Clay3 was evaluate in the human  cells lines Caco-2 and 
HepG2 using basal cytotoxicity biomarkers. In addition, the potential mutagenicity was 
assayed using 5 Salmonella typhimurium strains. In addition, the migration of the major 
metals presented in clays structure was measured in food stimulants obtained from 
polypropylene (PP) and Clay3. 
Materials and Methods 
Supplies and Chemicals 
Culture medium, fetal bovine serum and cell culture reagents were obtained 
from Gibco (Biomol, Sevilla, Spain). Chemicals for the different assays were provided 
by Sigma-Aldrich (Spain) and VWR International Eurolab (Spain). 
Clays and clays test solutions 
Clay3 has been developed and characterized as it was described in chapter 13.1. 
The test concentrations were selected taking into account previous dispersion 
experiments in order to avoid interferences with the measurement system. The highest 
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concentration tested was 250µg/mL. Test solutions were prepared in serum-free 
medium. Three sonication steps of 10 s each one at an amplitude of 40% were 
performed using an ultrasonic tip (Dr. Hielscher, Germany) to disperse the test 
concentrations. 
Cell cultures 
Caco-2 cell line (human colon carcinoma, ATCC® HTB-37) and HepG2 
(human hepatocellular carcinoma epithelial cell line) were obtained from the American 
Type Culture Collection (ATCC, Manassas, VA, USA). Cells were maintained in 
Eagle's minimal essential medium (EMEM) supplemented with 10% fetal bovine serum 
(FBS), 1% non-essential amino acids, 2 mM L-glutamine, 1 mM pyruvate. In the case 
of Caco-2 50 μg/mL gentamicine was added and 100 U/mL penicillin/ streptomycin 
(Gibco, New Zealand) was used for HepG2. Cells were grown near confluence in 75-
cm2 plastic flasks at 37°C in an atmosphere containing 5% CO2 at 95% relative 
humidity (CO2 incubator, NuAire®, Spain) and harvested weekly with 0.25% trypsin. 
They were counted in an improved Neubauer hemocytometer and viability was 
determined by the Trypan Blue exclusion test. Cells were plated at a density of 7.5×10
5
 
cells/mL to perform all experiments. 
Cytotoxicity assays 
From the initial solution, serial dilutions in medium were prepared (0–250 
µg/mL). Culture medium without clay was used as control group. After replacing the 
previous medium, the exposure solutions in culture medium without serum were added 
to the systems, and incubated at 37°C for 24 and 48h. The basal cytotoxicity endpoints 
were supravital dye neutral red celular uptake (NRU) and tetrazolium salt reduction 
(MTS). 
NR uptake is a suitable endpoint to determine viable cells, because this dye is 
taken up by viable lysosomes. This assay was performed according to Borenfreund and 
Puerner (1984). Furthemore, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt) reduction is carried out 
by dehydrogenases enzymes present in mitochondria, being this endpoint a good marker 
of the damage induced in this organelle. MTS reduction was measured according to the 
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procedure of Baltrop et al. (1991). Both assays were performed according to Maisanaba 
et al. (2013). 
Ames test 
The incorporation version of the Ames test has been described briefly in 
Maisanaba et al. (2015) and was performed according to the recommendations of Maron 
and Ames (1983) and following the principles of OCDE guideline 471 (1997). 
Migration assay 
The presence of characteristic metals of the clays structure in polypropylene 
(PP)–Clay3 and only PP (as control) unfiltered extracts was analyzed. Al, Fe and Mg 
were quantified by (ICP-MS) (Agilent 7500C, Agilent ICP-MS Systems, USA). These 
determinations were carried out in the Scientific- Techniques Services (University of 
Oviedo) based on standard operating protocols. 
Statistical analysis 
All experiments were performed at least three times and at least in duplicate per 
concentration. Statistical analysis was carried out using analysis of variance (ANOVA), 
followed by Dunnett’s multiple comparison tests. Differences were considered 
significant from p < 0.05.  
 
Results 
 
Cytotoxixity assays 
No significant differences was observed in Caco-2 cells exposed up to 250 
µg/mL Clay3 in NRU endpoint after 24h or 48h of exposure (Fig. 1a). Similarly, no 
remarkable cytotoxic effect was observed in MTS reduction assay, except for a 
significant decrease at the highest concentration and exposure time assayed (250 µg/mL 
after 48h) (Fig 1b). 
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Figure 1. Neutral red uptake (a) and MTS reduction (b) of Caco-2 cells after 24 h and 48 h of exposure to 
0–250 μg/mL Clay3. Results from 3 independent experiments with 6 replicates/experiment. All values are 
expressed as mean ± s.d. Differences were considered significant from p ≤0.05 (*) or p ≤ 0.01 (**). 
 
Similar pattern was observed when HepG2 cells were exposed to Clay 3 for 24 
and 48 h. No significant change could be distinguished in any assay performed (Fig. 2).  
No significant differences was observed in Caco-2 cells exposed up to 250 µg/mL 
Clay3 in NRU endpoint after 24h or 48h of exposure (Fig. 1a). Similarly, no remarkable 
cytotoxic effect was observed in MTS reduction assay, except for a significant decrease 
at the highest concentration and exposure time assayed (250 µg/mL after 48h) (Fig 1b).. 
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Figure 2. Neutral red uptake (a) and MTS reduction (b) of HepG2 cells after 24 h and 48 h of exposure to 
0–250 μg/mL Clay3. Results from 3 independent experiments with 6 replicates/experiment. All values are 
expressed as mean ± s.d. Differences were considered significant from p ≤0.05 (*) or p ≤ 0.01 (**). 
 
 
Ames test 
After exposure to Clay3, no significant changes were detected in any of the 
strains exposed to the organomodified clay in absence or presence of S9 fraction (Table 
1).  
 Concentratio
n (µg/mL) 
TA97A TA98 TA100 TA102 TA104 
 
 
 
 
 
Clay
3 
 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 
Negative 
controls 
270±45 250±37 29±9 28±7 119±33 114±26 292±66 272±23 295±17 358±31 
15.63 238±50 312±37 19±5 53±1 117±22 89±21 273±34 268±45 287±37 327±55 
31.25 269±26 309±49 20±7 47±1 95±13 73±11 300±50 241±22 245±26 269±62 
62.5 276±39 280±56 21±7 46±5 97±21 109±28 309±54 358±17 400±45 282±51 
125 273±51 250±37 24±6 37±11 106±5 101±29 289±46 282±57 258±30 298±57 
250 284±34 324±6 23±5 47±3 95±18 93±9 257±42 219±29 214±35 272±21 
Positive 
controls 
680±71*
* 
617±25*
* 
>1000*
* 
586±49*
* 
362±6*
* 
322±22*
* 
591±13*
* 
661±29*
* 
638±28*
* 
752±6*
* 
 DMSO 328±15 310±46 17±3 20±4 120±7 131±7 228±21 236±30 258±22 212±15 
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Table 1. Results of Ames test conducted with Clay3 for three independent experiments. MilliQ water was 
used as negative control and DMSO as solvent for positive controls. Data are given as mean ± SD 
revertants/plate for three replicates for each concentration in each experiment. Positive controls: 
TA97A/TA98/TA102/TA104 without S9 mix: 2-NF (0.1 µg/plate) and TA100 without S9 mix: NaN3 (1 
µg/plate). Positive controls for all strains with S9: 2-AF (20 µg/plate). * Significantly different from 
control (P ≤ 0.05). ** Very significantly different from control (P ≤ 0.01). 
 
Migration assay 
Some of the metals contained in the film PP-Clay3 were detected in the 
simulant. In the case of ethanol 10%, three metals released from the film to the 
migration media: Mg and Si (with quantities significantly different from the control 
group) and Ca (being its enhancement very significant in comparison to the control 
group). In the case of isooctane, only Mg increased significantly with the rest of the 
metals showing similar values to the control group. 
 
 Al Ca Fe Mg Si 
Ethanol 10% extract      
Control 25±7.8 110.5±19.1 0.4±0.3 7.3±2.5 12500.7±561.1 
Clay3 3.3±1.2 376.5±2.1** 0.2±0.1 48.7±7.1* 14693±243.5* 
Isooctane extract      
Control 60.3±5.5 275.7±65.6 42±7.1 20±4 4270.7±321.9 
Clay3 41.3±2.9 376±17 34.7±15.2 54.3±8.1* 3648.3±809.5 
Table 2. Al, Ca, Fe, Mg and Si content in the migration extracts with etanol 10% or isooctane from PP 
and PP–Clay3 (all the concentrations are expressed in µg/L). All values are expressed as mean ± SD, n=3. 
*Significant (p≤ 0.05), **very significant (p≤ 0.01) and ***extremely significant(p≤ 0.001) differences 
from control. 
 
Discussion 
Clay3 have shown no cytotoxic effects except for a significant decrease 
observed at 250 µg/mL after 48 h of exposure in Caco-2 cells when MTS assay was 
performed. Similarly, no remarkable effect was observed at any concentration and 
exposure time for HepG-2. In addition, no potencial mutagenicity was discernible in 
Ames test for any bacterial strain, both with and without metabolic activation.  
In the migration assay, several metals migrate from the film containing Clay3 to 
the food simulant, in the case of ethanol 10% Ca, Mg and Si and in isooctane only Mg 
was detected. However, no cytotoxic effect were recorded for the extract of migration 
exposed to Caco-2 and HepG2 (data not shown).  
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Considering all the results obtained in the present work, Clay3 seems to be safe. 
Therefore, it could be used in the manufacturing of films for its use in food packaging. 
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14.3. Toxicological assessment of two silane-modified clays in human hepatoma 
cells and Salmonella typhimurium strains 
Introduction 
Currently, the incorporation of organomodified clays into polymers intended for 
packaging industry is a great alternative in order to enhance the products perdurability. 
Clays or layered silicates typically have a stacked arrangement of silicate layers 
(nanoplatelets) with nanometric thickness, hence they are named as nanoclays. The 
development of nanocomposites is a new strategy to improve physical properties of 
polymers, including mechanical strength, thermal stability, and gas barrier properties 
(Arora and Padua, 2010). The incorporation of nano platelets of clays into polymers has 
been used to create a tortuous path that impedes the passage of water, oxygen, aroma 
and tainting compounds, hence reducing the rate of diffusion. Often, incorporation of 
only a low mass fraction such as a few percent in the nanocomposites, can increase 
barrier properties many-fold compared to the polymer alone (Smolander and Chaundry, 
2010; Bradley et al., 2011) 
Montmorillonite (Mt), one of the most used clays, is a layered silicate belonging 
to the structural family of the 2:1 phyllosilicates. The presence of inorganic cations on 
the planar surface of Mt layers makes them hydrophilic and hence ineffective in 
hydrophobic polymers. Cation exchange reactions is one of the possibilities to resolve 
this problem, replacing these inorganic cations with organic cationic surfactants which 
intercalate into the clay gallery, producing organically modified Mt with increased 
interlayer spacing, hydrophobic surface and improved interactions with organic 
polymers (De Azeredo, 2013). However, these kind of modifiers are degradated at high 
temperatures, being a disadvantage in some aspects. In this manner, the grafting 
silylation reaction in a real alternative which solve the above mentioned handicap, being 
irreversible and giving also to the polymers the improvements in the technological 
aspects (Chapter 13.1; Pisticelli et al., 2010). In this case, the modifiers used are silanes. 
There are a lot of studies which described the properties of these new silanes 
organomodified clays (Di Gianni et al., 2008; Pisticelli et al., 2010; Silva et al., 2011), 
but the toxicity information about them is scarce or non-existent. 
The Technological Institute of Packaging, Transport and Logistic (ITENE, 
Valencia) has developed two novel silane organoclays using vinyltrimethoxysilane 
317 
 
(VMTS), obtaining Clay4A and Clay4B, both of them based also Mt but with different 
proportions of silane, 4 and 8%, respectively as it is described in the chapter 13.1.. 
Due to the increase in the manufacture of nanoclay-containing products, data on 
the toxicological effects of these substances is required. In view of the limited 
toxicological information of these novel clays, in this study we aim to evaluate the 
toxicity of Clay4A and Clay4B in the human hepatocellular cell line HepG2 and 
Salmonella typhimurium strains. For this purpose, basal cytotoxicity biomarkers and 
mechanistic biomarkers of oxidative stress, genotoxicity and mutagenicity have been 
investigated.  
Materials and Methods 
Supplies and Chemicals 
Culture medium, fetal bovine serum and cell culture reagents were obtained 
from Gibco (Biomol, Sevilla, Spain). Chemicals for the different assays were provided 
by Sigma-Aldrich (Spain) and VWR International Eurolab (Spain). 
Clays and clays test solutions 
Clay4A and Clay4B have been developed and characterized as it was described 
in chapter 13.1. The test concentrations for both clays were selected taking into account 
previous dispersion experiments in order to avoid interferences with the measurement 
system. The highest concentrations tested were 250 µg/mL for both. Test solutions were 
prepared in serum-free medium. Three sonication steps of 10 s each one at an amplitude 
of 40% were performed using an ultrasonic tip (Dr. Hielscher, Germany) to disperse the 
test concentrations. 
Cell culture 
HepG2 (human hepatocellular carcinoma epithelial cell line) was obtained from 
the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were 
cultured in monolayer in Eagle’s Minimum Essential Medium (ATCC) supplemented 
with 10% of FBS (Gibco, New Zealand), 2 mM L-glutamine, 1% NEAA, 100 U/mL 
penicillin/ streptomycin (Gibco, New Zealand). Cells were grown at 37°C and 5% CO2 
in humidified atmosphere. Cells were used at passages between 8 and 18. 
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Cytotoxicity assays 
From the initial solution, serial dilutions in medium were prepared (0–250 
µg/mL for Clay4A and Clay4B). Culture medium without clay was used as control 
group. After replacing the previous medium, the exposure solutions in culture medium 
without serum were added to the systems, and incubated at 37°C for 24 and 48 h. The 
basal cytotoxicity endpoints were supravital dye neutral red celular uptake (NRU), and 
tetrazolium salt reduction (MTS). 
NR uptake is a suitable endpoint to determine viable cells, because this dye is 
taken up by viable lysosomes. This assay was performed according to Borenfreund and 
Puerner (1984). Furthemore, MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt) reduction is carried out 
by dehydrogenases enzymes present in mitochondria, being this endpoint a good marker 
of the damage induced in this organelle. MTS reduction was measured according to the 
procedure of Baltrop et al. (1991). Both assays were performed according to Maisanaba 
et al. (2013). 
Only when cytotoxicity was observed, mechanistic biomarkers were determined. 
In this case, the mean effective concentration (EC50) of the most sensitive cytotoxicity 
endpoint was chosen as the higher exposure concentration to investigate mechanistic 
biomarkers along with the fractions EC50/2 and EC50/4. In this sense, the EC50, 
EC50/2 and EC50/4 for Clay4A were 213, 106.5 and 53.25 µg/mL and for Clay4B were 
85, 42.5 and 21.25 µg/mL, respectively. 
Glutathion content and Reactive Oxygen Species generation, Comet Assay and Ames 
test 
The production of reactive oxygen species (ROS) was assessed in 96 wells 
microplates using the dichlorofluorescein (DCF) assay according Puerto et al. (2010). 
Cellular glutathione (GSH) content was evaluated by reaction with the fluorescent probe 
monochlorobimane (mBCl) as described by Jos et al. (2009).  
Regarding to the comet assay, it aims to detect DNA strand breaks. The comet 
assay was performed following the steps previously described by Collins et al. (1997) 
with modifications (Corcuera et al., 2011).  
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The incorporation version of the Ames test has been described briefly in 
Maisanaba et al. (2015) and was performed according to the recommendations of Maron 
and Ames (1983) and following the principles of OCDE guideline 471 (1997). 
Statistical analysis 
All experiments were performed at least three times and at least in duplicate per 
concentration. Statistical analysis was carried out using analysis of variance (ANOVA), 
followed by Dunnett’s multiple comparison tests. Differences were considered 
significant from p < 0.05. EC50 values, mean effective concentration, concentration of 
test chemical that modified each biomarker by 50% (positive or negative) in comparison 
with appropriate untreated controls, were determined by linear interpolation. 
 
Results 
 
Cytotoxixity assays 
HepG2 cells exposed to Clay4A showed significant differences in NRU 
endpoint from 125 µg/mL after 24h of exposure, and from 1.9 µg/mL after 48h. 
However, MTS biomarker did not display any change at the conditions tested after 
Clay4A exposure (Fig. 1a, 1c). On the other hand, the results obtained with Clay4B 
were more drastic than with the other clay. Hepatoma cells experimented a significant 
viability decrease with Clay4B in NRU endpoint from 31.25 µg/mL after 24 and 15.6 
µg/mL 48h of exposure, being more sensitive than MTS, which showed significant 
differences from 62.5 µg/mL after both times of exposure (Fig. 1b, 1d). 
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Figure 1. Neutral red uptake (a, b) and MTS reduction (c, d) of HepG2 cells after 24 h and 48 h of 
exposure to 0–250 μg/mL Clay4A (a, c) and Clay4B (b, d). Results from 3 independent experiments with 
6 replicates/experiment. All values are expressed as mean ± s.d. Differences were considered significant 
from p ≤0.05 (*) or p ≤ 0.01 (**). 
 
GSH content and ROS production 
When HepG2 cells were exposed to Clay4A during 24 and 48h, no significant 
alteration on GSH content was observed at any of the exposure concentrations in 
comparison to the control group (Fig. 2a). In contrast, a concentration-dependent 
increase of ROS production was observed at the concentrations assayed after both times 
of exposure (Fig. 2c). On the other hand, hepatoma cells exposed to Clay4B showed 
significant decreases of GSH content at the two highest concentrations tested after 24 
and 48h of exposure (Fig.2b), as well as, an increase of ROS production in all cases 
(Fig. 2d). 
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Figure 2. GSH content (a, b) and ROS production (c, d) in HepG2 cells after 24 and 48 h of exposure to 
53.25, 106.5 or 213 μg/mL Clay4A (a, c) or, 21.25, 42.5 or 85 µg/mL Clay4B (b, d). Results from 3 
independent experiments with 3 replicates/experiment. All values are expressed as mean ± s.d. 
**significantly different from control (p≤ 0.01). 
 
Comet assay 
Clay4A did not induce DNA strand-breaks in Hep-G2 cells at the concentrations 
tested after 24 and 48 h of exposure (Fig. 3a). In regard to HepG2 cells exposed to 
21.25 and 43 μg/mL of Clay4B, no significant variations of the DNA strand breaks were 
detected after 24 h and 48 h of exposure. However, the highest exposure concentration 
(85 μg/mL) led to a significant (p <0.05) increase of DNA in the tails, compared to that 
of the control (Fig. 3b). 
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Figure 3. Comet assay results of HepG2 cells after 24 and 48 h of exposure to 53.25, 106.5 or 213 μg/mL 
Clay4A (a) or, 21.25, 42.5 or 85 µg/mL Clay4B (b). Results from 3 independent experiments with 2 
replicates/experiment. All values are expressed as mean ± s.d. *significantly different from control (p 
≤0.05) or ** very significantly different from control (p ≤0.01). 
 
Ames test 
After exposure to Clay4A, no significant changes were detected in any of the 
strains exposed to the organomodified clay in absence or presence of S9 fraction (Table 
1). Clay4B showed significant increases in the revertant colonies compared to the 
negative control in TA102 from 62.5µg/mL without and with S9, while no change was 
recorded after the exposure in the other strains (Table 1). 
 
 Concentratio
n (µg/mL) 
TA97A TA98 TA100 TA102 TA104 
 
 
 
 
 
Clay4A 
 
 
 
 
 
 
 
 
Clay4B 
 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 
0 350±66 239±39 29±8 37±2 166±50 141±44 202±49 205±22 268±44 265±43 
15.65 378±60 267±54 23±6 43±1 89±19 82±9 260±66 282±79 287±66 273±66 
31.25 322±50 303±51 28±14 41±10 98±10 101±13 205±12 240±56 267±52 435±31 
62.5 250±38 236±59 18±4 30±4 94±21 91±25 166±21 203±56 234±63 275±32 
125 269±38 309±16 31±14 24±6 94±28 99±31 228±67 252±63 279±32 331±89 
250 254±70 328±49 26±6 27±3 90±18 95±31 250±5 262±49 300±79 267±76 
+ controls 546±27** 557±27** >1000** 423±21** 384±18** 331±26** 537±52** 571±13** 518±11** 594±65** 
DMSO 209±66 184±38 25±2 30±6 115±5 113±17 250±65 231±75 328±66 431±42 
           
0 152±31 152±21 23±5 17±8 105±24 112±26 123±41 150±39 240±27 259±46 
15.65 130±13 130±36 30±11 24±5 137±27 134±36 161±38 250±36 250±75 236±25 
31.25 150±11 153±28 24±6 21±8 103±29 97±25 205±46 266±58 207±31 255±57 
62.5 206±11 153±28 24±7 23±7 110±21 75±10 221±69* 319±58* 193±27 244±29 
125 205±53 251±65 20±3 22±5 126±34 113±21 292±56* 347±65* 326±34 361±66 
250 224±85 252±45 21±9 23±5 149±27 136±30 272±80* 307±21* 246±60 237±34 
+ controls 676±78** 676±10** >1000** >1000** 458±37** 395±4** 741±24** 774±11** 734±29** 741±46** 
 
DMSO 297±37 320±34 27±7 39±2 119±16 115±3 267±13 381±32 373±25 360±13 
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Table 1. Results of Ames test conducted with Clay4A and Clay4B for three independent experiments. 
MilliQ water was used as negative control and DMSO as solvent for positive controls. Data are given as 
mean ± SD revertants/plate for three replicates for each concentration in each experiment. Positive 
controls: TA97A/TA98/TA102/TA104 without S9 mix: 2-NF (0.1 µg/plate) and TA100 without S9 mix: 
NaN3 (1 µg/plate). Positive controls for all strains with S9: 2-AF (20 µg/plate). * Significantly different 
from control (P ≤ 0.05). ** Very significantly different from control (P ≤ 0.01). 
 
Discussion 
Both clays have presented a pronounced cytotoxicity and ROS production, 
however, only Clay4B showed pronounced genotoxic and mutagenic effects. This could 
be due to the silane amount in their structures, indicating a proportional response when 
the vyniltrimethoxysilane quantity is higher. Similar results were obtained in Caco-2 
cells exposed to Clay4A and Clay4B (chapter 13.4), where drastic cytotoxic effects 
were observed with the organomodified clay with higher silane amount, as well as, 
genotoxic effects by the comet assay. Nevertheless, it is important to note the significant 
ROS production observed in adenocarcinoma cells exposed to Clay4A but not to 
Clay4B. 
To the extent our knowledge, toxicity data about these clays are not available in 
the scientific literature till the moment. Other authors reported some studies about the 
non modified raw clay (Cloisite®Na
+
 (CNa
+
)) and other kinds of organomodified clays 
with quaternary ammonium salts in the same cell line. In this sense, Lordan et al. (2011) 
described a decrease in the viability of HepG2 cells exposed to CNa
+
 and Cloisite®93ª, 
a modified clay. However, only CNa
+
 induced intracellular ROS formation which 
coincided with increased cell membrane damage, whilst ROS generation did not play a 
role in Cloisite®93A-induced cell death. On the other hand, CNa
+
 did not induce DNA 
strand-breaks in HepG2 cells and Caco-2 cells after 24 h of exposure, as tested with the 
alkaline comet assay (Sharma et al., 2010; Maisanaba et al., 2014). However, Cloisite® 
30B induced genotoxic effects in hepatoma cells and contradictory results were 
obtained in adenocarcinoma cells (Sharma et al., 2010; Maisanaba et al., 2013; 
Maisanaba et al., 2014). 
Overall, the results obtained depend on the cell lines selected, concentrations and 
times assayed, as well as, the modifiers used and their quantity in the clay. 
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14.4. Cyotoxicity, oxidative stress and genotoxicity assays of silanes-modified clays 
in the human intestinal cell line Caco-2. 
Introduction 
Mineral clays present a vast variety of applications, many of them derived from 
their properties (Sharma et al., 2010). Montmorillonite (Mt) is one of the main 
components of bentonite, a layered silicate widely used due to its good swelling 
capacity, high specific surface area, good cation-exchange capacity, high platelet aspect 
ratio, strong adsorptive power, high structural stability, chemical inertia, strong capacity 
to form stable suspensions, modificable surface, etc. (Hu y col., 2007; Mallakpour and 
Dinari, 2011; Baek y col., 2012). Layered clays are of great interest in food packaging 
industry, since they confer better barrier properties when incorporated to composite 
materials (Rhim and Ng, 2007). Nielsen (1967) explained this fact through the winding 
path around the clay platelets, forcing the permeable gas to travel a longer way to 
diffuse through the packaging. Polymers incorporated with nanoparticulated clays are 
one of the first nanocomposite polymers to be used in the food packaging industry. One 
limitation of clays is their incompatibility with hydrophobic polymers due to their 
hydrophilic properties (Elmore y Andersen, 2003; Zeng y col., 2005). In order to solve 
this inconvenient, the surface modification of these clays through cation exchange with 
organic cations is used, giving place to organomodified clays compatible with those 
polymers used in food packaging industry (Sharma y col., 2010; Maisanaba et al., 
2014a). However, this modification is not stable at high temperatures, so the grafting 
silylation reaction became a real alternative since it is irreversible and also confers 
polymers technological improvements (Pisticelli et al., 2010). In this sense, the 
Technological Institute of Packaging, Transport and Logistics (ITENE, Valencia, Spain) 
has developed two Mt-based clays with their surface modified with different quantities 
of vinyltrimethoxysilane (VMTS): Clay4A (4% silane) and Clay4B (8% silane). Since 
these clays could migrate to food and also due to their novelty, a study concerning their 
safety must be carried out. As it can be assumed, the oral route is the main exposure 
route to humans. Tateo and Summa (2007) reported that the ingestion of clays is 
common at low doses, since they are present in food preparations, pharmaceutical 
preparations, and herbal remedies. Several authors have evaluated the potential toxicity 
of modified clay minerals destined to food packaging in target cell lines (Maisanaba et 
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al., 2015; Houtman et al., 2014; Maisanaba et al., 2014a,b; Maisanaba et al., 2013; 
Lordan et al., 2011; Sharma et al., 2010). 
In the present study we aim to evaluate the toxicity of C Clay4A and Clay4B in 
the human intestinal cell line Caco-2. For this purpose, basal cytotoxicity, oxidative 
stress biomarkers, apoptosis and necrosis biomarkers, and DNA damage were 
investigated. 
Materials and Methods 
Supplies and Chemicals 
Culture medium, fetal bovine serum and cell culture reagents were obtained from Gibco 
(Biomol, Sevilla, Spain). Chemicals for the different assays were provided by Sigma-
Aldrich (Spain) and VWR International Eurolab (Spain). 
Clays and clays test solutions 
Clay4A and Clay4B have been developed and characterized as it was described in 
chapter 13.1. The test concentrations for both clays were selected taking into account 
previous dispersion experiments in order to avoid interferences with the measurement 
system. The highest concentrations tested were 250 µg/mL for both. Test solutions were 
prepared in serum-free medium. Three sonication steps of 10 s each one at an amplitude 
of 40% were performed using an ultrasonic tip (Dr. Hielscher, Germany) to disperse the 
test concentrations. 
Cell culture 
Caco-2 cell line derives from a human colon carcinoma (ATCC® HTB-37) and was 
obtained from the American Type Culture Collection. Caco-2 cell line was maintained 
in Eagle's minimal essential medium (EMEM) supplemented with 10% fetal bovine 
serum (FBS), 1% non-essential amino acids, 50 μg/mL gentamicine, 2 mM L-
glutamine, and 1 mM pyruvate. Cells were grown near confluence in 75-cm2 plastic 
flasks at 37°C in an atmosphere containing 5% CO2 at 95% relative humidity (CO2 
incubator, NuAire®, Spain) and harvested weekly with 0.25% trypsin. They were 
counted in an improved Neubauer hemocytometer and viability was determined by the 
Trypan Blue exclusion test. Cells were plated at a density of 7.5×10
5
 cells/mL to 
perform all experiments. 
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Cytotoxicity assays 
From the initial solution, serial dilutions in medium were prepared (0–250 µg/mL for 
Clay4A and Clay4B). Culture medium without clay was used as control group. After 
replacing the previous medium, the exposure solutions in culture medium without 
serum were added to the systems, and incubated at 37°C for 24 and 48 h. The basal 
cytotoxicity endpoints were supravital dye neutral red celular uptake (NRU), and 
tetrazolium salt reduction (MTS). 
NR uptake is a suitable endpoint to determine viable cells, because this dye is taken up 
by viable lysosomes. This assay was performed according to Borenfreund and Puerner 
(1984). MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium salt) reduction is carried out by dehydrogenases enzymes 
present in mitochondria, being this endpoint a good marker of the damage induced in 
this organelle. MTS reduction was measured according to the procedure of Baltrop et al. 
(1991). Both assays were performed according to Maisanaba et al. (2013). 
Oxidative stress study 
After replacing the previous medium, exposure solutions were added to cells and 
incubated at 37ºC for 24 and 48 h. The oxidative stress endpoints measured were 
reactive oxidative species (ROS) content and glutathione (GSH) levels.  
The production of ROS was assessed in 96-well microplates using the 
dichlorofluorescein (DCF) assay. Cells were incubated with 20 µM DCFH-DA in 
culture medium at 37ºC for 30 min, and then washed with phosphate buffered saline 
(PBS) and resuspended in PBS. The formation of the fluorescent oxidised derivative of 
DCF-DA was monitored at emission wavelength of 535 nm and excitation wavelength 
of 485 nm. ROS production was expressed as fluorescent arbitrary units (Puerto et al., 
2010).  
GSH content in cells was evaluated by reaction with the fluorescent probe 
monochlorobimane (mBCl, Molecular probes, Invitrogen) (Jos et al., 2009). After the 
cell exposure, medium was discarded and cells were incubated at 37ºC for 20 min in the 
presence of 40 µM mBCl. Later on, cells were washed with PBS and the fluorescence 
was recorded in a spectrofluorometer (Biotek, USA) at the excitation/emission 
wavelengths of 380/460. Results were expressed as arbitrary units. 
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Comet Assay 
The comet assay was performed to detect DNA strand breaks. Caco-2 cells were seeded 
on to 12-well tissue culture-treated plates (Corning Costar Corporation, New York, 
USA). Approximately 3.5x10
5
 cells in each well were exposed with different 
concentrations of Clay4A (0, 62.5, 125, 250 µg/mL) and Clay4B (0, 10, 20, 40 µg/mL ) 
for 24 and 48 h. To monitor the ongoing process of the assay, a negative control (cells 
treated with medium without fetal calf serum) and a positive control (cells treated with a 
solution of 100 μM H2O2) were included. After treatments, cells were washed and 
detached in PBS. The comet assay was applied as previously described by Collins et al. 
(1997) with modifications (Corcuera et al., 2011). Briefly, cells were resuspended in 
PBS at a concentration of 2.5x10
6
 cells/mL. This suspension was mixed with 1% low 
melting point agarose and placed on a microscope slide. Once the gels had become 
solid, the slides were dipped into lysis solution at 4°C. All nucleotides were denatured 
in a high pH buffer (0.3 M NaOH, 1 mM EDTA, pH 13). Electrophoresis was carried 
out at approximately at 25 V (300 mA) and the DNA was gently reneutralized in PBS 
and washed in H2O. After neutralization, microscope slides are fixed in 96% ethanol 
and absolute ethanol. Finally, DNA was stained with SYBR Gold nucleic acid gel stain 
and was visualized with an Olympus BX61 fluorescence microscope (20x objective) 
coupled via a CCD camera to an image analysis system (DP controller–DP manager). 
Images of randomly selected nuclei (≥ 100) per experimental point were analyzed with 
the image analysis software (Comet Assay IV; Perceptive Instruments, Suffolk, 
England, UK). The results from four independent experiments are expressed as 
percentage of tail DNA and are shown as box plots. 
Flow Cytometry 
The detection of apoptosis was performed following the method described by Cárdeno 
et al. (2013) with modifications. Briefly, Caco-2 cells (7.5x10
5
 cells/mL) were seeded in 
6-well plates. After 24 h of incubation, cells were treated in presence of different 
concentrations of Clay4A (62.5, 125 and 250 µg/mL) and Clay4B (10, 20 and 40 
µg/mL). Moreover, a negative control without the presence of any compound, and a 
positive control with the presence of curcumin 40 µM were prepared. After 24 or 48 h 
of exposure, media were collected and cells were detached by trypsinization (0.05% 
Trypsin– EDTA) and collected in 0.5 mL of MEM without serum. Afterwards, cells 
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were centrifuged at 4500 rpm during 3 min at 4ºC, resuspended and washed with ice-
cold PBS, centrifuged, and resuspended in ice-cold 1x binding buffer (BB) to 5x10
5
 
cells/mL. Cells were incubated with 25 µL/mL Annexin V-FICT and 20 µg/mL 
propidium iodide (PI) solution (Annexin V-FICT Apoptosis Detection Kit, eBioscience, 
Vienna, Austria). Four different groups of cells were obtained based on their 
stainability: those unstainable with annexin V or PI [annexin()/PI()]: viable cells 
(quadrant E3); those stainable with annexin V but unstainable with PI 
[annexin(+)/PI()]: early apoptotic cells (quadrant E4); those stainable with both 
annexin V and PI [annexin(+)/PI(+)]: late apoptotic cells (quadrant E2); and those 
unstainable with annexin V but stainable with PI [annexin()/ PI(+)]: primary necrotic 
cells (quadrant E1). The untreated population was used to define the basal level of 
apoptotic and dead cells. 
Analysis of metal content in the migration extracts 
The presence of characteristic metals of the clays structure in polypropylene 
(PP)–Clay4 and only PP (as control) unfiltered extracts was analyzed. Al, Fe and Mg 
were quantified by (ICP-MS) (Agilent 7500C, Agilent ICP-MS Systems, USA). These 
determinations were carried out in the Scientific- Techniques Services (University of 
Oviedo) based on standard operating protocols. 
Statistical analysis 
All experiments were performed at least three times and at least in duplicate per 
concentration. Statistical analysis was carried out using analysis of variance (ANOVA), 
followed by Dunnett’s multiple comparison tests. Differences were considered 
significant from p < 0.05. EC50 values, mean effective concentration, concentration of 
test chemical that modified each biomarker by 50% (positive or negative) in comparison 
with appropriate untreated controls, were determined by linear interpolation. 
 
Results 
Cytotoxicity assays 
NR uptake performed by Caco-2 cells exposed to Clay4A remained unaltered with 
respect to the control cells after 24, whereas at 48h experienced a significant (p<0.05) 
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decrease with respect to the control at 125 and 250 μg/mL, respectively (Fig.1a). In the 
case of MTS reduction, Caco-2 cell line showed no alterations at 24 h. Moreover, after 
48h, MTS metabolization was significantly reduced between 62.5 and 250 
μg/mLClay4A (Fig 1b).  
On the other hand, the NR uptake with Clay4B presented a significant (p<0.05; 
p<0.001) decrease from 125 μg/mL after 24 h of exposure, and from 62.5 after 48h.  
(Fig. 1c). Similarly, MTS reduction presented a decrease from the concentration of 62.5 
μg/mL with significant differences after both exposure times (Fig. 1d). 
 
Figure 1. Neutral red uptake (a, c) and MTS reduction (b, d) of Caco-2 cells after 24 h and 48 h of 
exposure to 0–250 μg/mL Clay4A (a, b) and Clay4B (c, d). Results from 3 independent experiments with 
6 replicates/experiment. All values are expressed as mean ± s.d. Differences were considered significant 
from p ≤0.05 (*) or p ≤ 0.01 (**). 
 
Oxidative stress assays 
When Caco-2 was exposed to Clay4A during 24 and 48 h, no significant alteration on 
GSH content was observed at any of the exposure concentrations in comparison to the 
control group (Fig. 2a). Caco-2 cells experienced a significant increase in ROS levels 
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when they were exposed from the concentration of 125 μg/mL Clay4A after 24 h, while 
this increase occurred with 62.5 μg/mL Clay4A after 48 h (Fig. 2b). 
GSH content was not affected when Caco-2 was exposed to 10 or 20 μg/mL Clay4B 
(Fig. 2c) during 24 and 48h. In contrast, significant (p<0.001) reduced appeared at the 
highest concentration assayed in both times.  The percentage of GSH for 40 μg/mL after 
24 or 48h was 3.15 and 4.3 fold lower respectively, in comparison to that of the control 
group. (Fig.2c). Cells exposed to Clay4B did not show any change in GSH at any of the 
concentrations and exposure times assayed (Fig. 2d). 
 
Figure 2. GSH content (a, c) and ROS production (b, d) in Caco-2 cells after 24 and 48 h of exposure to 
62.5, 125 or 250 μg/mL Clay4A (a, b) or, 10, 20 or 40 µg/mL Clay4B (c, d). Results from 3 independent 
experiments with 3 replicates/experiment. All values are expressed as mean ± s.d. **significantly 
different from control (p≤ 0.01). 
 
Comet Assay 
The comet assay was performed in order to study the genotoxicity potential of the 
treatments in Caco-2. Clay4A (0–250 µg/mL) did not induce DNA strand breaks in 
Caco-2 cells at any concentrations tested after 24 or 48 h of exposure (Fig. 3a). Caco-2 
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cells exposed to 100 µM H2O2 (positive control), a significant (p < 0.001) increase of 
DNA damage was observed after 24 h and 48 h of exposure. However, when the Caco-2 
cells were exposed to the highest concentration of Clay4B (0-40 µg/mL) for 24, a 
significan (p < 0.001) difference in DNA damage was observed. The per cent DNA in 
the tail at 40 µg/mL was approximately 7-fold higher compared to the other 
concentrations of Clay4B. In contrast, after 48h, a significant (p < 0.001)  increase of 
DNA strand break was detected in cells exposed to 20 and 40 µg/mL (Fig 3b). 
Moreover, the damage was greater compared to 24 h (p < 0.001). The percentage of 
DNA in tail for 20 and 40 µg/mL was 15.5 and 30 fold higher respectively, in 
comparison to that the control group.  
 
Figure 3. Comet assay results of Caco-2 cells after 24 and 48 h of exposure to 62.5, 125, or 250 μg/mL 
Clay4A (a) or, 10, 20 or 40 µg/mL Clay4B (b). Results from 3 independent experiments with 2 
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replicates/experiment. All values are expressed as mean ± s.d. *** very significantly different from 
control (p ≤0.001) or ### groups exposed for 48h in comparison to 24h (p ≤0.001). 
 
Flow Cytometry 
An annexin-V/PI double staining assay was performed to detect apoptotic and necrotic 
cells after exposure to different concentrations of Clay4A and Clay4B during 24 and 48 
h. In the case of cells exposed to Clay4A (Fig. 4), a significant reduction of cell viability 
after 24 and 48 h was observed respect to the control group from the lowest 
concentration assayed (62.5 µg/mL).  However, after 48 h, an increment of apoptotic 
cells was observed compared to cells exposed to Clay4A during 24 h.  When cells were 
exposed to Clay4B (Fig. 5), a concentration-dependent increment of necrotic cells 
appeared after both exposure periods, although after 48 h this increment was more 
marked. Moreover, apoptosis was more intense in those cells exposed to 40 µg/mL after 
24 h and in those cells exposed from 20 µg/mL after 48 h. 
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Figure 4. Viable (E3), early and late apoptotic cells (E4 and E2, respectively) and primary necrotic cells 
(E1) detected by ﬂow cytometry after 24 and 48 h of exposure to 62.5, 125 and 250 µg/mL Clay4A. 
Moreover, a negative control and a positive control (Curcumin 40 µM) were used. * Significant respect to 
the negative control group (p<0.001). ^ Significant respect to the positive control group (p<0.001). 
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Figure 5. Viable (E3), early and late apoptotic cells (E4 and E2, respectively) and primary necrotic cells 
(E1) detected by ﬂow cytometry after 24 and 48 h of exposure to 10, 20 and 40 µg/mL Clay4B. 
Moreover, a negative control and a positive control (Curcumin 40 µM) were used. * Significant respect to 
the negative control group (p<0.001). ^ Significant respect to the positive control group (p<0.001). 
 
Metal content on the migration extracts 
 
Clay4A migration extracts presented significant changes with respect the control in Al 
and Ca with ethanol 10% and, in Ca and Mg with isooctane. 
 
 Al Ca Fe Mg Si 
Ethanol 10% 
extract      
Control 25±7.8 110.5±19.1 0.4±0.3 7.3±2.5 12500.7±561.1 
Clay4 45.7±8* 500±150* 0.7±0.3 18±7.1 14388±1572.9 
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Isooctane 
extract 
     
Control 60.3±5.5 275.7±65.6 42±7.1 20±4 4270.7±321.9 
Clay4 74±15.6 445.5±2.1* 44±15.5 41.5±10.6* 4549.5±292 
Table 1. Al, Ca, Fe, Mg and Si content in the migration extracts with etanol 10% or isooctane from PP 
and PP–Clay4 (all the concentrations are expressed in µg/L). All values are expressed as mean ± SD, n=3. 
*Significant (p≤ 0.05) and **very significant (p≤ 0.01) differences from control. 
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Abstract 
 The food industry is developing new packaging systems (active packaging) 
through the incorporation of essential oils or their main compounds into the films. This 
could confer to them the antimicrobial and/or antioxidant properties already described 
for these substances themselves, improving the shelf-life of perishable food products. 
However, a safe range of concentrations for their use in active food packaging should be 
established to reach the market proposals but avoiding risks for population. The aim of 
the present work was to review the scientific literature concerning these two properties 
together with the effects induced by these substances on human cell lines. 
 
Keywords: essential oil, active packaging, antimicrobial activity, antioxidant activity, 
cytotoxicity 
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1. Introduction 
The food industry, in order to satisfy consumers, is developing new packaging 
systems, such as smart packaging, application of nanocomposites, use of biosensors, 
active packaging, etc, in agreement with “green consumerism” (1). In addition, there is 
also a trend directed to obtaining biodegradable packaging materials composed by 
cellulose, starch, poly-beta-hydroxyalkanoates, polylactide acid, etc, in order to reduce 
the using of non-biodegradable plastics (derived from petroleum) (2). Moreover, 
synthetic chemicals additives are being substituted by natural alternatives, since several 
findings have elucidated some problems concerning the safety of these chemicals, 
including allergenicity and carcinogenicity (3). 
Food safety and quality are the two major concerns for food industry. Food-
related microorganisms can lead to deterioration of foodstuff, but also can produce 
several diseases in humans (4). In this sense, the WHO has estimated that, each year, 
foodborne diseases affect 30% of people from industrialised countries, being diarrheal 
diseases the more severe (5-7). According to a recent report, the European Food Safety 
Authority (EFSA) in collaboration with the European Centre for Disease Prevention and 
Control (ECDC) estimated that 55453 European fell ill, 5118 got hospitalized, and 41 
died in 2012 due to foodborne outbreaks (8). Among the microorganisms involved in 
foodborne diseases, the more common are Staphylococcus aureus, Salmonella spp., 
Bacillus cereus, Clostridium botulinum, Clostridium perfringens, Listeria 
monocytogenes, Campylobacter jejuni, Escherichia coli O157:H7, Toxoplasma gondii, 
Bacillus cereus, Aspergillus niger, and Saccharomyces cerevisiae (9-10). It is 
remarkably that Salmonella spp. with 31% food-related deaths, L. monocytogenes with 
28%, T. gondii with 21%, C.  jejuni with 5%, and E. coli O157:H7 with 3%, are the 
more harmful pathogens of the above mentioned (11). These microbes are usually found 
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in food of animal origin, particularly pork, beef, chicken, eggs, and milk, but also in 
fresh lettuce (12). 
In addition to microbial growth, oxidation also plays a role in numerous food 
products. The oxidation may occur when reactive oxygen species (ROS), including 
superoxide radicals, hydroxyl radicals, singlet oxygen, and hydrogen peroxide, 
accumulate in tissues (13). Lipids (mainly), proteins, and carbohydrates are susceptible 
to oxidation, which lead to the alteration of different food organoleptic properties 
(colour, flavour, texture), or even become a nutritional risk (14). 
Essential oils (EOs) are very interesting substances as they could substitute 
synthetic chemicals additives. This is justify by their antimicrobial and antioxidant 
properties, highlighting among some other properties as antitoxigenic, antiparasitic, 
insecticidal, antiphlogistic, spasmolytic, antinociceptive, immunomodulant, 
psychotropic, acaricide, expectorant, antidiabetic, cancer suppressive, etc (5; 15-16). 
These properties could be due to EOs per se or to the different compounds which are 
part of their composition. The EOs constituents are a wide group of molecules divided 
on the basis of their chemical structure (17-18). Depending on their structure, these 
compounds will have a related mechanism of action, which is interesting based on the 
type of activity required (18). In this sense, a previous review carried out by our group 
summarized the characteristics of the most common EOs used in food industry (19). 
Many EOs components are recognised by the Food and Drug Administration (FDA) of 
the United States of America as generally recognised as safe (GRAS) substances. In 
addition, not only these components appear in the list but also other EOs such as those 
obtained from clove, oregano, thyme, basil, and cinnamon (18; 20). Moreover, the 
European Commission authorised the use of some compounds from EOs (linalool, 
thymol, eugenol, carvone, cinnamaldehyde, vanillin, carvacrol, citral, limonene) as 
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flavourings in food products (21). On the contrary, no EOs or herbs extracts, with the 
exception of the rosemary EO, have been approved as additives for food by the 
European Commission (22).  
Some of the most evaluated EOs components are cinnmaldehyde, eugenol, 
geraniol, thymol, menthol, and carvacrol (12; 23). Ortega-Ramírez et al. (10) stated that 
the antimicrobial and antioxidant properties of bioactive compounds are mainly due to 
their REDOX properties, ability to chelate metals, and quenching reactive species of 
singlet oxygen. For this reason, EOs or their compounds alone are a good option to be 
used in food industry for the improvement of shelf life of foodstuff. However, there are 
some limitations for the application of these substances since chemical variability could 
play an important role on their activity (13).  
Solorzano-Santos and Miranda-Novales (12) pointed out that EOs or their 
compounds alone directly added to food, present desirable effects (antimicrobial and/or 
antioxidant) at certain concentrations, although these concentrations could produce 
undesirable changes in flavour, odour, etc. In order to avoid these effects, the use of 
packaging incorporated with EOs is an interesting alternative. These new systems 
receive the name of “active packaging”, a novel concept where the packaging interact 
with food to increase the shelf-life of the later. Nowadays, the interest is trusted in 
biopolymers derived from recycling materials or renewable resources, including 
naturally occurring polysaccharides (where chitosan plays an important role), lipids, 
proteins from plants and animals, and those chemically-synthesized from monomers 
such as lactic acid (2; 24). However, the use of this kind of packaging in Europe and the 
ingredients used for this purpose are still not regulated by the EFSA, whereas in non-
European countries as the USA, Japan and Australia this technology is approved (25).  
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The biological effects of many EOs intended for food preservation have been 
extensively reviewed. In this sense, Bakkali et al. (17) stated that EOs or their 
components induced cytotoxic effects in foodborne pathogens, mainly, through a 
prooxidant mechanism. Moreover, Llana-Ruiz-Cabello et al. (19) described in their 
review the more relevant mutagenic/genotoxic effects induced by EOs or their 
components in foodborne pathogens but also in human cell lines. However, to our 
knowledge, no other toxicological data such as cytotoxicity or morphological alterations 
in human cell lines have been recently brought together in a review. This would 
improve the understanding in this area as it could be another interesting tool to ensure 
the safety of EOs or their main components before being incorporated into food 
packaging. In addition, these mechanisms of action are related with the antimicrobial 
and/or the antioxidant properties of EOs or their main components, as we mentioned 
before, which could attribute active packaging interesting properties to become a real 
alternative in food preservation. 
The present manuscript is divided into thre  sections. In the first one, an 
approach to the antimicrobial activity of EOs or their main compounds either alone or 
incorporated in active food packaging has been addressed. The second section deals 
with recent studies performed concerning the antioxidant activity (AA) of these 
mixtures or substances. Finally, the third section presents the state-of-the-art of the 
cytotoxic and morphological studies carried out in human cell lines with EOs or their 
main compounds. All the information presented below would make an interesting 
approach to an updated state-of-the-art of these new interesting active packaging 
systems as well as the risk associated to the possible commercialization of these new 
packages. 
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2. Antimicrobial activity 
Below, is presented an approach to the antimicrobial characteristics of EOs and 
their main components per se and after their inclusion into film matrices intended to 
food packaging. Considering that previous works have already reviewed this activity, 
the present work, was focused on studies published between 2012 and 2015. 
2.1. Antimicrobial activity of essential oils or their main constituents per se 
The antimicrobial activity of EOs is of great interest, with more than 15000 
reports available in the scientific literature including several reviews (5; 18; 26-28). 
The currently available screening methods for the detection of antimicrobial 
activity of natural products fall into three groups, including bioautographic, diffusion, 
and dilution methods. Moreover, there are other less commonly used techniques such as 
turbidimetry or conductimetry, based on optical density evaluation or changes in the 
electrical conductivity, respectively (29). However, there are two methods which have 
been widely accepted and commonly used; agar disk diffusion and agar dilution. The 
agar diffusion method is a simple and commonly used method which basic principle is 
the diffusion of EOs through agar. An effective antimicrobial EO can inhibit the growth 
of microorganisms, producing an inhibition zone (15). The agar dilution method can be 
developed in two different ways: a) direct contact assay (agar or broth dilution method), 
where the microorganisms are first pre-cultured in a suitable growth broth and then, the 
bacterial suspensions are mixed with different dilutions of EOs and incubated under 
defined conditions depending on the microorganisms assayed, in order to know the 
Minimum Inhibitory Concentration (MIC) of the EO; b) vapor phase assay, which 
allows to evaluate the antimicrobial effectiveness of EOs in vapor phase through the 
addition of different concentrations of EOs to sterile filter disks placed on the lids of 
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Petri dishes, being an interesting method to evaluate antimicrobial active packaging 
(30). In this case, the MIC is determined as the lowest EO concentration which made a 
visible inhibition zone. These two methods together with turbidimetry, bioautography, 
or time killing assay have been discused by Seow et al. (27). 
The results of these different antimicrobial tests often depend on several factors 
such as composition of active agents, plant differences, physical and chemical 
characteristics of the EO components, the presence of other substances like starch, 
proteins, or lipids, species and strain, the method used, culture conditions, etc (31). As 
reported by Seow et al. (27), other different factors as the type and volume of broth, 
temperature, time of incubation, and concentration and age of inoculums, also play a 
role in the EO antimicrobial potency. 
Regarding the sensitivity of microorganisms to EOs, different authors suggested 
that Gram-positive (G+) bacteria are more susceptible to EOs or their components than 
Gram-negative (G-) bacteria (5; 27-28; 32). This could probably due to the outer 
membrane of G- bacteria, which contain hydrophilic lipopolysaccharides that create a 
barrier toward macromolecules and hydrophobic compounds, providing G- bacteria 
with a higher tolerance towards hydrophobic antimicrobial compounds from EOs (2; 
33-39). However, recent studies reveal that, in particular cases, G+ bacteria exhibited 
more resistance than G- to EOs (2; 37; 40). In any case, the antibacterial activity of EOs 
is not referable to one specific mechanism, but a result from several damages in cells. 
These damages include membrane permeabilization or membrane disruption, leakage of 
cellular components, changes in the concentration of ATP, or enzyme inhibition. The 
study of bactericidal mechanisms of EOs has been reviewed by Hylgaard et al. (18) and 
Seow et al. (27). With respect to fungi, some authors reported than molds growth is 
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difficult to be inhibited, due to their complex structure (41). However, EOs appears to 
be more effective against yeasts and molds than for bacteria (5; 35; 42-43). 
Despite the demonstrated antimicrobial potential of EOs and their constituents in 
vitro, their use as preservatives in food has been limited because high concentrations are 
needed to achieve sufficient antimicrobial activity (18). This may change the 
organoleptic properties of food resulting in palatability problems. For this reason, the 
development of active packaging containing EOs or their main constituents is an 
interesting strategy to solve this issue. 
2.2. Antimicrobial activity of active packaging containing essential oils or their 
main constituents  
The antimicrobial activity of films incorporated with EOs and their main 
components have been reviewed by several authors, proving the importance that these 
active packaging have acquired recently (26; 44-45). Thus, the oregano EO is the most 
frequently used for this purpose followed by cinnamon and clove EOs, taking into 
account the reviewed literature. Films containing the major compounds of EOs have 
been also studied, but advances in this field are scarce, and fewer reports are available 
in the scientific literature (46-48). The diversity of polymeric matrices studied is high 
but most of the studies are focused on the evaluation of the percentage of EO or the 
main compound required in the matrix to obtain the better antimicrobial properties, 
although there is no a comparison of different polymers with the same % EO or main 
compound. However, since the publication of these reviews, many other studies mainly 
concerning EOs incorporated to films have been carried out. This justifies the aim of the 
present review compiling studies on active packaging containing EOs, and it is 
summarized in table 1. 
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The antimicrobial activity of EOs has been attributed mainly to phenolic 
compounds, which have boiling points above 200 ºC. This fact makes these substances 
able to be incorporated into polymeric matrices for the development of antimicrobial 
active packaging, since they could be thermally processed without losing their 
properties (42). The advantage of applying EOs through the use of films, instead of 
applying them directly on foods, allows to attain the desired goal with lower oil 
concentrations, thus limiting unwanted flavors and odors to food (43; 49-50). 
Once the EO is incorporated into the film, the antimicrobial activity needs to be 
assured. In this regard, the antimicrobial activity of these systems has been recently 
reviewed by Sadaka et al. (26), who reported that many factors need to be considered 
during the design, such as targeted microorganism, antimicrobial agent, chemical nature 
of food and antimicrobials, or packaging process conditions. The increasing interest 
about these natural sources has brought forward a new determinant factor, the film 
matrix, since it is necessary to reach a minimum concentration of the active compounds 
in the medium during the lag phase of the microorganisms to inhibit their growth, which 
occurs at a different liberation rate depending on the film matrix (51-52). Other authors 
have stated that these systems could also present synergistic effects. Thus, there are 
studies that observed differences in the antimicrobial activity of EOs included in film 
matrices against the same microorganism depending on the nature of this matrix (2; 35; 
52-55). In addition, there are other reports that confirm these differences and also 
attributed these findings to different factors such as the resistance showed by collection 
strains and natural strains or the impaired penetration of EOs compounds in the products 
(43). For these reasons, it is very remarkable that Sung et al. (56-57) observed the same 
results for two different polymeric matrices containing the same amounts of garlic EO. 
In this regard, Avila-Sosa et al. (53) compared three different matrices (amaranth, 
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chitosan or starch edible films) with oregano and cinnamon EO and concluded that 
chitosan films exhibited the greatest inhibition against Aspergillus niger and Penicillium 
digitatum. Also, Otero et al. (52) observed that polyethylene terephthalate films 
incorporated with oregano EO presented a higher antimicrobial capacity than that 
presented by polypropylene films, also including oregano EO. Moreover, it has been 
demonstrated that the using of two or more EOs in active packaging improve their 
properties (58). 
 
3. Antioxidant activity 
The present section deals with the more recent advances concerning the AA of 
EOs and their main compounds per se and after the incorporation of them into different 
film matrices. Taking into account previous works in this field, this section have 
updated the information available in this concern from 2010 to 2015. 
3.1. Antioxidant activity of essential oils or their main constituents per se 
Antioxidant activity of EOs has been extensively described by many authors 
(59-63). This activity is due to their composition, rich in terpens, terpenoids, and 
aromatic compounds (17). The relatively recent interest of the consumers for natural 
products has lead to a renewal of scientific concern in these substances in detriment of 
synthetic antioxidants such as Butylated hydroxyanisol (BHA) and 
Butylhydroxytoluene (BHT) (5; 59).  
There are many methods used for the antioxidant evaluation of the EOs or their 
main components. Alam et al. (64) described 29 methods for the in vivo and in vitro AA 
evaluation of chemical compounds in general; including those described by Amorati et 
al. (59) who reported 11 methods for specifically evaluate the AA of EOs. In addition, 
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Valgimigli and Pratt (65) stated that compounds reacting with radical species are not 
necessary antioxidants, unless they meet three requirements: a) the radical specie is a 
peroxyl radical, b) the reaction of the compounds with the radical is faster than the 
reaction of the radical with the substrate, and c) the products do not worsen the 
situation. 
According to Sacchetti et al. (61) and Schlesier et al. (66), the AA of 
phytochemicals cannot be evaluated by a single method due to their complex reactive 
nature; therefore, at least two methods are recommended. Moreover, Amorati et al. (59) 
mentioned that it is a common practice in the literature to classify an EO as an 
antioxidant when it shows this activity in some methods, but not all of them, which can 
induce to confusion. Among the antioxidant methods, the most used in the literature are 
the DPPH (2,2-diphenyl-1-picrylhidrazyl) test, the TEAC (Trolox-Equivalent 
Antioxidant Capacity) test, and the TBARS (thiobarbituric acid reactive species). The 
DPPH and the TEAC tests are useful indirect methods for evaluating the AA of both 
hydrophilic and lipophilic substances, consisting in the measure of the color change of a 
solution by the action of antioxidant compounds, and ensuring a better comparison of 
the results (61; 67-68), whereas the TBARS method measure the formation of a colored 
adduct between thiobarbituric acid (TBA) and malondialdehyde (MDA), an end-product 
of the lipidic peroxidation (69). Amorati et al. (59) established that the best way to 
evaluate the AA of a compound is to measure the rate of oxidation of polyunsaturated 
lipids under certain conditions with or without the presence of the EO at issue. They 
also established that methods like DPPH or TEAC should be used for preliminary 
screening, and at any case, tests where the evaluation occurs in the absence of both 
radical species or oxidazable lipids (FRAP, Folin-Ciocalteu test, etc), should be 
avoided. In this sense, in table 2 there are 7 studies using the FRAP (Ferric Reducing 
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Antioxidant Power) method, and 6 studies employing the Folin-Ciocalteu test, 2 of 
which used the Folin-Ciocalteu test alone for the evaluation of the AA. Nevertheless, 
Sanches-Silva et al. (70) exposed that none of the methods mentioned could be 
recognized as the best one. 
There are several studies concerning the AA of EOs which compare the potential 
antioxidant ability of different oils. Thus, Sacchetti et al. (61) compared the AA of 
thyme and rosemary EOs, together with other 10 EOs, through 3 different methods: 
DPPH test, β-carotene bleaching test, and luminol-photochemiluminiscence (PCL) test. 
Thyme resulted to be the most potent antioxidant, followed by rosemary. Teixeira et al. 
(63) found that EOs of citronella, clove, oregano, and thyme were capable to inhibit 
50% of the radical-scavenging activity of DPPH, being the more potent the EOs from 
clove and oregano. By contrast, coriander and basil did not show AA. These results 
were also obtained after performing a FRAP test. Lee and Shibamoto (71) found that 
thyme, basil and rosemary presented high AA, whereas cinnamon presented the lowest 
AA when they performed two antioxidant lipophilic assays (aldehyde /carboxylic assay 
and conjugated diene assay). Bentayeb et al. (60), after performing an ORAC assay, 
found that oregano, clove, cinnamon, and thyme presented high AA, whereas basil and 
rosemary did not. In general, these differences could be due to the hydrophilic or 
lipophilic character of the components of the EO, the concentration used, or the nature 
and physicochemical properties of the EOs (72).  
Concerning the main compounds of the EOs, Bentayeb et al. (60) established a 
correlation between the main components of the EOs and the AA of the oil, such as 
carvacrol in oregano, eugenol in clove and cinnamon, thymol in thyme, etc. In this 
concern, Ruberto and Baratta (69) analyzed about 100 pure components of EOs for their 
antioxidant effectiveness. They found that phenols, such as α-terpinene, γ-terpinene, 
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14 
carvacrol, thymol, and eugenol, possessed the highest AA, whereas sesquiterpenes 
hydrocarbons and non isoprenoid compounds showed a low or absent AA. Although α-
terpinene and γ-terpinene presente AA and are present in the EOs from oregano, 
coriander, rosemary, and thyme, the AA of these oils could not be due to them, since 
they are not their main components, although many studies propose that the AA of EOs 
also depends on secondary components, such as α-terpinene and γ-terpinene (59; 69). 
3.2. Antioxidant activity of active packaging containing essential oils or their 
main constituents. 
These EOs or their main compounds are being incorporated into food packaging 
in order to take advantage of their antioxidant properties, considering that oxidation is 
one of the major causes of food deterioration (62; 70). Sanches-Silva et al. (70) and Eça 
et al. (73) gathered together in their respective reviews some of the literature concerning 
the antioxidant role of many films containing EOs or their main components intended 
for food packaging. It is noteworthy that the extracts more cited in the literature for this 
purpose are green tea, oregano, and rosemary, as table 3 shows. This fact could be 
related to their rich composition in catechins, carvacrol/thymol, and phenolic 
compounds (camphor, 1,8-cineole, α-pinene, geraniol, etc.), respectively, which are 
known as potent antioxidants (74-76). 
The aim of the present section is to provide a complete revision of the state-of-
the-art related with the antioxidant capacity of active packaging incorporated with EOs 
and/or their main compounds for better foodstuff preservation. Tables 2 and 3 
summarize the more recent advances in films incorporated with EOs or their main 
compounds, respectively, with special attention in the assays performed for the 
evaluation of their antioxidant efficiency as well as the type of film used. 
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The usual antioxidant assays described for EOs or their main components are not 
recommended when investigating the AA of films incorporated with these substances, 
since the manufacturing process could affect their composition. For this reason, only 
those assays based on the oxidation of polyunsaturated lipids provide meaningful results 
(59).  
Green tea is being used in active packaging due to its antioxidant properties, 
which have been mainly attributed to the phenolic compounds present in its 
composition, especially catechins (77-79).  Active packaging incorporated with green 
tea has been reported to delay lipidic oxidation in different food models, due to 
catechins are actively involved in the scavenging process of free radicals, as well as to 
the stimulation of transcription factors and mitogen-activated protein kinases-dependent 
cell cycle regulation (77; 80-81). Films incorporated with oregano and thyme EOs have 
shown different AA depending on the content in carvacrol and thymol, although it has 
been also demonstrated that there is a synergism between both components (59). As 
green tea extract, the AA of oregano and thyme is related with the retardation of lipid 
peroxidation through their potent radical-scavenging activity derived from their 
composition (82). Moreover, the AA of films added with basil, cinnamon, citronella, 
clove, lemongrass, and thyme have been also studied and summarized in the present 
work. 
It is also remarkable that the majority of films included in the present section 
have shown an AA to a greater o lesser extent. In this sense, chitosan or gelatin films 
have showed AA, possibly due to the fact that free radicals can react with the residual 
free amino groups NH2 of chitosan (83-84) or the peptide fraction from gelatin (85-86).  
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Concerning EOs-added films, their AA could vary depending on the EO used or 
on the composition of the films. Several authors have described a lower AA of films 
added with EOs compared to the oils alone (87-92). This fact could be due to 
interactions between the components of films and EOs, such as polyphenols and 
proteins, reducing the availability of the antioxidant compounds, and also could be due 
to the loss of volatile compounds during the films processing (91). Moreover, 
depending on the simulant used for the assays, the AA could also changes. Thus, López-
de-Dicastillo (93) found that AA of films was simulant-dependent, that is, depending on 
the hydrophilic or lipophilic character of the EO, a simulant or another (water or 
ethanol) must be chosen for the evaluation of the AA of the incorporated-films. Finally, 
there are also studies where the AA of a film was assessed after a simulated digestion, 
resulting in a decreased of the activity compared with the activity of the original film 
(78). These authors attributed this finding to the transformation of the components from 
the extract during the digestion process or to an interaction between compounds and 
film. 
Thus, the use of EOs or their main components in food packaging is a good 
alternative to the using of synthetic antioxidants such as BHA or BHT due to the refusal 
of consumers and to their possible toxic effects described at high concentrations (94). 
However, it is remarkable that any of the studies here mentioned involving a food 
matrix studied the organoleptic characteristics of these matrices, since EOs are known 
for their strong flavor and odor. For this reason, it should be also important to include 
this kind of parameters in new studies, in order to avoid controversial opinions from 
consumers. Moreover, studies concerning the safety of the EO added-films should be 
carried out in order to ensure their safe using in food packaging in the concentrations 
intended for this purpose. 
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4. Basal cytotoxicity assays, cell death and morphological studies induced by 
essential oils or their main constituents 
Considering the properties presented in the above sections, it is important to 
highlight that the use of EOs and their main compounds as pure substances, as well as 
incorporated in food packaging applications should be limited. In order to reach the 
market proposals but not trigger risk to the population, the toxicological assessment is 
required. In this sense, in vitro cytotoxicity tests are useful to define basal cytotoxicity, 
directly related to cell death induction (95). These studies are needed in order to define 
the concentration range for further in vitro testing (genotoxicity, mutagenicity) and 
ensure the safety of these substances before being incorporated in food packaging. In 
this regard, an updated revision of the cytotoxic studies of EOs and its components used 
in food packaging has been carried out and described below (Tables 4 and 5).  
 Despite de traditional use of EOs, most of the studies concerning the toxicity are 
very recent. Almost the 65% of the studies selected for this chapter are dated from 2010, 
the rest are ranged from 2000 to 2010, with only 3 works referenced before 2000 (96-
98). This finding may be due, in part, to the believed harmlessness that they have been 
conferred. However, the lately increase in the toxicity assessment of EOs is 
undoubtedly related to their new applications, hence, in the food industry, and 
particularly in food packaging.  
 It is interesting to point out that most of the experiments performed have been 
conducted in human cell lines, mainly HepG2 and Caco-2 cells, from hepatic and 
intestinal origin respectively, in order to assess the interest on  the safety of these 
substances (98-110). In the reviewed literature, the majority of the cytotoxic studies are 
relative to EOs obtained from basil, garlic, oregano, rosemary, and thyme (Tables 4 and 
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5). The more extensively used assays are the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay (MTT), the lactate dehydrogenase release assay 
(LDH), the trypan blue exclusion test, the neutral red uptake (NRU) and the total 
protein content assay (PC). The comparison between them is difficult since each one 
has been conducted with EOs containing different compositions. Moreover, the 
concentrations and times of exposure differed, as well as the cell line and the endpoints 
used. 
 The MTT assay has demonstrated to be, in general, more sensitive than other 
endpoints. In this sense, MTT cell viability of human lymphocytes exposed to 
palmarosa, citronella and lemongrass EOs as well as to geraniol and citral resulted more 
sensitive than that evaluated with the trypan blue dye exclusion method after 3 h of 
exposure (111). Also, Usta et al. (112) observed a higher sensitivity of the MTT assay 
(100% cell death) compared with the NRU and the trypan blue exclusion assays (20% 
cell death) in HepG2 cells exposed to linalool 2 µM. Similar findings were also 
observed in HT-29 and SH-SY5Y cells exposed to onion peel extracts (113) and to an 
aqueous extract of basil (114), respectively. Llana-Ruiz-Cabello et al. (110) also 
observed this fact (MTT assay vs. NRU and PC) in Caco-2 cells exposed to carvacrol, 
thymol, and their mixture. Thus, the higher sensitivity of the MTT assay may be related 
to the toxic mechanism of EOs which target mitochondria (17). In this sense, several 
studies have implicated mitochondria as one of the possible targets for EOs, initiating 
thus various biochemical events, such as enzyme inhibition or cell death through 
depolarisation of the mitochondrial membranes by decreasing the membrane potential 
(112). In this regard, Bakkali et al. (17) suggested that the permeabilization of outer and 
inner mitochondrial membranes leads to cell death by means of induction of apoptosis 
and/or necrosis. Although the mechanism of apoptosis induction has been largely 
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studied, these same authors reported that EOs alone or in combined treatments mainly 
induced necrosis rather than apoptosis. 
 It is important to point out that most of the reviewed studies are focused on 
assessing the toxicity of the main compounds from EOs. This may be related to the 
inconveniences in the use of EOs, since their lipophilic nature makes difficult to 
obtaining homogeneous exposure dilutions in cell culture media. In addition, their 
complex and variable composition complicate the interpretation of the results. In fact, 
the study of a single compound facilitates establishing a relationship between the 
damage observed and the toxic mechanism, including the mechanism of cell entering. In 
this regard, many authors have suggested that compounds from EOs, such as cinnamon 
and clove, can permeate the membranes due to their lipophilic nature and hence become 
accessible to various intracellular targets, including mitochondria (115). Linalool from 
coriander EO has been reported to be the responsible of the cytotoxicity of the oil (112; 
116). Similarly, carvacrol and thymol induced higher damage than the oregano EO in 
HepG2 cells (104) although Savini et al. (103) reported that no single compound 
seemed to be responsible for the cytotoxic effects observed, but the whole extract of 
oregano. Sinha et al. (111) also evidenced the involvement in the toxicity induced by 
citral in lemongrass oil and geraniol in palmarosa oil in human lymphocytes. Similarly, 
the biological activity of green tea has been attributed to its polyphenols, in particular, 
to catechins (117). Moreover, despite the difficulty in comparing the results from 
different studies, a concentration and time-dependent decrease in cell viability have 
been frequently reported. In this regard, the cytotoxicity of basil extract analyzed by 
MTT assay was reported to be non toxic in HepG2 cells exposed up to 50 µg/mL for 24 
h (101), and decreased the viability of SH-SY5Y cells exposed to 2000 µg/mL at the 
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same exposure time (114), and the viability of pancreatic cells exposed to 80 µg/mL up 
to 7 days (118).  
 In addition to cytotoxicity studies, the cell death evaluation and the most 
remarkable morphological features altered by EOs and their main compounds used or 
intended to be used in food packaging is of great concern, and studies related to this are 
summarised on Tables 6 and 7. The apoptosis induced by extracts of Origanum 
majorana in Jurkat cells has been related to an up-regulation of p53 protein levels and 
down-regulation of Bcl-2α (119). Similarly, Gu et al. (120) found that linalool-induced 
apoptosis might be associated with activation of p53 and cyclin-dependent kinase 
inhibitors. Moreover, water garlic extracts induced a p53/p21-dependent cell cycle 
arrest in G2/N phase and apoptosis in HepG2 cells (99). In this sense, Hong et al. (121) 
confirmed the p53-dependent pathway of apoptosis by reporting higher sensitivity in 
p53-wild type H460 cells than in the p53-null type H1299 non small cell lung cancer 
cells. In addition, diallyl sulfide (DAS)-induced apoptosis in ATC cells was associated 
with a decrease of Bcl-2 expression and with an increase of Bax expression, activation 
of caspase-9 and caspase-3, and mitochondrial release of cytochrome C (122). Similar 
findings were also observed in MDA-MB231 cells exposed to carvacrol (123) and in 
SH-SY5Y neuroblastoma cells exposed to limonene and linalyl acetate (124). In the 
case of thymol, the apoptosis induced in HL-60 cells involved both caspase dependent 
and independent pathways (125). This induction of apoptosis has been also related to 
the affectation in the homeostasis of Ca2+ in human glioblastoma cells (126). However, 
in the case of menthol, the induced cell death was not associated with Ca2+ influx 
pathways (113). In addition, rosemary extract also down-regulated 15 genes related to 
apoptosis in A2780 cells (127). 
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 Apoptosis caused by EOs and their components, as we mentioned before, has 
been also observed by morphological visualization. Hence, electron microscopy 
revealed that morphological changes characteristic of apoptosis occurred in cells treated 
with DADS (96). Similarly, carvacrol induced morphological characteristic of apoptosis 
changes such as cell shrinkage, rounding of cells and membrane blebbing in MDA-
MB231 cells (123) and intense vacuolization in the cytoplasm and release of the 
vacuoles in Caco-2 cells (110). Dusan et al. (100) performed a cell death assessment 
based on morphological changes on several EOs and its components. Thus, cinnamon 
and clove EOs and their major component eugenol had almost no cytotoxic effect at 
lower doses, oregano EO and its component carvacrol slightly increased the incidence 
of apoptotic cell death, and thyme EO presented relatively high cytotoxicity, which 
increased both apoptotic and necrotic cell death incidence, although its component 
thymol showed no cytotoxic effect at the used doses. Similarly, Stammati et al. (98) 
observed no signs of apoptosis in HepG2 cells induced by thymol at any of the 
concentrations tested, although a necrotic death pattern with cytoplasmic extrusion and 
no uptake of vital dye was observed. In contrast, the same morphological analysis 
suggested an involvement of carvone, carvacrol and cinnamaldehyde with apoptosis. 
Moreover, limonene and linalyl acetate produced cell shrinkage, cytoskeletal alterations, 
with necrotic and apoptotic cell death in SH-SY5Y cells (124). 
 Despite the great concern that all these effects on human cell lines arises, the 
cytotoxic effects as well as the induction of cell death and morphological death damage 
caused by EOs and their components on cancer cell lines have been considered a marker 
of their potential role as chemopreventive agents. Hence, the selective death of cancer 
cell lines have been studied with EOs from garlic (121; 128), basil (118) and green tea 
(129) among others.  In this regard, the effect of Origanum vulgare extract on viability 
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of human normal cells (colonocytes and fibroblasts) and colon cancer Caco-2 cells, 
confirmed a selectivity, since normal colonocytes were unaffected by the presence of 
the extract while the cancer cell line under the same conditions of exposure was highly 
affected (103). Also, Singh and Katiyar (130) suggested that EGCG was cytotoxic on 
skin cancer cells, but not in normal skin cells. However, these compounds have not only 
exhibited toxic effects on cancer cells but also on cells with non-tumoral origin (111). 
Therefore, in order to use EOs in the food industry, especially in food packaging, their 
safety should be completely ensured.  
 Taking into account all the information given about the cytotoxic effects of EOs 
or their components, a safe range of concentrations for its use in active food packaging 
could be established and, subsequently, the development of antimicrobial and/or 
antioxidant films for food preservation. 
 
5. Conclusion 
In the recent years, an exponential increasing of studies concerning the 
antimicrobial or antioxidant role of food packaging films incorporated with EOs or their 
main components has been observed, mainly due to the controversy showed by 
synthetic preservatives. These studies demonstrate the usefulness of these systems both 
in vitro and in vivo, although results are not always conclusive. This could be due to 
different factors inherent to the EO, the film, the conditions, etc. In this sense, it is 
important to establish an appropriate concentration range for their uses, based on 
toxicity studies, to ensure the safety of the consumers. For this reason, studies of 
suitable materials for film manufacturing as well as the compatibility of the EOs or their 
main compounds and the films, are of great importance. 
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Table captions 
Table 1. Antimicrobial activity of films incorporated with essential oils. 
Table 2. Antioxidant activity of films incorporated with essential oils. 
Table 3. Antioxidant activity of films incorporated with the main compounds from 
essential oils. 
Table 4. Cytotoxic effects of the main essential oils intended to be used in food active 
packaging. 
Table 5. Cytotoxic effects of the main components from essential oils intended to be 
used in food active packaging. 
Table 6. Cell death evaluation and morphological changes of the main essential oils 
intended to be used in food active packaging. 
Table 7. Cell death evaluation and morphological changes of the main components 
from essential oils intended to be used in food active packaging. 
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Table 1. Antimicrobial activity of films incorporated with essential oils. 
EO Species 
Experimental model 
Microorganism 
Food 
matrix 
Film Observations References 
Basil Ocimum 
basilicum 
Aspergillus niger 
Penicillium expansum 
Rhizopus arrhizus 
Saccharomyces cerevisiae 
Saccharomyces fibuliger 
 
Bacillus subtilis 
Escherichia coli Salmonella 
enteritidis 
Staphylococcus aureus 
- Pullulan films - 6, 12, 18, 
24 and 30 mg/cm2 
EO alone antimicrobial activity showed to be higher 
than films containing EO activity. 6 to 18 mg/cm
2
 
films inhibited the growth of G+ bacteria. S. aureus 
and B. subtilis were the most sensitive strains. Except 
for P. expansum, films did not inhibit moulds growth. 
(131) 
Mesophilic bacteria counts 
Rhizopus arrhizus 
Apples Pullulan films - 12.0 g 
EO d.w./100 ml 
Pullulan EO coating was found to offer low 
antibacterial protection. Regarding moulds, EO 
incorporation to pullulan coating caused total 
inhibition of the tested strain growth. 
Ocimum 
basilicum 
Escherichia coli 
Staphylococcus aureus 
- LDPE/EVA – 0.5, 2 and 
4% wt 
Film with EO did not reveal sufficient antimicrobial 
activity against the strains assayed. Pure EO (0.2 ml) 
was conducted to prove the antimicrobial activity and 
found to be highly efficient. 
(132) 
Cinnamon 
 
 
 
 
 
 
 
 
 
 
 
 
Cinnamomum 
verum 
Aspergillus niger 
Penicillium digitatum 
- Amaranth, chitosan or 
starch edible films – 
0.25, 0.5, 0.75, 1, 2 or 
4% EO 
For amaranth films only high concentrations of EO 
(2%) exerted antifungal activity for both A. niger and 
P. digitatum. Starch films showed similar activity 
against both microorganisms (from 0.5%). Chitosan 
films exhibited the greatest inhibition against both 
microorganisms. 
(53) 
 Escherichia coli O157:H7 
Listeria monocytogenes 
Salmonella enterica serovar 
choleraesuis 
Staphylococcus aureus 
- Pectin films– 7.3, 15.7, 
36.1 g/L 
Only films containing 36.1 g/L EO showed 
antimicrobial activity against: E. coli O157:H7 > L. 
monocytogenes > S. aureus. More inhibition was 
detected for S. choleraesuis. 
(133) 
Fresh-cut 
peach 
Pectin-cinnamon leaf oil 
coating – 7.3, 15.7, 36.1 
g/L 
At the end of storage (15 days at 5 ºC), the coated 
peaches with the highest EO concentration showed 
less microbial growth than controls. 
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Cinnamomun 
zeylanicum 
fortified with 
cinnamaldehyde 
(900mg/g) 
Aspergillus flavus 
(0.1 mg/mL) 
- * - 0.025 mg/mL to 1.6 
mg/mL 
After 48 (72) h of incubation, non-growth was found 
at 0.1 mg/mL. This MIC was slightly dependent on 
the concentration of the fungal suspension. 
(41) 
- PET – 2, 4, 6 and 8% EO 4% and 8% EO films caused total inhibition for all 
suspensions (10
4
, 10
5
 and 10
6
 CFU/mL). After 
extending the incubation period for two months, 
films maintained the antifungal activity. Material 
stored at 4 ºC for two months showed the same 
antimicrobial activity against A. flavus than fresh 
film. 
EO 
(cinnamaldehyd
e 82.5g/100g) 
Eurotium amstelodami 
(0.5g/ 100g) 
Penicillium commune 
(2g/ 100g) 
- * - 0.5 to 32g/100g EO E. amstelodami showed to be more sensitive to 
cinnamon EO than P. commune. 0.8% EO film 
induced 91% inhibition. 
(134) 
- Cassava starch – 0.4, 0.6 
and 0.8% EO 
0.8% EO film produced 25% inhibition to E. 
amstelodami. However, even at minimum 
concentration applied into the film, cinnamon EO 
showed inhibition against both strains. 
Cinnamomun 
zeylanicum 
Escherichia coli 
Listeria monocytogenes 
Staphylococcus aureus 
- Alginate/Clay 
nanocomposite film – 
0.5, 1 and 1.5 w/v 
The highest level of EO led to a complete inhibition 
of L. monocytogenes growth for the first 3 days. 
Moreover, for S. aureus and E. coli this activity was 
observed for the first 6 days. Then, E. coli > S. 
aureus> L. monocytogenes increased its growth. 
(4) 
Cinnamomun 
zeylanicum 
Escherichia coli 
Listeria monocytogenes 
Photobacterium 
phosphoreum 
Pseudomonas fluorescens 
Salmonella choleraesuis 
Shewanella putrefaciens 
Staphylococcus aureus 
Vibrio parahaemolyticus 
- Agar film – 2g/100mL 
 
Sodium alginate film – 
2g/100mL 
Disc diffusion method revealed that P. phosphoreum 
was the most sensitive microorganism. Moreover, 
antimicrobial activity of agar films was 1.4-fold 
higher than sodium alginate films. 
(2) 
Total bacteria counts 
Aerobic mesophiles 
Luminescent bacteria 
H2S-producers 
peeled 
shrimps 
Agar film – 2g/100mL 
 
Sodium alginate film – 
2g/100mL 
For the in vivo assay, alginate films showed better 
activity than agar films. The antimicrobial activity of 
alginate films remained throughout the studied period 
and contributed to extend shelf life of peeled shrimps. 
Cinnamomun Candida albicans - * – 0.8 and 1.5% EO Film forming solution exhibited considerable (37) 
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zeylanicum  
Bacillus subtilis 
Escherichia coli 
Lactobacillus lactis 
Listeria monocytogenes 
Pseudomonas putida 
Streptococcus agalactiae 
inhibition against most of the strains. The lower 
activity of this solution was observed for S. 
agalactiae while B. subtilis was the most sensitive 
bacteria. 
- Whey protein edible film 
– 0.8 and 1.5% EO 
Results for films were similar to that for film forming 
solution; however, inhibition zones were smaller than 
those on the film forming solution. 
Cinnamon EO 
and rhubarb 
ethanol extract 
Total viable counts beef PP/PVA containing both 
REE (0-4 v/v) and 
Cinnamon EO (0-0.32 
v/v) 
All treatments with antimicrobial films maintained 
better quality in comparison to the control. 
Higher concentrations of natural extracts inhibit 
bacterial growth more efficiently. 
(135) 
Cinnamon 
zeylanicum 
fortified with 
cinnamaldehyde 
(900mg/g) 
Aspergillus flavus 
 
- * Cinnamon EO in vapour phase produced a significant 
reduction in Aflatoxin B1 production. 
(136) 
- PP – 2, 4 and 6% EO PP containing 2% EO showed a significant reduction 
in Aflatoxin B1 production while PP containing 4 
and 6% EO produced a total inhibition. 
Cinnamomun 
zeylanicum 
Escherichia coli 
Staphylococcus aureus 
- LDPE/EVA – 0.5, 2 and 
4% wt 
Films with 2 and 4 % EO almost completely inhibit 
both strains. 
(132) 
Cinnamon EO Lactic acid bacteria 
Enterobacteriaceae 
Pseoudomonas spp. 
Chilled 
pork 
Low densisty 
polyethylene films 
coated with 112 to 527 
nm cinnamon EO 
nanoparticles (C-NPs) 
The bacterial counts resulted in a significant 
increment with the storage time increasing (15 days). 
However, all counts were lower with the 
concentration increasing of C-NPs, being the 527 nm 
C-NPs the best ones preserving the samples. 
(137) 
Cinnamon EO 
and cinnamon 
EO-
nanoliposomes 
Aspergillus niger 
 
Escherichia coli 
Staphylococcus aureus 
- Fish gelatin film – 5% 
v/v 
Although at short time storage, gelatin-EO films 
showed better antimicrobial effects, the nano-active 
film indicated better control of pathogen after storage 
for one month. EO-nanoliposomes improved 
antimicrobial stability of films and prolonged the 
antimicrobial time. 
(138) 
Cinnamon bark 
oil 
Salmonella thyphimurium Cherry 
tomatoes 
Zein-based coating – 5 to 
20% EO 
Zein with 20% cinnamon EO achieved a more than 5 
log CFU/g reduction of S. Typhimurium compared 
with initial control tomato samples. 
(139) 
 Cinnamon bark 
oil (CBO) 
(Cinnamomun 
cassia) 
Escherichia coli 
Listeria monocytogenes 
Salmonella enterica 
- Sodium alginate film – 1 
and 2% CBO 
After 24 hours, films with CBO presented larger 
inhibition zones for L. monocytogenes. After 48 
hours all inhibition zones drecreased, being more 
marked for L. monocytogenes. Overall, E. coli and S. 
(140) 
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enterica resulted more sensitive to this film. No 
differences were observed between different 
concentrations of CBO in films. 
Clove 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Aspergillus niger 
Debaryomyces hansenii 
Penicillium expansum 
 
Aeromonas hydrophila 
Bacillus cereus 
Bacillus coagulans 
Bifidobacterium animalis 
subespecies lactis 
Bifidobacterium bifidum 
Brochothrix thermosphacta 
Citrobacte freundii 
Clostridium perfringens 
Enterococcus faecium 
Escherichia coli 
Lactobacillus acidophilus 
Lactobacillus helveticus 
Listeria innocua 
Listeria monocytogenes 
Photobacterium 
phosphoreum 
Pseudomonas aeruginosa 
Pseudomonas fluorescens 
Salmonella cholerasuis 
Shewanella putrefaciens 
Shigella sonnei 
Staphylococcus aureus 
Vibrio parahaemolyticus 
Yersinia enterocolitica 
- Sunflower protein (SFP) 
film – 0.75 mL/ g protein 
Antimicrobial activity against all the strains assayed 
was observed in different degrees. The yeast D. 
hansenii presented the highest inhibition while C. 
perfringens was the lowest inhibited microorganism. 
(43) 
 
Syzygium 
aromaticum 
Escherichia coli 
Listeria monocytogenes 
Staphylococcus aureus 
- Alginate/Clay 
nanocomposite film – 
0.5, 1 and 1.5 w/v 
The highest level of EO led to a complete inhibition 
of L. monocytogenes growth for the first 7 days. 
Moreover, for S. aureus and E. coli this activity was 
observed for the first 6 days although the 
(4) 
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antimicrobial effectiveness decreased afterwards in 
the case of E. coli. 
Eugenia 
caryophyllata 
Aspergillus niger 
Candida albicans 
Penicillium citrinum 
 
Bacillus cereus 
Enterococcus faecalis 
Escherichia coli 
Salmonella enterica 
Salmonella typhimurium 
Staphylococcus aureus 
Streptococcus mutans 
- Cassava bagasse-PVA 
biodegradable trays - 6.5, 
8.5 and 10%  w/w for 
direct incorporation (DI) 
and 2.5, 5 and 7.5% w/w 
for surface coating (SC) 
The trays were more effective against moulds and 
yeasts than to bacteria. For DI assay, antimicrobial 
activity of films was observed only for C. albicans, 
while SC assay showed that films were effective 
against all microorganisms from 5% EO in films. 
Any concentration of EO in films showed total 
inhibition of strains. 
(42) 
Eugenia 
caryophyllata 
(71.80 % 
eugenol) 
Enterobacteriaceae 
Lactic acid bacteria 
Pseudomonas spp. 
Total aerobic mesophilic 
bacteria 
Total aerobic 
Psychrotrophic bacteria 
Chicken 
breast 
fillets 
 
WPI – 10 or       20 g /Kg The higher EO concentration in the formulations, the 
higher the effectiveness of coatings. Clove coating 
exhibited lower activity than oregano coating. 
Antimicrobial edible coatings proved to be much 
more effective on chicken breast than the use of the 
direct addition of EO. 
(141) 
EO – 20 g/Kg A detrimental effect was observed with clove 
treatment. Significantly higher microbial counts were 
detected in treated samples compared with the control 
ones. 
 
 
 
Bacillus cereus 
Escherichia coli 
Pseudomonas fluorescens 
Staphylococcus aureus 
- CMC/PVOH – 1, 2 and 
3% EO 
Films did not show any activity against G- bacteria 
(E. coli and P. fluorescens). Films with 3% EO 
showed the best antimicrobial activity. 
(54) 
Ground 
chicken 
meat 
CMC/PVOH – 3% EO Shelf life extension was observed during refrigerate 
storage due to the antimicrobial effect of films 
containing clove EO. Chicken samples inoculated 
with S. aureus experienced a total elimination of 
bacteria from 7 days after packaging in 3% clove EO 
films. 
 Escherichia coli O157:H7 
Listeria monocytogenes 
- Chicken feather protein 
film – 0.5, 1 and 1.5% 
EO 
Results of disc diffusion method indicated strong 
antimicrobial properties of clove EO films against 
both bacteria, being more significantly for films with 
1.5% of EO to L. monocytogenes. 
(142) 
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Smoked 
salmon 
Chicken feather protein 
film – 0.5, 1 and 1.5% 
EO 
Films with 1.5% EO showed a strong inhibitory 
effect against both strains. 
 Listeria monocytogenes 
Staphilococcus aureus 
Escherichia coli 
Salmonella enteritidis 
- Chicken feet proteins 
(5%) – 1% EO 
Films presented a better antimicrobial activity against 
Gram-positive bacteria. 
(143) 
Sliced 
cheddar 
cheese 
Chicken feet proteins 
(5%) – 1% EO 
 
Samples wrapped with the control films presented an 
exponential growing of microorganisms, while 
samples wrapped with the film containing clove EO 
presented a lower number of microorganisms.  
Eugenia spp. Bochothrix thermosphacta 
Escherichia coli 
Listeria innocua 
Listeria monocytogenes 
Pseudomonas putida 
Salmonella typhimurium 
Shewanella putrefaciens 
- Fish protein film-0.1 µL 
EO/cm
2
 film 
No antimicrobial activity was found for clove EO 
films with the agar diffusion method. However, these 
films showed antimicrobial activity in macrodilution 
assay only for both strains of Listeria. Moreover, 
clove EO films exhibited the highest antibacterial 
activity against S. putrefaciens. 
(91) 
Syzygium 
aromaticum 
Escherichia coli 
Staphylococcus aureus 
- LDPE/EVA – 0.5, 2 and 
4% wt 
Films with higher amount of EO showed better 
antimicrobial activity. Moreover, E. coli appeared to 
be more sensitive. 
(132) 
Coriander Coriandrum 
sativum 
Brochothrix thermosphacta 
Escherichia coli 
Listeria innocua 
Listeria monocytogenes 
Pseudomonas putida 
Salmonella typhimurium 
Shewanella putrefaciens 
- Hake protein edible film 
– 0.25 mL/g protein 
Films containing EO did not showed inhibition in the 
agar diffusion method. However, in macrodilution 
method results showed inhibition only for L. innocua 
and S. putrefaciens. 
(90) 
 
  Escherichia coli 
Listeria monocytogenes 
 
- Porcine protein film – 
0.8, 1, and 1.5% EO 
The antimicrobial activity increased with the 
increment of EO incorporated into the films. 
Moreover, the inhibition was more significant for L. 
monocytogenes than for E. coli. 
(144) 
Garlic Allium sativum Total aerobic counts Shrimps Chitosan coating 
incorporated with garlic 
EO – 0.5, 1 and 1.5% 
(w/v) 
Coating samples, even with chitosan only, improved 
the shelf life of shrimps, being 7 days for uncoated 
samples and 9 days for chitosan coated samples. 
The combined effect of garlic EO and chitosan 
coatings resulted in a longer storage time (11 days). 
(145) 
Allium sativum Brochothrix thermosphacta Ready- LDPE – 2, 4, 6 and 8% For L. monocytogenes, all active films showed (56) 
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Escherichia coli 
Listeria monocytogenes 
to-eat 
beef 
loaves 
EO w/w growth suppression, thus 2% EO was sufficient to 
suppress the growth. For B. thermosphacta and E. 
coli the antimicrobial effect was consider not 
effective since differences in counts between controls 
and films were low at <0.3 log cfu/g and <0.2 log 
cfu/g, respectively. 
Allium sativum Brochothrix thermosphacta 
Escherichia coli 
Listeria monocytogenes 
- LDPE/EVA – 2, 4, 6 and 
8% EO w/w 
2-4% EO films produced not obvious inhibition 
zones. However, a large retraction zone was observed 
for 6% EO films to L. monocytogenes and for 8% EO 
films to B. thermosphacta and E. coli. 
(57) 
Cooked 
beef 
LDPE/EVA – 2, 4, 6 and 
8% EO w/w 
For L. monocytogenes, all active films showed 
growth suppression, thus 2% EO was sufficient to 
suppress the growth. For B. thermosphacta and E. 
coli the antimicrobial effect was consider not 
effective since differences in counts between controls 
and active films were low at <0.3 log cfu/g and <0.2 
log cfu/g, respectively. 
 Brochothrix thermosphacta 
Escherichia coli 
Listeria innocua 
Listeria monocytogenes 
Pseudomonas putida 
Salmonella typhimurium 
Shewanella putrefaciens 
- Fish protein film-0.1 µL 
EO/cm
2
 film 
The agar diffusion method revealed only a slightly 
inhibition for Listeria monocytogenes; however, 
macrodilution method revealed inhibition for B. 
thermosphacta, both strains of Listeria and S. 
putrefaciens. 
(91) 
Oregano 
 
 
 
 
 
 
 
 
 
 
 
Lithobates 
berlandieri 
Aspergillus niger 
Penicillium digitatum 
- Amaranth, chitosan or 
starch edible films – 
0.25, 0.5, 0.75, 1, 2 or 
4% EO 
For amaranth films only 4% EO exerted antifungal 
activity and only against A. niger. Starch films 
showed better activity against P. digitatum (from 
0.5% EO) than that for A. niger (from 2%). Chitosan 
films exhibited the greatest inhibition against both 
microorganisms. 
(53) 
Origanum 
vulgare 
Escherichia coli 
Listeria monocytogenes 
Salmonella enteritidis 
Staphylococcus aureus 
- Alginate films – 0.5, 1 
and 1.5% w/v 
Alginate films showed antibacterial effect after the 
incorporation of 1% EO. As the concentration of EO 
increased in the alginate films, the zone of inhibition 
also increased significantly. Alginate films 
containing EO were more effective against G+ 
bacteria. The inhibitory effects of alginate films 
(146) 
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containing EO was lower than that found for pure EO 
(data no shown) 
 Escherichia coli 
Pseudomonas aeuginosa 
Staphylococcus aureus 
 Triticale protein film – 1 
and 2% w/v 
Higher concentration of EO showed larger inhibition 
zones. G+ was more sensitive for these films. 
P. aeruginosa was the most resistant strain assayed. 
(147) 
 Listeria monocytogenes (30 
µL/mL) 
- * 30 µL/mL of EO produced a clear inhibition zone 
against L. monocytogenes. 
(38) 
Cold-
smoked 
salmon 
Potato peel waste-based 
edible film- 0.97 and 
1.92% EO (185 and 286 
mg oil/g film) 
Films containing 289 mg oil/g film showed the 
highest antilisterial activity. Growth depression of L. 
monocytogenes on cold-smoked salmon during 
storage (4 ºC for 28 days). 
Zataria 
multiflora 
Escherichia coli 
Listeria innocua 
Pseudomonas spp. 
Salmonella enterica 
Staphylococcus aureus 
- Paper - 2, 4 and 6% w/w) All bacteria were inhibited with 4% to 6% films. 2% 
films only inhibited Staphylococcus aureus and 
Salmonella entérica. 
(148) 
Origanum 
vulgare 
Aspergillus niger 
Candida albicans 
Penicillium citrinum 
 
Bacillus cereus 
Enterococcus faecalis 
Escherichia coli 
Salmonella enterica 
Salmonella typhimurium 
Staphylococcus aureus 
Streptococcus mutans 
- Cassava bagasse-PVA 
biodegradable trays - 6.5, 
8.5 and 10% w/w for 
direct incorporation (DI) 
and 2.5, 5 and 7.5% w/w 
for surface coating (SC) 
The trays were more effective against moulds and 
yeasts. G+ bacteria were more sensitive than G-. 
The lowest activity was observed for E. faecalis and 
S. mutans. These bacteria are able to form a biofilm 
that can reduce the antimicrobial effect of the EO. 
Antimicrobial activity stability of films showed that 
inhibition zones against S. aureus and E. coli were 
not altered during 15 days of storage. The largest 
inhibition zones were observed for the trays produced 
by SC method 
(42) 
Coridothymus 
capitatus 
(48.56 % 
carvacrol) 
Enterobacteriaceae 
Lactic acid bacteria 
Pseudomonas spp. 
Total aerobic mesophilic 
bacteria 
Total aerobic 
psychrotrophic bacteria 
Chicken 
breast 
fillets 
 
WPI – 10 or       20 g /Kg The higher EO concentration in the formulations, the 
higher the effectiveness of coatings.Antimicrobial 
edible coatings proved to be much more effective on 
chicken breast than the use of the direct addition of 
EO. 
(141) 
EO – 20 g/Kg Direct addition of EO did not show inhibitory effects 
against microbial development. Lack of effectiveness 
was detected in most cases. 
 Enterobacteriaceae Rainbow Quince seeds mucilage Films with 1 and 1.5% EO did not show any (149) 
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H2S-producer bacteria 
Lactic acid bacteria 
Pseudomonas spp. 
Aerobic and psychrotrophic 
count 
Total viable counts 
trout 
fillets 
films – 1, 1.5 and 2% EO 
(v/v) 
remarkable activity. Moreover, 2% EO films showed 
lower counts significantly different only for 
psychrotrophic count. 
 
Zataria 
multiflora 
Bacillus subtilis 
Escherichia coli 
Pseudomonas aeruginosa 
Staphylococcus aureus 
- Gelatin films – 2, 4, 6 
and 8% w/w 
All films containing EO showed antibacterial 
activity. G+ bacteria were more sensitive than G-. 
Higher amounts of EO in films showed larger 
inhibition zones. 
(150) 
 Moulds and yeasts 
Enterobacteriaceae 
Lactic acid bacteria 
Pseudomonas spp. 
Total viable counts 
Foal 
meat 
PET/PE/EVOH/PE-1.5-2 
g/m
2
 
Although all microorganisms counts studied 
gradually increased along storage time (0, 4, 7, 10 
and 14 days) at 2ºC, Enterobacteriaceae and moulds 
and yeasts showed more sustained growth. 
Significant differences between samples and control 
were found from day 10, but Pseudomonas spp. 
showed statistical differences from day 7. 
(151) 
Origanum 
vulgare 
Escherichia coli O157:H7 
M364VO (400 mg/L) 
Escherichia coli O157:H7 
CECT 5947 (200 mg/L) 
- PP and PET – 0, 4, 6 and 
8% EO 
In the vapour phase assay, oregano EO only inhibited 
partially or totally the growth of E. coli from 6 or 8%. 
Moreover, for films, higher concentration of EO in 
the active coatings resulted in higher antimicrobial 
activity, being 6% the minimum concentration 
showing inhibition against both strains. In direct 
contact assay PET films showed stronger in vitro 
antibacterial activity than films of PP. 
(52) 
Ripened 
sheep 
cheese 
PP and PET – 0, 4, 6 and 
8% EO 
4% EO PP films decreased counts of both strains, 
however films with 6 and 8% EO did not 
significantly reduce the growth. PET films 
antimicrobial capacity was greater than that of PP 
films. 
Zataria 
multiflora 
Bacillus cereus 
Escherichia coli 
Pseudomonas aeruginosa 
Salmonella typhimurium 
Staphylococcus aureus 
- Soluble soybean 
polysaccharide – 1, 2 and 
3% oil v/v 
No inhibition area was observed in the vapour-phase 
assay for films with 1% EO. All films inhibited the 
growth of the five tested bacteria in the overlay assay 
except P. aeruginosa, which was not inhibited at the 
lowest concentration.Vapour-phase test indicated that 
the effective levels of EO added to film were higher 
(152) 
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than those for the overlay assay. 
Thymus 
capitatus 
Bochothrix thermosphacta 
Escherichia coli 
Listeria innocua 
Listeria monocytogenes 
Pseudomonas putida 
Salmonella typhimurium 
Shewanella putrefaciens 
- Fish protein film-0.1 µL 
EO/cm
2
 film 
The agar diffusion method revealed only inhibition 
for both Listeria strains; however, macrodillution 
method revealed inhibition for Bochothrix 
thermosphacta and L. innocua. 
The addition of EO to films did not reduce the 
growth of G- bacteria. 
(91) 
 Bacillus subtilis 
Escherichia coli 
Salmonella enteritidis 
Staphylococcus aureus 
Shigabacillus 
- * Oregano EO showed to be effective against all the 
strains assayed. S. aureus was the most sensitive 
bacteria, while S. enteritidis presented the smaller 
inhibition zone. However, results for all strains were 
slightly different. 
(39) 
- Gelatin (from silver carp 
skin)/chitosan – 1, 2, 3 
and 4% EO v/v 
 
Films presented antimicrobial activity when 
concentration of EO in film was higher that 1%. 
Greater inhibition zones were observed with higher 
concentrations of EO. 
Zataria 
multiflora 
Bacillus cereus 
Escherichia coli 
Pseudomonas aeruginosa 
Salmonella typhimurium 
Staphylococcus aureus 
- CMC – 1, 2 and 3 % v/v Significant inhibitory effects on both G+ and G- 
bacteria. Effects increased with increasing EO 
concentration. 
(153) 
 Staphylococcus aureus 
Listeria monocytogenes 
Salmonella enteritidis 
Escherichia coli 
- Fish gelatin-Chitosan 
(2%-1.5%)  – 0.4, 0.8, 
and 1.2% EO w/v 
 
Films incorporated with 1.2% oregano EO presented 
the highest antimicrobial activity against all 4 
pathogens studied. Among them, S. aureus appeared 
to be the most sensitive and E. coli the most resistant. 
(154) 
 Penicillium expansum 
 
Escherichia coli 
Listeria monocytogenes 
- EVOH – 5% w/w Strong effect against fungal growth was observed. 
Regarding bacteria, agar diffusion method in vapour 
phase revealed higher inhibition for E. coli. For 
liquid media assay total inhibition of both strains was 
observed. 
(79) 
  Escherichia coli 
Staphylococcus aureus 
- Bovine hide gelatine 
(5%) 
EO 0-6000 ppm 
Both microorganisms where sensitive to the film 
incorporated with the EO, being the inhibition higher 
with the EO content increasing in the film. E. coli 
appeared to be more sensitive than S. aureus. 
(92) 
Pennyroya  Bacillus cereus - Soluble soybean No inhibition area was observed in the vapour-phase (152) 
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l Escherichia coli 
Pseudomonas aeruginosa 
Salmonella typhimurium 
Staphylococcus aureus 
polysaccharide – 1, 2 and 
3% oil v/v 
assay for films with 1% EO and 2% EO only formed 
an inhibition zone for G+ bacteria. Films containing 
3% EO did not show antimicrobial activity against G- 
bacteria in vapour phase assay. However, vapour-
phase test indicated that the effective levels of EO 
added to films were higher than for the overlay assay. 
Rosemary 
 
 
 
 
 
 
 
 
 
 Aspergillus niger 
 
Escherichia coli 
- Starch-sodium alginate - 
0.3, 0.6, 0.9 and 1.2% 
(w/w) 
Results showed antimicrobial activity of all films 
against E. coli in a concentration dependent way. 
However, no activity was observed against A. niger 
in any film. 
(155) 
 Escherichia coli O157:H7 
Listeria monocytogenes 
Salmonella typhimurium 
Fresh 
broccoli 
MC films 
 
PCL/alginate films 
The antimicrobial effects on the growth of different 
microorganisms in broccoli during 12 days of storage 
at 4 ºC of two formulations (Acetic acid+rosemary 
extract+Asian EO (a) and Acetic acid+rosemary 
extract+italian EO (b)) were studied. Results showed 
that PCL/ALG- had strong, stable antimicrobial 
properties against L. monocytogenes compared to the 
others films. However, MC films were more effective 
against E. coli and S. typhimurium in mid- and long-
term storage, being S. typhimurium the most sensitive 
microorganisms to these films. 
(55) 
 Listeria monocytogenes - * - 0.1, 0.2, 0.4 and 0.5% 
EO (v/v) 
Rosemary EO with 0.5% (v/v) proved to be 
bactericidal after 48 h storage at 10 ºC 
(135) 
Lactic acid bacteria 
Listeria monocytogenes 
Total aerobic counts 
Mozzarel
la cheese 
Nylon/EVOH/PE bag 
with paper sachets 
containing thyme EO – 
1% EO 
Results showed that sachets containing 1% EO did 
not exert strong antilisterial activity, but slower 
growth and lower counts of L. monocytogenes were 
observed. However, the growth of LAB and TAB 
decreased with this treatment. 
Thyme 
 
 
 
 
 
 
 
Thymus vulgaris Brochothrix thermosphacta 
Enterobacteriaceae 
Lactic acid bacteria 
Pseudomonas spp. 
Total mesophilic counts 
Chicken 
liver 
LDPE/PA films. Thyme 
oil (0.1 and 0.3% (v/w)) 
was massaged into the 
product 
0.3% thymol EO produced the lowest mesophilic and 
Pseudomonas spp. counts. B. thermosphacta 
increased during storage time under all treatments. 
Lactic acid bacteria and Enterobacteriaceae showed 
significantly differences between treated and 
untreated samples. 
(156) 
Thymus vulgaris Brochothrix thermosphacta 
Escherichia coli 
- Hake protein edible film 
– 0.25 mL/g protein 
Films containing EO showed to be effective against 
both Listeria strains in agar diffusion method, while 
(90) 
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Listeria innocua 
Listeria monocytogenes 
Pseudomonas putida 
Salmonella typhimurium 
Shewanella putrefaciens 
macrodilution method revealed inhibitory activity for 
B. thermosphacta, L. innocua, S. typhimurium and S. 
putrefaciens. 
 
 Listeria monocytogenes - Acai edible film – 3 and 
6% EO w/w 
The highest inhibition zone was presented by 6% EO 
acai films. 
(157) 
 Listeria monocytogenes - * - 0.05, 0.075 and 0.1% 
(v/v) 
Although thyme EO at 0.1% showed antibacterial 
activity, samples with 0.05 and 0.075% demonstrated 
bacteriostatic effects after 48 h storage at 10 ºC. 
(135) 
Lactic acid bacteria 
Listeria monocytogenes 
Total aerobic counts 
Mozzarel
la cheese 
Nylon/EVOH/PE bag 
with paper sachets 
containing thyme EO – 
1% EO 
1% EO sachets showed to be effective against all the 
strains assayed in cheese inoculated with L. 
monocytogenes. 
 
 Enterobacteriaceae 
H2S-producer bacteria 
Lactic acid bacteria 
Pseudomonas spp. 
Psychrotrophic count 
Total viable counts 
Rainbow 
trout 
fillets 
Quince seeds mucilage 
films – 1, 1.5 and 2% EO 
(v/v) 
At the end of storage time, samples wrapped with 2% 
EO film did not exceed the acceptable microbial limit 
(7 log CFU/g) for total viable counts. Successful 
inhibition of Psychrotrophic bacteria and 
Enterobacteriaceae was also observed. Pseudomonas 
spp. showed to be the most resistant microorganisms. 
No substantial effects were observed for Lactic acid 
and H2S-producer bacteria. 
(149) 
 Bacillus cereus 
Escherichia coli 
Escherichia coli O157:H7 
Lactobacillus plantarum 
Listeria monocytogenes 
Pseudomonas aeruginosa 
Salmonella typhimurium 
Shewanella putrefaciens 
Staphylococcus aures 
Vibrio cholerae 
Yersinia enterocolitica 
- Quince seeds mucilage 
films – 1, 1.5 and 2% EO 
(v/v) 
After the incorporation of 1% EO, films showed 
antibacterial activity against all strains assayed. 
Inhibition was increased with increasing 
concentration of EO. P. aeruginosa showed the 
highest resistance, while S. putrefaciens was the most 
sensitive to thyme films. 
(40) 
* Essential oil assay, not film. Abbreviations: CFU: Colony-forming Unit; CMC: Carboxymethyl Cellulose; EO: Essential Oil; EVA: Ethylene Vinyl Acetate; EVOH: 
Ethylene Vinyl Alcohol; G-: Gram negative bacteria; G+: Gram positive bacteria; LAB: Lactic Acid Bacteria; LDPE: Low Density Polyethylene; MC: Methylcellulose; MIC: 
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Minimum Inhibitory Concentration; PA: Polyamide; PE: Polyethylene; PET: Polyethylene Terephthalate; PCL: Polycaprolactone; PP: Polypropylene; PVHO: Polyvinyl 
Alcohol; REE: Rhubarb ethanol extract; TAB: Total Aerobic Bacteria; WPI Whey Protein Isolated. 
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Table 2. Antioxidant activity of films incorporated with essential oils. 
EO Species Film 
Antioxidant Assay- 
Food Matrix (FM) 
Observations References 
Basil Ocimum 
basilicum 
Fish skin gelatine (tilapia) 
(3.5%) 
Surfactants: Soy lecithin, 
Tween-20, Tween-80 as  
EO 1:1 
DPPH 
TEAC 
FRAP 
Films incorporated with basil EO and any of the surfactants presented 
the highest DPPH and ABTS radical-scavenging activities compared to 
other films added with citronella, lemongrass or kaffir lime EOs. With 
respect to the FRAP assay, the basil-film presented the lowest activity. 
Films prepared with soy lecithin as surfactant presented the best 
antioxidant activity. 
(158) 
  Pullulan films 
EO 6-30 mg/cm
2
 
DPPH Films incorporated with basil EO resulted in a concentration- 
dependent AA increment. Nevertheless, this activity was much lower 
than that exhibited by the EO alone.  
(131) 
  Fish skin gelatine (tilapia) 
(3.5%) 
Surfactant: Soy lecithin  
EO 1:1 
DPPH 
TEAC 
FRAP 
Films incorporated with EOs presented a marked antioxidant activity, 
although it was much lower than the EOs alone. Films incorporated 
with basil presented the best antioxidant activity through the DPPH and 
the ABTS radical-scavenging assays in comparison with films with 
other EOs from plai and lemon. However, films with the basil EO 
presented the lowest reducing power compared with the other two 
films. 
(159) 
Cinnamon Cinnamomum 
zeylanicum 
Cellulose (3.3%) 
EO 0.05%, 0.1%, 0.25% 
 
β-carotene-linoleate 
bleaching broth 
method 
DPPH 
Cellulose-based films containing CEO presented a positive AA against 
the oxidative bleaching of β-carotene-linoleate, being this activity 
lower than presented by films added with clove, and higher than 
presented by films added with green tea (clove > cinnamon > green 
tea). Films also presented a positive radical-scavenging activity against 
DPPH radicals following the same order given before. The activity 
appeared to be higher than that observed in the first method. 
(160) 
  Low densisty polyethylene 
films coated with 112 to 
527 nm cinnamon EO 
nanoparticles (C-NPs) 
TBARS 
FM: chilled pork 
A significant increase respect to control group was observed during the 
storage (15 days). Samples treated with C-NPs presented lower 
TBARS levels than the control, being the NPs loaded with 527 
cinnamon EO the more effective a the end of the storage time. 
(137) 
 Cinnamomun 
cassia 
Alginate-Polycaprolactone 
(3%-1%) 
EO 1% 
DPPD The antiradical activity of films incorporated with CEO increased 
significantly with respect to the control film, although this activity was 
the lowest observed compared to films added with oregano or savory. 
Thus, the increment for AP-CEO-films was only 1.2 times higher than 
(82) 
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ascorbic acid. 
Citronella Cymbopogon 
nardus 
Fish skin gelatine (tilapia) 
(3.5%) 
Surfactants: Soy lecithin, 
Tween-20, Tween-80 
EO 1:1 
DPPH 
TEAC 
FRAP 
Films incorporated with citronella EO and any of the surfactants 
presented a lower DPPH radical- and ABTS radical-scavenging 
activity than that incorporated with basil EO, But higher than those 
added with lemongrass or kaffir lime EOs. With respect to the reducing 
power, the citronella-film presented the second lower activity before 
basil-films. Films prepared with soy lecithin as surfactant presented the 
best antioxidant activity. 
(158) 
Clove Eugenia 
caryophyllata 
Cellulose (3.3%) 
EO 0.05%, 0.1%, 0.25% 
 
β-carotene-linoleate 
bleaching broth 
method 
DPPH 
Cellulose-based films containing clove EO resulted to have a high AA 
against the oxidative bleaching of β-carotene-linoleate, followed by 
films added with cinnamon and green tea (clove > cinnamon > green 
tea). Clove-films also presented the best radical-scavenging activity 
against DPPH radicals. 
(160) 
  Sunflower proteins (5%) 
EO 0.75:1 
ABTS 
FRAP 
Photochemiluminisce
nce assay 
Clove EO improved both the radical scavenging and the reducing 
capacities of films. Moreover, the radical-scavenging ability was much 
higher against the ABTS radical than against the superoxide anion 
radical. These results were corroborated with the PCL assay. 
(43) 
  Hake proteins 
(cape hake)  
EO 0.001:4 
DPPH 
Reducing power 
The DPPH radical-scavenging activity of films incorporated with clove 
EO was lower than that presented by the free EO, although it increased 
the antioxidant ability of the film. This also occurred when the 
reducing power of the film was studied and compared with the free EO 
(clove EO > clove-film). In both studies, clove EO resulted more 
effective than oregano EO (clove > oregano). 
(91) 
  Chicken feet proteins (5%) 
Surfactants: Tween-20 
(0.25%) 
EO 1% 
 
DPPH 
ABTS 
TBARS 
FM: sliced cheddar 
cheese 
Films incorporated with clove EO presented the highest DPPH and 
ABTS radical scavenging activities compared to films containing other 
EOs from coriander and marjoram. Moreover, the ABTS activity was 
stronger than the DPPH activity in all cases. In addition, TBARS 
values in cheese were significantly lower respect to control group after 
15 days. 
(143) 
Green tea Camellia 
sinensis 
Gelidium corneum-
Gelatine (0.75%-5%) 
GTE 0.5%, 1.4%, 2.8%, 
4.2% 
TBARS 
FM: pork loins 
Films containing GTE showed a decreased in the TBARS values 
compared to the control. However, there was a limited reduction in 
TBARS values during the storage except at the 10
th
 day. 
(161) 
  Cellulose (3.3%) 
EO 0.05%, 0.1%, 0.25% 
 
β-carotene-linoleate 
bleaching broth 
method 
Cellulose-based films containing GTE resulted to have the lowest AA 
against the oxidative bleaching of β-carotene-linoleate, as well as the 
lowest DPPH radical-scavenging activity, compared with clove and 
(160) 
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DPPH cinnamon EOs.  
  EVOH (5%) 
GTE 5% 
DPPH 
TEAC 
GTE alone presented high DPPH radical- and ABTS radical-
scavenging activities, especially dissolved in ethanol instead of water. 
When incorporated to the film, the antioxidant activity of the resulted 
increased, although this activity resulted significantly reduced after the 
film processing, and also was simulant-dependent, being 95% ethanol 
simulant the one which presented the best antioxidant activity. 
(162) 
  Agar (1.5%) 
GTE 50% 
Folin-Ciocalteu test 
FRAP 
TEAC 
Films containing GTE presented antioxidant activity when FRAP and 
TEAC assays were performed, although this activity was lower than 
the observed before a digestion. 
(78) 
  Polyethylene terephtalate 
GTE 4 films from 0.7 g 
GTE/m
2
 film to 0.3 g 
GTE/m2 film 
ORAC 
Free radicals assay 
The antioxidant capacity appeared determined by the solubility of the 
extracts in ethanol and by the content in catechins, presenting the 
higher antioxidant activity the GTE soluble in ethanol and with the 
higher content in catechins. The free radicals assay was performed in 
films containing 2 GTE at 4 different grammages, being the second 
film the most antioxidant. 
(81) 
  Agar (1.5%) 
Agar-gelatine (1%-0.5%) 
GTE 50% 
FRAP 
TEAC 
Agar films with GTE presented increasing values of FRAP and ABTS 
with time, which indicates an increasing release of antioxidant 
compounds from the film. Approximately 60% of the antioxidant 
power was release during the first 15 min of the assays (16 h). The 
reducing power of the agar-gelatin film was lower compared to agar-
films during all the monitored time. 
(89) 
  Fish skin gelatine (4%) 
GTE 0.3%, 0.7% 
Folin-Ciocalteu test 
DPPH 
Reducing power 
The phenolic content increased as the increasing concentration of GTE 
in the film. The antioxidant activity of the gelatine-GTE film was 
significantly improved compared to gelatine film alone, and augmented 
with the increasing GTE concentration. 
(163) 
  Agar, β-cyclodextrin, 
activated carbon, methyl-
cellulose, Arabic gum, 
sodium alginate (10%, 
35%) 
GTE 50%, 70% 80% 
DPPH 
Free radicals assay 
All the prototypes presented excellent antioxidant activities in both 
assays, increasing with the percentage of GTE. 
(164) 
  Fish skin gelatine (3%) 
GTE 0.01 mg/mL, 1 
mg/mL, 5 mg/mL 
DPPH 
Reducing power 
Retardation of pig oil 
oxidation 
The addition of GTE to the film remarkably increased the antioxidant 
activity of the film. This activity also increased with the concentration 
of GTE used. In the same way, the reducing power of films 
incorporated with GTE was much higher than that from the film alone. 
(165) 
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When POV was evaluated, the addition of GTE to the film induced a 
retardation of lipid oxidation. 
  EVOH 
GTE 5% w/w 
DPPH Films containing GTE presented the highest AA when compared with 
the film alone and films containing oregano EO, being this activity 
derived from its content in catechins. 
(79) 
Lemongrass Cymbopogon 
citratus 
Fish skin gelatine (tilapia) 
(3.5%) 
Surfactants: Soy lecithin, 
Tween-20, Tween-80 
EO 1:1 
DPPH 
TEAC 
FRAP 
Films incorporated with lemongrass EO and any of the surfactants 
presented DPPH and ABTS radical-scavenging activities, although it 
was lower than those from films added with basil or citronella EOs. 
With respect to the reducing power, lemongrass-films presented the 
highest activity when films were prepared with Tween-20 or Tween-
80. Nevertheless, films prepared with soy lecithin as surfactant 
presented the best antioxidant activity. 
(158) 
Oregano Origanum 
vulgare 
Hake proteins 
(cape hake)  
EO 0.001:4 
DPPH 
Reducing power 
The DPPH radical-scavenging activity of films incorporated with 
oregano EO was lower than that presented by the free EO, although it 
increased the antioxidant ability of the film. This also occurred when 
the reducing power of the film was studied and compared with the free 
EO. In both studies, oregano EO resulted less effective than clove EO. 
(91) 
  Bovine hide gelatine (5%) 
EO 6000 ppm 
FRAP 
DPPH 
Films incorporated with oregano EO presented the highest AA through 
the FRAP and the DPPH assays compared with films incorporated with 
lavender EO and control films. However, the AA of films was lower 
than that presented by the EO alone, possibly due to the interactions 
between the components of the EO and the proteins from the film. 
(92) 
  EVOH 
EO 5% w/w 
DPPH Films containing oregano EO presented a lower AA than films 
containing GTE. 
(79) 
 Zataria 
multiflora 
CMC (1%) 
Surfactants: Tween-80 
EO 1%, 2% 
 
DPPH The AA of films incorporated with oregano EO increased with the 
increment in EO concentration. Thus, the film containing 3% EO 
presented the highest AA. 
(153) 
 Corydothymus 
capitatus 
Alginate-Polycaprolactone 
(3%-1%) 
EO 1% 
DPPD The antiradical activity of films incorporated with oregano EO 
increased significantly in respect to the control group. Thus, the 
increment for AP-OEO-films was 3 times higher than ascorbic acid. 
(82) 
Rosemary Rosmarinus 
officinalis 
Chitosan (2%) 
Surfactant: Tween-80 
(0.2%) 
EO 0.5%, 1%, 1.5% 
Folin-Ciocalteu test Total phenol content of chitosan film increased significantly by 
incorporating rosemary EO. 
(166) 
  Chitosan-Clay (2%-1%, Folin-Ciocalteu test Total phenol content of chitosan-clay films increased significantly by (167) 
Page 72 of 98
URL: http:/mc.manuscriptcentral.com/lfri  Email: rwhartel@wisc.edu
Food Reviews International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
3%, 5%) 
Surfactant: Tween-80 
(0.2%) 
EO 0.5%, 1%, 1.5% 
incorporating rosemary EO. Moreover, the best values were reached 
using a film formulated with clay 3% and EO 1.5%. 
Thyme Thymus 
vulgaris 
Chitosan (2%) 
EO 0.2%, 0.4%, 0.6%, 
0.8%, 1%, 1.2% 
TEAC Incorporation of 0.2 and 0.4% thyme EO to the chitosan film did not 
significantly affect the antioxidant activity. However, the addition of 1 
and 1.2% of thyme caused a more marked antioxidant activity (4 and 8 
times, respectively) than the control film. The antioxidant compounds 
were released from the film in the first 2 minutes, except from the film 
with the higher content of thyme EO. 
(168) 
  Quince seed mucilage 
(1%) 
Surfactant: Tween-80 
(0.2%) 
EO 1%, 1.5%, 2% 
Folin-Ciocalteu test 
DPPH 
QSM films showed radical-scavenging activity, although films 
incorporated with thyme EO exhibited a higher activity, directly 
proportional to the quantity of EO added to the film. The phenolic 
content of the films presented a linear correlation with the DPPH assay. 
(40) 
 Thymus 
kotschyanus 
Starch-Chitosan (1.75%-
1%) 
Surfactant: Tween-80 
(0.2%) 
EO 0.5%, 1%, 2% 
Folin-Ciocalteu test 
DPPH 
The DPPH radical-scavenging activity of the S-Ch films significantly 
was increased with increasing thyme EO concentration (0-2%). In the 
same way, the total phenolic content in the films significantly increased 
with the EO concentration. 
(169) 
Abbreviations: DPPH:2,2-diphenyl-1-picryhidrazyl; TEAC: Trolox-equivalent antioxidant capacity; FRAP: ferric reducing antioxidant power; DPPD: n.n´-diphenyl-p-
phenylenediamine; ABTS: 2,2´-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid); TBARS: thiobarbituric acid reactive species; ORAC: oxygen radical absorbance capacity; 
POV: peroxide value 
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Table 3. Antioxidant activity of films incorporated with the main compounds from essential oils. 
Compound Film 
Antioxidant Assay-
Food Matrix (FM) 
Observations References 
Carvacrol Gelidium corneum 
Carvacrol 0.4%, 0.6%, 1% 
TBARS 
FM: ham 
Ham samples packaged with films containing 0.6% carvacrol showed 
lower lipid peroxidation than control films, being significative this 
difference after 9 days of storage.  
(170) 
 Linear low density polyethylene-
Corn-zein (20%) 
Carvacrol 1.5%, 3%, 5% 
DPPH 
 
DPPH radical-scavenging assay showed an exponential increased 
liberation of carvacrol with storage time, being this activity 
concentration-dependent. 
(171) 
 Chitosan (2%) 
Surfactant: Tween-80 
Carvacrol 0.5%, 1%, 1.5% 
DPPH 
TEAC 
The antioxidant capacity of films increased at a rate of 4.8, 4.7, and 2.6 
from 1.5% to 0.5%. In the TEAC assay, this increasing rate was 4.82, 
4.78, and 4.62 from 1.5% to 0.5%. 
(172) 
 Polypropylene 
Carvacrol 8% 
DPPH The antioxidant activity of films incorporated with carvacrol resulted to 
be lower than those added with thymol. 
(173) 
Catechin Gelidium corneum (1.5%) 
Catechin 0.05%, 0.1%, 0.15% 
 
TBARS 
FM: sausages 
The TBARS values increased with increasing storage time. However, 
sausages packed with films containing GTE showed a significant 
decrease in TBARS values compared to the control, especially after 12 
days. 
(174) 
 PVA-Starch 
Catechin 167, 500, 667, 1000, 2000 
ppm 
 
TBARS 
FM: soybean oil 
The TBARS values of all treated oil samples were less than those for 
the control. A significant retardation of the lipid peroxidation was 
observed in films added with 500 or 667 ppm GTE. Films incorporated 
with 167 ppm GTE did not present any antioxidation pattern. 
(175) 
 Zein (0.17 g/mL) 
Catechins 0.75, 1.5, 2.25, 3, 4.5, 6 
mg/cm
2
 film 
TEAC Catechins-added films resulted to present less antioxiodant activity 
than films incorporated with gallic acid. Thus, the TEAC values from 
GA released from 1.5 to 3 mg/cm
2
 phenolic containing films were 3.6 
and 4.1 fold higher than the TEAC values from catechin. 
(176) 
 Poly(L-lactic acid) 
Catechin 17.6 mg/g 
DPPH PLLA films containing catechin showed a higher percentage of 
scavenging the DPPH than an extract with the same catechin 
concentration and also than the control film. 
(177) 
 Chitosan (4%) 
Catechin 10%, 20%, 30%, 40% 
Folin-Ciocalteu test 
DPPH 
After incorporating catechin, the content of polyphenols increased 
significantly in respect to control film. This content increased with the 
concentration of catechin used. The radical-scavenging activity of films 
incorporated with catechin correlates with this content. 
(178) 
 Gelatin (3%) TBARS Stored samples suffered a TBARS increment during the storage. (179) 
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Catechin 0.5% FM: minced pork However, sample wrapped with the gelatine-catechin film presented a 
non significant increment. Nevertheless, the oxidation was not 
inhibited, possibly due to the low migration rate of catechins to food. 
 Methylcellulose (2%) 
Catechin 0.5%, 1%, 2% 
DPPH 
TEAC 
 
Films incorporated with catechins resulted to be effective in 
scavenging free radicals. Films incorporated with 0.5 and 1% catechins 
presented a better AA for both assays than those incorporated with 2% 
catechins. 
(180) 
Epicatechin Poly(L-lactic acid) 
Epicatechin 21.38 mg/g 
DPPH PLLA films containing epicatechin showed a higher percentage of 
scavenging the DPPH than an extract with the same catechin 
concentration and also than the control film. 
(177) 
Eugenol Linear low density polyethylene-
Corn-zein (20%) 
Eugenol 1.5%, 3%, 5% 
DPPH 
TBARS 
FM: beef patties 
DPPH radical-scavenging assay showed an exponential increased 
liberation of eugenol with storage time, being this activity 
concentration-dependent.  Moreover, TBARS content in patties 
increased during the storage, although concentrations of 0.3% or 3% 
eugenol where enough for significantly decreasing this levels in respect 
to control group. 0.3% eugenol was sufficient to retard lipid oxidation. 
(171) 
Quercetin Chitosan (1%) 
Quercetin 
TEAC The test film showed strong inhibitory capacity to ABTS radicals, 
although quercetin per se presented the highest antioxidant activity. 
Chitosan films alone also showed radical-scavenging activity. 
(181) 
 EVOH (29%) 
Quercetin 5% 
DPPH 
TBARS 
FM: brined sardines 
The radical-scavenging activity of films incorporated with quercetin 
was proportional to the concentration released in the different 
simulants, being higher in those lipophilic simulants. Quercetin-films 
showed a protective role against lipid oxidation, although films 
incorporated with green tea extract showed a better profile (TBARS). 
(162) 
Thymol Linear low density polyethylene-
Corn-zein (20%) 
Thymol 1.5%, 3%, 5% 
DPPH 
 
DPPH radical-scavenging assay showed an exponential increased 
liberation of thymol with storage time, being this activity 
concentration-dependent. 
(171) 
 Bovine gelatine (10%) 
Thymol 1%, 2%, 4%, 8% 
TEAC Thymol-added films showed a concentration-dependent radical-
scavenging activity. 
(182) 
 Polypropylene 
Thymol 8% 
DPPH The antioxidant activity of films incorporated with thymol resulted to 
be higher than those added with carvacrol. Moreover, the best results 
were obtained in isooctane as simulant. 
(173) 
Carvacrol/Thymol Polypropylene 
Carvacrol-Thymol 4%-4% 
DPPH The combined activity of carvacrol and thymol added to films resulted 
to present some additive effect of both compounds, with similar 
radical-scavenging activity than compounds separately. 
(173) 
Abbreviations: TBARS: thiobarbituric acid reactive species; DPPH:2,2-diphenyl-1-picryhidrazyl; TEAC: Trolox-equivalent antioxidant capacity. 
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Table 4. Cytotoxic effects of the main essential oils intended to be used in food active packaging. 
Plant Main compound 
Experimental 
model 
Assays 
performed 
Exposure conditions Observations References 
Basil (Ocimum 
basilicum) extract 
 HepG2 MTT  2.5-50 µg/mL 
24 h 
The extract was not cytotoxic at the 
conditions assayed 
(101) 
Basil (Ocimum 
basilicum) extract 
Water extract from 
basil 
SH-SY5Y 
CV1-P  
MTT 
LDH 
0.01-2 mg/mL 
12, 24 h 
Extract from basil only significantly 
decreased the metabolic activity of SH-
SY5Y cells after 12 h of treatment (2 
mg/mL). Similarly, cell death was only 
observed at the highest concentration 
assayed 
(114) 
Basil (Ocimum 
basilicum) leaf 
extract 
EO from leaf and leaf 
extract 
AsPC-1 
MiaPaCa 
MTT Ethanolic extract: 0.8 
and 80 µg/mL 
EO: 0.001% and 
0.1% v/v 
24, 48, 72, 96, 120, 
144,168 h 
The highest dose of both treatments 
significantly inhibited the proliferation of 
cells over time. Higher effects were 
observed after exposure to the extract in 
comparison to the EO in both cells 
(118) 
Cinnamon 
(Cinnamomum 
cassia) extract 
Water soluble 
cinnamon extract 
B16F10, 
Clone M3, 
HeLa, 
Caco-2 
EZ-Cytox cell 
viability assay 
kit 
0.5 mg/mL 
48, 72 h 
Cinnamon extract strongly inhibited 
tumor cell proliferation in vitro 
(183) 
Citronella 
(Cymbopogon 
winterianus) EO 
 Human 
lymphocytes  
TBET 
MTT 
100-2000 µg/mL 
3 h 
Cell viability showed a concentration-
dependent decrease when they were 
exposed to the EO, being significant at 
the highest concentrations assayed (1500 
and 2000 µg/mL) 
(111) 
Coriander 
(Coriandrum 
sativum) leaf 
extract 
Linalool (75.4%), 
camphor (5.1%), γ –
terpinene (4.9%), α-
pinene (4.8%), 
geranyl-acetate (3%), 
geraniol (2.8%), 
limonene (2.7%) 
293Q  
WRL-68 
MTT 0.4-8 µg/mL 
24 h 
Whereas low concentration of the extract 
(0.4 and 0.8  µg/mL) induced cell 
proliferation, higher concentrations (3.2 
to 8 µg/mL) reduced cell survival by 
60% or more 
(184) 
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Coriander 
(Coriandrum 
sativum) extract 
 RAW 264.7 MTT 100 µg/ml with either 
the ethyl acetate, 
chloroform, or 
methanol fractions of 
coriander 
48 h 
The cytotoxicity of the extracts was 
different with the ethyl acetate fraction 
being the most toxic (27.9 % cell 
viability) and the chloroform fraction the 
less (47.1% of living cells) 
(185) 
Garlic oil Diallyl disulfide  
(56.6%), methyl allyl 
disulfide (12.2%), 
methyl allyl trisulfide 
(12.0%), diallyl 
trisulfide (11.8%)  
HL-60 TBET 
LDH leakage 
0-100 µg/mL 
96 h 
Garlic oil inhibited cell proliferation in a 
concentration-dependent way. However, 
no cytotoxic effect was observed in the 
LDH leakage assay 
(186) 
Garlic extracts of 
two regions of Italy 
Water garlic extracts HepG2 TBET 0.1 , 0.5 and 1% 
12, 24, 36, 48 h 
Water garlic extracts showed more 
inhibitory power in the growth of cells 
than the oil-soluble isolated compound 
diallyl disulfide 
(99) 
Garlic extract Commercially 
purchase 
NCI-H460  
NCI-H1299 
MTT 0-200 µg/mL 
1 h 
The growth of both cells was slightly 
inhibited 
(121) 
Green Tea 
(Camellia sinensis) 
extract 
Epicatechin (EC), 
epicatechin-3-gallate 
(ECG), 
epigallocatechin 
(EGC), 
epigallocatechin 3-
gallate (EGCG) 
3T3-L1 MTT 2, 4, 8 % of extract in 
film  
24 h 
Only the exposure to the film with 2% 
resulted in cell viabilities over 50% 
(89) 
Green Tea 
(Camellia sinensis) 
extract 
EC, ECG, EGC, 
EGCG and theaflavin 
HepG2 TBET 
MTT 
2-80 µg/mL 
24, 48, 72, 96 h 
A concentration and time-dependent 
decrease in cell proliferation was 
observed. Significant reduction in 
metabolic activity was observed in cells 
treated with 10 µg/mL and above 
(107) 
Lemongrass 
(Cymbopogon  
citratus ) EO 
 Human 
lymphocytes  
TBET 
MTT 
100-2000 µg/mL 
3 h 
Cell viability showed a concentration-
dependent decrease when they were 
exposed to the EO, being this reduction 
significant at the highest concentrations 
assayed (1500 and 2000 µg/mL) 
(111) 
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Marjoran 
(Majorana 
hortensis) extract 
RA (7.87%), luteolin-
7-O-glucuronide 
(3.95%), caffeic acid 
(1.12%) 
MCF-7/Adr 
MCF-7 
MTT 8-2000 mg/L of dried 
aqueous extracts 
48 h 
The dried aqueous extract of marjoram 
showed at low concentrations 
stimulatory impact on the viability of the 
wild-type MCF-7 cells, increasing the 
percentage of living g cells in 20-50%. 
The calculated EC50 was 220 mg/L 
(187) 
Onion oil Dipropyl disulfide 
(42.1%), dipropyl 
trisulfide (30.8%), 
methyl propyl 
trisulfide (9.9%), 
methyl propyl 
disulfide (5.9%)  
HL-60 TBET 
LDH leakage 
0-100  µg/mL 
96 h 
Onion oil inhibited this proliferation in a 
concentration-dependent way. However, 
LDH leakage from the cells was not 
significantly influenced 
(186) 
Onion (Allium cepa 
) peel extract 
p-Coumaric acid 
(583.2 ± 9.4 µg/g), 
vanillic acid (245.0 ± 
3.5 µg/g), epicatechin 
(275.0 ± 3.3 µg/g), 
morin (158.7 ± 5.7 
µg/g) 
HT-29 MTT 
LDH leakage 
0-250 µg/mL 
24 h 
The cell viability decreased in a dose-
dependent manner 
(113) 
Origanum 
majorana extracts 
 Jurkat LDH release 
WST-1 
0-8 mg/mL 
48, 96 h 
The oregano extract decreased the 
viability of cells in a dose-dependent 
manner. IC50 of approximately 8 and 
5mg/mL after 48 and 96 h, respectively 
(119) 
Origanum onites 
EO 
Linalool (50.53%), 
carvacrol (24.52%), 
thymol (15.66%) 
HepG2 CellTiter-Blue® 
Cell Viability 
0-200 µg/mL 
24 h 
Cell viability decreased in a 
concentration-dependent way. The EO 
was found to be less cytototoxic (IC50: 
149.12 µg/mL) than carvacrol and 
thymol (IC50:53.09 and 60.01 µg/mL, 
respectively) 
(104) 
Origanum onites 
EO 
Carvacrol (64.3%), 
linalool (13.8%), ρ-
cymene (7.1%), γ-
terpinene (3.5%), 
thymol (1.4%) 
5RP7 
RATE 
MTT 0-500 µg/mL  
24, 48, 72, 96 h 
A concentration and time-dependent 
decrease on cell viability at 125, 250 and 
500 µg/ml concentrations in both cell 
lines was observed. In addition, the 
results indicated 5RP7 cells were more 
sensitive to this EO than RATECs. 
(188) 
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Origanum vulgare 
extract 
RA (31.8% of 
identified phenol), ρ-
couraaric acid (0.81% 
of identified phenol), 
carvacrol (0.75% of 
identified phenol) 
Caco-2 MTT - 300/500 µg/mL 
oregano extract  
- Mix: a mixture of 
gallic acid, catechin, 
chlorogenic acid, 
caffeic acid, p-
coumaric, RA, 
carvacrol 
 
Oregano: 12, 24, 48, 
72 h / Mix: 24 h 
Oregano extract exerted cytotoxic effects 
on cancer cells in a concentration- and 
time-dependent manner. 
However, the mixture of the main 
compounds present in the extract induced 
significant toxic effects only at the 
highest concentration induced 
(103) 
Palmarosa 
(Cymbopogon 
martini) EO 
 Human 
lymphocytes  
TBET 
MTT  
100-2000 µg/mL 
3 h 
Cell viability showed a concentration-
dependent decrease, being this reduction 
significant at the highest concentrations 
assayed (1500 and 2000 µg/mL) 
(111) 
Rosemary 
(Rosmarinus 
officinalis) extracts 
Two extracts: 
- AquaROX® 15: RA 
(17%) 
-  VivOX® 40: 
carnosic acid 
(50.27%) and 
carnosol (5.65%) 
HepG2 MTT 0.5-100 µg/mL 
21 h 
0.5-100µg/ml of AquaROX® 15 extract 
had no effect on cell viability, while 
VivOX® 40 extract at  concentrations 25 
µg/ml and higher (25-100 µg/ml), 
significantly decreased cell viability 
(106) 
Rosemary 
(Rosmarinus 
officinalis.) extract 
RA ,carnosol, 
carnosic acid 
A2780 MTT 1/400 - 1/1200 
dilution of rosemary 
ethanol extract 
48 h 
The antiproliferation activity was 
influenced by the treatment of the EO 
extract. The filtrate following 
ultrafiltration centrifugation reduced 
proliferation while dialysis treatment 
cancelled this effect 
(127) 
Rosemary 
(Rosmarinus 
officinalis) extract 
Ursolic acid (190.0 
mg/g dry extract), 
oleanolic acid (89.7 
mg/g dry extract), 
betulinic acid (46.9 
mg/g dry extract) 
RINm5F MTT 12-100 µg/mL 
24 h 
Significant decrease in cell viability was 
observed from 25 µg/mL. The calculated 
IC50 was 35.6 µg/mL 
(189) 
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Thyme (Thymus 
zygis subsp. 
sylvestris) EO 
Carvacrol (25.0%), 
thymol (23.8%), 
geranyl acetate 
(20.8%), geraniol 
(19.8), linalool 
(30.0%) 
FSDC MTT 0.08–0.32 µL/mL 
3 and 24 h 
Only the highest concentration of EO 
decreased significantly cell viability after 
3 h of exposure, being this reduction 
extremely significant after 24 h 
(190) 
Thyme (Thymus 
serpyllum) extract 
RA (19.3%), luteolin-
7-O-glucuronide 
(10.1%), lithospermic 
acid (6.27%), caffeic 
acid (0.29%) 
MCF-7/Adr  
MCF-7 
MTT 8-2000 mg/L of dried 
aqueous extracts 
48 h 
Increased in viability of the wild-type 
MCF-7 cells was observed, enhancing 
the percentage of living g cells in 10-
40%. The calculated EC50 was 399 
mg/L 
(187) 
Thyme (Thymus 
serpyllum) extract 
RA (14.72 mg/g dry 
weight (d.w.), 
salvanolic acid K 
isomer (3.10 mg/g 
d.w.), diglucosyl-
apigenin (2.22 mg/g 
d.w.), luteolin-
hexoside (2.04 mg/g 
d.w.) 
HepG2 MTT 0-100 mg/mL 
24 h 
A concentration-dependent decrease was 
observed. The calculated IC50 value was 
4.3 mg/mL 
(108) 
Thyme (Thymus 
vulgaris) extract 
RA (15.1%), luteolin-
7-O-glucuronide 
(6.64%), caffeic acid 
(0.43%) 
MCF-7/Adr  
MCF-7 
MTT 8-2000 mg/L of dried 
aqueous extracts 
48 h 
Stimulation in the viability of the wild-
type MCF-7 cells was observed at the 
lowest concentration, increasing the 
percentage of living g cells in 10–60%. 
The calculated EC50 was 407 mg/L 
(187) 
Thyme (Thymus 
vulgaris) EO 
Thymol (36.1%), ρ-
Cymene (22.1%), γ-
Terpinene (10.1%) 
Differentiated PC12 
cells normal and 
with downregulated 
Mgst1 (PC12_M) 
TBET 100 and 400 µM 
24 h 
In PC12_M line a significant decrease in 
the number of viable cells was detected 
only after treatment with 400 mM thyme 
oil 
(191) 
Cell lines: AsPC-1: Human pancreatic adenocarcinoma cell line; A2780: human ovarian carcinoma cell line; Caco-2: human colorectal adenocarcinoma cell line; Clone M3: 
mouse melanoma cell line; CV1-P: green monkey kidney fibroblast cell line; FSDC: mouse fetal skin dendritic cell line; HeLa: human cervical epithelial adenocarcinoma cell 
line; HepG2: human liver hepatocellular carcinoma cell line; HL-60: human promyelocytic leukemia cell line; HT-29: human colon epithelial carcinoma cell line; Jurkat: 
human lymphoblast acute T cell leukemia cell line; LO2: human fetal normal liver cell line; MCF-7: human breast adenocarcinoma cell line; MCF-7/Adr: adriamycin-
resistant  human breast adenocarcinoma cell line; MiaPaCa: human epithelial pancreatic carcinoma cell line; NCI-H1299: non small cell lung cancer cell line lacking p53 
gene; NCI-H460: non small cell lung cancer cell line; PC12: rat adrenal gland cell line; RATEC: rat adipose tissue endothelial cell line; RAW 264.7: murine monocytic 
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lineage cell line; RINm5F: rat insulinoma cell line; SH-SY5Y: human neuroblastoma cell line; WRL-68: human fetal liver epithelial cell line; 293Q: human fetal kidney 
epithelial cell line; 3T3-L1: fibroblast cell line; 5RP7: c-H-ras transformed rat embryonic fibroblasts cell line. 
Other abbreviations: d.w.:  dry weight; EC: epicatechin; ECG: epicatechin-3-gallate; EO: essential oil; EGC: epigallocatechin; EGCG: epigallocatechin 3-gallate; LDH: 
lactate dehydrogenase; IC50: median inhibitory concentrations that cause approximately 50% cell death; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 
NRU: neutral red uptake; TBET: Trypan blue exclusion test; WST-1: 4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate]; RA: rosmarinic acid. 
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Table 5. Cytotoxic effects of the main components from essential oils intended to be used in food active packaging. 
Main compound Experimental model 
Assays 
performed 
Exposure 
conditions 
Observations References 
Apigenin HepG2 MTT  0-100 µM 
24, 48, 72 h 
At concentrations greater than 10 µM, apigenin decreased cell 
survival in a concentration and time-dependent way 
(109) 
Carvacrol HepG2 TPC 
NRU 
0.03-3.12 mM 
48 h 
Carvacrol inhibited the viability and proliferation of HepG2 cells in 
a concentration-dependent manner, being the IC50 around 0.2 mM) 
in the proliferation test 
(98) 
A549 Cell number 
TPC  
0-1000 µM  
24 h 
Exposure to 250, 500 and 1000 µM carvacrol decreased cell 
number and TPC. Although cell number increased in 100 µM 
treated plates 
(192) 
CO25 MTT 1-150 µg/mL 
24, 48, 72 h 
Carvacrol inhibited growth of myoblast cells in a concentration-
dependent way. IC50 value for CO25 myoblast cells was 
determined as 60 µg/mL. 
(193) 
HepG2 
Caco-2 
TBET 0-900 µmol  
24 h 
A concentration-dependent decrease was observed in both cell 
types 
(194) 
IPEC-1 MTT  0-1000 µM 
48, 96 h 
Carvacrol inhibited the proliferation of purified lymphocytes with 
an IC50 of 182 ± 67 µM 
(195) 
Caco-2 MTT  0.7 and 1.4 µg/mL 
24 h 
The highest concentration assayed significantly decreased cell 
viability 
(103) 
MDA-MB231 MTT  20,40,80,100 µM  
24, 48 h 
A dose-dependent decrease in the growth of cells was observed. 
The IC50 of carvacrol was determined to be 100 µM at 48h 
(123) 
5RP7 
CO25 
TBET  
MTT 
0-0.1 mg/mL 
24, 48 h 
A time- and dose-dependent cytotoxic effects was recorded in both 
cells, being the IC50 0.04 mg/mL  for 5RP7 cells in both exposure 
times, and  0.1 mg/mL for 24 h and 0.05 mg/mL for 48 h in CO25 
cells 
(196) 
HeLa  
SiHa 
MTT  
LDH release  
0-500 µg/mL 
48 h 
Dose-dependent cytotoxic effect was recorded. The IC50 obtained 
in MTT and LDH both assays were around 50 µg/mL in both cells 
lines 
(197) 
HepG2 CellTiter-Blue® 
Cell Viability  
0-200 µg/mL 
24 h 
Cell viability decreased in a concentration-dependent way. The 
IC50 value was 53.09 µg/mL 
(104) 
HepG2  
LO2 
MTT  0–0.4 mmol/L 
24 h 
No significant effect on LO2 cell viability was observed. However, 
after a similar treatment of HepG2 cells, the viability decreased in 
(105) 
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a concentration-dependent way, with an IC50 around 0.4 mmol/L 
DBTRG-05MG WST-1  0–1000 µM 
24 h 
Carvacrol was cytotoxic to human glioblastoma cells in a 
concentration-dependent manner 
(198) 
Cultured primary rat 
neurons 
N2a cells 
MTT  0-400 mg/L 
24 h 
Only the high doses of carvacrol (200 and 400 mg/L) exhibited an 
highly cytotoxic effect on both cell cultures 
(199) 
HepG2 TBET  
MTT  
0–1000 µM 
24 h 
Carvacrol decreased  HepG2 cell viability in a concentration 
dependent manner, reaching a maximum cytotoxic effect at 500-
600 µM 
(200) 
Caco-2 TPC  
NRU 
MTS  
0-2500 µM 
24, 48 h 
A concentration and time-dependent decrease was observed. The 
EC50 was set at 460 µM after 24 h 
(110) 
S(+)-carvone HepG2 TPC 
NRU  
0.06- 3.21 mM 
48 h 
Carvone inhibited viability and proliferation of HepG2 cells in a 
concentration-dependent manner. The IC50 ranged from 0.47 mM 
in the proliferation test to 0.62 mM in viability test 
(98) 
Catechin gallate CAL27 
HSG 
S-G 
HGF-1 
NRU  0-250 µM 
24, 48, 72 h 
The calculated EC50 values in S-G cells, for the 1, 2 and 3 days of 
exposure were 127, 67 and 58 µM, respectively. The EC50 for 
other cells were 62 µM, 90 µM and 132 µM for CAL27, HSG and 
HGF-1 cells, respectively 
(117) 
Catechin  S-G NRU  0-500 µM 
72 h 
After  3 days of exposure the calculated EC50 value was 500 µM (117) 
Cinnamaldehyde HepG2 TPC  
NRU  
0.16-0.53 mM 
48 h 
Cell viability and proliferation of HepG2 cells was inhibited in a 
concentration-dependent manner, being the IC50 around 0.3 mM in 
both assays 
(98) 
Citral Human lymphocytes  TBET  
MTT  
25-800 µg/mL 
3 h 
Cell viability showed a concentration-dependent decrease, being 
significant from 100 µg/mL 
(111) 
DADS HCT-15 
A549 
SK MEL-2 
TBET 0-500 µM 
48 h 
A marked growth inhibition after exposure to 100 µM DADS was 
observed, being skin cells the most sensitive and lung cells the less 
sensitive 
(96) 
NCI-H460  
NCI-H1299 
MTT 0-50 µM 
1 h 
The growth of both cells was significantly inhibited by DADS (121) 
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PC-3 TBET 0-40 µM 
24, 48, 72 h 
The viability was reduced in a concentration-dependent manner 
upon 24 h. Cells exposed to the highest concentration underwent 
significant reductions 
(201) 
HepG2 TBET 
 NRU  
0-100 µM 
4 , 20 h 
None of the concentrations assayed was found to affect cell 
viability 
(202) 
HepG2 TBET 0-50 µM 
12, 24, 36, 48 h 
The oil-soluble isolated compound DADS showed lower inhibitory 
of the growth of in HepG2 than water garlic extracts 
(99) 
U937 FCA 0–100 µM 
72 h 
Significant cell death was only observed in cells exposed to the 
highest concentration assayed 
(203) 
U937 MTT  0–300 µM 
48 h 
No effect on cell viability was recorded after 48 h of exposure (204) 
DAS 
 
NCI-H460 
NCI-H1299  
MTT 0-50 µM 
1 h 
The growth of both cells was significantly inhibited by DAS  (121) 
PC-3 TBET 0-40 µM  
24, 48, 72 h 
The viability of PC-3 cells was only reduced significantly after 72 
h to 40 µM DAS 
(201) 
HepG2 TBET  
NRU  
0-100 µM 
4, 20 h 
None of the concentrations assayed was found to affect cell 
viability 
(202) 
U937 FCA 0–100 µM 
72 h 
No effect on cell proliferation was observed in cells exposed to up 
to 100 µM DAS 
(203) 
U937 MTT  0–300 µM 
48 h 
No effect on cell viability was recorded after 48 h (204) 
ARO MTT   0–400 µM 
24 h 
DAS treatment inhibited the proliferation of ARO cells in a dose-
dependent manner 
(122) 
DATS  PC-3 TBET 0-40 µM 
24, 48, 72 h 
Cell viability was dramatically reduced from 24 h of exposure at all 
concentrations assayed 
(201) 
MCF-7 MTT  0-50 µM 
24 h 
DATS-induced cytototoxicity can be attenuated by an inhibitor of 
c-Jun N-terminal kinase 
(205) 
Diallyl 
thiosulfinate 
U937 FCA 0–100 µM 
72 h 
No effect on cell proliferation was observed in cells exposed to up 
to 100 µM of this compound 
(203) 
Dimethyl 
thiosulfinate 
U937 FCA 0-100 µM 
72 h 
Living cells were dramatically reduced from 2-5 µM, with an 
increase in the dead cells number at 5 µM 
(203) 
DPDS 
 
HCT-15 
A549 
TBET 0-500 µM 
48 h 
Both lung and skin tumor cell lines were not sensitive to the 
addition of 100 µM DPDS 
(96) 
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SK MEL-2 
PC-3 TBET 0-160 µM  
24 h 
The viability of PC-3 cells was not affected, even at 160 µM 
concentration after 24 h 
(201) 
U937 FCA 0–100 µM, 
72 h 
No effect on cell proliferation was observed  (203) 
Caco-2 TPC  
NRU 
MTS 
0-200 µM 
24, 48 h 
No effect in cell viability was recorded (206) 
DPS PC-3  TBET 0-160 µM  
24, h 
The viability of PC-3 cells was not affected (201) 
Caco-2  TPC  
NRU 
MTS 
0-200 µM 
24, 48 h 
No remarkable changes in cell viability was observed at any 
exposure time and concentrations assayed 
(206) 
Dipropyl 
thiosulfinate 
U937  FCA 0-100 µM 
72 h 
Living cells were dramatically reduced from 2 µM (203) 
Epicatechin (EC) S-G  NRU 0-500 µM 
72 h 
For a 3-day exposure, the calculated EC50 value was 500 µM EC (117) 
Epicatechingallate 
(ECG) 
S-G  NRU  0-50 µM 
72 h 
The overall cytotoxicity of ECG was similar to its epimer, 
catechingallate. For a 3-day exposure of this compound, the 
calculated EC50 value was 36 µM ECG 
(117) 
Epigallocatechin 
(EGC) 
S-G  NRU  0-500 µM 
72 h 
For a 3-day exposure, the calculated EC50 value was 324 µM EGC (117) 
EGCGEGCG S-G  NRU 0-150 µM 
72 h 
For a 3-day exposure, the calculated EC50 value was 80 µM 
EGCG 
(117) 
U87 
U251 
LN229 
MTT  
colony-
formation 
1-100 µM 
48 h 
EGCG at concentrations ranging from 1 to 100 µM did not 
substantially reduce cell survival in MTT assays. In contrast, 100 
µM was able to completely prevent colony formation, and the IC50 
was slightly below 50 µM 
(207) 
A431  
SCC13  
MTT  
TBET 
10- 60 µg/mL 
24, 48, 72 h 
EGCG was cytotoxic on skin cancer cells, but is not cytotoxic for 
normal skin cells. However, TBET evidenced cell death at 60 
µg/mL in both cells 
(130) 
Estragole V79 
CHO  
MTT  0-3 mM 
24 h 
Concentration-dependent decrease in cell viability was observed in 
both cells 
(208) 
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Eugenol AA8 
EM9  
MTT  0-800 µM 
3, 24 h 
Concentration-dependent decrease in viability was observed in 
both cells exposed to eugenol. No significant reduction in cell 
viability was found after 3 h of treatment, although it was reduced 
below  50% when cells were treated  for 24 h with concentrations 
higher than 500 µM or 1000 µM, for AA8 and EM9 cells, 
respectively 
(209) 
Geraniol Human lymphocytes  TBET  
MTT  
25-800 µg/mL 
3 h 
Cell viability showed a concentration-dependent decrease  (111) 
Limonene SH-SY5Y  FCA 750 µM 
24 h 
Reduced cell viability was only observed in cells cotreated with 
limonene and linalyl acetate 
(124) 
Linalool 
 
HepG2  
NC–NC  
MTT  0.065, 0.65, 6.5 and 
64.8 µM 
20 h 
No significant effect on cell viability was observed after all 
exposures. However, incubation of NC–NC cells with 64.8 µM 
reduced their viability by about 80% 
(210) 
HepG2 
MCF7 
Hek293 
NIH3T3  
Caco-2 
TBET,  
MTT  
NRU  
0-4 µM 
24 h 
HepG2 cells were most sensitive to linalool (100% cell death at 
2µM), followed by Caco-2 cells (42% cell death at 2 µM). The 
viability of the rest of the cells was not affected. A concentration-
dependent decrease in HepG2 cells was also observed 
(112) 
Kasumi-1 
HL-60 
Molt-4 
Raji, K562 
 Jurkat 
NB4 
THP1 
U937 
KG-1 
L428 
MTT  20-640 µM 
48 h 
Linalool preferentially inhibited growth of a variety of leukemia 
cells with wild type p53 while sparing normal hematopoietic cells 
(120) 
RAW 264.7 MTT  40, 80, and 120 
mg/mL 
18 h 
Cells viabilities were not affected at the concentrations used (211) 
Linalyl acetate SH-SY5Y FCA 375 µM 
24 h 
No cytotoxic effect was induced at concentrations up to 500 µM (124) 
Lithospermic acid MCF-7/Adr  
MCF-7  
MTT 0.08 - 10 mM 
48 h 
Cells’ survival was lowered by around 60% at 0.63 mM, and by 
around 80% at 1.25 mM in the case of normal MCF cells. 
However, the extent of damage observed for MCF-7/Adr cells was 
(187) 
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lower 
RA 
 
Caco-2  MTT  30 and 60 µg/mL 
24 h 
Cell exposed to 30 µg/mL rosmarinic acid for 24 h remained 
unaltered. However the exposure to 60 µg/mL induced a significant 
reduced viability 
(103) 
A2780  MTT  2.5-10 µg/mL 
48 h 
No significant antiproliferative effect was observed  (127) 
MCF-7/Adr  
MCF-7  
MTT  0.08 - 10 mM 
48 h 
A marked toxicity was observed at 1.25 mM, decreasing cell 
viability by around 86%. Against the wild-type MCF-7 cells, a 
decrease in the number of living cells by 92% at 1.25 mM was 
observed 
(187) 
B16F10 
McCoy 
TBET  
NRU  
0.001-1000 µM 
24 h 
The viability of B16F10 cells was altered at 1000 µM RA. 
However, it was significantly deleterious for McCoy cells at 100 
and 1000 µM, reducing their viability to 70 and 35%, respectively. 
(212) 
N2A MTT  
LDH release 
0-500 µM 
12, 24 h 
Exposures to 1-250 µM for 24 h did not alter the viability. 
However, higher concentrations were found to be moderately toxic. 
Rosmarinic acid prevents H2O2-induced cell death and LDH 
leakage in N2A cells 
(213) 
Thymol 
 
HepG2  TPC 
NRU 
0.25-2.20 mM 
48 h 
Cell viability and proliferation decreased in a concentration-
dependent manner. The IC50 was around 0.7 mM in both assays 
(98) 
HepG2 
Caco-2  
TBET 0-900 µmol 
24 h 
A concentration-dependent decrease was observed, being HepG2 
more sensitive that Caco-2 cells 
(194) 
Primary cultures of 
cortical neurons 
MTT 
LDH release 
0-1 mM 
30 min and 24 h 
Thymol did not affect cell viability  (214) 
HL-60 
PBMC 
MTT  0-100 µM 
24 h 
Dose dependent cytotoxic effects were demonstrated on HL-60 
cells after 24 h; although no cytotoxic effect was observed in 
PBMC cells 
(125) 
DBTRG-05MG  WST-1  0–800 µM 
24 h 
In the presence of 200–600 µM thymol, cell viability decreased in a 
concentration dependent manner. At a concentration of 800 µM, 
thymol killed all cells 
(126) 
Hep G2  CellTiter-Blue® 
Cell Viability  
0-200 µg/mL 
24 h 
Cell viability decreased in a concentration-dependent way. The 
IC50 value was 60.01 µg/mL 
(104) 
Caco-2 TPC  0-250 µM No cytotoxic effect was evidenced (110) 
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Cell lines: AA8: Chinese hamster ovary epithelial cell line; ARO: human anaplastic thyroid carcinoma cell line; A2780: human ovarian carcinoma cell line; A431: human 
skin cancer cell line; A-549: human alveolar adenocarcinoma cell line; B16F10: mouse skin melanoma cell line; Caco-2: human colorectal adenocarcinoma cell line; CAL27: 
human tongue epithelial cell line; CHO: chinese hamster ovary cell line; CO25: N-ras transformed myoblast cell line; DBTRG-05MG: human glioblastoma cell line; EM9 : 
Chinese hamster ovary cell line; HCT-15: human colon tumor cell line; Hek293: human embryonic kidney cell line; HeLa: human cervical epithelial adenocarcinoma cell 
line; HepG2: human liver hepatocellular carcinoma cell line; HGF-1: human gingival fibroblasts cell line; HL-60: human promyelocytic leukemia cell line; HSG: human 
submandibular gland cell line; IPEC-1: porcine small intestine cell line; Jurkat: human lymphoblast acute T cell leukemia cell line; Kasumi-1: peripheral blood of an acute 
myeloid leukemia;  KG-1:  human macrophage  acute leukemia cell line; K562: human chronic myelogenous leukemia cell line; LN229: human glioblastoma epithelial cell 
line; LO2: human fetal normal liver cell line; L428: Hodgkin's lymphoma cell line; McCoy: mouse fibroblast cell line; MCF-7: human breast adenocarcinoma cell line; MCF-
7/Adr: adriamycin-resistant  human breast adenocarcinoma cell line; MDA-MB231: human metastatic breast cancer cell line; Molt-4: human acute lymphoblastic leukemia 
cell line; NB4: human promyelocytic leukemia cell line; NC-NC: human B lymphoblastoid cell line; NCI-H1299: non small cell lung cancer cell line lacking p53 gene; NCI-
H460: non small cell lung cancer cell line; NIH3T3: mouse fibroblast cell line; N2a: mouse neuroblastoma cell line; PBMC: human peripheral blood mononuclear cell line; 
PC12: rat adrenal gland cell line; PC-3: human prostate cancer cell line; Raji: human Burkitt's lymphoma cell line; RAW 264.7: mouse macrophage cell line; SCC13: human 
skin normal cell line; S-G: immortalized epithelioid cells; SH-SY5Y: human neuroblastoma cell line; SiHa: human cervical epithelial cancer cell line; SK MEL-2: human 
melanoma cell line; THP1: human acute monocytic leukemia cell line; U251: human glioblastoma cell line; U87: human glioblastoma epithelial cell line; U937: human 
leukemic monocyte lymphoma cell line; V79: chinese hamster lung cell line; 5RP7: c-H-ras transformed rat embryonic fibroblasts cell line. 
Other abbreviations: DADS: diallyl disulfide; DAS: diallyl sulfide; DATS: diallyl trisulfide; DPDS: dipropyl disulfide; EC: epicatechin; ECG: epicatechin-3-gallate; EGC: 
epigallocatechin; EGCG: epigallocatechin 3-gallate; FCA: flow cytometry analysis; LDH: lactate dehydrogenase; IC50: median inhibitory concentrations that cause 
approximately 50% cell death; NRU: neutral red uptake; MTS: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium salt); MTT: 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; RA: rosmarinic acid; TBET: Trypan blue exclusion test; WST-1: 4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-
tetrazolio-1,3-benzene disulfonate]; TPC: total protein content. 
NRU 
MTS 
24, 48 h 
Differentiated PC12 
cells normal and with 
downregulated Mgst1 
TBET 100 and 400 µM 
24 h 
No cytotoxic effects were observed after exposure (191) 
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Table 6. Cell death evaluation and morphological changes of the main essential oils intended to be used in food active packaging. 
Plant Main compound 
Experimental 
model 
Assays 
performed 
Exposure 
conditions 
Observations Reference 
Basil (Ocimum 
basilicum) leaf 
extract 
EO from leaf and 
leaf extract 
AsPC-1  
MiaPaCa 
Annexin V-FITC 
kit 
Hematoxylin and 
eosin staining 
and light 
microscope 
visualization 
Ethanolic extract: 
80 µg/ml 
EO: 0.1% v/v 
48 h 
The percentage of apoptotic cells was 
significantly higher upon treatment with the 
basil extract and EO.  Both exposures 
significantly inhibited the ability of pancreatic 
cells to migrate and close a scratch wound 
(118) 
Cinnamon 
(Cinnamomum 
zeylanicum) EO 
Eugenol (77%) Caco-2  PI staining and 
TUNEL assay 
0.01, 0.05 % 
1, 24 h 
The addition of the highest concentration 
increased the percentage of both necrotic 
(9.11%) and apoptotic (2.51%) cells after 1 h. 
After 24 h, cells led to general damage 
presented by 100% cell death. However, 0.01% 
of cinnamon oil showed no significant 
damaging effect even after 24 of exposure 
(100) 
Cinnamon 
(Cinnamomum 
cassia) extract 
Water soluble 
cinnamon extract 
B16F10 
Clone M3, 
HeLa  
Caco-2  
 
Annexin V-PE, 
inmunoblot, gen 
and protein 
expression 
0.5 mg/mL 
12, 24, 36, 48 h 
Cinnamon extract induced active cell death of 
tumor cells by up-regulating pro-apoptotic 
molecules while inhibiting NFκB and AP1 
activity and their target genes such as Bcl-2 and 
BcL-xL 
(183) 
Citronella 
(Cymbopogon 
winterianus) EO 
 Human 
lymphocytes  
FCA of annexin 
V-FITC/PI 
staining 
1000, 1500 and 
2000 µg/mL 
3 h 
Induction of considerable apoptosis (39.62%) 
was observed 
(111) 
Clove (Syzygium 
aromaticum) EO 
Eugenol (85%) Caco-2 PI staining and 
TUNEL assay 
0.01, 0.05 % 
1, 24 h 
The exposure to 0.05% for 1 h induced 18.04% 
of necrotic cells and 5.71% of apoptotic cells, 
reaching a 100% of death cells after 24 h. No 
significant damage was observed  after 24 of 
exposure to 0.01% 
(100) 
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Coriander 
(Polygonatum 
odoratum) extract 
8-methyl-
dihydrobenzopyran
one (8-methyl-
DBP), 8-methoxy-
dihydrobenzopyran
one (8-methoxy-
DBP) 
T47D  
MCF-7  
Western blot 
analysis 
Ethylacetate 
extract: 30:1 (v/v) 
8-methyl-DBP: 10–
80 µM 
8-methoxy-DBP: 
10-100 µM 
12 h 
Vietnamese coriander root extract induced 
apoptosis and G2/M cell cycle arrest in breast 
cancer cell lines. 8-methyl-DBP was the 
bioactive compound 
(215) 
Coriander 
(Coriandrum 
sativum) leaf extract 
Linalool (75.4%), 
camphor (5.1%) 
γ –terpinene 
(4.9%), α-pinene 
(4.8%), geranyl-
acetate (3%), 
geraniol (2.8%), 
limonene (2.7%) 
293Q  
WRL-68 
FCA 0-80 µg/mL 
24 h 
The percentage of apoptotic and necrotic cells 
are increased significantly from 1.6 to 80 µg/mL 
in both cells. This concentration-dependent 
increase ranged from 28-41% in apoptotic cells 
in WRL-68 cells and 9-22% in necrotic cells for 
293Q cells 
(184) 
Garlic extract  NCI-H460  
NCI-H1299  
 
Western and 
northern blot 
analysis, and 
acridine orange 
staining  
100 µg/mL 
1 h 
Garlic extract treatment did not induce any 
significant apoptotic cells 
(121) 
Garlic extracts  HepG2  
 
Annexin V-FITC 
staining and 
Western blotting 
0.1%, 0.5% and 1% 
12 , 24, 48 h 
Water garlic extracts induced a p53/p21-
dependent cell cycle arrest in G2/M phase and 
apoptosis 
(99) 
Green Tea (Camellia 
sinensis) extract 
Epicatechin, 
epicatechin-3-
gallate, 
epigallocatechin, 
epigallocatechin-3-
gallate and 
theaflavin 
HepG2  FCA of annexin 
V-FITC/PI 
staining 
20-80 µg/mL 
72 h 
Exposure of cells to 20 µg/ml of the extract 
induced 93.5% of apoptotic cells and 2.3% of 
necrotic cells. However, 80 µg/ml induced 
apoptosis in 78.4% of cell population and 11.2% 
of necrotic cells 
(107) 
Lemongrass 
(Cymbopogon 
citratus ) EO 
Lemongrass Human 
lymphocytes  
FCA of annexin 
V-FITC/PI 
staining 
200, 400 and 800 
µg/mL 
3 h 
Significant increase in early apoptosis cells was 
found at concentrations of 200 and 800 µg/mL 
with a total of 39.62% of apoptotic cells 
(111) 
Origanum majorana 
extracts 
 Jurkat  Annexin V-FITC, 
Western blot and 
FCA 
0-2 mg/mL 
24 h 
The induction of apoptosis observed is related to 
an up-regulation of p53 protein levels and 
down-regulation of Bcl-2α 
(119) 
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Oregano (Origanum 
onites) EO 
Carvacrol 64.3%, 
linalool 13.8%, ρ-
cymene 7.1%, γ-
terpinene 3.5%, 
thymol 1.4% 
5RP7 
RATE 
DAPI staining 
Inverted 
microscope 
observation for 
morphological 
changes 
0-500 µg/mL  
12 h 
125, 250 and 500 µg/mL of oregano EO 
markedly induced apoptosis of 5RP7 cells. 
Inhibitory effect of Origanum onites EO on 
angiogenesis and tube formation of RATEC was 
observed. 
(188) 
Oregano (Origanum 
vulgare) EO 
Carvacrol (55%) Caco-2  PI staining and 
TUNEL assay 
0.01, 0.05 % 
1, 24 h 
Concentration and time-dependent increase in 
cell death was observed, both apoptotic and 
necrotic. The highest concentration of EO 
induced 100% cell death and massive loss of 
monolayer adhesion ability 
(100) 
Oregano (Origanum 
vulgare) extract 
Rosmarinic acid 
(RA): 31.8% of 
phenol, ρ-couraaric 
acid: 0.81% of 
phenol, carvacrol: 
0.75% of phenol 
Caco-2  FCA and 
Western blot 
analysis 
500 µg/ml extract 
24 h 
Oregano extract leads to growth arrest and cell 
death in a dose- and time-dependent manner. 
Oregano triggered both necrotic and apoptotic 
cell death 
(103) 
Palmarosa 
(Cymbopogon 
martini) EO 
 Human 
lymphocytes  
FCA of annexin 
V-FITC/PI 
staining 
1000, 1500 and 
2000 µg/mL 
3 h 
Only a small fraction of cells were found to 
undergo apoptosis (10.77% apoptotic cells)  
(111) 
Rosemary 
(Rosmarinus 
officinalis) extract 
RA, carnosol, 
carnosic acid 
A2780  Human apoptosis 
antibody array kit 
1/600 dilution of 
rosemary ethanol 
extract 
24 h 
The extract downregulated 15 genes out of 35 
genes assayed. Two genes that were upregulated 
were that encoding for cytochrome C and heat 
shock protein 70 
(127) 
Rosemary 
(Rosmarinus 
officinalis) extract 
Ursolic acid (190.0 
mg/g dry extract 
(d.e.), oleanolic 
acid (89.7 mg/g 
d.e.), betulinic acid 
(46.9 mg/g d.e.) 
RINm5F  ELISA test 25 and 50 µg/mL 
24 h 
Both concentrations of rosemary extract assayed 
induced apoptotic cell death in RINm5F  
(189) 
Thyme (Thymus 
vulgaris) EO 
Thymol (24%) Caco-2  PI staining and 
TUNEL assay 
0.01, 0.05 % 
1, 24 h 
0.01% of thyme EO increased the percentage of 
both necrotic (12.95%) and apoptotic (0.73%) 
cells after 1 h, although at 24 h cells were 
dramatically death. Lower death effects were 
observed in the exposure to 0.01% even after 24 
(100) 
Page 91 of 98
URL: http:/mc.manuscriptcentral.com/lfri  Email: rwhartel@wisc.edu
Food Reviews International
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 
 
Thyme (Thymus 
vulgaris) EO 
Thymol (36.1%), ρ-
Cymene (22.1%), γ-
Terpinene (10.1%) 
Differentiated PC12 
cells normal and 
with downregulated 
Mgst1 (PC12-M) 
Inverted 
microscope 
observation 
100 and 400 µM 
24 h 
400 µM led to a cytoplasm condensation, cells 
shrink and loss of contact with the plate in 
PC12_M cells 
(191) 
Cell lines: AsPC-1: human pancreatic adenocarcinoma cell line; A2780: human ovarian carcinoma cell line; Caco-2: human colorectal adenocarcinoma cell line; Clone M3: 
mouse melanoma cell line; HepG-2: human hepatocellular carcinoma cell line; Jurkat: human T-lymphoblastoid cell line; MCF-7: human breast cancer cell line; MiaPaCa: 
human epithelial pancreatic carcinoma cell line; NCI-H1299: non small cell lung cancer cell line lacking p53 gene; NCI-H460: non small cell lung cancer cell line; PC12: rat 
adrenal gland cell line; RATEC: rat adipose tissue endothelial cell line; RINm5F: rat insulinoma cell line; SH-SY5Y: human neuroblastoma cell line; T47D: human ductal 
breast epithelial tumor cell line; WRL-68: human fetal liver epithelial cell line; 293Q: human fetal kidney epithelial cell line; 5RP7: c-H-ras transformed rat embryonic 
fibroblasts cell line.  
Other abbreviations: DAPI: fluorescence microscopy following staining with 40,6-diamidino-2-phenylindole; d.e.: dry extract; ELISA: enzyme-linked immunosorbent 
assay; EO: essential oil; FCA: flow cytometric analysis; FITC: fluorescein isothiocyanate; PI: propidium iodide; ROS: reactive oxygen species; RA: rosmarinic acid; TUNEL: 
terminal deoxynucleotidyl transferasemediated dUTP nick end labeling; 8-methyl-DBP: 8-methyl-dihydrobenzopyranone; 8-methoxy-DBP: 8-methoxy-
dihydrobenzopyranone. 
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Table 7. Cell death evaluation and morphological changes of the main components from essential oils intended to be used in food active 
packaging. 
Main compound 
Experimental 
model 
Assays performed 
Exposure 
conditions 
Observations References 
Apigenin HPBL  Fluorescence microscope 
and Western blot 
analysis 
37.2 µM 
60 min 
Anti-apoptotic effect was observed. Apigenin treatment 
prior to γ-irradiation showed a significant decrease in the 
apoptotic incidence (38.91%) when compared to 
radiation treatment alone 
(216) 
HepG2  ELISA (Enzyme-Linked 
ImmunoSorbent Assay) 
20 µΜ 
1, 3, 6, 12, 24, 48 h 
Potential apoptotic effect after 24 h was observed (109) 
Carvacrol HepG2 DAPI staining 
Inverted microscope 
observation 
0.6 mM 
48 h 
Carvacrol caused cell detachment. Their irregular shape 
with several protrusions suggested an apoptotic fate, 
which was confirmed by the DAPI staining assay  
(98) 
A549  Fluorescence microscope 
observation 
0-1000 µM 
24 h 
Some apoptotic characteristics as well as morphological 
changes were observed at 500 and 1000 µM  
(192) 
Caco-2  PI staining and TUNEL 
assay 
0.37 and 1.83 mM 
1, 24 h 
The exposure to 1.83 mM for 1 h induced 23.14% of 
necrotic cells and 3.94% of apoptotic cells, reaching 
100% of cell death at 24h. 0.37mM showed no 
significant damage effect even after 24 of exposure 
(100) 
5RP7 
CO25  
Acridine 
orange/ethidium bromide 
staining, flow cytometric 
analysis (FCA) and 
analyses of DNA 
fragmentation 
5RP7 cells: 0.02 
and 0.04 mg/mL 
CO25 cells: 0.005-
0.1 mg/mL  
8, 24 h 
5RP7 cells are more sensitive to carvacrol than CO25 
cells since carvacrol induced morhological changes 
characteristic of apoptosis in both cell types but no DNA 
laddering nor phosphatidilserine localization was 
observed in CO25 cells 
(196) 
MDA-MB231 
 
Annexin V, 
mitochondrial membrane 
potential assay, Western 
blot and FCA 
Inverted microscope 
observation for 
morphological changes 
20,40,80,100 µM  
24, 48 h 
The induction of apoptosis appears to be mediated by 
cell cycle arrest at S phase, cytochrome c release, 
decrease in Bcl2/Bax ratio, increase in caspase activity, 
and cleavage of PARP and fragmentation of DNA.  
Carvacrol induced morphological changes such as cell 
shrinkage, rounding of cells and membrane blebbing 
which are characteristic feature of apoptosis 
(123) 
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HeLa  
SiHa  
DNA fragmentation 
assay 
0-500 µg/mL 
48 h 
Carvacrol induced apoptosis of both cells (197) 
HepG2 Hoechst 33258 stain and 
FCA 
0–0.4 mmol/L 
24 h 
Inhibition of HepG2 cell growth by inducing apoptosis (105) 
DBTRG-05MG  Annexin V/PI staining 
Inverted microscope 
observation for 
morphological changes 
0-600 µM 
24 h 
Carvacrol-induced cell death involved apoptosis and 
necrosis. This apoptosis might be related to increase in 
ROS. Morphological changes such as cell shrinkage 
indicating apoptotic cells and cell swelling for necrosis 
were observed 
(198) 
Caco-2  FCA 
Light and electron 
microscope observation 
0-2500 µM 
24, 48 h 
Cell death evidenced in the FCA was confirmed in the 
ultrastructural study 
(110) 
Carvone HepG2  DAPI staining 
Inverted microscope 
observation 
3.2 mM  
48 h 
Carvone caused cell detachment, but cells seemed to be 
still vital. Fragmentation of nuclei was observed, which 
is typical for condensed apoptotic phenotype 
(98) 
Catechin gallate S-G  Nuclear staining with 
acridine orange and 
TUNEL assay 
225, 250 µM 
24 h 
CG-induced apoptosis was detected in S-G cells exposed 
for 24 h to 225 µM CG. Morphological changes, 
characteristic of apoptosis, were noted, highlighting 
hypercondensed chromatin in spherical or irregular 
shapes and blebbing of membrane 
(117) 
Cinnamaldehyde HepG2  DAPI staining 
Inverted microscope 
observation 
0.4 mM  
48 h 
Cell detachment and morphological changes such as 
irregular shape with several protrusions suggested 
apoptosis  
(98) 
Citral Human 
lymphocytes  
FCA of annexin V-
FITC/PI staining 
200, 400 and 800 
µg/mL 
3 h 
Citral induced early and late apoptosis, with a 43.94% 
increase of apoptotic cells with respect to the control 
(111) 
DADS  HCT-15 
A549  
SK MEL-2 
Morphological changes 
and DNA fragmentation 
0-500 µM 
48 h 
Exposure to ≥ 100 µM DADS caused apoptosis, which 
was confirmed by electron microscopy 
(96) 
NCI-H460  
NCI-H1299  
Western and northern 
blot analysis, and 
acridine orange staining  
20 µM 
1 h 
Apoptosis was regulated through p53-dependent or p53-
independent related Bax/Bcl-2 dual pathway 
(121) 
SH-SY5Y  
 
Annexin V-FITC 
staining and Western blot 
analysis 
0-50 µM 
12, 24 h 
Arrest of cell cycle in G2/M phase and commitment to 
apoptosis through the activation of the mitochondrial 
pathway was observed 
(217) 
PC-3 TUNEL assay and DAPI 0-40 µM DADS only induced significantly apoptosis at 40 µM (201) 
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DU145  staining 1, 4, 16, 24 h observed by the TUNEL assay 
HepG2  Annexin V-FITC 
staining and Western blot 
analysis 
0-50 µM 
12, 24, 48 h 
DAS did not produced apoptosis in HepG2 cells (99) 
HL-60  
HepG2  
TUNEL assay and FCA 1-5 µM 
72 h 
DADS did not increase significantly the percentage of 
apoptosis in the absence of N-nitrosamines 
(102) 
NCI-H460  
NCI-H1299  
Western and northern 
blot analysis, and 
acridine orange staining  
5 µM 
1 h 
The results showed an increase in the apoptotic cells. 
The level of p53 protein in H460 cell was increased, 
suggesting that apoptosis was regulated through p53-
dependent pathway 
(121) 
DAS NCI-H460  
NCI-H1299  
Western blot northern 
blot analysis, and 
acridine orange staining  
20 µM 
1 h 
The induction of apoptosis by DAS seemed to be 
regulated through p53-independent related Bax/Bcl-2 
pathway 
(121) 
PC-3 
DU145 
TUNEL assay and DAPI 
staining 
0-40 µM 
1, 4, 16, 24 h 
No significant apoptosis was induced  (201) 
ARO  FCA and Western blot 
analysis 
0–200 µM 
24 h 
Induction of apoptosis via mitochondrial pathway (122) 
Dimethyl 
thiosulfinate 
U937 
NB4  
HL-60 
MonoMac-6 
FCA, ELISA, gelatin 
zymogaphy and RT-PCR 
0-100 µM 
72 h 
Inhibited cell proliferation in a dose- and time-dependent 
manner and this process was neither due to cytotoxicity 
nor apoptosis 
(203) 
DATS PC-3 
DU145  
TUNEL assay and DAPI 
staining 
0-40 µM 
1, 4, 16, 24 h 
DATS-induced apoptosis involves c-Jun N-terminal 
kinase and extracellular-signal regulated kinase-mediated 
phosphorylation of Bcl-2 
(201) 
MCF-7  Annexin V/PI staining, 
TUNEL assay and 
Western blot analysis 
0-50 µM 
24 h 
Apoptosis is mediated through ROS generation and 
subsequent activation of c-Jun N-terminal kinase and 
activator protein-1 
(205) 
DPDS HCT-15 
A549 
SK MEL-2  
Morphological changes 
and DNA fragmentation 
0-500 µM 
48 h 
Any concentration assayed caused apoptosis. Electron 
microscopy showed no significant changes 
(96) 
HL-60  
HepG2 
TUNEL assay and FCA 1-5 µM 
0-200 µM 
None of the concentrations selected induced a significant 
percentage of apoptosis. However, DPDS showed a 
protective effect against an induced apoptosis situation 
(102) 
Caco-2  Light and electron 
microscope observation 
0-200 µM 
24, 48 h 
No significant damage was detected in comparison to the 
control group 
(206) 
Dipropyl sulfide Caco-2 Light and electron 0-200 µM No significant morphological changes were observed in (206) 
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microscope observation 24, 48 h Caco-2 cells exposed to DPS 
Dipropyl 
thiosulfinate 
U937 
NB4 
HL-60 
MonoMac-6  
FCA, ELISA, gelatin 
zymogaphy and RT-PCR 
0-100 µM 
72 h 
Inhibited cell proliferation in a dose- and time-dependent 
manner and this process was neither due to cytotoxicity 
nor apoptosis 
(203) 
Epigallocatechin 
3-gallate 
U251 PI staining and TUNEL 
assay 
20 and 100 µM 
48 h 
No increase in apoptotic cells were observed in treatment 
with EGCG alone; however, in combination to 
temozolomide apoptotic bodies were observed 
(207) 
Estragole V79 
CHO  
Apoptosis annexin assay 0-2000 µM 
8, 12, 24 h 
Estragole induces apoptosis, but only at the highest 
concentration, and after long treatment period 
(208) 
Eugenol Caco-2  PI staining and TUNEL 
assay 
0.52 and 2.50 mM 
1, 24 h 
Eugenol caused a concentration-dependent cell death. 
The exposure to 2.50 mM for 1 h induced 21.64% of 
necrotic cells and 0.62% of apoptotic cells. While after 
24 h of exposure all cells died. The concentration of 0.52 
mM showed no significant damage effect even after 24 
of exposure 
(100) 
AA8  
EM9  
Caspases activation, and 
the TUNEL assay 
0-800 µM 
24 h 
Enhanced activation of caspases was evidenced by 
fluorimetric analysis and fluorescence microscopy in 
both cells treated with 750 µM eugenol. The percentage 
of apoptotic cells was 38.9% and 35.8% in AA8 and 
EM9 cells, respectively. 
(209) 
Geraniol Human 
lymphocytes  
FCA of annexin V-
FITC/PI staining 
1000, 1500 and 
2000 µg/mL 
3 h 
Only a small fraction of cells were found to undergo 
apoptosis (7.16%) 
(111) 
Limonene SH-SY5Y  FCA with Annexin V/PI 
staining and microscope 
observation 
750 µM 
24 h 
No change in cell viability was observed following 
single exposure to limonene. Although the co-treatment 
with linalyl acetate increased the percentage of apoptotic 
and necrotic cells (61.5 ± 4.4 %). These findings were 
corroborated by the morphological alterations observed 
(124) 
Linalool Molt-4  FCA with Annexin V/PI 
staining 
20-640 µM 
12, 24, 48 h 
Linalool-induced apoptosis of Molt-4 lymphoblastic 
leukemia cells occurred at 12 h, and peaked at 48 h 
(120) 
Linalyl acetate SH-SY5Y  FCA with Annexin V/PI 
staining 
375 µM 
24 h 
Linalyl acetate was not able to induced cell death. 
However, the co-treatment with limonene increased the 
number of apoptotic and necrotic cells. Morphological 
alterations such as cell shrinkage and cytoskeletal 
alterations were also observed 
(124) 
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Rosmarinic acid B16F10 
McCoy  
Phase-contrast 
microscopy observation 
10 µM 
24 h 
Melanocytes appeared as flattened cells, with scattered 
and darkened cytoplasm surrounded by multipli 
protrusions 
(212) 
Thymol HepG2  DAPI staining 
Inverted microscope 
observation 
0.7 mM 
48 h 
No signs of apoptosis were induced at any of the 
concentrations tested. However, cells exhibited a 
typically necrotic death pattern, with cytoplasmic 
extrusion and no uptake of vital dye 
(98) 
Caco-2  PI staining and TUNEL 
assay 
0.80 and 0.17mM 
1, 24 h 
The exposure to 0.80 mM for 1 h induced 10.08% of 
necrotic cells and 0.53% of apoptotic cells. Similar 
results were obtained after 24 h. Slightly lower effects 
were recorded in exposure to 0.17 m M 
(100) 
HL-60 
PBMC 
DNA fragmentation 
assay, Western Blot 
analysis, caspases assay, 
and apoptosis inducing 
factor 
0-100 µM 
24 h 
Thymol produced apoptotic cell death based on genomic 
DNA fragmentation pattern, involving both caspase 
dependent and caspase independent pathways 
(125) 
DBTRG-05MG  Alexa®Flour 488 
annexin V/PI staining 
0–800 µM 
24 h 
Treatment with 200, 400, or 600 µM thymol significantly 
induced apoptosis in a concentration-dependent manner. 
At 400 and 600 µM, thymol also induced necrosis. 
(126) 
Caco-2  FCA 
Light and electron 
microscope observation 
0-250 µM 
24, 48 h 
Although no cell death was observed for thymol at any 
concentration, ultrastructural changes evidenced cellular 
damage such as lipid degeneration, mitochondrial 
damage, nucleolar segregation and apoptosis 
(110) 
Differentiated 
PC12 cells normal 
and with 
downregulated 
Mgst1 (PC12-M) 
Inverted microscope 
observation 
100 and 400 µM 
24 h 
PC12_M cells exhibited higher sensitivity to 400 µM 
thymol showing enhanced tendency to grow in clusters, 
and to form multilayered colonies 
(191) 
Cell lines: AA8: Chinese hamster ovary epithelial cell line; ARO: human thyroid anaplastic carcinoma cell line; A549: human alveolar adenocarcinoma cell line; B16F10: 
mouse skin melanoma cell line; Caco-2: human colorectal adenocarcinoma cell line; CHO: chinese hamster ovary cell line; CO25: N-ras transformed myoblast cell line; 
DBTRG-05MG: human glioblastoma cell line; DU145: human prostate cancer cell line; EM9 : Chinese hamster ovary cell line; HCT-15: human colon tumor cell line; HeLa: 
human cervical epithelial adenocarcinoma cell line; HepG-2: human hepatocellular carcinoma cell line; HL-60: human promyelocytic leukemia cell line; HPBL: human 
peripheral blood lymphocytes cell line; Jurkat: human T-lymphoblastoid cell line; McCoy: mouse fibroblast cell line; MCF-7: human breast cancer cell line; MDA-MB231: 
human metastatic breast cancer cell line; Molt-4: human acute lymphoblastic leukemia cell line; MonoMac-6: human monocytic cell line; NB4: mouse neuroblastoma cell 
line; NCI-H1299: non small cell lung cancer cell line lacking p53 gene; NCI-H460: non small cell lung cancer cell line; PBMC: human peripheral blood mononuclear cell 
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line; PC12: rat adrenal gland cell line; PC-3: human prostate cancer cell line; S-G: immortalized epithelioid cells; SH-SY5Y: human neuroblastoma cell line; SiHa: human 
cervical epithelial cancer cell line;  SK MEL 28: human melanoma cell line; U251: human glioblastoma cell line; U937: human leukemic monocyte lymphoma cell line; V79: 
chinese hamster lung cell line; 5RP7: c-H-ras transformed rat embryonic fibroblasts cell line.  
Other abbreviations: CG: Catechin gallate; DADS: diallyl disulfide; DAS: diallyl sulfide; DATS: diallyl trisulfide; DAPI: with 40,6-diamidino-2-phenylindole; DPDS: 
dipropyl disulfide; DPS: dipropyl sulfide; EGCG: epigallocatechin 3-gallate; ELISA: enzyme-linked immunosorbent assay; FCA: flow cytometric analysis; FITC: fluorescein 
isothiocyanate; PI: propidium iodide; ROS: reactive oxygen species; ROS: reactive oxygen species; TUNEL: terminal deoxynucleotidyl transferasemediated dUTP nick end 
labeling  
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Abstract 
Currently, antimicrobial additives derived from essential oils (Eos) extracted from plants or 
spices, such as Origanum vulgare, are used in food packaging. Thymol and carvacrol, the major 
EO compounds of O. vulgare, EO have demonstrated their potential use as active additives. 
These new applications suppose the use of high concentrations, thereby increasing the concern 
regarding their toxicological profile, and especially their genotoxic risk. The aim of this work 
was to investigate in vitro the potential in vitro genotoxicity of thymol (0-250 µM) and 
carvacrol (0-2500 µM) at equivalent doses to those used in food packaging. The micronucleus 
test (MN) test and the mouse lymphoma (MLA) assay (MLA) on L5178Y/Tk+/- mouse 
lymphoma cells have beenwere used. The negativenegative results for thymol with the MN with 
and without the S9 fraction, and also with the MLA assay reinforce the view that this compound 
is not genotoxic in mammalian cells. However, carvacrol presented slight genotoxic effects, but 
only in the MN test at the highest concentration assayed (700 µM) and in the absence of 
metabolic activation. The lack of, but no genotoxic response was found in the MLA assay after 
4 and 24 h of exposure would. This would indicates a low genotoxic potentialrisk for carvacrol. 
Alternatively, the general negative findings observed in both assays would suggest that the MN 
results of carvacrol are just marginal data without biological relevance. These results can be 
useful should be used to identify the appropriate concentrations of these substances to be used 
as additives in food packaging. 
 
Keywords: carvacrol, thymol, micronucleus test, mouse lymphoma assay, food packaging
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1. Introduction 
 
 Essential oils (Eos) and their main components are used as additives in the food industry 
due to their flavour, antimicrobial, and antioxidant properties [1-4].   Additionally, EOs and 
their main components have been traditionally used to extend the shelf life of food, due to their 
antimicrobial/antifungal activity [2-4] or their antioxidant properties [5-7]. The use of Eos as 
food preservatives has been limited because high concentrations are required to reach sufficient 
activity [8]. Active packaging ,is a new preservation system where volatile compounds from 
Eos originatescreate a preservative atmosphere. This, is considered a good alternative to the 
direct incorporation of EOs these oils into food, . This method enables a slow release of the 
agent onto the food surface, maintaining an adequate concentration of the active compounds to 
preserve the quality of the aliment and avoiding the undesirable secondary effects produced by 
the direct addition of high levels of EOs [6-79-10]. 
 
 Currently, Eos derived from oregano species, including its major components, carvacrol  
and thymol, are currently among one of the most frequently EOs used in active food packaging. 
At present, tis that are those derived from oregano species (Origanum vulgare), rosemary 
(Rosmarinus officinalis), green tea (Camellia sinensis), cinnamon (Cinnamum zeylanicum), and 
clove (Eugenia caryophyllata). The Among them, oregano EO and its major components, 
carvacrol (5-isopropyl-2-methylphenol) and thymol (2-isopropyl- 5-methylphenol), have 
beenare already used as food preservatives, and the usefulness possibility to useof these 
compounds as substitutes of the common synthetic antioxidants (butylated hydroxyanisole and 
butylated hydroxytoluene) is under discussion [811]. SinceBecause tThus, carvacrol can be 
directly incorporated by dissolution, microencapsulation, or melt blending in packaging 
materials, such as wheat gluten coated papers, apple and tomato based films, polypropylene 
films, and corn-zein laminated linear low density polyethylene [12]. On the other hand, thymol 
has been incorporated by direct dissolution into soy protein isolate-based films to package olive 
oil [13]. Moreover, both carvacrol and thymol are suitable for their microencapsulated use in 
Formatted: Tab stops:  0.75 cm, Left
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+ Not at  0 cm
Formatted: English (U.K.)
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polymer matrices for fresh food preservation [14]. The use of carvacrol and thymol, and Eos in 
general, for these new applications requires high doses, there isconcentrations; thereby,  an  
increasing concern regarding potential exposure to these compounds is arising. 
ConsequentlyTherefore, more research is needed to establish effective and safe concentrations 
of Eos and their components [9-101]5]. 
 
  It is also needed to assess their cytotoxic and genotoxic potential, identifying possible 
toxic/mutagenic components, and trying to construct an almost complete profile of the 
risks/benefits associated with their use [16-17]. 
 
 At present, no single genotoxicity test is able to detect all relevant genotoxic agents. For 
this reason, batteries of different genotoxicity assays are usually proposed. In all regulatory 
genetic toxicity testing schemes, the first test to be performed is the bacterial reverse mutation 
assay, generally conducted in Salmonella typhimurium strains (the Ames test). A positive 
response in the test leads to the presumption that the chemical can be a potential carcinogen. In 
addition to the Ames test, chemicals are also tested in vitro on mammalian cells for gene 
mutation (usually the mouse lymphoma assay, MLA, that uses the Tk gene as a target) and/or 
for chromosome aberrations (CA) or micronuclei (MN) induction [18]. In fact, iIn accordance 
with the Guidelines of the Scientific Committee on Food for Safety Assessment of Substances 
Used in Food Contact Materials [19], the core set of tests used to construct an almost completea 
profile of the risks/benefits associated with the use of Eos and their components as food contact 
materials, cconsists ofnf the following 3 in vitro genotoxicity in vitrostudies: 1) a test of the 
induction of gene mutations in bacteria; 2) a test for the induction of gene mutations in 
mammalian cells (preferably the mouse lymphoma Tk assay); and 3) a test for the induction of 
chromosomal mutations (chromosome aberrations, (CA or miccronucleus/, MN tests) in 
mammalian cells [11-13]. It should be indicated that aAmong the different in vitro mammalian 
gene-mutation assays Tthe mouse lymphoma assay (MLA) is the most widely used method 
among various in vitro mammalian gene-mutation assays [14]. SimilarlyIn addition, according 
Formatted: Tab stops:  0.75 cm, Left
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to internationally accepted standards, the in vitro MN assay is being increasingly used in the 
evaluation of Eos [15-17] instead of the classical CA assay [18-20].. 
 
 With respect to the battery of genotoxicity assays conducted according to internationally 
accepted standards, the in vitro MN assay is being increasingly used in the evaluation of EOs 
[20-24] instead of the classicalCA assay [25-27]. The MN assay allows a high reliable, rapid, 
and a broad-spectrum determination of DNA damage at the chromosome level [28], being able 
to detect aneuploidy. The mouse lymphoma assay (MLA) is the most widely used method 
among various in vitro mammalian gene-mutation assays [29]. This assay uses a mouse 
lymphoblastoid cell line (L5178Y) and has the thymidine kinase (Tk) gene as a target [30]. The 
MLA is able to detect and quantify genetic alterations affecting the expression of the Tk gene, 
covering a wide range of genetic lesions including point mutations, chromosome aberrations, 
mitotic recombination, and aneuploidy [31-33].These features make this assay particularly 
useful to evaluate the ability of toxicants to induce mutational events [30, 33]. 
 
  
 Regarding to the genotoxic potential of thymol and carvacrol,, several studies have already 
been conducted with different results, dependingaccording on to the assay system and the range 
of concentrations usedtested [21-2734-40]. In bacterial systems, negative results were obtained 
for thymol using the Ames test [2740], whereas for carvacrol, the results weare contradictory 
[28-2941-42]. Recent studies from our laboratory found that carvacrol exhibited mutagenic 
potential, being more active in the presence of a metabolic source [2740]. When In the 
cometcComet assay was used,using mammalian cells, conflicting results werehave been 
reported. Thus, aAlthough Aydin et al. [2134] demonstrated that carvacrol and thymol induced 
DNA damage in human lymphocytes, Horváthová et al. [2336] concluded that both the 
compounds wereare not associated with a DNA-damaging effects on human hepatoma HepG2 
and colonic Caco-2 cells. 
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 Taking all these facts into account, the aim of the present work was to investigate in vitro 
the potential in vitro genotoxicity/mutagenicity of carvacrol and thymol at relevant 
concentrations, according to their possible use in food packaging. The MN and MLA tests Two 
methods have been used, the micronucleus test (MN) and the mouse lymphoma assay (MLA) 
using the L5178Y/Tk+/- mouse lymphoma cell- line have been carried outwere performed. It 
must be pointed out that, sinceBecause no previous data exist  usingfor the selected genotoxicity 
assays, the obtained data will beare relevant to assess or confirm their potential health hazards 
for humans. 
 
Formatted: Tab stops:  0.75 cm, Left
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2. Material and methods 
 
2.1. Chemicals 
  Thymol (2-isopropyl- 5-methylphenol, 99.5%; CAS No. 89-83-8), carvacrol (5-
isopropyl-2-methylphenol, 98%; CAS No. 499-75-2), mitomycin (MMC, CAS No. 50-07-7 ), 
cyclophosphamide (CP, CAS No. 6055-19-2 ), methyl methanesulfonate (MMS, 99% purity; 
CAS No. 66-27-3), thiazolyl blue tetrazolium bromide (MTT, 99.7% purity; CAS No. 298-93-
1), trifluorothymidine (TFT, ≥99% purity; CAS No. 70-00-8), thymidine (CAS No. 4449-43-8), 
hypoxanthine (99% purity; CAS No. 68- 94-0), methotrexate (CAS No. 59-05-2), glycine 
(≥99% purity; CAS No. 56-40-6) , cythochalasin B ( Cyt-B, 98%, CAS No. 14930-96-2), 
Giemsa stain (CAS No. 51811-82-6), and trypan blue solution 0.4% (CAS No. 72-57-1) were 
purchased from Sigma–Aldrich (Madrid, Spain). RPMI 1640 medium, horse serum, L-
glutamine solution (CAS No. 56-85-9), penicillin/ streptomycin solution, sodium pyruvate 
solution (CAS No. 113-24-6), and amphotericin B solution (CAS No. 1397-89-3) were 
purchased from Gibco (Biomol, Sevilla, Spain). 
 
2.2. Cells and culture conditions  
L5178Y/Tk
+/−
 mouse lymphoma cells were usedtilized for both assays and. They were 
initially provided by Dr. Olivier Gillardeux (Safoni-Synthélabo, Paris, France).  and maintained 
since then in the laboratory of the University Autonoma of Barcelona (UAB). Cells were 
cultured to prepare master stocks, which were maintained in liquid nitrogen at a density of 2 × 
10
6 
cells/mL in a culture medium containing 10% DMSO. TheyCells were confirmed as free of 
mycoplasma by PCR. 
 
L5178Y/Tk
+/−
L5178Y cells were cultured in RPMI 1640 medium supplemented with 10% 
heat-inactivated horse serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 g/mL streptomycin, 
1 mM sodium pyruvate, and 2.5 g/mL amphotericin B. Cells were routinely diluted at 2 × 10
5
 
cells/mL each day to prevent overgrowth (more than 10
6
 cells/mL). Cell density was determined 
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with an automated cell counter (Countess
®
Automated cell Counter, Invitrogen
®
). Cultures were 
maintained in a humidified incubator with 5% CO2 in air at 37°C. 
 
2.3. Test solutions 
The concentration ranges of thymol and carvacrol concentrations for the tests wereas 
selected taking into account the considerations described in Llana-Ruiz-Cabello et al. [1], 
considering the content of these active compounds to be incorporated into the packaging 
materials and their possible migration to the food, whatwhich represents the (worst case 
scenario of exposure) [30]. In this sense, the maximum concentration was calculated 
considering that the active compounds completely migrate from the active package into the food 
(worst scenario of exposure). 
 
Stock concentrations solutions of thymol (0.5 M) and carvacrol (2.5 M) were prepared in 
dimethyl sulfoxide (DMSO)100.%., to dilute the chemicals. RPMI 1640 medium was used to 
prepare For the different testedexposure solutions, wherein which the final quantity of DMSO 
was always less than 0.1%. , concentrations RPMI 1640 medium was used.  as a solvent, 
obtaining a final concentration of DMSO less than 0.1%. Cyclophosphamide, MMC, and MMS 
were dissolved in distilled water. RPMI 1640 medium served as a negative control, 
whereasileand MMC (0.0625 µg/mL), cyclophosphamide CP (8 µg/mL), and MMS (10 µg/mL) 
were used as positive controls in the different assays. Each compound stock and working 
solutions wasere prepared justimmediately previously prior to its use. 
 
2.4. Micronucleus test (MN) 
This experiment assay was carried outperformed according to the procedure OECD 487 
from the Guideline for the Testing of Chemicals [3143]., . The test was performed in T25 flasks 
T(two duplicate cultures/concentrations were )stablished in T25 flasks in the absence or 
presence of the S9 metabolic activation system. 
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2.4.1. Cell viability forEC50 determination for the MN test 
The viability trypan blue exclusion test [44] was performed in order to establish the EC50of 
L5178Y/Tk+/−L5178Y cells were exposed to different concentrations of thymol (0-250 µM) or 
carvacrol (0-2500 µM), and the viability was assessed using the trypan blue exclusion test [32], 
in order to establish the half maximal effective concentration (EC50). using this value to select 
the highest concentration of exposure for the MN assay. CThus, cells were seeded at 2 x 10
5
 
cells/mL and were treated exposed for 24 h different concentrations of each chemical when the 
metabolic S9 fraction was not used, or for 3-6  4 h when this fraction was used.. 
 The EC50 after 24 h of treatment was determined using an automated cell counter 
(Countess®Automated cell Counter, Invitrogen) following the indications given. 
 
2.4.2. Micronucleus Genotoxicity assay 
L5178Y/Tk+/− L5178Y cells were seeded at a concentration of 2 x 105 cells/mL per flask 
and were incubated for 24 h at 37 °C in a, 5% CO2 atmosphere. Then, culture media were 
removed from the flask by centrifugation (600 rpm, 6 min), and  the cells were treated with five 
different concentrations of thymol (0-250 µM) or carvacrol (0-700 µM), which were defined 
selected according   to their EC50 (without or with S9) previously obtained(Figs. 1A; 1B). The 
solvent RPMI medium was used as a negative control, whereas and ileMMC 0.0625 µg/mL of 
MMC (in absence of S9) or andCP cyclophosphamide8 µg/m L ofcyclophosphamide (in 
presence of S9) were used as positive controls. The exposure times were 24 h in absence of S9 
or 4h  in the presence of S9, according to the OECD guidelines [31]. After these periods, cells 
were exposed to In absence of S9,  cell cultures treatment last for 1.5-2.0 normal cell cycles (24 
h), after this time treated medium was removed and fresh medium withCyt-B (6 µg/mL) was 
added during 1.5-2.0 normal cell cycles moreduringfor  (20 h). Then, , Cells were treated during 
3-6 h in presence of S9 (50 µL, 1%); later, the treated medium with S9 was removed and fresh 
medium with Cyt-B (6 µg/mL) was added during 1.5-2.0 normal cell cycles more (20 h). 
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After Cyt-B treatment period, cultures were centrifuged (at 600 rpm, for 6 min),   the 
supernatant was removed, and   cells were subjected to a hypotonic treatment (5 mL KCl 0.051 
M, 20 min, room temperature). After that,this time, cells were centrifuged and  another 
centrifugation was carried out. Cells were fixed with methanol/acetic acid (3:1).  at least 3 
times. In the last centrifugation, the supernatant was eliminated and the pThe resultant pellets 
were asresuspended and dropped on clean microscope slides (2 drops of 20 µL each one). After 
drying, cells were stained with Giemsa 10% solution for 3-5 min. 
 
All slides were encoded by a person outside unconnected with the study, and the scoring 
was carried outconducted by a unique different person using an Olympus BX61 light 
microscope at 100X magnification under oil immersion. MNMicronuclei frequencies were 
analyzed analysed in at least 2000 binucleated cells per concentration.  (at least 1000 
binucleated cells per culture; two cultures per concentration). In addition, cells were scored to 
evaluate the cytokinesis-block proliferation index (CBPI) [43] or nuclear division index (NDI) 
[3345]. 
 
2.5. Mouse lymphoma thymidine-kinase assay (MLA) 
The MLA was carried out according to Soriano et al. [32]. Taking into account the cell 
culture conditions, serum concentration was lowered during the treatment to 5% and raised to 
20% when cells were dispensed into microwells-plates. 
For a successful outcome of the MLA, L5178Y/Tk
+/−
cells were subjected to a cleansing t 
2.5.1. Cell cleansing 
To prepare working stocks for gene-mutation experiments, cultures were purged anof  
excess of possible Tk
−/−
 mutants by culturing the cells for 24 h in THMG THMG medium , 
which contains(thymidine (9 µg/mL;, ),hypoxantine (15 µg/mL;,), methotrexate (0.3 µg/mLL);, 
and glycine (22.5 µg/mL). Then, Ccells were then transferred to THG medium (THMG without 
methotrexate) for 2 days. The purged cultures were checked for a low background of Tk
−/−
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mutants and were stored in liquid nitrogen. The MLA was carried outperformed according to 
Soriano et al. [34]. 
 
In first place, 2.5.2. Gene-mutation assay 
PpPreliminary experiments were carried outconducted to determine thehe solubility and 
cytotoxicity of thymol or both carvacrol and thymol to be tested. Cytotoxicity was determined 
by the relative total growth (RTG) following after a treatment of 4 h -treatment with thymol (0- 
250 µM) orand 4 h- and 24 h -treatments with carvacrol (0-2500 µM), without an external 
metabolic activation source. The RTG measurement takes into account cell loss after treatment, 
reduction in growth rate over the expression period, and any reduction in cloning efficiency on 
the day of the selection mutants [46]. The recommended highest concentration was one with an 
RTG of 20% [3547].  
 
Each main experiment comprised saone negative control (RPMI 1640 medium), aone 
positive control (MMS 1 µg/mL), and six concentrations for each tested compound (at least four 
are recommended). A total of 10
7
 cells per culture were grown in R10 medium (10% horse 
serum) and placed in a series of sterile centrifuge tubes. Solvent, test chemicals or positive 
control were added. Cells were incubated with gentle shaking (50 rpm) in an incubator at 37°C 
for 4 h. After exposure, cultures were washed and diluted to 2 × 105 cells/mL. Cells were 
transferred to culture flasks, counted daily and sub-cultured to 2 × 10
5 
cells/mL for a period of 
48 h to allow expression of induced mutations (Tk-deficient phenotype). Then, cells were 
seeded in duplicate plates per culture to calculate viability and mutation frequency (MF) on day 
two. Cell count data were used, in conjunction with viability data on day two, to generate the 
RTG values corrected for post-treatment toxicity, which provides an indication of post-
treatment toxicity in comparison with that of the vehicle control. RTG values were used to 
decide on the acceptability of the toxicity at each dose level. Thereby, the range selected ranges 
for thymol and carvacrol, taking into account the obtained RTG values, were 0-250 µM and 0-
1500 µM, respectively  and 0-250 µM of carvacrol and thymol, respectively (Tables 5-7). 
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Once the exposure concentrations were selected,  
 
2.5.3. Plating for viability 
Ccells were plated  counted and theat a density of was adjusted to 10
4
 cells/mL in . A 
portion of each culture was removed and diluted up to 10 cells/mL. Each culture was dispensed 
at 0.2 mL/well on 96-well plates (two replicates platesper experimental group) in order to 
evaluate the viability of cells after an incubation were used for each exposure concentration; two 
plates for the negative control; two plates for the positive control). The plates were incubated of 
12 days at 37 °C,  and 5% CO2. After this time, viable colonies of platess were counted. In 
addition,  
 
2.5.4. Plating for 5-trifluorothymidine (TFT) resistance 
For mutant analysis, two more replicates per experimental group were exposed to TFT was 
added to cell cultures (10
4 
cells/mL) presenting a final concentration of 4 µg/mL for the 
mutantion analysis. Each TFT-treated culture was dispensed at 0.2 mL/well on 96-well plates 
(two plates were used for each exposure concentration; two plates for the negative control; two 
plates for the positive control). Plates were also incubated duringfor 12 days at 37 °C,  and 5% 
CO2. To assist the scoring of TFT mutation colonies, MTT 2.5 mg/mL was added to each well 
and the plates were incubated for 4 h. After this time, the mutant colonies of each plate and 
counted for the number of microwells containing colonieswere counted. To assist the scoring of 
TFT mutation plates, thiazolyl blue tetrazolium bromide solution (MTT, 25 µL, 2.5 mg/mL) 
was added to each well, and the plates were incubated for 4 h. Colony size was estimated in a 
similar manner to that described by Honma et al. [3648]. A small colony was defined as a 
colony having a size of ≤ 25% of the well diameter. On the other hand, large colonies are 
defined as those > 25% of the well diameter. 
 
2.6. Statistical analysis 
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The IWTG Mouse Lymphoma Workgroup states that biological relevance should be a 
major factor in MLA data evaluation, determining whether a response was positive or negative 
[49]. Therefore, the workgroup recommends a biologically relevant approach to evaluate MLA 
data, which requires that the induced mutant frequency (IMF) exceeds some value based on the 
global background mutant frequency (MF). This value is the global evaluation factor (GEF), 
which is considered to be 126 for the microwell version. The induced mutant frequency (IMF) 
was determined according to the formula IMF= is obtained by MF−SMF= IMF, where MF is 
one of the test culture mutant frequencies frequency and SMF is the spontaneous mutant 
frequency. Positive responses are determined as those which,that for any treatment meet or 
exceed the global evaluation factor (GEF, 126 for the microwell assay) plus vehicle control MF, 
and also when a positive trend test test is obtained.  
 
The statistical approach was included the one-way ANOVA followed by Dunnett’s test, 
which was used to evaluate the significance of the differences in micronucleated cells, NDI and 
MF between the control and treated cultures. ,in the MN assay the two first, and in the MLA the 
last one. Results were considered statistically significant when the P-value was < 0.05. 
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3. Results 
 
3.1. Micronucleus test  
The doses to be tested in the MN test were selected according to the obtained EC50 (Figure 
1). GThe genotoxicity rResults obtained from thymol and carvacrol are shown in Tables 1-4. As 
indicated, both chemicals were evaluated in the absence and presence of the metabolic 
activation fraction. Neither the frequency of binucleated cells presenting at least one 
micronucleus (BNMN) nor the frequency of total micronuclei (data not shown), scored per 2000 
binucleated cells, showed any a significant increase with respect to the control values in the case 
of thymol (Tables 1 and 2). However, after treatment withWhen carvacrol was tested,, a 
significant but singleincrease of BNMN was observed but only at the highest concentration 
tested (700 µM) and in the absence of S9 mix.  was observed; but No effects were observed not 
in the presence of the external metabolic activation (Tables 3 and 4). According to the overall 
data this positive value can be considered as marginal.As expected, treatments with the specific 
positive controls MMC and CP cyclophosphamide,in absence or presence of S9, respectively, 
induced significant increases in the frequency of BNMN with respect to their negative controls.  
 
On the other hand, tTables 1-4 also show the NDI values obtained after the treatments with 
thymol and carvacrol. As observed, no significant differences were found in NDI values 
between the experimental groups and the negative control. Although Moreover, additional 
nuclear anomalies,, such as bridges or buds, ,were checked, but no significant presences have 
beenwerwase observed (data not shown). 
This would indicate that, at the selected doses, no important toxic effects were observed for 
any of the two tested compounds in the presence of S9, andor in the absence of S9 also in 
absence with thymol. Nevertheless, it is important to take into account the positive response of 
L5178Y/Tk
+/−
L5178Y cells exposed to carvacrol up at 700 µM, in the absence of metabolic 
activation. 
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3.2. Mouse lymphoma assay 
The results obtained in the MLA after treatments for 4 h of L5178Y/Tk
+/−
 cells with thymol 
and carvacrol for 4 h are shown in Ttables 5 and 6, respectively. Each compound was tested in 
two independent experiments, and a good concordance was observed between them. Positive 
controls with MMS (10 µg/mL) were run in parallel, showing significantly increased mutant 
frequencies. 
 
As observed, tThymol did not present a mutagenic response, and the cytotoxicity test did 
not show any bioavailability reduction (taking into account the RTG values) after exposure to 
this compoundsubstance (up 250 µM) (Table 5). In relationWith respect to carvacrol, the 
obtained results after treatment for 4 h are indicated shown in Ttable 6. As observed, aAt 
concentrations higher than 500 µM, pronounced decreases in the relative total growth (RTG) 
were found. Although higher concentrations (up 2500 µM) were assayed to assess the toxicity, 
the results are not considered for mutagenicity when the percentage of RTG is lower than 20%, 
which is the lowest acceptable value. The limit of 20% RTG is widely accepted as the 
maximum level of cytotoxicity for mutagenicity testing in this case, to avoid biologically 
irrelevant effects that might occur in heavily stressed cells. However, although cytotoxicity was 
observed (from 500-1500 µM), no mutagenic response at concentrations up to 1500 µM was 
obtained. Taking into account what observed inthe observations of the MN assay, we extended 
the exposure time with carvacrol until to 24 h. As indicated in Ttable 7, this increased time also 
reported resulted in non-mutagenic effects.  Figure 2 shows the overall results obtained in the 
MLA assay with thymol and carvacrol, 
 
Formatted: Indent: First line:  0.75
cm
16 
 
4. Discussion 
 
  Previous studies on the mutagenic and genotoxic/mutagenic risk of thymol and 
carvacrol have already been conducted, butalthough the results weare inconclusive but reporting 
conflictive results, especially in the case of carvacrol. [REFS]. As consequenceTherefore, 
further studies are required to determine the potential real genotoxic risks associated towith 
these  that supposes the exposure to these compounds and their use in the food industry. Here, 
we present studies using the MN and MLA assays to extend our knowledge onf the potential 
genotoxic risk of these compounds.. 
 
  In relation to thymol, sSeveral studies of thymol in bacterial systems concluded that it 
was non- e absence of mutagenic potential onverat the range of concentrations and conditions 
tested [28, 3741, 50]. Specifically, when the regarding to the potential concentrationsquantities 
added to food packaging were evaluated,, the Ames test revealed no non-mutagenic response in 
any of the five S. typhimurium strains assayed (S. typhimurium) in the the presence or absence 
of S9 [2740]. In the present studyour study, the range of concentrations selected (0-250 µM 
thymol) was in agreement with the levels expected in packaging conditions. In this context, the 
negative results for thymol observed for thymol in the MN assay, with and without the S9 
fraction, and also inwith the MLA assay (without S9), reinforce the view view ideathat this 
compound is nont- genotoxic infor in mammalian cells. It should be remarked that in the present 
study we have used a range of concentrations (0-250 µM) selected according the levels expected 
in package conditions. Thiseis lack of genotoxicity would confirms those the epreviouslyresults 
previously obtained by using the Ccomet assay in different Caco-2 and HepG2 cellscell lines 
[23, 26-27]. using the comet assay [36, 40]. Similarly, an absence of activity for thymol at 
biologically relevant concentrations has been reported in V70 Chinese hamster lung fibroblast 
cells using the comet assay [39].On the other hand, although Although a dose-dependent 
response whas been reported in human lymphocytes for thymol using thee comet same comet 
assay, although only the higher concentrations of this compoundthymol (above 0.1-0.2 mM) 
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induced DNA damage. No effects were observed at lower concentrations (below 0.1 mM) [21-
2234-35]. These results contrast with those reported byIn additionBy contrast, Buyukleyla and 
Rencuzogullari [38] who reported that thymol significantly increased the frequency of sister-
chromatid exchanges (SCE), and induced structural CA and MN in human lymphocytes at all 
the  all of the concentrations tested (25-100 μg/mL, equivalent to 17-66.5 µM) in human 
lymphocytes. These differences contradictory results could beare related with to the the existing 
differences between the selected cells typeslinesexperimental model selected, beingwith so it 
seems that human lymphocytes being could be more sensitive thaen established cell-lines, 
including compared to to the effects of thymol in comparison to the mouse lymphoma cells 
(used in our present study). The absence of genotoxicity observed for thymol in the present 
work could be attributed to its extensively proven antioxidant properties [21, 24, 38]. As a 
phenolic compound, thymol has high potential to scavenge oxidative radicals by donating 
protons from theirits phenolic hydroxyl groups [38]. This fact has already been described in 
several studies, which reported the antigenotoxic potential or the protective effects of thymol in 
several experimental models exposed to DNA-damaging agents [21-23, 39]. It is important to 
point out that nNo previous genotoxic data for thymol by using thefrom MLA has been reported 
in the scientific literature so far to compare with our negative results. In this context, it must be 
remembered that the MLA detects a wide spectrum of genetic damage, including both gene and 
chromosomal mutations, in contrast with other gene-mutation assays.  
 
The absence of genotoxicity of thymol could be attributed to its antioxidant properties 
demonstrated by several authors [34, 37, 51]. Thymol, as a phenolic compound, has high 
potential to scavenge radical by its ability to donatea hydrogen atom from their phenolic 
hydroxyl groups [51]. In fact, several studies reported the antigenotoxic potential or protective 
effects of thymol in several experimental models against representative DNA-damaging agents,  
such as H2O2 [34, 36], 2-amino-3-methyl-3H-imidazo[4,5-F]quinoline (IQ) and mitomycin C 
(MMC ) [35], and bleomycin [52]. 
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In the case of carvacrol, According to the data obtained in the MN assay, carvacrol induced 
showed an slight but significant increase in the frequency of BNMN in the mouse lymphoma 
cell line, but only at the highest concentration tested (700 µM) and only in the absence of 
external metabolic activation. However, negative results were obtained in this in vitro assay in 
the presence of the S9 mix. This result would,  suggeststing a higher genotoxic potential forof 
the parent compound with respect to instead that forof its potential generated metabolites. Tho 
understand the potential role of metabolic activation on the genotoxicity of carvacrol, we can 
compare our results on the MN assay with those previously obtained by us esinglelonedamage 
observed  positive results obtained arecould be in agreement with thosee previous  mutagenic 
potentialmutagenic effects exhibited by carvacrol inby the Ames test (with and without S9) by 
us. Surprisingly, iIn this assay, carvacrolcarried out in our laboratory, with and without S9, 
although it displayed a greater genotoxic activity in the presence of the metabolic fraction and at 
lower concentrations (29-460 µM) [2740]. To solve this type of discrepanciesy between assays, 
Recently, it has been Kirkland et al. [18] have discussed the situation where a chemical present 
a positive response in the Ames test but a negative one in the MN assay (such as carvacrol with 
S9). As described by Kirkland et al. [12], proposed that differences between the Ames and the 
MN assay and indicated that such results need to be considered inthis discordance could would 
beare explained by assumingbyrelated  light ofwiththe differences in the metabolism between 
bacterial and mammalian cells. These authors point outroposeproposed that. For example: 1) 
different S9 concentrations are used, most usually 10–30% S9 mix in the Ames test, but 2–4% 
S9 mix  and in the in vitro mammalian cell tests; 2) the duration of exposure is longer in the 
Ames test (72 h) as compared to the mammalian cell tests (3-6 h in the MN assay); 3) the 
intrinsic metabolism of the bacterial and mammalian cells may produce different metabolic 
profiles with a test chemical; and 4) the S9 mix used favours oxidative metabolism, which 
mammalian cells are able to counteract through phase II metabolism to promote detoxification, 
whereasand bacteria may be less able to defend against such oxidative metabolitesdamage 
whereas. Thus, all tThese points would help us to explain the present data in the MN assay with 
respect to those previously obtained in the Ames test. Nevertheless, an alternative proposal 
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would be to consider the positive result at the concentration of 700 µM just as a marginal, 
without biological relevance and to attribute non- genotoxic potential to carvacrol in 
mammalian cells. mammalian cells may have sufficient phase II metabolism to promote 
detoxification. 
 
 
In spite of this positive effect observed in the MN assay in absence of S9, negative findings  
were obtained with the MLA assay after 4 h and 24 h of exposure. These differences could be 
due to the fact that the Ames and chromosome damage (MN, MLA) tests measure different 
molecular endpoints, and it is possible for a chemical to be capable of inducing base-pair 
changes, of the type measured by the Ames test, but not induce chromosome breakage or non-
disjunction [53]  mentioned 
The lack of positive effects observed for carvacrol in the MLA assay, both after exposures 
lasting for 4 and 24 h, would suggest that carvacrol is non-mutagenic, at least under our testing 
conditions of testing. It must be emphasized that MLA detects most of the mutational events 
associated with the aetiology of cancer and other human diseases, including point mutations and 
a number of different types of chromosomal mutations. For all these  all of these reasons, the 
MLA is recommended by a number of international regulatory agencies, including the U.S. 
Food and Drug Administration, the U.S. Environmental Protection Agency, several EU 
Directives, and the EU REACH integrated testing strategy. Thus, the relevance of the MLA 
assay would reinforces our suggestion of the low or null genotoxic potential of carvacrol. 
Nevertheless, it must be stated that c. In addition, the observed differences could be also 
explained by the differences that could exist in the uptake and the metabolism of the cells. 
 
CContradictory results have been reported in the scientific literature regarding the 
mutagenicity and genotoxicitygenotoxicity/mutagenicity of carvacrol. AThe aThe us, absence of 
mutagenicity activity of this monoterpene has been was observed in the Salmonella/microsome 
reversion test [2841], whereas andor other studies reported that carvacrol behaves as a strong 
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antimutagenic agent [2942the SCE assay [54], while other studies have reported that carvacrol 
behaves as . In contrast, according to Ipek et al. [42], carvacrol was reported as a strong direct 
acting mutagen [42]. ]. In mammalian cells, although a Moreover, other  in the Ames test 
system and its metabolites showed weaker mutagenicity at lower concentrations, at least for 
TA98 strains of S. typhimurium. Ppositive genotoxic responses have beenwas obtained in 
different mammalian cell lines (human lymphocytes) through the standard cComet assay  of 
carvacrol has also been reported by Aydin et al. [21-2234-3], whereas a lack of genotoxicity 
using on differentother cell- lines (Caco-2, HepG2, V79, N2a) has also been reported also 
showed  [26, 405].  
 
in human lymphocytes using the standard comet assay, whereas a lack of genotoxicity on 
several human cells, such as HepG2 and Caco-2 cells, was observed [36], as well as in V70 
cells [39], fast-growing mouse neuroblastoma N2a cells, and cultured primary rat neurons [55]. 
Confirming the contradictory data on the genotoxic effects of carvacrol, Ündeger et al. [26] 
revealed non- oxidative DNA damage by low concentrations of this compound using the use of 
the formamidopyrimidine glycosylase (FPG)-modified cometcComet assay in V79 cellsrevealed 
no oxidative DNA damage induction for any of the concentrations assayed [39], whereas, but 
positive effects were recorded were observed in the same assay by using Caco-2 cells exposed 
toafter 48 h of exposure at 460 µM carvacrol [2740]. These contradictory results can be 
associated to bothwith the pro-oxidants and anti-oxidants properties reported for EOs [1016].   
The increase e increase in the levels of oxidative DNA damage observed for carvacrolin Caco-2 
cells  is probably a consequence of its capacity to disturb redox cellular equilibrium . In this 
sense, Llana-Ruiz-Cabello et al. [1] demonstrateda significant increases in the levels of reactive 
oxygen species (ROS) when Caco-2 cells wereere exposed to carvacrol for 24 h (460 µM) and 
48 h (230 µM). In the case of EOs and their main components, many authors have indicated the 
involvement of oxidative stress as one of their main toxicity pathways, suggesting a phenolic-
like pro-oxidant activity [16].It should be indicated that the majority of antioxidant compounds 
could have also pro-oxidant activity when their concentrations reach high levels [56]. This has 
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also been reported for major compounds of EOs [57], what would modify their mutagenic and 
genotoxic properties [58]. This pro-oxidant activity could accelerate the structural changes of 
membranes (through the oxidation of lipids forming the lipidic bilayers) and, therefore, increase 
the permeability allowing for an abnormal exchange of substances, including ROS, which could 
interact with lipids or phenolic components of EOs, increasing the oxidation [16]. As already 
indicated, there are no previous studies of carvacrol using gene-mutation assays in mammalian 
cells to compare with our data.  ]. 
 
Overall, the present study shows that thymol was nont -genotoxic when tested within the 
MN and MLA assays at concentrations potentially intended to be used as additives in food 
packaging. This fact is reinforced by our previous results in the Ames and cCcomet assays 
[2740]. On the other hand, aAlthough carvacrol exhibited   a slight genotoxic potential in the 
MN test, this effects was only observed at the highest concentration assayed (700 µM, 
equivalent to 10,.6% of carvacrol in the EO) in L5178Y/Tk
+/−
L5178Y cells, and no genotoxic 
response was found in the MLA assay after 4 h and 24 h of exposure. This result , what 
couldwould indicates a low genotoxic risk if already exist, or just consider thisthe result as 
acould be considered marginal one and without biological relevance. Nevertheless, this potential 
discrepancy would suggests to extendfurther studies with carvacrol trying to determine its real 
genotoxic potential. It must be indicated that the content of many EOs, from the same or from 
severalOriganum species, can depend on many factors including cultivation, origin, vegetative 
stage and growing season of the plants [59]. For example, carvacrol and thymol contents in the 
same species of oregano (Origanum onites from Western Anatolia, Turkey) may change 
considerably, from 64.3 to 24.52%, and 1.4 to 15.66%, respectively [60-61]. Thus, it is 
important to select an EO with appropriate proportions of their major compounds, since 
although we have shown low risk associated to the selected compounds, it would be desirable to 
choose EOs with high thymol and low carvacrol contentsvariations in their composition have 
been described [59].for their intended use in food packaging.  
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5. Conclusion 
 
In the present study, the, analysis of the genotoxic potential of thymol and carvacrol has 
beenwas evaluated by using the MN and MLA tests. by  It should be emphasized that tThis is 
the first study using the MLA determiningto determine the potential mutagenic effect of both 
compounds. RThe results indicate the MN test revealed that only carvacrol exhibits  aexhibits a 
weak genotoxic potential damage on L5178Y/Tk+/−L5178Y cells, but only when the MN was 
used, and at the highest concentration assayed (700 µM),, and in the absence of S9. The 
genotoxic response in the MLA assay was studied for the first time for carvacrol and thymol, 
obtaining a lack of genotoxicity in both cases.. This would suggest a weak genotoxic potential 
for carvacrol or, alternatively, that these positive findings are just marginal data without 
biological relevance. Nevertheless, according to the conflictiveing data reported for carvacrol  in 
the literature, fFurther research is needed to confirm their its safety before it isthey are used as 
an active additives in food packaging. 
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Figure Captions 
Figure 1. Cell toxicity viability of thymol (A) and carvacrol (B). Treatment lasted for 3-6 h in 
the presence of an S9 mix and for 24 h in the absence of the S9 mix. Results expressed as the 
mean ± SD. *Significant differences fromat Pp<0.01.and viability was measured by the trypan 
blue exclusion assay. 
 
Figure 2. Mutagenicity of thymol and carvacrol on L5178Y/Tk+/- mouse lymphoma cells. 
Results are from two different experiments. 
 
Formatted: Font: Italic
35 
 
Table Captions 
Table 1. Percentage of binucleated cells with micronuclei (BNMN) and the nuclear division 
index (NDI) in cultured mouse lymphoma cells treated with thymol in the absence of the 
metabolic fraction S9. 
 
Table 2. Percentage of binucleated cells with micronuclei (BNMN) and the nuclear division 
index (NDI) in cultured mouse lymphoma cells treated with thymol in the presence of the 
metabolic fraction S9. 
 
Table 3. Percentage of binucleated cells with micronuclei (BNMN) and the nuclear division 
index (NDI) in cultured mouse lymphoma cells treated with carvacrol in the absence of the 
metabolic fraction S9. 
 
Table 4. Percentage of binucleated cells with micronuclei (BNMN) and the nuclear division 
index (NDI) in cultured mouse lymphoma cells treated with carvacrol in the presence of the 
metabolic fraction S9. 
 
Table 5. Results of the toxicity and mutagenicity of thymol in mouse lymphoma cells 
(L5178Y/Tk+/-) after 4 h of treatment. 
 
Table 6. Results of the toxicity and mutagenicity of carvacrol in mouse lymphoma cells 
(L5178Y/Tk
+/-
) after 4 h of treatment. 
 
Table 7: . Results of the toxicity and mutagenicity of carvacrol in mouse lymphoma cells 
(L5178Y/Tk
+/-
) after 24 h of treatment. 
 Test substance Treatment time (h) Concentrations BNMN (%)±SE NDI±SE 
Negative control 24 - 0.9±0.1 1.3±0.0 
Mitomycin C 24 0.0625 µg/mL 15.6±3.0** 1.4±0.1 
Thymol 
24 15.62 µM 0.7±0.3 1.4±0.0 
24 31.25 µM 0.6±0.3 1.5±0.1 
24 62.5µM 1.0±0.5 1.5±0.0 
24 125 µM 0.8±0.2 1.3±0.0 
24 250 µM 1.2±0.1 1.5±0.1 
Values are expressed as mean  SD. The significance levels observed are **P<0.01 in comparison to the negative 
control. 
 
 
Table 1
Test substance Treatment time (h) Concentrations BNMN (%)±SE NDI±SE 
Negative controls 3-6 - 0.9±0.1 2.0±0.1 
Cyclophosfamide 3-6 8 µg/mL 3.6±0.4** 2.0±0.0 
 
 
 
 
Thymol 
 
 
 
 
3-6 15.62 µM 0.7±0.3 1.9±0.0 
3-6 31.25 µM 1.0±0.4 2.0±0.1 
3-6 62.5 µM 0.8±0.5 2.0±0.1 
3-6 125 µM 1.1±0.1 2.0±0.1 
3-6 250 µM 1.1±0.1 1.9±0.1 
Values are expressed as mean  SD. The significance levels observed are **P<0.01 in comparison to the negative 
control. 
       
        
Table 2
 Test substance Treatment time (h) Concentrations BNMN (%)±SE NDI±SE 
Negative control 24 - 3.0±1.1 1.5±0.1 
Mitomycin C 24 0.0625 µg/mL 31.2±2.2** 1.1±0.0** 
Carvacrol 
24 43.75 µM 5.0±0.7 1.4±0.0.3 
24 87.5 µM 4.9±0.6 1.4±0.0 
24 175 µM 3.1±0.6 1.4±0.0 
24 350 µM 5.0±0.9 1.5±0.1 
24 700 µM 6.1±1.0** 1.5±0.1 
Values are expressed as mean  SD. The significance levels observed are **P<0.01 in comparison to the negative 
control. 
 
Table 3
Test substance Treatment time (h) Concentrations BNMN (%)±SE NDI±SE 
Negative control 3-6 - 3.1±0.1 1.9±0.0 
Cyclophosphamide 
 
3-6 8 µg/mL 5.5±0.8** 1.9±0.1 
Carvacrol 
3-6 43.75 µM 3.1±0.7 1.9±0.1 
3-6 87.5 µM 3.1±0.4 1.9±0.1 
3-6 175 µM 3.5±0.7 1.9±0.1 
3-6 350 µM 3.3±0.7 1.9±0.0 
3-6 700 µM 3.5±0.3 1.9±0.1 
Values are expressed as mean  SD. The significance levels observed are **P<0.01 in comparison to the negative 
control. 
 
Table 4
Concentration (µM) Percent plating efficiency Mutant frequency (x 10
-6
) Relative total growth MF (S/L)
a
 IMF (MF-SMF) 
Experiment 1      
0 95 138 100 81/57 - 
7.8 95 152 110 55/97 14 
15.65 80 176 160 68/108 38 
31.25 74 177 137 80/97 39 
62.5 74 168 140 87/80 30 
125 95 182 90 98/84 44 
250 104 177 93 81/96 39 
MMS (10 µg/mL) 104 773*** 87 648/125 635 
      
Experiment 2      
0 100 137 100 77/60 - 
7.8 82 162 97 97/65 25 
15.65 76 171 118 105/66 34 
31.25 75 174 99 108/66 37 
62.5 106 110 86 78/32 -27 
125 96 146 106 99/47 9 
250 76 158 101 103/55 21 
MMS (10 µg/mL) 47 986*** 77 765/221 849 
***P ≤ 0.001 (significantly different from negative control). a Total mutant frequency divided into small/large (S/L) colony mutant frequencies. 
Table 5
***P ≤ 0.001 (significantly different from negative control). a Total mutant frequency divided into small/large (S/L) colony mutant frequencies. 
 
Concentration (µM) Percent plating efficiency Mutant frequency (x 10
-6
) Relative total growth MF (S/L)
a
 IMF (MF-SMF) 
Experiment 1      
0 78 120 100 69/51 - 
62.5 76 112 88 79/33 -8 
125 74 141 80 90/51 21 
250 93 133 75 77/56 12 
500 77 182 74 134/48 62 
1000 88 118 69 69/49 -2 
1500 78 104 20 60/44 -16 
MMS (10 µg/mL) 51 906*** 60 805/101 786 
      
Experiment 2      
0 78 132 100 84/48 - 
62.5 81 113 99 68/55 -19 
125 74 128 102 61/67 -4 
250 85 122 89 81/41 -10 
500 78 116 73 86/30 -16 
1000 75 143 57 73/70 11 
1500 56 210 56 126/84 78 
MMS (10 µg/mL) 56 604*** 61 400/204 472 
Table 6
Concentration (µM) Percent plating efficiency Mutant frequency (x 10
-6
) Relative total growth MF (S/L)
a
 IMF (MF-SMF) 
Experiment 1      
0 110 112 100 75/37 - 
62.5 96 111 73 48/63 -1 
125 96 118 71 58/60 6 
250 115 113 63 67/46 1 
500 93 122 58 37/85 10 
1000 94 110 54 46/64 -2 
1500 113 100 36 32/68 -12 
MMS (10 µg/mL) 46 1470*** 37 956/515 1358 
      
Experiment 2      
0 82 146 100 76/70 - 
62.5 77 191 91 57/134 45 
125 94 106 82 31/75 -40 
250 65 220 82 103/117 74 
500 85 141 55 65/76 -5 
1000 80 148 54 46/102 2 
1500 77 200 38 76/124 54 
MMS (10 µg/mL) 34 2560*** 37 1715/845 2414 
***P ≤ 0.001 (significantly different from negative control). a Total mutant frequency divided into small/large (S/L) colony mutant frequencies. 
Table 7
Figure(s)
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La apuesta de la industria alimentaria por la incorporación al envasado de 
materiales de origen natural es hoy una realidad. El objetivo de esta nueva aplicación es 
aumentar la perdurabilidad de los alimentos perecederos en el mercado, y así, reducir 
las notables pérdidas económicas que esto supone. Entre los materiales seleccionados 
para obtener envases con propiedades tecnológicas mejoradas se encuentran las arcillas 
y organoarcillas derivadas. Por esta razón, decidimos realizar una serie de estudios que 
nos permitieran conocer, dada la escasez de información hasta el momento, el perfil 
toxicológico tanto in vitro como in vivo de cada una serie de arcillas y de los extractos 
de migración (simulantes alimentarios) obtenidos de materiales nanocompuestos 
resultantes tras la inclusión de las arcillas en el polímero.  
Por otra parte, cabe también destacar el uso de aceites esenciales y compuestos 
mayoritarios de los mismos con el fin de obtener envases activos, centrados en 
aprovechar las propiedades antioxidantes/antimicrobianas de las sustancias en cuestión. 
En este caso se ha abordado la evaluación del perfil genotóxico de timol y carvacrol, 
dos compuestos mayoritarios del aceite de orégano, siendo necesaria también una 
exhaustiva evaluación toxicológica antes de la comercialización de los mismos. 
 
1. ESTUDIOS IN VITRO SOBRE ARCILLAS Y MATERIALES 
NANOCOMPUESTOS  
Debido al auge del uso de las arcillas en diversas aplicaciones, sobre todo en la 
industria alimentaria, existen en la bibliografía diversos estudios acerca de la toxicidad 
inducida por arcillas y materiales nanocompuestos derivados de ellas, principalmente de 
la montmorillonita (Mt), bentonita y caolinita, en diferentes líneas celulares. Las líneas 
celulares de origen humano son el modelo in vitro escogido con más frecuencia, 
seguido de líneas celulares de roedores. 
En primera instancia, hay diversos trabajos publicados acerca del potencial 
citotóxico de la Mt, comercialmente conocida como CNa
+
. En los estudios disponibles 
en líneas celulares de tejidos diana, como son las pertenecientes a los órganos del 
sistema digestivo, podemos encontrar una importante disparidad de resultados. Los 
datos obtenidos en el presente trabajo mostraron de forma general una ausencia de 
citotoxicidad en las líneas celulares ensayadas (HepG2, Caco-2 y HUVEC) en el rango 
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de concentraciones seleccionado y con los biomarcadores empleados (captación de rojo 
neutro (RN), reducción de la sal MTS (MTS) y el contenido proteico total (PT)), 
observando únicamente leves diferencias en la concentración más alta ensayada (62,5 
µg/mL) en HepG2 en el PT tras ambos tiempos de exposición (24 y 48h) y en Caco-2 
tras 48h a las dos concentraciones más altas ensayadas (62,5 y 125 µg/mL) en la 
reducción de la sal MTS. Estos resultados coinciden con los obtenidos por Sharma y 
col. (2010), los cuales no observaron signos de citotoxicidad en células Caco-2 
expuestas a CNa
+
 (concentración máxima 226 µg/mL) mediante el ensayo Alarmar 
Blue. Otros autores también han descrito la ausencia de citotoxidad en la línea celular 
monocítica U937 expuesta a CNa
+ 
(Lordan y Higgimbotham, 2012). Sin embargo, 
existen trabajos publicados en bibliografía que informan del descenso de viabilidad e 
inhibición en la proliferación celular de células intestinales (INT-407) expuestas a CNa
+
 
a concentraciones superiores (1000 µg/mL) tras tiempos mayores de exposición (Baek y 
col., 2012). Por otro lado, Lordan y col. (2011) también observaron efectos citotóxicos 
en HepG2 tras la exposición a Mt desde concentraciones muy inferiores a las ensayadas 
en nuestro caso (1 µg/mL) mediante el ensayo de MTT. Otros autores han estudiado el 
potencial citotóxico en células de ovario de hamster (CHO) expuestas a 1mg/mL de Mt 
durante 24h, obteniéndose una reducción significativa en la viabilidad celular con 
respecto al control (Li y col., 2010). Murphy y col. (1993), por su parte, pusieron de 
manifiesto un descenso de la viabilidad celular en células HUVEC expuestas durante 
24h a 0,1 mg / mL bentonitas, aunque se obtuvieron resultados no significativos en las 
líneas celulares neuronales N1E-115 y ROC-1.  
En el caso de arcillas modificadas basadas en CNa
+
 se han obtenido una importante 
diversidad de datos, según el modificador empleado, las concentraciones ensayadas y el 
modelo experimental seleccionado. Cabe destacar los efectos citotóxicos obtenidos en 
nuestro caso por C30B, Clay2, Clay4A y Clay4B en las líneas celulares elegidas 
(HepG2, Caco-2 y HUVEC) mediante los biomarcadores seleccionados (RN, MTS y 
PT), mientras que no se obtuvieron efectos significativos de descenso de la viabilidad 
celular con C20A, Clay1 y Clay3. Hay autores que sugieren que el modificador incluido 
en la arcilla madre interviene en la modulación de la toxicidad ejercida por la arcilla 
resultante (Sharma y col., 2010).  
Los resultados obtenidos con C30B en el presente estudio son avalados por los 
resultados publicados por Sharma y col. (2010), los cuales observaron una depleción de 
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la viabilidad de las células Caco-2 expuestas a C30B a la concentración más alta 
ensayada (226µg/mL). Otras arcillas disponibles comercialmente también han sido 
evaluadas como es el caso de C93A, la cual dio lugar en células HepG2 a un descenso 
de la viabilidad celular y a un incremento de la liberación de la lactato deshidrogenasa 
(LDH) dependiente del rango de concentración ensayado (0-1000µg/mL) (Lordan y 
col., 2011).  
Hasta el momento los estudios toxicológicos llevados a cabo con arcillas 
modificadas con silanos, como es el caso de Clay3, Clay4A y Clay4B, son muy 
limitados. Vergaro y col. (2010) evaluaron nanotubos de halosita funcionalizados con 
aminopropiltrietoxisilano (APTES), modificador presente en Clay3. Los resultados 
obtenidos en células epiteliales HeLa y MCF- 7 (epiteliales) por exposición a la arcilla 
funcionalizada (1-1000µg/mL) indicaron una inhibición en el crecimiento de forma 
dependiente en el tiempo en ambas líneas celulares.  
Por otro lado, Verma y col. (2012) estudiaron el efecto de la Mt modificada con 
oligo(estireno-co-acronitrilo) (0-250 µg/mL) en células renales (HEK293) y 
fibroblásticas (NIH 3T3), obteniendo un descenso significativo de la viabilidad celular 
mediante el ensayo de MTT, así como un aumento de la liberación de la LDH. Sin 
embargo, es muy curioso destacar que la Mt sin modificar presentó mayor toxicidad que 
la modificada bajo las condiciones ensayadas (Verma y col., 2012). Otros autores han 
evaluado el potencial citotóxico de la bentonita nativa (arcilla con estructura similar a la 
Mt) y modificada con H2SO4 en células HMy2.CIR durante 4 y 24h, observando una 
depleción de la viabilidad por exposición a ambas, siendo más significativo en el caso 
de la arcilla modificada (Meibian y col., 2010).  
Una vez realizados los estudios de citotoxicidad con las arcillas disponibles 
continuamos con la evaluación del perfil toxicológico que presentaba cada una, 
ahondando en las alteraciones morfológicas celulares producidas tras su exposición, 
determinación de los mecanismos de acción (incluyendo estrés oxidativo, 
genotoxicidad/mutagenicidad, inflamación y mecanismos de muerte celular). De este 
modo se trataba de esclarecer la mayor información posible acerca del perfil 
toxicológico de arcillas destinadas a aplicaciones en la industria alimentaria. 
Entre los marcadores de toxicidad celular más frecuentes usados están los que se 
basan en la alteración de la morfología celular (Borenfreud y Borrero 1984). Los datos 
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recogidos en nuestro estudio muestran una alteración de diversas estructuras celulares 
como mitocondrias, formación de heterofagosomas y gotas lipídicas tras exposición de 
HepG2 a C30B, y, variaciones en el aparato de Golgi y segregación nuclear tras 
exposición de Caco-2 a la misma arcilla modificada, durante 24 y 48h en ambos casos. 
De acuerdo con estos resultados, encontramos en bibliografía un estudio llevado a cabo 
en células HepG2 expuestas a CNa
+
 y C93A en el cual donde se observa muerte celular 
y degradación de orgánulos tras la exposición a ambas después de 24h de exposición 
(Lordan y col., 2011). Del mismo modo, Murphy y col. (1993a,b) examinaron cambios 
morfológicos producidos en HUVEC y cultivos primarios de neuronas expuestas a 0.1 
mg/mL de un grupo de arcillas entre la que se encontraba la Mt, además de bentonita, 
erionita y caolinita, mostrando la Mt un mayor daño morfológico. Únicamente, Geh y 
col. (2006) informaron sobre una ausencia de alteraciones morfológicas en la línea 
celular de fibroblastos IMR90 expuesta a bentonitas nativas y modificadas (10 µg/cm
2
).  
Por otro lado, valoramos la posibilidad de estudiar in vitro el estrés oxidativo como 
posible mecanismo de acción tóxica, mediante la generación de especies reactivas de 
oxígeno (ERO) y el descenso del contenido de glutatión (GSH). Varios autores han 
evaluado los efectos relacionados con la generación de ERO y otras alteraciones en 
diversas líneas celulares expuestas a arcillas no modificadas y modificadas. Respecto a 
los datos obtenidos acerca de CNa
+
 se expone una gran disparidad de los mismos en los 
trabajos disponibles en la literatura científica, dependiendo sobre todo del modelo 
experimental seleccionado. En este sentido, Baek y col. (2012) indicaron una 
producción significativa de ERO a la concentración más alta ensayada de Mt expuesta a 
la línea celular intestinal INT-407 (1000µg/mL) tras 24h de exposición, aunque a 
tiempos superiores (48-72h) de ensayo el daño apareció desde concentraciones mucho 
menores (a partir de 50µg/mL). De forma similar, Lordan y col. (2011) evidenció la 
generación de ERO en HepG2 expuestas a CNa
+
 desde concentraciones muy bajas 
(50µg/mL) a todos los tiempos de exposición ensayados (4, 16 y 24h). Sin embargo, por 
su parte, Sharma y col. (2010) publicó la ausencia de alteración por exposición de CNa
+
 
a Caco-2 (226 µg/mL). 
En consideración a las arcillas modificadas con sales de amonio cuaternario, en 
nuestro estudio sólo se ha observado un incremento en la generación de ERO con un 
descenso significativo del contenido en GSH en células Caco-2 expuestas a C30B a la 
concentración más alta ensayada (40 µg/mL), mientras que las células HepG2 
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únicamente mostraron una depleción del compuesto antioxidante en todas las 
concentraciones ensayadas (22, 44 y 88 µg/mL) pero no un incremento de ERO. En el 
caso de la exposición de ambas líneas a Clay2, sólo se observó alteración en el 
contenido de GSH en la línea hepática, presentándose una disminución en todas las 
concentraciones ensayadas a ambos tiempos de exposición (22, 44 y 88 µg/mL). En 
contraste con estos resultados, otros estudios no observaron generación de ERO tras la 
exposición de C30B a Caco-2 a concentraciones superiores a las ensayadas en nuestro 
caso (0-226 µg/mL) (Sharma y col., 2010). Sin embargo, C93A expuesta a HepG2 dio 
lugar a un incremento en la producción de ERO, siendo las concentraciones de 
exposición más elevadas que las seleccionadas en nuestro estudio (1000µg/mL), dando 
lugar a una respuesta de estrés posiblemente debido no sólo al efecto tóxico sino 
también pudiendo estar relacionada con la posible precipitación de la arcilla y 
generación de estrés físico en las células. 
Respecto a las arcillas modificadas con silanos, Clay3, Clay4A y Clay4B, se 
observaron niveles significativos de ERO en el caso de HepG2 expuestas a Clay4A y 
Clay4B, y Caco-2 expuesta a Clay4A; sin embargo, no se produjo ninguna alteración 
por exposición a Clay3. Por otro lado, sólo en el caso de ambas líneas celulares 
expuestas a Clay4B se obtuvo un descenso en el contenido de GSH a la concentración 
más alta ensayada para Caco-2 (40µg/mL) y a las dos concentraciones superiores para 
HepG2 (42,5 y 85µg/mL). Podríamos suponer que el papel que juega el modificador 
empleado en cada caso cuenta con un papel crucial, modulando la toxicidad generada. 
Hasta el momento, los estudios disponibles en bibliografía sobre arcillas modificadas 
con silanos son inexistentes. 
Además de la Mt y arcillas modificadas basadas en ella podemos encontrar trabajos 
sobre otras arcillas con estructura similar. Meibian y col. (2010) determinaron la 
generación de ERO, la actividad de la superóxido dismutasa (SOD) y peroxidación 
lipídica (LPO) en una línea celular linfoblastoide expuesta a dos bentonitas, una nativa 
y otra modificada con H2SO4. Los autores observaron que la mayor respuesta de estrés 
oxidativo fue mostrada con la bentonita modificada bajo las condiciones ensayadas. 
Por otra parte, teniendo en consideración la variedad de mecanismos que conducen 
al daño en el ADN inducido por xenobióticos, y, la gama de acontecimientos 
genotóxicos y mutagénicos que pueden ocurrir como resultado, se requiere una batería 
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de ensayos para el establecimiento del perfil y potencial genotóxico de una sustancia 
que esté siendo investigada (Doak y col., 2012). En la actualidad, los ensayos in vitro de 
genotoxicidad y mutagenicidad se incluyen entre el conjunto básico de pruebas de 
toxicidad que debe llevarse a cabo para la evaluación de la seguridad, requerida dicha 
información por las autoridades europeas con el fin de autorizar nuevas sustancias para 
ser usadas como materiales en contacto con alimentos (EFSA 2011b, 2015). Dentro de 
los ensayos de genotoxicidad reclamados por la EFSA se encuentran el ensayo de 
Micronúcleos (MN) y el test de Ames (2011b, 2015). Además, el ensayo Cometa se 
lleva a cabo en muchas ocasiones con el fin de confirmar resultados no concluyentes, 
contradictorios o equívocos en los tests anteriores , ya que nos proporciona una 
información más completa acerca del potencial genotóxico de la sustancia objeto de 
estudio.  
Los resultados presentados en esta Tesis Doctoral muestran diferentes respuestas 
según la arcilla seleccionada. De tal forma, CNa
+
 mostró una respuesta positiva en la 
inducción de MN y otras anomalías celulares, como brotes nucleares, a concentraciones 
no citotóxicas (0-62,5µg/mL) tras 24h de exposición en células HepG2; sin embargo, no 
se observó una respuesta mutagénica mediante la exposición de 5 cepas de Salmonella 
typhimurium a concentraciones superiores de la misma (hasta 125µg/mL). Por otro lado, 
las arcillas modificadas disponibles comercialmente, C30B y C20A, mostraron un perfil 
genotóxico muy diferente. C20A indicó ausencia de genotoxicidad mediante el ensayo 
cometa en las células HepG2 y Caco-2, mientras que, C30B indujo rotura de las hebras 
de ADN en la línea hepática (0-88µg/mL) pero no en la línea intestinal (0-40µg/mL) 
con las condiciones ensayadas. Sin embargo, no se observó daño genotóxico mediante 
el ensayo MN a concentraciones subcitotóxicas (0-31,25µg/mL) en células HepG2 
aunque sí daño mutagénico mediante el test Ames, siendo en este último más elevadas 
las concentraciones ensayadas (0-250µg/mL). En el caso de Clay1 (0-8µg/mL), 
solamente se obtuvo una respuesta positiva en el caso del test de Ames en presencia de 
fracción metabólica externa, mientras que no produjo genotoxicidad bajo las 
condiciones de los ensayos de MN y cometa. Clay2 causó daño en el ADN en células 
HepG2 y Caco-2 mediante el ensayo cometa (0-88 y 0-34µg/mL, respectivamente), así 
como cambios significativos en ensayo de MN y test de Ames con respecto al grupo 
control (0-15,6 y 0-125 µg/mL para ambos ensayos, respectivamente).  
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Li y col. (2010) coincidieron con la respuesta obtenida por Mt (0-1000µg/ placa)
 
en 
el test de Ames, no mostrando diferencias significativas con el grupo control. Por el 
contrario, Taylor y col. (2014) informaron del incremento de colonias revertientes de 
Salmonella typhimurium expuestas a CNa
+
 (0-0.01g), indicando potencial mutagénico 
de la misma. Los resultados obtenidos en nuestro estudio se contraponen también a los 
publicados por Sharma y col. (2010), que observaron efectos genotóxicos en Caco-2 
expuestas a C30B (0-226µg/mL) mediante el ensayo cometa, siendo superiores las 
concentraciones ensayadas en este caso. 
Otros autores, incluyendo la EFSA, evaluaron también el potencial genotóxico 
presente en bentonitas nativas y modificadas. Los datos disponibles informan de una 
ausencia de genotoxicidad de la bentonita nativa, confirmada mediante el ensayo de 
MN, test de Ames y enyaso cometa, frente al potencial genotóxico presentado por la 
bentonita modificada con H2SO4. 
En cuanto a Clay3, Clay4A y Clay4B se obtuvieron resultados muy variados, desde 
la ausencia de genotoxidad (ensayo Cometa) y mutagenicidad por exposición de Clay3 
y Clay4A en HepG2 y Caco-2, y, Salmonella typhimurium, respectivamente, hasta la 
repuesta positiva de Clay4B en ambos ensayos mencionados bajo las condiciones 
ensayadas. En la literatura científica no existen estudios de genotoxicidad realizados con 
arcillas modificadas con silanos. 
Por otro lado, entre los biomarcadores más comúnmente ensayados en relación al 
proceso inflamatorio se encuentran la liberación de citoquinas, principalmente 
interleucina-6 (IL-6) y el factor de necrosis tumoral α (TNF-α). Hasta el momento, los 
estudios de inflamación levados a cabo con arcillas son muy escasos. Únicamente, 
Elmore y col. (2003) informaron de la producción de citotoxicidad en células 
macrófagas así como actividad hemolítica en células sanguíneas de diferentes especies 
generadas tras la exposición a diversas arcillas, entre ellas Mt. Además, se ha publicado 
que la Mt promueve infección mediante citotoxicidad directa en neutrófilos, dejándoles 
inservibles para la fagocitosis bacteriana (Dougherty y col., 1985). Estos resultados no 
coinciden con los obtenidos en nuestro estudio, donde HepG2 y Caco-2 expuestas a 
C30B y Clay2 no mostraron un incremento en la liberación de la IL-6. 
Otros parámetros a tener en cuenta son los diferentes marcadores utilizados para 
determinar el mecanismo de muerte celular, destacando entre ellos la citometría de 
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flujo, que informa del porcentaje de células que sufren muerte celular programada 
(apoptosis o necrosis) y la actividad de las enzimas caspasas indicativa de apoptosis 
(Napierska y col., 2009; Lordan y col., 2011). 
En nuestro estudio se obtuvo una respuesta de la actividad caspasa 3/7 de células 
HepG2 expuestas a C30B (0-500µg/mL). Estos resultados son similares a los obtenidos 
por Lordan y col. (2011) en células HepG2 expuestas a CNa
+
 y C93A (0-1000µg/mL), 
informando de unos niveles no significativos con respecto el grupo control. 
Recientemente, Janer y col. (2014) han diferido de los resultados obtenidos hasta el 
momento, encontrando diferencias de la actividad caspasa 3/7 así como alteraciones 
mediante citometría de flujo de células HepG2 y SKMEL en presencia de Mt y arcillas 
modificadas con sales cuaternarias de amonio (0-500µg/mL). Estos resultados 
concuerdan con los publicados por Liu y col. (2010), los cuales describieron un 
incremento de la actividad caspasa e inducción de apoptosis en células NIH3T3 y 
HEK293 tras exposición a Mt y Mt modificada con oligo(estireno-co-acrilonitrilo) 
(1g/L). Además, Meibian y col. (2010) observó en células HMyR2 una inducción de 
apoptosis mediante citometría de flujo por exposición a partículas de bentonita, arcillas 
muy similares a la Mt. 
Por otro lado, Caco-2 fueron expuestas a Clay4A (0-250µg/mL) y Clay4B (0-
40µg/mL), observándose un mecanismo de apoptosis y necrosis tras la exposición a 
ambas, respectivamente, mediante citometría de flujo.  
La expresión génica y abundancia proteica son dos marcadores imprescindibles para 
determinar que está ocurriendo realmente a nivel molecular tras la exposición a diversas 
sustancias. Los datos obtenidos por la exposición de concentraciones subcitotóxicas de 
CNa+ y Clay2 a HepG2 demuestran una importante desregulación génica de genes 
involucrados en la activación/ destoxicación así como en mecanismos de toxicidad, 
mientras que, no se obtuvo una significativa sobreexpresión o baja regulación de genes 
con respecto al control en el caso de C30B y Clay1. Actualmente, no existen en 
bibliografía trabajos acerca del potencial de modulación en líneas celulares eucariotas 
que presentan las arcillas destinadas al envasado sobre la regulación génica; sin 
embargo, Abatte y col. (2009) estudiaron la influencia de arcillas comerciales, entre 
ellas C30B, sobre la comunidad eurobacteriana presente en el suelo. Tras la exposición 
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de C30B se observaron únicamente alteraciones leves en Pseudomonas putida, pero no 
en el resto de bacterias ensayadas. 
En relación a la toxicidad in vitro de los materiales nanocompuestos y extractos de 
migración obtenidos a partir de ellos, la información disponible es mucho más escasa. 
La citotoxicidad y mutagenicidad de los extractos de migración generados a partir de 
ácido poli(láctico) (PLA) y Clay1, y, PLA-Clay2, y, polipropileno (PP)- Clay3, han sido 
evaluadas en nuestras investigaciones, no observando efectos citotóxicos en HepG2 y 
Caco-2 mediante tres biomarcadores ensayados (RN, MTS y PT) en un rango de 
concentraciones de 0-100%. Del mismo modo, Salmonella typhimurium no mostró un 
incremento de colonias revertientes tras la exposición a ambos simulantes. Además, se 
ha observado un incremento de la vida útil de carnes de aproximadamente 24h, 
indicando la compatibilidad y mejora de los materiales resultantes. Otros autores han 
descrito también la inexistencia de efectos citotóxicos y cambio morfológicos, así como 
la buena biocompatibilidad de materiales nanocompuestos investigados en diferentes 
líneas celulares (NIH3T3, L929, IMR32, fibroblastos y osteoblastos) durante periodos 
de exposición generalmente amplios (1-7 días) (Zia y col., 2011; Liu y col., 2012; 
Fukushima y col., 2012, 2013; Kevadiya y col., 2013, 2014). La generación de estrés 
oxidativo también fue menor en aquellos grupos expuestos a materiales 
microcompuestos de polímero y arcillas modificadas (Kevadiya y col., 2013, 2014). 
Hasta el momento no existen en la literatura científica más estudios acerca del potencial 
genotóxico de extractos o materiales nanocompuestos; sin embargo, podemos encontrar 
algunos trabajosde genotoxicidad y mutagenicidad de modificadores potenciales, 
mostrando tanto efectos positivos como negativos (Dmochowska y col., 2011; 
Grabinska-Sota, 2011). 
Por último, nos resultó de interés evaluar el contenido de la migración de los 
metales más característicos que se encuentran en la estructura de la Mt (Al, Ca, Fe, Mg 
y Si) en los simulantes alimentarios utilizados que constituyen los extractos de 
migración de PLA-Clay1, PLA-Clay2, siendo en este caso agua destilada, y, PP-Clay3 y 
PP-Clay4B, utilizándose para ello etanol al 10% e isooctano. No se encontraron 
diferencias significativas con respecto al grupo control en el caso de los extractos 
obtenidos a partir de PLA-Clay1 y PLA-Clay2; sin embargo, se obtuvieron diferencias 
significativas en los contenidos de Al, Ca y Si de los simulantes empleados en PP-Clay3 
y PP-Clay4B. Podemos hallar en la literatura científica trabajos que evalúan la 
Resultados y Discusión General / Results and General Discussion 
464 
 
migración de metales de materiales nancompuestos a diversos simulantes y/o alimentos. 
Avella y col. (2005) estudiaron la migración de metales a lechuga y espinacas en 
contacto con materiales nanocompuestos de almidón de patata y Mt. No se observaron 
diferencias significativas en los contenidos de Fe y Mg, mientras que sí se observó un 
mayor contenido de Si, siendo fácilmente atribuible al alto contenido de este metal que 
presenta a arcilla. Por otro lado, Busolo y Lagaron (2012) investigaron la migración de 
Al y Fe de materiales nanocompuestos de poliolefinas con caolinitas. Los simulantes 
seleccionados fueron agua e isooctano, no hallándose diferencias significativas en 
ninguna de las muestras ensayadas con respecto al control. 
De forma resumida podemos concluir este apartado que los resultados obtenidos por 
los diferentes autores están principalmente influidos por los diferentes parámetros: a) 
modelo experimental seleccionado; b) concentraciones y tiempos de exposición 
ensayados; c) modificadores incorporados (si los hubiere) y d) sensibilidad de los 
biomarcadores ensayados. 
 
2. ESTUDIOS IN VIVO SOBRE ARCILLAS Y MATERIALES 
NANOCOMPUESTOS  
El número de estudios experimentales de toxicidad in vivo realizados recientemente 
con arcillas en la literatura científica es bajo en comparación con los estudios in vitro, 
obteniéndose una amplia variabilidad de resultados dependiendo de la selección de la 
arcilla, las rutas de exposición y concentraciones utilizadas.  
Los estudios llevados a cabo con arcillas nativas, como es el caso de la Mt, 
mostraron de forma general una ausencia de efectos histopatológicos después de una 
exposición aguda (Baek y col., 2012; Lee y col., 2005; Mascolo y col., 2004) o una 
exposición subcrónica o crónica en roedores (Afrie-Gyawu y col., 2005; EFSA, 2013), 
siendo éste último caso el que corresponde a los estudios realizados en la presente Tesis 
Doctoral. 
De tal forma, Baek y col. (2012) estimaron una dosis letal media (DL50) de la Mt 
superior a 1000mg/Kg en ratones tras 14 días de exposición. La ausencia de toxicidad o 
la obtención de efectos mínimos de toxicidad coincide con lo expuesto por Wiles y col. 
(2004), los cuales no observaron diferencias significativas entre embriones de ratas 
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embarazadas Sprague-Dawley expuestas a Mt (2%w/w) y el grupo control. Por el 
contrario, Patterson y Stasak (1977) publicaron los efectos negativos encontrados en 
ratas madre Sprague-Dawley expuestas a 20% de caolín durante el periodo de gestación, 
observando alteraciones en el desarrollo, anemia materna y una considerable reducción 
en el peso de nacimiento de las crías. Sin embargo, el consumo de arcillas por animales 
salvajes en la naturaleza es común, estando dicha práctica bien documentada (Slamova 
y col., 2011). Se han propuesto varias hipótesis para explicar el comportamiento 
geofágico (comer “arcillas”): (i) la desintoxicación de compuestos nocivos o 
desagradables presentes en la dieta, (2) alivio de trastornos gastrointestinales, tales 
como diarrea, (3) la suplementación del cuerpo con minerales y (4) alivio de la 
hiperacidez en el tracto digestivo (Wilson, 2003). De hecho, existen informes 
disponibles acerca de la capacidad de la arcilla para reducir micotoxicosis, metales, 
aliviar trastornos gastrointestinales etc., como se ha explicado anteriormente la 
Introducción. 
En nuestro caso, una vez seleccionada la arcilla de mejor perfil tecnológico y 
toxicológico, Clay1, realizamos un estudio de toxicidad subcrónica de 90 días en ratas 
Wistar expuestas a Clay1 en la comida (40 mg/kg/día) y a su extracto de migración 
como agua de bebida. La inexistencia de cambios histopatólogicos con respecto al 
grupo control tras la exposición a arcillas descrita con anterioridad coinciden con los 
datos presentados en nuestras investigaciones, no observándose ningún daño en el grupo 
de órganos estudiados. Además, en nuestro estudio, la ausencia de efectos tóxicos fue 
recogida de forma general con todos los parámetros evaluados, siendo únicamente 
significativa la actividad de la enzima catalasa (CAT) en riñón, así como su expresión 
génica y abundancia proteica tras exposición a Clay1. Ningún cambio fue observado en 
el caso del extracto de migración. En cuanto al estudio de biomarcadores de estrés 
oxidativo podemos encontrar los datos publicados por Kibanova y col. (2009), los 
cuales informan de un incremento de peroxidación lipídica (LPO) en sobrenadante de 
cerebros de roedores expuestos a hectorita (1000ppm).  
En relación a la genotoxicidad, la EFSA (2013) ha publicado en su informe sobre la 
bentonita la no detección de aberraciones cromosómicas tras su exposición en ratas 
durante 15 días. Del mismo modo, Sharma y col. (2014) tampoco observaron rotura en 
la hebras de ADN en colon, hígado y riñón de ratas Wistar expuestas mediante sonda a 
C30B (250-1000mg/kg/ peso corporal). Igualmente, también informaron de la ausencia 
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de respuestas inflamatorias tras exposición a la arcilla modificada. Estos últimos 
resultados coinciden con los revelados por Hsu y col. (2012), los cuales expusieron 
mediante inyección subcutánea a ratas Sprague-Dawley a Mt sin la obtención de 
respuestas inflamatorias en los tejidos. 
La Agencia Internacional de Investigación contra el Cáncer (IARC) ha evaluado  la 
sepiolita con el fin de clasificarla según su potencial carcinogénico, quedando 
finalmente situada en el Grupo 3 (no puede ser clasificado respecto a su 
carcinogenicidad para el ser humano), basado esto en la información tan limitada que 
hay acerca de la carcinogenicidad producida tras largos periodos de exposición en 
animales (IARC, 1997). 
Algunos autores justifican la ausencia de efectos tóxicos a la escasez de estudios 
sobre la exposición sistémica (Sharma y col., 2014). Sin embargo, Baek y col. (2012) no 
observaron toxicidad alguna incluso a concentraciones mucho más elevadas de las 
utilizadas normalmente, 1000mg/kg de peso corporal, informando que la arcilla puede 
ser absorbida en un periodo de 2h sin acumulación en ningún órgano específico. 
Para investigar la acumulación de minerales de arcilla realizamos la cuantificación 
del contenido de los metales estructurales característicos (Al, Ca, Fe, Mg y Si) en bazo 
de ratas expuestas a Clay1 y su extracto de migración, no obteniendo diferencias 
significativas con respecto el grupo control. En este sentido, se han encontrado 
resultados contradictorios en la literatura científica. Mascolo y col. (1999, 2004) 
observaron un aumento de la acumulación progresiva de los metales en la orina y 
diferentes tejidos de ratas en el siguiente orden: riñón> hígado> corazón> cerebro. 
Además, Reichardt y col. (2007) informaron que la caolinita se disocia en el lumen y 
que el Al pasa directamente a través de la barrera intestinal. En contraste, Sharma y col. 
(2014) no encontraron un aumento en el contenido de Al en el hígado y los riñones de 
las ratas expuestas por sonda a 1000mg/kg de peso corporal a C30B. La EFSA (2013) 
también consideró que la bentonita y sepiolita, de manera similar a otras arcillas, no son 
absorbidas en una medida cuantificable. 
Respecto a la evaluación toxicológica de materiales nanocompuestos, a parte de los 
resultados obtenidos en nuestro ensayo, no obteniendo diferencia alguna con respecto al 
control en los parámetros ensayados de ratas Wistar expuestas al extracto de migración 
de Clay1, solamente encontramos en bibliografía un trabajo disponible. Hsu y col. 
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(2012) publicaron el aumento de biocompatibilidad de un material nanocompuesto de 
de Mt/ quitosano con respecto al material de partida en un ensayo llevado a cabo con 
ratas Sprague-Dawley. 
 
3. ESTUDIOS DE GENOTOXICIDAD SOBRE ACEITES ESENCIALES Y 
COMPONENTES MAYORITARIOS 
Por todo lo expuesto a lo largo de este Tesis Doctoral, la evaluación toxicológica de 
materiales que van a entrar en contacto con alimentos es necesaria. El uso en el 
envasado de aceites esenciales y componentes mayoritarios es una tendencia en auge. 
En este caso, el aceite esencial de orégano y, más específicamente, sus componentes 
mayoritarios, timol y carvacrol, son un ejemplo de ello. Estudios sobre el riesgo de estos 
compuestos mayoritarios se han realizado con anterioridad, no siendo concluyentes los 
resultados obtenidos, sobre todo en el caso del carvacrol. En este sentido, son necesarias 
más evaluaciones para determinar los riesgos potenciales asociados a estos compuestos 
y su uso en la industria alimentaria. Por ello, nos propusimos a investigar el potencial 
genotóxico de timol y carvacrol mediante el ensayo de MN y el ensayo de linfoma de 
ratón (MLA), realizándose éste último por primera vez dada la inexistencia de 
resultados publicados al respecto en la literatura científica. Los datos obtenidos 
demostraron que el timol no dio lugar a una respuesta genotóxica mediante los ensayos 
de MN y el MLA con las concentraciones enyasadas, destinadas las mismas a ser 
incorporadas en el envasado de alimentos. Este hecho se ve reforzado por los resultados 
obtenidos por Llana-Ruíz-Cabello y col. (2014), los cuales mostraron ausencia de daño 
en el ADN mediante el ensayo cometa en células Caco-2 y una respuesta negativa en el 
test de Ames en cepas de Salmonella typhimurium bajo las condiciones ensayadas. 
Además, otros autores también coinciden con estos resultados, describiendo una 
respuesta no significativa por exposición de timol mediante el ensayo cometa en otras 
líneas celulares tales como Caco-2 (intestinales) o V79 (fibroblastos) (Horvathová y 
col., 2006; Undeger y col., 2009). Por el contario, nuestros resultados se contraponen a 
los publicados por Buyukleyla y Rencuzogullari (2009), quienes informaron del 
aumento significativo en la frecuencia de intercambios de cromátidas hermanas (SCE) e 
inducción de aberraciones cromosómicas y MN en linfocitos humanos a todas las 
concentraciones ensayadas (25-100 mg/ml). La ausencia de genotoxicidad observada 
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para timol en el presente trabajo se podría atribuir a sus propiedades antioxidantes 
ampliamente probadas (Aydin y col., 2005a; Slamenova y col., 2007; Buyukleyla y 
Rencuzogullari, 2009). 
En relación al carvacrol, éste exhibió un ligero potencial genotóxico en el ensayo 
de MN, en la concentración más alta ensayada (700 mM) en células L5178Y sin 
presencia de fracción metabólica externa, y, no se encontró ninguna respuesta 
significativa en el ensayo MLA después de 4 y 24h de exposición. Este resultado indica 
un riesgo genotóxico bajo, pudiendo ser considerado incluso como marginal y sin 
relevancia biológica. Podemos comparar nuestros resultados de MN con los 
previamente obtenidos por la prueba de Ames (con y sin S9) (Llana-Ruíz-Cabello y 
col., 2014). En este ensayo, carvacrol muestra una mayor actividad genotóxica en 
presencia de la fracción metabólica y a bajas concentraciones (29-460 M). Para resolver 
esta discrepancia entre ensayos, Kirkland y col. (2014) propone que las diferencias entre 
ambos ensayos, Ames y MN, podrían explicarse debido a las diferencias en el 
metabolismo de células bacterianas y de mamíferos. Estos autores propusieron que 1) 
las concentraciones de S9 que se usan en casa ensayo son diferentes; 2) la duración de la 
exposición es más larga en el test de Ames (72h) en comparación con las pruebas de 
células de mamíferos (3-6 h en el ensayo de MN); 3) el metabolismo intrínseco de las 
células bacterianas y de mamíferos puede producir diferentes perfiles metabólicos; y 4) 
la mezcla S9 favorece el metabolismo oxidativo, el cual las células de mamíferos son 
capaces de contrarrestar a través del metabolismo de fase II para promover la 
desintoxicación, mientras que las bacterias pueden ser menos capaces de defenderse 
contra este tipo de daño.  
Por otra parte, en bibliografía podemos encontrar una importante disparidad de 
los resultados obtenidos por carvacrol en diferentes modelos experimentales. Stammati 
y col. (1999) indicaron una ausencia de mutagenicidad de este monoterpeno mediante el 
Test de Ames, mientras que otros estudios informaron del potencial antimutagénico 
(Ipek y col., 2005). Por otro lado, Aydin y col. (2005a, b) informaron de una respuesta 
genotóxica positiva en linfocitos humanos mediante el ensayo cometa, mientras que 
otros autores han descrito la falta de genotoxicidad a través del mismo ensayo en líneas 
mamíferas tales como Caco-2, HepG2, V79 y N2a (Undeger y col., 2009; Aydin y col., 
2014). 
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 Los resultados obtenidos en la presente Tesis Doctoral serán de gran interés para 
el futuro empleo de las sustancias estudiadas, arcillas y componentes mayoritarios de 
aceites esenciales, en el envasado de alimentos salvaguardando la salud de los 
consumidores. 
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De los resultados obtenidos durante el desarrollo de la presente Tesis Doctoral se ha 
llegado a las siguientes conclusiones: 
PRIMERA. Los perfiles de toxicidad de los minerales de arcilla y nanocompuestos derivados 
se definen de acuerdo con diferentes parámetros, incluyendo (i) las condiciones de 
exposición, tales como las concentraciones o tiempos ensayados, (ii) los modelos 
experimentales seleccionados, (iii) los modificadores o agentes tensioactivos incorporados en 
sus estructuras y sus concentraciones, (iv) la sensibilidad de los ensayos realizados, etc. Por 
todo ellos se hace necesaria una evaluación toxicológica caso por caso. 
SEGUNDA. La evaluación in vitro en la línea celular de hepatoma humano (HepG2) 
expuesta a la arcilla no modificada, CNa
+
 y diversas arcillas organomodificadas con sales de 
amonio cuaternario (C30B, C20A, Clay1 y Clay2), dio lugar a diferentes respuestas según el 
material objeto de estudio ensayado tras 24 y 48h de exposición. De forma general, no se 
observó ningún efecto citotóxico tras la exposición a CNa
+
, aunque sí pudo observarse una 
respuesta positiva en el ensayo de MN. En el caso de C30B se obtuvo daño citotóxico 
acompañado además de alteración de la morfología celular, daño genotóxico mediante el 
ensayo cometa y disminución de contenido en GSH. La línea HepG2 expuesta a C20A y 
Clay1 presentó una ausencia de toxicidad de forma general; sin embargo, Clay2 produjo una 
disminución de la viabilidad celular, inducción de rotura de la hebra de ADN y genotoxicidad 
en el ensayo de MN, y, descenso en el contenido de GSH. 
TERCERA. Se ha demostrado por primera vez que concentraciones subcitotóxicas de CNa
+
, 
C30B, Clay1 y Clay2 modulan la expresión génica en células HepG2. Únicamente se 
observaron importantes desregulaciones en la expresión de genes implicados en la 
activación/destoxicación y diferentes mecanismos de acción, tales como respuesta al daño en 
el ADN y muerte celular, en el caso de CNa
+
 y Clay2. 
CUARTA. Se ha comprobado también el efecto tóxico de las arcillas CNa
+
, C30B, C20A, 
Clay1 y Clay2 en la línea de adenocarcinoma humano Caco-2, no obteniendo de forma 
general efectos citotóxicos y genotóxicos tras la exposición a CNa
+
 y Clay1. No obstante, 
tanto C30B como Clay2 mostraron un descenso en la viabilidad celular y daño morfológico 
(C30B), y en el caso de Clay2, un efecto genotóxico mediante el ensayo cometa. 
QUINTA. De forma similar, se encontró una baja respuesta tóxica en la línea celular 
endotelial de vena umbilical (HUVEC) tras la exposición por primera vez a CNa
+
 y Clay1, 
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aunque se observaron efectos citotóxicos tras la exposición a C30B y Clay2 en todos los 
biomarcadores ensayados tras 24 y 48h de exposición. 
SEXTA. La evaluación del potencial mutagénico mediante el Test de Ames de CNa
+
, C30B, 
Clay1 y Clay2 ha demostrado una ausencia de mutagenicidad en el caso de la arcilla no 
modificada y de Clay2. No obstante, Clay1 manifiesta un efecto tóxico notable, presentando 
respuesta mutagénica en presencia de activación metabólica en una de las cepas ensayadas, 
TA102. Del mismo modo, C30B presentó un aumento en las colonias revertientes de la cepa 
TA98 de Salmonella typhimurium, también en presencia de la fracción metabólica S9. 
SÉPTIMA. Se ha demostrado la ausencia de efectos citotóxicos en las líneas HepG2 y Caco-
2 tras la exposición a extractos de migración obtenidos a partir de PLA con Clay1 y PLA con 
Clay2. Además, la ausencia de potencial mutagénico en S. typhimurium también fue 
observada tras la exposición a ambos extractos. Por otro lado,  no se constató migración de los 
metales mayoritarios presentes en la estructura de las arcillas (Al, Ca, Fe, Mg, Si) en ambos 
extractos. 
OCTAVA. Tras la realización de un ensayo de toxicidad subcrónica durante 90 días en ratas 
Wistar expuestas a Clay1 (40 mg/kg/día), se ha comprobado la ausencia de daño 
hitopatológico en diversos órganos (hígado, riñón, intestino, corazón, cerebro, pulmones, 
testículos y bazo), así como alteraciones en la bioquímica clínica, liberación de interleucina-6 
y ratio GSH/GSSG. Además, fueron estudiados en hígado y riñón los niveles de LPO (MDA), 
la actividad de las enzimas antioxidantes SOD, CAT, GPx y GST, y, la expresión génica y 
abundancia proteica de SOD y CAT. Únicamente se observaron cambios significativos en la 
actividad antioxidante, expresión génica y abundancia proteica de CAT en riñón.   
NOVENA. Ratas Wistar expuestas durante 90 días al extracto de PLA-Clay1 como agua de 
bebida no mostraron ningún tipo de alteración en todos los parámetros considerados en el 
estudio, incluyendo: análisis histopatológico, liberación de IL-6, biomarcadores de estrés 
oxidativo (GSH/GSSG, LPO, CAT, SOD, GPx, GST), análisis de expresión génica y 
abundancia proteica de SOD y CAT. Además, se evaluó el contenido de Al, Ca, Fe, Mg y Si 
en bazo de ratas expuestas a Clay1 y su extracto de migración, no observándose cambios 
significativos. 
DÉCIMA. Los resultados preliminares demuestran que el desarrollo de tres arcillas 
modificadas con silanos, Clay3, Clay4A y Clay4B, ha resultado ser exitoso dada la presencia 
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de los modificadores en la estructura de la arcilla, constatado mediante espectroscopía 
infrarroja (FTIR), difracción de rayos X y termogravimetría (TGA). Además, se analizó la 
migración de Al, Ca, Fe, Mg y Si en simulantes en contacto con PP-Clay3 y PP-Clay4B 
(etanol al 10% e isooctano). Se obtuvieron diferencias significativas con respecto al control y 
Clay3 en Ca, Mg y Si en el caso de etanol al 10%, y, de Si en el caso de isooctano. Los 
extractos de migración de Clay4A presentaron diferencias en Al y Ca en etanol al 10% y, Ca 
y Mg en isooctano. Los envases de PP-Clay3 mejoraron la vida útil de los alimentos (carne) 
en 24h. 
UNDÉCIMA. Los resultados preliminares sugieren que Clay3 no induce descenso en la 
viabilidad de las células HepG2 y Caco-2. Sin embargo, tras la exposición de Clay4A se 
observaron efectos citotóxicos en las líneas hepática e intestinal, además de un incremento en 
la producción de ERO en ambas líneas celulares. Por otro lado, Clay4B es la arcilla que peor 
perfil toxicológico presenta de las tres sintetizadas. Dicha arcilla ha dado lugar a un descenso 
en la viabilidad celular, potencial genotóxico mediante el ensayo cometa y disminución del 
contenido de GSH en las líneas celulares ya mencionadas. Sólo se observó un incremento de 
ERO en el caso de HepG2 tras exposición a Clay4B. En cuanto al potencial mutagénico, fue 
la única que presentó una respuesta positiva, obteniéndose índices mutagénicos superiores a 2 
en el caso de TA102 en ausencia y presencia de S9. 
DUODÉCIMA. Se ha demostrado tras la revisión bibliográfica la disparidad de los resultados 
publicados hasta el momento sobre el efecto antioxidante y antimicrobiano de los aceites 
esenciales y componentes mayoritarios incorporados a envases, pudiendo ser debido a: (i) 
factores inherentes de los aceites esenciales, (ii) películas plásticas, (iii) condiciones 
ensayadas, (iv) tiempos de exposición, etc. En este sentido, es necesario establecer un rango 
de concentraciones de uso apropiado con el fin de asegurar la salud de los consumidores. 
DÉCIMOTERCERA. Se ha investigado el potencial genotóxico de timol y carvacrol, 
componentes mayoritarios del aceite esencial de orégano, mediante el ensayo de MN y el 
ensayo de Linfoma de Ratón. Se ha observado a las condiciones ensayadas la ausencia de 
potencial genotóxico de timol, sin embargo, carvacrol presentó diferencias significativas con 
respecto al control en la concentración más alta ensayada únicamente en el ensayo de MN. 
Teniendo en cuenta la información previa obtenida acerca de carvacrol en otros ensayos de 
genotoxicidad, incluidos los observados en el ensayo de linfoma de ratón, podrían 
considerarse los resultados genotóxicos obtenidos biológicamente no relevantes.  
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The main conclusions that can be drawn on the basis of the obtained results in the 
present Thesis are: 
FIRST. The toxicity profiles of clay minerals and derived nanocomposites are defined 
according to different parameters, including (i) exposure conditions such as time or 
concentrationstested , (ii) the selected experimental models, (iii) modifiers or surfactants 
incorporated in their structures and their concentrations,(iv) the sensitivity of the tests 
performed, etc. For all these aspects a case by case toxicological assessment is necessary.  
SECOND. The in vitro evaluation in human hepatoma cell line (HepG2) exposed to the 
unmodified clay, CNa
+
 and several quaternary ammonium salts-modified clays (C30B, C20A, 
Clay1 and Clay2), gave different results depending on the material under study tested after 24 
and 48h exposure. In general, no cytotoxic effects after exposure to CNa
+
 were observed, 
although a positive response in the MN test was observed. Regarding to C30B, cytotoxic 
damage, alteration in cell morphology, genotoxic damage studied by the comet assay and 
decrease in GSH content were observed. HepG2 cell line exposed to C20A and Clay1 
generally presented an absence of toxicity; however, Clay2 produced a cell viability decrease, 
induction of DNA strand breaks and genotoxicity observed by the comet and MN assays, 
respectively, and decrease in GSH content. 
THIRD. For first time, the modulation of gene expression after subcytotoxic concentrations 
of CNa
+
, C30B, Clay1 and Clay2 have been demonstrated. Important deregulations in the 
expression of genes involved in the activation/detoxification and different mechanisms of 
action, such as response to DNA damage and cell death, were only observed in the case of 
CNa
+
 and Clay2. 
FORTH. The toxic effects of the adenocarcinoma Caco-2 cell line exposed to the CNa
+
, 
C30B, C20A, Clay1 and Clay2 were showed. In general, cytotoxic and genotoxic effects after 
exposure of CNa
+
, C20A and Clay1 were not obtained. However, C30B and Clay2 induced a 
decrease in cell viability and morphological damage (C30B), and genotoxicity by comet assay 
in the case of Clay2.  
FIFTH. Similarly, a low toxic response in human umbilical vein endothelial cells (HUVEC) 
exposed to CNa
+
 and Clay1 was found, although cytotoxic effects after C30B and Clay2 
exposure in all the biomarkers tested after 24 and 48h were observed. 
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SIXTH. The mutagenic potential of CNa
+
, C30B, Clay1 and Clay2 has been evaluated by the 
Ames Test, being demonstrated a lack of mutagenicity with the non modified clay an Clay2; 
however, Clay1 showed a remarkable toxic effect, presenting mutagenic response in the 
strains tested (TA102) in the presence of metabolic activation. Similarly, C30B produced an 
increase in revertant colonies of Salmonella typhimurium strain TA98, also in the presence of 
S9 metabolic fraction. 
SEVENTH. The absence of cytotoxic effects in HepG2 and Caco-2 cell lines exposed to the 
migration extracts obtained from PLA-Clay1 and PLA-Clay2 has been showed. Moreover, the 
lack of mutagenic potential in S. typhimurium after exposure to both extracts was also 
observed. Furthermore, no migration of the major metal present in the structure of the clay 
(Al, Ca, Fe, Mg, Si) was found in both extracts. 
EIGHTH. Once the repeated dose 90-day oral toxicity study in Wistar rats exposed to Clay1 
(40mg/kg/day) has been conducted, absence of histopathological damage in several organs 
(liver, kidney, intestine, heart, brain, lungs, testicles and spleen) was observed, as well as, no 
changes in clinical biochemistry, interleukin-6 release and alterations in GSH/GSSG ratio. 
Additionally, levels of LPO (MDA), activities of antioxidant enzymes SOD, CAT, GPx and 
GST, gene expression and protein abundance of SOD and CAT in liver and kidney were 
determined. Only significant changes in CAT antioxidant activity in kidney, as well as, gene 
expression and protein abundance, were demonstrated. 
NINTH. Wistar rats exposed to PLA-Clay1 migration extract by drinking water during 90 
days did not show any alterations in all the parameters considered, including: 
histopathological analysis, IL-6 leackage, oxidative stress biomarkers (GSH/GSSG, LPO, 
CAT, SOD, GPx, GST), gene expression analysis and protein abundance of SOD and CAT. 
Moreover, the migration content of Al, Ca, Fe, Mg and Si in the spleen of rats exposed to 
Clay1 and its migration extract was determined and no significance differences were 
observed. 
TENTH. Preliminary results showed a successful development of three silane-modified clays 
due to the presence of modifier in clays structure, evaluated by: infrared spectroscopy (FTIR), 
X-ray diffraction and thermogravimetry (TGA). Furthermore, migration of Al, Ca, Fe, Mg 
and Si was analyzed in PP-Clay3 and PP-Clay4 simulants (ethanol 10% and isooctane). 
Significant differences between from control Clay3 were obtained in Ca, Mg and Si in the 
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case of ethanol 10%, and in Si with the isooctane simulant. Clay4A migration extracts 
presented significant changes in Al and Ca with ethanol 10% and, in Ca and Mg with 
isooctane. PP-Clay3 packages showed an improved of food shelf-life (meat) of 24h. 
ELEVENTH. Preliminary results suggest no induction in cell viability decrease produced by 
Clay3 in HepG2 and Caco-2 cells. However, cytotoxic effects and an increase in ROS 
generation in both cell lines after Clay4A exposure were obtained. Clay4B is the clay with the 
worst toxicological profile, giving a cell viability decrease, genotoxicity by the comet assay 
and GSH content depletion in the above mentioned cell lines. An increase in ROS was only 
observed in HepG2 exposed to Clay4B. Moreover, a positive mutagenic potential was 
determined with Clay4B, obtaining mutagenic indexes higher than 2 in TA102 strain in 
absence and presence of S9. 
TWELFTH. A disparity of the results published about the antioxidant and antimicrobial 
properties presented in active packaging obtained from essential oils and main compounds, as 
well as, their cytotoxic effects in human cell lines were found. They could be due to: (i) 
different factors inherent to the essential oils, (ii) the film, (iii) the conditions assayed, (iv) 
exposure times, etc. In this sense, it is important to establish an appropriate concentration 
range for their uses, based on toxicity studies, to ensure the safety of the consumers.  
THIRTEENTH. Genotoxic potential has been investigated of thymol and carvacrol, two 
main compounds of oregano essential oil, by the MN and mouse lymphoma assays. An 
absence of genotoxic potential of thymol under the conditions tested was demonstrated; 
however, significant differences from the control at the highest concentration assayed with 
carvacrol in MN test were presented. Taking into account the previous information about 
carvacrol genotoxicity observed through other tests, including mouse lymphoma assay, the 
results obtained could be considered not relevant biologically. 
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RIESGOS DERIVADOS DEL EMPLEO DE NANOARCILLAS EN EL 
ENVASADO DE ALIMENTOS 
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Área de Toxicología, Facultad de Farmacia, Universidad de Sevilla. C/ Profesor García 
González nº 2, C.P. 41012, Sevilla, España. 
 
Resumen 
La industria del envasado alimentario, para lograr ser cada día más competitiva e 
ir consiguiendo avances que les ofrezcan beneficios, está apostando por nuevos 
materiales que incorporados a los polímeros permitan incrementar la vida útil de los 
alimentos. Entre estos materiales se encuentran las arcillas organomodificadas con sales 
de amonio cuaternario, las cuales una vez imbuidas en el film de envasado adquieren 
una conformación en plaquetas de grosor nanométrico dando lugar a un material 
nanocompuesto. El objetivo de este trabajo es realizar una revisión de la evaluación 
toxicológica de estas nanoarcillas, las ya disponibles comercialmente y las que están 
desarrollándose en la actualidad, relacionándolas con el posible efecto que podrían tener 
en un futuro si el consumidor estuviese en contacto con ellas. Esta revisión se estructura 
en dos grandes bloques, por un lado los estudios in vitro llevados a cabo, subdivididos 
en ensayos de citotoxicidad, genotoxicidad y estrés oxidativo, así como los resultados 
obtenidos hasta el momento. Y, por otro lado, los estudios in vivo, claramente 
diferenciados en estudios a corto y largo plazo, obteniéndose a partir de ellos 
conclusiones muy diversas. 
 
Abstract 
The food packaging industry, in order to become more competitive and get new 
advances and benefits, is focused in the development of novel materials, which 
incorporated into the polymers allow to increase the shelf-life of food products. Among 
these materials the organomodified clays with quaternary ammonium salts show the 
major potential. When these clays are imbued in the packaging film, they are dispersed 
as platelets of nanometric size, giving a resultant material known as nanocomposite. 
The aim of this paper is to review the toxicological evaluation of these nanoclays, those 
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commercially available and those that are under development, identifying the potential 
effects they can induce if consumers in the future get in contact with them. This review 
is divided into two blocks, first, in vitro studies, subdivided into cytotoxicity, 
genotoxicity and oxidative stress assays, and the results obtained so far. On the other 
hand, in vivo studies, clearly differentiated in short and long term assays, obtaining 
from them very different conclusions. 
 
Palabras clave: nanoarcillas, envases, toxicidad, in vitro, in vivo  
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1. Introducción 
Los plásticos han reemplazado en el envasado de alimentos a los materiales 
usados más convencionalmente (el vidrio, la cerámica, el metal, el papel y el cartón) 
debido a su funcionalidad, peso ligero, bajo precio y la facilidad a la hora de ser 
procesados (Majeed y col., 2013). Sin embargo, no todo son ventajas, estos polímeros 
presentan una alta permeabilidad a gases y vapores, limitándose su uso para 
determinados alimentos (Arora y col., 2010). Debido a la debilidad que presentan, en 
los últimos años se han desarrollado unos nuevos polímeros conocidos como polímeros 
nancocompuestos (PNCs). Estos plásticos han sido diseñados con el fin de mejorar las 
deficiencias del material madre, añadiendo en su desarrollo materiales que hagan 
posible, entre otras cosas, un material menos permeable. Los PNCs más prometedores 
son aquellos compuestos por polímeros orgánicos y arcillas minerales inorgánicas. 
Entre las arcillas más utilizadas como nanorelleno se encuentra la montmorillonita 
(MMT) (Duncan y col., 2011), un hidroxisilicato de magnesio y aluminio. Esta arcilla 
presenta una estructura laminar de un grosor nanométrico (Chen y col., 2003) una vez 
incorporada al polímero, de ahí que el material resultante tome el nombre de material 
nanocompuesto. La MMT, comercialmente conocida como Cloisite®Na
+
 (CNa
+
), está 
compuesta por dos láminas tetraédricas formadas por silicio (Si) y oxígeno (O) acoplada 
a una lámina octaédrica formada por átomos de magnesio (Mg) y aluminio (Al) unidos 
a O y grupos hidroxilo (OH) (Jordá-Beneyto y col., 2008) (Fig. 1). Además, entre otras 
características, la MMT presenta una elevada área superficial y un amplio ratio tamaño-
superficie, haciendo que sea un efectivo relleno de refuerzo (De Azeredo y col., 2009). 
También se caracteriza por una alta resistencia y rigidez, considerándose los materiales 
obtenidos como rígidos e impermeables (Majeed y col., 2013). 
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Figura 1. Estructura de la MMT (T, lámina tetraédrica; O, lámina octaédrica; C, cationes intercalados; d, 
distancia interlaminar) (Lagaly y col., 2005). 
Un inconveniente importante relacionado con el desarrollo de materiales 
nanocompuestos mediante el uso de filosilicatos es la intercalación de las cadenas de la 
matriz polimérica entre las láminas de arcilla. La exfoliación de estas láminas de arcillas 
tiene un papel crucial, así como una uniforme dispersión, siendo esencial para un mejor 
refuerzo de los materiales nanocompuestos. Varios grupos de investigación han 
estudiado el efecto de la organofilización de los silicatos laminares, concluyendo que la 
energía superficial de las arcillas no tratadas, como es el caso de la MMT, es muy 
elevada, por lo que las fuerzas que mantienen unidas las láminas que la componen son 
muy fuertes (Kádar y col., 2006). Hay determinados agentes, como los tensioactivos, 
que incorporados a la arcilla dan lugar a una reducción de la energía superficial, siendo 
directamente proporcional al aumento en la separación de las láminas. Teniendo en 
cuenta la hidrofilia que presentan estas arcillas, frente a la hidrofobia de la mayoría de 
los polímeros, para que se dé una buena exfoliación debe llevarse a cabo una 
modificación química superficial, consiguiendo de esta forma un mejor resultado. Éste 
mayor rendimiento puede ser conseguido fácilmente por el intercambio de cationes de la 
superficie hidrófila de la arcilla (Na
+
, K
+
) con cationes orgánicos, como sales de amonio 
cuaternario. Ésta última modificación es la más común llevada a cabo con la MMT, 
tratada con alcaliamonios (Pavlidou y Papaspyrides., 2008). La figura 2 muestra la 
estructura química de algunas sales de amonio cuaternario utilizadas para la 
modificación de la MMT. La incorporación a la arcilla de estos modificadores da lugar 
a un descenso de la energía superficial entre las láminas del hidrosilicato, así como un 
refuerzo de la afinidad entre el polímero y la arcilla (Ráquez y col., 2013). 
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Figura2. Estructura química de organomodificadores: (a) metil, 2bis-hidroxietil, amonio cuaternario (b) 
dimetil, benzyl, hidrogenado amonio cuaternario (c) octadecilamina. 
Una vez incorporadas las arcillas modificadas a los polímeros, deben presentar 
una buena exfoliación de las láminas, una distribución homogénea y estar orientadas en 
la dirección correcta constituyendo una fase continua. Finalmente se obtendrán unos 
polímeros nanocompuestos destinados a reducir la permeabilidad de los gases, como 
oxígeno y dióxido de carbono, vapores orgánicos y humedad, siendo la principal 
debilidad que presentan los polímeros convencionales (Silvestre y col., 2011). Muchos 
estudios han demostrado que los polímeros nanocompuestos de arcilla pueden retardar 
la migración de aditivos potencialmente dañinos del envase al alimento. En general, las 
plaquetas de arcillas son impermeables y la incorporación en la matriz polimérica da 
lugar a un paso tortuoso para una difusión lenta a través del material nanocompuesto 
(Fig. 3).  
 
Figura 3. Difusión de una molécula permeable a través de (a) Film polimérico (b) Film nanocompuesto 
con una disposición exfoliada de las plaquetas impermeables de arcilla (Duncan, 2011). 
En definitiva, la incorporación de arcillas a polímeros y la obtención de materiales 
nancompuestos van a suponer dentro de la industria alimentaria un campo en continuo 
Permeabilidad Permeabilidad 
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desarrollo, ya que supondría, a nivel industrial, una mejora destacada que conlleva 
ahorro en costes y pérdidas de productos. 
En cuanto al aspecto tecnológico, es amplia la información disponible sobre estos 
nuevos materiales, por qué características destacan y cuál es el fin de los mismos. Sin 
embargo, en cuanto al riesgo del empleo de las arcillas como materiales de refuerzo en 
plásticos destinados a la industria alimentaria, la información es más escasa. 
Debido al amplio espectro de aplicaciones que tienen estas arcillas 
organomodificadas, el consumidor cada vez va a estar más expuesto a ellas. Hasta el 
momento, la vía inhalatoria era la principal vía de entrada para que se produjesen 
intoxicaciones por arcillas minerales (Carretero y col., 2006). Sin embargo, al estar 
presente estas arcillas en materiales de envasado, la vía de entrada más común en la 
actualidad es la oral, pudiendo presentarse migración de las mismas desde el material de 
envasado hasta el alimento En la bibliografía existen estudios llevados a cabo tanto in 
vitro como in vivo, siendo los primeros más numerosos, centrados en arcillas 
provenientes de la MMT, ya sea la propia arcilla inicial o bien arcillas modificadas con 
las sales de amonio cuaternario anteriormente citadas. En dichos estudios se evalúan 
determinados marcadores que reflejan el efecto que pueden tener sobre el organismo, 
así como los posibles mecanismos de acción para dar lugar al efecto tóxico.  
A continuación, se presenta una exhaustiva revisión de los resultados en materia de 
evaluación toxicológica publicados hasta el momento por distintos grupos de 
investigación, distinguiendo entre ensayos in vitro e in vivo. 
 
2. Evaluación toxicológica in vitro 
Los métodos in vitro proporcionan un medio efectivo y rápido para la selección 
(screnning) y clasificación de compuestos, además de ser ética y moralmente más 
correctos que los ensayos in vivo. Entre otras ventajas destacan que el uso de animales 
es considerablemente menor, e incluso nulo en muchas ocasiones, se utiliza material 
muy homogéneo obtenido con técnicas estandarizadas, posibilitan el uso de material de 
origen humano, lo que se puede simplificar por extrapolación, son más fácilmente 
objetivables y cuantificables que los ensayos in vivo y los resultados presentan mayor 
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reproducibilidad. A todo ello se le une un menor coste, mayor rapidez e instalaciones 
menos complejas.  
Son varios los indicadores de toxicidad que se pueden determinar con los métodos in 
vitro, entre los que destacan los valorados en la bibliografía y que a continuación se 
exponen. 
 
 
2.1. Ensayos de Citotoxicidad  
Seleccionadas las líneas celulares de trabajo, los ensayos de citotoxicidad son los 
llevados a cabo en primera instancia para valorar los efectos adversos o interferencias 
con estructuras y/o propiedades esenciales para la supervivencia, proliferación y/o 
función celular una vez que se les ha expuesto el compuesto objeto de estudio. 
Diversos grupos han evaluado mediante diferentes biomarcadores de citotoxicidad 
la alteración funcional producida por exposición de diferentes líneas celulares a dichas 
arcillas organomodificadas. El grupo de investigación de Li y col., 2010, estudió la 
citotoxicidad en una línea celular ovárica de hámster (CHO) expuesta a nanoláminas de 
silicato (NSP) de MMT. Los biomarcadores evaluados fueron el ensayo de viabilidad 
MTT (de acuerdo con las instrucciones del fabricante), que evalúa la capacidad 
mitocondrial para reducir el Bromuro de 3-(4,5-dimetiltiazol-2-ilo)-2,5-difeniltetrazol 
(MTT), comprobando la funcionalidad mitocondrial tras la exposición al compuesto. 
Además, se estudió la liberación de la enzima Lactato Deshidrogenasa (LDH) para 
evaluar el daño en la membrana celular. Las células fueron expuestas a diferentes 
concentraciones de NSP (62,5; 125; 250; 500; 1000 µg/mL) durante 3, 12 y 24h. Ambos 
biomarcadores mostraron que los efectos tóxicos más evidentes aparecieron a la 
concentración y tiempo más altos ensayados, reduciéndose la viabilidad en un 40%, sin 
embargo en concentraciones y tiempos más bajos se mantenía aún un 70% de viabilidad 
celular. Del mismo modo, otros autores evaluaron la citotoxicidad de la arcilla 
comercial sin modificar, CNa+. Baek et al., 2012, evaluó mediante los mismos 
biomarcadores la citotoxicidad de la línea celular intestinal INT-407 expuesta a la 
arcilla (0- 1000 µg/mL) durante 24, 48 y 72h. Mediante el ensayo MTT se observó una 
inhibición de la proliferación celular después de los tres tiempos de exposición y de 
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forma creciente en torno a los 100µg/mL, sin embargo se aprecia un aumento de LDH 
únicamente en la concentración más alta ensayada después de 48 y 72h.  
Además de la arcilla comercial CNa+, existen otras arcillas modificadas 
disponibles comercialmente, como es el caso de Cloisite®30B (C30B), Cloisite®93A 
(C93A), Cloisite®20A (C20A), entre otras. De las mismas también se han llevado a 
cabo una evaluación toxicológica así como estudios de comparación entre unas arcillas 
y otras. Sharma y col., 2010, evaluaron mediante el ensayo Azul Trypan (Binderup y 
col., 2002) la proliferación celular de la línea intestinal de adenocarcinoma de colon 
Caco-2 expuesta a nueve concentraciones de CNa+ y C30B (0- 226 µg/mL) durante 
24h. En el caso de CNa+, no se obtuvieron diferencias significativas con respecto al 
control en ninguno de los casos estudiados, mientras que tras la exposición a C30B no 
filtrada se observa un 40% de citotoxicidad en la concentración más alta ensayada, 
eliminando esta concentración para futuros ensayos. En el caso de C30B filtrada se 
obtuvieron niveles citotóxicos menores según el biomarcador utilizado. Otros autores, 
más recientemente, han evaluado las mismas arcillas en la misma línea celular. 
Maisanaba y col., 2013a, expusieron Caco-2 a CNa+ (0- 250 µg/mL) y C30B (0- 125 
µg/mL), determinando las concentraciones de exposición según su límite de dispersión 
en el medio, durante 24 y 48 h. En este caso se evaluaron tres biomarcadores como son 
el ensayo de Rojo Neutro (RN) (Borenfreud y Puerner., 1984) (Fig. 4) para evaluar el 
daño lisosomal, la capacidad de reducción de la sal de tetrazolio MTS (MTS) (Baltrop y 
col., 1991) y la proliferación celular y contenido proteico total (PT) mediante el método 
de Bradford (1976). En el caso de Caco-2 expuesta a CNa+ se observaron diferencias 
significativas con respecto al control en la concentración y tiempo más altos ensayados 
en el caso del biomarcador MTS, coincidiendo con los resultados de los autores 
nombrados anteriormente. Sin embargo, con C30B los tres biomarcadores proporcionan 
evidencias de citotoxicidad por exposición de la misma. En el caso del ensayo de PT, 
tras 24 horas de exposición se aprecian diferencias con respecto al control desde 
concentraciones medias ensayadas (31,25 µg/mL), sin embargo, esta citotoxicidad es 
más pronunciada tras 48h donde a partir de 15,65 µg/mL se observaron diferencias 
significativas con respecto al grupo control. Algo similar ocurre en el ensayo de RN, 
donde se aprecia un descenso de la viabilidad desde 62,5 y 31,25 µg/mL de exposición 
tras 24 y 48h, respectivamente. En la misma línea se ensayó un tercer biomarcador, 
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MTS, observándose tras 24h un descenso de la viabilidad a partir de 62,5 µg/mL y un 
descenso dependiente de concentración tras las 48 horas de exposición. El biomarcador 
más sensible en dicho estudio resultó ser PT, con una concentración efectiva media 
(CE50) de 40 µg/mL. En este caso, se obtuvieron efectos citotóxicos a concentraciones 
más bajas comparados con los resultados que hasta el momento había en la bibliografía.  
También existen estudios llevados a cabo en otras líneas celulares que cabe 
destacar, con las arcillas comerciales ya comentadas. El efecto citotóxico de CNa+ 
también se ha evaluado en la línea celular HepG2, junto con la exposición a esta misma 
línea de C93A (Lordan y col., 2011). La línea celular fue expuesta a diferentes 
concentraciones que iban desde 1 a 1000 µg/mL, valorándose los biomarcadores MTT y 
liberación de la LDH tras 24h. En el caso del primer biomarcador mencionado se 
aprecian diferencias significativas en el rango completo de concentraciones ensayadas, 
siendo más acusado en la más alta, pudiéndose observar un 23 y 37% de reducción en la 
viabilidad y alteración mitocondrial tras la exposición de CNa+ y C93A, 
respectivamente. Respecto a la liberación de LDH, la línea celular HepG2 expuesta a 
CNa+ presentó un leve pero significativo incremento en las concentraciones de 50, 100 
y 500µg/mL, mientras que a la concentración más alta ensayada no se observaron 
cambios de la LDH comparado con el grupo control. Sin embargo, no ocurrió lo mismo 
en el caso de C93A, donde se mostró una liberación de la enzima mucho más 
pronunciada, con una significación de p<0,01, desde 50-1000 µg/mL. En esta misma 
línea celular, Maisanaba y col., 2013b evaluó la citotoxicidad de CNa+ y C30B. El 
tiempo de exposición fue de 24 y 48h y el rango de concentraciones ensayadas para este 
caso fue para CNa+ de 0-62,5 µg/mL y para C30B de 0-500 µg/mL. Los resultados 
obtenidos por exposición de HepG2 a CNa+ teniendo en cuenta los mismos 
biomarcadores que en el caso de la línea Caco-2, mostraron que no se producía un 
descenso en la viabilidad en ninguno de los biomarcadores estudiados. Sin embargo, 
tras la exposición a C30B la línea celular sí presentó alteraciones. En el caso de PT, se 
observó tras 24h de ensayo cambios con respecto al grupo control en las dos 
concentraciones más altas ensayadas (250 y 500 µg/mL), mientras que después de 48h 
estas diferencias aparecen en las tres últimas concentraciones (125-500 µg/mL). El 
biomarcador RN coincidió en efecto en los tiempos ensayados, donde se observaron 
alteraciones de 62,5 a 500µg/mL en ambos periodos. Y por último, MTS denotó 
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diferencias en las tres concentraciones más elevadas tras 24h y de 62,5 a 500 µg/mL 
después de 48h de ensayo. En tal caso, la CE50 calculada fue 88µg/mL, siendo el 
biomarcador RN el más sensible. 
 
Figura 4. Vista al microscopio óptico (40x) de la captación lisosomal de Rojo Neutro de diferentes líneas 
celulares. 
Además de todas las arcillas que hoy por hoy hay disponibles comercialmente, 
también encontramos algunas que se encuentran en fase de desarrollo y evaluación, 
como es el caso de Clay1 y Clay2. Ambas arcillas han sido desarrolladas en el Instituto 
Tecnológico del Embalaje, Transporte y Logística de Valencia (ITENE). Previamente al 
lanzamiento comercial se ha evaluado su potencial toxicólogico, estudio que se recoge 
en el trabajo publicado por Houtman y col., 2013, en el cual no sólo se evalúan estas 
dos arcillas sino también la ya comercial antes mencionada C20A. 
En el caso de la evaluación de la citotoxicidad de C20A (0-62,5µg/mL) y Clay1 
(0-8 µg/mL) no se observó una reducción en la viabilidad celular en ninguna de las 
líneas celulares, Caco-2 y HepG2, tiempos (24 y 48h) y concentraciones ensayadas. Por 
otro lado, sí es importante mencionar el efecto que causó Clay2 sobre las dos líneas 
seleccionadas. Las concentraciones ensayadas oscilaron en un rango de 0 a 125µg/mL y 
los biomarcadores ensayados fueron PT y MTS durante 24 y 48h de exposición. Para 
Caco2 se observó en el biomarcador PT un descenso en la viabilidad dependiente del 
tiempo y la concentración de exposición, sin embargo HepG2 presentó únicamente 
diferencias a 24h a 125µg/mL y a 48h en las dos últimas concentraciones. Respecto al 
segundo biomarcador, la línea celular Caco2 presentó diferencias significativas con 
respecto al control en las dos concentraciones más altas ensayadas después de 24h, 
presentándose aún una reducción de la actividad mitocondrial más significativa a las 
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48h, donde se aprecian cambios desde concentraciones medias (30µg/mL). En el caso 
de HepG2, ésta resulto ser de nuevo menos sensible que la anterior, observándose 
alteraciones en la concentración más alta tras 24h y desde 40µg/mL a 48h. En el caso de 
las CE50 halladas para cada una de las líneas, se obtuvieron 34 µg/mL para Caco-2 y 88 
µg/mL para HepG2. 
En resumen, cada arcilla, puede presentar un perfil toxicológico diferente 
teniendo en cuenta las líneas celulares expuestas, tiempos ensayados y concentraciones 
de exposición, obteniendo de tal forma una amplia diversidad en los resultados. 
 
2.2. Ensayos de Genotoxicidad 
Según la Autoridad Europea de Seguridad Alimentaria (EFSA, 2011), los ensayos 
de genotoxicidad son un requisito indispensable a llevar a cabo en la evaluación de 
toxicidad previa a la aprobación y comercialización de un compuesto destinado a entrar 
en contacto con alimentos. Los ensayos de genotoxicidad están diseñados para detectar 
compuestos que inducen directa o indirectamente daño en el material genético por 
diferentes mecanismos. Generalmente se considera que este daño es esencial para 
producir efectos heredables o para mediar las distintas etapas de formación de tumores. 
Existe una amplia gama de  ensayos de genotoxicidad, entre ellos los más comunes para 
evaluar el potencial genotóxico de las arcillas son: 
 Ensayo Cometa (o Single Cell Gel Electroforesis Assay): mediante una 
electroforesis se puede saber el daño en el núcleo celular que ha ejercido el 
compuesto objeto de estudio. Puede ser aplicado a cualquier línea celular y 
permite el análisis del daño genético a nivel de células individuales, 
observándose la desintegración de la hebra de ADN (Fig.5a) 
 Test de Ames: considerado también como test de mutagenicidad. Salmonella 
Typhimurium his
-
 es expuesta a las diferentes concentraciones del compuesto 
tóxico en un medio his
-
. Se comprueba el crecimiento de diferentes cepas 
después de la exposición del tóxico, evaluando si se ha producido el 
crecimiento de la misma por alteración en el material genético, revirtiendo así la 
mutación que presenta (Fig.5b). 
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 Micronúcleos (MN): Los MN se producen por irregularidades en el proceso de 
división celular, generándose estas estructuras derivadas del núcleo, más 
pequeñas y que pueden contener o bien cromosomas enteros o bien fragmentos 
cromosómicos derivados de roturas no reparadas (Fig. 5c). 
 
Figura 5. Visualización del resultado del Ensayo Cometa (a), Test de Ames (b) y Micronúcleos (c).  
Es posible encontrar en la bibliografía científica diversos ensayos de 
genotoxicidad llevados a cabo con arcillas modificadas. Li y col., 2010, evaluaron la 
genotoxicidad en la línea CHO de NSP mediante los tres ensayos nombrados 
anteriormente, el ensayo Cometa, el Test de Ames y MN. En ninguno de los tres 
ensayos se observaron daños a las concentraciones ensayadas, concluyendo la ausencia 
de genotoxicidad y mutagenicidad del compuesto. 
Respecto a arcillas comerciales, Sharma y col., 2010, evaluó el potencial 
genotóxico sobre Caco-2 de C30B, filtrada y no filtrada, mediante el ensayo Cometa, y 
el potencial mutagénico mediante el Test de Ames. Los resultados observados con el 
primer ensayo y C30B mostraron que la arcilla tanto no filtrada como filtrada resulta ser 
genotóxica sobre la línea celular dependiente de la concentración de exposición, 
presentándose las diferencias significativas más claras en las dos concentraciones más 
elevadas ensayadas, 113 y 170µg/mL. Otros autores también evaluaron el potencial 
genotóxico de C30B en Caco-2 y HepG2 mediante el ensayo Cometa (Maisanaba y col., 
2013a, Maisanaba y col., 2013b). Caco-2 no presentó diferencias con el control en las 
concentraciones ensayadas (10, 20, 40µg/mL) a ningún tiempo de exposición (24y 48h), 
mientras que C30B resultó ser genotóxica para HepG2 a la concentración más alta 
ensayada, 88µg/mL, tras 48h de exposición. 
En el caso de Clay2, ésta causó daño en el material genético de las células Caco-
2 a la concentración más alta ensayada después de 24 y 48h de exposición, en el ensayo 
Cometa. Por otro lado, HepG2 presentó daños después de 24h expuesta a la CE50 antes 
mencionada, y a 48h desde la CE50/2 (Houtman y col., 2013). 
a
) 
b
) 
c
) 
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2.3. Ensayos de Estrés oxidativo 
La producción de formas activas de oxígeno es tóxica para los organismos y un 
exceso de las mismas da lugar a lo que se conoce como estrés oxidativo. La estructura 
electrónica del oxígeno hace que sea susceptible de reducciones parciales, dando lugar a 
especies reactivas de oxígeno (EROs). Las EROs se producen normalmente en las 
células como producto del metabolismo celular. La concentración de EROS está 
controlada por acción de los antioxidantes. Si un agente estresante induce un aumento 
en la producción de EROs, este equilibrio puede romperse causándose daños en las 
estructuras celulares. Los daños serán reparados por mecanismos celulares específicos. 
Si no se recupera el equilibrio se producirán disfunciones que pueden desembocar en la 
muerte celular.  
Los autores hasta ahora mencionados han valorado también el estrés oxidativo 
como posible mecanismo de acción tóxica de las arcillas sobre las líneas celulares de 
estudio. Baek y col., 2012 evaluaron la posible producción de EROs en la línea INT-
407. Obtuvieron diferencias significativas a una concentración aproximada de 50µg/mL 
después de 48 y 72h de tratamiento, mientras que a la concentración más alta ensayada 
fue únicamente donde se observó daño oxidativo con respecto al control en todos los 
tiempo ensayados. En el caso de CNa+ y C30B, Sharma y col., 2010 no encontraron 
daño oxidativo en Caco-2 en el rango de concentraciones ensayadas, con lo que 
determinaron que la genotoxicidad que producía C30B no era mediada por la 
producción de EROs. Sin embargo, estos últimos resultados contrastan con los 
encontrados por Maisanaba y col., 2013a, donde observaron tanto un aumento en la 
producción de EROs y diferencias en el contenido de glutatión (GSH) a 40µg/mL a 
ambos tiempos de exposición y al más alto ensayado, respectivamente. 
Por otro lado, en los ensayos realizados con HepG2 expuesta a CNa+ y C93A se 
observó producción de EROs en el caso de CNa+ a partir de 50µg/mL en los tres 
tiempos ensayados por estos autores, mientras que los resultados obtenidos por 
exposición a C93A fueron más variables. Se mostró una producción de daño oxidativo 
en la concentración de 50µg/mL a las 24h del ensayo, y a las dos concentraciones 
superiores a ésta a 16 y 24h de exposición. Sin embargo, llama la atención la ausencia 
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de producción de EROs a la concentración más alta ensayada (Lordan y col., 2011). 
Estos autores sugieren a partir de los resultados obtenidos que el incremento de la 
generación de EROs está asociado con la citotoxicidad y el daño en la membrana celular 
inducido por ambas arcillas. Maisanaba y col., 2013b, no observaron diferencias con 
respecto al control en la producción de EROs por exposición de HepG2 a CNa+, aunque 
sí con el contenido en GSH, donde observaron alteraciones en el rango de 
concentraciones ensayadas. 
Por último, los ensayos llevados a cabo por Houtman et al., 2013, para dilucidar 
si se producía daño oxidativo en Caco-2 y HepG2 por exposición a Clay 2, resultaron 
ser negativos en producción de EROs y GSH para Caco-2 en las tres concentraciones de 
tratamiento, mientras que para HepG2 coincidía la ausencia de EROs pero no la de 
GSH, mostrándose diferencias con respecto al control en todas las concentraciones de 
exposición.  
 
3. Ensayos de toxicidad in vivo 
In vivo se refiere a experimentación hecha dentro o en el tejido vivo de un 
organismo vivo. Los ensayos llevados a cabo in vivo presentan aquellas ventajas que 
para los in vitro son carencias. Éstos dan una información más completa de lo que 
ocurre en el organismo cuando se encuentra expuesto a cualquier xenobiótico objeto de 
estudio, proporcionando datos extrapolables al ser humano y pudiendo detectar efectos 
secundarios. Son métodos validados formalmente y son los que comúnmente se llevan a 
cabo para los ensayos clínicos y registro de nuevos fármacos. 
Los ensayos in vivo llevados a cabo con arcillas son más escasos que los 
publicados  in vitro, y la mayoría se centran en cortos periodos de exposición. A 
continuación se presenta una breve revisión de lo que actualmente se puede encontrar en 
la literatura científica. 
 
 
 
498 
 
 
3.1. Efectos a corto plazo 
Autores ya mencionados en este capítulo han llevado a cabo estudios de 
toxicidad oral evaluando diferentes parámetros tras  exponer a los roedores a 
concentraciones mucho más elevadas que las usadas  in vitro. Li y col., 2010, diseñaron 
un experimento con cuatro grupos bien diferenciados de ratas, administrándole a cada 
uno una dosis única de NSP (0, 1500, 3000 y 5700 mg/mL) disuelta en agua destilada. 
Los animales fueron observados durante 14 días, no produciéndose mortalidad por 
exposición de ninguna de las dosis, ni tampoco aparición de signos clínicos ni cambios 
macroscópicos notables con respecto al grupo control. No hubo pérdidas de peso ni 
diferencias en el consumo de comida entre los grupos experimentales. Por otro lado, 
Baek y col., 2012, llevaron a cabo a rasgos generales el mismo ensayo que los autores 
anteriores pero con MMT pura y cuatro dosis diferentes (5, 50, 300 y 1000 mg/mL). 
Los resultados obtenidos coincidieron con Li y col., 2010, no observando ninguna 
anormalidad ni pérdida de peso en los animales durante el periodo de tratamiento. 
Mascolo y col., 2004 realizaron un estudio en ratas centrado en la ingestión y 
distribución de arcillas en los diferentes órganos. Los animales estuvieron expuestos 
durante tres días a una dosis de 450 mg/mL de arcillas y a las 72h de la administración 
fueron sacrificados y procedieron a evaluar los diferentes tejidos. No se observaron 
efectos macroscópicos, aunque sí un aumento de la concentración de los elementos traza 
en varios órganos: riñón > hígado > corazón > cerebro. La captación de las arcillas 
estaba directamente correlacionada con la composición de las mismas dando lugar a un 
apreciable incremento en determinados órganos, incluso siendo destacable los 
elementos traza. Estos autores concluyeron que la salud de los consumidores podría 
verse comprometida. 
También se han llevado a cabo estudios del efecto protector de la MMT, como 
es el caso de Abbès y col., 2007. En este estudio evalúan la capacidad de la arcilla de 
captar cadmio (Cd), un destacado elemento que puede causar múltiples alteraciones en 
el organismo. Entre otros parámetros evaluaron marcadores bioquímicos del suero 
sanguíneo, observando en los animales tratados con MMT (tres grupos: 400,600 y 800 
mg/kg) diferencias con respecto al grupo control que estaba expuesto directamente a 
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CdCl2. Los animales expuestos a CdCl2 revelaron un incremento de los niveles en 
sangre de transaminasas (ALT, AST) y de LDH, y un significativo descenso de los 
niveles de creatinina, creatinkinasa (CK), triglicéridos y proteínas totales. Sin embargo, 
en los animales tratados con la arcilla se apreció una restauración de los niveles 
sanguíneos normales en ratas de ALT, AST y LDH comparado con el grupo control y 
una mejora de CK y creatinina. 
 
3.2. Efectos a largo plazo 
La escasez de ensayos de toxicidad subcrónica con arcillas modificadas es 
manifiesta en la bibliografía científica, a pesar de que, tal y como se ha comentado, el 
escenario de exposición humana más probable se corresponde con ingestas bajas y 
prolongadas en el tiempo. Hasta el momento podemos encontrar los llevados a cabo por 
Maisanaba y col., 2013c,d. 
En el primero mencionado, Maisanaba y col., 2013c, se lleva a cabo un ensayo de 90 
días con ratas Wistar expuestas a una dosis de 40mg/kg de Clay1, considerando la 
misma como escenario de peor exposición humana. Se evaluaron diferentes parámetros 
como fueron: la histopatología de nueve órganos (cerebro, corazón, pulmón, hígado, 
intestino, bazo, riñón y testículos), marcadores bioquímicos del suero sanguíneo 
(glucosa, urea, creatinina, PT, albúmina, colesterol, AST, ALT, fosfatasa alcalina, Na y 
K), la liberación de IL-6 y el ratio en sangre de GSH/ GSSG. En ninguno de los 
parámetros evaluados durante el estudio se experimentó una alteración significativa en 
ratas expuestas a Clay1 comparadas con el grupo control. 
El mismo grupo evaluó la peroxidación lipídica (LPO) y la actividad de las enzimas 
antioxidantes Superóxido Dismutada (SOD) y Catalasa (CAT) en bazo de ratas 
expuestas a Clay1 (Maisanaba y col., 2013d). Los resultados obtenidos mostraron que 
no se produjeron diferencias con respecto al grupo control en ninguno de los tres 
parámetros evaluados.  
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4. Conclusión 
A lo largo de esta revisión se han mostrado las diferentes alternativas que se 
presentan para poder evaluar la toxicidad de estos nuevos materiales incorporados al 
envasado en la industria alimentaria, las nanoarcillas. De los ensayos in vitro realizados 
hasta el momento, se puede concluir que el efecto que produzcan en este caso las 
nanoarcillas va a variar enormemente según la línea celular seleccionada y a la arcilla a 
la que se exponga (es decir, al modificador que contengan), los biomarcadores y 
tiempos ensayados, así como de las concentraciones seleccionadas para el tratamiento. 
Respecto a los ensayos in vivo, los escasos estudios existentes parecen indicar un bajo 
riesgo tóxico por exposición a estas sustancias. No obstante, serían necesarios más 
estudios para confirmar su seguridad.  
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